index,smiles,predicted_label,probability,confidence,SMILES,Name,Source_File,Mol_Index,Catalog_NO,Alternative_Names,CAS,Target,Pathway,Formula,Concentration,ResearchArea,ClinicalInformation,SMILES_cleaned,cleaning_status,Max_Similarity
5230,O=S1(=O)CCN(Cc2cc(NC3CCOCC3)c3[nH]c(-c4ccccc4)cc3c2)CC1,1,0.9940040707588196,0.9940040707588196,O=S1(CCN(CC1)CC2=CC3=C(C(NC4CCOCC4)=C2)NC(C5=CC=CC=C5)=C3)=O,NecroX-7,Data.sdf,6158,HY-124750,,1120332-55-9,Interleukin Related; Reactive Oxygen Species; TNF Receptor; Toll-like Receptor (TLR),Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?oB,C24H29N3O3S,10mM,Inflammation/Immunology; Cardiovascular Disease,No Development Reported,O=S1(=O)CCN(Cc2cc(NC3CCOCC3)c3[nH]c(-c4ccccc4)cc3c2)CC1,清洗成功,0.2921348314606741
7517,Cc1c(N(C(=O)c2cc(-c3cc(Cl)ccc3C(=O)N3Cc4ccccc4C[C@H]3CN3CCOCC3)n(C)c2C)c2ccc(O)cc2)cc(C#N)n1C,1,0.9935277104377747,0.9935277104377747,O=C(C1=C(C)N(C)C(C2=C(C=CC(Cl)=C2)C(N3[C@@H](CC4=CC=CC=C4C3)CN5CCOCC5)=O)=C1)N(C6=CC=C(C=C6)O)C7=C(C)N(C)C(C#N)=C7,S65487,Data.sdf,8893,HY-138697,VOB560,1644600-79-2,Apoptosis; Bcl-2 Family,Apoptosis,C41H41ClN6O4,10mM,Cancer,Phase 2,Cc1c(N(C(=O)c2cc(-c3cc(Cl)ccc3C(=O)N3Cc4ccccc4C[C@H]3CN3CCOCC3)n(C)c2C)c2ccc(O)cc2)cc(C#N)n1C,清洗成功,0.224
7518,Cc1c(N(C(=O)c2cc(-c3cc(Cl)ccc3C(=O)N3Cc4ccccc4C[C@H]3CN3CCOCC3)n(C)c2C)c2ccc(O)cc2)cc(C#N)n1C,1,0.9935277104377747,0.9935277104377747,O=C(C1=C(C)N(C)C(C2=C(C=CC(Cl)=C2)C(N3[C@@H](CC4=CC=CC=C4C3)CN5CCOCC5)=O)=C1)N(C6=CC=C(C=C6)O)C7=C(C)N(C)C(C#N)=C7.O=S(O)(O)=O,S65487 (sulfate),Data.sdf,8894,HY-138697A,VOB560 (sulfate),2416937-01-2,Apoptosis; Bcl-2 Family,Apoptosis,C41H43ClN6O8S,10mM,Cancer,Phase 2,Cc1c(N(C(=O)c2cc(-c3cc(Cl)ccc3C(=O)N3Cc4ccccc4C[C@H]3CN3CCOCC3)n(C)c2C)c2ccc(O)cc2)cc(C#N)n1C,清洗成功,0.2170542635658914
7519,Cc1c(N(C(=O)c2cc(-c3cc(Cl)ccc3C(=O)N3Cc4ccccc4C[C@H]3CN3CCOCC3)n(C)c2C)c2ccc(O)cc2)cc(C#N)n1C,1,0.9935277104377747,0.9935277104377747,O=C(C1=C(C)N(C)C(C2=C(C=CC(Cl)=C2)C(N3[C@@H](CC4=CC=CC=C4C3)CN5CCOCC5)=O)=C1)N(C6=CC=C(C=C6)O)C7=C(C)N(C)C(C#N)=C7.[H]Cl,S65487 (hydrochloride),Data.sdf,8895,HY-138697B,VOB560 (hydrochloride),1644543-95-2,Apoptosis; Bcl-2 Family,Apoptosis,C41H42Cl2N6O4,10mM,Cancer,Phase 2,Cc1c(N(C(=O)c2cc(-c3cc(Cl)ccc3C(=O)N3Cc4ccccc4C[C@H]3CN3CCOCC3)n(C)c2C)c2ccc(O)cc2)cc(C#N)n1C,清洗成功,0.2222222222222222
3983,O=C(c1cc(-c2cc3c(cc2C(=O)N2Cc4ccccc4C[C@H]2CN2CCOCC2)OCO3)n2c1CCCC2)N(c1ccccc1)c1ccc(O)cc1,1,0.9933236241340637,0.9933236241340637,O=C(C1=C2CCCCN2C(C3=C(C(N4CC5=C(C=CC=C5)C[C@H]4CN6CCOCC6)=O)C=C(OCO7)C7=C3)=C1)N(C8=CC=C(O)C=C8)C9=CC=CC=C9,S55746,Data.sdf,4679,HY-117288,BCL201,1448584-12-0,Bcl-2 Family,Apoptosis,C43H42N4O6,10mM,Cancer,Phase 1,O=C(c1cc(-c2cc3c(cc2C(=O)N2Cc4ccccc4C[C@H]2CN2CCOCC2)OCO3)n2c1CCCC2)N(c1ccccc1)c1ccc(O)cc1,清洗成功,0.217391304347826
3984,O=C(c1cc(-c2cc3c(cc2C(=O)N2Cc4ccccc4C[C@H]2CN2CCOCC2)OCO3)n2c1CCCC2)N(c1ccccc1)c1ccc(O)cc1,1,0.9933236241340637,0.9933236241340637,O=C(C1=C2CCCCN2C(C3=C(C(N4CC5=C(C=CC=C5)C[C@H]4CN6CCOCC6)=O)C=C(OCO7)C7=C3)=C1)N(C8=CC=C(O)C=C8)C9=CC=CC=C9.Cl,S55746 (hydrochloride),Data.sdf,4680,HY-117288A,BCL201 (hydrochloride),1448525-91-4,Bcl-2 Family,Apoptosis,C43H43ClN4O6,10mM,Cancer,Phase 1,O=C(c1cc(-c2cc3c(cc2C(=O)N2Cc4ccccc4C[C@H]2CN2CCOCC2)OCO3)n2c1CCCC2)N(c1ccccc1)c1ccc(O)cc1,清洗成功,0.2155172413793103
5563,CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1,1,0.9933085441589355,0.9933085441589355,O=C(NC1=NNC2=C1C=C(CC3=CC(F)=CC(F)=C3)C=C2)C4=C(NC5CCOCC5)C=C(N6CCN(C)CC6)C=C4,Entrectinib,Data.sdf,6568,HY-12678,NMS-E628; RXDX-101,1108743-60-7,Anaplastic lymphoma kinase (ALK); Autophagy; ROS Kinase; Trk Receptor,Autophagy; Neuronal Signaling; Protein Tyrosine Kinase/RTK,C31H34F2N6O2,10mM,Cancer,Launched,CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1,清洗成功,0.3265306122448979
5821,C[C@@H](C(=O)N(C)c1ccc2cc(-c3n[nH]c4c3CCC(C)(C)C4)[nH]c2c1)N1CCOCC1,1,0.9932938814163208,0.9932938814163208,CC1(CC2=C(C(C3=CC4=CC=C(N(C)C([C@@H](N5CCOCC5)C)=O)C=C4N3)=NN2)CC1)C,ITK inhibitor 2,Data.sdf,6885,HY-128726,,1309784-09-5,Itk,Protein Tyrosine Kinase/RTK,C25H33N5O2,10mM,Inflammation/Immunology,No Development Reported,C[C@@H](C(=O)N(C)c1ccc2cc(-c3n[nH]c4c3CCC(C)(C)C4)[nH]c2c1)N1CCOCC1,清洗成功,0.2358490566037736
1500,O=S1(=O)CCN(Cc2cc(NCC3CCOCC3)c3[nH]c(-c4ccccc4)cc3c2)CC1,1,0.9932618737220764,0.9932618737220764,O=S1(CCN(CC2=CC3=C(NC(C4=CC=CC=C4)=C3)C(NCC5CCOCC5)=C2)CC1)=O.CS(=O)(O)=O.CS(=O)(O)=O,NecroX-5,Data.sdf,1766,HY-104015,,1383718-29-3,Calcium Channel,Membrane Transporter/Ion Channel; Neuronal Signaling,C27H39N3O9S3,10mM,Cancer; Inflammation/Immunology,No Development Reported,O=S1(=O)CCN(Cc2cc(NCC3CCOCC3)c3[nH]c(-c4ccccc4)cc3c2)CC1,清洗成功,0.28125
1535,O=C(NCCN1CCOCC1)c1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)ccnc2[nH]1,1,0.9931567311286926,0.9931567311286926,O=C(NC1=CC=C(C=C1)F)C2(CC2)C(NC3=CC=C(C=C3)OC4=C5C(NC(C(NCCN6CCOCC6)=O)=C5)=NC=C4)=O,Tyrosine kinase inhibitor,Data.sdf,1809,HY-10421,,1021950-26-4,c-Met/HGFR,Protein Tyrosine Kinase/RTK,C31H31FN6O5,10mM,Cancer,No Development Reported,O=C(NCCN1CCOCC1)c1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)ccnc2[nH]1,清洗成功,0.2924528301886792
1644,O=C(N[C@H]1CN2CCC1CC2)c1cc2ccoc2cn1,1,0.9930737018585205,0.9930737018585205,O=C(C1=CC2=C(OC=C2)C=N1)N[C@H]3CN4CCC3CC4,PHA-543613,Data.sdf,1943,HY-105670,,478149-53-0,nAChR,Membrane Transporter/Ion Channel; Neuronal Signaling,C15H17N3O2,10mM,Neurological Disease,No Development Reported,O=C(N[C@H]1CN2CCC1CC2)c1cc2ccoc2cn1,清洗成功,0.282051282051282
12319,N=C(N)c1cc2ccc(OC(=O)c3cccs3)cc2s1,1,0.9929178357124329,0.9929178357124329,N=C(C1=CC2=CC=C(OC(C3=CC=CS3)=O)C=C2S1)N.O=S(O)(C)=O,BCX 1470 (methanesulfonate),Data.sdf,14576,HY-50875,,217099-44-0,Complement System,Immunology/Inflammation,C15H14N2O5S3,10mM,Inflammation/Immunology,No Development Reported,N=C(N)c1cc2ccc(OC(=O)c3cccs3)cc2s1,清洗成功,0.288135593220339
4882,Oc1cc(O)cc(-c2cc3ccc(O)cc3o2)c1,1,0.99285489320755,0.99285489320755,OC1=CC(C2=CC3=CC=C(O)C=C3O2)=CC(O)=C1,Moracin M,Data.sdf,5748,HY-122942,,56317-21-6,Autophagy; Endogenous Metabolite; NF-?oB; Phosphodiesterase (PDE),Autophagy; Metabolic Enzyme/Protease; NF-?oB,C14H10O4,10mM,Inflammation/Immunology,No Development Reported,Oc1cc(O)cc(-c2cc3ccc(O)cc3o2)c1,清洗成功,0.3181818181818182
4429,O=C(NO)c1ccc(CNC(=O)c2[nH]c(-c3ccc(O)cc3)cc2-c2ccoc2)cc1,1,0.9928391575813293,0.9928391575813293,O=C(C1=C(C2=COC=C2)C=C(C3=CC=C(O)C=C3)N1)NCC4=CC=C(C(NO)=O)C=C4.O=C(O)C(F)(F)F,QTX125 (TFA),Data.sdf,5218,HY-120448A,,2989537-78-0,Apoptosis; HDAC,Apoptosis; Cell Cycle/DNA Damage; Epigenetics,C25H20F3N3O7,10mM,Cancer,No Development Reported,O=C(NO)c1ccc(CNC(=O)c2[nH]c(-c3ccc(O)cc3)cc2-c2ccoc2)cc1,清洗成功,0.3043478260869565
852,N#Cc1c2nc3ccccc3nc2n2ccc(NC(=O)c3cccs3)cc12,1,0.9928340911865234,0.9928340911865234,O=C(C1=CC=CS1)NC2=CC3=C(C#N)C4=NC5=CC=CC=C5N=C4N3C=C2,HI-TOPK-032,Data.sdf,976,HY-101550,,487020-03-1,TOPK,Cell Cycle/DNA Damage,C20H11N5OS,2mM,Cancer,No Development Reported,N#Cc1c2nc3ccccc3nc2n2ccc(NC(=O)c3cccs3)cc12,清洗成功,0.2916666666666667
4120,CN1CCN(C(=O)c2[nH]c3ccc([N+](=O)[O-])cc3c2-c2ccccc2)CC1,1,0.9927299618721008,0.9927299618721008,O=C(C(NC1=C2C=C([N+]([O-])=O)C=C1)=C2C3=CC=CC=C3)N4CCN(CC4)C,MJN228,Data.sdf,4843,HY-118319,,459168-97-9,Liposome,Metabolic Enzyme/Protease,C20H20N4O3,10mM,Metabolic Disease,No Development Reported,CN1CCN(C(=O)c2[nH]c3ccc([N+](=O)[O-])cc3c2-c2ccccc2)CC1,清洗成功,0.3225806451612903
8128,O=C(NCC1CCNCC1)c1cc2ccc(-c3ccoc3)cc2[nH]1,1,0.9926896691322327,0.9926896691322327,O=C(C1=CC2=CC=C(C=C2N1)C3=COC=C3)NCC4CCNCC4,NS2B/NS3-IN-3,Data.sdf,9598,HY-144644,,2832876-90-9,Flavivirus; Virus Protease,Anti-infection,C19H21N3O2,10mM,Infection,No Development Reported,O=C(NCC1CCNCC1)c1cc2ccc(-c3ccoc3)cc2[nH]1,清洗成功,0.3333333333333333
8129,O=C(NCC1CCNCC1)c1cc2ccc(-c3ccoc3)cc2[nH]1,1,0.9926896691322327,0.9926896691322327,O=C(C1=CC2=CC=C(C=C2N1)C3=COC=C3)NCC4CCNCC4.[H]Cl,NS2B/NS3-IN-3 (hydrochloride),Data.sdf,9599,HY-144644A,,2832876-91-0,Flavivirus; Virus Protease,Anti-infection,C19H22ClN3O2,10mM,Infection,No Development Reported,O=C(NCC1CCNCC1)c1cc2ccc(-c3ccoc3)cc2[nH]1,清洗成功,0.3297872340425531
399,CC(=O)N1CCc2c(c(Nc3ccc(-c4cnn(C)c4)cc3F)nn2[C@H]2CCOC2)C1,1,0.992672860622406,0.992672860622406,CC(N1CCC2=C(C(NC3=C(F)C=C(C4=CN(C)N=C4)C=C3)=NN2[C@@H]5COCC5)C1)=O,GNE-272,Data.sdf,453,HY-100726,,1936428-93-1,Epigenetic Reader Domain; Histone Acetyltransferase,Epigenetics,C22H25FN6O2,10mM,Cancer,No Development Reported,CC(=O)N1CCc2c(c(Nc3ccc(-c4cnn(C)c4)cc3F)nn2[C@H]2CCOC2)C1,清洗成功,0.3146067415730337
3748,O=C1Nc2ccc(C(=O)c3ccco3)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1,1,0.9925939440727234,0.9925939440727234,O=C1NC2=C(C=C(C(C3=CC=CO3)=O)C=C2)/C1=C/C4=CC(Cl)=C(O)C(Cl)=C4,GW406108X,Data.sdf,4413,HY-115570,GW108X,1644443-92-4,Autophagy; Kinesin; ULK,Autophagy; Cell Cycle/DNA Damage; Cytoskeleton,C20H11Cl2NO4,10mM,Cancer,No Development Reported,O=C1Nc2ccc(C(=O)c3ccco3)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1,清洗成功,0.296875
11974,COc1ccc2[nH]c(C(=O)N3CCC(CC(C)(C)O)CC3)cc2c1,1,0.9925500154495239,0.9925500154495239,O=C(N1CCC(CC(C)(O)C)CC1)C(N2)=CC3=C2C=CC(OC)=C3,ASP-9521,Data.sdf,14162,HY-19903,,1126084-37-4,17?2-HSD,Metabolic Enzyme/Protease,C19H26N2O3,10mM,Cancer,Phase 2,COc1ccc2[nH]c(C(=O)N3CCC(CC(C)(C)O)CC3)cc2c1,清洗成功,0.2698412698412698
3949,Cn1nccc1-c1ccc(Sc2cccc(C3(C(N)=O)CCOCC3)c2)cc1,1,0.9925222992897034,0.9925222992897034,O=C(C1(C2=CC=CC(SC3=CC=C(C4=CC=NN4C)C=C3)=C2)CCOCC1)N,PF-4191834,Data.sdf,4640,HY-117048,PF-04191834,1029317-21-2,Lipoxygenase,Metabolic Enzyme/Protease,C22H23N3O2S,10mM,Inflammation/Immunology,Phase 2,Cn1nccc1-c1ccc(Sc2cccc(C3(C(N)=O)CCOCC3)c2)cc1,清洗成功,0.2528735632183908
3924,CNC(=O)c1c(-c2ccc(O)cc2)oc2ccc(O)c(CN3CCCCC3)c12,1,0.9925217032432556,0.9925217032432556,O=C(C1=C(C2=CC=C(O)C=C2)OC3=CC=C(O)C(CN4CCCCC4)=C13)NC,TAM-16,Data.sdf,4610,HY-116838,,2030241-59-7,Bacterial,Anti-infection,C22H24N2O4,10mM,Infection,No Development Reported,CNC(=O)c1c(-c2ccc(O)cc2)oc2ccc(O)c(CN3CCCCC3)c12,清洗成功,0.2738095238095238
11142,CN1CCN(c2ccc(-c3cccc(CN4CCOCC4)c3)cc2NC(=O)c2c[nH]c(=O)cc2C(F)(F)F)CC1,1,0.992493748664856,0.992493748664856,O=C(C1=CNC(C=C1C(F)(F)F)=O)NC2=CC(C3=CC(CN4CCOCC4)=CC=C3)=CC=C2N5CCN(C)CC5,OICR-9429,Data.sdf,13197,HY-16993,,1801787-56-3,Apoptosis; WDR5,Apoptosis; Epigenetics,C29H32F3N5O3,10mM,Cancer,No Development Reported,CN1CCN(c2ccc(-c3cccc(CN4CCOCC4)c3)cc2NC(=O)c2c[nH]c(=O)cc2C(F)(F)F)CC1,清洗成功,0.3469387755102041
5658,Oc1cc(-c2[nH]c(-c3ccccc3)nc2-c2ccncc2)ccc1Cl,1,0.992464542388916,0.992464542388916,OC1=CC(C2=C(C3=CC=NC=C3)N=C(C4=CC=CC=C4)N2)=CC=C1Cl,L-779450,Data.sdf,6675,HY-12787,,303727-31-3,Autophagy; Raf,Autophagy; MAPK/ERK Pathway,C20H14ClN3O,10mM,Cancer,No Development Reported,Oc1cc(-c2[nH]c(-c3ccccc3)nc2-c2ccncc2)ccc1Cl,清洗成功,0.3454545454545454
12001,Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1,1,0.9923999309539795,0.9923999309539795,O=C(C1=C(N)N(C2=CC=C3N=C(C)NC3=C2)N=C1)C(N4)=CC5=C4C=CC=C5,Zoligratinib,Data.sdf,14191,HY-19957,Debio 1347; CH5183284,1265229-25-1,FGFR,Protein Tyrosine Kinase/RTK,C20H16N6O,10mM,Cancer,Phase 2,Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1,清洗成功,0.296875
9769,O=C(N[C@H]1CN2CCC1CC2)c1cc2cccc(Cl)c2s1,1,0.9923838973045349,0.9923838973045349,O=C(C1=CC2=C(C(Cl)=CC=C2)S1)N[C@H]3CN4CCC3CC4.[H]Cl,Encenicline hydrochloride,Data.sdf,11545,HY-15430A,EVP-6124 (hydrochloride),550999-74-1,nAChR,Membrane Transporter/Ion Channel; Neuronal Signaling,C16H18Cl2N2OS,10mM,Neurological Disease,Phase 3,O=C(N[C@H]1CN2CCC1CC2)c1cc2cccc(Cl)c2s1,清洗成功,0.2676056338028169
8341,Nc1c(C(=O)OCC2CCCO2)c2nc3ccccc3nc2n1-c1ccc2c(c1)OCCO2,1,0.9923818707466125,0.9923818707466125,O=C(C1=C(N)N(C2=CC=C3OCCOC3=C2)C4=C1N=C5C=CC=CC5=N4)OCC6OCCC6,EP2 receptor antagonist-1,Data.sdf,9839,HY-145684,,848920-08-1,Prostaglandin Receptor,GPCR/G Protein,C24H22N4O5,10mM,Inflammation/Immunology,No Development Reported,Nc1c(C(=O)OCC2CCCO2)c2nc3ccccc3nc2n1-c1ccc2c(c1)OCCO2,清洗成功,0.2823529411764706
8884,O=C(O)/C=C/c1cc(-c2ccc3c(c2)OCO3)c(-c2ccc3c(c2)OCO3)o1,1,0.992323637008667,0.992323637008667,O=C(O)/C=C/C1=CC(C2=CC=C(OCO3)C3=C2)=C(C4=CC=C(OCO5)C5=C4)O1,OSM-SMI-10B,Data.sdf,10480,HY-148692,,,STAT,JAK/STAT Signaling; Stem Cell/Wnt,C21H14O7,10mM,Cancer,No Development Reported,O=C(O)/C=C/c1cc(-c2ccc3c(c2)OCO3)c(-c2ccc3c(c2)OCO3)o1,清洗成功,0.2982456140350877
2536,CC1(C)CCC(NC(=O)c2cc3c(F)cc(F)cc3[nH]2)CC1,1,0.9922987818717957,0.9922987818717957,O=C(C(N1)=CC2=C1C=C(F)C=C2F)NC3CCC(C)(C)CC3,NITD-349,Data.sdf,2974,HY-109588,,1473450-62-2,Bacterial,Anti-infection,C17H20F2N2O,10mM,Infection,No Development Reported,CC1(C)CCC(NC(=O)c2cc3c(F)cc(F)cc3[nH]2)CC1,清洗成功,0.2535211267605634
10922,Oc1cccc(-c2c3nc(c(-c4cccc(O)c4)c4ccc([nH]4)c(-c4cccc(O)c4)c4nc(c(-c5cccc(O)c5)c5ccc2[nH]5)CC4)C=C3)c1,1,0.9922828078269958,0.9922828078269958,OC1=CC=CC(/C2=C3CCC(/C(C4=CC(O)=CC=C4)=C5C=C/C(N/5)=C(C6=CC(O)=CC=C6)/C(C=C/7)=NC7=C(C8=CC(O)=CC=C8)/C9=CC=C2N9)=N\3)=C1,Temoporfin,Data.sdf,12944,HY-16488,m-THPC; KW2345,122341-38-2,Reactive Oxygen Species,Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?oB,C44H32N4O4,10mM,Cancer,Launched,Oc1cccc(-c2c3nc(c(-c4cccc(O)c4)c4ccc([nH]4)c(-c4cccc(O)c4)c4nc(c(-c5cccc(O)c5)c5ccc2[nH]5)CC4)C=C3)c1,清洗成功,0.35
2674,Oc1ccc(-c2cc3ccc(O)cc3s2)cc1,1,0.9922722578048706,0.9922722578048706,OC1=CC=C(C=C(C2=CC=C(O)C=C2)S3)C3=C1,Estrogen receptor modulator 1,Data.sdf,3138,HY-110201,,63676-22-2,Estrogen Receptor/ERR,Vitamin D Related/Nuclear Receptor,C14H10O2S,10mM,Cancer,No Development Reported,Oc1ccc(-c2cc3ccc(O)cc3s2)cc1,清洗成功,0.35
5987,CNCCN(C)Cc1c[nH]nc1-c1ccc(O[C@H]2C[C@H](OCCC3CCOCC3)C2)cc1,1,0.9922584891319275,0.9922584891319275,CNCCN(C)CC1=CNN=C1C2=CC=C(O[C@H]3C[C@H](OCCC4CCOCC4)C3)C=C2,EPZ020411,Data.sdf,7085,HY-12970,,1700663-41-7,Apoptosis; Histone Methyltransferase,Apoptosis; Epigenetics,C25H38N4O3,10mM,Cancer,No Development Reported,CNCCN(C)Cc1c[nH]nc1-c1ccc(O[C@H]2C[C@H](OCCC3CCOCC3)C2)cc1,清洗成功,0.2371134020618556
5990,CNCCN(C)Cc1c[nH]nc1-c1ccc(O[C@H]2C[C@H](OCCC3CCOCC3)C2)cc1,1,0.9922584891319275,0.9922584891319275,CNCCN(C)CC1=CNN=C1C2=CC=C(O[C@H]3C[C@H](OCCC4CCOCC4)C3)C=C2.Cl[H],EPZ020411 (hydrochloride),Data.sdf,7088,HY-12970A,,2070015-25-5,Apoptosis; Histone Methyltransferase,Apoptosis; Epigenetics,C25H39ClN4O3,10mM,Cancer,No Development Reported,CNCCN(C)Cc1c[nH]nc1-c1ccc(O[C@H]2C[C@H](OCCC3CCOCC3)C2)cc1,清洗成功,0.2346938775510204
2198,O=C(Nc1ccc(Cl)cc1)C1CCCN(C(=O)c2cccc(-c3ccco3)c2)C1,1,0.9922277331352234,0.9922277331352234,O=C(C1CN(C(C2=CC=CC(C3=CC=CO3)=C2)=O)CCC1)NC4=CC=C(Cl)C=C4,CCG-203971,Data.sdf,2579,HY-108361,,1443437-74-8,Ras,GPCR/G Protein; MAPK/ERK Pathway,C23H21ClN2O3,10mM,Inflammation/Immunology; Cancer,No Development Reported,O=C(Nc1ccc(Cl)cc1)C1CCCN(C(=O)c2cccc(-c3ccco3)c2)C1,清洗成功,0.275
15356,COc1c(-c2ccccc2)oc2c(ccc3occc32)c1=O,1,0.9922020435333252,0.9922020435333252,O=C1C2=CC=C(OC=C3)C3=C2OC(C4=CC=CC=C4)=C1OC,Karanjin,Data.sdf,18288,HY-N2534,,521-88-0,AMPK; Apoptosis; Cytochrome P450; NF-?oB; Phosphatase,Apoptosis; Epigenetics; Metabolic Enzyme/Protease; NF-?oB; PI3K/Akt/mTOR,C18H12O4,10mM,Cancer; Endocrinology; Metabolic Disease; Inflammation/Immunology; Neurological Disease,No Development Reported,COc1c(-c2ccccc2)oc2c(ccc3occc32)c1=O,清洗成功,0.3148148148148148
14694,O=C(O)[C@H]1O[C@@H](Oc2cc3oc(-c4ccc(O)cc4)cc(=O)c3c(O)c2O)[C@H](O)[C@@H](O)[C@@H]1O,1,0.992201566696167,0.992201566696167,O=C(C=C(C1=CC=C(O)C=C1)OC2=CC(O[C@@H]([C@@H]([C@@H](O)[C@@H]3O)O)O[C@@H]3C(O)=O)=C4O)C2=C4O,Scutellarin,Data.sdf,17406,HY-N0751,,27740-01-8,Akt; HIV; STAT,Anti-infection; JAK/STAT Signaling; PI3K/Akt/mTOR; Stem Cell/Wnt,C21H18O12,10mM,Cancer; Infection,No Development Reported,O=C(O)[C@H]1O[C@@H](Oc2cc3oc(-c4ccc(O)cc4)cc(=O)c3c(O)c2O)[C@H](O)[C@@H](O)[C@@H]1O,清洗成功,0.2716049382716049
843,CN1CCC(c2cc(-c3ccncc3)c(-c3ccc(F)cc3)[nH]2)CC1,1,0.992196798324585,0.992196798324585,CN1CCC(C2=CC(C3=CC=NC=C3)=C(C4=CC=C(F)C=C4)N2)CC1,MBP146-78,Data.sdf,966,HY-101525,,188343-77-3,Parasite,Anti-infection,C21H22FN3,10mM,Infection,No Development Reported,CN1CCC(c2cc(-c3ccncc3)c(-c3ccc(F)cc3)[nH]2)CC1,清洗成功,0.2950819672131147
4187,Cc1cn(-c2cc(F)c(C(N)=O)c(N[C@H]3CCOC3)c2)c2c1C(=O)CC(C)(C)C2,1,0.992171049118042,0.992171049118042,O=C(N)C1=C(N[C@@H]2COCC2)C=C(N3C=C(C)C4=C3CC(C)(C)CC4=O)C=C1F,SNX-0723,Data.sdf,4929,HY-119046,,1073969-18-2,HSP; Parasite,Anti-infection; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease,C22H26FN3O3,10mM,Infection,No Development Reported,Cc1cn(-c2cc(F)c(C(N)=O)c(N[C@H]3CCOC3)c2)c2c1C(=O)CC(C)(C)C2,清洗成功,0.2391304347826087
13237,CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,1,0.9921557307243347,0.9921557307243347,O[C@@]([C@@](CCC1)([H])N1C2=O)(O[C@](NC([C@@H](CN(C)[C@]3([H])C4)C[C@]3([H])C5=C6C4=CNC6=CC=C5)=O)(C)C7=O)N7[C@H]2CC8=CC=CC=C8.CS(=O)(O)=O,Dihydroergotamine (mesylate),Data.sdf,15628,HY-B0670A,,6190-39-2,5-HT Receptor,GPCR/G Protein; Neuronal Signaling,C34H41N5O8S,10mM,Neurological Disease,Launched,CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,清洗成功,0.208695652173913
2893,Cc1cccc(-c2[nH]c(C34CCC(C(N)=O)(CC3)CC4)nc2-c2ccc3c(c2)OCO3)n1,1,0.9921361207962036,0.9921361207962036,O=C(C1(CC2)CCC2(C3=NC(C4=CC=C(OCO5)C5=C4)=C(C6=NC(C)=CC=C6)N3)CC1)N,SM 16,Data.sdf,3396,HY-111482,,614749-78-9,TGF-?2 Receptor,TGF-beta/Smad,C25H26N4O3,10mM,Cancer; Inflammation/Immunology; Cardiovascular Disease,No Development Reported,Cc1cccc(-c2[nH]c(C34CCC(C(N)=O)(CC3)CC4)nc2-c2ccc3c(c2)OCO3)n1,清洗成功,0.3188405797101449
1276,O=c1cc(-c2ccccc2F)[nH]c2cc3c(cc12)OCO3,1,0.992113471031189,0.992113471031189,O=C1C=C(C2=CC=CC=C2F)NC3=C1C=C4C(OCO4)=C3,CHM-1,Data.sdf,1488,HY-103257,NSC656158,154554-41-3,Microtubule/Tubulin,Cell Cycle/DNA Damage; Cytoskeleton,C16H10FNO3,10mM,Cancer,No Development Reported,O=c1cc(-c2ccccc2F)[nH]c2cc3c(cc12)OCO3,清洗成功,0.3064516129032258
1703,Cc1nccn1-c1ccc(Sc2cccc(C3(C(N)=O)CCOCC3)c2)cc1,1,0.9920989274978638,0.9920989274978638,NC(C1(C2=CC(SC3=CC=C(N4C(C)=NC=C4)C=C3)=CC=C2)CCOCC1)=O,"CJ-13,610",Data.sdf,2020,HY-106200,,179420-17-8,Lipoxygenase,Metabolic Enzyme/Protease,C22H23N3O2S,10mM,Inflammation/Immunology,Phase 2,Cc1nccn1-c1ccc(Sc2cccc(C3(C(N)=O)CCOCC3)c2)cc1,清洗成功,0.2298850574712643
7767,CN(C)Cc1ccc(-n2cc(-c3ccc4cc[nH]c4c3)c3c(Cl)ccnc32)cc1,1,0.9920623302459717,0.9920623302459717,ClC1=C(C(C2=CC3=C(C=CN3)C=C2)=CN4C5=CC=C(CN(C)C)C=C5)C4=NC=C1,MPO-IN-1,Data.sdf,9190,HY-139915,,2471981-21-0,Glutathione Peroxidase,Apoptosis; Metabolic Enzyme/Protease,C24H21ClN4,10mM,Inflammation/Immunology,No Development Reported,CN(C)Cc1ccc(-n2cc(-c3ccc4cc[nH]c4c3)c3c(Cl)ccnc32)cc1,清洗成功,0.2962962962962963
8856,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cc3ccccc3o1)CC2,1,0.9920377731323242,0.9920377731323242,O=C1NCCC12CCN(C3=C(C4=CC5=CC=CC=C5O4)C=NC=C3Cl)CC2,CDK8-IN-12,Data.sdf,10451,HY-148561,,2613307-67-6,CDK; GSK-3; PKC,Cell Cycle/DNA Damage; Epigenetics; PI3K/Akt/mTOR; Stem Cell/Wnt; TGF-beta/Smad,C21H20ClN3O2,10mM,Cancer,No Development Reported,O=C1NCCC12CCN(c1c(Cl)cncc1-c1cc3ccccc3o1)CC2,清洗成功,0.2183908045977011
3595,COc1cc(-c2cnc(N)c(-c3ccc(NC(=O)c4cn(CC5CCOCC5)cc(-c5ccc(C)cn5)c4=O)cc3F)c2)ccc1OC[C@H]1COCCO1,1,0.9920320510864258,0.9920320510864258,O=C(C1=CN(CC2CCOCC2)C=C(C3=NC=C(C)C=C3)C1=O)NC4=CC=C(C5=CC(C6=CC=C(OC[C@@H]7OCCOC7)C(OC)=C6)=CN=C5N)C(F)=C4,DS-1205b (free base),Data.sdf,4236,HY-114357A,,1855860-24-0,c-Met/HGFR; TAM Receptor; Trk Receptor,Neuronal Signaling; Protein Tyrosine Kinase/RTK,C41H42FN5O7,10mM,Cancer,No Development Reported,COc1cc(-c2cnc(N)c(-c3ccc(NC(=O)c4cn(CC5CCOCC5)cc(-c5ccc(C)cn5)c4=O)cc3F)c2)ccc1OC[C@H]1COCCO1,清洗成功,0.2538461538461538
11681,O=C1CCc2c(Oc3ccc4c(c3)[C@@H]3[C@H](O4)[C@H]3c3nc4ccc(C(F)(F)F)cc4[nH]3)ccnc2N1,1,0.9920209050178528,0.9920209050178528,O=C1NC2=NC=CC(OC3=CC=C(O[C@@]4([H])[C@]5([H])[C@@H]4C6=NC7=CC=C(C(F)(F)F)C=C7N6)C5=C3)=C2CC1,Lifirafenib,Data.sdf,13823,HY-18957,BGB-283,1446090-79-4,EGFR; Raf,JAK/STAT Signaling; MAPK/ERK Pathway; Protein Tyrosine Kinase/RTK,C25H17F3N4O3,10mM,Cancer,Phase 1,O=C1CCc2c(Oc3ccc4c(c3)[C@@H]3[C@H](O4)[C@H]3c3nc4ccc(C(F)(F)F)cc4[nH]3)ccnc2N1,清洗成功,0.2470588235294117
4720,Cc1nn(-c2ccccc2)c(C)c1NC(=O)CN1CCCC(c2nc3ccccc3s2)C1,1,0.9920114874839783,0.9920114874839783,O=C(CN1CCCC(C1)C2=NC3=C(S2)C=CC=C3)NC4=C(C)N(C5=CC=CC=C5)N=C4C,Amb123203,Data.sdf,5544,HY-122046,,956571-77-0,Endogenous Metabolite,Metabolic Enzyme/Protease,C25H27N5OS,10mM,Infection,No Development Reported,Cc1nn(-c2ccccc2)c(C)c1NC(=O)CN1CCCC(c2nc3ccccc3s2)C1,清洗成功,0.3134328358208955
14958,O=C(O)[C@H]1O[C@@H](Oc2cc(O)c3c(=O)cc(-c4ccc(O)cc4)oc3c2)[C@H](O)[C@@H](O)[C@@H]1O,1,0.9919968247413635,0.9919968247413635,O[C@H]([C@H]([C@@H]([C@@H](C(O)=O)O1)O)O)[C@@H]1OC2=CC(O)=C3C(C=C(C4=CC=C(O)C=C4)OC3=C2)=O,Apigenin-7-glucuronide,Data.sdf,17769,HY-N1454,Apigenin 7-O-glucuronide,29741-09-1,MMP,Metabolic Enzyme/Protease,C21H18O11,10mM,Cancer,No Development Reported,O=C(O)[C@H]1O[C@@H](Oc2cc(O)c3c(=O)cc(-c4ccc(O)cc4)oc3c2)[C@H](O)[C@@H](O)[C@@H]1O,清洗成功,0.2839506172839506
15595,COC(=O)[C@H]1O[C@@H](Oc2cc3oc(-c4ccccc4)cc(=O)c3c(O)c2O)[C@H](O)[C@@H](O)[C@@H]1O,1,0.9919888377189636,0.9919888377189636,OC1=C2C(OC(C3=CC=CC=C3)=CC2=O)=CC(O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(OC)=O)=C1O,Baicalin methyl ester,Data.sdf,18617,HY-N4297,,82475-03-4,Others,Others,C22H20O11,10mM,Others,No Development Reported,COC(=O)[C@H]1O[C@@H](Oc2cc3oc(-c4ccccc4)cc(=O)c3c(O)c2O)[C@H](O)[C@@H](O)[C@@H]1O,清洗成功,0.2926829268292683
130,Cc1csc(Cl)c1Nc1nc2ccccc2[nH]1,1,0.9919832348823547,0.9919832348823547,CC1=CSC(Cl)=C1NC2=NC3=CC=CC=C3N2,NHE3-IN-1,Data.sdf,151,HY-100325,,632355-68-1,Na+/H+ Exchanger (NHE),Membrane Transporter/Ion Channel,C12H10ClN3S,10mM,Neurological Disease,No Development Reported,Cc1csc(Cl)c1Nc1nc2ccccc2[nH]1,清洗成功,0.35
3303,O=c1nc(Cc2ccccn2)[nH]c2c1cnn2C1CCOCC1,1,0.9919791221618652,0.9919791221618652,O=C1C2=C(N(C3CCOCC3)N=C2)NC(CC4=CC=CC=N4)=N1,Osoresnontrine,Data.sdf,3885,HY-112831,BI-409306,1189767-28-9,Phosphodiesterase (PDE),Metabolic Enzyme/Protease,C16H17N5O2,10mM,Neurological Disease,Phase 2,O=c1nc(Cc2ccccn2)[nH]c2c1cnn2C1CCOCC1,清洗成功,0.2804878048780488
15299,O=C(O)[C@H]1O[C@@H](O[C@H]2[C@H](Oc3cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc4c3)O[C@H](C(=O)O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,1,0.9919771552085876,0.9919771552085876,O=C1C2=C(O)C=C(O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C(O)=O)O)O)O[C@@H]4O[C@@H]([C@H]([C@@H]([C@H]4O)O)O)C(O)=O)C=C2OC(C5=CC=C(C=C5)O)=C1,Clerodendrin,Data.sdf,18216,HY-N2426,,119738-57-7,Interleukin Related,Immunology/Inflammation,C27H26O17,10mM,Inflammation/Immunology,No Development Reported,O=C(O)[C@H]1O[C@@H](O[C@H]2[C@H](Oc3cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc4c3)O[C@H](C(=O)O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,清洗成功,0.264367816091954
14878,COc1ccc(-c2cc(=O)c3c(O)cc(O[C@@H]4O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]4O)cc3o2)cc1,1,0.991952121257782,0.991952121257782,O=C1C2=C(O)C=C(O[C@@H]3O[C@@H]([C@H]([C@@H]([C@H]3O)O)O)C(O)=O)C=C2OC(C4=CC=C(C=C4)OC)=C1,Acacetin 7-O-glucuronide,Data.sdf,17658,HY-N12028,,38226-83-4,Others,Others,C22H20O11,10mM,Others,No Development Reported,COc1ccc(-c2cc(=O)c3c(O)cc(O[C@@H]4O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]4O)cc3o2)cc1,清洗成功,0.3170731707317073
4024,CN(C)c1ccc(/N=N\c2ccc(C(=O)Nc3cc(-c4cccs4)ccc3O)cc2)cc1,1,0.9919517040252686,0.9919517040252686,O=C(C1=CC=C(C=C1)/N=N\C2=CC=C(C=C2)N(C)C)NC3=CC(C4=CC=CS4)=CC=C3O,cis-BG47,Data.sdf,4726,HY-117583,,,HDAC; Histone Methyltransferase,Cell Cycle/DNA Damage; Epigenetics,C25H22N4O2S,10mM,Neurological Disease,No Development Reported,CN(C)c1ccc(/N=N\c2ccc(C(=O)Nc3cc(-c4cccs4)ccc3O)cc2)cc1,清洗成功,0.2976190476190476
10119,Cc1ccc(-c2noc([C@H]3C[C@@H]3F)n2)cc1NC(=O)c1cnc2ccccn12,1,0.9919427633285522,0.9919427633285522,CC1=CC=C(C2=NOC([C@@H]3[C@H](C3)F)=N2)C=C1NC(C4=CN=C5N4C=CC=C5)=O,Labuxtinib,Data.sdf,11970,HY-156619,,1426449-01-5,c-Kit,Protein Tyrosine Kinase/RTK,C20H16FN5O2,10mM,cancer,No Development Reported,Cc1ccc(-c2noc([C@H]3C[C@@H]3F)n2)cc1NC(=O)c1cnc2ccccn12,清洗成功,0.2717391304347826
15272,O=C(O)[C@H]1O[C@@H](Oc2cc(O)c3c(=O)cc(-c4ccccc4)oc3c2)[C@H](O)[C@@H](O)[C@@H]1O,1,0.9919345378875732,0.9919345378875732,O=C1C2=C(O)C=C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)C=C2OC(C4=CC=CC=C4)=C1,Chrysin-7-O-glucuronide,Data.sdf,18181,HY-N2376,,35775-49-6,Others,Others,C21H18O10,10mM,Others,No Development Reported,O=C(O)[C@H]1O[C@@H](Oc2cc(O)c3c(=O)cc(-c4ccccc4)oc3c2)[C@H](O)[C@@H](O)[C@@H]1O,清洗成功,0.2682926829268293
1067,O=C1/C(=C/c2ccc(O)cc2)Oc2cc(O)ccc21,1,0.9919241070747375,0.9919241070747375,O=C1C2=CC=C(O)C=C2O/C1=C\C3=CC=C(O)C=C3,Hispidol,Data.sdf,1227,HY-102040,(Z)-Hispidol,5786-54-9,TNF Receptor,Apoptosis,C15H10O4,10mM,Inflammation/Immunology,No Development Reported,O=C1/C(=C/c2ccc(O)cc2)Oc2cc(O)ccc21,清洗成功,0.2962962962962963
8452,O=C(CN1CCCCC1)Nc1ccc(Oc2cc(=O)oc3ccccc23)cc1,1,0.9919113516807556,0.9919113516807556,O=C(NC1=CC=C(C=C1)OC2=CC(OC3=CC=CC=C32)=O)CN4CCCCC4,TGF?2-IN-2,Data.sdf,9976,HY-146434,,2387678-02-4,TGF-beta/Smad,Stem Cell/Wnt; TGF-beta/Smad,C22H22N2O4,10mM,Inflammation/Immunology,No Development Reported,O=C(CN1CCCCC1)Nc1ccc(Oc2cc(=O)oc3ccccc23)cc1,清洗成功,0.2823529411764706
11504,O=C(Nc1ncc(-c2cc(C(F)F)nn2-c2c(Cl)cccc2Cl)s1)C1CC1,1,0.9918972253799438,0.9918972253799438,O=C(C1CC1)NC2=NC=C(C3=CC(C(F)F)=NN3C4=C(Cl)C=CC=C4Cl)S2,BMS-3,Data.sdf,13608,HY-18304,,1338247-30-5,LIM Kinase (LIMK),Cell Cycle/DNA Damage,C17H12Cl2F2N4OS,10mM,Cancer,No Development Reported,O=C(Nc1ncc(-c2cc(C(F)F)nn2-c2c(Cl)cccc2Cl)s1)C1CC1,清洗成功,0.3076923076923077
3138,CNC(=O)c1ccc(-c2cnc3cnc(-c4ccccc4)cn23)cc1,1,0.9918861389160156,0.9918861389160156,O=C(NC)C(C=C1)=CC=C1C2=CN=C3C=NC(C4=CC=CC=C4)=CN32,AZ32,Data.sdf,3680,HY-112305,,2288709-96-4,ATM/ATR,Cell Cycle/DNA Damage; PI3K/Akt/mTOR,C20H16N4O,10mM,Cancer,No Development Reported,CNC(=O)c1ccc(-c2cnc3cnc(-c4ccccc4)cn23)cc1,清洗成功,0.3142857142857143
11703,Cc1cc(-c2nc(C(=O)Nc3cn(C4CCOCC4)nc3C(N)=O)co2)ccn1,1,0.9918780326843262,0.9918780326843262,O=C(NC1=CN(C2CCOCC2)N=C1C(N)=O)C3=COC(C4=CC=NC(C)=C4)=N3.[H]Cl,AS2444697,Data.sdf,13850,HY-18992,,1287665-60-4,IRAK,Immunology/Inflammation,C19H21ClN6O4,10mM,Inflammation/Immunology,No Development Reported,Cc1cc(-c2nc(C(=O)Nc3cn(C4CCOCC4)nc3C(N)=O)co2)ccn1,清洗成功,0.3152173913043478
4359,Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12,1,0.9918698072433472,0.9918698072433472,O=C(OC[C@H]1NCCOC1)NC2=CN(C3=C2C)N=CN=C3NC4=CC5=C(C=C4)N(CC6=CC(F)=CC=C6)N=C5.Cl,BMS-599626 (Hydrochloride),Data.sdf,5129,HY-12010,AC480 (Hydrochloride),873837-23-1,EGFR,JAK/STAT Signaling; Protein Tyrosine Kinase/RTK,C27H28ClFN8O3,10mM,Cancer,Phase 1,Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12,清洗成功,0.2672413793103448
11459,CN1CCCN(C(=O)c2cccc(-c3ccc(/C=C4/C(=O)Nc5ccc(Cl)cc54)o3)c2)CC1,1,0.9918609261512756,0.9918609261512756,O=C1NC2=CC=C(Cl)C=C2/C1=C\C3=CC=C(C4=CC=CC(C(N5CCCN(C)CC5)=O)=C4)O3,CX-6258,Data.sdf,13551,HY-18095,,1202916-90-2,Pim,JAK/STAT Signaling,C26H24ClN3O3,10mM,Cancer,No Development Reported,CN1CCCN(C(=O)c2cccc(-c3ccc(/C=C4/C(=O)Nc5ccc(Cl)cc54)o3)c2)CC1,清洗成功,0.3424657534246575
11460,CN1CCCN(C(=O)c2cccc(-c3ccc(/C=C4/C(=O)Nc5ccc(Cl)cc54)o3)c2)CC1,1,0.9918609261512756,0.9918609261512756,O=C1NC2=CC=C(Cl)C=C2/C1=C\C3=CC=C(C4=CC=CC(C(N5CCCN(C)CC5)=O)=C4)O3.[H]Cl.O,CX-6258 (hydrochloride hydrate),Data.sdf,13552,HY-18095A,,1353858-99-7,Pim,JAK/STAT Signaling,C26H27Cl2N3O4,10mM,Cancer,No Development Reported,CN1CCCN(C(=O)c2cccc(-c3ccc(/C=C4/C(=O)Nc5ccc(Cl)cc54)o3)c2)CC1,清洗成功,0.3333333333333333
11461,CN1CCCN(C(=O)c2cccc(-c3ccc(/C=C4/C(=O)Nc5ccc(Cl)cc54)o3)c2)CC1,1,0.9918609261512756,0.9918609261512756,O=C1NC2=CC=C(Cl)C=C2/C1=C\C3=CC=C(C4=CC=CC(C(N5CCCN(C)CC5)=O)=C4)O3.[H]Cl,CX-6258 (hydrochloride),Data.sdf,13553,HY-18095B,,1353859-00-3,Pim,JAK/STAT Signaling,C26H25Cl2N3O3,10mM,Cancer,No Development Reported,CN1CCCN(C(=O)c2cccc(-c3ccc(/C=C4/C(=O)Nc5ccc(Cl)cc54)o3)c2)CC1,清洗成功,0.3378378378378378
4427,COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC,1,0.9918573498725891,0.9918573498725891,O=C([C@H](CC(O)=O)O)O.O=C(NC1=CC=C(C=C1)OC2=CC=NC3=CC(OC)=C(C=C23)OC)C4(CC4)C(NC5=CC=C(C=C5)F)=O,Cabozantinib (S-malate),Data.sdf,5216,HY-12044,XL184 (S-malate); BMS-907351 (S-malate),1140909-48-3,Apoptosis; VEGFR,Apoptosis; Protein Tyrosine Kinase/RTK,C32H30FN3O10,10mM,Cancer,Launched,COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC,清洗成功,0.2696629213483146
5455,O=C(c1ccc2[nH]c(-c3ccccc3)nc2c1)N1CCN(Cc2ccccc2F)CC1,1,0.9918571710586548,0.9918571710586548,O=C(N1CCN(CC2=CC=CC=C2F)CC1)C3=CC=C4NC(C5=CC=CC=C5)=NC4=C3,Bractoppin,Data.sdf,6428,HY-126020,,2290527-07-8,DNA/RNA Synthesis; RAD51,Cell Cycle/DNA Damage,C25H23FN4O,10mM,Cancer,No Development Reported,O=C(c1ccc2[nH]c(-c3ccccc3)nc2c1)N1CCN(Cc2ccccc2F)CC1,清洗成功,0.2987012987012987
6038,COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC,1,0.9918527007102966,0.9918527007102966,O=C(C1(CC1)C(NC2=CC=C(F)C=C2)=O)NC3=CC=C(C=C3)OC4=C5C=C(OC)C(OC)=CC5=NC=C4,Cabozantinib,Data.sdf,7143,HY-13016,XL184; BMS-907351,849217-68-1,Apoptosis; c-Kit; c-Met/HGFR; FLT3; TAM Receptor; VEGFR,Apoptosis; Protein Tyrosine Kinase/RTK,C28H24FN3O5,10mM,Cancer,Launched,COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC,清洗成功,0.3116883116883117
11581,CN1CCN(CCC(=O)Nc2ccc3c(c2)Sc2cccc(-c4cc(=O)cc(N5CCOCC5)o4)c2S3)CC1,1,0.9918518662452698,0.9918518662452698,O=C(NC(C=C1S2)=CC=C1SC3=C2C=CC=C3C4=CC(C=C(N5CCOCC5)O4)=O)CCN6CCN(C)CC6,KU 59403,Data.sdf,13702,HY-18650,,845932-30-1,ATM/ATR,Cell Cycle/DNA Damage; PI3K/Akt/mTOR,C29H32N4O4S2,10mM,Cancer,No Development Reported,CN1CCN(CCC(=O)Nc2ccc3c(c2)Sc2cccc(-c4cc(=O)cc(N5CCOCC5)o4)c2S3)CC1,清洗成功,0.28
15244,CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O,1,0.9918501377105713,0.9918501377105713,O[C@@]([C@@](CCC1)([H])N1C2=O)(O[C@](NC([C@@H](CN(C)[C@]3([H])C4)C[C@]3([H])C5=C6C4=CNC6=CC=C5)=O)(C(C)C)C7=O)N7[C@H]2CC8=CC=CC=C8.CS(=O)(O)=O,Dihydroergocristine (mesylate),Data.sdf,18141,HY-N2319,DHEC (mesylate),24730-10-7,Amyloid-?2,Neuronal Signaling,C36H45N5O8S,10mM,Neurological Disease,Launched,CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O,清洗成功,0.2033898305084746
10480,Cc1cccc(/C=N/Nc2cc(N3CCOCC3)n3nc(-c4ccncc4)cc3n2)c1,1,0.9918301701545715,0.9918301701545715,CC1=CC(/C=N/NC2=NC3=CC(C4=CC=NC=C4)=NN3C(N5CCOCC5)=C2)=CC=C1,APY0201,Data.sdf,12421,HY-15982,,1232221-74-7,Interleukin Related; PIKfyve,Immunology/Inflammation; PI3K/Akt/mTOR,C23H23N7O,10mM,Inflammation/Immunology,No Development Reported,Cc1cccc(/C=N/Nc2cc(N3CCOCC3)n3nc(-c4ccncc4)cc3n2)c1,清洗成功,0.2804878048780488
9125,Cc1c[nH]c2nccc(-c3ccc(C(=O)N[C@@H]4c5c(F)cc(C(F)F)cc5C[C@@H]4O)cn3)c12,1,0.991826057434082,0.991826057434082,FC1=CC(C(F)F)=CC2=C1[C@H]([C@@H](O)C2)NC(C(C=C3)=CN=C3C4=C(C(C)=CN5)C5=NC=C4)=O,BLU2864,Data.sdf,10763,HY-150076,,2810747-89-6,PKA,Stem Cell/Wnt; TGF-beta/Smad,C24H19F3N4O2,10mM,Cancer; Metabolic Disease,No Development Reported,Cc1c[nH]c2nccc(-c3ccc(C(=O)N[C@@H]4c5c(F)cc(C(F)F)cc5C[C@@H]4O)cn3)c12,清洗成功,0.2765957446808511
7261,O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12,1,0.9918175339698792,0.9918175339698792,O=C(C1=C(C2=CC=C(O)C=C2)SC3=CC(O)=CC=C31)C4=CC=C(OCCN5CCCCC5)C=C4,Raloxifene,Data.sdf,8593,HY-13738,Keoxifene; LY156758 (free base); LY139481,84449-90-1,Estrogen Receptor/ERR,Vitamin D Related/Nuclear Receptor,C28H27NO4S,10mM,Cancer,Launched,O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12,清洗成功,0.3218390804597701
7262,O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12,1,0.9918175339698792,0.9918175339698792,O=C(C1=C(C2=CC=C(O)C=C2)SC3=CC(O)=CC=C31)C4=CC=C(OCCN5CCCCC5)C=C4.Cl,Raloxifene (hydrochloride),Data.sdf,8594,HY-13738A,Keoxifene (hydrochloride); LY156758; LY139481 (hydrochloride),82640-04-8,Autophagy; Estrogen Receptor/ERR,Autophagy; Vitamin D Related/Nuclear Receptor,C28H28ClNO4S,10mM,Endocrinology; Cancer,Launched,O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12,清洗成功,0.3181818181818182
11862,O=C(N[C@H]1CN2CCC1CC2)c1c[nH]c2ccsc2c1=O,1,0.9918127059936523,0.9918127059936523,O=C(C1=CNC(C=CS2)=C2C1=O)N[C@H]3CN4CCC3CC4.[H]Cl,Pumosetrag Hydrochloride,Data.sdf,14033,HY-19650,MKC-733; DDP-733,194093-42-0,5-HT Receptor,GPCR/G Protein; Neuronal Signaling,C15H18ClN3O2S,10mM,Metabolic Disease,Phase 3,O=C(N[C@H]1CN2CCC1CC2)c1c[nH]c2ccsc2c1=O,清洗成功,0.2911392405063291
4455,CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1,1,0.991806149482727,0.991806149482727,O=C(C1=CN=CC2=C1C=NN2C3=CC=C(F)C=C3)NC4(C5=CC(S(=O)(C)=O)=NC=C5)CC4,BI 639667,Data.sdf,5249,HY-120588,CCR1 antagonist 8,1295298-26-8,CCR,GPCR/G Protein; Immunology/Inflammation,C22H18FN5O3S,10mM,Inflammation/Immunology; Endocrinology,Phase 1,CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1,清洗成功,0.2553191489361702
2046,N=C(N)Nc1ccc2[nH]c3c(c2c1)C[C@@]1(O)[C@H]2Cc4ccc(O)c5c4[C@@]1(CCN2CC1CC1)[C@H]3O5,1,0.9918028712272644,0.9918028712272644,NC(NC1=CC2=C(NC3=C2C[C@]([C@]4([H])N(CC5CC5)CC6)(O)[C@]76[C@@]3([H])OC8=C(O)C=CC(C4)=C87)C=C1)=N.[H]Cl.[H]Cl,5'-Guanidinonaltrindole (hydrochloride),Data.sdf,2402,HY-107748,5'-GNTI (hydrochloride),351183-88-5,Opioid Receptor,GPCR/G Protein; Neuronal Signaling,C27H31Cl2N5O3,10mM,Neurological Disease,No Development Reported,N=C(N)Nc1ccc2[nH]c3c(c2c1)C[C@@]1(O)[C@H]2Cc4ccc(O)c5c4[C@@]1(CCN2CC1CC1)[C@H]3O5,清洗成功,0.1869918699186991
10135,Cc1c(C(=O)NCc2ccccc2)oc2ccc(S(=O)(=O)N3CCCC(C)C3)cc12,1,0.9918021559715271,0.9918021559715271,O=C(C1=C(C)C2=C(C=CC(S(=O)(N3CCCC(C3)C)=O)=C2)O1)NCC4=CC=CC=C4,Calcium Channel antagonist 3,Data.sdf,11989,HY-156664,,687573-14-4,Calcium Channel,Membrane Transporter/Ion Channel; Neuronal Signaling,C23H26N2O4S,10mM,Neurological Disease,No Development Reported,Cc1c(C(=O)NCc2ccccc2)oc2ccc(S(=O)(=O)N3CCCC(C)C3)cc12,清洗成功,0.2638888888888889
1341,COc1ccc(-c2nc(C(=O)N3CCN(C)CC3)sc2-c2ccc(OC)cc2)cc1,1,0.9917998909950256,0.9917998909950256,O=C(C1=NC(C2=CC=C(OC)C=C2)=C(C3=CC=C(OC)C=C3)S1)N4CCN(C)CC4.[H]Cl,FR122047,Data.sdf,1563,HY-103386,,130717-51-0,COX,Immunology/Inflammation,C23H26ClN3O3S,10mM,Inflammation/Immunology,No Development Reported,COc1ccc(-c2nc(C(=O)N3CCN(C)CC3)sc2-c2ccc(OC)cc2)cc1,清洗成功,0.3142857142857143
2425,Cn1cc(-c2ccc(S(=O)(=O)[C@@H]3C[C@@H](C(=O)NC4(C#N)CC4)N(C(=O)C4(C(F)(F)F)CC4)C3)c(C(F)(F)F)c2)cn1,1,0.9917992353439331,0.9917992353439331,O=C(N1[C@@H](C[C@@H](S(=O)(C2=C(C=C(C3=CN(C)N=C3)C=C2)C(F)(F)F)=O)C1)C(NC4(CC4)C#N)=O)C5(CC5)C(F)(F)F,Petesicatib,Data.sdf,2850,HY-109069,RO5459072; RG-7625,1252637-35-6,Cathepsin,Metabolic Enzyme/Protease,C25H23F6N5O4S,10mM,Inflammation/Immunology,Phase 2,Cn1cc(-c2ccc(S(=O)(=O)[C@@H]3C[C@@H](C(=O)NC4(C#N)CC4)N(C(=O)C4(C(F)(F)F)CC4)C3)c(C(F)(F)F)c2)cn1,清洗成功,0.3444444444444444
11880,CN1CCN(C(=O)c2ccc(-c3ccc4c(C=O)c(O)ccc4c3)s2)CC1,1,0.9917683601379395,0.9917683601379395,O=CC1=C(O)C=CC2=C1C=CC(C3=CC=C(C(N4CCN(C)CC4)=O)S3)=C2,MKC3946,Data.sdf,14056,HY-19710,,1093119-54-0,IRE1,Cell Cycle/DNA Damage,C21H20N2O3S,10mM,Cancer,No Development Reported,CN1CCN(C(=O)c2ccc(-c3ccc4c(C=O)c(O)ccc4c3)s2)CC1,清洗成功,0.3026315789473684
2104,COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12,1,0.9917656779289246,0.9917656779289246,CC(NN=C1C2CC2)=C1C3=CC(NC(OC)=O)=C(C=NN4)C4=C3,DS28120313,Data.sdf,2471,HY-107980,,2146177-09-3,Ferroportin,Membrane Transporter/Ion Channel,C16H17N5O2,10mM,Inflammation/Immunology,No Development Reported,COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12,清洗成功,0.2439024390243902
5354,Cn1c(-c2ccc3c(c2)OCO3)cc(=O)c2ccccc21,1,0.9917601943016052,0.9917601943016052,O=C1C=C(C2=CC=C(OCO3)C3=C2)N(C)C4=C1C=CC=C4,Graveoline,Data.sdf,6310,HY-12538,Rutamine,485-61-0,Apoptosis; Autophagy; Fungal,Anti-infection; Apoptosis; Autophagy,C17H13NO3,10mM,Cancer; Infection,No Development Reported,Cn1c(-c2ccc3c(c2)OCO3)cc(=O)c2ccccc21,清洗成功,0.34375
5855,CC(C)(C)OC(=O)N[C@@H]1CCCN(Cc2ccnc(C(=O)Nc3ccc(-c4cc5c(N6CCOCC6)ncnc5[nH]4)cc3)c2)C1,1,0.9917565584182739,0.9917565584182739,O=C(OC(C)(C)C)N[C@H]1CN(CC2=CC(C(NC3=CC=C(C4=CC5=C(N6CCOCC6)N=CN=C5N4)C=C3)=O)=NC=C2)CCC1,Menin-MLL inhibitor 20,Data.sdf,6924,HY-128798,,2448173-47-3,Epigenetic Reader Domain,Epigenetics,C33H40N8O4,10mM,Cancer,No Development Reported,CC(C)(C)OC(=O)N[C@@H]1CCCN(Cc2ccnc(C(=O)Nc3ccc(-c4cc5c(N6CCOCC6)ncnc5[nH]4)cc3)c2)C1,清洗成功,0.3047619047619048
11361,CN1CCC(NC(=O)c2cc(-c3c(O)cc(O)cc3Oc3ccc([N+](=O)[O-])cc3)on2)CC1,1,0.9917542934417725,0.9917542934417725,O=C(C1=NOC(C2=C(OC3=CC=C([N+]([O-])=O)C=C3)C=C(O)C=C2O)=C1)NC4CCN(C)CC4,NMS-E973,Data.sdf,13439,HY-17547,,1253584-84-7,HSP,Cell Cycle/DNA Damage; Metabolic Enzyme/Protease,C22H22N4O7,10mM,Cancer,No Development Reported,CN1CCC(NC(=O)c2cc(-c3c(O)cc(O)cc3Oc3ccc([N+](=O)[O-])cc3)on2)CC1,清洗成功,0.2474226804123711
14963,O=C(O)[C@H]1O[C@@H](Oc2cc(O)c3c(=O)cc(-c4ccc(O)c(O)c4)oc3c2)[C@H](O)[C@@H](O)[C@@H]1O,1,0.9917078614234924,0.9917078614234924,O[C@H]([C@H]([C@@H]([C@@H](C(O)=O)O1)O)O)[C@@H]1OC2=CC(O)=C3C(C=C(C4=CC=C(O)C(O)=C4)OC3=C2)=O,Luteolin 7-O-glucuronide,Data.sdf,17775,HY-N1463,Luteolin 7-glucuronide,29741-10-4,MMP,Metabolic Enzyme/Protease,C21H18O12,10mM,Inflammation/Immunology; Neurological Disease,No Development Reported,O=C(O)[C@H]1O[C@@H](Oc2cc(O)c3c(=O)cc(-c4ccc(O)c(O)c4)oc3c2)[C@H](O)[C@@H](O)[C@@H]1O,清洗成功,0.3086419753086419
15174,O=c1c2cc(O)ccc2oc2cc(O)c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@@H]3OC[C@](O)(CO)[C@H]3O)c(O)c12,1,0.9917009472846985,0.9917009472846985,O[C@@H]1[C@H]([C@H](C(C(O)=CC(OC2=CC=C(O)C=C32)=C4C3=O)=C4O)O[C@H](CO)[C@H]1O)O[C@@](OC[C@]5(O)CO)([H])[C@@H]5O,Sibiricaxanthone B,Data.sdf,18048,HY-N2171,,241125-81-5,Others,Others,C24H26O14,10mM,Others,No Development Reported,O=c1c2cc(O)ccc2oc2cc(O)c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@@H]3OC[C@](O)(CO)[C@H]3O)c(O)c12,清洗成功,0.2375
6453,Cc1nc(N2CCC3(CC2)CO[C@@H](C)[C@H]3N)cc(=O)n1-c1cccc(Cl)c1Cl,1,0.9916906356811523,0.9916906356811523,ClC1=CC=CC(N2C(C)=NC(N3CCC4([C@H](N)[C@H](C)OC4)CC3)=CC2=O)=C1Cl,IACS-15414,Data.sdf,7644,HY-132901,,2411321-29-2,Phosphatase; SHP2,Metabolic Enzyme/Protease; Protein Tyrosine Kinase/RTK,C20H24Cl2N4O2,10mM,Cancer,No Development Reported,Cc1nc(N2CCC3(CC2)CO[C@@H](C)[C@H]3N)cc(=O)n1-c1cccc(Cl)c1Cl,清洗成功,0.2291666666666666
15962,O=C(O)[C@H]1O[C@@H](O[C@H]2[C@H](Oc3cc(O)c4c(=O)cc(-c5ccc(O)c(O)c5)oc4c3)O[C@H](C(=O)O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,1,0.9916890263557434,0.9916890263557434,O[C@@H]([C@@H]([C@@H](C(O)=O)O1)O)[C@@H](O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](C(O)=O)O2)O)O)O)[C@@H]1OC3=CC(O)=C4C(C=C(C5=CC=C(O)C(O)=C5)OC4=C3)=O,Luteolin 7-diglucuronide,Data.sdf,19079,HY-N7269,,96400-45-2,Others,Others,C27H26O18,10mM,Cancer; Inflammation/Immunology,No Development Reported,O=C(O)[C@H]1O[C@@H](O[C@H]2[C@H](Oc3cc(O)c4c(=O)cc(-c5ccc(O)c(O)c5)oc4c3)O[C@H](C(=O)O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,清洗成功,0.2873563218390804
15835,COC(=O)[C@H]1O[C@@H](Oc2cc3oc(-c4ccc(O)cc4)cc(=O)c3c(O)c2O)[C@H](O)[C@@H](O)[C@@H]1O,1,0.9916797280311584,0.9916797280311584,OC1=C2C(OC(C3=CC=C(O)C=C3)=CC2=O)=CC(O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(OC)=O)=C1O,Scutellarin methyl ester,Data.sdf,18918,HY-N6925,,119262-68-9,Others,Others,C22H20O12,10mM,Cardiovascular Disease,No Development Reported,COC(=O)[C@H]1O[C@@H](Oc2cc3oc(-c4ccc(O)cc4)cc(=O)c3c(O)c2O)[C@H](O)[C@@H](O)[C@@H]1O,清洗成功,0.2926829268292683
9665,O=C1CCC(N2C(=O)c3cccc(NCc4cc5ccccc5o4)c3C2=O)C(=O)N1,1,0.9916786551475525,0.9916786551475525,O=C1NC(C(CC1)N2C(C3=C(C2=O)C(NCC4=CC5=C(C=CC=C5)O4)=CC=C3)=O)=O,CC-3060,Data.sdf,11421,HY-153698,,444288-86-2,Ligands for E3 Ligase,PROTAC,C22H17N3O5,10mM,Cancer,No Development Reported,O=C1CCC(N2C(=O)c3cccc(NCc4cc5ccccc5o4)c3C2=O)C(=O)N1,清洗成功,0.25
10845,CN1CC[C@@H](NC(=O)Nc2ccc(C#N)cc2)C[C@@H]1c1nc2ccccc2[nH]1,1,0.9916778802871704,0.9916778802871704,O=C(NC1=CC=C(C#N)C=C1)N[C@H]2C[C@H](C3=NC4=CC=CC=C4N3)N(C)CC2,Glasdegib,Data.sdf,12856,HY-16391,PF-04449913,1095173-27-5,Smo,Stem Cell/Wnt,C21H22N6O,10mM,Cancer,Launched,CN1CC[C@@H](NC(=O)Nc2ccc(C#N)cc2)C[C@@H]1c1nc2ccccc2[nH]1,清洗成功,0.2988505747126437
10138,Cc1c(C(=O)NCc2ccccc2)oc2ccc(S(=O)(=O)N3CCC(C)CC3)cc12,1,0.9916701316833496,0.9916701316833496,O=C(C1=C(C)C2=C(C=CC(S(=O)(N3CCC(CC3)C)=O)=C2)O1)NCC4=CC=CC=C4,Calcium Channel antagonist 4,Data.sdf,11994,HY-156669,,687574-49-8,Calcium Channel,Membrane Transporter/Ion Channel; Neuronal Signaling,C23H26N2O4S,10mM,Neurological Disease,No Development Reported,Cc1c(C(=O)NCc2ccccc2)oc2ccc(S(=O)(=O)N3CCC(C)CC3)cc12,清洗成功,0.2794117647058823
12330,CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1,1,0.9916685819625854,0.9916685819625854,O=C1NC(C=CC=C2F)=C2C(N)=C1C3=NC4=CC=C(N5CCN(C)CC5)C=C4N3,Dovitinib,Data.sdf,14593,HY-50905,CHIR-258; TKI258,405169-16-6,c-Fms; c-Kit; FGFR; FLT3; PDGFR; VEGFR,Protein Tyrosine Kinase/RTK,C21H21FN6O,10mM,Cancer,Phase 3,CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1,清洗成功,0.2840909090909091
840,COC(=O)c1ccc2c(c1)/C(=C(/Nc1ccc(N(C)C(=O)CN3CCN(C)CC3)cc1)c1ccccc1)C(=O)N2,1,0.9916645884513855,0.9916645884513855,O=C(C1=CC2=C(NC(/C2=C(NC3=CC=C(N(C)C(CN4CCN(C)CC4)=O)C=C3)/C5=CC=CC=C5)=O)C=C1)OC,MELK-IN-1,Data.sdf,962,HY-101515,,2095596-44-2,MELK,PI3K/Akt/mTOR,C31H33N5O4,10mM,Cancer,No Development Reported,COC(=O)c1ccc2c(c1)/C(=C(/Nc1ccc(N(C)C(=O)CN3CCN(C)CC3)cc1)c1ccccc1)C(=O)N2,清洗成功,0.2666666666666666
1086,CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1,1,0.9916644096374512,0.9916644096374512,O=C(N1)C(C(NC2=C3)=NC2=CC=C3N4CCN(C)CC4)=C(N)C5=C1C=CC=C5F.O=C(O)C(C)O,Dovitinib (lactate),Data.sdf,1248,HY-10207,CHIR-258 lactate; TKI-258 lactate,692737-80-7,c-Kit; FGFR; FLT3; PDGFR; VEGFR,Protein Tyrosine Kinase/RTK,C24H27FN6O4,10mM,Cancer,Phase 3,CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1,清洗成功,0.2934782608695652
4056,OCC1(c2ccc(-c3cc4nc(O[C@@H]5CO[C@H]6[C@@H]5OC[C@H]6O)[nH]c4cc3Cl)cc2)CC1,1,0.9916608929634094,0.9916608929634094,O[C@H]1[C@]([H])([C@@]2(OC1)[H])OC[C@H]2OC3=NC4=CC(C5=CC=C(C=C5)C6(CC6)CO)=C(C=C4N3)Cl,PF-739,Data.sdf,4761,HY-117755,,1852452-14-2,AMPK,Epigenetics; PI3K/Akt/mTOR,C23H23ClN2O5,10mM,Metabolic Disease,No Development Reported,OCC1(c2ccc(-c3cc4nc(O[C@@H]5CO[C@H]6[C@@H]5OC[C@H]6O)[nH]c4cc3Cl)cc2)CC1,清洗成功,0.2051282051282051
1373,Cc1c(-c2ccc(O)cc2)nn(-c2ccc(O)cc2)c1-c1ccc(OCCN2CCCCC2)cc1,1,0.9916568994522095,0.9916568994522095,OC1=CC=C(C2=NN(C3=CC=C(O)C=C3)C(C4=CC=C(OCCN5CCCCC5)C=C4)=C2C)C=C1.[H]Cl.[H]Cl,MPP (dihydrochloride),Data.sdf,1605,HY-103454,,911295-24-4,Apoptosis; Estrogen Receptor/ERR,Apoptosis; Vitamin D Related/Nuclear Receptor,C29H33Cl2N3O3,10mM,Cancer; Endocrinology,No Development Reported,Cc1c(-c2ccc(O)cc2)nn(-c2ccc(O)cc2)c1-c1ccc(OCCN2CCCCC2)cc1,清洗成功,0.3164556962025316
1374,Cc1c(-c2ccc(O)cc2)nn(-c2ccc(O)cc2)c1-c1ccc(OCCN2CCCCC2)cc1,1,0.9916568994522095,0.9916568994522095,OC1=CC=C(C2=NN(C3=CC=C(O)C=C3)C(C4=CC=C(OCCN5CCCCC5)C=C4)=C2C)C=C1.[H]Cl,MPP (hydrochloride),Data.sdf,1606,HY-103454B,,2863676-89-3,Apoptosis; Estrogen Receptor/ERR,Apoptosis; Vitamin D Related/Nuclear Receptor,C29H32ClN3O3,10mM,Cancer; Endocrinology,No Development Reported,Cc1c(-c2ccc(O)cc2)nn(-c2ccc(O)cc2)c1-c1ccc(OCCN2CCCCC2)cc1,清洗成功,0.3164556962025316
10020,COC(=O)N[C@H](C(=O)N1CC2(CC2)C[C@H]1c1ncc(-c2ccc3c(c2)C(F)(F)c2cc(-c4ccc5nc([C@@H]6[C@H]7CC[C@H](C7)N6C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]c5c4)ccc2-3)[nH]1)C(C)C,1,0.9916497468948364,0.9916497468948364,O=C(OC)N[C@H](C(N([C@H](C1=NC=C(C2=CC(C(F)(F)C3=C4C=CC(C5=CC=C6N=C([C@H]7N(C([C@@H](NC(OC)=O)C(C)C)=O)[C@]8([H])CC[C@@]7([H])C8)NC6=C5)=C3)=C4C=C2)N1)C9)CC%109CC%10)=O)C(C)C,Ledipasvir,Data.sdf,11851,HY-15602,GS-5885,1256388-51-8,HCV; SARS-CoV,Anti-infection,C49H54F2N8O6,10mM,Infection,Launched,COC(=O)N[C@H](C(=O)N1CC2(CC2)C[C@H]1c1ncc(-c2ccc3c(c2)C(F)(F)c2cc(-c4ccc5nc([C@@H]6[C@H]7CC[C@H](C7)N6C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]c5c4)ccc2-3)[nH]1)C(C)C,清洗成功,0.2222222222222222
10023,COC(=O)N[C@H](C(=O)N1CC2(CC2)C[C@H]1c1ncc(-c2ccc3c(c2)C(F)(F)c2cc(-c4ccc5nc([C@@H]6[C@H]7CC[C@H](C7)N6C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]c5c4)ccc2-3)[nH]1)C(C)C,1,0.9916497468948364,0.9916497468948364,O=C(OC)N[C@H](C(N([C@H](C1=NC=C(C2=CC(C(F)(F)C3=C4C=CC(C5=CC=C6N=C([C@H]7N(C([C@@H](NC(OC)=O)C(C)C)=O)[C@]8([H])CC[C@@]7([H])C8)NC6=C5)=C3)=C4C=C2)N1)C9)CC%109CC%10)=O)C(C)C.CC(C)=O,Ledipasvir (acetone),Data.sdf,11855,HY-15602A,GS-5885 (acetone),1441674-54-9,HCV,Anti-infection,C52H60F2N8O7,10mM,Infection,Launched,COC(=O)N[C@H](C(=O)N1CC2(CC2)C[C@H]1c1ncc(-c2ccc3c(c2)C(F)(F)c2cc(-c4ccc5nc([C@@H]6[C@H]7CC[C@H](C7)N6C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]c5c4)ccc2-3)[nH]1)C(C)C,清洗成功,0.2184873949579832
10024,COC(=O)N[C@H](C(=O)N1CC2(CC2)C[C@H]1c1ncc(-c2ccc3c(c2)C(F)(F)c2cc(-c4ccc5nc([C@@H]6[C@H]7CC[C@H](C7)N6C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]c5c4)ccc2-3)[nH]1)C(C)C,1,0.9916497468948364,0.9916497468948364,O=C(OC)N[C@H](C(N([C@H](C1=NC=C(C2=CC(C(F)(F)C3=C4C=CC(C5=CC=C6N=C([C@H]7N(C([C@@H](NC(OC)=O)C(C)C)=O)[C@]8([H])CC[C@@]7([H])C8)NC6=C5)=C3)=C4C=C2)N1)C9)CC%109CC%10)=O)C(C)C.O[C@@H]([C@@H](C(O)=O)O)C(O)=O,Ledipasvir (D-tartrate),Data.sdf,11856,HY-15602B,GS-5885 D-tartrate,1502654-87-6,HCV,Anti-infection,C53H60F2N8O12,10mM,Infection,Launched,COC(=O)N[C@H](C(=O)N1CC2(CC2)C[C@H]1c1ncc(-c2ccc3c(c2)C(F)(F)c2cc(-c4ccc5nc([C@@H]6[C@H]7CC[C@H](C7)N6C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]c5c4)ccc2-3)[nH]1)C(C)C,清洗成功,0.2113821138211382
4713,CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1,1,0.9916438460350037,0.9916438460350037,O=C(NC1CCN(CC1)C)C2=C(C3=C(C4=CC(C)=CN=C4N3)C(C5=CC=CC(S(=O)(CC)=O)=C5)=C2)C,TAK-901,Data.sdf,5533,HY-12201,,934541-31-8,Aurora Kinase,Cell Cycle/DNA Damage; Epigenetics,C28H32N4O3S,10mM,Cancer,Phase 1,CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1,清洗成功,0.2828282828282828
10359,CN1CCN(c2cccc(Nc3cc4c(cn3)cc(-c3cccc(O)c3)c(=O)n4C)c2)CC1,1,0.9916415214538574,0.9916415214538574,CN1CCN(CC1)C2=CC(NC3=NC=C4C=C(C(N(C4=C3)C)=O)C5=CC(O)=CC=C5)=CC=C2,UH15-38,Data.sdf,12282,HY-158312,,2540881-21-6,Influenza Virus; Necroptosis; RIP kinase,Anti-infection; Apoptosis,C26H27N5O2,10mM,Infection; Inflammation/Immunology,No Development Reported,CN1CCN(c2cccc(Nc3cc4c(cn3)cc(-c3cccc(O)c3)c(=O)n4C)c2)CC1,清洗成功,0.3333333333333333
9602,CNc1nc2ccccc2n2c(-c3ccc(O)c(O)c3)cnc12,1,0.9916291236877441,0.9916291236877441,OC(C=C1)=C(O)C=C1C2=CN=C3C(NC)=NC4=CC=CC=C4N32,EAPB 02303,Data.sdf,11343,HY-153384,,1958290-51-1,Apoptosis; Microtubule/Tubulin,Apoptosis; Cell Cycle/DNA Damage; Cytoskeleton,C17H14N4O2,10mM,Cancer,No Development Reported,CNc1nc2ccccc2n2c(-c3ccc(O)c(O)c3)cnc12,清洗成功,0.3148148148148148
14559,O=c1cc(-c2ccc(O)cc2)oc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@@H]3OC[C@](O)(CO)[C@H]3O)cc(O)c12,1,0.9916214942932129,0.9916214942932129,O=C(C=C(C1=CC=C(O)C=C1)OC2=CC(O[C@H](O[C@H](CO)[C@@H](O)[C@@H]3O)[C@@H]3O[C@@](OC[C@]4(O)CO)([H])[C@@H]4O)=C5)C2=C5O,Apiin,Data.sdf,17236,HY-N0577,,26544-34-3,NO Synthase,Immunology/Inflammation,C26H28O14,10mM,Inflammation/Immunology,No Development Reported,O=c1cc(-c2ccc(O)cc2)oc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@@H]3OC[C@](O)(CO)[C@H]3O)cc(O)c12,清洗成功,0.2580645161290322
6187,CC(=O)N1CC(F)(F)c2c(Sc3ncc(N4CCC5(CC4)COC[C@H]5N)nc3N)cccc21,1,0.9916098713874817,0.9916098713874817,CC(N1CC(F)(F)C2=C1C=CC=C2SC3=NC=C(N(CC4)CCC54[C@H](N)COC5)N=C3N)=O,JAB-3068,Data.sdf,7319,HY-131132,SHP2-IN-6,2169223-48-5,Phosphatase; SHP2,Metabolic Enzyme/Protease; Protein Tyrosine Kinase/RTK,C22H26F2N6O2S,10mM,Cancer,Phase 2,CC(=O)N1CC(F)(F)c2c(Sc3ncc(N4CCC5(CC4)COC[C@H]5N)nc3N)cccc21,清洗成功,0.2403846153846154
6188,CC(=O)N1CC(F)(F)c2c(Sc3ncc(N4CCC5(CC4)COC[C@H]5N)nc3N)cccc21,1,0.9916098713874817,0.9916098713874817,CC(N1CC(F)(F)C2=C1C=CC=C2SC3=NC=C(N(CC4)CCC54[C@H](N)COC5)N=C3N)=O.[H]Cl,JAB-3068 (hydrochloride),Data.sdf,7320,HY-131132A,SHP2-IN-6 (hydrochloride),2169223-49-6,Phosphatase; SHP2,Metabolic Enzyme/Protease; Protein Tyrosine Kinase/RTK,C22H27ClF2N6O2S,10mM,Cancer,Phase 2,CC(=O)N1CC(F)(F)c2c(Sc3ncc(N4CCC5(CC4)COC[C@H]5N)nc3N)cccc21,清洗成功,0.238095238095238
8572,COC(=O)c1ccc2c(n1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1,1,0.9916037917137146,0.9916037917137146,CN(CC1)CCN1CC(N(C)C(C=C2)=CC=C2N/C(C3=CC=CC=C3)=C4C5=CC=C(C(OC)=O)N=C5NC/4=O)=O,Ansornitinib,Data.sdf,10113,HY-147243,ANG-3070,1448874-96-1,PDGFR; VEGFR,Protein Tyrosine Kinase/RTK,C30H32N6O4,10mM,Inflammation/Immunology; Cardiovascular Disease,Phase 2,COC(=O)c1ccc2c(n1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1,清洗成功,0.2659574468085106
10,Fc1cccc(-n2cnc3c(NCc4nc5ccc(F)c(F)c5[nH]4)nc(N4CCOCC4)nc32)c1,1,0.991600513458252,0.991600513458252,FC1=CC(N2C=NC3=C(NCC4=NC5=CC=C(F)C(F)=C5N4)N=C(N6CCOCC6)N=C23)=CC=C1,SR-3029,Data.sdf,10,HY-100011,,1454585-06-8,Casein Kinase,Cell Cycle/DNA Damage; Stem Cell/Wnt,C23H19F3N8O,10mM,Cancer,No Development Reported,Fc1cccc(-n2cnc3c(NCc4nc5ccc(F)c(F)c5[nH]4)nc(N4CCOCC4)nc32)c1,清洗成功,0.2745098039215686
8942,Cc1nn(-c2ccc(C(N)=O)c(N[C@H]3CC[C@H](O)CC3)c2)c2c1C(=O)CC(C)(C)C2,1,0.9915988445281982,0.9915988445281982,CC1=NN(C2=CC(N[C@@H]3CC[C@H](CC3)O)=C(C=C2)C(N)=O)C(CC(C)(C4)C)=C1C4=O,AT-533,Data.sdf,10548,HY-148877,,908112-37-8,Akt; ERK; FAK; HIF/HIF Prolyl-Hydroxylase; HSP; HSV; NF-?oB; VEGFR,Anti-infection; Cell Cycle/DNA Damage; MAPK/ERK Pathway; Metabolic Enzyme/Protease; NF-?oB; PI3K/Akt/mTOR; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt,C23H30N4O3,10mM,Cancer; Infection; Inflammation/Immunology,No Development Reported,Cc1nn(-c2ccc(C(N)=O)c(N[C@H]3CC[C@H](O)CC3)c2)c2c1C(=O)CC(C)(C)C2,清洗成功,0.2716049382716049
15657,O=c1cc(-c2ccc(O)cc2)oc2cc(O)c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@@H]3OC[C@H](O)[C@H](O)[C@H]3O)c(O)c12,1,0.9915881752967834,0.9915881752967834,O=C1C=C(C2=CC=C(O)C=C2)OC3=CC(O)=C([C@H]4[C@@H]([C@H]([C@@H]([C@@H](CO)O4)O)O)O[C@H]5[C@@H]([C@H]([C@H](CO5)O)O)O)C(O)=C13,Isovitexin 2''-O-arabinoside,Data.sdf,18692,HY-N5114,,53382-71-1,Others,Others,C26H28O14,10mM,Others,No Development Reported,O=c1cc(-c2ccc(O)cc2)oc2cc(O)c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@@H]3OC[C@H](O)[C@H](O)[C@H]3O)c(O)c12,清洗成功,0.2580645161290322
9618,COC(=O)c1cc2c(=O)[nH]c(-c3cnn(Cc4ccc(OC)cc4)c3)cn2n1,1,0.9915662407875061,0.9915662407875061,O=C(C1=NN2C=C(C3=CN(CC4=CC=C(C=C4)OC)N=C3)NC(C2=C1)=O)OC,JAK-IN-25,Data.sdf,11362,HY-153440,,2127110-22-7,JAK,Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt,C19H17N5O4,10mM,Cancer,No Development Reported,COC(=O)c1cc2c(=O)[nH]c(-c3cnn(Cc4ccc(OC)cc4)c3)cn2n1,清洗成功,0.2954545454545454
8592,COc1ccc([C@H]2CC[C@H](CN(c3cccc(-c4cnn(C5CC5)c4)c3)C(=O)[C@H]3CC[C@H](O)CC3)CC2)cc1C,1,0.9915538430213928,0.9915538430213928,CC(C=C1[C@@H](CC2)CC[C@H]2CN(C3=CC(C4=CN(C5CC5)N=C4)=CC=C3)C([C@@H]6CC[C@H](CC6)O)=O)=C(C=C1)OC,Omesdafexor,Data.sdf,10133,HY-147296,MET642,2244440-85-3,FXR,Metabolic Enzyme/Protease,C34H43N3O3,10mM,Cancer; Inflammation/Immunology,Phase 2,COc1ccc([C@H]2CC[C@H](CN(c3cccc(-c4cnn(C5CC5)c4)c3)C(=O)[C@H]3CC[C@H](O)CC3)CC2)cc1C,清洗成功,0.2772277227722772
10676,COc1ccc(S(=O)(=O)Nc2cc(-c3csc(C#N)c3)ccc2C)cc1,1,0.9915452003479004,0.9915452003479004,O=S(C1=CC=C(OC)C=C1)(NC2=CC(C3=CSC(C#N)=C3)=CC=C2C)=O,EL-102,Data.sdf,12650,HY-16187,,1233948-61-2,Apoptosis; HIF/HIF Prolyl-Hydroxylase,Apoptosis; Metabolic Enzyme/Protease,C19H16N2O3S2,10mM,Cancer,No Development Reported,COc1ccc(S(=O)(=O)Nc2cc(-c3csc(C#N)c3)ccc2C)cc1,清洗成功,0.3090909090909091
7502,Nc1ccc2[nH]c(-c3cccc(-c4nc5cc(N)ccc5[nH]4)c3)nc2c1,1,0.9915444850921631,0.9915444850921631,NC1=CC=C2C(N=C(C3=CC=CC(C4=NC5=CC(N)=CC=C5N4)=C3)N2)=C1,TGP-377/421,Data.sdf,8872,HY-138647,Targapre-miR-377/421,16752-89-9,MicroRNA,Epigenetics,C20H16N6,10mM,Cardiovascular Disease,No Development Reported,Nc1ccc2[nH]c(-c3cccc(-c4nc5cc(N)ccc5[nH]4)c3)nc2c1,清洗成功,0.3333333333333333
6767,COC(=O)Nc1nc2ccc(C(=O)c3cccs3)cc2[nH]1,1,0.9915394186973572,0.9915394186973572,O=C(OC)NC1=NC2=CC=C(C(C3=CC=CS3)=O)C=C2N1,Nocodazole,Data.sdf,8031,HY-13520,Oncodazole; R17934,31430-18-9,Apoptosis; Autophagy; Bcr-Abl; CRISPR/Cas9; Microtubule/Tubulin,Apoptosis; Autophagy; Cell Cycle/DNA Damage; Cytoskeleton; Protein Tyrosine Kinase/RTK,C14H11N3O3S,10mM,Cancer,No Development Reported,COC(=O)Nc1nc2ccc(C(=O)c3cccs3)cc2[nH]1,清洗成功,0.2976190476190476
10816,C=CC(=O)N(C)[C@H]1C[C@@](C)(Oc2nc(-c3cnn(C)c3)cn3nccc23)C1,1,0.9915383458137512,0.9915383458137512,CN(N=C1)C=C1C2=CN3C(C(O[C@]4(C[C@H](C4)N(C)C(C=C)=O)C)=N2)=CC=N3,BIIB129,Data.sdf,12824,HY-163565,,2770960-52-4,Btk,Protein Tyrosine Kinase/RTK,C19H22N6O2,10mM,Neurological Disease,No Development Reported,C=CC(=O)N(C)[C@H]1C[C@@](C)(Oc2nc(-c3cnn(C)c3)cn3nccc23)C1,清洗成功,0.3
12088,COc1c2occc2cc2ccc(=O)oc12,1,0.991534948348999,0.991534948348999,O=C1OC(C(C=C1)=C2)=C(OC)C3=C2C=CO3,Methoxsalen,Data.sdf,14292,HY-30151,8-Methoxypsoralen; Xanthotoxin; 8-MOP,298-81-7,Cytochrome P450,Metabolic Enzyme/Protease,C12H8O4,10mM,Inflammation/Immunology; Cancer,Launched,COc1c2occc2cc2ccc(=O)oc12,清洗成功,0.2549019607843137
15522,O=C(O)[C@H]1O[C@@H](Oc2cc(-c3cc(=O)c4c(O)cc(O)cc4o3)ccc2O)[C@H](O)[C@@H](O)[C@@H]1O,1,0.9915335774421692,0.9915335774421692,O=C1C2=C(O)C=C(O)C=C2OC(C3=CC(O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)=C(O)C=C3)=C1,Luteolin-3-O-beta-D-glucuronide,Data.sdf,18514,HY-N4099,,53527-42-7,Others,Others,C21H18O12,10mM,Inflammation/Immunology,No Development Reported,O=C(O)[C@H]1O[C@@H](Oc2cc(-c3cc(=O)c4c(O)cc(O)cc4o3)ccc2O)[C@H](O)[C@@H](O)[C@@H]1O,清洗成功,0.35
10460,Cn1nc(C(=O)Nc2n[nH]c(-c3c(F)cccc3F)n2)cc1C1CC1,1,0.9915281534194946,0.9915281534194946,CN1N=C(C(NC2=NNC(C3=C(F)C=CC=C3F)=N2)=O)C=C1C4CC4,PAR4 antagonist 6,Data.sdf,12397,HY-159632,,,Protease Activated Receptor (PAR),GPCR/G Protein,C16H14F2N6O,10mM,Inflammation/Immunology,No Development Reported,Cn1nc(C(=O)Nc2n[nH]c(-c3c(F)cccc3F)n2)cc1C1CC1,清洗成功,0.2840909090909091
8348,c1ccc2oc(-c3csc(C4CCN(Cc5nc6ncccc6[nH]5)CC4)n3)cc2c1,1,0.9915177226066589,0.9915177226066589,C12=C(OC(C3=CSC(C4CCN(CC5=NC6=C(C=CC=N6)N5)CC4)=N3)=C2)C=CC=C1,BAY-179,Data.sdf,9847,HY-145707,,2764880-87-5,Mitochondrial Metabolism,Metabolic Enzyme/Protease,C23H21N5OS,10mM,Cancer,No Development Reported,c1ccc2oc(-c3csc(C4CCN(Cc5nc6ncccc6[nH]5)CC4)n3)cc2c1,清洗成功,0.2365591397849462
16083,O=c1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,1,0.991513192653656,0.991513192653656,O=C1C(O[C@H](O[C@@H]2CO)[C@@H]([C@H]([C@@H]2O)O)O[C@H](OC[C@H]3O)[C@@H]([C@H]3O)O)=C(C(C=C4)=CC(O)=C4O)OC5=CC(O)=CC(O)=C15,Quercetin 3-O-sambubioside,Data.sdf,19227,HY-N8028,,83048-35-5,Others,Others,C26H28O16,10mM,Cancer,No Development Reported,O=c1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,清洗成功,0.3055555555555556
9436,Cn1cc(-c2cc(Oc3cc(F)c(NC(=O)C4(C(=O)Nc5ccccc5)CC4)cc3F)ccn2)cn1,1,0.9915114045143127,0.9915114045143127,O=C(C1(CC1)C(NC2=CC=CC=C2)=O)NC3=CC(F)=C(OC4=CC=NC(C5=CN(C)N=C5)=C4)C=C3F,c-Kit-IN-1,Data.sdf,11136,HY-15240,,1225278-16-9,c-Kit; c-Met/HGFR,Protein Tyrosine Kinase/RTK,C26H21F2N5O3,10mM,Cancer,Launched,Cn1cc(-c2cc(Oc3cc(F)c(NC(=O)C4(C(=O)Nc5ccccc5)CC4)cc3F)ccn2)cn1,清洗成功,0.3152173913043478
4076,CCOC1(c2ccc(-c3cc4c(N5CCN(C(=O)O[C@@H]6CCOC6)CC5)ccnn4c3)nc2)CCN(C(C)C)CC1,1,0.9915062785148621,0.9915062785148621,O=C(N1CCN(C2=CC=NN3C2=CC(C4=NC=C(C5(OCC)CCN(C(C)C)CC5)C=C4)=C3)CC1)O[C@H]6COCC6,Fidrisertib,Data.sdf,4785,HY-117887,BLU-782; IPN-60130; ALK2-IN-1,2141955-96-4,TGF-?2 Receptor,TGF-beta/Smad,C31H42N6O4,10mM,Cancer,Phase 1,CCOC1(c2ccc(-c3cc4c(N5CCN(C(=O)O[C@@H]6CCOC6)CC5)ccnn4c3)nc2)CCN(C(C)C)CC1,清洗成功,0.2564102564102564
185,O=C(Nc1ccccc1)C12CC1/C(=N\O)c1ccccc1O2,1,0.9915043711662292,0.9915043711662292,O=C(C12C(C2)/C(C3=CC=CC=C3O1)=N\O)NC4=CC=CC=C4,PHCCC,Data.sdf,214,HY-100409,,179068-02-1,mGluR,GPCR/G Protein; Neuronal Signaling,C17H14N2O3,10mM,Cancer,No Development Reported,O=C(Nc1ccccc1)C12CC1/C(=N\O)c1ccccc1O2,清洗成功,0.2575757575757575
6228,COc1cccc2c(Nc3ccc4[nH]c(C(=O)N/N=C/c5ccc(SC)cc5)cc4c3)cc(C)nc12,1,0.9914972186088562,0.9914972186088562,CC1=NC2=C(OC)C=CC=C2C(NC3=CC4=C(NC(C(N/N=C/C5=CC=C(SC)C=C5)=O)=C4)C=C3)=C1,Nur77 modulator 1,Data.sdf,7366,HY-131364,,2469975-55-9,Apoptosis; Nuclear Hormone Receptor 4A/NR4A,Apoptosis; Vitamin D Related/Nuclear Receptor,C28H25N5O2S,10mM,Cancer,No Development Reported,COc1cccc2c(Nc3ccc4[nH]c(C(=O)N/N=C/c5ccc(SC)cc5)cc4c3)cc(C)nc12,清洗成功,0.2527472527472527
2770,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1,1,0.9914969801902771,0.9914969801902771,O=C(C1=CC(NC/2=O)=C(C=C1)C2=C(NC3=CC=C(N(C)C(CN4CCN(C)CC4)=O)C=C3)/C5=CC=CC=C5)OC.CCS(=O)(O)=O,Nintedanib esylate,Data.sdf,3256,HY-11106,BIBF 1120 (esylate),656247-18-6,FGFR; PDGFR; VEGFR,Protein Tyrosine Kinase/RTK,C33H39N5O7S,10mM,Cancer,Launched,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1,清洗成功,0.2647058823529412
6685,COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(I)n[nH]c3c1)C(=O)N2,1,0.9914899468421936,0.9914899468421936,O=C([C@@]12[C@H](C3=CC4=C(C=C3)C(I)=NN4)C1)NC5=C2C=C(OC)C=C5,PLK4-IN-1,Data.sdf,7935,HY-134775,,1247001-12-2,Polo-like Kinase (PLK),Cell Cycle/DNA Damage,C18H14IN3O2,10mM,Cancer,No Development Reported,COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(I)n[nH]c3c1)C(=O)N2,清洗成功,0.2985074626865671
12329,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1,1,0.9914897680282593,0.9914897680282593,O=C1NC2=CC(C(OC)=O)=CC=C2/C1=C(NC3=CC=C(N(C(CN4CCN(C)CC4)=O)C)C=C3)\C5=CC=CC=C5,Nintedanib,Data.sdf,14592,HY-50904,BIBF 1120,656247-17-5,FGFR; PDGFR; VEGFR,Protein Tyrosine Kinase/RTK,C31H33N5O4,10mM,Cancer,Launched,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1,清洗成功,0.28125
8359,CN1CC[C@@H](Nc2cccc3c2cc(-c2noc(CNC(=O)c4cnn(C(C)(C)C)c4)n2)n3CC(F)(F)F)[C@@H](F)C1,1,0.9914873838424683,0.9914873838424683,FC(F)(F)CN1C2=CC=CC(N[C@H]3[C@H](CN(CC3)C)F)=C2C=C1C4=NOC(CNC(C5=CN(N=C5)C(C)(C)C)=O)=N4,Mutant p53 modulator-1,Data.sdf,9860,HY-145759,,2746371-35-5,MDM-2/p53,Apoptosis,C27H32F4N8O2,10mM,Cancer,No Development Reported,CN1CC[C@@H](Nc2cccc3c2cc(-c2noc(CNC(=O)c4cnn(C(C)(C)C)c4)n2)n3CC(F)(F)F)[C@@H](F)C1,清洗成功,0.2586206896551724
14527,COc1ccc(-c2cc(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3o2)cc1,1,0.9914777874946594,0.9914777874946594,O=C(C=C(C1=CC=C(OC)C=C1)OC2=CC(O[C@@H]([C@@H]([C@@H](O)[C@@H]3O)O)O[C@@H]3CO[C@H](O[C@@H](C)[C@H](O)[C@H]4O)[C@@H]4O)=C5)C2=C5O,Linarin,Data.sdf,17196,HY-N0528,Buddleoside; Linarine,480-36-4,Apoptosis; Bacterial; Cholinesterase (ChE); HIV; Influenza Virus; PKA; TNF Receptor,Anti-infection; Apoptosis; Neuronal Signaling; Stem Cell/Wnt; TGF-beta/Smad,C28H32O14,10mM,Cancer; Infection; Inflammation/Immunology; Neurological Disease,No Development Reported,COc1ccc(-c2cc(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3o2)cc1,清洗成功,0.3023255813953488
621,Cc1nc(-c2ccc(-c3ccc(C(=O)N4CCc5cc6c(cc54)C4(CCN(C)CC4)CO6)cc3)c(C)c2)no1,1,0.9914655089378357,0.9914655089378357,O=C(C1=CC=C(C2=CC=C(C3=NOC(C)=N3)C=C2C)C=C1)N4CCC5=C4C=C6C(OCC67CCN(C)CC7)=C5.Cl,SB-224289 (hydrochloride),Data.sdf,705,HY-101105A,SB-224289A,180084-26-8,5-HT Receptor,GPCR/G Protein; Neuronal Signaling,C32H33ClN4O3,2mM,Neurological Disease,No Development Reported,Cc1nc(-c2ccc(-c3ccc(C(=O)N4CCc5cc6c(cc54)C4(CCN(C)CC4)CO6)cc3)c(C)c2)no1,清洗成功,0.24
14926,COc1cc2c(=O)c3c(O)c([C@@H]4O[C@H](CO[C@@H]5OC[C@](O)(CO)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)c(O)cc3oc2cc1O,1,0.991463840007782,0.991463840007782,COC1=C(O)C=C(OC(C=C(O)C([C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]3OC[C@@](CO)(O)[C@H]3O)O2)=C4O)=C4C5=O)C5=C1,Polygalaxanthone III,Data.sdf,17725,HY-N1407,,162857-78-5,Cytochrome P450,Metabolic Enzyme/Protease,C25H28O15,10mM,Inflammation/Immunology,No Development Reported,COc1cc2c(=O)c3c(O)c([C@@H]4O[C@H](CO[C@@H]5OC[C@](O)(CO)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)c(O)cc3oc2cc1O,清洗成功,0.2717391304347826
17452,COc1ccnc(CSc2nc3cc(OC(F)F)ccc3[nH]2)c1OC,1,0.9914596080780029,0.9914596080780029,COC1=C(OC)C(CSC2=NC3=CC(OC(F)F)=CC=C3N2)=NC=C1,Pantoprazole sulfide,Data.sdf,20785,HY-W016033,,102625-64-9,Drug Metabolite; Proton Pump,Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease,C16H15F2N3O3S,10mM,Metabolic Disease,No Development Reported,COc1ccnc(CSc2nc3cc(OC(F)F)ccc3[nH]2)c1OC,清洗成功,0.2985074626865671
10166,COc1ccc(-c2c(C)nc3c(N4CC[C@@H](NC(=O)Oc5ccccc5)C4)cc(C)nn23)cc1OC,1,0.991452693939209,0.991452693939209,CC1=C(C2=CC(OC)=C(C=C2)OC)N(N=C(C=C3N4C[C@@H](CC4)NC(OC5=CC=CC=C5)=O)C)C3=N1,PDDC,Data.sdf,12026,HY-156800,,2232878-43-0,Phospholipase,Metabolic Enzyme/Protease,C27H29N5O4,10mM,Others,No Development Reported,COc1ccc(-c2c(C)nc3c(N4CC[C@@H](NC(=O)Oc5ccccc5)C4)cc(C)nn23)cc1OC,清洗成功,0.2745098039215686
11436,CNS(=O)(=O)c1ccc(F)c(-c2c3nc(c(-c4c(F)ccc(S(=O)(=O)NC)c4F)c4ccc([nH]4)c(-c4c(F)ccc(S(=O)(=O)NC)c4F)c4nc(c(-c5c(F)ccc(S(=O)(=O)NC)c5F)c5ccc2[nH]5)CC4)CC3)c1F,1,0.9914447665214539,0.9914447665214539,O=S(C1=CC=C(F)C(/C2=C3CCC(/C(C4=C(F)C(S(=O)(NC)=O)=CC=C4F)=C5C=C/C(N/5)=C(C6=C(F)C(S(=O)(NC)=O)=CC=C6F)/C(CC/7)=NC7=C(C8=C(F)C(S(=O)(NC)=O)=CC=C8F)/C9=CC=C2N9)=N\3)=C1F)(NC)=O,Redaporfin,Data.sdf,13521,HY-17644,LUZ11; F2BMet,1224104-08-8,Reactive Oxygen Species,Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?oB,C48H38F8N8O8S4,10mM,Cancer,Phase 2,CNS(=O)(=O)c1ccc(F)c(-c2c3nc(c(-c4c(F)ccc(S(=O)(=O)NC)c4F)c4ccc([nH]4)c(-c4c(F)ccc(S(=O)(=O)NC)c4F)c4nc(c(-c5c(F)ccc(S(=O)(=O)NC)c5F)c5ccc2[nH]5)CC4)CC3)c1F,清洗成功,0.2105263157894736
2271,CC1(C)CCC(C)(C)c2cc3cc(-c4cc(C(=O)O)cs4)ccc3cc21,1,0.9914417862892151,0.9914417862892151,O=C(C1=CSC(C2=CC=C3C=C4C(C)(C)CCC(C)(C)C4=CC3=C2)=C1)O,CD2314,Data.sdf,2663,HY-108533,,170355-37-0,RAR/RXR,Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor,C23H24O2S,10mM,Cancer,No Development Reported,CC1(C)CCC(C)(C)c2cc3cc(-c4cc(C(=O)O)cs4)ccc3cc21,清洗成功,0.303030303030303
4090,Cc1ccsc1-c1nc(-c2ccc(O)c(O)c2)cs1,1,0.9914358258247375,0.9914358258247375,OC1=CC=C(C=C1O)C2=CSC(C3=C(C=CS3)C)=N2,MTBT,Data.sdf,4801,HY-118034,,1110905-26-4,p38 MAPK,MAPK/ERK Pathway,C14H11NO2S2,10mM,cancer,No Development Reported,Cc1ccsc1-c1nc(-c2ccc(O)c(O)c2)cs1,清洗成功,0.2542372881355932
2415,Cc1noc(C)c1-c1cc(C(O)(c2ccccn2)c2ccccn2)c2[nH]c(C3CC3)nc2c1,1,0.9914320707321167,0.9914320707321167,OC(C1=CC=CC=N1)(C2=CC=CC=N2)C3=C(NC(C4CC4)=N5)C5=CC(C(C(C)=NO6)=C6C)=C3,Alobresib,Data.sdf,2840,HY-109050,GS-5829,1637771-14-2,Epigenetic Reader Domain,Epigenetics,C26H23N5O2,10mM,Cancer,Phase 2,Cc1noc(C)c1-c1cc(C(O)(c2ccccn2)c2ccccn2)c2[nH]c(C3CC3)nc2c1,清洗成功,0.2285714285714285
15604,O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@@H]3OC[C@](O)(CO)[C@H]3O)cc(O)c12,1,0.9914234280586243,0.9914234280586243,O=C1C2=C(O)C=C(O[C@H]3[C@@H]([C@H]([C@H](O)[C@@H](CO)O3)O)O[C@@]4([H])[C@@H]([C@](CO)(O)CO4)O)C=C2OC(C5=CC(O)=C(O)C=C5)=C1,Graveobioside A,Data.sdf,18628,HY-N4318,,506410-53-3,Others,Others,C26H28O15,10mM,Metabolic Disease,No Development Reported,O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@@H]3OC[C@](O)(CO)[C@H]3O)cc(O)c12,清洗成功,0.2659574468085106
10071,CC1(Nc2nc(N)nc3cc(-c4cc[nH]n4)ccc23)CC1,1,0.9914201498031616,0.9914201498031616,NC1=NC(NC2(C)CC2)=C3C(C=C(C=C3)C4=NNC=C4)=N1,NLRP3 agonist 1,Data.sdf,11913,HY-156413,,2454019-69-1,NOD-like Receptor (NLR),Immunology/Inflammation,C15H16N6,10mM,Inflammation/Immunology,No Development Reported,CC1(Nc2nc(N)nc3cc(-c4cc[nH]n4)ccc23)CC1,清洗成功,0.273972602739726
15746,CNc1ccc2oc(C[C@H]3O[C@@]4(CC[C@H]3C)O[C@H]([C@H](C)C(=O)c3ccc[nH]3)[C@H](C)C[C@H]4C)nc2c1C(=O)O,1,0.9914150834083557,0.9914150834083557,O=C(C1=C2N=C(C[C@H]3O[C@]4(O[C@H]([C@H](C)C(C5=CC=CN5)=O)[C@H](C)C[C@H]4C)CC[C@H]3C)OC2=CC=C1NC)O,Calcimycin,Data.sdf,18819,HY-N6687,A-23187; Antibiotic A-23187,52665-69-7,Antibiotic; Apoptosis; Autophagy; Bacterial; Fungal; Oxidative Phosphorylation,Anti-infection; Apoptosis; Autophagy; Metabolic Enzyme/Protease,C29H37N3O6,10mM,Cancer; Infection,Phase 4,CNc1ccc2oc(C[C@H]3O[C@@]4(CC[C@H]3C)O[C@H]([C@H](C)C(=O)c3ccc[nH]3)[C@H](C)C[C@H]4C)nc2c1C(=O)O,清洗成功,0.1875
2910,CN(c1ccc(-c2ccc(-c3cn[nH]c3)cc2O)nn1)C1CC(C)(C)NC(C)(C)C1,1,0.9914095997810364,0.9914095997810364,OC1=C(C(N=N2)=CC=C2N(C(CC3(C)C)CC(C)(N3)C)C)C=CC(C4=CNN=C4)=C1,NVS-SM2,Data.sdf,3415,HY-111520,,1562333-92-9,DNA/RNA Synthesis,Cell Cycle/DNA Damage,C23H30N6O,10mM,Neurological Disease,No Development Reported,CN(c1ccc(-c2ccc(-c3cn[nH]c3)cc2O)nn1)C1CC(C)(C)NC(C)(C)C1,清洗成功,0.2857142857142857
12984,N[C@@H]1CN(c2c(F)cc3c(=O)c(C(=O)O)cn([C@@H]4C[C@@H]4F)c3c2Cl)CC12CC2,1,0.9914095997810364,0.9914095997810364,O=C(C1=CN([C@H]2[C@@H](F)C2)C3=C(C=C(F)C(N(C[C@H]4N)CC54CC5)=C3Cl)C1=O)O,Sitafloxacin,Data.sdf,15348,HY-B0395,DU6859a,127254-12-0,Antibiotic; Bacterial,Anti-infection,C19H18ClF2N3O3,10mM,Infection,Launched,N[C@@H]1CN(c2c(F)cc3c(=O)c(C(=O)O)cn([C@@H]4C[C@@H]4F)c3c2Cl)CC12CC2,清洗成功,0.2613636363636363
3913,CN1CCC(n2nc(-c3c(-c4ccccc4)nn4ccccc34)ccc2=O)CC1,1,0.9914062023162842,0.9914062023162842,O=C1C=CC(C2=C3C=CC=CN3N=C2C4=CC=CC=C4)=NN1C5CCN(CC5)C,FR194921,Data.sdf,4599,HY-116800,,202646-80-8,Adenosine Receptor,GPCR/G Protein,C23H23N5O,2mM,Neurological Disease,No Development Reported,CN1CCC(n2nc(-c3c(-c4ccccc4)nn4ccccc34)ccc2=O)CC1,清洗成功,0.25
10794,CN1CCC[C@@H](NC(=O)Cn2nc(C(C)(C)O)n3c(cc4sc(Cl)cc43)c2=O)C1,1,0.9914056062698364,0.9914056062698364,CC(O)(C(N1C2=C(SC(Cl)=C2)C=C13)=NN(CC(N[C@H]4CN(CCC4)C)=O)C3=O)C,NP3-562,Data.sdf,12795,HY-163159,,2409825-32-5,NOD-like Receptor (NLR),Immunology/Inflammation,C19H24ClN5O3S,10mM,Inflammation/Immunology,No Development Reported,CN1CCC[C@@H](NC(=O)Cn2nc(C(C)(C)O)n3c(cc4sc(Cl)cc43)c2=O)C1,清洗成功,0.2659574468085106
15185,O=c1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,1,0.9914029240608215,0.9914029240608215,O=C1C(O[C@H](O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H]2O[C@@](OC[C@@H](O)[C@@H]3O)([H])[C@@H]3O)=C(C4=CC=C(O)C=C4)OC5=CC(O)=CC(O)=C15,Leucoside,Data.sdf,18062,HY-N2186,,27661-51-4,Others,Others,C26H28O15,10mM,Others,No Development Reported,O=c1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,清洗成功,0.2957746478873239
7895,COC(=O)NC12CCC(n3cc(-c4cc(N)c(Cl)cc4F)c4c(N)ncnc43)(CC1)CC2,1,0.9913899302482605,0.9913899302482605,O=C(NC12CCC(CC1)(CC2)N3C=C(C4=C3N=CN=C4N)C5=C(F)C=C(Cl)C(N)=C5)OC,RET-IN-7,Data.sdf,9330,HY-141896,,2763386-05-4,RET,Protein Tyrosine Kinase/RTK,C22H24ClFN6O2,10mM,Cancer,No Development Reported,COC(=O)NC12CCC(n3cc(-c4cc(N)c(Cl)cc4F)c4c(N)ncnc43)(CC1)CC2,清洗成功,0.2291666666666666
7656,O=C1Nc2cccc(C#CC3(O)CCNCC3)c2/C1=C/c1cc2ccccc2[nH]1,1,0.9913764595985413,0.9913764595985413,O=C1/C(C2=C(C=CC=C2C#CC3(O)CCNCC3)N1)=C\C4=CC5=C(N4)C=CC=C5,SBI-581,Data.sdf,9061,HY-139439,,,Ser/Thr Protease,Metabolic Enzyme/Protease,C24H21N3O2,10mM,Cancer,No Development Reported,O=C1Nc2cccc(C#CC3(O)CCNCC3)c2/C1=C/c1cc2ccccc2[nH]1,清洗成功,0.2394366197183098
4410,CN(C)C(=O)Cn1cc(-c2ccc(-c3cncc4ccccc34)cc2)cn1,1,0.9913763403892517,0.9913763403892517,O=C(N(C)C)CN1N=CC(C2=CC=C(C3=CN=CC4=C3C=CC=C4)C=C2)=C1,BI-1347,Data.sdf,5194,HY-120350,,2163056-91-3,CDK,Cell Cycle/DNA Damage,C22H20N4O,10mM,Cancer,No Development Reported,CN(C)C(=O)Cn1cc(-c2ccc(-c3cncc4ccccc34)cc2)cn1,清洗成功,0.3
15031,O=c1cc(-c2ccc(O)cc2)oc2cccc(O)c12,1,0.991373598575592,0.991373598575592,O=C1C=C(C2=CC=C(O)C=C2)OC3=CC=CC(O)=C13,"4',5-Dihydroxyflavone",Data.sdf,17854,HY-N1881,,6665-67-4,Glycosidase; Lipoxygenase,Metabolic Enzyme/Protease,C15H10O4,10mM,Others,No Development Reported,O=c1cc(-c2ccc(O)cc2)oc2cccc(O)c12,清洗成功,0.3333333333333333
7033,Cc1cccc(Cn2nc(C3CC3)c3c(NC(=O)c4cnc5cc(OCCN6CCN(C)CC6)ccn45)cccc32)n1,1,0.9913662075996399,0.9913662075996399,O=C(C1=CN=C2C=C(OCCN3CCN(C)CC3)C=CN21)NC4=CC=CC5=C4C(C6CC6)=NN5CC7=NC(C)=CC=C7,ARRY-382,Data.sdf,8337,HY-136362,,1313407-95-2,c-Fms,Protein Tyrosine Kinase/RTK,C32H36N8O2,10mM,Cancer; Inflammation/Immunology,Phase 2,Cc1cccc(Cn2nc(C3CC3)c3c(NC(=O)c4cnc5cc(OCCN6CCN(C)CC6)ccn45)cccc32)n1,清洗成功,0.2685185185185185
5564,Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,1,0.9913647174835205,0.9913647174835205,O=C1NCCC12CCN(C3=C(Cl)C=NC=C3C4=CC=C(C5=CN(C)N=C5)C=C4)CC2,CCT251545,Data.sdf,6569,HY-12681,,1661839-45-7,Wnt,Stem Cell/Wnt,C23H24ClN5O,10mM,Cancer,No Development Reported,Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1,清洗成功,0.3
7730,CN1CCC(S(=O)(=O)c2ccc3cnc(Nc4ccc(-n5ccc(CO)n5)cc4F)cc3n2)CC1,1,0.9913555979728699,0.9913555979728699,O=S(C1=CC=C2C=NC(NC3=CC=C(N4N=C(CO)C=C4)C=C3F)=CC2=N1)(C5CCN(CC5)C)=O,CDK5-IN-1,Data.sdf,9148,HY-139725,,2639540-19-3,CDK,Cell Cycle/DNA Damage,C24H25FN6O3S,10mM,Metabolic Disease,No Development Reported,CN1CCC(S(=O)(=O)c2ccc3cnc(Nc4ccc(-n5ccc(CO)n5)cc4F)cc3n2)CC1,清洗成功,0.268041237113402
16149,COc1ccc(-c2cc(=O)c3ccccc3o2)cc1OC,1,0.9913486838340759,0.9913486838340759,O=C1C=C(C2=CC=C(OC)C(OC)=C2)OC3=CC=CC=C13,"3',4'-Dimethoxyflavone",Data.sdf,19312,HY-N8572,,4143-62-8,Aryl Hydrocarbon Receptor; PARP; Reactive Oxygen Species,Cell Cycle/DNA Damage; Epigenetics; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?oB,C17H14O4,10mM,Cancer; Inflammation/Immunology; Neurological Disease; Cardiovascular Disease,No Development Reported,COc1ccc(-c2cc(=O)c3ccccc3o2)cc1OC,清洗成功,0.3454545454545454
2845,O[C@@H]1CO[C@H]2[C@@H]1OC[C@H]2Oc1nc2nc(-c3ccc(-c4ccccc4)cc3)c(Cl)cc2[nH]1,1,0.9913397431373596,0.9913397431373596,O[C@H]1[C@@]([C@]2([H])OC1)([H])OC[C@H]2OC3=NC4=NC(C(C=C5)=CC=C5C6=CC=CC=C6)=C(Cl)C=C4N3,MK8722,Data.sdf,3342,HY-111363,,1394371-71-1,AMPK,Epigenetics; PI3K/Akt/mTOR,C24H20ClN3O4,10mM,Metabolic Disease,No Development Reported,O[C@@H]1CO[C@H]2[C@@H]1OC[C@H]2Oc1nc2nc(-c3ccc(-c4ccccc4)cc3)c(Cl)cc2[nH]1,清洗成功,0.2786885245901639
6410,O=c1[nH]c2ccc(Cl)cc2c(N[C@@H]2CN3CCC2CC3)c1-c1nc2ccccc2[nH]1,1,0.9913350939750671,0.9913350939750671,ClC1=CC2=C(NC(C(C3=NC4=C(C=CC=C4)N3)=C2N[C@@H]5CN6CCC5CC6)=O)C=C1,CHIR-124,Data.sdf,7588,HY-13263,,405168-58-3,Apoptosis; Checkpoint Kinase (Chk); FLT3; PDGFR,Apoptosis; Cell Cycle/DNA Damage; Protein Tyrosine Kinase/RTK,C23H22ClN5O,10mM,Cancer,No Development Reported,O=c1[nH]c2ccc(Cl)cc2c(N[C@@H]2CN3CCC2CC3)c1-c1nc2ccccc2[nH]1,清洗成功,0.3382352941176471
9433,CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@@H](O)[C@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)O[C@H]1C,1,0.9913327097892761,0.9913327097892761,OC1=CC(O)=C(C(C(O[C@@H]2O[C@@H](C)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H]2O)=C(C3=CC=C(O)C=C3)O4)=O)C4=C1,SL 0101-1,Data.sdf,11133,HY-15237,SL0101,77307-50-7,Ribosomal S6 Kinase (RSK),MAPK/ERK Pathway,C25H24O12,10mM,Cancer,No Development Reported,CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@@H](O)[C@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)O[C@H]1C,清洗成功,0.328125
7436,O=C(/N=c1\sccn1Cc1ccccc1)c1c[nH]c2ncccc12,1,0.9913318157196045,0.9913318157196045,O=C(C1=CNC2=NC=CC=C12)/N=C(SC=C3)/N3CC4=CC=CC=C4,TRULI,Data.sdf,8801,HY-138489,Lats-IN-1,1424635-83-5,YAP,Stem Cell/Wnt,C18H14N4OS,10mM,Others,No Development Reported,O=C(/N=c1\sccn1Cc1ccccc1)c1c[nH]c2ncccc12,清洗成功,0.3380281690140845
5094,CN(C)CC[C@@H](c1ccccc1)n1cc(NC(=O)c2n[nH]c3c2CCC(C)(C)C3)cn1,1,0.9913191199302673,0.9913191199302673,CN(C)CC[C@H](N1N=CC(NC(C2=NNC3=C2CCC(C)(C)C3)=O)=C1)C4=CC=CC=C4,GNE-9822,Data.sdf,5998,HY-12410,,1557232-32-2,Itk,Protein Tyrosine Kinase/RTK,C24H32N6O,10mM,Inflammation/Immunology,No Development Reported,CN(C)CC[C@@H](c1ccccc1)n1cc(NC(=O)c2n[nH]c3c2CCC(C)(C)C3)cn1,清洗成功,0.2788461538461538
4741,Cc1c(Cc2ccc(-n3cccn3)cc2)cc2c(c1F)CN([C@H]1COCC[C@@H]1O)C2=O,1,0.9913190007209778,0.9913190007209778,O=C1C2=CC(CC3=CC=C(N4C=CC=N4)C=C3)=C(C)C(F)=C2CN1[C@@H]5[C@H](CCOC5)O,TAK-071,Data.sdf,5572,HY-122190,,1820812-16-5,mAChR,GPCR/G Protein; Neuronal Signaling,C24H24FN3O3,10mM,Neurological Disease,Phase 2,Cc1c(Cc2ccc(-n3cccn3)cc2)cc2c(c1F)CN([C@H]1COCC[C@@H]1O)C2=O,清洗成功,0.2626262626262626
14540,COc1cc(O)c2c(c1)oc(=O)c1c3cc(O)c(O)cc3oc21,1,0.9913089275360107,0.9913089275360107,O=C1C2=C(OC3=CC(O)=C(O)C=C32)C4=C(O)C=C(OC)C=C4O1,Wedelolactone,Data.sdf,17212,HY-N0551,,524-12-9,Apoptosis; Caspase; Lipoxygenase,Apoptosis; Metabolic Enzyme/Protease,C16H10O7,10mM,Cancer; Inflammation/Immunology,No Development Reported,COc1cc(O)c2c(c1)oc(=O)c1c3cc(O)c(O)cc3oc21,清洗成功,0.3469387755102041
233,C[C@@H]1CC(=O)Nc2cccc(-c3ccc4c(c3)c(-c3cnn(C)c3)nn4C)c2N1,1,0.9913017153739929,0.9913017153739929,O=C1NC2=CC=CC(C3=CC4=C(N(C)N=C4C5=CN(C)N=C5)C=C3)=C2N[C@H](C)C1,CPI-637,Data.sdf,266,HY-100482,,1884712-47-3,Epigenetic Reader Domain; Histone Acetyltransferase,Epigenetics,C22H22N6O,10mM,Cancer,No Development Reported,C[C@@H]1CC(=O)Nc2cccc(-c3ccc4c(c3)c(-c3cnn(C)c3)nn4C)c2N1,清洗成功,0.3095238095238095
15771,COc1cc2c(=O)c3c(O)c([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4OC[C@](O)(CO)[C@H]4O)c(O)cc3oc2cc1O,1,0.9912981986999512,0.9912981986999512,OC1=C2C(OC3=CC(O)=C(OC)C=C3C2=O)=CC(O)=C1[C@H]4[C@@H]([C@H]([C@H](O)[C@@H](CO)O4)O)O[C@@]5([H])[C@@H]([C@](CO)(O)CO5)O,Polygalaxanthone XI,Data.sdf,18845,HY-N6803,,857859-82-6,Others,Others,C25H28O15,10mM,Neurological Disease,No Development Reported,COc1cc2c(=O)c3c(O)c([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4OC[C@](O)(CO)[C@H]4O)c(O)cc3oc2cc1O,清洗成功,0.2934782608695652
7273,CC#CC(=O)N1CC[C@@H](n2cc(-c3ccc(Oc4c(F)cccc4F)cc3)c3c(N)n[nH]c(=O)c32)C1,1,0.9912972450256348,0.9912972450256348,O=C1C2=C(C(N)=NN1)C(C(C=C3)=CC=C3OC(C(F)=CC=C4)=C4F)=CN2[C@@](CC5)([H])CN5C(C#CC)=O,Edralbrutinib,Data.sdf,8608,HY-137438,TG-1701,1858206-58-2,Btk,Protein Tyrosine Kinase/RTK,C26H21F2N5O3,10mM,Cancer,Phase 1,CC#CC(=O)N1CC[C@@H](n2cc(-c3ccc(Oc4c(F)cccc4F)cc3)c3c(N)n[nH]c(=O)c32)C1,清洗成功,0.268041237113402
5915,CNC(=O)c1ccc(-c2cnc3cnc(C(=O)N(C)c4ccc(Cl)cc4)cn23)cc1,1,0.991294801235199,0.991294801235199,ClC1=CC=C(N(C(C2=CN3C(C=N2)=NC=C3C4=CC=C(C(NC)=O)C=C4)=O)C)C=C1,KDU691,Data.sdf,6995,HY-12912,,1513879-19-0,Parasite; PI4K,Anti-infection; PI3K/Akt/mTOR,C22H18ClN5O2,10mM,Infection,No Development Reported,CNC(=O)c1ccc(-c2cnc3cnc(C(=O)N(C)c4ccc(Cl)cc4)cn23)cc1,清洗成功,0.3164556962025316
6121,CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1,1,0.9912872910499573,0.9912872910499573,O=C(NC1=CC=C(C=C1F)OC2=CC(NC(N3CCC(CC3)N4CCN(CC4)C)=O)=NC=C2)C5(CC5)C(NC6=CC=C(C=C6)F)=O,Golvatinib,Data.sdf,7243,HY-13068,E-7050,928037-13-2,c-Met/HGFR; VEGFR,Protein Tyrosine Kinase/RTK,C33H37F2N7O4,10mM,Cancer,Phase 2,CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1,清洗成功,0.2912621359223301
10563,C[C@@]1(C(F)(F)F)CN(C(=O)Nc2cnc(-n3nccn3)c(Cl)c2)c2cnc3cc(F)nn3c21,1,0.9912872910499573,0.9912872910499573,FC(F)([C@]1(C2=C(C=NC3=CC(F)=NN32)N(C1)C(NC4=CN=C(N5N=CC=N5)C(Cl)=C4)=O)C)F,SGR-1505,Data.sdf,12519,HY-160698,,2661481-41-8,MALT1,Metabolic Enzyme/Protease; NF-?oB,C18H12ClF4N9O,10mM,Cancer,Phase 1,C[C@@]1(C(F)(F)F)CN(C(=O)Nc2cnc(-n3nccn3)c(Cl)c2)c2cnc3cc(F)nn3c21,清洗成功,0.2531645569620253
15454,CC(C)(O)[C@H]1Cc2cc3cc(-c4cc(O)cc(O)c4)oc3cc2O1,1,0.9912863373756409,0.9912863373756409,CC(O)([C@H]1CC2=CC(C=C(C3=CC(O)=CC(O)=C3)O4)=C4C=C2O1)C,Moracin O,Data.sdf,18423,HY-N3244,,123702-97-6,HIF/HIF Prolyl-Hydroxylase; Reactive Oxygen Species,Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?oB,C19H18O5,10mM,Cancer; Inflammation/Immunology; Neurological Disease,No Development Reported,CC(C)(O)[C@H]1Cc2cc3cc(-c4cc(O)cc(O)c4)oc3cc2O1,清洗成功,0.2
8092,Cc1cnn(-c2ccncc2N2CCC(C(=O)N(C)C)CC2)c1,1,0.9912797808647156,0.9912797808647156,O=C(C1CCN(C2=C(N3N=CC(C)=C3)C=CN=C2)CC1)N(C)C,Cholesterol 24-hydroxylase-IN-1,Data.sdf,9558,HY-144309,,1613480-70-8,Cytochrome P450,Metabolic Enzyme/Protease,C17H23N5O,10mM,Neurological Disease,No Development Reported,Cc1cnn(-c2ccncc2N2CCC(C(=O)N(C)C)CC2)c1,清洗成功,0.32
7717,CN(C)CCNc1ccc2cc(C(=O)Nc3cc(-c4cccs4)ccc3N)ncc2c1,1,0.9912795424461365,0.9912795424461365,O=C(C1=CC2=CC=C(NCCN(C)C)C=C2C=N1)NC3=C(N)C=CC(C4=CC=CS4)=C3,HDAC1/2-IN-3,Data.sdf,9130,HY-139650,,2121516-17-2,HDAC,Cell Cycle/DNA Damage; Epigenetics,C24H25N5OS,10mM,Cancer,No Development Reported,CN(C)CCNc1ccc2cc(C(=O)Nc3cc(-c4cccs4)ccc3N)ncc2c1,清洗成功,0.3222222222222222
9132,C=CC(=O)N[C@@H]1CCCN(Cc2ccnc(C(=O)Nc3ccc(-c4cc5c(N6CCOCC6)ncnc5[nH]4)cc3)c2)C1,1,0.991278350353241,0.991278350353241,O=C(C1=CC(CN2C[C@@H](CCC2)NC(C=C)=O)=CC=N1)NC3=CC=C(C=C3)C4=CC5=C(N6CCOCC6)N=CN=C5N4,BMF-219,Data.sdf,10770,HY-150105,Menin-MLL inhibitor 21,2448172-22-1,Epigenetic Reader Domain,Epigenetics,C31H34N8O3,10mM,Cancer; Inflammation/Immunology,Phase 2,C=CC(=O)N[C@@H]1CCCN(Cc2ccnc(C(=O)Nc3ccc(-c4cc5c(N6CCOCC6)ncnc5[nH]4)cc3)c2)C1,清洗成功,0.3137254901960784
14597,CC1(C)Oc2cc3oc(-c4cc(O)cc(O[C@@H]5OC[C@@H](O)[C@H](O)[C@H]5O)c4)cc3cc2CC1O,1,0.9912692308425903,0.9912692308425903,OC1=CC(O[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)=CC(C3=CC4=C(C=C(OC(C)(C)C(O)C5)C5=C4)O3)=C1,Mulberroside C,Data.sdf,17280,HY-N0620,,102841-43-0,HCV,Anti-infection,C24H26O9,10mM,Infection,No Development Reported,CC1(C)Oc2cc3oc(-c4cc(O)cc(O[C@@H]5OC[C@@H](O)[C@H](O)[C@H]5O)c4)cc3cc2CC1O,清洗成功,0.1764705882352941
8203,O=C(Nc1ccn(-c2ccnc(F)c2)n1)C1(c2ccccc2F)CC1,1,0.9912672638893127,0.9912672638893127,O=C(C1(CC1)C2=C(F)C=CC=C2)NC3=NN(C4=CC(F)=NC=C4)C=C3,ELOVL1-IN-1,Data.sdf,9688,HY-145122,,2227482-41-7,ELOVL,Metabolic Enzyme/Protease,C18H14F2N4O,10mM,Metabolic Disease,No Development Reported,O=C(Nc1ccn(-c2ccnc(F)c2)n1)C1(c2ccccc2F)CC1,清洗成功,0.2631578947368421
12258,Cn1cc(-c2ccncc2)c(-c2ccc(OCc3ccc4ccccc4n3)cc2)n1,1,0.9912624359130859,0.9912624359130859,CN(N=C1C2=CC=C(OCC3=NC4=CC=CC=C4C=C3)C=C2)C=C1C5=CC=NC=C5,Mardepodect,Data.sdf,14503,HY-50098,PF-2545920,898562-94-2,Phosphodiesterase (PDE),Metabolic Enzyme/Protease,C25H20N4O,10mM,Neurological Disease,Phase 2,Cn1cc(-c2ccncc2)c(-c2ccc(OCc3ccc4ccccc4n3)cc2)n1,清洗成功,0.2769230769230769
12259,Cn1cc(-c2ccncc2)c(-c2ccc(OCc3ccc4ccccc4n3)cc2)n1,1,0.9912624359130859,0.9912624359130859,CN1N=C(C2=CC=C(OCC3=NC4=CC=CC=C4C=C3)C=C2)C(C5=CC=NC=C5)=C1.Cl[H],Mardepodect (hydrochloride),Data.sdf,14504,HY-50098A,PF-2545920 (hydrochloride),2070014-78-5,Phosphodiesterase (PDE),Metabolic Enzyme/Protease,C25H21ClN4O,10mM,Cancer,Phase 2,Cn1cc(-c2ccncc2)c(-c2ccc(OCc3ccc4ccccc4n3)cc2)n1,清洗成功,0.2727272727272727
10162,Cc1cccnc1-c1csc(C(=O)Nc2cc(Cl)cc(NS(C)(=O)=O)c2)c1,1,0.991257905960083,0.991257905960083,ClC1=CC(NC(C2=CC(C3=NC=CC=C3C)=CS2)=O)=CC(NS(C)(=O)=O)=C1,ATX968,Data.sdf,12022,HY-156784,DHX9-IN-2,2973395-71-8,DNA/RNA Synthesis,Cell Cycle/DNA Damage,C18H16ClN3O3S2,10mM,cancer,No Development Reported,Cc1cccnc1-c1csc(C(=O)Nc2cc(Cl)cc(NS(C)(=O)=O)c2)c1,清洗成功,0.32
10127,CNC(=O)c1ccc(NCC#Cc2cc3c(N[C@@H]4CCN(C)C[C@@H]4F)cccc3n2CC(F)(F)F)c(OC)c1,1,0.9912497997283936,0.9912497997283936,FC(F)(F)CN1C2=CC=CC(N[C@H]3[C@H](CN(CC3)C)F)=C2C=C1C#CCNC4=C(C=C(C=C4)C(NC)=O)OC,Rezatapopt,Data.sdf,11979,HY-156633,PC14586,2636846-41-6,MDM-2/p53,Apoptosis,C28H31F4N5O2,10mM,cancer,Phase 2,CNC(=O)c1ccc(NCC#Cc2cc3c(N[C@@H]4CCN(C)C[C@@H]4F)cccc3n2CC(F)(F)F)c(OC)c1,清洗成功,0.2586206896551724
9009,C=Cc1cc(O)cc2nc(-c3ccc(O)c(F)c3)oc12,1,0.9912421703338623,0.9912421703338623,OC1=CC(C=C)=C(OC(C2=CC=C(O)C(F)=C2)=N3)C3=C1,Prinaberel,Data.sdf,10623,HY-14933,ERB-041,524684-52-4,Apoptosis; Estrogen Receptor/ERR; Wnt,Apoptosis; Stem Cell/Wnt; Vitamin D Related/Nuclear Receptor,C15H10FNO3,10mM,Cancer,Phase 2,C=Cc1cc(O)cc2nc(-c3ccc(O)c(F)c3)oc12,清洗成功,0.2545454545454545
14665,COc1cc(-c2oc3cc(O)cc(O)c3c(=O)c2O[C@@H]2O[C@H](CO[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)ccc1O,1,0.9912378191947937,0.9912378191947937,O=C1C(O[C@H](O[C@H](CO[C@H](O[C@@H](C)[C@H](O)[C@H]2O)[C@@H]2O)[C@@H](O)[C@@H]3O)[C@@H]3O[C@@](O[C@@H](C)[C@H](O)[C@H]4O)([H])[C@@H]4O)=C(C5=CC(OC)=C(O)C=C5)OC6=CC(O)=CC(O)=C16,Typhaneoside,Data.sdf,17371,HY-N0712,,104472-68-6,Autophagy,Autophagy,C34H42O20,10mM,Inflammation/Immunology; Cardiovascular Disease,No Development Reported,COc1cc(-c2oc3cc(O)cc(O)c3c(=O)c2O[C@@H]2O[C@H](CO[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)ccc1O,清洗成功,0.3225806451612903
9926,CN(C)[C@]1(c2ccccc2)CC[C@]2(CC1)OCCc1c3cc(F)ccc3[nH]c12,1,0.9912359714508057,0.9912359714508057,CN(C)[C@]1(C2=CC=CC=C2)CC[C@]3(C(N4)=C(CCO3)C5=C4C=CC(F)=C5)CC1,Cebranopadol,Data.sdf,11733,HY-15536,GRT6005,863513-91-1,Opioid Receptor,GPCR/G Protein; Neuronal Signaling,C24H27FN2O,10mM,Neurological Disease; Cancer,Phase 3,CN(C)[C@]1(c2ccccc2)CC[C@]2(CC1)OCCc1c3cc(F)ccc3[nH]c12,清洗成功,0.2361111111111111
8812,CCn1c(-c2cc(N3CCN(C)CC3)cnc2[C@H](C)OC)c2c3cc(ccc31)-c1csc(n1)C[C@H](NC(=O)[C@H]1C[C@@H]1C)C(=O)N1CCC[C@H](N1)C(=O)OCC(C)(C)C2,1,0.9912273287773132,0.9912273287773132,CC(COC([C@H]1NN(C([C@H](CC2=NC3=CS2)NC([C@H]4C[C@@H]4C)=O)=O)CCC1)=O)(C)CC5=[C@@](N(CC)C6=C5C=C3C=C6)[C@@]7=C([C@H](C)OC)N=CC(N8CCN(C)CC8)=C7,RMC-6236,Data.sdf,10403,HY-148439,RAS-IN-2,2765081-21-6,PERK; Ras,Cell Cycle/DNA Damage; GPCR/G Protein; MAPK/ERK Pathway,C44H58N8O5S,10mM,Cancer,Phase 3,CCn1c(-c2cc(N3CCN(C)CC3)cnc2[C@H](C)OC)c2c3cc(ccc31)-c1csc(n1)C[C@H](NC(=O)[C@H]1C[C@@H]1C)C(=O)N1CCC[C@H](N1)C(=O)OCC(C)(C)C2,清洗成功,0.2237762237762237
11852,Clc1cc2cc(c1)-c1cnn3c1N/C(=N/CCOCCO2)C=C3,1,0.9912270903587341,0.9912270903587341,ClC1=CC(C2=C3N/C(C=CN3N=C2)=N/CCOCCO4)=CC4=C1,OD36,Data.sdf,14019,HY-19628,,1638644-62-8,RIP kinase; TGF-?2 Receptor,Apoptosis; TGF-beta/Smad,C16H15ClN4O2,10mM,Inflammation/Immunology,No Development Reported,Clc1cc2cc(c1)-c1cnn3c1N/C(=N/CCOCCO2)C=C3,清洗成功,0.2
7593,CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1,1,0.9912160634994507,0.9912160634994507,O=C1C=COC2=CC(OCC(NC3=CC(NC(C4=CC=C(N(C)C)C=C4)=O)=CC=C3)=O)=CC=C12,CAY10746,Data.sdf,8987,HY-139170,,2247240-76-0,ROCK,Cell Cycle/DNA Damage; Cytoskeleton; Stem Cell/Wnt; TGF-beta/Smad,C26H23N3O5,10mM,Metabolic Disease,No Development Reported,CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1,清洗成功,0.3181818181818182
9629,COc1ccc(C23CCC(CN(c4cc(-c5cnn(C(C)(C)C)c5)ccn4)C(=O)[C@H]4CC[C@H](OC(=O)N5CC(O)C5)CC4)(CC2)CC3)cc1C,1,0.9912035465240479,0.9912035465240479,CC1=C(OC)C=CC(C23CCC(CC2)(CC3)CN(C4=CC(C5=CN(N=C5)C(C)(C)C)=CC=N4)C([C@@H]6CC[C@H](CC6)OC(N7CC(C7)O)=O)=O)=C1,FXR agonist 5,Data.sdf,11374,HY-153525,,2414008-05-0,FXR,Metabolic Enzyme/Protease,C40H53N5O5,10mM,Metabolic Disease; Inflammation/Immunology,No Development Reported,COc1ccc(C23CCC(CN(c4cc(-c5cnn(C(C)(C)C)c5)ccn4)C(=O)[C@H]4CC[C@H](OC(=O)N5CC(O)C5)CC4)(CC2)CC3)cc1C,清洗成功,0.2352941176470588
6844,O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2c(C(=O)c3ccc(OCCN4CCCCC4)cc3)c(O)ccc12,1,0.9912022352218628,0.9912022352218628,OC1=CC=C(C2=C(C(C3=CC=C(OCCN4CCCCC4)C=C3)=O)C5=CC=C(O)C(C(C6=CC=C(OCCN7CCCCC7)C=C6)=O)=C5S2)C=C1,7-[4-(2-Piperidinyl)ethoxy]benzoyl Raloxifene,Data.sdf,8121,HY-135589,,1159977-58-8,,GPCR/G Protein,C42H44N2O6S,10mM,Cancer,No Development Reported,O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2c(C(=O)c3ccc(OCCN4CCCCC4)cc3)c(O)ccc12,清洗成功,0.3295454545454545
15317,COc1cc(-c2[o+]c3cc(O)cc(O)c3cc2O)ccc1O,1,0.9912018775939941,0.9912018775939941,COC1=CC(C2=C(O)C=C3C(C=C(O)C=C3O)=[O+]2)=CC=C1O.[Cl-],Peonidin (chloride),Data.sdf,18240,HY-N2459,YGM-6 (chloride),134-01-0,COX,Immunology/Inflammation,C16H13ClO6,10mM,Cancer,No Development Reported,COc1cc(-c2[o+]c3cc(O)cc(O)c3cc2O)ccc1O,清洗成功,0.3166666666666666
16084,O=C(O)[C@H]1O[C@@H](Oc2cc(O)c3c(=O)cc(-c4ccccc4)oc3c2O)[C@H](O)[C@@H](O)[C@@H]1O,1,0.9912001490592957,0.9912001490592957,O=C1C(C(OC(C2=CC=CC=C2)=C1)=C3O)=C(C=C3O[C@@H]([C@@H]([C@H]4O)O)O[C@@H]([C@H]4O)C(O)=O)O,Glychionide A,Data.sdf,19228,HY-N8034,,119152-50-0,Apoptosis; Autophagy,Apoptosis; Autophagy,C21H18O11,10mM,Cancer,No Development Reported,O=C(O)[C@H]1O[C@@H](Oc2cc(O)c3c(=O)cc(-c4ccccc4)oc3c2O)[C@H](O)[C@@H](O)[C@@H]1O,清洗成功,0.325
8982,CC1(C)C(=O)N(c2ccc3c(cnn3-c3ccc(F)cc3)c2)[C@H](c2ccccc2)[C@H]1NC(=O)C1CC1,1,0.9911999106407166,0.9911999106407166,O=C(C1CC1)N[C@@H]2[C@@H](C3=CC=CC=C3)N(C4=CC=C(N(C5=CC=C(C=C5)F)N=C6)C6=C4)C(C2(C)C)=O,Glucocorticoid receptor modulator 2,Data.sdf,10591,HY-149165,,2452396-89-1,Glucocorticoid Receptor,Immunology/Inflammation; Vitamin D Related/Nuclear Receptor,C29H27FN4O2,10mM,Inflammation/Immunology,No Development Reported,CC1(C)C(=O)N(c2ccc3c(cnn3-c3ccc(F)cc3)c2)[C@H](c2ccccc2)[C@H]1NC(=O)C1CC1,清洗成功,0.2608695652173913
9777,O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1,1,0.9911971092224121,0.9911971092224121,O=C(C(NC1=CC=C(O)C(Cl)=C1)=C2C3=CC=CC=C3[N+]([O-])=O)NC2=O,SB 415286,Data.sdf,11553,HY-15438,,264218-23-7,Apoptosis; GSK-3,Apoptosis; PI3K/Akt/mTOR; Stem Cell/Wnt,C16H10ClN3O5,10mM,Metabolic Disease,No Development Reported,O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1,清洗成功,0.3478260869565217
11116,COCCNCc1ccc(-c2cc3nccc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)cc4F)c3s2)nc1,1,0.9911924004554749,0.9911924004554749,O=C(C1(C(NC2=CC=C(F)C=C2)=O)CC1)NC3=CC=C(OC4=C5C(C=C(C6=NC=C(CNCCOC)C=C6)S5)=NC=C4)C(F)=C3,Sitravatinib,Data.sdf,13169,HY-16961,MGCD516; MG-516,1123837-84-2,c-Kit; Discoidin Domain Receptor; FLT3; Trk Receptor; VEGFR,Neuronal Signaling; Protein Tyrosine Kinase/RTK,C33H29F2N5O4S,10mM,Cancer; Inflammation/Immunology,Phase 3,COCCNCc1ccc(-c2cc3nccc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)cc4F)c3s2)nc1,清洗成功,0.23
690,Oc1ccc(-c2nc3cc(O)cc(Br)c3o2)cc1,1,0.9911879301071167,0.9911879301071167,OC1=CC(Br)=C(OC(C2=CC=C(O)C=C2)=N3)C3=C1,WAY-200070,Data.sdf,790,HY-101271,,440122-66-7,Estrogen Receptor/ERR,Vitamin D Related/Nuclear Receptor,C13H8BrNO3,10mM,Neurological Disease,No Development Reported,Oc1ccc(-c2nc3cc(O)cc(Br)c3o2)cc1,清洗成功,0.2857142857142857
11771,CC(=O)N(C)c1cc(-c2ccnc3c(C(=O)c4cccs4)cnn23)ccc1F,1,0.9911875128746033,0.9911875128746033,CC(N(C1=CC(C2=CC=NC3=C(C(C4=CC=CS4)=O)C=NN23)=CC=C1F)C)=O,Lorediplon,Data.sdf,13926,HY-19371,,917393-39-6,GABA Receptor,Membrane Transporter/Ion Channel; Neuronal Signaling,C20H15FN4O2S,10mM,Neurological Disease,Phase 2,CC(=O)N(C)c1cc(-c2ccnc3c(C(=O)c4cccs4)cnn23)ccc1F,清洗成功,0.3376623376623376
3839,C[C@@](Cc1c[nH]c2ccccc12)(NC(=O)Nc1ccc([N+](=O)[O-])cc1)C(=O)NCC1(c2ccccn2)CCCCC1,1,0.991184413433075,0.991184413433075,O=C([C@](C)(CC1=CNC2=C1C=CC=C2)NC(NC3=CC=C(C=C3)[N+]([O-])=O)=O)NCC4(CCCCC4)C5=NC=CC=C5,PD 168368,Data.sdf,4517,HY-116216,,204066-82-0,Bombesin Receptor,GPCR/G Protein,C31H34N6O4,10mM,Cancer,No Development Reported,C[C@@](Cc1c[nH]c2ccccc12)(NC(=O)Nc1ccc([N+](=O)[O-])cc1)C(=O)NCC1(c2ccccn2)CCCCC1,清洗成功,0.26
9722,CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12,1,0.991172730922699,0.991172730922699,O=C(NC)C1=CC=CC2=C1C=CC(OC3=CC=NC4=CC(OCC5(N)CC5)=C(OC)C=C43)=C2,Lucitanib,Data.sdf,11490,HY-15391,E-3810,1058137-23-7,FGFR; VEGFR,Protein Tyrosine Kinase/RTK,C26H25N3O4,10mM,Cancer,Phase 3,CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12,清洗成功,0.3132530120481928
7516,CNC(=O)c1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)ccnc2cc1OC,1,0.9911726117134094,0.9911726117134094,O=C(C1=CC2=C(OC3=CC=C(NC(C4(CC4)C(NC5=CC=C(C=C5)F)=O)=O)C=C3)C=CN=C2C=C1OC)NC,Zanzalintinib,Data.sdf,8892,HY-138696,XL092,2367004-54-2,c-Met/HGFR; TAM Receptor; VEGFR,Protein Tyrosine Kinase/RTK,C29H25FN4O5,10mM,Cancer,Phase 3,CNC(=O)c1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)ccnc2cc1OC,清洗成功,0.3103448275862069
2383,Cc1nc2ccc(NC(=O)Nc3ccnc4cccnc34)cc2o1,1,0.9911656975746155,0.9911656975746155,O=C(NC1=CC(OC(C)=N2)=C2C=C1)NC3=CC=NC4=CC=CN=C43.Cl,SB-334867,Data.sdf,2801,HY-10895,SB 334867A,249889-64-3,Orexin Receptor (OX Receptor),GPCR/G Protein; Neuronal Signaling,C17H14ClN5O2,10mM,Neurological Disease; Endocrinology,No Development Reported,Cc1nc2ccc(NC(=O)Nc3ccnc4cccnc34)cc2o1,清洗成功,0.328125
7724,O=C(NCc1n[nH]c2ccccc12)c1cc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)ccc1F,1,0.9911515116691589,0.9911515116691589,O=C(NCC1=NNC2=CC=CC=C12)C(C=C3[C@@](CCNC4)([H])[C@@H]4COC5=CC=C(OCO6)C6=C5)=C(C=C3)F,CCG258747,Data.sdf,9142,HY-139690,,2615910-00-2,Opioid Receptor,GPCR/G Protein; Neuronal Signaling,C28H27FN4O4,10mM,Cardiovascular Disease,No Development Reported,O=C(NCc1n[nH]c2ccccc12)c1cc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)ccc1F,清洗成功,0.2641509433962264
11448,O=C(N[C@@H]1C2CCN(CC2)[C@H]1Cc1cccnc1)c1cc2ccccc2o1,1,0.9911173582077026,0.9911173582077026,O=C(C1=CC2=CC=CC=C2O1)N[C@H]3[C@H](CC4=CC=CN=C4)N5CCC3CC5,Bradanicline,Data.sdf,13538,HY-18060,TC-5619,639489-84-2,nAChR,Membrane Transporter/Ion Channel; Neuronal Signaling,C22H23N3O2,10mM,Neurological Disease,Phase 2,O=C(N[C@@H]1C2CCN(CC2)[C@H]1Cc1cccnc1)c1cc2ccccc2o1,清洗成功,0.2857142857142857
5758,CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)cc2F)n(-c2ccccc2)n1,1,0.9911167621612549,0.9911167621612549,O=C1NC2=NC=CC(OC3=CC=C(NC(NC4=CC(C(C)(C)C)=NN4C5=CC=CC=C5)=O)C(F)=C3)=C2N=C1,CCT196969,Data.sdf,6801,HY-12846,,1163719-56-9,Raf,MAPK/ERK Pathway,C27H24FN7O3,10mM,Cancer,No Development Reported,CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)cc2F)n(-c2ccccc2)n1,清洗成功,0.2688172043010752
236,NS(=O)(=O)OC[C@H]1C[C@@H](Nc2ccnc3cc(-c4cccc(SC(F)(F)F)c4)nn23)[C@H](O)[C@@H]1O,1,0.9911162853240967,0.9911162853240967,O=S(OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](NC2=CC=NC3=CC(C4=CC=CC(SC(F)(F)F)=C4)=NN23)C1)(N)=O,TAK-243,Data.sdf,269,HY-100487,MLN7243,1450833-55-2,Apoptosis; E1/E2/E3 Enzyme; NF-?oB,Apoptosis; Metabolic Enzyme/Protease; NF-?oB,C19H20F3N5O5S2,10mM,Cancer,Phase 1,NS(=O)(=O)OC[C@H]1C[C@@H](Nc2ccnc3cc(-c4cccc(SC(F)(F)F)c4)nn23)[C@H](O)[C@@H]1O,清洗成功,0.2210526315789473
15331,O=C(O)CC(=O)OC[C@H]1O[C@@H](Oc2cc(O)c3c(=O)cc(-c4ccc(O)cc4)oc3c2)[C@H](O)[C@@H](O)[C@@H]1O,1,0.9911144971847534,0.9911144971847534,O=C1C2=C(O)C=C(O[C@@H]3O[C@@H]([C@H]([C@@H]([C@H]3O)O)O)COC(CC(O)=O)=O)C=C2OC(C4=CC=C(C=C4)O)=C1,Apigenin 7-O-malonylglucoside,Data.sdf,18260,HY-N2496,,86546-87-4,Others,Others,C24H22O13,10mM,Others,No Development Reported,O=C(O)CC(=O)OC[C@H]1O[C@@H](Oc2cc(O)c3c(=O)cc(-c4ccc(O)cc4)oc3c2)[C@H](O)[C@@H](O)[C@@H]1O,清洗成功,0.2790697674418604
15463,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc4c3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,1,0.9911131262779236,0.9911131262779236,O=C1C2=C(O)C=C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)CO[C@H]4[C@@H]([C@@H]([C@@H](O)[C@H](C)O4)O)O)C=C2OC(C5=CC=C(O)C=C5)=C1,Isorhoifolin,Data.sdf,18443,HY-N3460,,552-57-8,Reactive Oxygen Species,Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?oB,C27H30O14,10mM,Cardiovascular Disease,No Development Reported,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc4c3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,清洗成功,0.2823529411764706
6977,CCOC(=O)c1ccc2c3c([nH]c2c1)[C@@H]1Oc2c(O)ccc4c2[C@@]12CCN(CC1CC1)[C@H](C4)[C@]2(O)C3,1,0.9911094903945923,0.9911094903945923,O=C(C1=CC2=C(C=C1)C3=C([C@@](OC4=C(O)C=CC(C5)=C46)([H])[C@]76[C@@]([C@]5([H])N(CC8CC8)CC7)(O)C3)N2)OCC,TAN-452,Data.sdf,8277,HY-136208,,892039-23-5,Opioid Receptor,GPCR/G Protein; Neuronal Signaling,C29H30N2O5,10mM,Neurological Disease,No Development Reported,CCOC(=O)c1ccc2c3c([nH]c2c1)[C@@H]1Oc2c(O)ccc4c2[C@@]12CCN(CC1CC1)[C@H](C4)[C@]2(O)C3,清洗成功,0.2795698924731182
11944,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)c(F)c3)nc3[nH]ccc23)c1,1,0.9911056160926819,0.9911056160926819,O=C(C=C)NC1=CC=CC(OC2=NC(NC3=CC(F)=C(N4CCN(C)CC4)C=C3)=NC5=C2C=CN5)=C1,Avitinib,Data.sdf,14130,HY-19816,Abivertinib; AC0010,1557267-42-1,Apoptosis; Btk; EGFR,Apoptosis; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK,C26H26FN7O2,10mM,Cancer,Phase 3,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)c(F)c3)nc3[nH]ccc23)c1,清洗成功,0.3267326732673267
11945,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)c(F)c3)nc3[nH]ccc23)c1,1,0.9911056160926819,0.9911056160926819,O=C(O)/C=C\C(O)=O.O=C(C=C)NC1=CC=CC(OC2=NC(NC3=CC(F)=C(N4CCN(C)CC4)C=C3)=NC5=C2C=CN5)=C1,Avitinib (maleate),Data.sdf,14131,HY-19816A,Abivertinib (maleate); AC0010 (maleate),1557268-88-8,Apoptosis; Btk; EGFR,Apoptosis; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK,C30H30FN7O6,10mM,Cancer,Phase 3,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)c(F)c3)nc3[nH]ccc23)c1,清洗成功,0.3113207547169811
1864,COc1nn(C)cc1Nc1nccc(-c2c[nH]c3c(NC(=O)[C@@H](C)N4CCN(C)CC4)cccc23)n1,1,0.9911019802093506,0.9911019802093506,C[C@@H](N1CCN(C)CC1)C(NC2=C3C(C(C4=NC(NC5=CN(C)N=C5OC)=NC=C4)=CN3)=CC=C2)=O,Golidocitinib,Data.sdf,2199,HY-107361,AZD4205,2091134-68-6,JAK,Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt,C25H31N9O2,10mM,Cancer,Phase 2,COc1nn(C)cc1Nc1nccc(-c2c[nH]c3c(NC(=O)[C@@H](C)N4CCN(C)CC4)cccc23)n1,清洗成功,0.345679012345679
6467,CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1,1,0.9911003708839417,0.9911003708839417,CN(C)CCOC1=C(NC(C2OC(C=CC=C3)=C3OC2)=O)C=CC(C4=CNN=C4)=C1,SR-3677,Data.sdf,7665,HY-13300,,1072959-67-1,Autophagy; ROCK,Autophagy; Cell Cycle/DNA Damage; Cytoskeleton; Stem Cell/Wnt; TGF-beta/Smad,C22H24N4O4,10mM,Cancer,No Development Reported,CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1,清洗成功,0.3086419753086419
4282,COc1ccc(-c2cc(=O)c3c(O)cc(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)cc3o2)cc1,1,0.9910979866981506,0.9910979866981506,O=C1C=C(OC2=CC(O[C@H]3[C@H](O[C@H]4[C@H](O)[C@H](O)[C@@H](O)[C@@H](O4)C)[C@@H](O)[C@H](O)[C@H](O3)CO)=CC(O)=C12)C5=CC=C(C=C5)OC,Fortunellin,Data.sdf,5036,HY-119678,,20633-93-6,AMPK; Keap1-Nrf2,Epigenetics; NF-?oB; PI3K/Akt/mTOR,C28H32O14,10mM,Metabolic Disease; Cardiovascular Disease,No Development Reported,COc1ccc(-c2cc(=O)c3c(O)cc(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)cc3o2)cc1,清洗成功,0.3333333333333333
10968,N#Cc1cc(F)c(C(=O)Nc2ccnc(NC(=O)[C@H]3C[C@H]3F)c2)c(Cl)c1,1,0.9910780191421509,0.9910780191421509,O=C(NC1=CC(NC([C@@H]2[C@H](F)C2)=O)=NC=C1)C3=C(F)C=C(C#N)C=C3Cl,TCJL37,Data.sdf,13000,HY-16640,,1258294-34-6,JAK,Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt,C17H11ClF2N4O2,10mM,Inflammation/Immunology,No Development Reported,N#Cc1cc(F)c(C(=O)Nc2ccnc(NC(=O)[C@H]3C[C@H]3F)c2)c(Cl)c1,清洗成功,0.2592592592592592
7149,CN1CCC(CNc2cc(Cl)nn3c(-c4cc5nc(Nc6ccccc6)[nH]c5cc4F)cnc23)CC1,1,0.9910777807235718,0.9910777807235718,CN1CCC(CNC2=CC(Cl)=NN3C2=NC=C3C4=C(F)C=C5C(N=C(NC6=CC=CC=C6)N5)=C4)CC1,IRE1?± kinase-IN-1,Data.sdf,8465,HY-136735,,2328097-41-0,IRE1,Cell Cycle/DNA Damage,C26H26ClFN8,10mM,Cancer; Neurological Disease,No Development Reported,CN1CCC(CNc2cc(Cl)nn3c(-c4cc5nc(Nc6ccccc6)[nH]c5cc4F)cnc23)CC1,清洗成功,0.2653061224489796
2465,O=C(c1cccnc1-c1ccncc1)N1CCC(O)(Cc2ccccc2)CC1,1,0.9910712242126465,0.9910712242126465,O=C(N1CCC(CC2=CC=CC=C2)(O)CC1)C3=C(C4=CC=NC=C4)N=CC=C3,Soticlestat,Data.sdf,2892,HY-109123,TAK-935; OV935,1429505-03-2,Cytochrome P450,Metabolic Enzyme/Protease,C23H23N3O2,10mM,Neurological Disease,Phase 3,O=C(c1cccnc1-c1ccncc1)N1CCC(O)(Cc2ccccc2)CC1,清洗成功,0.3220338983050847
15601,COc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)cc3o2)cc1,1,0.9910688400268555,0.9910688400268555,O=C1C=C(C2=CC=C(OC)C=C2)OC3=CC(OC)=C(OC)C(OC)=C13,Scutellarein tetramethyl ether,Data.sdf,18625,HY-N4314,"4',5,6,7-Tetramethoxyflavone",1168-42-9,Bacterial; COX; NF-?oB; NO Synthase,Anti-infection; Immunology/Inflammation; NF-?oB,C19H18O6,10mM,Cancer; Infection; Inflammation/Immunology,No Development Reported,COc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)cc3o2)cc1,清洗成功,0.3188405797101449
1042,COCCN1CCC(N(Cc2ccc(-c3ccc(C(F)(F)F)cc3)cc2)C(=O)Cn2c(SCc3cccc(F)c3F)cc(=O)c3ccccc32)CC1,1,0.9910645484924316,0.9910645484924316,O=C(N(C1CCN(CCOC)CC1)CC2=CC=C(C3=CC=C(C(F)(F)F)C=C3)C=C2)CN4C(SCC5=CC=CC(F)=C5F)=CC(C6=C4C=CC=C6)=O,Rilapladib,Data.sdf,1198,HY-102004,SB 659032,412950-08-4,Phospholipase,Metabolic Enzyme/Protease,C40H38F5N3O3S,10mM,Inflammation/Immunology; Neurological Disease,Phase 2,COCCN1CCC(N(Cc2ccc(-c3ccc(C(F)(F)F)cc3)cc2)C(=O)Cn2c(SCc3cccc(F)c3F)cc(=O)c3ccccc32)CC1,清洗成功,0.3364485981308411
16170,O=C(O)CC(=O)OC[C@H]1O[C@@H](Oc2c(-c3ccc(O)c(O)c3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H](O)[C@@H]1O,1,0.9910624027252197,0.9910624027252197,O=C(C(O[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)COC(CC(O)=O)=O)=C(C2=CC(O)=C(C=C2)O)OC3=CC(O)=C4)C3=C4O,Quercetin 3-O-(6''-O-malonyl)-?2-D-glucoside,Data.sdf,19341,HY-N9397,,96862-01-0,Others,Others,C24H22O15,10mM,Metabolic Disease,No Development Reported,O=C(O)CC(=O)OC[C@H]1O[C@@H](Oc2c(-c3ccc(O)c(O)c3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H](O)[C@@H]1O,清洗成功,0.3188405797101449
12886,COC(=O)Nc1nc2ccc(S(=O)c3ccccc3)cc2[nH]1,1,0.9910576343536377,0.9910576343536377,O=C(OC)NC1=NC2=CC=C(S(C3=CC=CC=C3)=O)C=C2N1,Oxfendazole,Data.sdf,15235,HY-B0291,,53716-50-0,Parasite,Anti-infection,C15H13N3O3S,10mM,Cancer; Infection,Phase 3,COC(=O)Nc1nc2ccc(S(=O)c3ccccc3)cc2[nH]1,清洗成功,0.2878787878787879
9119,O=C(/N=c1\scc(CO)n1Cc1ccccc1)c1c[nH]c2ncccc12,1,0.9910553693771362,0.9910553693771362,O=C(C1=CNC2=NC=CC=C12)/N=C(SC=C3CO)/N3CC4=CC=CC=C4,TDI-011536,Data.sdf,10755,HY-150042,,2687970-96-1,YAP,Stem Cell/Wnt,C19H16N4O2S,10mM,Cardiovascular Disease; Others,No Development Reported,O=C(/N=c1\scc(CO)n1Cc1ccccc1)c1c[nH]c2ncccc12,清洗成功,0.3243243243243243
9956,Cc1cc(C)c(CNC(=O)c2cc(-c3ccc(CN4CCOCC4)cc3)cc3c2cnn3C2CCCC2)c(=O)[nH]1,1,0.9910545945167542,0.9910545945167542,O=C(NCC1=C(C)C=C(C)NC1=O)C2=CC(C3=CC=C(CN4CCOCC4)C=C3)=CC5=C2C=NN5C6CCCC6,EPZ005687,Data.sdf,11770,HY-15555,,1396772-26-1,Histone Methyltransferase,Epigenetics,C32H37N5O3,10mM,Cancer,No Development Reported,Cc1cc(C)c(CNC(=O)c2cc(-c3ccc(CN4CCOCC4)cc3)cc3c2cnn3C2CCCC2)c(=O)[nH]1,清洗成功,0.3265306122448979
8015,O=c1[nH][nH]c(=O)c2cc(OCc3ccsc3)ccc12,1,0.9910444021224976,0.9910444021224976,O=C1NNC(C2=C1C=CC(OCC3=CSC=C3)=C2)=O,PARP10/15-IN-1,Data.sdf,9466,HY-143398,,2892065-01-7,PARP,Cell Cycle/DNA Damage; Epigenetics,C13H10N2O3S,10mM,Cancer,No Development Reported,O=c1[nH][nH]c(=O)c2cc(OCc3ccsc3)ccc12,清洗成功,0.303030303030303
8826,Cn1ccnc1SC[C@H]1CCN(S(=O)(=O)c2ccc3c(c2)CCO3)C[C@@H]1F,1,0.9910402894020081,0.9910402894020081,O=S(C1=CC2=C(OCC2)C=C1)(N(CC[C@@H]3CSC4=NC=CN4C)C[C@@H]3F)=O,VU6019650,Data.sdf,10420,HY-148502,,2926782-31-0,mAChR,GPCR/G Protein; Neuronal Signaling,C18H22FN3O3S2,10mM,Neurological Disease,No Development Reported,Cn1ccnc1SC[C@H]1CCN(S(=O)(=O)c2ccc3c(c2)CCO3)C[C@@H]1F,清洗成功,0.25
7763,COc1ccc(C(=O)C2CCN(CC(=O)N(Cc3nc4c(c(=O)[nH]3)COCC4)CC3CC3)CC2)cc1,1,0.9910333752632141,0.9910333752632141,O=C(N(CC1CC1)CC2=NC3=C(COCC3)C(N2)=O)CN4CCC(C(C5=CC=C(OC)C=C5)=O)CC4,NVP-TNKS656,Data.sdf,9186,HY-13990,TNKS656,1419949-20-4,Apoptosis; PARP,Apoptosis; Cell Cycle/DNA Damage; Epigenetics,C27H34N4O5,10mM,Cancer,No Development Reported,COc1ccc(C(=O)C2CCN(CC(=O)N(Cc3nc4c(c(=O)[nH]3)COCC4)CC3CC3)CC2)cc1,清洗成功,0.238095238095238
10147,CNC(=O)c1ccc(-c2cnn3ccc(C(=O)N(C)c4ccc(Cl)c(C(=O)OC)c4)cc23)cc1,1,0.9910332560539246,0.9910332560539246,O=C(C1=CC(N(C)C(C2=CC3=C(C4=CC=C(C(NC)=O)C=C4)C=NN3C=C2)=O)=CC=C1Cl)OC,EDI048,Data.sdf,12004,HY-156685,,2767264-57-1,Parasite; PI4K,Anti-infection; PI3K/Akt/mTOR,C25H21ClN4O4,10mM,Infection,Phase 1,CNC(=O)c1ccc(-c2cnn3ccc(C(=O)N(C)c4ccc(Cl)c(C(=O)OC)c4)cc23)cc1,清洗成功,0.3058823529411765
13312,O=C(Nc1cc(Oc2cc(F)c(NC(=O)C3(C(=O)Nc4ccc(F)cc4)CC3)cc2F)ccn1)C1CC1,1,0.9910321831703186,0.9910321831703186,O=C(C1(C(NC2=CC=C(F)C=C2)=O)CC1)NC3=CC(F)=C(OC4=CC(NC(C5CC5)=O)=NC=C4)C=C3F,Altiratinib,Data.sdf,15712,HY-B0791,DCC-2701,1345847-93-9,c-Met/HGFR; FLT3; Trk Receptor; VEGFR,Neuronal Signaling; Protein Tyrosine Kinase/RTK,C26H21F3N4O4,10mM,Cancer,Phase 1,O=C(Nc1cc(Oc2cc(F)c(NC(=O)C3(C(=O)Nc4ccc(F)cc4)CC3)cc2F)ccn1)C1CC1,清洗成功,0.3333333333333333
8648,O=C(NCCc1c[nH]cn1)C1CC(=O)N(c2n[nH]c3c(Cl)cccc23)C1,1,0.9910290241241455,0.9910290241241455,O=C(C1CC(N(C1)C2=NNC3=C2C=CC=C3Cl)=O)NCCC4=CNC=N4,PAC1R antagonist 1,Data.sdf,10200,HY-147557,,2305204-24-2,PACAP Receptor,GPCR/G Protein,C17H17ClN6O2,10mM,Neurological Disease,No Development Reported,O=C(NCCc1c[nH]cn1)C1CC(=O)N(c2n[nH]c3c(Cl)cccc23)C1,清洗成功,0.2647058823529412
4860,C=CC(=O)Nc1cc(C(=O)NC)cc(-c2n[nH]c3ccccc23)c1,1,0.9910262227058411,0.9910262227058411,O=C(NC)C1=CC(NC(C=C)=O)=CC(C2=NNC3=C2C=CC=C3)=C1,MKK7-COV-9,Data.sdf,5720,HY-122872,,2283355-59-7,p38 MAPK,MAPK/ERK Pathway,C18H16N4O2,10mM,Cancer,No Development Reported,C=CC(=O)Nc1cc(C(=O)NC)cc(-c2n[nH]c3ccccc23)c1,清洗成功,0.325
14713,O=c1cc(-c2ccc(O)cc2)oc2cc(O)c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)c12,1,0.9910200238227844,0.9910200238227844,OC1=C(C2=O)C(OC(C3=CC=C(O)C=C3)=C2)=CC(O)=C1[C@@H]([C@@H]([C@@H](O)[C@@H]4O)O)O[C@@H]4CO,Isovitexin,Data.sdf,17429,HY-N0773,Saponaretin; Homovitexin,38953-85-4,JNK; NF-?oB,MAPK/ERK Pathway; NF-?oB,C21H20O10,10mM,Inflammation/Immunology,No Development Reported,O=c1cc(-c2ccc(O)cc2)oc2cc(O)c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)c12,清洗成功,0.2716049382716049
1107,CC1(C)CC(=O)c2c(C(F)(F)F)nn(-c3ccc(C(N)=O)c(N[C@H]4CC[C@H](O)CC4)c3)c2C1,1,0.9910178184509277,0.9910178184509277,FC(F)(C1=NN(C2=CC(N[C@@H]3CC[C@H](CC3)O)=C(C=C2)C(N)=O)C(CC(C)(C4)C)=C1C4=O)F,SNX-2112,Data.sdf,1272,HY-10214,PF-04928473,908112-43-6,Autophagy; HSP,Autophagy; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease,C23H27F3N4O3,10mM,Cancer,No Development Reported,CC1(C)CC(=O)c2c(C(F)(F)F)nn(-c3ccc(C(N)=O)c(N[C@H]4CC[C@H](O)CC4)c3)c2C1,清洗成功,0.2307692307692307
5344,COC[C@H]1C[C@@H](c2ncc(-c3ccc4c(c3)COc3cc5c(ccc6nc([C@@H]7CC[C@H](C)N7C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]c65)cc3-4)[nH]2)N(C(=O)[C@H](NC(=O)OC)c2ccccc2)C1,1,0.9910159111022949,0.9910159111022949,O=C(N([C@H]1C)[C@@H](CC1)C2=NC3=C(C(C=C(OCC4=CC(C5=CN=C([C@H](C[C@H](COC)C6)N6C([C@@H](C7=CC=CC=C7)NC(OC)=O)=O)N5)=CC=C84)C8=C9)=C9C=C3)N2)[C@H](C(C)C)NC(OC)=O,Velpatasvir,Data.sdf,6299,HY-12530,GS-5816,1377049-84-7,HCV; SARS-CoV,Anti-infection,C49H54N8O8,10mM,Cancer; Infection; Inflammation/Immunology,Launched,COC[C@H]1C[C@@H](c2ncc(-c3ccc4c(c3)COc3cc5c(ccc6nc([C@@H]7CC[C@H](C)N7C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]c65)cc3-4)[nH]2)N(C(=O)[C@H](NC(=O)OC)c2ccccc2)C1,清洗成功,0.1959459459459459
15780,COc1ccc(-c2cc(=O)c3c(OC)cc(OC)cc3o2)cc1,1,0.9910157918930054,0.9910157918930054,COC1=C(C(C=C(C2=CC=C(OC)C=C2)O3)=O)C3=CC(OC)=C1,"5,?7,?4'-?Trimethoxyflavone",Data.sdf,18855,HY-N6818,MTF,5631-70-9,Apoptosis; Caspase; CFTR; Endogenous Metabolite; PARP,Apoptosis; Cell Cycle/DNA Damage; Epigenetics; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease,C18H16O5,10mM,Cancer,No Development Reported,COc1ccc(-c2cc(=O)c3c(OC)cc(OC)cc3o2)cc1,清洗成功,0.3283582089552239
15309,O=C(/C=C/c1ccc(O)cc1)OC[C@H]1O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H](O)[C@@H]1O,1,0.9910100698471069,0.9910100698471069,O=C1C(O[C@@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)COC(/C=C/C3=CC=C(O)C=C3)=O)=C(C4=CC=C(O)C=C4)OC5=CC(O)=CC(O)=C51,Tribuloside,Data.sdf,18230,HY-N2443,,22153-44-2,Bacterial,Anti-infection,C30H26O13,10mM,Infection; Neurological Disease,No Development Reported,O=C(/C=C/c1ccc(O)cc1)OC[C@H]1O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H](O)[C@@H]1O,清洗成功,0.2957746478873239
2546,CN(C)CCOc1ccc(-c2nc(-c3ccc4c(c3)CC/C4=N/O)c(-c3ccncc3)[nH]2)cc1,1,0.9910025000572205,0.9910025000572205,O/N=C1CCC2=CC(C3=C(NC(C4=CC=C(C=C4)OCCN(C)C)=N3)C5=CC=NC=C5)=CC=C/12,SB-590885,Data.sdf,2986,HY-10966,,405554-55-4,Raf,MAPK/ERK Pathway,C27H27N5O2,10mM,Cancer,No Development Reported,CN(C)CCOc1ccc(-c2nc(-c3ccc4c(c3)CC/C4=N/O)c(-c3ccncc3)[nH]2)cc1,清洗成功,0.3170731707317073
5684,COc1ccc2nc(SCC(=O)Nc3ccc([N+](=O)[O-])cc3)[nH]c2c1,1,0.9910011887550354,0.9910011887550354,O=C(NC1=CC=C([N+]([O-])=O)C=C1)CSC2=NC3=CC=C(OC)C=C3N2,AG-09/1,Data.sdf,6711,HY-128113,,356776-32-4,Formyl Peptide Receptor (FPR),GPCR/G Protein,C16H14N4O4S,10mM,Inflammation/Immunology,No Development Reported,COc1ccc2nc(SCC(=O)Nc3ccc([N+](=O)[O-])cc3)[nH]c2c1,清洗成功,0.3380281690140845
10776,Cn1cc(-c2c(Cl)cnc3[nH]c(C4CCNCC4)cc23)cn1,1,0.9910007119178772,0.9910007119178772,ClC1=CN=C(NC(C2CCNCC2)=C3)C3=C1C4=CN(C)N=C4,YK-2168,Data.sdf,12771,HY-162919,,2571068-74-9,CDK,Cell Cycle/DNA Damage,C16H18ClN5,10mM,Cancer,No Development Reported,Cn1cc(-c2c(Cl)cnc3[nH]c(C4CCNCC4)cc23)cn1,清洗成功,0.3424657534246575
14855,O=C(OC[C@H]1O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H](O)[C@@H]1O)c1cc(O)c(O)c(O)c1,1,0.9909991025924683,0.9909991025924683,OC1=CC(C(OC[C@H]2O[C@H]([C@@H]([C@H]([C@@H]2O)O)O)OC3=C(C4=CC=C(O)C=C4)OC5=CC(O)=CC(O)=C5C3=O)=O)=CC(O)=C1O,Kaempferol-3-O-(6a?2a??galloyl)-?2-glucopyranoside,Data.sdf,17619,HY-N10776,,56317-05-6,HIV,Anti-infection,C28H24O15,10mM,Infection,No Development Reported,O=C(OC[C@H]1O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H](O)[C@@H]1O)c1cc(O)c(O)c(O)c1,清洗成功,0.3043478260869565
15632,O=C(/C=C/c1ccc(O)cc1)O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1c1c(O)cc(O)c2c(=O)cc(-c3ccc(O)c(O)c3)oc12,1,0.9909979104995728,0.9909979104995728,O=C1C=C(C2=CC=C(O)C(O)=C2)OC3=C([C@H]4[C@@H]([C@H]([C@@H]([C@@H](CO)O4)O)O)OC(/C=C/C5=CC=C(O)C=C5)=O)C(O)=CC(O)=C13,Orientin-2''-O-p-trans-coumarate,Data.sdf,18658,HY-N5047,,1229437-75-5,Others,Others,C30H26O13,10mM,Others,No Development Reported,O=C(/C=C/c1ccc(O)cc1)O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1c1c(O)cc(O)c2c(=O)cc(-c3ccc(O)c(O)c3)oc12,清洗成功,0.3296703296703296
2972,O=C1Cc2cc(-c3c(-c4ccc(F)cc4)nn4c(N5CCC(O)CC5)nccc34)ccc2N1,1,0.9909946322441101,0.9909946322441101,OC1CCN(C2=NC=CC3=C(C4=CC=C(NC(C5)=O)C5=C4)C(C6=CC=C(F)C=C6)=NN32)CC1,JNJ-61432059,Data.sdf,3481,HY-111751,,2035814-50-5,iGluR,Membrane Transporter/Ion Channel; Neuronal Signaling,C25H22FN5O2,10mM,Neurological Disease,No Development Reported,O=C1Cc2cc(-c3c(-c4ccc(F)cc4)nn4c(N5CCC(O)CC5)nccc34)ccc2N1,清洗成功,0.2826086956521739
11063,COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc2ccc(-c3csc4c(-c5ccc(-c6cnc([C@@H]7CCCN7C(=O)[C@H](NC(=O)OC)c7ccccc7)[nH]6)cc5)csc34)cc2[nH]1)C(C)C,1,0.9909899234771729,0.9909899234771729,O=C(OC)N[C@H](C1=CC=CC=C1)C(N2[C@H](C3=NC=C(C4=CC=C(C5=CSC6=C5SC=C6C7=CC=C8N=C([C@H]9N(C([C@@H](NC(OC)=O)C(C)C)=O)CCC9)NC8=C7)C=C4)N3)CCC2)=O,Samatasvir,Data.sdf,13103,HY-16784,IDX719; IDX18719,1312547-19-5,HCV; HCV Protease,Anti-infection; Metabolic Enzyme/Protease,C47H48N8O6S2,10mM,Infection,Phase 2,COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc2ccc(-c3csc4c(-c5ccc(-c6cnc([C@@H]7CCCN7C(=O)[C@H](NC(=O)OC)c7ccccc7)[nH]6)cc5)csc34)cc2[nH]1)C(C)C,清洗成功,0.2429906542056074
9559,CCc1c(N(CC)C2CCOCC2)cc2oc(CN3CCCCC3)cc2c1C(=O)NCc1c(C)cc(C)[nH]c1=O,1,0.9909893870353699,0.9909893870353699,O=C1NC(C)=CC(C)=C1CNC(C2=C3C=C(CN4CCCCC4)OC3=CC(N(C5CCOCC5)CC)=C2CC)=O,EZH2-IN-15,Data.sdf,11291,HY-153191,,2098545-98-1,Histone Methyltransferase,Epigenetics,C32H44N4O4,10mM,Cancer,Phase 3,CCc1c(N(CC)C2CCOCC2)cc2oc(CN3CCCCC3)cc2c1C(=O)NCc1c(C)cc(C)[nH]c1=O,清洗成功,0.2336448598130841
3064,CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)(C)C4)c(Cl)cn2)C1,1,0.9909842014312744,0.9909842014312744,ClC1=CN=C(NC([C@H]2CCC[C@@H](NC(C)=O)C2)=O)C=C1C3=C(CC(C)(C)C4)N4N=C3,AZD4573,Data.sdf,3584,HY-112088,,2057509-72-3,CDK,Cell Cycle/DNA Damage,C22H28ClN5O2,10mM,Cancer,Phase 2,CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)(C)C4)c(Cl)cn2)C1,清洗成功,0.3152173913043478
6941,CNC(=O)c1cc(F)c(-c2nc3cc(C)ccn3c2C[C@H]2CN(C(=O)OC)CCO2)c(F)c1,1,0.9909718036651611,0.9909718036651611,O=C(N1C[C@H](CC2=C(C3=C(F)C=C(C(NC)=O)C=C3F)N=C4C=C(C)C=CN42)OCC1)OC,Camlipixant,Data.sdf,8233,HY-136026,BLU-5937,1621164-74-6,P2X Receptor,Membrane Transporter/Ion Channel,C23H24F2N4O4,10mM,Inflammation/Immunology,Phase 3,CNC(=O)c1cc(F)c(-c2nc3cc(C)ccn3c2C[C@H]2CN(C(=O)OC)CCO2)c(F)c1,清洗成功,0.2450980392156862
2891,CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4c([nH]3)CCN(C3CCN(C)CC3)C4)n[nH]c2c1,1,0.9909640550613403,0.9909640550613403,CN1CCC(N2CC(N=C(C3=NNC4=C3C=CC(C5=C(CC)C=C(O)C(F)=C5)=C4)N6)=C6CC2)CC1.[H]Cl,JAK-IN-5 (hydrochloride),Data.sdf,3393,HY-111471A,,2751323-21-2,JAK,Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt,C27H32ClFN6O,2mM,Inflammation/Immunology,No Development Reported,CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4c([nH]3)CCN(C3CCN(C)CC3)C4)n[nH]c2c1,清洗成功,0.3229166666666667
9443,O=C(Oc1ccc([N+](=O)[O-])cc1)N1CCC(C(O)(c2ccc3c(c2)OCO3)c2ccc3c(c2)OCO3)CC1,1,0.9909597635269165,0.9909597635269165,OC(C1=CC=C(OCO2)C2=C1)(C3CCN(C(OC4=CC=C([N+]([O-])=O)C=C4)=O)CC3)C5=CC(OCO6)=C6C=C5,JZL 184,Data.sdf,11145,HY-15249,,1101854-58-3,MAGL,Metabolic Enzyme/Protease,C27H24N2O9,10mM,Neurological Disease,No Development Reported,O=C(Oc1ccc([N+](=O)[O-])cc1)N1CCC(C(O)(c2ccc3c(c2)OCO3)c2ccc3c(c2)OCO3)CC1,清洗成功,0.2317073170731707
2358,O/N=c1\cc(-c2cc3sccc3cn2)oc2ccc(CCCN3CCOCC3)cc12,1,0.9909589290618896,0.9909589290618896,O/N=C1C=C(C2=CC3=C(C=CS3)C=N2)OC4=CC=C(CCCN5CCOCC5)C=C\14.Cl,Foliglurax (monohydrochloride),Data.sdf,2765,HY-108703A,PXT002331 (monohydrochloride),2133294-96-7,mGluR,GPCR/G Protein; Neuronal Signaling,C23H24ClN3O3S,10mM,Neurological Disease,Phase 2,O/N=c1\cc(-c2cc3sccc3cn2)oc2ccc(CCCN3CCOCC3)cc12,清洗成功,0.2560975609756097
10881,CN(CCCN1CCNCC1)c1ccc2nccc(C(=O)NCC(=O)N3CC(F)(F)C[C@H]3C#N)c2c1,1,0.9909571409225464,0.9909571409225464,O=C(N1[C@@H](CC(F)(C1)F)C#N)CNC(C2=CC=NC3=C2C=C(N(C)CCCN4CCNCC4)C=C3)=O,FT-FAPI-12_9,Data.sdf,12895,HY-164316,,2883407-81-4,FAP,Immunology/Inflammation,C25H31F2N7O2,10mM,Cancer,No Development Reported,CN(CCCN1CCNCC1)c1ccc2nccc(C(=O)NCC(=O)N3CC(F)(F)C[C@H]3C#N)c2c1,清洗成功,0.2636363636363636
10882,CN(CCCN1CCNCC1)c1ccc2nccc(C(=O)NCC(=O)N3CC(F)(F)C[C@H]3C#N)c2c1,1,0.9909571409225464,0.9909571409225464,O=C(N1[C@@H](CC(F)(C1)F)C#N)CNC(C2=CC=NC3=C2C=C(N(C)CCCN4CCNCC4)C=C3)=O.OC(C(F)(F)F)=O,FT-FAPI-12_9 (TFA),Data.sdf,12896,HY-164316A,,,FAP,Immunology/Inflammation,C27H32F5N7O4,10mM,Cancer,No Development Reported,CN(CCCN1CCNCC1)c1ccc2nccc(C(=O)NCC(=O)N3CC(F)(F)C[C@H]3C#N)c2c1,清洗成功,0.25
4435,CN(C)c1ccc(-c2nc3c(N4CCN(CC(=O)Nc5nccs5)CC4)c(Cl)cnc3[nH]2)cc1,1,0.9909522533416748,0.9909522533416748,CN(C1=CC=C(C2=NC3=C(C(Cl)=CN=C3N2)N4CCN(CC4)CC(NC5=NC=CS5)=O)C=C1)C,CCT129202,Data.sdf,5226,HY-12049,,942947-93-5,Aurora Kinase,Cell Cycle/DNA Damage; Epigenetics,C23H25ClN8OS,2mM,Cancer,No Development Reported,CN(C)c1ccc(-c2nc3c(N4CCN(CC(=O)Nc5nccs5)CC4)c(Cl)cnc3[nH]2)cc1,清洗成功,0.2941176470588235
1415,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1,1,0.9909456968307495,0.9909456968307495,O=C1NC2=CC=CC=C2N1C3CCN(CC4=CC=C(C5=NC6=CC(NC=N7)=C7C=C6N=C5C8=CC=CC=C8)C=C4)CC3,AKT inhibitor VIII,Data.sdf,1658,HY-10355,AKTi-1/2,612847-09-3,Akt; Apoptosis,Apoptosis; PI3K/Akt/mTOR,C34H29N7O,10mM,Cancer; Metabolic Disease,No Development Reported,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1,清洗成功,0.2888888888888888
14297,O=C(O)[C@H]1O[C@@H](Oc2cc3oc(-c4ccccc4)cc(=O)c3c(O)c2O)[C@H](O)[C@@H](O)[C@@H]1O,1,0.9909449815750122,0.9909449815750122,O[C@H]([C@H]([C@@H]([C@@H](C(O)=O)O1)O)O)[C@@H]1OC2=C(O)C(O)=C3C(C=C(C4=CC=CC=C4)OC3=C2)=O,Baicalin,Data.sdf,16895,HY-N0197,Baicalein 7-O-?2-D-glucuronide,21967-41-9,Autophagy; HIV; NF-?oB,Anti-infection; Autophagy; NF-?oB,C21H18O11,10mM,Inflammation/Immunology; Cancer,Launched,O=C(O)[C@H]1O[C@@H](Oc2cc3oc(-c4ccccc4)cc(=O)c3c(O)c2O)[C@H](O)[C@@H](O)[C@@H]1O,清洗成功,0.275
16078,O=C(OC[C@H]1O[C@@H](Oc2c(-c3ccc(O)c(O)c3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H](O)[C@@H]1O)c1cc(O)c(O)c(O)c1,1,0.9909335374832153,0.9909335374832153,O=C1C(O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](COC(C3=CC(O)=C(O)C(O)=C3)=O)O2)O)O)O)=C(C4=CC=C(O)C(O)=C4)OC5=CC(O)=CC(O)=C15,Quercetin 3-O-(6''-O-galloyl)-?2-D-glucoside,Data.sdf,19221,HY-N7989,Tellimoside,56316-75-7,Others,Others,C28H24O16,10mM,Others,No Development Reported,O=C(OC[C@H]1O[C@@H](Oc2c(-c3ccc(O)c(O)c3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H](O)[C@@H]1O)c1cc(O)c(O)c(O)c1,清洗成功,0.3142857142857143
4644,CN(C)CCCn1c(N)c(-c2nc3ccccc3[nH]2)c2nc3ccccc3nc21,1,0.9909323453903198,0.9909323453903198,NC1=C(C2=NC3=CC=CC=C3N=C2N1CCCN(C)C)C4=NC5=CC=CC=C5N4,INI-43,Data.sdf,5459,HY-121607,,881046-01-1,AP-1; Apoptosis,Apoptosis; Immunology/Inflammation,C22H23N7,10mM,Cancer,No Development Reported,CN(C)CCCn1c(N)c(-c2nc3ccccc3[nH]2)c2nc3ccccc3nc21,清洗成功,0.28
3078,Cc1nc2ccc(-c3c(Nc4ccccn4)[nH]c4c(-c5ccccc5)c(-c5ccccc5)nn4c3=O)cc2s1,1,0.9909195899963379,0.9909195899963379,O=C1C(C2=CC=C3N=C(C)SC3=C2)=C(NC4=NC=CC=C4)NC5=C(C6=CC=CC=C6)C(C7=CC=CC=C7)=NN15,MAT2A inhibitor 1,Data.sdf,3603,HY-112131,,2201057-10-3,Methionine Adenosyltransferase (MAT),Epigenetics; Metabolic Enzyme/Protease,C31H22N6OS,2mM,Cancer,No Development Reported,Cc1nc2ccc(-c3c(Nc4ccccn4)[nH]c4c(-c5ccccc5)c(-c5ccccc5)nn4c3=O)cc2s1,清洗成功,0.2790697674418604
7345,COc1ccc(-c2oc3cc(OC)cc(OC)c3c(=O)c2OC)cc1,1,0.9909189939498901,0.9909189939498901,O=C1C(OC)=C(C2=CC=C(OC)C=C2)OC3=CC(OC)=CC(OC)=C13,Tetramethylkaempferol,Data.sdf,8688,HY-137794,,16692-52-7,Fungal,Anti-infection,C19H18O6,10mM,Infection,No Development Reported,COc1ccc(-c2oc3cc(OC)cc(OC)c3c(=O)c2OC)cc1,清洗成功,0.3
9727,COc1ccc2c(c1)C[C@H](C(=O)Nc1ccc(-c3cn[nH]c3)cc1OCCN(C)C)CO2,1,0.9909173846244812,0.9909173846244812,O=C([C@@H]1COC2=CC=C(OC)C=C2C1)NC3=CC=C(C4=CNN=C4)C=C3OCCN(C)C,Chroman 1,Data.sdf,11497,HY-15392,,1273579-40-0,ROCK,Cell Cycle/DNA Damage; Cytoskeleton; Stem Cell/Wnt; TGF-beta/Smad,C24H28N4O4,10mM,Cardiovascular Disease,No Development Reported,COc1ccc2c(c1)C[C@H](C(=O)Nc1ccc(-c3cn[nH]c3)cc1OCCN(C)C)CO2,清洗成功,0.2873563218390804
9728,COc1ccc2c(c1)C[C@H](C(=O)Nc1ccc(-c3cn[nH]c3)cc1OCCN(C)C)CO2,1,0.9909159541130066,0.9909159541130066,O=C([C@@H]1COC2=CC=C(OC)C=C2C1)NC3=CC=C(C4=CNN=C4)C=C3OCCN(C)C.Cl.Cl,Chroman 1 (dihydrochloride),Data.sdf,11499,HY-15392A,,,ROCK,Cell Cycle/DNA Damage; Cytoskeleton; Stem Cell/Wnt; TGF-beta/Smad,C24H30Cl2N4O4,10mM,Cardiovascular Disease,No Development Reported,COc1ccc2c(c1)C[C@H](C(=O)Nc1ccc(-c3cn[nH]c3)cc1OCCN(C)C)CO2,清洗成功,0.2840909090909091
8239,O=C1CCC(n2cc(-c3ccsc3)nn2)C(=O)N1,1,0.990915834903717,0.990915834903717,O=C(C(N1N=NC(C2=CSC=C2)=C1)CC3)NC3=O,TMX-4100,Data.sdf,9730,HY-145321,,2367619-63-2,Molecular Glues; Phosphodiesterase (PDE),Metabolic Enzyme/Protease; PROTAC,C11H10N4O2S,10mM,Cancer,No Development Reported,O=C1CCC(n2cc(-c3ccsc3)nn2)C(=O)N1,清洗成功,0.2222222222222222
2501,C[C@@H]1CN(Cc2ncccn2)C[C@H]1c1cn2c(C3CCOCC3)ncc2c(=O)[nH]1,1,0.9909091591835022,0.9909091591835022,O=C1C2=CN=C(C3CCOCC3)N2C=C([C@@H]4CN(CC5=NC=CC=N5)C[C@H]4C)N1,Tovinontrine,Data.sdf,2934,HY-109193,IMR-687,2062661-53-2,Phosphodiesterase (PDE),Metabolic Enzyme/Protease,C21H26N6O2,10mM,Cardiovascular Disease,Phase 2,C[C@@H]1CN(Cc2ncccn2)C[C@H]1c1cn2c(C3CCOCC3)ncc2c(=O)[nH]1,清洗成功,0.2197802197802197
16814,O=C(C[N+]12CCC(CC1)[C@@H](OC(=O)N(Cc1cc(F)c(F)c(F)c1)c1cccc(F)c1)C2)c1cccs1,1,0.9909067153930664,0.9909067153930664,O=C(C1=CC=CS1)C[N+]23C[C@@H](C(CC3)CC2)OC(N(C4=CC(F)=CC=C4)CC5=CC(F)=C(F)C(F)=C5)=O.[Br-],CHF5407,Data.sdf,20008,HY-U00302,,1004312-94-0,mAChR,GPCR/G Protein; Neuronal Signaling,C27H25BrF4N2O3S,10mM,Inflammation/Immunology,No Development Reported,O=C(C[N+]12CCC(CC1)[C@@H](OC(=O)N(Cc1cc(F)c(F)c(F)c1)c1cccc(F)c1)C2)c1cccs1,清洗成功,0.25
2691,COC(=O)[C@@H]1C[C@H](O)C(=O)[C@H]2[C@@]1(C)CC[C@H]1C(=O)O[C@H](c3ccoc3)C[C@]21C,1,0.9908985495567322,0.9908985495567322,C[C@@]12[C@@]3([C@](CC[C@]1(C(O[C@@H](C2)C4=COC=C4)=O)[H])(C)[C@H](C(OC)=O)C[C@@H](C3=O)O)[H],Salvinorin B,Data.sdf,3160,HY-110252,,92545-30-7,Endogenous Metabolite,Metabolic Enzyme/Protease,C21H26O7,10mM,Others,No Development Reported,COC(=O)[C@@H]1C[C@H](O)C(=O)[C@H]2[C@@]1(C)CC[C@H]1C(=O)O[C@H](c3ccoc3)C[C@]21C,清洗成功,0.17
10372,CCn1c(-c2cc(N3CCN(C)CC3)cnc2[C@H](C)OC)c2c3cc(ccc31)-c1csc(n1)C[C@H](NC(=O)[C@H]1[C@H](C)[C@@H]1C)C(=O)N1N[C@H](C(=O)OCC(C)(C)C2)C2CC1C2,1,0.9908936023712158,0.9908936023712158,O=C1OCC(C)(CC2=[C@@]([C@@]3=C([C@H](C)OC)N=CC(N4CCN(C)CC4)=C3)N(CC)C5=CC=C(C6=CSC(C[C@H](NC([C@H]7[C@H](C)[C@@H]7C)=O)C(N8N[C@H]1C9CC8C9)=O)=N6)C=C25)C,Pan-RAS-IN-2,Data.sdf,12296,HY-158409,,3034673-92-9,Cyclophilin; Molecular Glues; Ras,GPCR/G Protein; Immunology/Inflammation; MAPK/ERK Pathway; PROTAC,C46H60N8O5S,10mM,Cancer,No Development Reported,CCn1c(-c2cc(N3CCN(C)CC3)cnc2[C@H](C)OC)c2c3cc(ccc31)-c1csc(n1)C[C@H](NC(=O)[C@H]1[C@H](C)[C@@H]1C)C(=O)N1N[C@H](C(=O)OCC(C)(C)C2)C2CC1C2,清洗成功,0.2230215827338129
11794,O=c1cc(-c2cccs2)[nH]c(C2CCCN(Cc3cn(-c4ncccn4)cn3)C2)n1,1,0.9908822774887085,0.9908822774887085,O=C1C=C(C2=CC=CS2)NC(C3CCCN(CC4=CN(C5=NC=CC=N5)C=N4)C3)=N1,Ribocil-C (Racemate),Data.sdf,13953,HY-19488,,2309762-18-1,Bacterial,Anti-infection,C21H21N7OS,10mM,Infection,No Development Reported,O=c1cc(-c2cccs2)[nH]c(C2CCCN(Cc3cn(-c4ncccn4)cn3)C2)n1,清洗成功,0.2886597938144329
11795,O=c1cc(-c2cccs2)[nH]c([C@H]2CCCN(Cc3cn(-c4ncccn4)cn3)C2)n1,1,0.9908822774887085,0.9908822774887085,O=C1C=C(C2=CC=CS2)NC([C@H]3CCCN(CC4=CN(C5=NC=CC=N5)C=N4)C3)=N1,Ribocil-C,Data.sdf,13954,HY-19488A,,1825355-56-3,Bacterial,Anti-infection,C21H21N7OS,10mM,Infection,No Development Reported,O=c1cc(-c2cccs2)[nH]c([C@H]2CCCN(Cc3cn(-c4ncccn4)cn3)C2)n1,清洗成功,0.2886597938144329
11796,O=c1cc(-c2cccs2)[nH]c([C@@H]2CCCN(Cc3cn(-c4ncccn4)cn3)C2)n1,1,0.9908822774887085,0.9908822774887085,O=C1N=C([C@H](CCC2)CN2CC3=CN(C4=NC=CC=N4)C=N3)NC(C5=CC=CS5)=C1,Ribocil-C (R enantiomer),Data.sdf,13955,HY-19488B,,2177266-81-6,Bacterial,Anti-infection,C21H21N7OS,10mM,Infection,No Development Reported,O=c1cc(-c2cccs2)[nH]c([C@@H]2CCCN(Cc3cn(-c4ncccn4)cn3)C2)n1,清洗成功,0.2886597938144329
3999,COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(-c2ccc(-c3ccc(-c4c[nH]c([C@@H]5CCCN5C(=O)[C@@H](NC(=O)OC)C(C)C)n4)c4c3OCO4)cc2)c[nH]1)C(C)C,1,0.9908802509307861,0.9908802509307861,O=C(N[C@H](C(N1[C@@H](CCC1)C2=NC(C3=CC=C(C=C3)C4=C5OCOC5=C(C=C4)C6=CNC([C@H]7N(CCC7)C([C@H](C(C)C)NC(OC)=O)=O)=N6)=CN2)=O)C(C)C)OC.[H]Cl.[H]Cl,Coblopasvir (dihydrochloride),Data.sdf,4700,HY-117411A,KW-136 (dihydrochloride),1966138-53-3,HCV; HCV Protease,Anti-infection; Metabolic Enzyme/Protease,C41H52Cl2N8O8,10mM,Infection,Launched,COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(-c2ccc(-c3ccc(-c4c[nH]c([C@@H]5CCCN5C(=O)[C@@H](NC(=O)OC)C(C)C)n4)c4c3OCO4)cc2)c[nH]1)C(C)C,清洗成功,0.2346938775510204
4874,Cn1cc(-c2cnc(N)c3c(-c4ccc5c(c4)CCN5C(=O)Cc4ccccc4)csc23)cn1,1,0.9908797740936279,0.9908797740936279,CN1N=CC(C2=CN=C(N)C3=C2SC=C3C4=CC5=C(N(C(CC6=CC=CC=C6)=O)CC5)C=C4)=C1,GSK2593074A,Data.sdf,5738,HY-122909,GSK'074,1337531-06-2,RIP kinase,Apoptosis,C27H23N5OS,10mM,Inflammation/Immunology,No Development Reported,Cn1cc(-c2cnc(N)c3c(-c4ccc5c(c4)CCN5C(=O)Cc4ccccc4)csc23)cn1,清洗成功,0.348314606741573
6816,O=c1[nH]nc2c3c(cccc13)Oc1ccc(CN3CCC(O)CC3)cc1-2,1,0.9908797740936279,0.9908797740936279,O=C1NN=C2C3=C1C=CC=C3OC4=CC=C(CN5CCC(O)CC5)C=C42,E7016,Data.sdf,8091,HY-13540,GPI 21016,902128-92-1,PARP,Cell Cycle/DNA Damage; Epigenetics,C20H19N3O3,10mM,Cancer,Phase 2,O=c1[nH]nc2c3c(cccc13)Oc1ccc(CN3CCC(O)CC3)cc1-2,清洗成功,0.2903225806451613
5920,Oc1cc(O)c2cc(O[C@@H]3OC[C@H](O)[C@H](O)[C@H]3O)c(-c3ccc(O)c(O)c3)[o+]c2c1,1,0.990871012210846,0.990871012210846,OC1=CC2=[O+]C(C3=CC=C(O)C(O)=C3)=C(O[C@H]4[C@@H]([C@H]([C@H](CO4)O)O)O)C=C2C(O)=C1.[Cl-],Cyanidin-3-O-arabinoside,Data.sdf,7000,HY-129139,,111613-04-8,Others,Others,C20H19ClO10,2mM,Others,No Development Reported,Oc1cc(O)c2cc(O[C@@H]3OC[C@H](O)[C@H](O)[C@H]3O)c(-c3ccc(O)c(O)c3)[o+]c2c1,清洗成功,0.2456140350877192
7290,CC(=O)N(C)C1CCN(c2cccc(-c3ccc4nc(-c5cccnc5N)n(-c5ccc(C6(N)CCC6)cc5)c4n3)c2)CC1,1,0.9908655285835266,0.9908655285835266,NC1=C(C=CC=N1)C2=NC3=CC=C(C4=CC(N(CC5)CCC5N(C)C(C)=O)=CC=C4)N=C3N2C6=CC=C(C7(CCC7)N)C=C6,Vevorisertib,Data.sdf,8627,HY-137458,ARQ 751,1416775-46-6,Akt; Ser/Thr Protease,Metabolic Enzyme/Protease; PI3K/Akt/mTOR,C35H38N8O,10mM,Cancer,Phase 1,CC(=O)N(C)C1CCN(c2cccc(-c3ccc4nc(-c5cccnc5N)n(-c5ccc(C6(N)CCC6)cc5)c4n3)c2)CC1,清洗成功,0.2777777777777778
7291,CC(=O)N(C)C1CCN(c2cccc(-c3ccc4nc(-c5cccnc5N)n(-c5ccc(C6(N)CCC6)cc5)c4n3)c2)CC1,1,0.9908655285835266,0.9908655285835266,NC1=C(C=CC=N1)C2=NC3=CC=C(C4=CC(N(CC5)CCC5N(C)C(C)=O)=CC=C4)N=C3N2C6=CC=C(C7(CCC7)N)C=C6.[H]Cl.[H]Cl.[H]Cl,Vevorisertib (trihydrochloride),Data.sdf,8628,HY-137458A,ARQ 751 (trihydrochloride),1416775-08-0,Akt,PI3K/Akt/mTOR,C35H41Cl3N8O,10mM,Cancer,Phase 1,CC(=O)N(C)C1CCN(c2cccc(-c3ccc4nc(-c5cccnc5N)n(-c5ccc(C6(N)CCC6)cc5)c4n3)c2)CC1,清洗成功,0.2747252747252747
7192,Cc1cc(-c2ccc3nc(C4CCOCC4)n(CCOC(F)(F)F)c3c2)cn(C)c1=O,1,0.9908632040023804,0.9908632040023804,O=C1C(C)=CC(C2=CC=C3N=C(C4CCOCC4)N(CCOC(F)(F)F)C3=C2)=CN1C,NEO2734,Data.sdf,8515,HY-136938,EP31670,2081072-29-7,Epigenetic Reader Domain; Histone Acetyltransferase,Epigenetics,C22H24F3N3O3,10mM,Cancer,Phase 1,Cc1cc(-c2ccc3nc(C4CCOCC4)n(CCOC(F)(F)F)c3c2)cn(C)c1=O,清洗成功,0.2394366197183098
7800,O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1,1,0.9908530116081238,0.9908530116081238,O=C(O[C@H]1C[N+]2(CCCOC3=CC=CC=C3)CCC1CC2)C(C4=CC=CS4)(O)C5=CC=CS5.[Br-],Aclidinium (Bromide),Data.sdf,9225,HY-14144,LAS 34273; LAS-W 330,320345-99-1,mAChR,GPCR/G Protein; Neuronal Signaling,C26H30BrNO4S2,10mM,Inflammation/Immunology,Launched,O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1,清洗成功,0.2023809523809523
5976,Oc1ccc2nc(CN3CCC(Cc4ccccc4F)CC3)[nH]c2c1,1,0.9908520579338074,0.9908520579338074,OC1=CC=C2N=C(CN3CCC(CC4=CC=CC=C4F)CC3)NC2=C1.[H]Cl,NMDA-IN-1,Data.sdf,7072,HY-12962,,700878-19-9,iGluR,Membrane Transporter/Ion Channel; Neuronal Signaling,C20H23ClFN3O,10mM,Neurological Disease,No Development Reported,Oc1ccc2nc(CN3CCC(Cc4ccccc4F)CC3)[nH]c2c1,清洗成功,0.2790697674418604
15383,COc1cc(O)c2c(=O)c(-c3ccc(O)cc3)coc2c1,1,0.9908487796783447,0.9908487796783447,O=C1C(C2=CC=C(O)C=C2)=COC3=CC(OC)=CC(O)=C13,Prunetin,Data.sdf,18325,HY-N2597,,552-59-0,Aldehyde Dehydrogenase (ALDH),Metabolic Enzyme/Protease,C16H12O5,10mM,Inflammation/Immunology,No Development Reported,COc1cc(O)c2c(=O)c(-c3ccc(O)cc3)coc2c1,清洗成功,0.32
227,CC(=O)N1CCC(Cn2cnc3scc(-c4ccc(C)o4)c3c2=O)CC1,1,0.9908409118652344,0.9908409118652344,O=C(C)N1CCC(CN2C=NC(SC=C3C4=CC=C(C)O4)=C3C2=O)CC1,REV7/REV3L-IN-1,Data.sdf,260,HY-100468,,1979192-13-6,DNA/RNA Synthesis,Cell Cycle/DNA Damage,C19H21N3O3S,10mM,Cancer,No Development Reported,CC(=O)N1CCC(Cn2cnc3scc(-c4ccc(C)o4)c3c2=O)CC1,清洗成功,0.2439024390243902
9615,CN1CCN(c2cccc(Nc3nc4c(-c5ccc(S(C)(=O)=O)cc5)cccn4n3)c2)CC1,1,0.9908360242843628,0.9908360242843628,O=S(C1=CC=C(C2=CC=CN3C2=NC(NC4=CC=CC(N5CCN(C)CC5)=C4)=N3)C=C1)(C)=O,CEP-33779,Data.sdf,11358,HY-15343,,1257704-57-6,JAK,Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt,C24H26N6O2S,10mM,Cancer,No Development Reported,CN1CCN(c2cccc(Nc3nc4c(-c5ccc(S(C)(=O)=O)cc5)cccn4n3)c2)CC1,清洗成功,0.3421052631578947
68,CC[N+]1(C)CCC(OC(=O)C(c2noc3ccccc23)N2CCCCCC2)CC1,1,0.9908339381217957,0.9908339381217957,C[N+]1(CC)CCC(OC(C(C2=NOC3=C2C=CC=C3)N4CCCCCC4)=O)CC1.[I-],Beperidium iodide,Data.sdf,80,HY-100152,SX 810,86434-57-3,mAChR,GPCR/G Protein; Neuronal Signaling,C23H34IN3O3,10mM,Inflammation/Immunology,No Development Reported,CC[N+]1(C)CCC(OC(=O)C(c2noc3ccccc23)N2CCCCCC2)CC1,清洗成功,0.2222222222222222
13004,COC(=O)Nc1nc2ccc(Sc3ccccc3)cc2[nH]1,1,0.9908321499824524,0.9908321499824524,O=C(OC)NC1=NC2=CC=C(SC3=CC=CC=C3)C=C2N1,Fenbendazole,Data.sdf,15369,HY-B0413,,43210-67-9,Antibiotic; HIF/HIF Prolyl-Hydroxylase; Microtubule/Tubulin; Parasite,Anti-infection; Cell Cycle/DNA Damage; Cytoskeleton; Metabolic Enzyme/Protease,C15H13N3O2S,10mM,Infection; Cancer,No Development Reported,COC(=O)Nc1nc2ccc(Sc3ccccc3)cc2[nH]1,清洗成功,0.2923076923076923
7381,CSc1ccc(OCc2ncc([N+](=O)[O-])n2C)cc1,1,0.9908308982849121,0.9908308982849121,O=[N+](C1=CN=C(COC2=CC=C(SC)C=C2)N1C)[O-],Fexinidazole,Data.sdf,8732,HY-13801,HOE 239,59729-37-2,Parasite,Anti-infection,C12H13N3O3S,10mM,Infection,Launched,CSc1ccc(OCc2ncc([N+](=O)[O-])n2C)cc1,清洗成功,0.2307692307692307
288,COc1nc(-c2ccc3c(c2)OCO3)n(-c2ccc(NC(=O)CSc3ccccc3)cc2)n1,1,0.9908050298690796,0.9908050298690796,O=C(NC1=CC=C(N2N=C(OC)N=C2C3=CC=C(OCO4)C4=C3)C=C1)CSC5=CC=CC=C5,SecinH3,Data.sdf,328,HY-100559,,853625-60-2,Apoptosis,Apoptosis,C24H20N4O4S,10mM,Endocrinology; Metabolic Disease; Cancer,No Development Reported,COc1nc(-c2ccc3c(c2)OCO3)n(-c2ccc(NC(=O)CSc3ccccc3)cc2)n1,清洗成功,0.3037974683544304
14900,COc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1,1,0.9908040761947632,0.9908040761947632,O=C1C=C(C2=CC=C(OC)C=C2)OC3=CC(OC)=C(OC)C(O)=C13,Salvigenin,Data.sdf,17686,HY-N1318,Psathyrotin,19103-54-9,Apoptosis; Autophagy; ROS Kinase,Apoptosis; Autophagy; Protein Tyrosine Kinase/RTK,C18H16O6,10mM,Cancer; Inflammation/Immunology; Neurological Disease,No Development Reported,COc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1,清洗成功,0.3380281690140845
9651,Oc1c(C(Nc2cccnc2)c2ccsc2)ccc2cccnc12,1,0.9908031225204468,0.9908031225204468,OC1=C(C(C2=CSC=C2)NC3=CC=CN=C3)C=CC4=CC=CN=C14,B-Raf IN 15,Data.sdf,11404,HY-153603,,832107-31-0,Raf,MAPK/ERK Pathway,C19H15N3OS,10mM,Cancer,No Development Reported,Oc1c(C(Nc2cccnc2)c2ccsc2)ccc2cccnc12,清洗成功,0.2692307692307692
11330,COc1ccc(-c2cc(C(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1F,1,0.9908003211021423,0.9908003211021423,O=S(C1=CC=C(N2N=C(C(F)F)C=C2C3=CC=C(OC)C(F)=C3)C=C1)(N)=O,Deracoxib,Data.sdf,13406,HY-17509,SC 046; SC 46; SC 59046,169590-41-4,Apoptosis; COX,Apoptosis; Immunology/Inflammation,C17H14F3N3O3S,10mM,Inflammation/Immunology,Launched,COc1ccc(-c2cc(C(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1F,清洗成功,0.24
10546,Cn1c(C(=O)N2CCN(Cc3ccc(OCC(F)(F)F)cc3)CC2)cc2ccc(Oc3cnc(-c4nc(-c5ccc(C(F)(F)F)cc5)no4)cn3)cc21,1,0.9907983541488647,0.9907983541488647,O=C(C(N1C)=CC2=C1C=C(OC3=NC=C(C4=NC(C5=CC=C(C(F)(F)F)C=C5)=NO4)N=C3)C=C2)N6CCN(CC7=CC=C(OCC(F)(F)F)C=C7)CC6,STAT3-IN-25,Data.sdf,12500,HY-160496,,2591440-75-2,STAT,JAK/STAT Signaling; Stem Cell/Wnt,C36H29F6N7O4,2mM,Cancer,No Development Reported,Cn1c(C(=O)N2CCN(Cc3ccc(OCC(F)(F)F)cc3)CC2)cc2ccc(Oc3cnc(-c4nc(-c5ccc(C(F)(F)F)cc5)no4)cn3)cc21,清洗成功,0.2654867256637168
15556,COc1cc(O[C@@H]2O[C@H](CO[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@H](O)[C@H]2O)c2c(O)c3c(=O)cc(C)oc3cc2c1,1,0.9907820820808411,0.9907820820808411,OC1=C2C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)CO[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)CO)=CC(OC)=CC2=CC5=C1C(C=C(C)O5)=O,Rubrofusarin gentiobioside,Data.sdf,18562,HY-N4177,,24577-90-0,Others,Others,C27H32O15,10mM,Metabolic Disease,No Development Reported,COc1cc(O[C@@H]2O[C@H](CO[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@H](O)[C@H]2O)c2c(O)c3c(=O)cc(C)oc3cc2c1,清洗成功,0.3493975903614458
2700,CN1C(=O)C(F)=C[C@]2(C)[C@H]3CC[C@]4(C)[C@@H](C(=O)NCc5nc6cccnc6[nH]5)CC[C@H]4[C@@H]3CC[C@@H]12,1,0.9907804131507874,0.9907804131507874,O=C([C@H]1CC[C@]2([H])[C@]1(C)CC[C@]3([H])[C@@]4(C)C=C(F)C(N(C)[C@]4([H])CC[C@]32[H])=O)NCC5=NC6=CC=CN=C6N5,MK-0773,Data.sdf,3170,HY-11027,PF-05314882,606101-58-0,Androgen Receptor,Vitamin D Related/Nuclear Receptor,C27H34FN5O2,10mM,Endocrinology,Phase 2,CN1C(=O)C(F)=C[C@]2(C)[C@H]3CC[C@]4(C)[C@@H](C(=O)NCc5nc6cccnc6[nH]5)CC[C@H]4[C@@H]3CC[C@@H]12,清洗成功,0.2075471698113207
570,CN1CCC(S(=O)(=O)c2c(Cl)ccc(NC(=O)Nc3cccc(F)c3Cl)c2O)CC1,1,0.9907746911048889,0.9907746911048889,ClC1=CC=C(NC(NC2=CC=CC(F)=C2Cl)=O)C(O)=C1S(=O)(C3CCN(C)CC3)=O,CXCR2-IN-1,Data.sdf,645,HY-101022,,1873376-49-8,CXCR,GPCR/G Protein; Immunology/Inflammation,C19H20Cl2FN3O4S,10mM,Inflammation/Immunology; Endocrinology,No Development Reported,CN1CCC(S(=O)(=O)c2c(Cl)ccc(NC(=O)Nc3cccc(F)c3Cl)c2O)CC1,清洗成功,0.2840909090909091
8898,Cc1cn(-c2cc(CN3CCC[C@H](N)C3)cc(NC(=O)c3ccc(C)c(Oc4ccccc4)c3)c2)cn1,1,0.9907727241516113,0.9907727241516113,O=C(C1=CC(OC2=CC=CC=C2)=C(C=C1)C)NC3=CC(N4C=C(N=C4)C)=CC(CN5C[C@H](CCC5)N)=C3,PCSK9-IN-13,Data.sdf,10500,HY-148758,,2244129-23-3,PCSK9,Metabolic Enzyme/Protease,C30H33N5O2,10mM,Metabolic Disease; Cardiovascular Disease,No Development Reported,Cc1cn(-c2cc(CN3CCC[C@H](N)C3)cc(NC(=O)c3ccc(C)c(Oc4ccccc4)c3)c2)cn1,清洗成功,0.284313725490196
8548,CN1CCC(c2ccc(-c3ccc4c(c3)C(=O)N(C(C(=O)Nc3nccs3)c3cc(F)ccc3O)C4)cc2)CC1,1,0.9907708168029785,0.9907708168029785,O=C(NC1=NC=CS1)C(C2=CC(F)=CC=C2O)N(CC3=C4C=C(C5=CC=C(C6CCN(C)CC6)C=C5)C=C3)C4=O.O=C(O)C(F)(F)F,JBJ-09-063 (TFA),Data.sdf,10085,HY-147183A,,,EGFR,JAK/STAT Signaling; Protein Tyrosine Kinase/RTK,C33H30F4N4O5S,10mM,Cancer,No Development Reported,CN1CCC(c2ccc(-c3ccc4c(c3)C(=O)N(C(C(=O)Nc3nccs3)c3cc(F)ccc3O)C4)cc2)CC1,清洗成功,0.25
8549,CN1CCC(c2ccc(-c3ccc4c(c3)C(=O)N(C(C(=O)Nc3nccs3)c3cc(F)ccc3O)C4)cc2)CC1,1,0.9907708168029785,0.9907708168029785,O=C(NC1=NC=CS1)C(C2=CC(F)=CC=C2O)N(CC3=C4C=C(C5=CC=C(C6CCN(C)CC6)C=C5)C=C3)C4=O.[H]Cl,JBJ-09-063 (hydrochloride),Data.sdf,10086,HY-147183B,,,EGFR,JAK/STAT Signaling; Protein Tyrosine Kinase/RTK,C31H30ClFN4O3S,10mM,Cancer,No Development Reported,CN1CCC(c2ccc(-c3ccc4c(c3)C(=O)N(C(C(=O)Nc3nccs3)c3cc(F)ccc3O)C4)cc2)CC1,清洗成功,0.2616822429906542
1213,COc1ccc(-c2cc3onc(-c4ccncc4)c3c(=O)n2C)cc1,1,0.9907654523849487,0.9907654523849487,O=C1C2=C(ON=C2C3=CC=NC=C3)C=C(C4=CC=C(OC)C=C4)N1C.[H]Cl,MMPIP (hydrochloride),Data.sdf,1405,HY-103111,,1215566-78-1,mGluR,GPCR/G Protein; Neuronal Signaling,C19H16ClN3O3,10mM,Neurological Disease,No Development Reported,COc1ccc(-c2cc3onc(-c4ccncc4)c3c(=O)n2C)cc1,清洗成功,0.328125
12273,N#CC1C(=O)Nc2scc(-c3ccc(-c4ccccc4O)cc3)c2C1=O,1,0.9907552599906921,0.9907552599906921,N#CC1C(C2=C(NC1=O)SC=C2C3=CC=C(C4=CC=CC=C4O)C=C3)=O,A-769662,Data.sdf,14519,HY-50662,,844499-71-4,AMPK,Epigenetics; PI3K/Akt/mTOR,C20H12N2O3S,10mM,Cancer,No Development Reported,N#CC1C(=O)Nc2scc(-c3ccc(-c4ccccc4O)cc3)c2C1=O,清洗成功,0.2285714285714285
6793,N[C@@H]1CCCN(C(=O)c2cc3c4c(c2)nc(-c2cc5cccc(Cl)c5n2CC2CC2)n4CCO3)C1,1,0.9907513856887817,0.9907513856887817,O=C(N1C[C@H](N)CCC1)C2=CC3=C4N(C(C(N5CC6CC6)=CC7=C5C(Cl)=CC=C7)=N3)CCOC4=C2,PAD-IN-2,Data.sdf,8061,HY-135304,,2304852-21-7,Protein Arginine Deiminase,Epigenetics,C27H28ClN5O2,10mM,Cancer; Inflammation/Immunology,No Development Reported,N[C@@H]1CCCN(C(=O)c2cc3c4c(c2)nc(-c2cc5cccc(Cl)c5n2CC2CC2)n4CCO3)C1,清洗成功,0.2989690721649484
1106,CC1(C)CC(=O)c2c(C(F)(F)F)nn(-c3ccc(C(N)=O)c(N[C@H]4CC[C@H](OC(=O)CN)CC4)c3)c2C1,1,0.9907439351081848,0.9907439351081848,FC(F)(C1=NN(C2=CC(N[C@@H]3CC[C@H](CC3)OC(CN)=O)=C(C=C2)C(N)=O)C(CC(C)(C4)C)=C1C4=O)F,SNX-5422,Data.sdf,1271,HY-10213,PF-04929113,908115-27-5,HSP,Cell Cycle/DNA Damage; Metabolic Enzyme/Protease,C25H30F3N5O4,10mM,Cancer,Phase 2,CC1(C)CC(=O)c2c(C(F)(F)F)nn(-c3ccc(C(N)=O)c(N[C@H]4CC[C@H](OC(=O)CN)CC4)c3)c2C1,清洗成功,0.2169811320754717
15166,COc1cc(/C=C/C(=O)OC[C@H]2O[C@@H](O[C@@H]3[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]3c3c(OC)cc4oc(-c5ccc(O)cc5)cc(=O)c4c3O)[C@H](O)[C@@H](O)[C@@H]2O)ccc1O,1,0.990738570690155,0.990738570690155,O[C@@H]1[C@H]([C@H](C(C(O)=C(C2=O)C(OC(C3=CC=C(O)C=C3)=C2)=C4)=C4OC)O[C@H](CO)[C@H]1O)O[C@]([C@@H]([C@@H](O)[C@@H]5O)O)([H])O[C@@H]5COC(/C=C/C6=CC(OC)=C(O)C=C6)=O,6'''-Feruloylspinosin,Data.sdf,18037,HY-N2160,,77690-92-7,GABA Receptor,Membrane Transporter/Ion Channel; Neuronal Signaling,C38H40O18,10mM,Neurological Disease,No Development Reported,COc1cc(/C=C/C(=O)OC[C@H]2O[C@@H](O[C@@H]3[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]3c3c(OC)cc4oc(-c5ccc(O)cc5)cc(=O)c4c3O)[C@H](O)[C@@H](O)[C@@H]2O)ccc1O,清洗成功,0.3366336633663366
12658,CN1C(=O)COc2c(C(=O)N[C@H]3CN4CCC3CC4)cc(Cl)cc21,1,0.990731418132782,0.990731418132782,O=S(O)(C1=CC=CC=C1)=O.O=C(C2=C(OCC(N3C)=O)C3=CC(Cl)=C2)N[C@H]4CN5CCC4CC5,(R)-Azasetron (besylate),Data.sdf,14977,HY-B0019C,SENS-401,2025360-91-0,Phosphatase,Metabolic Enzyme/Protease,C23H26ClN3O6S,10mM,Cancer,Phase 3,CN1C(=O)COc2c(C(=O)N[C@H]3CN4CCC3CC4)cc(Cl)cc21,清洗成功,0.2234042553191489
1461,CN1CCN(Cc2cc(CNC3(c4ccccc4F)CCCC3)ccc2O)CC1,1,0.9907268285751343,0.9907268285751343,OC1=CC=C(CNC2(C3=CC=CC=C3F)CCCC2)C=C1CN4CCN(C)CC4.Cl[H].Cl[H].Cl[H],ARN5187 (trihydrochloride),Data.sdf,1713,HY-103691A,,1700693-96-4,Apoptosis; Autophagy; REV-ERB,Apoptosis; Autophagy; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor,C24H35Cl3FN3O,10mM,Cancer,No Development Reported,CN1CCN(Cc2cc(CNC3(c4ccccc4F)CCCC3)ccc2O)CC1,清洗成功,0.2444444444444444
7159,COc1cc2c(-c3cnn4cc(N5CCC(N6CCN(C)CC6)CC5)cnc34)ccnc2cc1F,1,0.9907242655754089,0.9907242655754089,FC(C=C1C(C(C2=C3N(C=C(C=N3)N4CCC(CC4)N5CCN(CC5)C)N=C2)=CC=N1)=C6)=C6OC,KER047,Data.sdf,8475,HY-136773,ALK2-IN-4,2248154-85-8,TGF-?2 Receptor,TGF-beta/Smad,C26H30FN7O,10mM,Metabolic Disease,Phase 2,COc1cc2c(-c3cnn4cc(N5CCC(N6CCN(C)CC6)CC5)cnc34)ccnc2cc1F,清洗成功,0.336734693877551
7160,COc1cc2c(-c3cnn4cc(N5CCC(N6CCN(C)CC6)CC5)cnc34)ccnc2cc1F,1,0.9907242655754089,0.9907242655754089,FC(C=C1C(C(C2=C3N(C=C(C=N3)N4CCC(CC4)N5CCN(CC5)C)N=C2)=CC=N1)=C6)=C6OC.O=C(O)CCC(O)=O,KER047 (succinate),Data.sdf,8476,HY-136773A,ALK2-IN-4 (succinate),2416307-25-8,TGF-?2 Receptor,TGF-beta/Smad,C30H36FN7O5,2mM,Metabolic Disease,Phase 2,COc1cc2c(-c3cnn4cc(N5CCC(N6CCN(C)CC6)CC5)cnc34)ccnc2cc1F,清洗成功,0.320754716981132
12675,CN1C(=O)COc2c(C(=O)NC3CN4CCC3CC4)cc(Cl)cc21,1,0.990723192691803,0.990723192691803,O=C(C1=C(OCC(N2C)=O)C2=CC(Cl)=C1)NC3CN4CCC3CC4.[H]Cl,Azasetron (hydrochloride),Data.sdf,14997,HY-B0068,Y-25130 hydrochloride,123040-16-4,5-HT Receptor,GPCR/G Protein; Neuronal Signaling,C17H21Cl2N3O3,10mM,Neurological Disease,Launched,CN1C(=O)COc2c(C(=O)NC3CN4CCC3CC4)cc(Cl)cc21,清洗成功,0.2325581395348837
9707,COc1ccc2nc(SCCOc3ccccc3Cl)[nH]c2c1,1,0.9907207489013672,0.9907207489013672,ClC1=C(OCCSC2=NC3=C(N2)C=C(OC)C=C3)C=CC=C1,Sperm motility agonist-2,Data.sdf,11470,HY-153819,,926079-67-6,Mitochondrial Metabolism,Metabolic Enzyme/Protease,C16H15ClN2O2S,10mM,Endocrinology,No Development Reported,COc1ccc2nc(SCCOc3ccccc3Cl)[nH]c2c1,清洗成功,0.35
12022,Cn1ncc2cc(-c3cnc(N)c(Cl)c3N3CCC4(CCNC4=O)CC3)ccc21,1,0.9907207489013672,0.9907207489013672,O=C1NCCC12CCN(C3=C(Cl)C(N)=NC=C3C4=CC5=C(N(C)N=C5)C=C4)CC2,CCT-251921,Data.sdf,14213,HY-19984,,1607837-31-9,CDK,Cell Cycle/DNA Damage,C21H23ClN6O,10mM,Cancer,No Development Reported,Cn1ncc2cc(-c3cnc(N)c(Cl)c3N3CCC4(CCNC4=O)CC3)ccc21,清洗成功,0.3132530120481928
14525,O=C(O[C@H]1[C@H](Oc2c(-c3ccc(O)c(O)c3)oc3cc(O)cc(O)c3c2=O)O[C@H](CO)[C@H](O)[C@@H]1O)c1cc(O)c(O)c(O)c1,1,0.9907158613204956,0.9907158613204956,O=C1C(O[C@H](O[C@H](CO)[C@H](O)[C@@H]2O)[C@@H]2OC(C3=CC(O)=C(O)C(O)=C3)=O)=C(C4=CC(O)=C(O)C=C4)OC5=CC(O)=CC(O)=C15,2"-O-Galloylhyperin,Data.sdf,17194,HY-N0526,,53209-27-1,Others,Others,C28H24O16,10mM,Inflammation/Immunology,No Development Reported,O=C(O[C@H]1[C@H](Oc2c(-c3ccc(O)c(O)c3)oc3cc(O)cc(O)c3c2=O)O[C@H](CO)[C@H](O)[C@@H]1O)c1cc(O)c(O)c(O)c1,清洗成功,0.3176470588235294
14537,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc4c3)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,1,0.9907156229019165,0.9907156229019165,O=C(C=C(C1=CC=C(O)C=C1)OC2=CC(O[C@H](O[C@H](CO[C@H](O[C@@H](C)[C@H](O)[C@H]3O)[C@@H]3O)[C@@H](O)[C@@H]4O)[C@@H]4O[C@@](O[C@@H](C)[C@H](O)[C@H]5O)([H])[C@@H]5O)=C6)C2=C6O,Ligustroflavone,Data.sdf,17209,HY-N0546,Nuezhenoside,260413-62-5,CaSR,GPCR/G Protein,C33H40O18,10mM,Metabolic Disease,No Development Reported,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc4c3)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,清洗成功,0.2553191489361702
9148,O=C(Cn1c(=O)oc2ccccc21)NCc1cncc(-c2ccsc2)c1,1,0.9907128214836121,0.9907128214836121,O=C1OC2=C(N1CC(NCC3=CN=CC(C4=CSC=C4)=C3)=O)C=CC=C2,NLRP3-IN-13,Data.sdf,10788,HY-150206,,1704638-35-6,NOD-like Receptor (NLR),Immunology/Inflammation,C19H15N3O3S,10mM,Inflammation/Immunology; Neurological Disease,No Development Reported,O=C(Cn1c(=O)oc2ccccc21)NCc1cncc(-c2ccsc2)c1,清洗成功,0.2978723404255319
7101,CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)cc2F)n(-c2cccc(F)c2)n1,1,0.9907103180885315,0.9907103180885315,O=C(NC1=CC(C(C)(C)C)=NN1C2=CC=CC(F)=C2)NC3=CC=C(OC4=C(N=C5)C(NC5=O)=NC=C4)C=C3F,TBAP-001,Data.sdf,8414,HY-136567,,1777832-90-2,Raf,MAPK/ERK Pathway,C27H23F2N7O3,10mM,Cancer,No Development Reported,CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)cc2F)n(-c2cccc(F)c2)n1,清洗成功,0.2736842105263158
7665,C=CC(=O)N1CCC(F)(CNc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)CC1,1,0.9907083511352539,0.9907083511352539,O=C(N1CCC(CNC2=NC=NC(N)=C2C3=CC=C(C=C3)OC4=CC=CC=C4)(CC1)F)C=C,TL-895,Data.sdf,9071,HY-139481,,1415823-49-2,Btk,Protein Tyrosine Kinase/RTK,C25H26FN5O2,10mM,Cancer; Infection,Phase 2,C=CC(=O)N1CCC(F)(CNc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)CC1,清洗成功,0.2674418604651162
7383,CCN(c1cc(-c2ccc(CN3CCOCC3)cc2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCOCC1,1,0.9907082319259644,0.9907082319259644,O=C(C1=CC(C2=CC=C(CN3CCOCC3)C=C2)=CC(N(CC)C4CCOCC4)=C1C)NCC5=C(C)C=C(C)NC5=O,Tazemetostat,Data.sdf,8734,HY-13803,EPZ-6438; E-7438,1403254-99-8,Apoptosis; Histone Methyltransferase,Apoptosis; Epigenetics,C34H44N4O4,10mM,Cancer,Launched,CCN(c1cc(-c2ccc(CN3CCOCC3)cc2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCOCC1,清洗成功,0.282051282051282
10673,Cc1sc2c(c1C)C(c1ccc(-c3cccc(NC(=O)c4cnn5cccnc45)c3)cc1)=N[C@@H](CC(N)=O)c1nnc(C)n1-2,1,0.9906976819038391,0.9906976819038391,O=C(N)C[C@H]1C2=NN=C(C)N2C3=C(C(C)=C(C)S3)C(C4=CC=C(C5=CC=CC(NC(C6=C7N(C=CC=N7)N=C6)=O)=C5)C=C4)=N1,PLX-3618,Data.sdf,12646,HY-161779,,2851986-76-8,Apoptosis; Epigenetic Reader Domain; Molecular Glues,Apoptosis; Epigenetics; PROTAC,C32H27N9O2S,10mM,Cancer,No Development Reported,Cc1sc2c(c1C)C(c1ccc(-c3cccc(NC(=O)c4cnn5cccnc45)c3)cc1)=N[C@@H](CC(N)=O)c1nnc(C)n1-2,清洗成功,0.2783505154639175
3631,Cc1nn(-c2ncccc2CO)cc1CN1CCC2(CC1)OCC(F)(F)c1cc(Cl)sc12,1,0.9906975626945496,0.9906975626945496,OCC1=CC=CN=C1N2N=C(C)C(CN3CCC4(C5=C(C=C(Cl)S5)C(F)(F)CO4)CC3)=C2,LY2940094,Data.sdf,4272,HY-114452,BTRX-246040,1307245-86-8,Opioid Receptor,GPCR/G Protein; Neuronal Signaling,C22H23ClF2N4O2S,10mM,Neurological Disease,Phase 2,Cc1nn(-c2ncccc2CO)cc1CN1CCC2(CC1)OCC(F)(F)c1cc(Cl)sc12,清洗成功,0.205607476635514
14708,O=c1c(O[C@@H]2O[C@H]([C@H](O)CO)[C@H](O)[C@H]2O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,1,0.99069744348526,0.99069744348526,O=C1C(O[C@@H]2O[C@@]([C@H](O)CO)([H])[C@H](O)[C@H]2O)=C(C3=CC(O)=C(O)C=C3)OC4=CC(O)=CC(O)=C14,Quercetin 3-O-?2-D-glucofuranoside,Data.sdf,17424,HY-N0768,,21637-25-2,Reactive Oxygen Species,Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?oB,C21H20O12,10mM,Inflammation/Immunology,No Development Reported,O=c1c(O[C@@H]2O[C@H]([C@H](O)CO)[C@H](O)[C@H]2O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,清洗成功,0.3492063492063492
17659,C=C[C@H]1C[N@]2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(O)cc12,1,0.9906966686248779,0.9906966686248779,O[C@@H](C1=CC=NC2=C1C=C(O)C=C2)[C@]3([H])[N@](C[C@@H]4C=C)CC[C@H]4C3,O-Desmethyl quinidine,Data.sdf,21039,HY-W037282,Cupreidine,70877-75-7,Drug Metabolite,Metabolic Enzyme/Protease,C19H22N2O2,10mM,Neurological Disease,No Development Reported,C=C[C@H]1C[N@]2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(O)cc12,清洗成功,0.216867469879518
3232,CC(=O)N(C)c1cccc(-c2ccc3nnc(C)n3n2)c1,1,0.9906908273696899,0.9906908273696899,CN(C(C)=O)C1=CC=CC(C2=NN3C(C)=NN=C3C=C2)=C1,Lin28-let-7 antagonist 1,Data.sdf,3800,HY-112659,,108825-65-6,Others,Others,C15H15N5O,10mM,Cancer; Neurological Disease,No Development Reported,CC(=O)N(C)c1cccc(-c2ccc3nnc(C)n3n2)c1,清洗成功,0.2916666666666667
10118,C=CC(=O)N[C@H]1CCOC[C@H]1Nc1ncc2cc(-c3c(F)c(OC)cc(OC)c3F)nc(N3CC(C)(OC)C3)c2n1,1,0.990689754486084,0.990689754486084,FC(C(OC)=CC(OC)=C1F)=C1C2=CC(C=N3)=C(C(N4CC(C)(C4)OC)=N2)N=C3N[C@H]5[C@H](CCOC5)NC(C=C)=O,Irpagratinib,Data.sdf,11969,HY-156618,ABSK011,2230974-62-4,FGFR,Protein Tyrosine Kinase/RTK,C28H32F2N6O5,10mM,cancer,Phase 2,C=CC(=O)N[C@H]1CCOC[C@H]1Nc1ncc2cc(-c3c(F)c(OC)cc(OC)c3F)nc(N3CC(C)(OC)C3)c2n1,清洗成功,0.2666666666666666
4827,C[C@@H](NC(=O)[C@@H]1C[C@H]2C[C@H]2N1C(=O)Cn1nc(C(N)=O)c2ccncc21)c1cccc(Cl)c1F,1,0.9906870722770691,0.9906870722770691,O=C([C@H]1N(C(CN2N=C(C(N)=O)C3=C2C=NC=C3)=O)[C@]4([H])C[C@]4([H])C1)N[C@@H](C5=CC=CC(Cl)=C5F)C,Factor D inhibitor 6,Data.sdf,5678,HY-122700,,1386455-51-1,Complement System,Immunology/Inflammation,C23H22ClFN6O3,10mM,Inflammation/Immunology,No Development Reported,C[C@@H](NC(=O)[C@@H]1C[C@H]2C[C@H]2N1C(=O)Cn1nc(C(N)=O)c2ccncc21)c1cccc(Cl)c1F,清洗成功,0.2448979591836734
4407,CCn1c(-c2nc3ccc(C(=O)N4CCCC(N)C4)cc3n2C)cc2ccccc21,1,0.9906851649284363,0.9906851649284363,O=C(N1CC(N)CCC1)C2=CC=C3N=C(C(N4CC)=CC5=C4C=CC=C5)N(C)C3=C2.Cl,GSK106,Data.sdf,5190,HY-120343,,1652591-82-6,Protein Arginine Deiminase,Epigenetics,C24H28ClN5O,10mM,Cancer; Inflammation/Immunology; Cardiovascular Disease,No Development Reported,CCn1c(-c2nc3ccc(C(=O)N4CCCC(N)C4)cc3n2C)cc2ccccc21,清洗成功,0.3488372093023256
1832,Cc1c(C(=O)Nc2ccc(Oc3ccnc4cc(OCC(C)(C)O)ccc34)c(F)c2)c(=O)n(-c2ccccc2)n1C,1,0.9906843900680542,0.9906843900680542,CC1=CC=C(S(=O)(O)=O)C=C1.CC2=C(C(NC3=CC(F)=C(OC4=CC=NC5=C4C=CC(OCC(C)(O)C)=C5)C=C3)=O)C(N(C6=CC=CC=C6)N2C)=O,Ningetinib Tosylate,Data.sdf,2163,HY-107145,,1394820-77-9,c-Met/HGFR; TAM Receptor; VEGFR,Protein Tyrosine Kinase/RTK,C38H37FN4O8S,10mM,Cancer,Phase 2,Cc1c(C(=O)Nc2ccc(Oc3ccnc4cc(OCC(C)(C)O)ccc34)c(F)c2)c(=O)n(-c2ccccc2)n1C,清洗成功,0.2692307692307692
1833,Cc1c(C(=O)Nc2ccc(Oc3ccnc4cc(OCC(C)(C)O)ccc34)c(F)c2)c(=O)n(-c2ccccc2)n1C,1,0.9906843900680542,0.9906843900680542,CC1=C(C(NC2=CC(F)=C(OC3=CC=NC4=C3C=CC(OCC(C)(O)C)=C4)C=C2)=O)C(N(C5=CC=CC=C5)N1C)=O,Ningetinib,Data.sdf,2164,HY-107145A,,1394820-69-9,c-Met/HGFR; TAM Receptor; VEGFR,Protein Tyrosine Kinase/RTK,C31H29FN4O5,10mM,Cancer,Phase 2,Cc1c(C(=O)Nc2ccc(Oc3ccnc4cc(OCC(C)(C)O)ccc34)c(F)c2)c(=O)n(-c2ccccc2)n1C,清洗成功,0.2872340425531915
6401,Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1,1,0.9906843900680542,0.9906843900680542,CC1=CSC(C2=NN=C(C3=C2C=CC=C3)NC4=CC=C(C=C4)OC5=C(C=CC=N5)C6=CC=NC(N)=N6)=C1,AMG 900,Data.sdf,7572,HY-13253,,945595-80-2,Aurora Kinase,Cell Cycle/DNA Damage; Epigenetics,C28H21N7OS,10mM,Cancer,Phase 1,Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1,清洗成功,0.3076923076923077
10167,O=C(Cc1ccc(OCc2ccccc2)cc1)NC1(C(=O)O)CCN(C(=O)c2ccc(-c3cccc(Cl)c3)cc2)CC1,1,0.9906835556030273,0.9906835556030273,O=C(NC1(C(O)=O)CCN(C(C2=CC=C(C3=CC=CC(Cl)=C3)C=C2)=O)CC1)CC4=CC=C(OCC5=CC=CC=C5)C=C4,YL-365,Data.sdf,12028,HY-156815,,,LPL Receptor,GPCR/G Protein,C34H31ClN2O5,10mM,cancer,No Development Reported,O=C(Cc1ccc(OCc2ccccc2)cc1)NC1(C(=O)O)CCN(C(=O)c2ccc(-c3cccc(Cl)c3)cc2)CC1,清洗成功,0.2574257425742574
14281,COc1ccc(-c2cc(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3o2)cc1O,1,0.9906787276268005,0.9906787276268005,O=C1C=C(C2=CC=C(OC)C(O)=C2)OC3=CC(O[C@H]4[C@@H]([C@H]([C@@H]([C@@H](CO[C@H]5[C@@H]([C@@H]([C@H]([C@H](C)O5)O)O)O)O4)O)O)O)=CC(O)=C13,Diosmin,Data.sdf,16873,HY-N0178,,520-27-4,Aryl Hydrocarbon Receptor,Immunology/Inflammation,C28H32O15,10mM,Cancer; Cardiovascular Disease,Launched,COc1ccc(-c2cc(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3o2)cc1O,清洗成功,0.3372093023255814
14264,C[C@@H]1O[C@@H](Oc2c(-c3cc(O)c(O)c(O)c3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@H](O)[C@H]1O,1,0.9906777143478394,0.9906777143478394,O=C1C(O[C@H]2[C@@H]([C@@H]([C@H]([C@H](C)O2)O)O)O)=C(C3=CC(O)=C(O)C(O)=C3)OC4=CC(O)=CC(O)=C14,Myricitrin,Data.sdf,16847,HY-N0152,,17912-87-7,NO Synthase; Parasite; PKC; TNF Receptor,Anti-infection; Apoptosis; Epigenetics; Immunology/Inflammation; TGF-beta/Smad,C21H20O12,10mM,Infection; Inflammation/Immunology; Neurological Disease,No Development Reported,C[C@@H]1O[C@@H](Oc2c(-c3cc(O)c(O)c(O)c3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@H](O)[C@H]1O,清洗成功,0.3448275862068966
5947,Cc1nc2ccc(C(=O)N3CCC4(CC3)CC(=O)c3c(cnn3C(C)C)C4)cc2[nH]1,1,0.9906764030456543,0.9906764030456543,O=C1CC2(CCN(C(C3=CC=C4C(NC(C)=N4)=C3)=O)CC2)CC5=C1N(C(C)C)N=C5,PF-05175157,Data.sdf,7033,HY-12942,,1301214-47-0,Acetyl-CoA Carboxylase,Metabolic Enzyme/Protease,C23H27N5O2,10mM,Metabolic Disease,Phase 2,Cc1nc2ccc(C(=O)N3CCC4(CC3)CC(=O)c3c(cnn3C(C)C)C4)cc2[nH]1,清洗成功,0.2588235294117647
9149,CC(=O)N1CCC(COc2cc(F)c3c(=O)[nH]c(CSC4CCOCC4)nc3c2)CC1,1,0.9906746745109558,0.9906746745109558,O=C1NC(CSC2CCOCC2)=NC3=CC(OCC4CCN(CC4)C(C)=O)=CC(F)=C13,RBN-3143,Data.sdf,10789,HY-150207,,2360853-16-1,PARP,Cell Cycle/DNA Damage; Epigenetics,C22H28FN3O4S,10mM,Inflammation/Immunology,Phase 1,CC(=O)N1CCC(COc2cc(F)c3c(=O)[nH]c(CSC4CCOCC4)nc3c2)CC1,清洗成功,0.2427184466019417
10561,Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1,1,0.990673840045929,0.990673840045929,CC1=CC(NC2=C3C=C(NC4=NC(C)(C)CO4)C=CC3=NC=N2)=CC=C1OC5=CC6=NC=NN6C=C5,Tucatinib,Data.sdf,12517,HY-16069,Irbinitinib; ARRY-380; ONT-380,937263-43-9,EGFR,JAK/STAT Signaling; Protein Tyrosine Kinase/RTK,C26H24N8O2,10mM,Cancer,Launched,Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1,清洗成功,0.2987012987012987
10565,Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1,1,0.990673840045929,0.990673840045929,CC1=CC(NC2=C3C=C(NC4=NC(C)(C)CO4)C=CC3=NC=N2)=CC=C1OC5=CC6=NC=NN6C=C5.CCO,Tucatinib (hemiethanolate),Data.sdf,12521,HY-16069A,Irbinitinib (hemiethanolate); ARRY-380 (hemiethanolate); ONT-380 (hemiethanolate),1429755-56-5,EGFR,JAK/STAT Signaling; Protein Tyrosine Kinase/RTK,C26H24N8O2.1/2C2H6O,10mM,Cancer,Launched,Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1,清洗成功,0.2962962962962963
4340,Cn1cc(-c2ccc(CN3Cc4ncccc4C3=O)c(F)c2)cn1,1,0.9906713962554932,0.9906713962554932,O=C1N(CC2=CC=C(C3=CN(C)N=C3)C=C2F)CC4=NC=CC=C41,VU0453595,Data.sdf,5106,HY-120023,,1432436-13-9,mAChR,GPCR/G Protein; Neuronal Signaling,C18H15FN4O,10mM,Neurological Disease,No Development Reported,Cn1cc(-c2ccc(CN3Cc4ncccc4C3=O)c(F)c2)cn1,清洗成功,0.328125
8668,Cc1ccc2nc(-c3cccc(NC(=O)CCc4ccccc4)c3)[nH]c2c1,1,0.9906703233718872,0.9906703233718872,CC1=CC=C2N=C(NC2=C1)C3=CC=CC(NC(CCC4=CC=CC=C4)=O)=C3,MMP2-IN-3,Data.sdf,10223,HY-147746,,897799-81-4,MMP,Metabolic Enzyme/Protease,C23H21N3O,10mM,Cancer,No Development Reported,Cc1ccc2nc(-c3cccc(NC(=O)CCc4ccccc4)c3)[nH]c2c1,清洗成功,0.3222222222222222
15311,C=C[C@H]1[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2OC(=O)c2c(O)cc(O)cc2-c2cccc(O)c2)OC=C2C(=O)OCC[C@H]21,1,0.9906702041625977,0.9906702041625977,C=C[C@H]([C@@]1([H])C(C(OCC1)=O)=CO2)[C@@H]2O[C@@](O[C@H](CO)[C@@H](O)[C@@H]3O)([H])[C@@H]3OC(C4=C(C5=CC(O)=CC=C5)C=C(O)C=C4O)=O,Amarogentin,Data.sdf,18233,HY-N2447,,21018-84-8,AMPK; Apoptosis,Apoptosis; Epigenetics; PI3K/Akt/mTOR,C29H30O13,10mM,Cancer; Metabolic Disease,No Development Reported,C=C[C@H]1[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2OC(=O)c2c(O)cc(O)cc2-c2cccc(O)c2)OC=C2C(=O)OCC[C@H]21,清洗成功,0.26
4888,CN(C)c1cccc(-c2c3c(=O)n(-c4ccccc4Cl)[nH]c3cc(=O)n2C)c1,1,0.9906659722328186,0.9906659722328186,O=C1N(C2=CC=CC=C2Cl)NC(C1=C(C3=CC=CC(N(C)C)=C3)N4C)=CC4=O,Setanaxib,Data.sdf,5756,HY-12298,GKT137831; GKT831,1218942-37-0,Ferroptosis; NADPH Oxidase,Apoptosis; Metabolic Enzyme/Protease,C21H19ClN4O2,10mM,Cardiovascular Disease,Phase 2,CN(C)c1cccc(-c2c3c(=O)n(-c4ccccc4Cl)[nH]c3cc(=O)n2C)c1,清洗成功,0.2539682539682539
8558,Cc1nccnc1-c1nn2c(=O)cc(-c3ccc(C4CCCCC4)cc3)[nH]c2c1C(=O)N1CC(CF)C1,1,0.9906657934188843,0.9906657934188843,O=C(C=C(C1=CC=C(C2CCCCC2)C=C1)N3)N4C3=C(C(N5CC(CF)C5)=O)C(C6=NC=CN=C6C)=N4,GNE-7883,Data.sdf,10096,HY-147214,,2648450-42-2,YAP,Stem Cell/Wnt,C28H29FN6O2,10mM,Cancer,No Development Reported,Cc1nccnc1-c1nn2c(=O)cc(-c3ccc(C4CCCCC4)cc3)[nH]c2c1C(=O)N1CC(CF)C1,清洗成功,0.2358490566037736
10072,COc1ccc2nc(NC(=O)c3cc(C)n(-c4sc(C)cc4C#N)c3C)[nH]c2c1,1,0.9906657934188843,0.9906657934188843,COC1=CC=C2N=C(NC2=C1)NC(C3=C(N(C(C)=C3)C4=C(C=C(S4)C)C#N)C)=O,KY386,Data.sdf,11914,HY-156418,,2787598-01-8,DNA/RNA Synthesis,Cell Cycle/DNA Damage,C21H19N5O2S,10mM,Cancer,No Development Reported,COc1ccc2nc(NC(=O)c3cc(C)n(-c4sc(C)cc4C#N)c3C)[nH]c2c1,清洗成功,0.3285714285714285
15735,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3cc(O)c4c(=O)cc(-c5ccc(O)c(O)c5)oc4c3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,1,0.9906625151634216,0.9906625151634216,O=C1C=C(C2=CC=C(O)C(O)=C2)OC3=CC(O[C@H]4[C@@H]([C@H]([C@@H]([C@@H](CO[C@H]5[C@@H]([C@@H]([C@H]([C@H](C)O5)O)O)O)O4)O)O)O)=CC(O)=C13,Luteolin-7-rutinoside,Data.sdf,18799,HY-N6647,,20633-84-5,Fungal,Anti-infection,C27H30O15,10mM,Infection; Inflammation/Immunology,No Development Reported,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3cc(O)c4c(=O)cc(-c5ccc(O)c(O)c5)oc4c3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,清洗成功,0.2954545454545454
15451,O=C1c2c(O)cc(O)cc2O[C@H](c2ccc(O)cc2)[C@@H]1[C@@H]1C(=O)c2c(O)cc(O)cc2O[C@H]1c1ccc(O)cc1,1,0.9906606078147888,0.9906606078147888,O=C1[C@]([C@@]2([H])[C@@H](C3=CC=C(O)C=C3)OC4=CC(O)=CC(O)=C4C2=O)([H])[C@H](C5=CC=C(O)C=C5)OC6=CC(O)=CC(O)=C16,Neochamaejasmin B,Data.sdf,18419,HY-N3205,(+)-Neochamaejasmin B,90411-12-4,Others,Others,C30H22O10,10mM,Others,No Development Reported,O=C1c2c(O)cc(O)cc2O[C@H](c2ccc(O)cc2)[C@@H]1[C@@H]1C(=O)c2c(O)cc(O)cc2O[C@H]1c1ccc(O)cc1,清洗成功,0.3389830508474576
10312,COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc3c(c2)O[C@@H](c2ccccc2)n2c-3cc3cc(-c4cnc([C@@H]5CCCN5C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]4)ccc32)[nH]1)C(C)C,1,0.9906578063964844,0.9906578063964844,O=C([C@H](C(C)C)NC(OC)=O)N(CCC1)[C@@H]1C(N2)=NC=C2C(C=C3)=CC4=C3C5=CC6=CC(C7=CN=C([C@H]8N(C([C@H](C(C)C)NC(OC)=O)=O)CCC8)N7)=CC=C6N5[C@H](C9=CC=CC=C9)O4,Elbasvir,Data.sdf,12215,HY-15789,MK-8742,1370468-36-2,HCV,Anti-infection,C49H55N9O7,10mM,Infection,Launched,COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc3c(c2)O[C@@H](c2ccccc2)n2c-3cc3cc(-c4cnc([C@@H]5CCCN5C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]4)ccc32)[nH]1)C(C)C,清洗成功,0.2413793103448276
964,COc1ccc(C2(CNC(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)Nc3ccc([N+](=O)[O-])cc3)CCCCC2)cc1,1,0.9906556010246277,0.9906556010246277,O=C([C@@H](NC(NC1=CC=C([N+]([O-])=O)C=C1)=O)CC2=CNC3=CC=CC=C23)NCC4(C5=CC=C(OC)C=C5)CCCCC4,ML-18,Data.sdf,1105,HY-101844,,1422269-30-4,Bombesin Receptor,GPCR/G Protein,C32H35N5O5,10mM,Cancer,No Development Reported,COc1ccc(C2(CNC(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)Nc3ccc([N+](=O)[O-])cc3)CCCCC2)cc1,清洗成功,0.2857142857142857
11900,COc1ccc(-n2c(SCc3nc(-c4ccc(C)cc4)no3)nnc2-c2ccncc2)cc1,1,0.9906550049781799,0.9906550049781799,CC1=CC=C(C2=NOC(CSC3=NN=C(C4=CC=NC=C4)N3C5=CC=C(OC)C=C5)=N2)C=C1,JW74,Data.sdf,14080,HY-19739,,863405-60-1,Wnt,Stem Cell/Wnt,C24H20N6O2S,10mM,Cancer,No Development Reported,COc1ccc(-n2c(SCc3nc(-c4ccc(C)cc4)no3)nnc2-c2ccncc2)cc1,清洗成功,0.2698412698412698
5271,O=c1c(-c2ccc(O)c(O)c2)coc2cc(O)ccc12,1,0.9906479716300964,0.9906479716300964,OC1=CC=C2C(C(C3=CC(O)=C(C=C3)O)=COC2=C1)=O,"7,3',4'-Trihydroxyisoflavone",Data.sdf,6213,HY-124953,,485-63-2,Apoptosis; MAP3K,Apoptosis; MAPK/ERK Pathway,C15H10O5,10mM,Cancer,No Development Reported,O=c1c(-c2ccc(O)c(O)c2)coc2cc(O)ccc12,清洗成功,0.3125
14707,O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)c12,1,0.9906473755836487,0.9906473755836487,OC1=C(C2=O)C(OC(C3=CC(O)=C(O)C=C3)=C2)=CC(O)=C1[C@@H]([C@@H]([C@@H](O)[C@@H]4O)O)O[C@@H]4CO,Isoorientin,Data.sdf,17423,HY-N0767,Homoorientin,4261-42-1,COX,Immunology/Inflammation,C21H20O11,10mM,Cancer; Inflammation/Immunology,No Development Reported,O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)c12,清洗成功,0.2804878048780488
6272,N#Cc1c(C2(c3ccc(Cl)cc3)CC2)nn2c1[nH]c(=O)c1cc(I)ccc12,1,0.9906466007232666,0.9906466007232666,N#CC1=C(N2)N(N=C1C3(C4=CC=C(Cl)C=C4)CC3)C5=C(C=C(I)C=C5)C2=O,Dynapyrazole-A,Data.sdf,7425,HY-131873,,2226517-75-3,Dynamin,Cytoskeleton,C20H12ClIN4O,10mM,Infection,No Development Reported,N#Cc1c(C2(c3ccc(Cl)cc3)CC2)nn2c1[nH]c(=O)c1cc(I)ccc12,清洗成功,0.2631578947368421
8914,CCn1cc(S(=O)(=O)N2CCC3(CC2)C[C@@H](NC[C@H](O)COc2cccc(S(C)(=O)=O)c2)CO3)c(=O)c2ccccc21,1,0.990646481513977,0.990646481513977,CS(C1=CC=CC(OC[C@@H](O)CN[C@@H]2CC3(OC2)CCN(CC3)S(=O)(C4=CN(CC)C5=CC=CC=C5C4=O)=O)=C1)(=O)=O,Vemtoberant,Data.sdf,10517,HY-148804,APD418,2169905-68-2,Adrenergic Receptor,GPCR/G Protein; Neuronal Signaling,C29H37N3O8S2,10mM,Endocrinology,Phase 2,CCn1cc(S(=O)(=O)N2CCC3(CC2)C[C@@H](NC[C@H](O)COc2cccc(S(C)(=O)=O)c2)CO3)c(=O)c2ccccc21,清洗成功,0.2211538461538461
11584,Cn1c2cc(S(C)=O)sc2c2cnn(Cc3cccc(N)c3)c(=O)c21,1,0.9906442165374756,0.9906442165374756,O=C1C(N(C)C2=C3SC(S(C)=O)=C2)=C3C=NN1CC4=CC=CC(N)=C4,TEPP-46,Data.sdf,13705,HY-18657,ML-265,1221186-53-3,Pyruvate Kinase,Metabolic Enzyme/Protease,C17H16N4O2S2,10mM,Cancer,No Development Reported,Cn1c2cc(S(C)=O)sc2c2cnn(Cc3cccc(N)c3)c(=O)c21,清洗成功,0.2325581395348837
6429,c1cc(-c2sc(-c3ccncc3)c(-c3ccncc3)c2-c2ccncc2)ccn1,1,0.9906300902366638,0.9906300902366638,C1(C2=C(C(C3=CC=NC=C3)=C(S2)C4=CC=NC=C4)C5=CC=NC=C5)=CC=NC=C1,GANT 58,Data.sdf,7615,HY-13282,NSC 75503,64048-12-0,Gli,Stem Cell/Wnt,C24H16N4S,10mM,Cancer,No Development Reported,c1cc(-c2sc(-c3ccncc3)c(-c3ccncc3)c2-c2ccncc2)ccn1,清洗成功,0.2857142857142857
3216,COc1cc2c(cc1-c1c(C)noc1C)[nH]c1nc(C)nc(Nc3cc(C4CC4)nn3C)c12,1,0.9906255006790161,0.9906255006790161,COC1=C(C2=C(C)ON=C2C)C=C(NC3=C4C(NC5=CC(C6CC6)=NN5C)=NC(C)=N3)C4=C1,CF53,Data.sdf,3782,HY-112610,,1808160-52-2,Epigenetic Reader Domain; Histone Acetyltransferase,Epigenetics,C24H25N7O2,10mM,Cancer,No Development Reported,COc1cc2c(cc1-c1c(C)noc1C)[nH]c1nc(C)nc(Nc3cc(C4CC4)nn3C)c12,清洗成功,0.2365591397849462
1944,COC(=O)c1cnn(-c2ccc(F)cc2F)c1/C=N/NC(=S)NC(C)(C)C,1,0.9906207323074341,0.9906207323074341,O=C(C1=C(/C=N/NC(NC(C)(C)C)=S)N(C2=CC=C(C=C2F)F)N=C1)OC,CID 2745687,Data.sdf,2291,HY-107537,,264233-05-8,GPR35 ,GPCR/G Protein,C17H19F2N5O2S,10mM,Inflammation/Immunology; Cardiovascular Disease,No Development Reported,COC(=O)c1cnn(-c2ccc(F)cc2F)c1/C=N/NC(=S)NC(C)(C)C,清洗成功,0.2564102564102564
1781,CC1CC(=O)NN=C1c1cc(-n2ccnc2)cs1,1,0.9906128644943237,0.9906128644943237,CC(C1)C(C2=CC(N3C=CN=C3)=CS2)=NNC1=O,Motapizone,Data.sdf,2108,HY-106739,NAT 05-239,90697-57-7,Phosphodiesterase (PDE),Metabolic Enzyme/Protease,C12H12N4OS,10mM,Inflammation/Immunology,No Development Reported,CC1CC(=O)NN=C1c1cc(-n2ccnc2)cs1,清洗成功,0.2166666666666666
8384,COc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1,1,0.9906105399131775,0.9906105399131775,OC1=C2C(OC(C3=CC=CC=C3)=CC2=O)=CC(OC)=C1,Tectochrysin,Data.sdf,9892,HY-14592,Techtochrysin; NSC 80687,520-28-5,NF-?oB; STAT,JAK/STAT Signaling; NF-?oB; Stem Cell/Wnt,C16H12O4,10mM,Cancer,No Development Reported,COc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1,清洗成功,0.3492063492063492
11419,Cc1nc2cc(C(=O)N(C)C)cc(O[C@@H]3CCOc4cc(F)cc(F)c43)c2[nH]1,1,0.9906050562858582,0.9906050562858582,CN(C)C(C1=CC(O[C@H]2C3=C(F)C=C(F)C=C3OCC2)=C4C(N=C(N4)C)=C1)=O,(R)-Tegoprazan,Data.sdf,13504,HY-17623C,(R)-CJ-12420; (R)-RQ-00000004,942195-56-4,Proton Pump,Membrane Transporter/Ion Channel,C20H19F2N3O3,10mM,Metabolic Disease,No Development Reported,Cc1nc2cc(C(=O)N(C)C)cc(O[C@@H]3CCOc4cc(F)cc(F)c43)c2[nH]1,清洗成功,0.2093023255813953
1756,Cc1cc(NC(=O)NCCN2CCC(O)(Cc3ccccc3)CC2)c2ccccc2n1,1,0.990603506565094,0.990603506565094,OC(CC1=CC=CC=C1)(CC2)CCN2CCNC(NC3=CC(C)=NC4=CC=CC=C34)=O,Palosuran,Data.sdf,2080,HY-10655,ACT-058362,540769-28-6,Urotensin Receptor,GPCR/G Protein,C25H30N4O2,10mM,Cardiovascular Disease,Phase 2,Cc1cc(NC(=O)NCCN2CCC(O)(Cc3ccccc3)CC2)c2ccccc2n1,清洗成功,0.3
1757,Cc1cc(NC(=O)NCCN2CCC(O)(Cc3ccccc3)CC2)c2ccccc2n1,1,0.990603506565094,0.990603506565094,OC(CC1=CC=CC=C1)(CC2)CCN2CCNC(NC3=CC(C)=NC4=CC=CC=C34)=O.[H]Cl,Palosuran (hydrochloride),Data.sdf,2081,HY-10655A,ACT-058362 (hydrochloride),2469274-58-4,Urotensin Receptor,GPCR/G Protein,C25H31ClN4O2,10mM,Cardiovascular Disease,No Development Reported,Cc1cc(NC(=O)NCCN2CCC(O)(Cc3ccccc3)CC2)c2ccccc2n1,清洗成功,0.2967032967032967
7590,Cc1ccc2nc(CN(CCN(Cc3nc4ccc(C)cc4[nH]3)Cc3nc4ccc(C)cc4[nH]3)Cc3nc4ccc(C)cc4[nH]3)[nH]c2c1,1,0.9905977845191956,0.9905977845191956,CC1=CC=C2N=C(CN(CC3=NC4=CC=C(C)C=C4N3)CCN(CC5=NC6=CC=C(C)C=C6N5)CC7=NC8=CC=C(C)C=C8N7)NC2=C1,NSC348884,Data.sdf,8982,HY-13915,,81624-55-7,Apoptosis,Apoptosis,C38H40N10,10mM,Cancer,No Development Reported,Cc1ccc2nc(CN(CCN(Cc3nc4ccc(C)cc4[nH]3)Cc3nc4ccc(C)cc4[nH]3)Cc3nc4ccc(C)cc4[nH]3)[nH]c2c1,清洗成功,0.2982456140350877
5225,Nc1n[nH]c(Sc2cc(-n3cccc3)c(Cl)cc2[N+](=O)[O-])n1,1,0.9905962944030762,0.9905962944030762,NC1=NNC(SC2=CC(N3C=CC=C3)=C(Cl)C=C2[N+]([O-])=O)=N1,RH01687,Data.sdf,6152,HY-124735,,302901-13-9,Others,Others,C12H9ClN6O2S,10mM,Metabolic Disease,No Development Reported,Nc1n[nH]c(Sc2cc(-n3cccc3)c(Cl)cc2[N+](=O)[O-])n1,清洗成功,0.2794117647058823
5554,Cc1c[nH]c2ncnc(N3CCC(CN)(C(=O)Nc4cccc(OC(=O)N(C)C)c4)CC3)c12,1,0.9905955791473389,0.9905955791473389,NCC1(C(NC2=CC(OC(N(C)C)=O)=CC=C2)=O)CCN(C3=C4C(NC=C4C)=NC=N3)CC1,LX7101,Data.sdf,6556,HY-12659,,1192189-69-7,LIM Kinase (LIMK); PKA; ROCK,Cell Cycle/DNA Damage; Cytoskeleton; Stem Cell/Wnt; TGF-beta/Smad,C23H29N7O3,10mM,Endocrinology,Phase 2,Cc1c[nH]c2ncnc(N3CCC(CN)(C(=O)Nc4cccc(OC(=O)N(C)C)c4)CC3)c12,清洗成功,0.3164556962025316
5980,Cc1c[nH]c2nc(Nc3ccc(N4CCN(C)CC4)c(F)c3)nc(-c3cccc(CC#N)c3)c12,1,0.9905954599380493,0.9905954599380493,N#CCC1=CC=CC(C2=C3C(NC=C3C)=NC(NC4=CC=C(N5CCN(C)CC5)C(F)=C4)=N2)=C1,SGI-7079,Data.sdf,7078,HY-12964,,1239875-86-5,TAM Receptor,Protein Tyrosine Kinase/RTK,C26H26FN7,10mM,Cancer,No Development Reported,Cc1c[nH]c2nc(Nc3ccc(N4CCN(C)CC4)c(F)c3)nc(-c3cccc(CC#N)c3)c12,清洗成功,0.3052631578947368
126,CN(C)CCn1c(C(=O)N2CCN(c3ccccc3Cl)CC2)c(C(c2ccc(O)cc2)c2ccc(O)cc2)c2ccccc21,1,0.9905942678451538,0.9905942678451538,O=C(N1CCN(CC1)C2=C(Cl)C=CC=C2)C3=C(C(C4=CC=C(C=C4)O)C5=CC=C(C=C5)O)C6=C(N3CCN(C)C)C=CC=C6.O=S(O)(C)=O,KW-8232,Data.sdf,147,HY-100304A,,217813-15-5,Prostaglandin Receptor; SARS-CoV,Anti-infection; GPCR/G Protein,C37H41ClN4O6S,10mM,Metabolic Disease; Endocrinology,No Development Reported,CN(C)CCn1c(C(=O)N2CCN(c3ccccc3Cl)CC2)c(C(c2ccc(O)cc2)c2ccc(O)cc2)c2ccccc21,清洗成功,0.2358490566037736
15514,O=c1c(O[C@@H]2O[C@H](CO[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,1,0.9905940294265747,0.9905940294265747,O=C1C(O[C@@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)CO[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)CO)=C(C4=CC(O)=C(O)C=C4)OC5=CC(O)=CC(O)=C51,Quercetin 3-gentiobioside,Data.sdf,18506,HY-N4089,,7431-83-6,Aldose Reductase,Metabolic Enzyme/Protease,C27H30O17,10mM,Metabolic Disease,No Development Reported,O=c1c(O[C@@H]2O[C@H](CO[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,清洗成功,0.3373493975903614
5105,COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc3cc(-c4ccc5nc([C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]c5c4)ccc3c2)[nH]1)C(C)C,1,0.9905886650085449,0.9905886650085449,COC(N[C@@H](C(C)C)C(N1[C@@H](CCC1)C2=NC3=CC=C(C4=CC5=C(C=C(C6=CN=C([C@H]7N(CCC7)C([C@H](C(C)C)NC(OC)=O)=O)N6)C=C5)C=C4)C=C3N2)=O)=O.Cl.Cl,Ravidasvir (hydrochloride),Data.sdf,6013,HY-124191,PPI-668 (hydrochloride),1303533-81-4,HCV,Anti-infection,C42H52Cl2N8O6,10mM,Infection,Phase 3,COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc3cc(-c4ccc5nc([C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]c5c4)ccc3c2)[nH]1)C(C)C,清洗成功,0.2783505154639175
6461,C=CC(=O)N1CCN2C(=O)c3cc(F)c(-c4ccc(F)c5sc(N)c(C#N)c45)c(Cl)c3OCC[C@H]2C1,1,0.9905886650085449,0.9905886650085449,FC1=CC=[C@]([C@]2=C(F)C=C(C(N3[C@@](CN(CC3)C(C=C)=O)([H])CCO4)=O)C4=C2Cl)C5=C1SC(N)=C5C#N,Olomorasib,Data.sdf,7657,HY-132980,KRAS G12C inhibitor 19,2771246-13-8,Ras,GPCR/G Protein; MAPK/ERK Pathway,C25H19ClF2N4O3S,10mM,Cancer,Phase 1,C=CC(=O)N1CCN2C(=O)c3cc(F)c(-c4ccc(F)c5sc(N)c(C#N)c45)c(Cl)c3OCC[C@H]2C1,清洗成功,0.2
1138,Cc1cc(N2CCOCC2)cc2nc(-c3c(NC[C@@H](O)c4cccc(Cl)c4)cc[nH]c3=O)[nH]c12,1,0.9905837774276733,0.9905837774276733,O=C1C(C2=NC3=CC(N4CCOCC4)=CC(C)=C3N2)=C(C=CN1)NC[C@@H](O)C5=CC=CC(Cl)=C5,BMS-536924,Data.sdf,1317,HY-10262,,468740-43-4,Apoptosis; IGF-1R; Insulin Receptor,Apoptosis; Protein Tyrosine Kinase/RTK,C25H26ClN5O3,10mM,Cancer; Endocrinology,No Development Reported,Cc1cc(N2CCOCC2)cc2nc(-c3c(NC[C@@H](O)c4cccc(Cl)c4)cc[nH]c3=O)[nH]c12,清洗成功,0.2711864406779661
9494,CNCc1cc(-c2ccccc2F)n(S(=O)(=O)c2cccnc2)c1,1,0.9905835390090942,0.9905835390090942,O=C(O)/C=C/C(O)=O.O=S(N1C=C(CNC)C=C1C2=CC=CC=C2F)(C3=CC=CN=C3)=O,Vonoprazan (Fumarate),Data.sdf,11209,HY-15295,TAK-438,881681-01-2,Proton Pump,Membrane Transporter/Ion Channel,C21H20FN3O6S,10mM,Metabolic Disease; Cancer,Launched,CNCc1cc(-c2ccccc2F)n(S(=O)(=O)c2cccnc2)c1,清洗成功,0.2560975609756097
11920,CC(C)(O)c1cnc(N2C[C@@]3(CCC[C@](C)(Cn4cnc5ccc(C#N)cc54)C3)OC2=O)cn1,1,0.990580141544342,0.990580141544342,N#CC1=CC=C2N=CN(C[C@](CCC3)(C)C[C@@]43CN(C5=NC=C(C(C)(O)C)N=C5)C(O4)=O)C2=C1,GSK2798745,Data.sdf,14104,HY-19765,,1419609-94-1,TRP Channel,Membrane Transporter/Ion Channel; Neuronal Signaling,C25H28N6O3,10mM,Cardiovascular Disease,Phase 2,CC(C)(O)c1cnc(N2C[C@@]3(CCC[C@](C)(Cn4cnc5ccc(C#N)cc54)C3)OC2=O)cn1,清洗成功,0.2653061224489796
5787,Cc1ccc(-c2csc(Cn3nc(CC4OCCCO4)c4ccccc4c3=O)n2)cc1,1,0.9905768632888794,0.9905768632888794,O=C1C2=C(C=CC=C2)C(CC3OCCCO3)=NN1CC4=NC(C5=CC=C(C)C=C5)=CS4,PHT-7.3,Data.sdf,6841,HY-128590,,1614225-93-2,Ras,GPCR/G Protein; MAPK/ERK Pathway,C24H23N3O3S,10mM,Cancer,No Development Reported,Cc1ccc(-c2csc(Cn3nc(CC4OCCCO4)c4ccccc4c3=O)n2)cc1,清洗成功,0.2150537634408602
15182,O=c1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,1,0.9905739426612854,0.9905739426612854,O=C1C(O[C@H](O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H]2O[C@]([C@@H]([C@@H](O)[C@@H]3O)O)([H])O[C@@H]3CO)=C(C4=CC(O)=C(O)C=C4)OC5=CC(O)=CC(O)=C15,Baimaside,Data.sdf,18059,HY-N2183,Quercetin 3-O-sophoroside,18609-17-1,Others,Others,C27H30O17,10mM,Others,No Development Reported,O=c1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,清洗成功,0.3333333333333333
7,CNCc1cc(-c2ccccc2F)n(S(=O)(=O)c2cccnc2)c1,1,0.9905732274055481,0.9905732274055481,O=S(N1C=C(CNC)C=C1C2=CC=CC=C2F)(C3=CC=CN=C3)=O,Vonoprazan,Data.sdf,7,HY-100007,TAK-438 (free base),881681-00-1,Bacterial; Proton Pump,Anti-infection; Membrane Transporter/Ion Channel,C17H16FN3O2S,10mM,Endocrinology; Cancer,Launched,CNCc1cc(-c2ccccc2F)n(S(=O)(=O)c2cccnc2)c1,清洗成功,0.2666666666666666
8238,CSc1cscc1-c1cn(C2CCC(=O)NC2=O)nn1,1,0.9905633926391602,0.9905633926391602,O=C(C(N1N=NC(C2=CSC=C2SC)=C1)CC3)NC3=O,TMX-4113,Data.sdf,9729,HY-145320,,2766385-92-4,Casein Kinase; Molecular Glues; Phosphodiesterase (PDE),Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; PROTAC; Stem Cell/Wnt,C12H12N4O2S2,10mM,Cancer,No Development Reported,CSc1cscc1-c1cn(C2CCC(=O)NC2=O)nn1,清洗成功,0.1818181818181818
10181,O=C1CCCN1CC1CCN(c2ccc(-c3cn[nH]c3)cc2F)CC1,1,0.9905595183372498,0.9905595183372498,FC1=CC(C2=CNN=C2)=CC=C1N(CC3)CCC3CN4C(CCC4)=O,20-HETE inhibitor-2,Data.sdf,12043,HY-156876,,2992666-48-3,Cytochrome P450,Metabolic Enzyme/Protease,C19H23FN4O,10mM,Metabolic Disease,No Development Reported,O=C1CCCN1CC1CCN(c2ccc(-c3cn[nH]c3)cc2F)CC1,清洗成功,0.3086419753086419
3796,COc1ccc2c(Nc3cccc(-c4csc(C)n4)c3)cc(C)nc2c1,1,0.9905591011047363,0.9905591011047363,CC1=NC(C2=CC(NC3=CC(C)=NC4=CC(OC)=CC=C34)=CC=C2)=CS1,HIF-1?±-IN-2,Data.sdf,4472,HY-115903,,2762315-06-8,HIF/HIF Prolyl-Hydroxylase,Metabolic Enzyme/Protease,C21H19N3OS,10mM,Cancer,No Development Reported,COc1ccc2c(Nc3cccc(-c4csc(C)n4)c3)cc(C)nc2c1,清洗成功,0.328125
3797,COc1ccc2c(Nc3cccc(-c4csc(C)n4)c3)cc(C)nc2c1,1,0.9905591011047363,0.9905591011047363,CC1=NC(C2=CC(NC3=CC(C)=NC4=CC(OC)=CC=C34)=CC=C2)=CS1.Cl,HIF-1?±-IN-2 (hydrochloride),Data.sdf,4473,HY-115903A,,,HIF/HIF Prolyl-Hydroxylase,Metabolic Enzyme/Protease,C21H20ClN3OS,10mM,Cancer,No Development Reported,COc1ccc2c(Nc3cccc(-c4csc(C)n4)c3)cc(C)nc2c1,清洗成功,0.3230769230769231
2455,CN1CCN(C(=O)N(CCCCCCC(=O)NO)c2ccc(-c3ccc4cnn(C)c4c3)cc2)CC1,1,0.9905579090118408,0.9905579090118408,O=C(N1CCN(C)CC1)N(CCCCCCC(NO)=O)C2=CC=C(C3=CC4=C(C=C3)C=NN4C)C=C2,Alteminostat,Data.sdf,2882,HY-109109,CKD-581,1246374-97-9,Apoptosis; HDAC,Apoptosis; Cell Cycle/DNA Damage; Epigenetics,C27H36N6O3,10mM,Cancer,Phase 1,CN1CCN(C(=O)N(CCCCCCC(=O)NO)c2ccc(-c3ccc4cnn(C)c4c3)cc2)CC1,清洗成功,0.3012048192771084
13345,CC1(C)[C@H](/C=C(\Cl)C(F)(F)F)[C@@H]1C(=O)O[C@@H](C#N)c1cccc(Oc2ccccc2)c1,1,0.9905576705932617,0.9905576705932617,O=C([C@@H]1C(C)(C)[C@@H]1/C=C(Cl)/C(F)(F)F)O[C@@H](C#N)C2=CC=CC(OC3=CC=CC=C3)=C2,??-Cyhalothrin,Data.sdf,15752,HY-B0836,,91465-08-6,Parasite; Sodium Channel,Anti-infection; Membrane Transporter/Ion Channel,C23H19ClF3NO3,10mM,Infection; Endocrinology; Neurological Disease,No Development Reported,CC1(C)[C@H](/C=C(\Cl)C(F)(F)F)[C@@H]1C(=O)O[C@@H](C#N)c1cccc(Oc2ccccc2)c1,清洗成功,0.2048192771084337
13205,CSc1nc2cc(Oc3cccc(Cl)c3Cl)c(Cl)cc2[nH]1,1,0.9905412793159485,0.9905412793159485,CSC1=NC2=CC(OC3=CC=CC(Cl)=C3Cl)=C(Cl)C=C2N1,Triclabendazole,Data.sdf,15592,HY-B0621,CGA89317,68786-66-3,Bcl-2 Family; Caspase; Parasite; PARP; Pyroptosis,Anti-infection; Apoptosis; Cell Cycle/DNA Damage; Epigenetics; Immunology/Inflammation,C14H9Cl3N2OS,10mM,Infection,Launched,CSc1nc2cc(Oc3cccc(Cl)c3Cl)c(Cl)cc2[nH]1,清洗成功,0.25
1426,CN(C(=O)c1ccn2ncc(-c3ccc(C(N)=O)cc3)c2c1)c1ccc(C#N)cn1,1,0.9905411601066589,0.9905411601066589,O=C(C1=CC2=C(C3=CC=C(C(N)=O)C=C3)C=NN2C=C1)N(C)C4=NC=C(C#N)C=C4,KDU731,Data.sdf,1672,HY-103583,,1610610-48-4,Parasite; PI4K,Anti-infection; PI3K/Akt/mTOR,C22H16N6O2,10mM,Infection,No Development Reported,CN(C(=O)c1ccn2ncc(-c3ccc(C(N)=O)cc3)c2c1)c1ccc(C#N)cn1,清洗成功,0.2659574468085106
10179,COc1cccc(Cn2ncc3ccc(-c4cn[nH]c4)cc3c2=O)c1,1,0.9905390739440918,0.9905390739440918,O=C1C2=C(C=NN1CC3=CC(OC)=CC=C3)C=CC(C4=CNN=C4)=C2,GRK2 Inhibitor 2,Data.sdf,12041,HY-156863,,2592436-21-8,Aurora Kinase; G Protein-coupled Receptor Kinase (GRK),Cell Cycle/DNA Damage; Epigenetics; GPCR/G Protein,C19H16N4O2,10mM,Cardiovascular Disease,No Development Reported,COc1cccc(Cn2ncc3ccc(-c4cn[nH]c4)cc3c2=O)c1,清洗成功,0.3373493975903614
14286,COc1ccc(-c2coc3cc(O)ccc3c2=O)cc1,1,0.9905334711074829,0.9905334711074829,O=C1C(C2=CC=C(OC)C=C2)=COC3=CC(O)=CC=C13,Formononetin,Data.sdf,16880,HY-N0183,Biochanin B; Flavosil; Formononetol,485-72-3,Apoptosis; FGFR,Apoptosis; Protein Tyrosine Kinase/RTK,C16H12O4,10mM,Cancer; Cardiovascular Disease,No Development Reported,COc1ccc(-c2coc3cc(O)ccc3c2=O)cc1,清洗成功,0.3448275862068966
2565,Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1,1,0.9905264377593994,0.9905264377593994,O=C(CC1=CC=CC=C1)NC(NC2=CC=C(C(F)=C2)OC3=C4C(C=C(S4)C5=CN(C=N5)C)=NC=C3)=S,MGCD-265 analog,Data.sdf,3009,HY-10991,,875337-44-3,Apoptosis; c-Met/HGFR; VEGFR,Apoptosis; Protein Tyrosine Kinase/RTK,C26H20FN5O2S2,10mM,Cancer,Phase 2,Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1,清洗成功,0.2777777777777778
11468,OC1(CN2CCC(COc3noc4cccc(O[C@@H]5CCOC5)c34)CC2)CCOCC1,1,0.9905258417129517,0.9905258417129517,OC1(CN2CCC(COC3=NOC4=CC=CC(O[C@H]5COCC5)=C34)CC2)CCOCC1,PF-04995274,Data.sdf,13560,HY-18137,,1331782-27-4,5-HT Receptor,GPCR/G Protein; Neuronal Signaling,C23H32N2O6,10mM,Neurological Disease,Phase 1,OC1(CN2CCC(COc3noc4cccc(O[C@@H]5CCOC5)c34)CC2)CCOCC1,清洗成功,0.2181818181818181
18,COCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNC(=O)C1,1,0.9905231595039368,0.9905231595039368,O=C1NCCN(CC2=C(COC)C(C3=CC4=CC(C)=CC(OC)=C4S3)=C5C(N)=NC=NN52)C1,Rogaratinib,Data.sdf,18,HY-100019,BAY1163877,1443530-05-9,FGFR,Protein Tyrosine Kinase/RTK,C23H26N6O3S,10mM,Cancer,Phase 3,COCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNC(=O)C1,清洗成功,0.2395833333333333
15453,CC1(C)Oc2cc3oc(-c4cc(O)cc(O)c4)cc3cc2C[C@H]1O,1,0.9905205965042114,0.9905205965042114,O[C@@H]1CC2=C(OC1(C)C)C=C(OC(C3=CC(O)=CC(O)=C3)=C4)C4=C2,Moracin P,Data.sdf,18422,HY-N3243,,102841-46-3,HIF/HIF Prolyl-Hydroxylase; Reactive Oxygen Species,Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?oB,C19H18O5,10mM,Cancer; Inflammation/Immunology; Neurological Disease,No Development Reported,CC1(C)Oc2cc3oc(-c4cc(O)cc(O)c4)cc3cc2C[C@H]1O,清洗成功,0.2
9911,O=C1NCCSc2c1sc1ccc(O)cc21,1,0.9905101656913757,0.9905101656913757,O=C1NCCSC2=C1SC3=CC=C(O)C=C32,kb NB 142-70,Data.sdf,11711,HY-15528,,1233533-04-4,PKD,Apoptosis,C11H9NO2S2,10mM,Cancer,No Development Reported,O=C1NCCSc2c1sc1ccc(O)cc21,清洗成功,0.3076923076923077
6050,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1,1,0.9905099272727966,0.9905099272727966,CC(C)(C)C1=NN(C(NC(NC2=C(F)C=C(OC3=CC(C(NC)=O)=NC=C3)C=C2)=O)=C1)C4=CC=C5C(C=CC=N5)=C4,Rebastinib,Data.sdf,7158,HY-13024,DCC-2036,1020172-07-9,Apoptosis; Bcr-Abl; FLT3; Src,Apoptosis; Protein Tyrosine Kinase/RTK,C30H28FN7O3,10mM,Cancer,Phase 2,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1,清洗成功,0.3043478260869565
6562,C=CC(=O)Nc1cccc(-c2c[nH]cc2CN(C)CCN)c1,1,0.9905084371566772,0.9905084371566772,NCCN(C)CC1=CNC=C1C2=CC=CC(NC(C=C)=O)=C2,MS117,Data.sdf,7781,HY-133740,,2702280-86-0,Histone Methyltransferase,Epigenetics,C17H22N4O,10mM,Cancer,No Development Reported,C=CC(=O)Nc1cccc(-c2c[nH]cc2CN(C)CCN)c1,清洗成功,0.2638888888888889
721,CN1CC[C@]2(c3cccc(O)c3)Cc3nc4ccccc4cc3C[C@H]2C1,1,0.9905011653900146,0.9905011653900146,OC1=CC=CC([C@]23[C@@](CN(C)CC3)([H])CC4=CC5=CC=CC=C5N=C4C2)=C1.Br.Br,TAN-67 (dihydrobromide),Data.sdf,826,HY-101317,SB-205607 (dihydrobromide),1217628-73-3,Opioid Receptor,GPCR/G Protein; Neuronal Signaling,C23H26Br2N2O,2mM,Neurological Disease,No Development Reported,CN1CC[C@]2(c3cccc(O)c3)Cc3nc4ccccc4cc3C[C@H]2C1,清洗成功,0.2285714285714285
8237,COc1cscc1-c1cn(C2CCC(=O)NC2=O)nn1,1,0.990497887134552,0.990497887134552,O=C(C(N1N=NC(C2=CSC=C2OC)=C1)CC3)NC3=O,FPFT-2216,Data.sdf,9728,HY-145319,,2367619-87-0,Casein Kinase; Molecular Glues; Phosphodiesterase (PDE),Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; PROTAC; Stem Cell/Wnt,C12H12N4O3S,10mM,Cancer; Inflammation/Immunology,No Development Reported,COc1cscc1-c1cn(C2CCC(=O)NC2=O)nn1,清洗成功,0.2142857142857142
14698,C[C@@H]1O[C@@H](O[C@H]2[C@H](Oc3cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc4c3)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,1,0.9904952049255371,0.9904952049255371,O=C(C=C(C1=CC=C(O)C=C1)OC2=CC(O[C@H](O[C@H](CO)[C@@H](O)[C@@H]3O)[C@@H]3O[C@@](O[C@@H](C)[C@H](O)[C@H]4O)([H])[C@@H]4O)=C5)C2=C5O,Rhoifolin,Data.sdf,17410,HY-N0755,,17306-46-6,Autophagy; GLUT; Insulin Receptor; NF-?oB; p38 MAPK,Autophagy; MAPK/ERK Pathway; Membrane Transporter/Ion Channel; NF-?oB; Protein Tyrosine Kinase/RTK,C27H30O14,10mM,Metabolic Disease; Endocrinology; Cancer,No Development Reported,C[C@@H]1O[C@@H](O[C@H]2[C@H](Oc3cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc4c3)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,清洗成功,0.313953488372093
1237,N#Cc1c(N)nc(SCc2ncc[nH]2)c(C#N)c1-c1ccc(O)cc1,1,0.9904932379722595,0.9904932379722595,N#CC1=C(C2=CC=C(O)C=C2)C(C#N)=C(SCC3=NC=CN3)N=C1N,LUF5834,Data.sdf,1433,HY-103170,,333962-91-7,Adenosine Receptor,GPCR/G Protein,C17H12N6OS,10mM,Others,No Development Reported,N#Cc1c(N)nc(SCc2ncc[nH]2)c(C#N)c1-c1ccc(O)cc1,清洗成功,0.3225806451612903
9525,O=C(Nc1ccc(Cl)cc1)C1CN(C(=O)c2cc(F)cc(-c3ccncc3)c2)CC(F)(F)C1,1,0.9904820919036865,0.9904820919036865,O=C(N1CC(CC(F)(C1)F)C(NC2=CC=C(C=C2)Cl)=O)C3=CC(F)=CC(C4=CC=NC=C4)=C3,MRTF/SRF-IN-1,Data.sdf,11248,HY-153078,,1922098-90-5,Ras,GPCR/G Protein; MAPK/ERK Pathway,C24H19ClF3N3O2,10mM,Cancer,No Development Reported,O=C(Nc1ccc(Cl)cc1)C1CN(C(=O)c2cc(F)cc(-c3ccncc3)c2)CC(F)(F)C1,清洗成功,0.2808988764044944
9273,COc1cc2c(C(=O)N3CCC(F)CC3)cn(-c3ccc4scc(C)c4c3)c(=O)c2cc1OC,1,0.9904747605323792,0.9904747605323792,O=C1N(C2=CC=C3C(C(C)=CS3)=C2)C=C(C(N4CCC(F)CC4)=O)C5=C1C=C(OC)C(OC)=C5,LPA5 antagonist 2,Data.sdf,10940,HY-151392,,2839471-44-0,LPL Receptor,GPCR/G Protein,C26H25FN2O4S,10mM,Inflammation/Immunology; Neurological Disease,No Development Reported,COc1cc2c(C(=O)N3CCC(F)CC3)cn(-c3ccc4scc(C)c4c3)c(=O)c2cc1OC,清洗成功,0.2535211267605634
16058,COc1cc(O)c2c(=O)c(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@@H]3OC[C@](O)(CO)[C@H]3O)c(-c3ccc(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc3)oc2c1,1,0.9904739260673523,0.9904739260673523,O=C1C(O[C@H](O[C@@H]2CO)[C@@H]([C@H]([C@@H]2O)O)O[C@H](OC[C@@](O)3CO)[C@@H]3O)=C(C(C=C4)=CC=C4O[C@@H]([C@@H]([C@H]5O)O)O[C@@H]([C@H]5O)CO)OC6=CC(OC)=CC(O)=C16,Complanatoside B,Data.sdf,19199,HY-N7903,,142473-99-2,Others,Others,C33H40O20,10mM,Inflammation/Immunology,No Development Reported,COc1cc(O)c2c(=O)c(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@@H]3OC[C@](O)(CO)[C@H]3O)c(-c3ccc(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc3)oc2c1,清洗成功,0.3125
14569,C=C[C@H]1CN2CC[C@]3(C(=O)Nc4ccccc43)[C@@H]2C[C@@H]1/C(=C\OC)C(=O)OC,1,0.9904729723930359,0.9904729723930359,O=C(NC1=C2C=CC=C1)[C@]32[C@@](C[C@H](/C(C(OC)=O)=C\OC)[C@@H](C=C)C4)([H])N4CC3,Corynoxeine,Data.sdf,17250,HY-N0590,,630-94-4,ERK,MAPK/ERK Pathway; Stem Cell/Wnt,C22H26N2O4,10mM,Cardiovascular Disease,No Development Reported,C=C[C@H]1CN2CC[C@]3(C(=O)Nc4ccccc43)[C@@H]2C[C@@H]1/C(=C\OC)C(=O)OC,清洗成功,0.1919191919191919
5955,N#Cc1ccnc(Nc2cc(C3CCN(C4COC4)CC3)cc(N3CCC(F)(F)C3)n2)c1,1,0.9904691576957703,0.9904691576957703,N#CC1=CC=NC(NC2=NC(N3CC(F)(F)CC3)=CC(C4CCN(C5COC5)CC4)=C2)=C1,GNE-3511,Data.sdf,7041,HY-12947,,1496581-76-0,MAP3K,MAPK/ERK Pathway,C23H26F2N6O,10mM,Neurological Disease,No Development Reported,N#Cc1ccnc(Nc2cc(C3CCN(C4COC4)CC3)cc(N3CCC(F)(F)C3)n2)c1,清洗成功,0.2571428571428571
10393,CN1CCN(c2ccc3nc(-c4ccc5nc(-c6cccc(OCCCC(=O)NCCCN=[N+]=[N-])c6)[nH]c5c4)[nH]c3c2)CC1,1,0.990468442440033,0.990468442440033,O=C(NCCCN=[N+]=[N-])CCCOC1=CC=CC(C2=NC3=CC=C(C4=NC5=CC=C(N6CCN(C)CC6)C=C5N4)C=C3N2)=C1,Targapremir-210,Data.sdf,12320,HY-15861,TGP-210,1049722-30-6,Apoptosis; MicroRNA,Apoptosis; Epigenetics,C32H36N10O2,10mM,Cancer,No Development Reported,CN1CCN(c2ccc3nc(-c4ccc5nc(-c6cccc(OCCCC(=O)NCCCN=[N+]=[N-])c6)[nH]c5c4)[nH]c3c2)CC1,清洗成功,0.2882882882882883
15968,O=C(O)[C@H]1O[C@@H](Oc2c(O)cc(O)c3c(=O)c(O)c(-c4ccc(O)c(O)c4)oc23)[C@H](O)[C@@H](O)[C@@H]1O,1,0.9904678463935852,0.9904678463935852,O[C@H]([C@H]([C@@H]([C@@H](C(O)=O)O1)O)O)[C@@H]1OC2=C3C(C(C(O)=C(C4=CC=C(O)C(O)=C4)O3)=O)=C(O)C=C2O,Hibifolin,Data.sdf,19088,HY-N7368,,55366-56-8,Adenosine Deaminase,Metabolic Enzyme/Protease,C21H18O14,10mM,Cancer; Inflammation/Immunology; Neurological Disease,No Development Reported,O=C(O)[C@H]1O[C@@H](Oc2c(O)cc(O)c3c(=O)c(O)c(-c4ccc(O)c(O)c4)oc23)[C@H](O)[C@@H](O)[C@@H]1O,清洗成功,0.2615384615384615
5181,CN(C)CCCOc1ccc(-c2nc3ccc(OCCCN(C)C)cc3o2)cc1,1,0.990462601184845,0.990462601184845,CN(C)CCCOC1=CC=C(C2=NC3=CC=C(OCCCN(C)C)C=C3O2)C=C1,AT791,Data.sdf,6102,HY-124603,,1219962-49-8,Toll-like Receptor (TLR),Immunology/Inflammation,C23H31N3O3,10mM,Inflammation/Immunology,No Development Reported,CN(C)CCCOc1ccc(-c2nc3ccc(OCCCN(C)C)cc3o2)cc1,清洗成功,0.2727272727272727
7844,O=C(NNc1nc(-c2ccc([N+](=O)[O-])cc2)cs1)c1ccc2nc[nH]c2c1,1,0.9904617667198181,0.9904617667198181,O=C(C1=CC=C2N=CNC2=C1)NNC3=NC(C4=CC=C([N+]([O-])=O)C=C4)=CS3,BSc3094,Data.sdf,9273,HY-141660,,946857-84-7,Tau Protein,Neuronal Signaling,C17H12N6O3S,10mM,Neurological Disease,No Development Reported,O=C(NNc1nc(-c2ccc([N+](=O)[O-])cc2)cs1)c1ccc2nc[nH]c2c1,清洗成功,0.3432835820895522
11418,Cc1nc2c(O[C@H]3CCOc4cc(F)cc(F)c43)cc(C(=O)N(C)C)cc2[nH]1,1,0.9904611706733704,0.9904611706733704,FC1=CC(F)=C2[C@@H](OC3=CC(C(N(C)C)=O)=CC4=C3N=C(C)N4)CCOC2=C1,Tegoprazan,Data.sdf,13503,HY-17623,CJ-12420; RQ-00000004,942195-55-3,Na+/K+ ATPase; Potassium Channel; Proton Pump,Membrane Transporter/Ion Channel,C20H19F2N3O3,10mM,Inflammation/Immunology,Launched,Cc1nc2c(O[C@H]3CCOc4cc(F)cc(F)c43)cc(C(=O)N(C)C)cc2[nH]1,清洗成功,0.2079207920792079
10111,COc1ccc(C(=O)N2CCC3(CCN(C(=O)CCCCCCCOc4cccc(Nc5[nH]nc(-c6ccc(NS(=O)(=O)C(F)F)cc6)c5C(N)=O)c4)CC3)CC2)cc1N1CCC(=O)NC1=O,1,0.9904590845108032,0.9904590845108032,O=C(C1=C(NN=C1C2=CC=C(C=C2)NS(C(F)F)(=O)=O)NC3=CC=CC(OCCCCCCCC(N4CCC5(CCN(CC5)C(C6=CC=C(C(N7CCC(NC7=O)=O)=C6)OC)=O)CC4)=O)=C3)N,PROTAC MLKL Degrader-1,Data.sdf,11962,HY-156591,,3032600-90-8,Mixed Lineage Kinase; PROTACs,MAPK/ERK Pathway; PROTAC,C46H55F2N9O9S,10mM,Others,No Development Reported,COc1ccc(C(=O)N2CCC3(CCN(C(=O)CCCCCCCOc4cccc(Nc5[nH]nc(-c6ccc(NS(=O)(=O)C(F)F)cc6)c5C(N)=O)c4)CC3)CC2)cc1N1CCC(=O)NC1=O,清洗成功,0.2479338842975206
2402,CNCc1cc(Oc2ccc3c(ccn3C(=O)Nc3cc(C(F)(F)F)n(C)n3)c2)ncn1,1,0.99045729637146,0.99045729637146,O=C(N1C2=CC=C(OC3=NC=NC(CNC)=C3)C=C2C=C1)NC4=NN(C)C(C(F)(F)F)=C4,Acrizanib,Data.sdf,2824,HY-109020,LHA510,1229453-99-9,VEGFR,Protein Tyrosine Kinase/RTK,C20H18F3N7O2,10mM,Others,Phase 2,CNCc1cc(Oc2ccc3c(ccn3C(=O)Nc3cc(C(F)(F)F)n(C)n3)c2)ncn1,清洗成功,0.2307692307692307
11443,CN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)cn(C)c3=O)nc2)CC1,1,0.9904499650001526,0.9904499650001526,O=C1C(NC2=CC=C(N3CCN(C)CC3)C=N2)=CC(C4=CC=CC(N5C=CC(C=C(C6CC6)C=C7F)=C7C5=O)=C4CO)=CN1C,RN486,Data.sdf,13532,HY-18018,,1242156-23-5,Btk,Protein Tyrosine Kinase/RTK,C35H35FN6O3,10mM,Inflammation/Immunology,No Development Reported,CN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)cn(C)c3=O)nc2)CC1,清洗成功,0.2636363636363636
14715,C=C[C@H]1CN2CC[C@@]3(C(=O)Nc4ccccc43)[C@@H]2C[C@@H]1/C(=C\OC)C(=O)OC,1,0.9904486536979675,0.9904486536979675,O=C(NC1=C2C=CC=C1)[C@@]32[C@@](C[C@H](/C(C(OC)=O)=C\OC)[C@@H](C=C)C4)([H])N4CC3,Isocorynoxeine,Data.sdf,17431,HY-N0775,7-Isocorynoxeine,51014-29-0,5-HT Receptor,GPCR/G Protein; Neuronal Signaling,C22H26N2O4,10mM,Neurological Disease,No Development Reported,C=C[C@H]1CN2CC[C@@]3(C(=O)Nc4ccccc43)[C@@H]2C[C@@H]1/C(=C\OC)C(=O)OC,清洗成功,0.1919191919191919
6146,Cc1nn(-c2ccc(C(N)=O)c(NCCCOCCOCCOCCOCCOCCCNC(=S)Nc3ccc4c(c3)C(=O)OC43c4ccc(O)cc4Oc4cc(O)ccc43)c2)c2c1C(=O)CC(C)(C)C2,1,0.9904373288154602,0.9904373288154602,O=C(N)C1=CC=C(N2N=C(C)C3=C2CC(C)(C)CC3=O)C=C1NCCCOCCOCCOCCOCCOCCCNC(NC4=CC5=C(C6(C7=C(OC8=C6C=CC(O)=C8)C=C(O)C=C7)OC5=O)C=C4)=S,HS-27,Data.sdf,7272,HY-130851,,1562024-11-6,HSP,Cell Cycle/DNA Damage; Metabolic Enzyme/Protease,C52H60N6O12S,10mM,Cancer,No Development Reported,Cc1nn(-c2ccc(C(N)=O)c(NCCCOCCOCCOCCOCCOCCCNC(=S)Nc3ccc4c(c3)C(=O)OC43c4ccc(O)cc4Oc4cc(O)ccc43)c2)c2c1C(=O)CC(C)(C)C2,清洗成功,0.184
8775,O=C(O[C@H]1CN2CCC1CC2)N(Cc1cc(F)c(F)c(F)c1)c1cccc(F)c1,1,0.9904345273971558,0.9904345273971558,O=C(O[C@H]1CN2CCC1CC2)N(C3=CC=CC(F)=C3)CC4=CC(F)=C(F)C(F)=C4.O[C@@H]([C@@H](C(O)=O)O)C(O)=O,Tarafenacin (D-tartrate),Data.sdf,10356,HY-14825A,SVT-40776 D-tartrate,1159101-48-0,mAChR,GPCR/G Protein; Neuronal Signaling,C25H26F4N2O8,10mM,Neurological Disease,Phase 2,O=C(O[C@H]1CN2CCC1CC2)N(Cc1cc(F)c(F)c(F)c1)c1cccc(F)c1,清洗成功,0.2235294117647059
14255,COc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)c(OC)c3o2)cc1,1,0.9904333353042603,0.9904333353042603,O=C1C=C(C2=CC=C(OC)C=C2)OC3=C(OC)C(OC)=C(OC)C(OC)=C13,Tangeretin,Data.sdf,16828,HY-N0133,Tangeritin; NSC53909; NSC618905,481-53-8,Apoptosis; Notch,Apoptosis; Neuronal Signaling; Stem Cell/Wnt,C20H20O7,10mM,Inflammation/Immunology; Cancer,No Development Reported,COc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)c(OC)c3o2)cc1,清洗成功,0.3283582089552239
15153,O=c1c(-c2ccc(O)cc2)coc2c([C@@H]3O[C@H](CO[C@@H]4OC[C@](O)(CO)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)c(O)ccc12,1,0.990432858467102,0.990432858467102,OC1=CC=C2C(OC=C(C3=CC=C(O)C=C3)C2=O)=C1[C@@H]([C@@H]([C@@H](O)[C@@H]4O)O)O[C@@H]4CO[C@H](OC[C@]5(O)CO)[C@@H]5O,Mirificin,Data.sdf,18020,HY-N2134,Puerarin apioside,103654-50-8,Tyrosinase,Metabolic Enzyme/Protease,C26H28O13,10mM,Endocrinology,No Development Reported,O=c1c(-c2ccc(O)cc2)coc2c([C@@H]3O[C@H](CO[C@@H]4OC[C@](O)(CO)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)c(O)ccc12,清洗成功,0.2083333333333333
8557,CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1,1,0.9904263615608215,0.9904263615608215,N#CC1=CC=CC(C(C=CC2=O)=NN2CC3=CC=CC(C4=NC=C(C=N4)OCC5CCN(CC5)C)=C3)=C1,Tepotinib,Data.sdf,10095,HY-14721,EMD-1214063,1100598-32-0,Autophagy; c-Met/HGFR,Autophagy; Protein Tyrosine Kinase/RTK,C29H28N6O2,10mM,Cancer,Launched,CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1,清洗成功,0.3095238095238095
8624,Cc1ccc2oc(=O)n(Cc3cccc(O)c3)c2c1,1,0.9904140830039978,0.9904140830039978,O=C1OC2=CC=C(C)C=C2N1CC3=CC=CC(O)=C3,MIF098,Data.sdf,10173,HY-147390,,1208448-95-6,Macrophage migration inhibitory factor (MIF),Immunology/Inflammation,C15H13NO3,10mM,Inflammation/Immunology,No Development Reported,Cc1ccc2oc(=O)n(Cc3cccc(O)c3)c2c1,清洗成功,0.3387096774193548
10246,c1cc(-c2ccc3nccc(Nc4ccc5scnc5c4)c3c2)ccn1,1,0.9904111623764038,0.9904111623764038,C12=CC(NC3=CC=NC4=CC=C(C5=CC=NC=C5)C=C34)=CC=C1SC=N2,RIPK2-IN-5,Data.sdf,12126,HY-157325,,2885227-09-6,RIP kinase,Apoptosis,C21H14N4S,10mM,Inflammation/Immunology,No Development Reported,c1cc(-c2ccc3nccc(Nc4ccc5scnc5c4)c3c2)ccn1,清洗成功,0.3333333333333333
8735,O=C([C@@H](Cc1ccccc1)NS(=O)(=O)c1ccc2[nH]c(=O)ccc2c1)N(Cc1ccco1)Cc1cccs1,1,0.9903979301452637,0.9903979301452637,O=C(N1)C=CC2=C1C=CC(S(N[C@H](CC3=CC=CC=C3)C(N(CC4=CC=CO4)CC5=CC=CS5)=O)(=O)=O)=C2,PG 34,Data.sdf,10308,HY-148113,,1681056-62-1,OGT,Neuronal Signaling,C28H25N3O5S2,10mM,Others,No Development Reported,O=C([C@@H](Cc1ccccc1)NS(=O)(=O)c1ccc2[nH]c(=O)ccc2c1)N(Cc1ccco1)Cc1cccs1,清洗成功,0.2307692307692307
8580,CN1C(=O)COc2c1cnc1ccc(Sc3nnc4c(F)cc(-c5cnn(C)c5)cn34)cc21,1,0.9903954863548279,0.9903954863548279,O=C1N(C)C2=CN=C3C=CC(SC4=NN=C5C(F)=CC(C6=CN(C)N=C6)=CN45)=CC3=C2OC1,Dalmelitinib,Data.sdf,10121,HY-147259,,1637658-98-0,c-Met/HGFR,Protein Tyrosine Kinase/RTK,C22H16FN7O2S,10mM,Cancer,No Development Reported,CN1C(=O)COc2c1cnc1ccc(Sc3nnc4c(F)cc(-c5cnn(C)c5)cn34)cc21,清洗成功,0.3372093023255814
10682,Nc1nccc(Sc2cnc(N3CCC4(CC3)Cc3ncccc3[C@H]4N)cn2)c1Cl,1,0.9903953671455383,0.9903953671455383,N[C@H](C(C=CC=N1)=C1C2)C2(CC3)CCN3C(N=C4)=CN=C4SC5=C(Cl)C(N)=NC=C5,JAB-3312,Data.sdf,12658,HY-161952,,2245082-05-5,SHP2,Protein Tyrosine Kinase/RTK,C21H22ClN7S,10mM,cancer,Phase 3,Nc1nccc(Sc2cnc(N3CCC4(CC3)Cc3ncccc3[C@H]4N)cn2)c1Cl,清洗成功,0.202127659574468
4193,N#Cc1cccc(CN2CCC(N(Cc3cccnc3)C(=O)Nc3ccccc3-c3ccccc3)CC2)c1,1,0.9903890490531921,0.9903890490531921,O=C(N(CC1=CC=CN=C1)C2CCN(CC2)CC3=CC=CC(C#N)=C3)NC4=CC=CC=C4C5=CC=CC=C5,BPU-11,Data.sdf,4935,HY-119102,,909664-41-1,HCN Channel,Membrane Transporter/Ion Channel,C32H31N5O,10mM,Inflammation/Immunology,No Development Reported,N#Cc1cccc(CN2CCC(N(Cc3cccnc3)C(=O)Nc3ccccc3-c3ccccc3)CC2)c1,清洗成功,0.3195876288659793
9043,O=C1/C(=N\O)Cc2ccc(-c3ccc(O)c(F)c3)cc21,1,0.9903804063796997,0.9903804063796997,O=C1C2=CC(C3=CC(F)=C(C=C3)O)=CC=C2C/C1=N/O,CIDD-0149897,Data.sdf,10660,HY-149584,,2862784-20-9,Estrogen Receptor/ERR,Vitamin D Related/Nuclear Receptor,C15H10FNO3,10mM,Cancer,No Development Reported,O=C1/C(=N\O)Cc2ccc(-c3ccc(O)c(F)c3)cc21,清洗成功,0.2340425531914893
11990,C[C@]1(O)C[C@@](N)(c2ccc(-c3nc4n(c3-c3ccccc3)COc3ccncc3-4)cc2)C1,1,0.990379810333252,0.990379810333252,C[C@@](C1)(O)C[C@]1(N)C2=CC=C(C3=C(N(COC4=CC=NC=C45)C5=N3)C6=CC=CC=C6)C=C2.[H]Cl,Pifusertib (hydrochloride),Data.sdf,14179,HY-19934A,TAS-117 (hydrochloride),2930090-28-9,Akt; Apoptosis; Autophagy,Apoptosis; Autophagy; PI3K/Akt/mTOR,C26H25ClN4O2,10mM,Cancer,Phase 2,C[C@]1(O)C[C@@](N)(c2ccc(-c3nc4n(c3-c3ccccc3)COc3ccncc3-4)cc2)C1,清洗成功,0.2247191011235955
3517,Cn1cc(C2=C(c3coc4ccc(F)cc34)C(=O)NC2=O)c2cc3c(cc21)OCO3,1,0.9903773665428162,0.9903773665428162,O=C(C(C1=COC2=CC=C(F)C=C12)=C3C4=CN(C)C5=C4C=C6C(OCO6)=C5)NC3=O,9-ING-41,Data.sdf,4139,HY-113914,Elraglusib,1034895-42-5,Apoptosis; Autophagy; GSK-3,Apoptosis; Autophagy; PI3K/Akt/mTOR; Stem Cell/Wnt,C22H13FN2O5,10mM,Cancer,Phase 2,Cn1cc(C2=C(c3coc4ccc(F)cc34)C(=O)NC2=O)c2cc3c(cc21)OCO3,清洗成功,0.2926829268292683
10569,COCCc1nc2c(N)nc3ccccc3c2n1CCCCN(C(C)=O)C1CCOCC1,1,0.9903771281242371,0.9903771281242371,O=C(C)N(C1CCOCC1)CCCCN2C(CCOC)=NC3=C2C4=C(C=CC=C4)N=C3N,BNT411,Data.sdf,12525,HY-160715,,2296821-50-4,Toll-like Receptor (TLR),Immunology/Inflammation,C24H33N5O3,10mM,Cancer,Phase 2,COCCc1nc2c(N)nc3ccccc3c2n1CCCCN(C(C)=O)C1CCOCC1,清洗成功,0.2637362637362637
8877,COc1ccc(-c2csc(N/N=C(\C)c3nc4ccccc4[nH]3)n2)cc1,1,0.9903661012649536,0.9903661012649536,COC(C=C1)=CC=C1C2=CSC(N/N=C(C3=NC4=CC=CC=C4N3)\C)=N2,SFI003,Data.sdf,10473,HY-148660,,2361332-90-1,Apoptosis; Reactive Oxygen Species,Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?oB,C19H17N5OS,10mM,Cancer,No Development Reported,COc1ccc(-c2csc(N/N=C(\C)c3nc4ccccc4[nH]3)n2)cc1,清洗成功,0.3043478260869565
9179,Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@H]2C[C@H](O)CN2C(=O)[C@@H](NC(=O)CNC(=O)c2ccc(F)c(-c3ccc(N4C[C@@H](C)N(C)[C@@H](C)C4)c(NC(=O)c4c[nH]c(=O)cc4C(F)(F)F)c3)c2)C(C)(C)C)cc1,1,0.9903661012649536,0.9903661012649536,O=C(C(C(C(F)(F)F)=C1)=CNC1=O)NC2=C(N3C[C@H](N([C@H](C3)C)C)C)C=CC(C4=CC(C(NCC(N[C@@H](C(C)(C)C)C(N5[C@H](C[C@@H](C5)O)C(N[C@H](C6=CC=C(C7=C(N=CS7)C)C=C6)C)=O)=O)=O)=O)=CC=C4F)=C2,XF067-68,Data.sdf,10824,HY-150403,,2407452-79-1,PROTACs; WDR5,Epigenetics; PROTAC,C52H59F4N9O7S,10mM,Cancer,No Development Reported,Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@H]2C[C@H](O)CN2C(=O)[C@@H](NC(=O)CNC(=O)c2ccc(F)c(-c3ccc(N4C[C@@H](C)N(C)[C@@H](C)C4)c(NC(=O)c4c[nH]c(=O)cc4C(F)(F)F)c3)c2)C(C)(C)C)cc1,清洗成功,0.2148148148148148
8566,CCN(c1cc(-c2ccc(CN3CCNCC3)cc2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCOCC1,1,0.9903644919395447,0.9903644919395447,O=C(C1=CC(C2=CC=C(CN3CCNCC3)C=C2)=CC(N(C4CCOCC4)CC)=C1C)NCC5=C(C)C=C(C)NC5=O,EZH2-IN-13,Data.sdf,10107,HY-147230,,1403255-41-3,Histone Methyltransferase,Epigenetics,C34H45N5O3,10mM,Cancer,No Development Reported,CCN(c1cc(-c2ccc(CN3CCNCC3)cc2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCOCC1,清洗成功,0.2540983606557377
7868,Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CNC(=O)c2ccc(F)c(-c3ccc(N4C[C@@H](C)N(C)[C@@H](C)C4)c(NC(=O)c4c[nH]c(=O)cc4C(F)(F)F)c3)c2)C(C)(C)C)cc1,1,0.9903634190559387,0.9903634190559387,O=C(C(C(C(F)(F)F)=C1)=CNC1=O)NC2=C(N3C[C@H](N([C@H](C3)C)C)C)C=CC(C4=CC(C(NCC(N[C@@H](C(C)(C)C)C(N5[C@@H](C[C@H](C5)O)C(N[C@H](C6=CC=C(C7=C(N=CS7)C)C=C6)C)=O)=O)=O)=O)=CC=C4F)=C2,MS67,Data.sdf,9298,HY-141796,,2407452-77-9,PROTACs; WDR5,Epigenetics; PROTAC,C52H59F4N9O7S,10mM,Cancer,No Development Reported,Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CNC(=O)c2ccc(F)c(-c3ccc(N4C[C@@H](C)N(C)[C@@H](C)C4)c(NC(=O)c4c[nH]c(=O)cc4C(F)(F)F)c3)c2)C(C)(C)C)cc1,清洗成功,0.2148148148148148
6430,COc1ncc(C)c(-c2ccc3c(c2)[nH]c(=O)c2cnn([C@H]4CCOC4)c23)c1C,1,0.9903600215911865,0.9903600215911865,O=C1C2=C(N([C@@]3([H])CCOC3)N=C2)C4=CC=C(C5=C(C)C=NC(OC)=C5C)C=C4N1,Irsenontrine,Data.sdf,7616,HY-132821,E2027,1429509-82-9,Phosphodiesterase (PDE),Metabolic Enzyme/Protease,C22H22N4O3,10mM,Neurological Disease,Phase 2,COc1ncc(C)c(-c2ccc3c(c2)[nH]c(=O)c2cnn([C@H]4CCOC4)c23)c1C,清洗成功,0.2564102564102564
6431,COc1ncc(C)c(-c2ccc3c(c2)[nH]c(=O)c2cnn([C@@H]4CCOC4)c23)c1C,1,0.9903600215911865,0.9903600215911865,O=C1C2=C(N([C@]3([H])CCOC3)N=C2)C4=CC=C(C5=C(C)C=NC(OC)=C5C)C=C4N1,(R)-Irsenontrine,Data.sdf,7617,HY-132821B,(R)-E2027,1429509-81-8,Phosphodiesterase (PDE),Metabolic Enzyme/Protease,C22H22N4O3,10mM,Neurological Disease,No Development Reported,COc1ncc(C)c(-c2ccc3c(c2)[nH]c(=O)c2cnn([C@@H]4CCOC4)c23)c1C,清洗成功,0.2564102564102564
129,Cn1cc(-c2[nH]c3cc(NC(=O)[C@H](N)C4CCCCC4)cc4c3c2C=NNC4=O)cn1,1,0.9903584122657776,0.9903584122657776,O=C([C@@H](C1CCCCC1)N)NC2=CC3=C(C(C=NNC4=O)=C(N3)C5=CN(N=C5)C)C4=C2,PF 477736,Data.sdf,150,HY-10032,PF 00477736,952021-60-2,Aurora Kinase; CDK; c-Fms; Checkpoint Kinase (Chk); FGFR; FLT3; RET; Src; VEGFR,Cell Cycle/DNA Damage; Epigenetics; Protein Tyrosine Kinase/RTK,C22H25N7O2,10mM,Cancer,Phase 1,Cn1cc(-c2[nH]c3cc(NC(=O)[C@H](N)C4CCCCC4)cc4c3c2C=NNC4=O)cn1,清洗成功,0.3218390804597701
5137,CCN(Cc1ccccc1C(F)(F)F)C(=O)C1CCN(S(=O)(=O)c2ccc3[nH]ncc3c2)CC1,1,0.9903516173362732,0.9903516173362732,O=C(C1CCN(S(=O)(C2=CC3=C(NN=C3)C=C2)=O)CC1)N(CC)CC4=CC=CC=C4C(F)(F)F,ML380,Data.sdf,6050,HY-12439,,1627138-52-6,mAChR,GPCR/G Protein; Neuronal Signaling,C23H25F3N4O3S,10mM,Neurological Disease,No Development Reported,CCN(Cc1ccccc1C(F)(F)F)C(=O)C1CCN(S(=O)(=O)c2ccc3[nH]ncc3c2)CC1,清洗成功,0.3255813953488372
5404,N#Cc1ccc(COc2cccc(C3CCN(Cc4nc5ccc(C(=O)O)cc5n4C[C@@H]4CCO4)CC3)n2)c(F)c1,1,0.9903408885002136,0.9903408885002136,FC(C=C(C=C1)C#N)=C1COC2=NC(C(CC3)CCN3CC(N(C4=C5)C[C@@H]6CCO6)=NC4=CC=C5C(O)=O)=CC=C2,Danuglipron,Data.sdf,6369,HY-125824,PF-06882961,2230198-02-2,GCGR,GPCR/G Protein,C31H30FN5O4,10mM,Metabolic Disease,Phase 2,N#Cc1ccc(COc2cccc(C3CCN(Cc4nc5ccc(C(=O)O)cc5n4C[C@@H]4CCO4)CC3)n2)c(F)c1,清洗成功,0.2307692307692307
15163,C[C@@H]1O[C@@H](O[C@H]2[C@H](Oc3cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc4c3)O[C@H](CO[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,1,0.9903404116630554,0.9903404116630554,O=C(C=C(C1=CC=C(O)C=C1)OC2=CC(O[C@H](O[C@H](CO[C@@H]([C@@H]([C@@H](O)[C@@H]3O)O)O[C@@H]3CO)[C@@H](O)[C@@H]4O)[C@@H]4O[C@@](O[C@@H](C)[C@H](O)[C@H]5O)([H])[C@@H]5O)=C6)C2=C6O,Apigenin-7-O-(2G-rhamnosyl)gentiobioside,Data.sdf,18032,HY-N2153,,174284-20-9,Others,Others,C33H40O19,10mM,Others,No Development Reported,C[C@@H]1O[C@@H](O[C@H]2[C@H](Oc3cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc4c3)O[C@H](CO[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,清洗成功,0.2934782608695652
6728,Cc1cc(C[C@@H](NC(=O)N2CCC(c3cc4ccccc4[nH]c3=O)CC2)C(=O)N2CCN(C3CCN(C)CC3)CC2)cc2cn[nH]c12,1,0.9903351068496704,0.9903351068496704,O=C(N1CCC(C2=CC3=C(NC2=O)C=CC=C3)CC1)N[C@H](CC4=CC5=C(NN=C5)C(C)=C4)C(N6CCN(C7CCN(C)CC7)CC6)=O,Vazegepant,Data.sdf,7986,HY-134992,Zavegepant; BHV-3500,1337918-83-8,CGRP Receptor,GPCR/G Protein; Neuronal Signaling,C36H46N8O3,10mM,Neurological Disease,Launched,Cc1cc(C[C@@H](NC(=O)N2CCC(c3cc4ccccc4[nH]c3=O)CC2)C(=O)N2CCN(C3CCN(C)CC3)CC2)cc2cn[nH]c12,清洗成功,0.2419354838709677
8387,CCN1CCN(Cc2ccc3cc(C(=O)Nc4cc(NC(=O)c5ccc6c(c5)OCCO6)ccc4F)ccc3n2)CC1,1,0.9903339743614197,0.9903339743614197,O=C(C1=CC=C2OCCOC2=C1)NC3=CC=C(C(NC(C4=CC5=C(N=C(CN6CCN(CC6)CC)C=C5)C=C4)=O)=C3)F,NXP800,Data.sdf,9895,HY-145927,CCT361814,1693734-80-3,HSP,Cell Cycle/DNA Damage; Metabolic Enzyme/Protease,C32H32FN5O4,10mM,Cancer,Phase 1,CCN1CCN(Cc2ccc3cc(C(=O)Nc4cc(NC(=O)c5ccc6c(c5)OCCO6)ccc4F)ccc3n2)CC1,清洗成功,0.3404255319148936
8988,O=C(Cn1cc(-c2ccc(-c3cncc4ccccc34)cc2)cn1)N1CCN(CCCC23CC4CC(CC(C4)C2)C3)CC1,1,0.9903326630592346,0.9903326630592346,O=C(CN1C=C(C2=CC=C(C3=CN=CC4=CC=CC=C43)C=C2)C=N1)N5CCN(CCCC67CC8CC(CC(C8)C7)C6)CC5,LL-K8-22,Data.sdf,10597,HY-149209,,,CDK; Early 2 Factor (E2F); PROTACs; STAT,Cell Cycle/DNA Damage; JAK/STAT Signaling; PROTAC; Stem Cell/Wnt,C37H43N5O,10mM,Cancer,No Development Reported,O=C(Cn1cc(-c2ccc(-c3cncc4ccccc34)cc2)cn1)N1CCN(CCCC23CC4CC(CC(C4)C2)C3)CC1,清洗成功,0.2446808510638297
14956,O=C(O)c1cc2c(c3c1c([N+](=O)[O-])cc1ccc(O)cc13)OCO2,1,0.9903318881988525,0.9903318881988525,O=C(C1=C2C([N+]([O-])=O)=CC3=CC=C(O)C=C3C2=C(OCO4)C4=C1)O,Aristolochic acid C,Data.sdf,17767,HY-N1450,,4849-90-5,Phospholipase,Metabolic Enzyme/Protease,C16H9NO7,10mM,Cancer,No Development Reported,O=C(O)c1cc2c(c3c1c([N+](=O)[O-])cc1ccc(O)cc13)OCO2,清洗成功,0.25
10288,N#Cc1c(Oc2ccc(F)c(NC(=O)Cc3cccc(C(F)(F)F)c3)c2)ccc2nc(NC(=O)C3CC3)sc12,1,0.9903291463851929,0.9903291463851929,O=C(NC1=CC(OC2=CC=C3N=C(NC(C4CC4)=O)SC3=C2C#N)=CC=C1F)CC5=CC=CC(C(F)(F)F)=C5,TAK-632,Data.sdf,12184,HY-15767,,1228591-30-7,Aurora Kinase; Raf,Cell Cycle/DNA Damage; Epigenetics; MAPK/ERK Pathway,C27H18F4N4O3S,10mM,Cancer,No Development Reported,N#Cc1c(Oc2ccc(F)c(NC(=O)Cc3cccc(C(F)(F)F)c3)c2)ccc2nc(NC(=O)C3CC3)sc12,清洗成功,0.3012048192771084
4509,Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2cccc(C#N)c2)ccc1Oc1ccncc1,1,0.9903269410133362,0.9903269410133362,O=C(NC1=CC=C(OC2=CC=NC=C2)C(C)=C1)NC3=CC(C(C)(C)C)=NN3C4=CC=CC(C#N)=C4,PF-05381941,Data.sdf,5308,HY-120823,,1474022-02-0,MAP3K; p38 MAPK,MAPK/ERK Pathway,C27H26N6O2,10mM,Inflammation/Immunology,No Development Reported,Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2cccc(C#N)c2)ccc1Oc1ccncc1,清洗成功,0.2891566265060241
9258,Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(CO)CO4)cc23)ccc1Oc1ccn2ncnc2c1,1,0.9903209805488586,0.9903209805488586,OCC1(C)N=C(NC2=CC3=C(NC4=CC=C(C(C)=C4)OC5=CC6=NC=NN6C=C5)N=CN=C3C=C2)OC1,ONT-993,Data.sdf,10916,HY-151239,AR 00440993,937263-81-5,Cytochrome P450,Metabolic Enzyme/Protease,C26H24N8O3,10mM,Cancer,No Development Reported,Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(CO)CO4)cc23)ccc1Oc1ccn2ncnc2c1,清洗成功,0.2804878048780488
10655,O=C1COc2cc(C(=O)N(Cc3ccc(C(=O)Nc4ccc(O)cc4)cc3)C3CC3)ccc2N1,1,0.9903178215026855,0.9903178215026855,O=C(N1)COC2=C1C=CC(C(N(C3CC3)CC4=CC=C(C(NC5=CC=C(O)C=C5)=O)C=C4)=O)=C2,NSD2 ligand 1,Data.sdf,12626,HY-161575,,,Histone Methyltransferase; Ligands for Target Protein for PROTAC,Epigenetics; PROTAC,C26H23N3O5,10mM,Cancer,No Development Reported,O=C1COc2cc(C(=O)N(Cc3ccc(C(=O)Nc4ccc(O)cc4)cc3)C3CC3)ccc2N1,清洗成功,0.2763157894736842
8530,CCN(c1cc(-c2ccc(C(=O)O)cc2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCOCC1,1,0.9903160929679871,0.9903160929679871,O=C(C1=CC=C(C2=CC(C(NCC3=C(C)C=C(C)NC3=O)=O)=C(C)C(N(C4CCOCC4)CC)=C2)C=C1)O,Tazemetostat de(methyl morpholine)-COOH,Data.sdf,10063,HY-147091,,2685873-44-1,Ligands for Target Protein for PROTAC,PROTAC,C30H35N3O5,10mM,Cancer,No Development Reported,CCN(c1cc(-c2ccc(C(=O)O)cc2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCOCC1,清洗成功,0.2393162393162393
3257,N#C/C(=C\c1ccc2oc(=O)[nH]c2c1)C(=O)c1ccc(O)c(O)c1,1,0.9903144240379333,0.9903144240379333,O=C(C1=CC(O)=C(O)C=C1)/C(C#N)=C/C2=CC=C(OC3=O)C(N3)=C2,AGL-2263,Data.sdf,3832,HY-112720,,638213-98-6,Insulin Receptor,Protein Tyrosine Kinase/RTK,C17H10N2O5,10mM,Metabolic Disease; Endocrinology,No Development Reported,N#C/C(=C\c1ccc2oc(=O)[nH]c2c1)C(=O)c1ccc(O)c(O)c1,清洗成功,0.2432432432432432
5011,O=C(CN1CCC(O)CC1)Nc1ccc(Oc2ccc3c(c2)CCC(c2ccccc2)O3)nc1,1,0.9903131723403931,0.9903131723403931,O=C(NC1=CC=C(OC2=CC=C3C(CCC(C4=CC=CC=C4)O3)=C2)N=C1)CN5CCC(O)CC5,ORM-10962,Data.sdf,5905,HY-123785,,763926-98-3,Na+/Ca2+ Exchanger,Membrane Transporter/Ion Channel,C27H29N3O4,10mM,Metabolic Disease,No Development Reported,O=C(CN1CCC(O)CC1)Nc1ccc(Oc2ccc3c(c2)CCC(c2ccccc2)O3)nc1,清洗成功,0.284313725490196
8345,CN1CCC([C@@](C)(O)c2ccc3cnc(Nc4ccccc4)cc3n2)CC1,1,0.9903125762939453,0.9903125762939453,C[C@@](C1=CC=C2C(C=C(NC3=CC=CC=C3)N=C2)=N1)(O)C4CCN(C)CC4,CDK5-IN-3,Data.sdf,9844,HY-145694,,2639542-32-6,CDK,Cell Cycle/DNA Damage,C22H26N4O,10mM,Metabolic Disease,No Development Reported,CN1CCC([C@@](C)(O)c2ccc3cnc(Nc4ccccc4)cc3n2)CC1,清洗成功,0.3086419753086419
8370,CNC(=O)c1ccc(N2CCN(Cc3ccc4nc(C)c(=O)[nH]c4c3F)CC2)c(F)n1,1,0.9903087019920349,0.9903087019920349,O=C(C1=NC(F)=C(N2CCN(CC2)CC3=C(F)C4=C(N=C(C)C(N4)=O)C=C3)C=C1)NC,Palacaparib,Data.sdf,9872,HY-145804,AZD-9574,2756333-39-6,PPAR,Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor,C21H22F2N6O2,10mM,Neurological Disease; Cancer,Phase 2,CNC(=O)c1ccc(N2CCN(Cc3ccc4nc(C)c(=O)[nH]c4c3F)CC2)c(F)n1,清洗成功,0.2448979591836734
5609,O=c1cc(-c2ccc(O)c(O)c2)oc2ccccc12,1,0.9903077483177185,0.9903077483177185,O=C1C=C(C2=CC=C(O)C(O)=C2)OC3=CC=CC=C13,"3',4'-Dihydroxyflavone",Data.sdf,6619,HY-127167,,4143-64-0,Histamine Receptor,GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling,C15H10O4,10mM,Inflammation/Immunology,No Development Reported,O=c1cc(-c2ccc(O)c(O)c2)oc2ccccc12,清洗成功,0.2978723404255319
13957,CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)c1ccc(F)c(Oc2ccccc2)c1,1,0.9903054237365723,0.9903054237365723,O=C(C1C(C)(C)C1/C=C(Cl)\Cl)OC(C#N)C2=CC=C(F)C(OC3=CC=CC=C3)=C2,Cyfluthrin,Data.sdf,16434,HY-B1837,,68359-37-5,Sodium Channel,Membrane Transporter/Ion Channel,C22H18Cl2FNO3,10mM,Infection,No Development Reported,CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)c1ccc(F)c(Oc2ccccc2)c1,清洗成功,0.2098765432098765
13958,CC1(C)C(C=C(Cl)Cl)[C@@H]1C(=O)O[C@@H](C#N)c1ccc(F)c(Oc2ccccc2)c1,1,0.9903054237365723,0.9903054237365723,O=C([C@@H]1C(C)(C)C1/C=C(Cl)\Cl)O[C@@H](C#N)C2=CC=C(F)C(OC3=CC=CC=C3)=C2,?2-Cyfluthrin,Data.sdf,16435,HY-B1837A,beta-Cyfluthrin,1820573-27-0,Calcium Channel,Membrane Transporter/Ion Channel; Neuronal Signaling,C22H18Cl2FNO3,10mM,Neurological Disease,No Development Reported,CC1(C)C(C=C(Cl)Cl)[C@@H]1C(=O)O[C@@H](C#N)c1ccc(F)c(Oc2ccccc2)c1,清洗成功,0.2098765432098765
5399,COc1cc2nc(C)nc(N[C@H](C)c3cc(N)cc(C(F)(F)F)c3)c2cc1O[C@H]1CCOC1,1,0.9903027415275574,0.9903027415275574,CC1=NC(N[C@@H](C2=CC(C(F)(F)F)=CC(N)=C2)C)=C3C=C(O[C@@H]4COCC4)C(OC)=CC3=N1,BI-3406,Data.sdf,6364,HY-125817,,2230836-55-0,p38 MAPK; Ras,GPCR/G Protein; MAPK/ERK Pathway,C23H25F3N4O3,10mM,Cancer,No Development Reported,COc1cc2nc(C)nc(N[C@H](C)c3cc(N)cc(C(F)(F)F)c3)c2cc1O[C@H]1CCOC1,清洗成功,0.2777777777777778
10112,Cn1c(C(=O)N2CC(F)(F)C2)cc2ccc(-c3nccc(Nc4ccc(-c5cn[nH]c5)cc4)n3)cc21,1,0.9902989864349365,0.9902989864349365,O=C(N1CC(F)(C1)F)C2=CC3=C(N2C)C=C(C4=NC(NC5=CC=C(C6=CNN=C6)C=C5)=CC=N4)C=C3.[H]Cl,ROCK2-IN-6 (hydrochloride),Data.sdf,11963,HY-156592A,,2762238-94-6,ROCK,Cell Cycle/DNA Damage; Cytoskeleton; Stem Cell/Wnt; TGF-beta/Smad,C26H22ClF2N7O,10mM,Inflammation/Immunology,No Development Reported,Cn1c(C(=O)N2CC(F)(F)C2)cc2ccc(-c3nccc(Nc4ccc(-c5cn[nH]c5)cc4)n3)cc21,清洗成功,0.2758620689655172
7655,Cc1ccc2oc(=O)c(-c3nc4ccncc4[nH]3)cc2c1,1,0.9902935028076172,0.9902935028076172,O=C1C(C(N2)=NC3=C2C=NC=C3)=CC4=CC(C)=CC=C4O1,JMJD6-IN-1,Data.sdf,9060,HY-139434,,899548-78-8,Histone Demethylase,Epigenetics,C16H11N3O2,10mM,Cancer,No Development Reported,Cc1ccc2oc(=O)c(-c3nc4ccncc4[nH]3)cc2c1,清洗成功,0.3246753246753247
14262,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)c(O)c4)oc4cc(O)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,1,0.9902908205986023,0.9902908205986023,O=C1C(O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](CO[C@H]3[C@@H]([C@@H]([C@H]([C@H](C)O3)O)O)O)O2)O)O)O)=C(C4=CC=C(O)C(O)=C4)OC5=CC(O)=CC(O)=C15,Rutin,Data.sdf,16843,HY-N0148,Rutoside; Quercetin 3-O-rutinoside,153-18-4,Amyloid-?2; Apoptosis; Autophagy; Endogenous Metabolite,Apoptosis; Autophagy; Metabolic Enzyme/Protease; Neuronal Signaling,C27H30O16,10mM,Inflammation/Immunology; Cancer,Launched,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)c(O)c4)oc4cc(O)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,清洗成功,0.3235294117647059
3594,Cc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1,1,0.9902849793434143,0.9902849793434143,CC1=CC=C(OC2=CC=NC3=CC(C4=CN(C5CCNCC5)N=C4)=CC=C23)C=C1,HS-1371,Data.sdf,4235,HY-114349,,2158197-70-5,RIP kinase,Apoptosis,C24H24N4O,10mM,Cancer; Cardiovascular Disease,No Development Reported,Cc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1,清洗成功,0.3411764705882353
9183,O=C(c1cccc(N2Cc3cccc(Cl)c3C2=O)c1)N1CCC2(CC1)CCN(c1ccncc1)CC2,1,0.9902815818786621,0.9902815818786621,ClC1=C2C(CN(C3=CC=CC(C(N4CCC5(CCN(C6=CC=NC=C6)CC5)CC4)=O)=C3)C2=O)=CC=C1,ELN-441958,Data.sdf,10829,HY-15043,,913064-47-8,Bradykinin Receptor,GPCR/G Protein,C29H29ClN4O2,10mM,Endocrinology; Inflammation/Immunology,No Development Reported,O=C(c1cccc(N2Cc3cccc(Cl)c3C2=O)c1)N1CCC2(CC1)CCN(c1ccncc1)CC2,清洗成功,0.2577319587628865
4983,O=C(OCC12CC3CC(CC(C3)C1)C2)c1ccc(NCc2cc(O)ccc2O)cc1,1,0.9902792572975159,0.9902792572975159,O=C(C1=CC=C(C=C1)NCC2=CC(O)=CC=C2O)OCC34CC5CC(CC(C4)C5)C3,NSC689857,Data.sdf,5874,HY-123578,,241127-79-7,E1/E2/E3 Enzyme; EGFR,JAK/STAT Signaling; Metabolic Enzyme/Protease; Protein Tyrosine Kinase/RTK,C25H29NO4,10mM,Cancer,No Development Reported,O=C(OCC12CC3CC(CC(C3)C1)C2)c1ccc(NCc2cc(O)ccc2O)cc1,清洗成功,0.2368421052631578
2884,C[C@H](NC(=O)C(C)(F)F)[C@H](Oc1ccc2c(cnn2-c2cccc(C(=O)N[C@@H]3CCOC3)c2)c1)c1ccc2c(c1)OCCO2,1,0.9902758598327637,0.9902758598327637,O=C(N[C@H]1COCC1)C2=CC=CC(N3N=CC4=C3C=CC(O[C@H](C5=CC=C(OCCO6)C6=C5)[C@@H](NC(C(F)(F)C)=O)C)=C4)=C2,Velsecorat,Data.sdf,3385,HY-111453,AZD7594; AZ13189620,1196509-60-0,Glucocorticoid Receptor,Immunology/Inflammation; Vitamin D Related/Nuclear Receptor,C32H32F2N4O6,10mM,Inflammation/Immunology; Endocrinology,Phase 2,C[C@H](NC(=O)C(C)(F)F)[C@H](Oc1ccc2c(cnn2-c2cccc(C(=O)N[C@@H]3CCOC3)c2)c1)c1ccc2c(c1)OCCO2,清洗成功,0.2233009708737864
9877,COc1cc(O[C@H]2CCN(C)CC2(F)F)c2c(Nc3ccc(Oc4ccn5ncnc5c4)c(C)c3)ncnc2c1,1,0.9902708530426025,0.9902708530426025,COC1=CC2=C(C(NC3=CC=C(C(C)=C3)OC4=CC5=NC=NN5C=C4)=NC=N2)C(O[C@H]6CCN(CC6(F)F)C)=C1,DZD1516,Data.sdf,11672,HY-155079,,2387570-00-3,EGFR,JAK/STAT Signaling; Protein Tyrosine Kinase/RTK,C28H27F2N7O3,10mM,Cancer,Phase 1,COc1cc(O[C@H]2CCN(C)CC2(F)F)c2c(Nc3ccc(Oc4ccn5ncnc5c4)c(C)c3)ncnc2c1,清洗成功,0.3076923076923077
9878,COc1cc(O[C@@H]2CCN(C)CC2(F)F)c2c(Nc3ccc(Oc4ccn5ncnc5c4)c(C)c3)ncnc2c1,1,0.9902708530426025,0.9902708530426025,COC1=CC2=C(C(NC3=CC=C(C(C)=C3)OC4=CC5=NC=NN5C=C4)=NC=N2)C(O[C@@H]6CCN(CC6(F)F)C)=C1,(R)-DZD1516,Data.sdf,11673,HY-155079A,,2387570-03-6,EGFR,JAK/STAT Signaling; Protein Tyrosine Kinase/RTK,C28H27F2N7O3,10mM,Others,No Development Reported,COc1cc(O[C@@H]2CCN(C)CC2(F)F)c2c(Nc3ccc(Oc4ccn5ncnc5c4)c(C)c3)ncnc2c1,清洗成功,0.3076923076923077
16798,O=C(NCCCOc1ccc2[nH]c(=O)ccc2c1)N(C1CC1)[C@@H]1CCCC[C@H]1O,1,0.9902685880661011,0.9902685880661011,O=C(NCCCOC1=CC2=C(NC(C=C2)=O)C=C1)N(C3CC3)[C@H]4[C@H](O)CCCC4,K134,Data.sdf,19991,HY-U00186,OPC33509,189362-06-9,Phosphodiesterase (PDE),Metabolic Enzyme/Protease,C22H29N3O4,10mM,Cardiovascular Disease,Phase 2,O=C(NCCCOc1ccc2[nH]c(=O)ccc2c1)N(C1CC1)[C@@H]1CCCC[C@H]1O,清洗成功,0.2345679012345679
3016,CC(=O)NC[C@H]1CN(c2ccc(OCC3(O)CCN(c4cc5c(cc4F)c(=O)c(C(=O)O)cn5C4CC4)CC3)c(F)c2)C(=O)O1,1,0.9902676939964294,0.9902676939964294,O=C(C1=CN(C2CC2)C3=C(C=C(F)C(N4CCC(O)(COC5=CC=C(N6C(O[C@@H](CNC(C)=O)C6)=O)C=C5F)CC4)=C3)C1=O)O,MCB-3681,Data.sdf,3530,HY-111902,,790704-42-6,Bacterial,Anti-infection,C31H32F2N4O8,10mM,Infection,No Development Reported,CC(=O)NC[C@H]1CN(c2ccc(OCC3(O)CCN(c4cc5c(cc4F)c(=O)c(C(=O)O)cn5C4CC4)CC3)c(F)c2)C(=O)O1,清洗成功,0.2761904761904762
2197,Cc1cc(Cn2c(=O)n(Cc3cnc(C)s3)c(=O)c3cc(S(=O)(=O)NC4(C)CC4)ccc32)n(C)n1,1,0.9902661442756653,0.9902661442756653,O=S(C1=CC2=C(N(CC3=CC(C)=NN3C)C(N(CC4=CN=C(C)S4)C2=O)=O)C=C1)(NC5(C)CC5)=O,PDD 00017273,Data.sdf,2578,HY-108360,,1945950-21-9,Poly(ADP-ribose) Glycohydrolase (PARG),Cell Cycle/DNA Damage,C23H26N6O4S2,10mM,Cancer,No Development Reported,Cc1cc(Cn2c(=O)n(Cc3cnc(C)s3)c(=O)c3cc(S(=O)(=O)NC4(C)CC4)ccc32)n(C)n1,清洗成功,0.2
6578,NC(=O)c1cc2c(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)ccnc2cc1O,1,0.9902635812759399,0.9902635812759399,O=C(C1=C(O)C=C2N=CC=C(OC3=CC=C(NC(NC4CC4)=O)C(Cl)=C3)C2=C1)N.Cl,O-Demethyl Lenvatinib (hydrochloride),Data.sdf,7803,HY-133980A,,,Drug Metabolite,Metabolic Enzyme/Protease,C20H18Cl2N4O4,10mM,Cancer,No Development Reported,NC(=O)c1cc2c(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)ccnc2cc1O,清洗成功,0.2873563218390804
6961,C[C@@H]1OCC2(CCN(c3cnc(Sc4ccnc(N)c4Cl)c(N)n3)CC2)[C@@H]1N,1,0.9902543425559998,0.9902543425559998,N[C@@H]1[C@H](C)OCC12CCN(C3=NC(N)=C(SC4=C(Cl)C(N)=NC=C4)N=C3)CC2,Batoprotafib,Data.sdf,8260,HY-136173,TNO155,1801765-04-7,Phosphatase; SHP2,Metabolic Enzyme/Protease; Protein Tyrosine Kinase/RTK,C18H24ClN7OS,10mM,Cancer,Phase 2,C[C@@H]1OCC2(CCN(c3cnc(Sc4ccnc(N)c4Cl)c(N)n3)CC2)[C@@H]1N,清洗成功,0.2111111111111111
1398,CC1(C)CC(=O)c2c(SCCO)sc(-c3nccs3)c2C1,1,0.9902424216270447,0.9902424216270447,O=C1CC(C)(C)CC2=C(C3=NC=CS3)SC(SCCO)=C21,TB-21007,Data.sdf,1639,HY-103510,,207306-50-1,GABA Receptor,Membrane Transporter/Ion Channel; Neuronal Signaling,C15H17NO2S3,10mM,Neurological Disease,No Development Reported,CC1(C)CC(=O)c2c(SCCO)sc(-c3nccs3)c2C1,清洗成功,0.1830985915492957
6027,Cc1nc(Nc2n[nH]c3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1,1,0.9902403354644775,0.9902403354644775,CC1=NC2=C(SC=C2)C(NC3=NNC4=C3CN(C(N[C@@H](C5=CC=CC=C5)CN(C)C)=O)C4(C)C)=N1,PF-3758309,Data.sdf,7130,HY-13007,PF-03758309,898044-15-0,Apoptosis; PAK,Apoptosis; Cell Cycle/DNA Damage; Cytoskeleton,C25H30N8OS,10mM,Cancer,Phase 1,Cc1nc(Nc2n[nH]c3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1,清洗成功,0.2967032967032967
8425,Cc1ncc(-c2nc3c(OC4(C)CC4)nc(Nc4cnn(C5CCN(C)CC5)c4)nc3cc2F)cn1,1,0.990240216255188,0.990240216255188,CC1=NC=C(C2=NC3=C(OC4(C)CC4)N=C(NC5=CN(C6CCN(C)CC6)N=C5)N=C3C=C2F)C=N1,IRAK4-IN-14,Data.sdf,9938,HY-146112,,2667681-71-0,IRAK,Immunology/Inflammation,C25H28FN9O,10mM,Cancer,No Development Reported,Cc1ncc(-c2nc3c(OC4(C)CC4)nc(Nc4cnn(C5CCN(C)CC5)c4)nc3cc2F)cn1,清洗成功,0.3146067415730337
8167,CSCC[C@H](NC(=O)c1ccn(S(C)(=O)=O)c1)C(=O)Nc1nc(-c2cccc(-c3ccncc3)c2)cs1,1,0.9902384281158447,0.9902384281158447,O=C(C1=CN(C=C1)S(C)(=O)=O)N[C@@H](CCSC)C(NC2=NC(C3=CC(C4=CC=NC=C4)=CC=C3)=CS2)=O,FHT-1015,Data.sdf,9644,HY-144896,,2368903-18-6,Epigenetic Reader Domain,Epigenetics,C25H25N5O4S3,10mM,Cancer,No Development Reported,CSCC[C@H](NC(=O)c1ccn(S(C)(=O)=O)c1)C(=O)Nc1nc(-c2cccc(-c3ccncc3)c2)cs1,清洗成功,0.2989690721649484
9592,Nc1nnc(-c2ccccc2O)cc1N1CCN(Cc2ccc(OCCOCCNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)c(F)c2)CC1,1,0.9902363419532776,0.9902363419532776,O=C1N(C2CCC(NC2=O)=O)C(C3=C1C=CC=C3NCCOCCOC4=C(F)C=C(CN5CCN(C6=C(N)N=NC(C7=C(O)C=CC=C7)=C6)CC5)C=C4)=O,YD23,Data.sdf,11332,HY-153361,,2951015-29-3,PROTACs,PROTAC,C38H39FN8O7,10mM,Cancer,No Development Reported,Nc1nnc(-c2ccccc2O)cc1N1CCN(Cc2ccc(OCCOCCNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)c(F)c2)CC1,清洗成功,0.2666666666666666
8838,Cc1nc2nc(C)c(O[C@@H]3CCN(c4ccc(-c5ccc(CN6CCOCC6)nn5)cc4)C3)c(C)n2n1,1,0.990236222743988,0.990236222743988,CC1=C(O[C@H]2CN(C3=CC=C(C4=NN=C(CN5CCOCC5)C=C4)C=C3)CC2)C(C)=NC6=NC(C)=NN16,AZD0095,Data.sdf,10432,HY-148517,,2750001-23-9,Monocarboxylate Transporter,Membrane Transporter/Ion Channel,C27H32N8O2,10mM,Cancer,No Development Reported,Cc1nc2nc(C)c(O[C@@H]3CCN(c4ccc(-c5ccc(CN6CCOCC6)nn5)cc4)C3)c(C)n2n1,清洗成功,0.3058823529411765
8393,CN1CCc2[nH]c(-c3ccnc(NC(=O)[C@@H](CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O,1,0.9902357459068298,0.9902357459068298,O=C1C2=C(NC(C3=CC=NC(NC([C@@H](CC(F)F)C4=CC=C(F)C=C4)=O)=C3)=C2NC5=CC=CC=C5)CCN1C,BAY-204,Data.sdf,9901,HY-145940,BRD3727,2468784-57-6,Casein Kinase,Cell Cycle/DNA Damage; Stem Cell/Wnt,C29H26F3N5O2,10mM,Cancer,No Development Reported,CN1CCc2[nH]c(-c3ccnc(NC(=O)[C@@H](CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O,清洗成功,0.2522522522522522
2784,CC(C)(C)[C@@H](CO)NC(=O)c1nn(-c2c[n+]([O-])ccn2)c2c1C[C@@H]1C[C@H]21,1,0.9902349710464478,0.9902349710464478,O=C(C1=NN(C2=C[N+]([O-])=CC=N2)C3=C1C[C@@]4([H])[C@]3([H])C4)N[C@H](CO)C(C)(C)C,Olorinab,Data.sdf,3273,HY-111110,APD 371,1268881-20-4,Cannabinoid Receptor,GPCR/G Protein; Neuronal Signaling,C18H23N5O3,10mM,Neurological Disease,Phase 2,CC(C)(C)[C@@H](CO)NC(=O)c1nn(-c2c[n+]([O-])ccn2)c2c1C[C@@H]1C[C@H]21,清洗成功,0.1868131868131868
12016,N#Cc1c(-c2cccs2)cc(-c2cccs2)nc1SCC(=O)c1cccs1,1,0.9902328252792358,0.9902328252792358,N#CC1=C(C2=CC=CS2)C=C(C3=CC=CS3)N=C1SCC(C4=CC=CS4)=O,RCM-1,Data.sdf,14207,HY-19979,,339163-65-4,DNA/RNA Synthesis,Cell Cycle/DNA Damage,C20H12N2OS4,10mM,Cancer,No Development Reported,N#Cc1c(-c2cccs2)cc(-c2cccs2)nc1SCC(=O)c1cccs1,清洗成功,0.2535211267605634
1177,CN(Cc1ccccc1)C(=O)C1CCCN(Cc2ccc(C(F)(F)F)cc2)C1,1,0.9902271032333374,0.9902271032333374,O=C(C1CN(CC2=CC=C(C(F)(F)F)C=C2)CCC1)N(C)CC3=CC=CC=C3,T.cruzi-IN-1,Data.sdf,1364,HY-103033,,1350920-22-7,Parasite,Anti-infection,C22H25F3N2O,10mM,Infection,No Development Reported,CN(Cc1ccccc1)C(=O)C1CCCN(Cc2ccc(C(F)(F)F)cc2)C1,清洗成功,0.2916666666666667
716,CN(C(=O)CCCOc1ccc2[nH]c(=O)ccc2c1)C1CCCCC1,1,0.9902231693267822,0.9902231693267822,O=C(N(C1CCCCC1)C)CCCOC2=CC3=C(NC(C=C3)=O)C=C2,Cilostamide,Data.sdf,821,HY-101312,OPC3689,68550-75-4,Phosphodiesterase (PDE),Metabolic Enzyme/Protease,C20H26N2O3,10mM,Cardiovascular Disease,No Development Reported,CN(C(=O)CCCOc1ccc2[nH]c(=O)ccc2c1)C1CCCCC1,清洗成功,0.273972602739726
15235,COc1c2c(cc3oc(C)cc(=O)c13)O[C@H](C(C)(C)O[C@@H]1O[C@H](CO[C@@H]3OC[C@](O)(CO)[C@H]3O)[C@@H](O)[C@H](O)[C@H]1O)C2,1,0.99021977186203,0.99021977186203,COC1=C(C[C@@H](C(C)(C)O[C@@H]([C@@H]([C@@H](O)[C@@H]2O)O)O[C@@H]2CO[C@H](OC[C@]3(O)CO)[C@@H]3O)O4)C4=CC(OC(C)=C5)=C1C5=O,6"-O-Apiosyl-5-O-Methylvisammioside,Data.sdf,18130,HY-N2295,,139446-82-5,Others,Others,C27H36O14,10mM,Neurological Disease,No Development Reported,COc1c2c(cc3oc(C)cc(=O)c13)O[C@H](C(C)(C)O[C@@H]1O[C@H](CO[C@@H]3OC[C@](O)(CO)[C@H]3O)[C@@H](O)[C@H](O)[C@H]1O)C2,清洗成功,0.2604166666666667
10134,Cc1c(C(=O)NCc2ccc(F)cc2)oc2ccc(S(=O)(=O)N3CCC(C)CC3)cc12,1,0.990216851234436,0.990216851234436,O=C(C1=C(C)C2=C(C=CC(S(=O)(N3CCC(CC3)C)=O)=C2)O1)NCC4=CC=C(C=C4)F,Calcium Channel antagonist 2,Data.sdf,11988,HY-156663,,874370-15-7,Calcium Channel,Membrane Transporter/Ion Channel; Neuronal Signaling,C23H25FN2O4S,10mM,Cancer,No Development Reported,Cc1c(C(=O)NCc2ccc(F)cc2)oc2ccc(S(=O)(=O)N3CCC(C)CC3)cc12,清洗成功,0.2470588235294117
9933,CN(C)Cc1ccc(CSCCN/C(=C/[N+](=O)[O-])NCc2ccc3c(c2)OCO3)o1,1,0.9902150630950928,0.9902150630950928,O=[N+](/C=C(NCCSCC1=CC=C(CN(C)C)O1)\NCC2=CC=C(OCO3)C3=C2)[O-],Niperotidine,Data.sdf,11742,HY-15539,,84845-75-0,Histamine Receptor,GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling,C20H26N4O5S,10mM,Metabolic Disease; Endocrinology,No Development Reported,CN(C)Cc1ccc(CSCCN/C(=C/[N+](=O)[O-])NCc2ccc3c(c2)OCO3)o1,清洗成功,0.2891566265060241
2105,O=c1[nH]ccc2cc(F)c(NS(=O)(=O)c3ccc(N4CC[C@@H](O)C4)s3)cc12,1,0.9902087450027466,0.9902087450027466,O=C1NC=CC2=C1C=C(NS(=O)(C3=CC=C(N4CC[C@@H](O)C4)S3)=O)C(F)=C2,LSN 3213128,Data.sdf,2472,HY-107981,,1941211-99-9,Antifolate,Cell Cycle/DNA Damage,C17H16FN3O4S2,10mM,Cancer,No Development Reported,O=c1[nH]ccc2cc(F)c(NS(=O)(=O)c3ccc(N4CC[C@@H](O)C4)s3)cc12,清洗成功,0.2317073170731707
9214,O=c1[nH]c2cc(-n3ccnc3)c([N+](=O)[O-])cc2[nH]c1=O,1,0.9902082085609436,0.9902082085609436,O=C1NC2=C(C=C(N3C=CN=C3)C([N+]([O-])=O)=C2)NC1=O.[H]Cl,YM90K,Data.sdf,10865,HY-15071,,154164-30-4,iGluR,Membrane Transporter/Ion Channel; Neuronal Signaling,C11H8ClN5O4,10mM,Neurological Disease,Phase 2,O=c1[nH]c2cc(-n3ccnc3)c([N+](=O)[O-])cc2[nH]c1=O,清洗成功,0.2777777777777778
6523,Cc1cnc(CNC(=O)c2c(=O)c3ccc(N4CCCN(C)CC4)nc3n3c2sc2ccccc23)cn1,1,0.9902073740959167,0.9902073740959167,[H]Cl.CC1=NC=C(CNC(C2=C3N(C4=NC(N5CCN(CCC5)C)=CC=C4C2=O)C6=C(S3)C=CC=C6)=O)N=C1.[H]Cl,CX-5461 (dihydrochloride),Data.sdf,7730,HY-13323A,,,DNA/RNA Synthesis,Cell Cycle/DNA Damage,C27H29Cl2N7O2S,2mM,Cancer,Phase 1,Cc1cnc(CNC(=O)c2c(=O)c3ccc(N4CCCN(C)CC4)nc3n3c2sc2ccccc23)cn1,清洗成功,0.29
12309,CN[C@H](CNC(=O)N1CCC[C@@H]([C@@H](OCCNC(=O)OC)c2cccc(Cl)c2)C1)C[C@H]1CCCOC1,1,0.9902054667472839,0.9902054667472839,O=C(O)C(F)(F)F.COC(NCCO[C@@H](C1=CC(Cl)=CC=C1)[C@@]2([H])CN(CCC2)C(NC[C@@H](NC)C[C@H]3CCCOC3)=O)=O,VTP-27999 (TFA),Data.sdf,14560,HY-50769,,1013937-63-7,Renin,Metabolic Enzyme/Protease,C28H42ClF3N4O7,10mM,Cardiovascular Disease,Phase 1,CN[C@H](CNC(=O)N1CCC[C@@H]([C@@H](OCCNC(=O)OC)c2cccc(Cl)c2)C1)C[C@H]1CCCOC1,清洗成功,0.2100840336134453
10301,O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1,1,0.9902032613754272,0.9902032613754272,O=C1NC2=C(C=CC(OCCCCN3CCN(C4=C(C=CS5)C5=CC=C4)CC3)=C2)C=C1,Brexpiprazole,Data.sdf,12204,HY-15780,OPC-34712,913611-97-9,5-HT Receptor; Adrenergic Receptor; Dopamine Receptor,GPCR/G Protein; Neuronal Signaling,C25H27N3O2S,10mM,Neurological Disease,Launched,O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1,清洗成功,0.2795698924731182
8822,CN1CCc2[nH]c(-c3ccnc(NC(=O)[C@H](CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O,1,0.990202009677887,0.990202009677887,O=C(N(CC1)C)C2=C1NC(C3=CC=NC(NC([C@@H](C4=CC=C(C=C4)F)CC(F)F)=O)=C3)=C2NC5=CC=CC=C5,CSNK1-IN-1,Data.sdf,10416,HY-148489,,2468784-55-4,Casein Kinase,Cell Cycle/DNA Damage; Stem Cell/Wnt,C29H26F3N5O2,2mM,Cancer,No Development Reported,CN1CCc2[nH]c(-c3ccnc(NC(=O)[C@H](CC(F)F)c4ccc(F)cc4)c3)c(Nc3ccccc3)c2C1=O,清洗成功,0.2522522522522522
2623,COc1cccc(Cn2ncc3c4sc(S(C)=O)cc4n(C)c3c2=O)c1,1,0.9902008175849915,0.9902008175849915,O=C1C2=C(C3=C(N2C)C=C(S(C)=O)S3)C=NN1CC4=CC(OC)=CC=C4,ML202,Data.sdf,3081,HY-110124,,1221186-52-2,Pyruvate Kinase,Metabolic Enzyme/Protease,C18H17N3O3S2,10mM,Cancer,No Development Reported,COc1cccc(Cn2ncc3c4sc(S(C)=O)cc4n(C)c3c2=O)c1,清洗成功,0.2911392405063291
12314,O=c1[nH]ccc2nc(-c3ccc(CN4CCC(c5n[nH]c(-c6ccccn6)n5)CC4)cc3)c(-c3ccccc3)cc12,1,0.9901988506317139,0.9901988506317139,O=C(NC=C1)C2=C1N=C(C(C3=CC=CC=C3)=C2)C(C=C4)=CC=C4CN5CCC(CC5)C6=NNC(C7=NC=CC=C7)=N6,Akt1/Akt2-IN-1,Data.sdf,14571,HY-50862,,893422-47-4,Akt,PI3K/Akt/mTOR,C33H29N7O,10mM,Cancer,No Development Reported,O=c1[nH]ccc2nc(-c3ccc(CN4CCC(c5n[nH]c(-c6ccccn6)n5)CC4)cc3)c(-c3ccccc3)cc12,清洗成功,0.3052631578947368
9856,O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1,1,0.9901981353759766,0.9901981353759766,O[C@H]1CC[C@H](NC2=NC=C3N=C(NC4=C(F)C=C(F)C=C4F)N([C@@H]5COCC5)C3=N2)CC1,Tanzisertib,Data.sdf,11645,HY-15495,CC-930,899805-25-5,JNK,MAPK/ERK Pathway,C21H23F3N6O2,10mM,Inflammation/Immunology,Phase 2,O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1,清洗成功,0.25
6933,CNC(=O)c1cc(F)c(-c2nc3cc(C)ccn3c2C[C@@H]2CCCN(C(=O)OC)C2)c(F)c1,1,0.9901975393295288,0.9901975393295288,O=C(OC)N1C[C@@H](CCC1)CC2=C(N=C3C=C(C=CN32)C)C4=C(C=C(C=C4F)C(NC)=O)F,P2X3 antagonist 34,Data.sdf,8225,HY-135976,,2417288-67-4,P2X Receptor,Membrane Transporter/Ion Channel,C24H26F2N4O3,10mM,Inflammation/Immunology; Neurological Disease,No Development Reported,CNC(=O)c1cc(F)c(-c2nc3cc(C)ccn3c2C[C@@H]2CCCN(C(=O)OC)C2)c(F)c1,清洗成功,0.2363636363636363
12428,CN[C@H](CNC(=O)N1CCC[C@@H]([C@@H](OCCNC(=O)OC)c2cccc(Cl)c2)C1)C[C@H]1CCCOC1,1,0.9901942610740662,0.9901942610740662,O=C(NC[C@H](C[C@@H]1COCCC1)NC)N(CCC2)C[C@]2([H])[C@](OCCNC(OC)=O)([H])C3=CC(Cl)=CC=C3.Cl,VTP-27999 (Hydrochloride),Data.sdf,14714,HY-76652,,1264191-73-2,Renin,Metabolic Enzyme/Protease,C26H42Cl2N4O5,10mM,Cardiovascular Disease,Phase 1,CN[C@H](CNC(=O)N1CCC[C@@H]([C@@H](OCCNC(=O)OC)c2cccc(Cl)c2)C1)C[C@H]1CCCOC1,清洗成功,0.2166666666666666
11845,CC1(C)CC(Oc2ccc(-c3ccc(-c4cn[nH]c4)cc3O)nn2)CC(C)(C)N1,1,0.9901903867721558,0.9901903867721558,OC1=CC(C2=CNN=C2)=CC=C1C3=CC=C(OC4CC(C)(C)NC(C)(C)C4)N=N3,Branaplam,Data.sdf,14012,HY-19620,LMI070; NVS-SM1,1562338-42-4,DNA/RNA Synthesis; Potassium Channel,Cell Cycle/DNA Damage; Membrane Transporter/Ion Channel,C22H27N5O2,2mM,Cancer,Phase 3,CC1(C)CC(Oc2ccc(-c3ccc(-c4cn[nH]c4)cc3O)nn2)CC(C)(C)N1,清洗成功,0.2933333333333333
11846,CC1(C)CC(Oc2ccc(-c3ccc(-c4cn[nH]c4)cc3O)nn2)CC(C)(C)N1,1,0.9901903867721558,0.9901903867721558,OC1=CC(C2=CNN=C2)=CC=C1C3=CC=C(OC4CC(C)(C)NC(C)(C)C4)N=N3.Cl,Branaplam (hydrochloride),Data.sdf,14013,HY-19620A,LMI070 (hydrochloride); NVS-SM1 (hydrochloride),1562338-39-9,DNA/RNA Synthesis; Potassium Channel,Cell Cycle/DNA Damage; Membrane Transporter/Ion Channel,C22H28ClN5O2,10mM,Cancer,Phase 2,CC1(C)CC(Oc2ccc(-c3ccc(-c4cn[nH]c4)cc3O)nn2)CC(C)(C)N1,清洗成功,0.2894736842105263
11635,CNC(=O)CNc1cnc2ccc(-c3ccc(OC)c(OC)c3)cc2n1,1,0.990189254283905,0.990189254283905,COC(C(OC)=C1)=CC=C1C2=CC3=NC(NCC(NC)=O)=CN=C3C=C2,BQR-695,Data.sdf,13767,HY-18748,NVP-BQR695,1513879-21-4,Parasite; PI4K,Anti-infection; PI3K/Akt/mTOR,C19H20N4O3,10mM,Infection,No Development Reported,CNC(=O)CNc1cnc2ccc(-c3ccc(OC)c(OC)c3)cc2n1,清洗成功,0.3380281690140845
11793,CNc1ncc(CN2CCCC(c3nc(=O)cc(-c4cccs4)[nH]3)C2)cn1,1,0.9901888966560364,0.9901888966560364,C1(C=C(NC(=N1)C1CN(CC2C=NC(NC)=NC=2)CCC1)C1=CC=CS1)=O,Ribocil,Data.sdf,13952,HY-19487,,1381289-58-2,Bacterial,Anti-infection,C19H22N6OS,10mM,Infection,No Development Reported,CNc1ncc(CN2CCCC(c3nc(=O)cc(-c4cccs4)[nH]3)C2)cn1,清洗成功,0.3225806451612903
14017,CC1(C)[C@H](C(=O)O[C@H](C#N)c2cccc(Oc3ccccc3)c2)[C@@H]1C=C(Br)Br,1,0.9901829361915588,0.9901829361915588,O=C([C@H]1C(C)(C)[C@H]1/C=C(Br)\Br)O[C@H](C#N)C2=CC=CC(OC3=CC=CC=C3)=C2,Deltamethrin,Data.sdf,16501,HY-B1971,Decamethrin,52918-63-5,Apoptosis; Bcl-2 Family; Calcium Channel; Caspase; Endogenous Metabolite; Interleukin Related; NF-?oB,Apoptosis; Immunology/Inflammation; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling; NF-?oB,C22H19Br2NO3,10mM,Cancer; Inflammation/Immunology; Neurological Disease,No Development Reported,CC1(C)[C@H](C(=O)O[C@H](C#N)c2cccc(Oc3ccccc3)c2)[C@@H]1C=C(Br)Br,清洗成功,0.2151898734177215
483,C=CC(=O)Nc1cc(-c2nn(C3CCC(N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1Oc1ccccc1,1,0.9901677370071411,0.9901677370071411,CC(N1CCN(C2CCC(N3N=C(C4=CC(NC(C=C)=O)=C(OC5=CC=CC=C5)C=C4)C6=C3N=CN=C6N)CC2)CC1)=O,TX1-85-1,Data.sdf,545,HY-100848,,1603845-32-4,EGFR,JAK/STAT Signaling; Protein Tyrosine Kinase/RTK,C32H36N8O3,2mM,Cancer,No Development Reported,C=CC(=O)Nc1cc(-c2nn(C3CCC(N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1Oc1ccccc1,清洗成功,0.3095238095238095
5477,O=C(NCC1(O)CCC(F)(F)CC1)c1cc(=O)c2cc(F)ccc2o1,1,0.9901643395423889,0.9901643395423889,FC1=CC=C(OC(C(NCC2(O)CCC(F)(F)CC2)=O)=CC3=O)C3=C1,LysRs-IN-2,Data.sdf,6453,HY-126130,,2170696-76-9,Aminoacyl-tRNA Synthetase,Metabolic Enzyme/Protease,C17H16F3NO4,10mM,Infection,No Development Reported,O=C(NCC1(O)CCC(F)(F)CC1)c1cc(=O)c2cc(F)ccc2o1,清洗成功,0.2289156626506024
6533,O=C(CCN1CCN(C(=O)OCc2cc(Cl)cc(Cl)c2)CC1)c1ccc2[nH]c(=O)oc2c1,1,0.9901629686355591,0.9901629686355591,O=C(N1CCN(CC1)CCC(C2=CC(O3)=C(C=C2)NC3=O)=O)OCC4=CC(Cl)=CC(Cl)=C4,PF-8380,Data.sdf,7747,HY-13344,,1144035-53-9,Phosphodiesterase (PDE),Metabolic Enzyme/Protease,C22H21Cl2N3O5,10mM,Cancer; Inflammation/Immunology,No Development Reported,O=C(CCN1CCN(C(=O)OCc2cc(Cl)cc(Cl)c2)CC1)c1ccc2[nH]c(=O)oc2c1,清洗成功,0.2477064220183486
6534,O=C(CCN1CCN(C(=O)OCc2cc(Cl)cc(Cl)c2)CC1)c1ccc2[nH]c(=O)oc2c1,1,0.9901629686355591,0.9901629686355591,O=C(N1CCN(CC1)CCC(C2=CC(O3)=C(C=C2)NC3=O)=O)OCC4=CC(Cl)=CC(Cl)=C4.[H]Cl,PF-8380 (hydrochloride),Data.sdf,7748,HY-13344A,,2070015-01-7,Phosphodiesterase (PDE),Metabolic Enzyme/Protease,C22H22Cl3N3O5,10mM,Cancer; Inflammation/Immunology,No Development Reported,O=C(CCN1CCN(C(=O)OCc2cc(Cl)cc(Cl)c2)CC1)c1ccc2[nH]c(=O)oc2c1,清洗成功,0.2454545454545454
3690,CNCCN1CCC(c2cc(CN(C)C(=O)c3cccc(Oc4ccccc4)c3)ccn2)CC1,1,0.9901628494262695,0.9901628494262695,O=C(C1=CC=CC(OC2=CC=CC=C2)=C1)N(CC3=CC(C4CCN(CC4)CCNC)=NC=C3)C,TP-064,Data.sdf,4344,HY-114965,,2080306-20-1,Histone Methyltransferase,Epigenetics,C28H34N4O2,10mM,Cancer; Inflammation/Immunology,No Development Reported,CNCCN1CCC(c2cc(CN(C)C(=O)c3cccc(Oc4ccccc4)c3)ccn2)CC1,清洗成功,0.2771084337349397
9049,CC(C)(C)[C@H](NC(=O)C(F)(F)F)C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)c1nc3c(F)cccc3s1)C2(C)C,1,0.9901561737060547,0.9901561737060547,O=C([C@@H]1[C@@]2([H])C(C)(C)[C@@]2([H])CN1C([C@@H](NC(C(F)(F)F)=O)C(C)(C)C)=O)N[C@@H](C[C@H]3C(NCC3)=O)C(C4=NC5=C(F)C=CC=C5S4)=O,TKB245,Data.sdf,10666,HY-149606,,2892688-16-1,SARS-CoV,Anti-infection,C30H35F4N5O5S,10mM,Infection,No Development Reported,CC(C)(C)[C@H](NC(=O)C(F)(F)F)C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)c1nc3c(F)cccc3s1)C2(C)C,清洗成功,0.1919191919191919
10309,CCN(c1cc(-c2ccc(CN3CCN(C(=O)CCCCCCCCCC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCc4ccc(-c5scnc5C)cc4)C(C)(C)C)CC3)cc2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCOCC1,1,0.9901560544967651,0.9901560544967651,CCN(C1CCOCC1)C2=CC(C3=CC=C(C=C3)CN4CCN(CC4)C(CCCCCCCCCC(N[C@@H](C(C)(C)C)C(N5[C@@H](C[C@H](C5)O)C(NCC6=CC=C(C7=C(N=CS7)C)C=C6)=O)=O)=O)=O)=CC(C(NCC8=C(C=C(NC8=O)C)C)=O)=C2C,NUCC-0226272,Data.sdf,12212,HY-157844,,3004503-12-9,Histone Methyltransferase; PROTACs,Epigenetics; PROTAC,C67H91N9O8S,10mM,Cancer,No Development Reported,CCN(c1cc(-c2ccc(CN3CCN(C(=O)CCCCCCCCCC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)NCc4ccc(-c5scnc5C)cc4)C(C)(C)C)CC3)cc2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCOCC1,清洗成功,0.2181818181818181
14695,O=c1cc(-c2ccc(O)cc2)oc2cc(O)c(O)c(O)c12,1,0.990155816078186,0.990155816078186,O=C1C=C(C2=CC=C(O)C=C2)OC3=CC(O)=C(O)C(O)=C13,Scutellarein,Data.sdf,17407,HY-N0752,"6-Hydroxyapigenin; 4',5,6,7-Tetrahydroxyflavone",529-53-3,Autophagy; SARS-CoV; Src,Anti-infection; Autophagy; Protein Tyrosine Kinase/RTK,C15H10O6,10mM,Cancer; Metabolic Disease; Inflammation/Immunology; Neurological Disease,No Development Reported,O=c1cc(-c2ccc(O)cc2)oc2cc(O)c(O)c(O)c12,清洗成功,0.3260869565217391
15662,O=c1cc(-c2ccc(O)cc2)oc2cc(O)c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)c12,1,0.9901551008224487,0.9901551008224487,O=C1C=C(C2=CC=C(O)C=C2)OC3=CC(O)=C([C@H]4[C@@H]([C@H]([C@@H]([C@@H](CO)O4)O)O)O[C@H]5[C@@H]([C@H]([C@@H]([C@@H](CO)O5)O)O)O)C(O)=C13,Meloside A,Data.sdf,18699,HY-N5124,Isovitexin 2''-O-glucoside; Isovitexin 2''-O-?2-D-glucoside,60767-80-8,Others,Others,C27H30O15,10mM,Infection,No Development Reported,O=c1cc(-c2ccc(O)cc2)oc2cc(O)c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)c12,清洗成功,0.2941176470588235
13238,CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O,1,0.9901527762413025,0.9901527762413025,O[C@@H]1[C@@H](O[C@@](O[C@@H](C)[C@H]2O)([H])C[C@@]2(N)C)[C@@H](O[C@H](CO)[C@H]1O)OC3=C(OC4=CC=C([C@H]([C@H]5NC([C@H](NC)CC(C)C)=O)O)C=C4Cl)C=C([C@](NC([C@@H](NC5=O)CC(N)=O)=O)([H])C(N[C@](C6=O)([H])C7=CC8=C(O)C=C7)=O)C=C3OC9=CC=C([C@H]([C@](C(N[C@@](C(O)=O)([H])C%10=C8C(O)=CC(O)=C%10)=O)([H])N6)O)C=C9Cl,Vancomycin,Data.sdf,15629,HY-B0671,,1404-90-6,Antibiotic; Autophagy; Bacterial,Anti-infection; Autophagy,C66H75Cl2N9O24,10mM,Infection; Cancer,Launched,CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O,清洗成功,0.1818181818181818
17742,C=C[C@H]1C[N@@]2CC[C@H]1C[C@@H]2[C@H](O)c1ccnc2ccc(OC)cc12,1,0.99014812707901,0.99014812707901,O[C@@H]([C@](C[C@@H]1CC2)([H])[N@@]2C[C@@H]1C=C)C3=CC=NC(C=C4)=C3C=C4OC,Epiquinidine,Data.sdf,21144,HY-W048510,,572-59-8,Others,Others,C20H24N2O2,10mM,Others,No Development Reported,C=C[C@H]1C[N@@]2CC[C@H]1C[C@@H]2[C@H](O)c1ccnc2ccc(OC)cc12,清洗成功,0.2957746478873239
13692,C=C[C@H]1C[N@]2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12,1,0.9901458621025085,0.9901458621025085,C=C[C@H]1C[N@](CC[C@H]1C2)[C@@]2([H])[C@@H](O)C3=CC=NC4=CC=C(OC)C=C34.[H]Cl.[H]O[H],Quinidine hydrochloride monohydrate,Data.sdf,16142,HY-B1302,,6151-40-2,Parasite; Potassium Channel,Anti-infection; Membrane Transporter/Ion Channel,C20H27ClN2O3,10mM,Infection; Cardiovascular Disease,Launched,C=C[C@H]1C[N@]2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12,清洗成功,0.2876712328767123
13027,C=C[C@H]1C[N@]2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12,1,0.9901446104049683,0.9901446104049683,COC1=CC2=C(N=CC=C2[C@H]([C@@]3([H])[N@](C[C@@H]4C=C)CC[C@@]4([H])C3)O)C=C1.Cl.O.O,Quinine (hydrochloride dihydrate),Data.sdf,15392,HY-B0433A,,6119-47-7,Dengue Virus; Flavivirus; Parasite; Potassium Channel,Anti-infection; Membrane Transporter/Ion Channel,C20H29ClN2O4,10mM,Infection,Launched,C=C[C@H]1C[N@]2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12,清洗成功,0.2876712328767123
13920,C=C[C@H]1C[N@]2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12,1,0.990142822265625,0.990142822265625,O[C@H](C1=CC=NC2=C1C=C(OC)C=C2)[C@@]3([H])[N@](C[C@@H]4C=C)CC[C@H]4C3.O=S(O)(O)=O,Quinine (sulfate),Data.sdf,16391,HY-B1751B,,549-56-4,Cytochrome P450; Parasite; Potassium Channel,Anti-infection; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease,C20H26N2O6S,10mM,Cancer; Infection; Cardiovascular Disease,Launched,C=C[C@H]1C[N@]2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12,清洗成功,0.2763157894736842
8010,C=CC(=O)N1CCN(c2ccc(CCC(=O)NCCCNC(=O)c3cccc(-c4nc(NC(=O)C5(c6ccc7c(c6)OC(F)(F)O7)CC5)ccc4C)c3)o2)C(=O)C1,1,0.9901416897773743,0.9901416897773743,C=CC(N1CCN(C(C1)=O)C2=CC=C(O2)CCC(NCCCNC(C3=CC=CC(C4=NC(NC(C5(CC5)C6=CC=C7OC(F)(OC7=C6)F)=O)=CC=C4C)=C3)=O)=O)=O,NJH-2-056,Data.sdf,9460,HY-143344,,2858812-69-6,CFTR; PROTACs,Membrane Transporter/Ion Channel; PROTAC,C41H40F2N6O8,10mM,Inflammation/Immunology,No Development Reported,C=CC(=O)N1CCN(c2ccc(CCC(=O)NCCCNC(=O)c3cccc(-c4nc(NC(=O)C5(c6ccc7c(c6)OC(F)(F)O7)CC5)ccc4C)c3)o2)C(=O)C1,清洗成功,0.2170542635658914
7198,O=c1[nH]c(CS[C@H]2CC[C@H](O)CC2)nc2cc(OCC3CC3)cc(F)c12,1,0.9901381731033325,0.9901381731033325,O=C1NC(CS[C@H]2CC[C@H](O)CC2)=NC3=C1C(F)=CC(OCC4CC4)=C3,RBN012759,Data.sdf,8522,HY-136979,,2360851-29-0,PARP,Cell Cycle/DNA Damage; Epigenetics,C19H23FN2O3S,10mM,Cancer; Inflammation/Immunology,No Development Reported,O=c1[nH]c(CS[C@H]2CC[C@H](O)CC2)nc2cc(OCC3CC3)cc(F)c12,清洗成功,0.2117647058823529
13919,C=C[C@H]1C[N@]2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12,1,0.9901374578475952,0.9901374578475952,C=C[C@H]1C[N@](CC[C@H]1C2)[C@@]2([H])[C@@H](O)C3=CC=NC4=CC=C(OC)C=C34,Quinidine (15% dihydroquinidine),Data.sdf,16390,HY-B1751,,56-54-2,Apoptosis; Cytochrome P450; Parasite; Potassium Channel,Anti-infection; Apoptosis; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease,C20H24N2O2,10mM,Cancer; Infection; Cardiovascular Disease,Launched,C=C[C@H]1C[N@]2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12,清洗成功,0.2957746478873239
14114,C=C[C@H]1C[N@]2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12,1,0.9901313781738281,0.9901313781738281,O[C@H](C1=CC=NC2=C1C=C(OC)C=C2)[C@@]3([H])[N@](C[C@@H]4C=C)CC[C@H]4C3,Quinine,Data.sdf,16626,HY-D0143,,130-95-0,Dengue Virus; Flavivirus; Parasite; Potassium Channel,Anti-infection; Membrane Transporter/Ion Channel,C20H24N2O2,10mM,Infection,Launched,C=C[C@H]1C[N@]2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12,清洗成功,0.2957746478873239
17798,O=S(=O)(N[C@@H]1COC[C@H](n2c3ccc(Cl)cc3c3cc(Cl)ccc32)[C@H]1O)c1ccc(OC(F)(F)F)cc1,1,0.9901291728019714,0.9901291728019714,O[C@@H]1[C@@](COC[C@H]1NS(=O)(C2=CC=C(C=C2)OC(F)(F)F)=O)([H])N3C4=CC=C(Cl)C=C4C5=CC(Cl)=CC=C53,Anticancer agent 7,Data.sdf,21215,HY-W072940,,2088956-21-0,FOXO; Phosphatase,Metabolic Enzyme/Protease,C24H19Cl2F3N2O5S,10mM,Cancer,No Development Reported,O=S(=O)(N[C@@H]1COC[C@H](n2c3ccc(Cl)cc3c3cc(Cl)ccc32)[C@H]1O)c1ccc(OC(F)(F)F)cc1,清洗成功,0.2564102564102564
17286,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)c(O)c4)oc4cc(O)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,1,0.9901257753372192,0.9901257753372192,O=C1C(O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](CO[C@H]3[C@@H]([C@@H]([C@H]([C@H](C)O3)O)O)O)O2)O)O)O)=C(C4=CC=C(O)C(O)=C4)OC5=CC(O)=CC(O)=C15.O.O.O,Rutin (trihydrate),Data.sdf,20594,HY-W013075,Rutoside (trihydrate); Quercetin 3-O-rutinoside (trihydrate),250249-75-3,Apoptosis; Endogenous Metabolite,Apoptosis; Metabolic Enzyme/Protease,C27H36O19,10mM,Neurological Disease; Cancer,Launched,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)c(O)c4)oc4cc(O)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,清洗成功,0.3188405797101449
242,C=CC(=O)N[C@H]1CCOC[C@H]1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1,1,0.9901228547096252,0.9901228547096252,C=CC(N[C@@H]1[C@H](NC2=NC=C3C=C(C4=C(Cl)C(OC)=CC(OC)=C4Cl)C=CC3=N2)COCC1)=O,Fisogatinib,Data.sdf,275,HY-100492,BLU-554,1707289-21-1,FGFR,Protein Tyrosine Kinase/RTK,C24H24Cl2N4O4,10mM,Cancer,Phase 2,C=CC(=O)N[C@H]1CCOC[C@H]1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1,清洗成功,0.2989690721649484
11942,N#Cc1cc2cc(CN3CCC(Nc4ncnc5sc(CC(F)(F)F)cc45)CC3)c(O)cc2n1Cc1cn[nH]c1,1,0.9901228547096252,0.9901228547096252,FC(F)(F)CC(S1)=CC2=C1N=CN=C2NC3CCN(CC4=C(O)C=C(N(CC5=CNN=C5)C(C#N)=C6)C6=C4)CC3,MI-538,Data.sdf,14128,HY-19810,,1857417-10-7,Epigenetic Reader Domain,Epigenetics,C27H25F3N8OS,10mM,Cancer,No Development Reported,N#Cc1cc2cc(CN3CCC(Nc4ncnc5sc(CC(F)(F)F)cc45)CC3)c(O)cc2n1Cc1cn[nH]c1,清洗成功,0.2049180327868852
11213,CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O,1,0.9901212453842163,0.9901212453842163,ClC1=CC([C@H]([C@@H](NC([C@H](NC)CC(C)C)=O)C(N[C@@H](CC(N)=O)C(N[C@@]2([H])C(N[C@]3([H])C4=CC(C5=C(C=C(O)C=C5O)[C@](C(O)=O)([H])NC([C@](NC3=O)([H])[C@H](O)C6=CC=C7C(Cl)=C6)=O)=C(O)C=C4)=O)=O)=O)O)=CC=C1OC8=C(C(O7)=CC2=C8)O[C@H]9[C@@H]([C@H]([C@H](O)[C@@H](CO)O9)O)O[C@@]%10([H])C[C@](N)([C@H](O)[C@H](C)O%10)C.Cl,Vancomycin (hydrochloride),Data.sdf,13276,HY-17362,,1404-93-9,Antibiotic; Autophagy; Bacterial,Anti-infection; Autophagy,C66H76Cl3N9O24,10mM,Infection; Cancer,Launched,CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O,清洗成功,0.1806451612903225
508,Oc1ccc2c3c1O[C@H]1c4[nH]c5c(c4C[C@@]4(O)[C@@H](C2)N(CC2CC2)CC[C@]314)C[C@@]1(O)[C@H]2Cc3ccc(O)c4c3[C@@]1(CCN2CC1CC1)[C@H]5O4,1,0.9901204109191895,0.9901204109191895,O[C@]12[C@]34[C@](OC5=C(O)C=CC(C[C@@]2([H])N(CC6CC6)CC4)=C35)([H])C7=C(C8=C([C@@](O9)([H])[C@]%10%11[C@](O)([C@](CC%12=C%11C9=C(C=C%12)O)([H])N(CC%13CC%13)CC%10)C8)N7)C1.Cl[H].Cl[H],Norbinaltorphimine dihydrochloride,Data.sdf,575,HY-100903,nor-Binaltorphimine dihydrochloride; nor-BNI dihydrochloride,113158-34-2,Opioid Receptor,GPCR/G Protein; Neuronal Signaling,C40H45Cl2N3O6,10mM,Neurological Disease,No Development Reported,Oc1ccc2c3c1O[C@H]1c4[nH]c5c(c4C[C@@]4(O)[C@@H](C2)N(CC2CC2)CC[C@]314)C[C@@]1(O)[C@H]2Cc3ccc(O)c4c3[C@@]1(CCN2CC1CC1)[C@H]5O4,清洗成功,0.1686746987951807
6281,CN(C)CCn1cc2cc(NC(=O)c3cccc(C(F)(F)F)n3)c(C(C)(C)O)cc2n1,1,0.9901177287101746,0.9901177287101746,O=C(NC1=CC2=CN(CCN(C)C)N=C2C=C1C(C)(O)C)C3=NC(C(F)(F)F)=CC=C3,HS271,Data.sdf,7434,HY-131903,,2410393-15-4,IRAK,Immunology/Inflammation,C21H24F3N5O2,10mM,Inflammation/Immunology,No Development Reported,CN(C)CCn1cc2cc(NC(=O)c3cccc(C(F)(F)F)n3)c(C(C)(C)O)cc2n1,清洗成功,0.3012048192771084
12751,CN(c1nccc(=O)[nH]1)C1CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)CC1,1,0.9901072978973389,0.9901072978973389,O=C1NC(N(C2CCN(C3=NC4=CC=CC=C4N3CC5=CC=C(F)C=C5)CC2)C)=NC=C1,Mizolastine,Data.sdf,15083,HY-B0164,,108612-45-9,Histamine Receptor,GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling,C24H25FN6O,10mM,Inflammation/Immunology,Launched,CN(c1nccc(=O)[nH]1)C1CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)CC1,清洗成功,0.2962962962962963
16097,COc1cc2cc(Oc3ccc4ccc(=O)oc4c3)c(=O)oc2cc1O[C@@H]1O[C@H](COC(=O)CC(C)(O)CC(=O)O)[C@@H](O)[C@H](O)[C@H]1O,1,0.990105926990509,0.990105926990509,O=C1C(OC2=CC=C(C(O3)=C2)C=CC3=O)=CC4=CC(OC)=C(O[C@H]5[C@@H]([C@H]([C@@H]([C@@H](COC(CC(C)(O)CC(O)=O)=O)O5)O)O)O)C=C4O1,Rutarensin,Data.sdf,19243,HY-N8128,,119179-04-3,Others,Others,C31H30O16,10mM,Others,No Development Reported,COc1cc2cc(Oc3ccc4ccc(=O)oc4c3)c(=O)oc2cc1O[C@@H]1O[C@H](COC(=O)CC(C)(O)CC(=O)O)[C@@H](O)[C@H](O)[C@H]1O,清洗成功,0.2947368421052631
3946,Oc1ccc2c3c1O[C@H]1c4[nH]c5c(c4C[C@@]4(O)[C@@H](C2)N(CC2CC2)CC[C@]314)C[C@@]1(O)[C@H]2Cc3ccc(O)c4c3[C@@]1(CCN2CC1CC1)[C@H]5O4,1,0.9901034832000732,0.9901034832000732,O[C@]12[C@]34[C@](OC5=C(O)C=CC(C[C@@]2([H])N(CC4)CC6CC6)=C53)([H])C7=C(C8=C([C@@]9([H])[C@]%10%11[C@@](C8)([C@](CC%12=C%11C(O9)=C(C=C%12)O)([H])N(CC%10)CC%13CC%13)O)N7)C1,nor-Binaltorphimine,Data.sdf,4637,HY-117040,Norbinaltorphimine; NorBNI,105618-26-6,Opioid Receptor,GPCR/G Protein; Neuronal Signaling,C40H43N3O6,10mM,Others,No Development Reported,Oc1ccc2c3c1O[C@H]1c4[nH]c5c(c4C[C@@]4(O)[C@@H](C2)N(CC2CC2)CC[C@]314)C[C@@]1(O)[C@H]2Cc3ccc(O)c4c3[C@@]1(CCN2CC1CC1)[C@H]5O4,清洗成功,0.1707317073170731
12129,c1ncc2nc[nH]c2n1,1,0.9901002049446106,0.9901002049446106,C12=NC=NC=C1N=CN2,Purine,Data.sdf,14346,HY-34431,"Purine (6CI,8CI); 3,5,7-Triazaindole; 3H-Imidazo[4,5-d]pyrimidine; 6H-Imidazo[4,5-d]pyrimidine; 7H-Purine; Isopurine; NSC 753; ?2-Purine",120-73-0,Endogenous Metabolite; PARP,Cell Cycle/DNA Damage; Epigenetics; Metabolic Enzyme/Protease,C5H4N4,10mM,Cancer; Metabolic Disease; Neurological Disease,No Development Reported,c1ncc2nc[nH]c2n1,清洗成功,0.2826086956521739
6219,CNC(=O)c1nn(C)c2ccc(Nc3nccc(-n4cc(CN(C)C)c(C)n4)n3)cc12,1,0.9900934100151062,0.9900934100151062,CC1=NN(C=C1CN(C)C)C2=NC(NC3=CC=C(N(C)N=C4C(NC)=O)C4=C3)=NC=C2,Syk-IN-4,Data.sdf,7357,HY-131341,,2932264-95-2,Syk,Protein Tyrosine Kinase/RTK,C21H25N9O,10mM,Cancer; Inflammation/Immunology,No Development Reported,CNC(=O)c1nn(C)c2ccc(Nc3nccc(-n4cc(CN(C)C)c(C)n4)n3)cc12,清洗成功,0.3043478260869565
1582,CNC(=O)c1ccc2cc([C@@]3(O)CCn4cncc43)ccc2c1,1,0.990092933177948,0.990092933177948,O=C(C1=CC=C2C=C([C@@]3(O)CCN4C=NC=C43)C=CC2=C1)NC,Orteronel,Data.sdf,1870,HY-10505,TAK-700,566939-85-3,Cytochrome P450,Metabolic Enzyme/Protease,C18H17N3O2,10mM,Cancer,Phase 3,CNC(=O)c1ccc2cc([C@@]3(O)CCn4cncc43)ccc2c1,清洗成功,0.3333333333333333
1265,Nc1ccc(-c2nc3cc(-c4nc5cc(N)ccc5[nH]4)ccc3[nH]2)cc1,1,0.9900898933410645,0.9900898933410645,NC1=CC=C2C(N=C(C3=CC=C4C(N=C(C5=CC=C(N)C=C5)N4)=C3)N2)=C1,Ro 90-7501,Data.sdf,1474,HY-103241,,293762-45-5,Amyloid-?2; Apoptosis; ATM/ATR; Phosphatase,Apoptosis; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Neuronal Signaling; PI3K/Akt/mTOR,C20H16N6,10mM,Cancer; Neurological Disease,No Development Reported,Nc1ccc(-c2nc3cc(-c4nc5cc(N)ccc5[nH]4)ccc3[nH]2)cc1,清洗成功,0.3333333333333333
15641,O=c1cc(-c2ccc(O)cc2)oc2c([C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)c(O)cc(O)c12,1,0.990088164806366,0.990088164806366,O=C1C=C(C2=CC=C(O)C=C2)OC3=C([C@H]4[C@@H]([C@H]([C@@H]([C@@H](CO)O4)O[C@H]5[C@@H]([C@H]([C@@H]([C@@H](CO)O5)O)O)O)O)O)C(O)=CC(O)=C13,Vitexin-4''-O-glucoside,Data.sdf,18669,HY-N5073,4''-O-Glucosylvitexin,178468-00-3,Others,Others,C27H30O15,10mM,Metabolic Disease; Cardiovascular Disease,No Development Reported,O=c1cc(-c2ccc(O)cc2)oc2c([C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)c(O)cc(O)c12,清洗成功,0.3176470588235294
4296,COc1ccccc1[C@@H](NS(=O)(=O)c1ccc2[nH]c(=O)ccc2c1)C(=O)N(Cc1ccco1)Cc1cccs1,1,0.9900879263877869,0.9900879263877869,O=C(N(CC1=CC=CS1)CC2=CC=CO2)[C@H](NS(C3=CC(C=C4)=C(C=C3)NC4=O)(=O)=O)C5=CC=CC=C5OC,OSMI-1,Data.sdf,5051,HY-119738,,1681056-61-0,Acyltransferase; OGT,Metabolic Enzyme/Protease; Neuronal Signaling,C28H25N3O6S2,10mM,Metabolic Disease,No Development Reported,COc1ccccc1[C@@H](NS(=O)(=O)c1ccc2[nH]c(=O)ccc2c1)C(=O)N(Cc1ccco1)Cc1cccs1,清洗成功,0.2363636363636363
4297,COc1ccccc1C(NS(=O)(=O)c1ccc2[nH]c(=O)ccc2c1)C(=O)N(Cc1ccco1)Cc1cccs1,1,0.9900879263877869,0.9900879263877869,O=C(N(CC1=CC=CS1)CC2=CC=CO2)C(NS(C3=CC(C=C4)=C(C=C3)NC4=O)(=O)=O)C5=CC=CC=C5OC,(Rac)-OSMI-1,Data.sdf,5052,HY-119738A,,2748153-92-4,Acyltransferase; OGT,Metabolic Enzyme/Protease; Neuronal Signaling,C28H25N3O6S2,10mM,Metabolic Disease,No Development Reported,COc1ccccc1C(NS(=O)(=O)c1ccc2[nH]c(=O)ccc2c1)C(=O)N(Cc1ccco1)Cc1cccs1,清洗成功,0.2363636363636363
6302,Cc1ccc2c(c1)nc(/C=C/c1cccc3cccnc13)n2-c1cccc(OCCCN2CCN(C)CC2)c1,1,0.99008709192276,0.99008709192276,CN1CCN(CCCOC2=CC(N3C(/C=C/C4=C5N=CC=CC5=CC=C4)=NC6=CC(C)=CC=C36)=CC=C2)CC1.[H]Cl.[H]Cl.[H]Cl,PDE10A-IN-2 (hydrochloride),Data.sdf,7456,HY-131973,,,Phosphodiesterase (PDE),Metabolic Enzyme/Protease,C33H38Cl3N5O,10mM,Metabolic Disease; Cardiovascular Disease,No Development Reported,Cc1ccc2c(c1)nc(/C=C/c1cccc3cccnc13)n2-c1cccc(OCCCN2CCN(C)CC2)c1,清洗成功,0.2653061224489796
4975,CN1CCN(C(=O)c2nc3cc(Cl)ccc3[nH]2)CC1,1,0.9900851249694824,0.9900851249694824,O=C(N1CCN(CC1)C)C2=NC3=CC(Cl)=CC=C3N2,JNJ10191584,Data.sdf,5864,HY-123532,VUF6002,73903-17-0,Histamine Receptor,GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling,C13H15ClN4O,10mM,Neurological Disease,No Development Reported,CN1CCN(C(=O)c2nc3cc(Cl)ccc3[nH]2)CC1,清洗成功,0.3283582089552239
1070,CC1(C)CCN(CCOc2ccc3[nH]ccc3c2)c2ccc(-c3cccnc3)cc21,1,0.9900780916213989,0.9900780916213989,CC(CCN1CCOC2=CC(C=CN3)=C3C=C2)(C)C4=C1C=CC(C5=CC=CN=C5)=C4,STAT5-IN-2,Data.sdf,1230,HY-102048,,2111834-61-6,Apoptosis; STAT,Apoptosis; JAK/STAT Signaling; Stem Cell/Wnt,C26H27N3O,10mM,Cancer,No Development Reported,CC1(C)CCN(CCOc2ccc3[nH]ccc3c2)c2ccc(-c3cccnc3)cc21,清洗成功,0.348314606741573
16827,Cc1nc2c(NCc3cccc(S(C)(=O)=O)c3)nccn2c1-c1ccc(O)c(F)c1,1,0.9900728464126587,0.9900728464126587,OC1=CC=C(C2=C(C)N=C3C(NCC4=CC=CC(S(=O)(C)=O)=C4)=NC=CN32)C=C1F,BF738735,Data.sdf,20023,HY-U00426,,1436383-95-7,PI4K; Reverse Transcriptase,Anti-infection; PI3K/Akt/mTOR,C21H19FN4O3S,10mM,Infection,No Development Reported,Cc1nc2c(NCc3cccc(S(C)(=O)=O)c3)nccn2c1-c1ccc(O)c(F)c1,清洗成功,0.3103448275862069
5653,CNC(=O)c1cc(C#N)cc(C)c1NC(=O)c1cc(Br)nn1-c1ncccc1Cl,1,0.9900661706924438,0.9900661706924438,O=C(C1=CC(Br)=NN1C2=NC=CC=C2Cl)NC3=C(C(NC)=O)C=C(C#N)C=C3C,Cyantraniliprole,Data.sdf,6670,HY-12779,HGW-86,736994-63-1,Parasite,Anti-infection,C19H14BrClN6O2,10mM,Others,No Development Reported,CNC(=O)c1cc(C#N)cc(C)c1NC(=O)c1cc(Br)nn1-c1ncccc1Cl,清洗成功,0.2696629213483146
9173,O=C(Cc1ccccc1Nc1c(Cl)cccc1Cl)Oc1ccc(-c2cc(=S)ss2)cc1,1,0.9900604486465454,0.9900604486465454,O=C(CC1=C(NC2=C(Cl)C=CC=C2Cl)C=CC=C1)OC3=CC=C(C(SS4)=CC4=S)C=C3,S-Diclofenac,Data.sdf,10818,HY-15035,ACS 15; ATB-337,912758-00-0,COX,Immunology/Inflammation,C23H15Cl2NO2S3,10mM,Inflammation/Immunology,No Development Reported,O=C(Cc1ccccc1Nc1c(Cl)cccc1Cl)Oc1ccc(-c2cc(=S)ss2)cc1,清洗成功,0.240506329113924
7658,Cc1[nH]n(-c2ccccc2)c(=O)c1C1(C(F)(F)F)C(=O)N(c2ccccc2)C2=C1C(=O)CC(C)(C)C2,1,0.9900581240653992,0.9900581240653992,O=C1C(C2(C(F)(F)F)C(N(C3=C2C(CC(C)(C3)C)=O)C4=CC=CC=C4)=O)=C(C)NN1C5=CC=CC=C5,ELOVL6-IN-3,Data.sdf,9064,HY-139451,,712346-06-0,ELOVL,Metabolic Enzyme/Protease,C27H24F3N3O3,10mM,Neurological Disease,No Development Reported,Cc1[nH]n(-c2ccccc2)c(=O)c1C1(C(F)(F)F)C(=O)N(c2ccccc2)C2=C1C(=O)CC(C)(C)C2,清洗成功,0.2923076923076923
7260,Cc1cc(Nc2nc(CC3(C(=O)O)CCN(C(=O)c4cccc(Cl)c4Cl)CC3)ccc2F)n[nH]1,1,0.9900553226470947,0.9900553226470947,O=C(C1(CC2=NC(NC3=NNC(C)=C3)=C(F)C=C2)CCN(C(C4=CC=CC(Cl)=C4Cl)=O)CC1)O,TAS-119,Data.sdf,8592,HY-137377,,1453099-83-6,Aurora Kinase,Cell Cycle/DNA Damage; Epigenetics,C23H22Cl2FN5O3,10mM,Cancer,Phase 1,Cc1cc(Nc2nc(CC3(C(=O)O)CCN(C(=O)c4cccc(Cl)c4Cl)CC3)ccc2F)n[nH]1,清洗成功,0.2346938775510204
7070,CS(=O)c1nc2cc(Oc3cccc(Cl)c3Cl)c(Cl)cc2[nH]1,1,0.9900490045547485,0.9900490045547485,O=S(C1=NC2=CC(OC3=CC=CC(Cl)=C3Cl)=C(Cl)C=C2N1)C,Triclabendazole sulfoxide,Data.sdf,8377,HY-136450,TCBZ-SO,100648-13-3,BCRP; Parasite,Anti-infection; Membrane Transporter/Ion Channel,C14H9Cl3N2O2S,10mM,Infection,No Development Reported,CS(=O)c1nc2cc(Oc3cccc(Cl)c3Cl)c(Cl)cc2[nH]1,清洗成功,0.2608695652173913
5508,Cc1cccc(Cn2nc(C)c3c(NC(=O)c4csc5c(N)ncnc45)cccc32)n1,1,0.9900471568107605,0.9900471568107605,NC1=NC=NC2=C1SC=C2C(NC3=C(C(C)=NN4CC5=CC=CC(C)=N5)C4=CC=C3)=O,c-Fms-IN-10,Data.sdf,6489,HY-126297,,1527517-50-5,c-Fms,Protein Tyrosine Kinase/RTK,C22H19N7OS,10mM,Cancer; Inflammation/Immunology,No Development Reported,Cc1cccc(Cn2nc(C)c3c(NC(=O)c4csc5c(N)ncnc45)cccc32)n1,清洗成功,0.2758620689655172
3998,Cn1cc(-c2ccc(Cn3cc(C(=O)N[C@H]4CCCC[C@@H]4O)c4c(F)cc(F)cc43)cn2)cn1,1,0.9900435209274292,0.9900435209274292,O=C(C1=CN(CC2=CC=C(C3=CN(C)N=C3)N=C2)C4=C1C(F)=CC(F)=C4)N[C@@H]5[C@@H](O)CCCC5,VU6004256,Data.sdf,4699,HY-117408,,2011034-33-4,mAChR,GPCR/G Protein; Neuronal Signaling,C25H25F2N5O2,10mM,Neurological Disease,No Development Reported,Cn1cc(-c2ccc(Cn3cc(C(=O)N[C@H]4CCCC[C@@H]4O)c4c(F)cc(F)cc43)cn2)cn1,清洗成功,0.3191489361702128
10271,Cc1cnccc1-c1[nH]c(N)nc1-c1ccc2c(c1)N(C(=O)C(C)(C)N)CCO2,1,0.9900434017181396,0.9900434017181396,CC1=CN=CC=C1C2=C(N=C(N2)N)C3=CC4=C(OCCN4C(C(C)(N)C)=O)C=C3,SMT-738,Data.sdf,12160,HY-157536,,,Bacterial,Anti-infection,C21H24N6O2,10mM,Infection,No Development Reported,Cc1cnccc1-c1[nH]c(N)nc1-c1ccc2c(c1)N(C(=O)C(C)(C)N)CCO2,清洗成功,0.2758620689655172
881,Cc1cnc(NCCCN(C)C)c2c1[nH]c1ccc3cc(O)ccc3c12,1,0.9900420904159546,0.9900420904159546,OC1=CC=C2C3=C(NC4=C3C(NCCCN(C)C)=NC=C4C)C=CC2=C1,Intoplicine,Data.sdf,1011,HY-101647,RP 60475,125974-72-3,Topoisomerase,Cell Cycle/DNA Damage,C21H24N4O,10mM,Cancer,Phase 1,Cc1cnc(NCCCN(C)C)c2c1[nH]c1ccc3cc(O)ccc3c12,清洗成功,0.3174603174603174
882,Cc1cnc(NCCCN(C)C)c2c1[nH]c1ccc3cc(O)ccc3c12,1,0.9900420904159546,0.9900420904159546,OC1=CC=C2C3=C(NC4=C3C(NCCCN(C)C)=NC=C4C)C=CC2=C1.CS(O)(=O)=O.CS(O)(=O)=O,Intoplicine (dimesylate),Data.sdf,1012,HY-101647A,RP 60475 (dimesylate),133711-99-6,Topoisomerase,Cell Cycle/DNA Damage,C23H32N4O7S2,10mM,Cancer,Phase 1,Cc1cnc(NCCCN(C)C)c2c1[nH]c1ccc3cc(O)ccc3c12,清洗成功,0.3134328358208955
4811,O=C(NCc1cccc(OCCOc2ncn[nH]2)c1)c1nc(=O)c2c(-c3cccc(F)c3)csc2[nH]1,1,0.9900387525558472,0.9900387525558472,O=C(C(NC1=C2C(C3=CC=CC(F)=C3)=CS1)=NC2=O)NCC4=CC=CC(OCCOC5=NC=NN5)=C4,MMP13-IN-2,Data.sdf,5656,HY-122624,,935759-55-0,MMP,Metabolic Enzyme/Protease,C24H19FN6O4S,10mM,Inflammation/Immunology,No Development Reported,O=C(NCc1cccc(OCCOc2ncn[nH]2)c1)c1nc(=O)c2c(-c3cccc(F)c3)csc2[nH]1,清洗成功,0.3333333333333333
9756,O=C1Nc2c(ccc(Cl)c2Cl)/C1=N/O,1,0.9900367259979248,0.9900367259979248,O=C1NC2=C(C=CC(Cl)=C2Cl)/C1=N/O,NS309,Data.sdf,11531,HY-15416,,18711-16-5,Potassium Channel,Membrane Transporter/Ion Channel,C8H4Cl2N2O2,10mM,Neurological Disease; Cardiovascular Disease,No Development Reported,O=C1Nc2c(ccc(Cl)c2Cl)/C1=N/O,清洗成功,0.3018867924528302
15543,C[C@@H]1O[C@@H](O[C@H]2[C@H](Oc3cc(O)c4c(=O)cc(-c5ccc(O)c(O)c5)oc4c3)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,1,0.9900360107421875,0.9900360107421875,O=C1C2=C(O)C=C(O[C@H]3[C@@H]([C@H]([C@H](O)[C@@H](CO)O3)O)O[C@@]4([H])[C@@H]([C@@H]([C@@H](O)[C@H](C)O4)O)O)C=C2OC(C5=CC(O)=C(O)C=C5)=C1,Lonicerin,Data.sdf,18543,HY-N4136,,25694-72-8,Apoptosis; Bacterial; Endogenous Metabolite,Anti-infection; Apoptosis; Metabolic Enzyme/Protease,C27H30O15,10mM,Infection,No Development Reported,C[C@@H]1O[C@@H](O[C@H]2[C@H](Oc3cc(O)c4c(=O)cc(-c5ccc(O)c(O)c5)oc4c3)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,清洗成功,0.3218390804597701
11045,CN(C)C(C(=O)Nc1ccc2c(=O)[nH]ccc2c1)c1ccsc1,1,0.990035891532898,0.990035891532898,O=C(NC1=CC2=C(C(NC=C2)=O)C=C1)C(N(C)C)C3=CSC=C3,Verosudil,Data.sdf,13085,HY-16758,AR-12286,1414854-42-4,ROCK,Cell Cycle/DNA Damage; Cytoskeleton; Stem Cell/Wnt; TGF-beta/Smad,C17H17N3O2S,10mM,Neurological Disease,Phase 2,CN(C)C(C(=O)Nc1ccc2c(=O)[nH]ccc2c1)c1ccsc1,清洗成功,0.25
10974,O=c1cc(CN2CCOCC2)occ1OCCCCCSc1ccnc2cc(C(F)(F)F)ccc12,1,0.9900357723236084,0.9900357723236084,O=C1C=C(CN2CCOCC2)OC=C1OCCCCCSC3=CC=NC4=CC(C(F)(F)F)=CC=C34.[H]Cl.[H]Cl,EHT 1864,Data.sdf,13006,HY-16659,,754240-09-0,Ras,GPCR/G Protein; MAPK/ERK Pathway,C25H29Cl2F3N2O4S,10mM,Neurological Disease; Cancer,No Development Reported,O=c1cc(CN2CCOCC2)occ1OCCCCCSc1ccnc2cc(C(F)(F)F)ccc12,清洗成功,0.264367816091954
10786,Cc1nc2cnccc2n1-c1ccc(OCc2cccc(/C=C/c3nc4cc(F)ccc4s3)c2)cc1,1,0.9900352358818054,0.9900352358818054,CC1=NC2=CN=CC=C2N1C3=CC=C(C=C3)OCC4=CC(/C=C/C5=NC6=CC(F)=CC=C6S5)=CC=C4,CP-96021,Data.sdf,12785,HY-163101,,139401-43-7,Leukotriene Receptor; Platelet-activating Factor Receptor (PAFR),GPCR/G Protein,C29H21FN4OS,10mM,Inflammation/Immunology,No Development Reported,Cc1nc2cnccc2n1-c1ccc(OCc2cccc(/C=C/c3nc4cc(F)ccc4s3)c2)cc1,清洗成功,0.264367816091954
991,C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1,1,0.990028440952301,0.990028440952301,O[C@@]1(C)C[C@@H](C2=NC(C3=CC=C4C=CC(C5=CC=CC=C5)=NC4=C3)=C6C(N)=NC=CN62)C1,Linsitinib,Data.sdf,1137,HY-10191,OSI-906,867160-71-2,IGF-1R; Insulin Receptor,Protein Tyrosine Kinase/RTK,C26H23N5O,10mM,Cancer; Endocrinology,Phase 3,C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1,清洗成功,0.2771084337349397
1730,C[N+](C)(CC(=O)Nc1ccccc1)CC(=O)Nc1ccccc1,1,0.9900231957435608,0.9900231957435608,O=C(NC1=CC=CC=C1)C[N+](C)(C)CC(NC2=CC=CC=C2)=O.[Cl-],Carcainium (chloride),Data.sdf,2052,HY-106372A,QX 572; RSD 931,1042-42-8,Others,Others,C18H22ClN3O2,10mM,Inflammation/Immunology; Neurological Disease; Cardiovascular Disease,Launched,C[N+](C)(CC(=O)Nc1ccccc1)CC(=O)Nc1ccccc1,清洗成功,0.2916666666666667
15857,C[C@@H]1O[C@@H](Oc2c(-c3ccc(O)c(O)c3)oc3cc(O)cc(O)c3c2=O)[C@H](O[C@@H]2O[C@H](COC(=O)/C=C/c3ccc(O)cc3)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O,1,0.9900223612785339,0.9900223612785339,O=C1C(O[C@H]2[C@@H]([C@@H]([C@H]([C@H](C)O2)O)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@@H](COC(/C=C/C4=CC=C(O)C=C4)=O)O3)O)O)O)=C(C5=CC=C(O)C(O)=C5)OC6=CC(O)=CC(O)=C16,Quercetin 3-O-?2-D-(6''-p-coumaroyl)glucopyranosyl(1a??)-?±-L-rhamnopyranoside,Data.sdf,18941,HY-N6964,Quercetin-3-O-[2-O-(6-O-p-hydroxyl-E-coumaroyl)-D-glucosyl]-(1a??)-L-rhamnoside,143061-65-8,Others,Others,C36H36O18,10mM,Metabolic Disease,No Development Reported,C[C@@H]1O[C@@H](Oc2c(-c3ccc(O)c(O)c3)oc3cc(O)cc(O)c3c2=O)[C@H](O[C@@H]2O[C@H](COC(=O)/C=C/c3ccc(O)cc3)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O,清洗成功,0.2558139534883721
11327,COc1ccnc(CS(=O)c2nc3ccc(OC(F)F)cc3[nH]2)c1OC,1,0.9900218844413757,0.9900218844413757,O=S(C1=NC2=CC=C(OC(F)F)C=C2N1)CC3=NC=CC(OC)=C3OC,Pantoprazole,Data.sdf,13402,HY-17507,BY1023; SKF96022,102625-70-7,Apoptosis; Autophagy; Bacterial; Proton Pump,Anti-infection; Apoptosis; Autophagy; Membrane Transporter/Ion Channel,C16H15F2N3O4S,10mM,Cancer; Inflammation/Immunology,Launched,COc1ccnc(CS(=O)c2nc3ccc(OC(F)F)cc3[nH]2)c1OC,清洗成功,0.3088235294117647
16557,CC[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC(=O)[C@@H](Cc2ccccc2)NC(=O)CN2CCN(CCO)CC2)CSSC[C@@H](C(=O)N[C@H](C(N)=O)[C@@H](C)O)NC1=O,1,0.9900155663490295,0.9900155663490295,O=C([C@@H](CC1=CNC2=CC=CC=C12)NC([C@H](CC3=CC=C(O)C=C3)N4)=O)N[C@@H](CCCCN)C(N[C@@H](CC)C(N[C@H](C(N[C@@H]([C@@H](C)O)C(N)=O)=O)CSSC[C@H](NC([C@@H](CC5=CC=CC=C5)NC(CN6CCN(CCO)CC6)=O)=O)C4=O)=O)=O.Cl,BIM-23190 (hydrochloride),Data.sdf,19742,HY-P3124A,,,Somatostatin Receptor,GPCR/G Protein; Neuronal Signaling,C57H80ClN13O12S2,10mM,Cancer,No Development Reported,CC[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC(=O)[C@@H](Cc2ccccc2)NC(=O)CN2CCN(CCO)CC2)CSSC[C@@H](C(=O)N[C@H](C(N)=O)[C@@H](C)O)NC1=O,清洗成功,0.2058823529411764
2427,CCOC(=O)Cn1nc(C(F)(F)F)cc1-c1ccc(-c2cccc(S(C)(=O)=O)c2)cc1,1,0.9900145530700684,0.9900145530700684,O=C(OCC)CN1C(C2=CC=C(C3=CC(S(C)(=O)=O)=CC=C3)C=C2)=CC(C(F)(F)F)=N1,Rovazolac,Data.sdf,2852,HY-109073,ALX-101,1454288-88-0,LXR,Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor,C21H19F3N2O4S,10mM,Inflammation/Immunology,Phase 2,CCOC(=O)Cn1nc(C(F)(F)F)cc1-c1ccc(-c2cccc(S(C)(=O)=O)c2)cc1,清洗成功,0.3421052631578947
14181,O=c1c(-c2ccc(O)cc2)coc2cc(O)ccc12,1,0.9900144338607788,0.9900144338607788,O=C1C(C2=CC=C(O)C=C2)=COC3=CC(O)=CC=C13,Daidzein,Data.sdf,16720,HY-N0019,,486-66-8,Endogenous Metabolite; PPAR,Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor,C15H10O4,10mM,Endocrinology; Cancer; Cardiovascular Disease,Launched,O=c1c(-c2ccc(O)cc2)coc2cc(O)ccc12,清洗成功,0.3333333333333333
12097,CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12,1,0.9900141954421997,0.9900141954421997,CN(C)CCCOC1=NN(CC2=CC=CC=C2)C3=C1C=CC=C3.[H]Cl,Benzydamine (hydrochloride),Data.sdf,14301,HY-30235A,,132-69-4,Bacterial; PGE synthase; TNF Receptor,Anti-infection; Apoptosis; Immunology/Inflammation,C19H24ClN3O,10mM,Inflammation/Immunology; Cancer,Launched,CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12,清洗成功,0.2769230769230769
9697,CC(=O)Nc1cccc(-c2cccc(Cn3c(=O)n(O)c(=O)c4sccc43)c2)c1,1,0.9900116324424744,0.9900116324424744,O=C1C2=C(N(CC3=CC=CC(C4=CC=CC(NC(C)=O)=C4)=C3)C(N1O)=O)C=CS2,FEN1-IN-5,Data.sdf,11459,HY-153790,,824983-93-9,FLAP,Immunology/Inflammation,C21H17N3O4S,10mM,Cancer,No Development Reported,CC(=O)Nc1cccc(-c2cccc(Cn3c(=O)n(O)c(=O)c4sccc43)c2)c1,清洗成功,0.3380281690140845
17535,O=C1Cc2cc(O)ccc2O1,1,0.9900111556053162,0.9900111556053162,OC1=CC=C(O2)C(CC2=O)=C1,Homogentisic acid lactone,Data.sdf,20888,HY-W017445,,2688-48-4,Fungal,Anti-infection,C8H6O3,10mM,Infection,No Development Reported,O=C1Cc2cc(O)ccc2O1,清洗成功,0.3181818181818182
10709,Cc1cc2c(-c3ccc(NC(=O)[C@H](N)CC(C)(C)C)cc3C)ccnc2[nH]1,1,0.9900085926055908,0.9900085926055908,CC1=CC(NC([C@H](N)CC(C)(C)C)=O)=CC=C1C2=C3C(NC(C)=C3)=NC=C2,C3TD879,Data.sdf,12692,HY-162266,,2850259-33-3,Ser/Thr Protease,Metabolic Enzyme/Protease,C22H28N4O,10mM,Cancer,No Development Reported,Cc1cc2c(-c3ccc(NC(=O)[C@H](N)CC(C)(C)C)cc3C)ccnc2[nH]1,清洗成功,0.2967032967032967
1673,COc1ccc(-c2cc(=O)c3c(OCCO)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3o2)cc1O,1,0.9900064468383789,0.9900064468383789,OCCOC1=C2C(OC(C3=CC(O)=C(C=C3)OC)=CC2=O)=CC(O[C@@H]4O[C@@H]([C@H]([C@@H]([C@H]4O)O)O)CO[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)O)O)O)=C1,Hidrosmin (mixture),Data.sdf,1979,HY-105946A,,115960-14-0,Drug Derivative,Others,C30H36O16,10mM,Cardiovascular Disease,No Development Reported,COc1ccc(-c2cc(=O)c3c(OCCO)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3o2)cc1O,清洗成功,0.3296703296703296
6169,Cc1c(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)ccc(Oc2ccnc(NC(=O)C3CC3)c2)c1C,1,0.9900055527687073,0.9900055527687073,O=C(C1=CC=CN(C2=CC=C(F)C=C2)C1=O)NC3=CC=C(OC4=CC(NC(C5CC5)=O)=NC=C4)C(C)=C3C,RIPK3-IN-1,Data.sdf,7300,HY-131064,,2361139-70-8,RIP kinase,Apoptosis,C29H25FN4O4,2mM,Inflammation/Immunology,No Development Reported,Cc1c(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)ccc(Oc2ccnc(NC(=O)C3CC3)c2)c1C,清洗成功,0.3295454545454545
12227,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1ccnc2ccc(OCCCN3CCNCC3)cc12,1,0.9899980425834656,0.9899980425834656,O=C(N1[C@@H](CC(F)(C1)F)C#N)CNC(C2=CC=NC3=C2C=C(OCCCN4CCNCC4)C=C3)=O,FAP-IN-2,Data.sdf,14466,HY-47979,,2471983-20-5,FAP,Immunology/Inflammation,C24H28F2N6O3,10mM,Others; Cancer,No Development Reported,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1ccnc2ccc(OCCCN3CCNCC3)cc12,清洗成功,0.2427184466019417
12228,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1ccnc2ccc(OCCCN3CCNCC3)cc12,1,0.9899980425834656,0.9899980425834656,O=C(N1[C@@H](CC(F)(C1)F)C#N)CNC(C2=CC=NC3=C2C=C(OCCCN4CCNCC4)C=C3)=O.O=C(O)C(F)(F)F,FAP-IN-2 (TFA),Data.sdf,14467,HY-47979A,,,FAP,Immunology/Inflammation,C26H29F5N6O5,10mM,Others; Cancer,No Development Reported,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1ccnc2ccc(OCCCN3CCNCC3)cc12,清洗成功,0.2368421052631578
14660,O=c1cc(-c2ccc(O)cc2)oc2c([C@@H]3OC[C@H](O)[C@H](O)[C@H]3O)c(O)c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)c12,1,0.9899975657463074,0.9899975657463074,OC1=C([C@@H]([C@@H]([C@@H](O)[C@@H]2O)O)O[C@@H]2CO)C(O)=C3C(OC(C4=CC=C(O)C=C4)=CC3=O)=C1[C@H](OC[C@H](O)[C@@H]5O)[C@@H]5O,Schaftoside,Data.sdf,17364,HY-N0703,,51938-32-0,Autophagy; Dynamin; Mitochondrial Metabolism; MyD88; Toll-like Receptor (TLR),Autophagy; Cytoskeleton; Immunology/Inflammation; Metabolic Enzyme/Protease,C26H28O14,10mM,Inflammation/Immunology,No Development Reported,O=c1cc(-c2ccc(O)cc2)oc2c([C@@H]3OC[C@H](O)[C@H](O)[C@H]3O)c(O)c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)c12,清洗成功,0.2823529411764706
6499,Cc1ccc(C)c(Cn2c(C(O)c3ccncc3)nc3ccc(-c4cnn(C)c4)cc32)c1,1,0.9899965524673462,0.9899965524673462,OC(C1=CC=NC=C1)C2=NC3=CC=C(C4=CN(C)N=C4)C=C3N2CC5=CC(C)=CC=C5C,UCB-9260,Data.sdf,7704,HY-133122,,1515888-53-5,TNF Receptor,Apoptosis,C26H25N5O,10mM,Inflammation/Immunology; Cancer,No Development Reported,Cc1ccc(C)c(Cn2c(C(O)c3ccncc3)nc3ccc(-c4cnn(C)c4)cc32)c1,清洗成功,0.3048780487804878
1563,CCN(Cc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1)C(C)(C)CO,1,0.9899930357933044,0.9899930357933044,CC1=CN2C(C(NC3=CC(CN(C(C)(CO)C)CC)=NS3)=N1)=NC=C2C4=CNN=C4,SCH-1473759,Data.sdf,1847,HY-10482,,1094069-99-4,Aurora Kinase,Cell Cycle/DNA Damage; Epigenetics,C20H26N8OS,10mM,Cancer,No Development Reported,CCN(Cc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1)C(C)(C)CO,清洗成功,0.2087912087912088
1564,CCN(Cc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1)C(C)(C)CO,1,0.9899930357933044,0.9899930357933044,[H]Cl.CC1=CN2C(C(NC3=CC(CN(C(C)(CO)C)CC)=NS3)=N1)=NC=C2C4=CNN=C4,SCH-1473759 (hydrochloride),Data.sdf,1848,HY-10483,,1094067-13-6,Aurora Kinase,Cell Cycle/DNA Damage; Epigenetics,C20H27ClN8OS,10mM,Cancer,No Development Reported,CCN(Cc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1)C(C)(C)CO,清洗成功,0.2065217391304347
5355,CCOc1ccc2c(-c3cccc(F)c3)nn(CC(=O)N(C)c3ccc4nc(C)oc4c3)c(=O)c2c1,1,0.9899898767471313,0.9899898767471313,O=C(N(C)C1=CC=C2N=C(C)OC2=C1)CN(N=C(C3=CC=CC(F)=C3)C4=C5C=C(OCC)C=C4)C5=O,CFTR corrector 2,Data.sdf,6311,HY-125381,,1628416-28-3,Autophagy; CFTR,Autophagy; Membrane Transporter/Ion Channel,C27H23FN4O4,10mM,Inflammation/Immunology; Cancer,Phase 2,CCOc1ccc2c(-c3cccc(F)c3)nn(CC(=O)N(C)c3ccc4nc(C)oc4c3)c(=O)c2c1,清洗成功,0.2688172043010752
10473,Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](c2cc(OCCCCN3CCCN(c4nccc(-c5noc([C@@]6(C)CCCc7sc(N)c(C#N)c76)n5)n4)[C@@H](C)C3)no2)C(C)C)cc1,1,0.9899898767471313,0.9899898767471313,C[C@@]1(C2=NC(C3=NC(N4[C@H](CN(CCC4)CCCCOC5=NOC([C@@H](C(C)C)C(N6[C@@H](C[C@H](C6)O)C(NCC7=CC=C(C8=C(N=CS8)C)C=C7)=O)=O)=C5)C)=NC=C3)=NO2)C9=C(CCC1)SC(N)=C9C#N,PROTAC K-Ras Degrader-4,Data.sdf,12414,HY-159788,,2938169-99-2,PROTACs; Ras,GPCR/G Protein; MAPK/ERK Pathway; PROTAC,C50H60N12O6S2,10mM,Cancer,No Development Reported,Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](c2cc(OCCCCN3CCCN(c4nccc(-c5noc([C@@]6(C)CCCc7sc(N)c(C#N)c76)n5)n4)[C@@H](C)C3)no2)C(C)C)cc1,清洗成功,0.2
2819,Cc1cc2occ(CN(C)CCN(C)Cc3cn(-c4cccc(C(F)(F)F)c4)c4ccccc34)c(=O)c2cc1C,1,0.9899874329566956,0.9899874329566956,O=C1C(CN(C)CCN(C)CC2=CN(C3=CC=CC(C(F)(F)F)=C3)C4=C2C=CC=C4)=COC5=CC(C)=C(C)C=C15,SPD304,Data.sdf,3309,HY-111255,,869998-49-2,TNF Receptor,Apoptosis,C32H32F3N3O2,10mM,Cancer,No Development Reported,Cc1cc2occ(CN(C)CCN(C)Cc3cn(-c4cccc(C(F)(F)F)c4)c4ccccc34)c(=O)c2cc1C,清洗成功,0.2111111111111111
2820,Cc1cc2occ(CN(C)CCN(C)Cc3cn(-c4cccc(C(F)(F)F)c4)c4ccccc34)c(=O)c2cc1C,1,0.9899874329566956,0.9899874329566956,O=C1C(CN(C)CCN(C)CC2=CN(C3=CC=CC(C(F)(F)F)=C3)C4=C2C=CC=C4)=COC5=CC(C)=C(C)C=C15.[H]Cl.[H]Cl,SPD304 (dihydrochloride),Data.sdf,3310,HY-111255A,,1049741-03-8,TNF Receptor,Apoptosis,C32H34Cl2F3N3O2,10mM,Inflammation/Immunology; Cancer,No Development Reported,Cc1cc2occ(CN(C)CCN(C)Cc3cn(-c4cccc(C(F)(F)F)c4)c4ccccc34)c(=O)c2cc1C,清洗成功,0.2222222222222222
11145,OC(c1ccc(-c2ccc(CN3CCN(Cc4ccncc4)CC3)cc2)c(F)c1)(C(F)(F)F)C(F)(F)F,1,0.9899858832359314,0.9899858832359314,FC1=C(C2=CC=C(CN3CCN(CC4=CC=NC=C4)CC3)C=C2)C=CC(C(C(F)(F)F)(O)C(F)(F)F)=C1,SR2211,Data.sdf,13203,HY-16998,,1359164-11-6,ROR,Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor,C26H24F7N3O,10mM,Inflammation/Immunology,No Development Reported,OC(c1ccc(-c2ccc(CN3CCN(Cc4ccncc4)CC3)cc2)c(F)c1)(C(F)(F)F)C(F)(F)F,清洗成功,0.3170731707317073
3960,NN1CC(=O)N2[C@H](c3ccc4c(c3)OCO4)c3[nH]c4ccccc4c3C[C@@H]2C1=O,1,0.9899849891662598,0.9899849891662598,O=C([C@@]1([H])CC2=C([C@@H](C3=CC=C(OCO4)C4=C3)N15)NC6=C2C=CC=C6)N(N)CC5=O,Amino Tadalafil,Data.sdf,4652,HY-117109,,385769-84-6,Drug Derivative,Others,C21H18N4O4,10mM,Others,No Development Reported,NN1CC(=O)N2[C@H](c3ccc4c(c3)OCO4)c3[nH]c4ccccc4c3C[C@@H]2C1=O,清洗成功,0.25
12639,Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O,1,0.9899808764457703,0.9899808764457703,O=C1C(CN2C=CN=C2C)CCC(N3C)=C1C4=C3C=CC=C4,Ondansetron,Data.sdf,14957,HY-B0002B,GR 38032; SN 307,99614-02-5,5-HT Receptor,GPCR/G Protein; Neuronal Signaling,C18H19N3O,10mM,Neurological Disease; Cancer,Launched,Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O,清洗成功,0.2837837837837837
710,NC1(C(=O)NCCCn2cc(-c3ccc(OC(F)(F)F)cc3)c3cc(CN4CCN(Cc5c(Cl)cccc5Cl)CC4)ccc32)CCNCC1,1,0.9899798631668091,0.9899798631668091,O=C(C1(N)CCNCC1)NCCCN2C3=CC=C(CN4CCN(CC5=C(Cl)C=CC=C5Cl)CC4)C=C3C(C6=CC=C(OC(F)(F)F)C=C6)=C2,Pan-RAS-IN-1,Data.sdf,813,HY-101295,,1835283-94-7,Ras,GPCR/G Protein; MAPK/ERK Pathway,C36H41Cl2F3N6O2,10mM,Cancer,No Development Reported,NC1(C(=O)NCCCn2cc(-c3ccc(OC(F)(F)F)cc3)c3cc(CN4CCN(Cc5c(Cl)cccc5Cl)CC4)ccc32)CCNCC1,清洗成功,0.2592592592592592
8065,CN1CCC(c2ncc(-c3cnc(N)c(OCc4cccc(C#CC(C)(C)O)c4)c3)s2)CC1,1,0.9899723529815674,0.9899723529815674,OC(C)(C)C#CC1=CC=CC(COC2=C(N)N=CC(C3=CN=C(C4CCN(CC4)C)S3)=C2)=C1,ZYF0033,Data.sdf,9528,HY-144088,HPK1-IN-22,2380300-79-6,MAP4K,MAPK/ERK Pathway,C26H30N4O2S,10mM,Cancer; Inflammation/Immunology,No Development Reported,CN1CCC(c2ncc(-c3cnc(N)c(OCc4cccc(C#CC(C)(C)O)c4)c3)s2)CC1,清洗成功,0.25
9350,Cc1nc(N[C@H](C)c2cccc(C(F)F)c2F)c2cc3c(cc2n1)OC[C@H]1CN(C(=O)C2(C#N)CC2)CCN31,1,0.989971399307251,0.989971399307251,N#CC1(CC1)C(N2CCN3C4=CC5=C(C=C4OC[C@H]3C2)N=C(C)N=C5N[C@H](C)C6=CC=CC(C(F)F)=C6F)=O,SOS1-IN-15,Data.sdf,11032,HY-151881,,2793404-47-2,Ras,GPCR/G Protein; MAPK/ERK Pathway,C28H27F3N6O2,2mM,Cancer,No Development Reported,Cc1nc(N[C@H](C)c2cccc(C(F)F)c2F)c2cc3c(cc2n1)OC[C@H]1CN(C(=O)C2(C#N)CC2)CCN31,清洗成功,0.224
8969,CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12,1,0.9899683594703674,0.9899683594703674,O=C(C1=C(CSC2=CC=CC=C2)N(C)C3=C1C(CN(C)C)=C(O)C(Br)=C3)OCC,Umifenovir,Data.sdf,10576,HY-14904,,131707-25-0,Influenza Virus; SARS-CoV,Anti-infection,C22H25BrN2O3S,10mM,Infection,Launched,CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12,清洗成功,0.282051282051282
8970,CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12,1,0.9899683594703674,0.9899683594703674,O=C(C1=C(CSC2=CC=CC=C2)N(C)C3=C1C(CN(C)C)=C(O)C(Br)=C3)OCC.[H]Cl,Umifenovir (hydrochloride),Data.sdf,10577,HY-14904A,,131707-23-8,Influenza Virus; SARS-CoV,Anti-infection,C22H26BrClN2O3S,10mM,Infection,Launched,CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12,清洗成功,0.2784810126582278
6395,O=C(NCC(=O)N1CC[C@H](N[C@H]2CC[C@@](O)(c3ccc(-c4ncccn4)cn3)CC2)C1)c1cccc(C(F)(F)F)c1,1,0.989966869354248,0.989966869354248,O[C@]1(CC[C@](CC1)([H])N[C@@H]2CN(CC2)C(CNC(C3=CC=CC(C(F)(F)F)=C3)=O)=O)C4=NC=C(C=C4)C5=NC=CC=N5,PF-4136309,Data.sdf,7566,HY-13245,INCB8761,1341224-83-6,CCR,GPCR/G Protein; Immunology/Inflammation,C29H31F3N6O3,10mM,Inflammation/Immunology; Endocrinology,Phase 2,O=C(NCC(=O)N1CC[C@H](N[C@H]2CC[C@@](O)(c3ccc(-c4ncccn4)cn3)CC2)C1)c1cccc(C(F)(F)F)c1,清洗成功,0.2571428571428571
6396,O=C(NCC(=O)N1CC[C@H](N[C@H]2CC[C@](O)(c3ccc(-c4ncccn4)cn3)CC2)C1)c1cccc(C(F)(F)F)c1,1,0.989966869354248,0.989966869354248,O[C@]1(CC[C@@](CC1)([H])N[C@@H]2CN(CC2)C(CNC(C3=CC=CC(C(F)(F)F)=C3)=O)=O)C4=NC=C(C=C4)C5=NC=CC=N5,(s)-PF-4136309,Data.sdf,7567,HY-13245A,(s)-INCB8761,1372407-07-2,CCR; Drug Isomer,GPCR/G Protein; Immunology/Inflammation; Others,C29H31F3N6O3,10mM,Endocrinology; Inflammation/Immunology,No Development Reported,O=C(NCC(=O)N1CC[C@H](N[C@H]2CC[C@](O)(c3ccc(-c4ncccn4)cn3)CC2)C1)c1cccc(C(F)(F)F)c1,清洗成功,0.2571428571428571
1238,N#Cc1c(N)nc(SCC(N)=O)c(C#N)c1-c1ccc(OCC2CC2)cc1,1,0.9899651408195496,0.9899651408195496,O=C(N)CSC1=NC(N)=C(C#N)C(C2=CC=C(OCC3CC3)C=C2)=C1C#N,BAY 60-6583,Data.sdf,1434,HY-103171,,910487-58-0,Adenosine Receptor,GPCR/G Protein,C19H17N5O2S,10mM,Inflammation/Immunology; Cardiovascular Disease,No Development Reported,N#Cc1c(N)nc(SCC(N)=O)c(C#N)c1-c1ccc(OCC2CC2)cc1,清洗成功,0.2878787878787879
4615,Cc1[nH]n(-c2ccc(OC(F)(F)F)cc2)c(=O)c1C1(C(F)(F)F)C(=O)N(c2ccccc2)C2=C1C(=O)CC(C)(C)C2,1,0.98996502161026,0.98996502161026,O=C1N(C2=CC=CC=C2)C3=C(C(CC(C)(C)C3)=O)C1(C4=C(C)NN(C5=CC=C(OC(F)(F)F)C=C5)C4=O)C(F)(F)F,ELOVL6-IN-2,Data.sdf,5426,HY-12146,,1067647-43-1,ELOVL,Metabolic Enzyme/Protease,C28H23F6N3O4,10mM,Metabolic Disease,No Development Reported,Cc1[nH]n(-c2ccc(OC(F)(F)F)cc2)c(=O)c1C1(C(F)(F)F)C(=O)N(c2ccccc2)C2=C1C(=O)CC(C)(C)C2,清洗成功,0.2567567567567567
8226,Cc1c(-c2ccc3c(c2)OCCO3)cccc1C(F)(F)Oc1cc(OCc2ccnc(C#N)c2)c(CN[C@@H]2C(O)O[C@H](CO)[C@@H](O)[C@@H]2O)cc1Cl,1,0.9899583458900452,0.9899583458900452,CC1=C(C=CC=C1C(F)(F)OC2=C(Cl)C=C(CN[C@@H]3C(O)O[C@H](CO)[C@@H](O)[C@@H]3O)C(OCC4=CC(C#N)=NC=C4)=C2)C5=CC=C(OCCO6)C6=C5,PD-1/PD-L1-IN-13,Data.sdf,9715,HY-145239,,2865841-81-0,PD-1/PD-L1,Immunology/Inflammation,C36H34ClF2N3O9,10mM,Cancer,No Development Reported,Cc1c(-c2ccc3c(c2)OCCO3)cccc1C(F)(F)Oc1cc(OCc2ccnc(C#N)c2)c(CN[C@@H]2C(O)O[C@H](CO)[C@@H](O)[C@@H]2O)cc1Cl,清洗成功,0.2641509433962264
3802,CCCOC(=O)[C@H]1O[C@@H](Oc2cc3oc(-c4ccccc4)cc(=O)c3c(O)c2O)[C@H](O)[C@@H](O)[C@@H]1O,1,0.9899575114250183,0.9899575114250183,OC1=C2C(OC(C3=CC=CC=C3)=CC2=O)=CC(O[C@@H]4O[C@@H]([C@H]([C@@H]([C@H]4O)O)O)C(OCCC)=O)=C1O,BEC2,Data.sdf,4479,HY-115938,,1429614-99-2,Others,Others,C24H24O11,10mM,Metabolic Disease; Cancer,Phase 3,CCCOC(=O)[C@H]1O[C@@H](Oc2cc3oc(-c4ccccc4)cc(=O)c3c(O)c2O)[C@H](O)[C@@H](O)[C@@H]1O,清洗成功,0.2758620689655172
5510,COCCNc1nc2ccc(C#CC3(O)CCCCC3)cc2n1-c1ccnc(N)n1,1,0.9899551868438721,0.9899551868438721,OC1(C#CC2=CC=C3N=C(NCCOC)N(C4=NC(N)=NC=C4)C3=C2)CCCCC1,GNE 2861,Data.sdf,6495,HY-12632,,1394121-05-1,PAK,Cell Cycle/DNA Damage; Cytoskeleton,C22H26N6O2,10mM,Cancer,No Development Reported,COCCNc1nc2ccc(C#CC3(O)CCCCC3)cc2n1-c1ccnc(N)n1,清洗成功,0.2857142857142857
11993,OC[C@H]1O[C@@H](S[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(-c4cccc(F)c4)nn3)[C@H]2O)[C@H](O)[C@@H](n2cc(-c3cccc(F)c3)nn2)[C@H]1O,1,0.9899539947509766,0.9899539947509766,O[C@H]([C@@H](N1N=NC(C2=CC=CC(F)=C2)=C1)[C@H]([C@@H](CO)O3)O)[C@@H]3S[C@H]4[C@@H]([C@@H](N5N=NC(C6=CC=CC(F)=C6)=C5)[C@H]([C@@H](CO)O4)O)O,Olitigaltin,Data.sdf,14183,HY-19940,TD139; GB0139,1450824-22-2,Galectin,Immunology/Inflammation,C28H30F2N6O8S,10mM,Inflammation/Immunology,Phase 2,OC[C@H]1O[C@@H](S[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(-c4cccc(F)c4)nn3)[C@H]2O)[C@H](O)[C@@H](n2cc(-c3cccc(F)c3)nn2)[C@H]1O,清洗成功,0.2738095238095238
8163,CCc1nc2ccc(CN3CCN(c4ccc(C(=O)NC)nc4C)CC3)c(F)c2[nH]c1=O,1,0.9899526238441467,0.9899526238441467,O=C(C1=NC(C)=C(N2CCN(CC3=C(F)C4=C(N=C(CC)C(N4)=O)C=C3)CC2)C=C1)NC,AZ3391,Data.sdf,9640,HY-144874,,2756333-42-1,PARP,Cell Cycle/DNA Damage; Epigenetics,C23H27FN6O2,10mM,Cancer; Neurological Disease,No Development Reported,CCc1nc2ccc(CN3CCN(c4ccc(C(=O)NC)nc4C)CC3)c(F)c2[nH]c1=O,清洗成功,0.2376237623762376
2545,O=S(=O)(O)c1ccc2nc(-c3ccccc3)[nH]c2c1,1,0.9899521470069885,0.9899521470069885,O=S(C1=CC=C2N=C(C3=CC=CC=C3)NC2=C1)(O)=O,Ensulizole,Data.sdf,2985,HY-109654,,27503-81-7,Reactive Oxygen Species,Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?oB,C13H10N2O3S,10mM,Metabolic Disease,Launched,O=S(=O)(O)c1ccc2nc(-c3ccccc3)[nH]c2c1,清洗成功,0.3272727272727272
3536,O=C(O)c1cc(-c2ccccc2)cc(Br)c1O,1,0.9899505376815796,0.9899505376815796,O=C(C1=CC(C2=CC=CC=C2)=CC(Br)=C1O)O,AKR1C1-IN-1,Data.sdf,4159,HY-114009,,4906-68-7,Others,Others,C13H9BrO3,10mM,Neurological Disease,No Development Reported,O=C(O)c1cc(-c2ccccc2)cc(Br)c1O,清洗成功,0.3404255319148936
934,CCc1nc(C)cn2nc(-c3cc(=O)n4cc(C5CCN(C)CC5)cc(C)c4n3)cc12,1,0.9899498224258423,0.9899498224258423,O=C1C=C(C2=NN3C(C(CC)=NC(C)=C3)=C2)N=C4N1C=C(C5CCN(C)CC5)C=C4C,RG7800,Data.sdf,1071,HY-101792,RO6885247,1449598-06-4,DNA/RNA Synthesis,Cell Cycle/DNA Damage,C24H28N6O,2mM,Others,Phase 1,CCc1nc(C)cn2nc(-c3cc(=O)n4cc(C5CCN(C)CC5)cc(C)c4n3)cc12,清洗成功,0.2558139534883721
935,CCc1nc(C)cn2nc(-c3cc(=O)n4cc(C5CCN(C)CC5)cc(C)c4n3)cc12,1,0.9899498224258423,0.9899498224258423,CC1=CC(C2CCN(C)CC2)=CN3C1=NC(C4=NN(C=C(C)N=C5CC)C5=C4)=CC3=O.[H]Cl.[H]Cl.[H]Cl.[H]Cl,RG7800 (tetrahydrochloride),Data.sdf,1072,HY-101792A,RO6885247 (tetrahydrochloride),,DNA/RNA Synthesis,Cell Cycle/DNA Damage,C24H32Cl4N6O,10mM,Neurological Disease,Phase 1,CCc1nc(C)cn2nc(-c3cc(=O)n4cc(C5CCN(C)CC5)cc(C)c4n3)cc12,清洗成功,0.2528735632183908
4866,Cc1cc(C(=O)CN2CCC(O)CC2)c(C)n1-c1ccc(C#N)cc1,1,0.9899498224258423,0.9899498224258423,N#CC1=CC=C(N2C(C)=C(C(CN3CCC(O)CC3)=O)C=C2C)C=C1,IU1-248,Data.sdf,5726,HY-122885,,2307472-03-1,Deubiquitinase,Cell Cycle/DNA Damage,C20H23N3O2,10mM,Cancer,No Development Reported,Cc1cc(C(=O)CN2CCC(O)CC2)c(C)n1-c1ccc(C#N)cc1,清洗成功,0.2439024390243902
11954,C[C@H]1CN(C2COC2)CCN1c1ccc(Nc2cc(-c3ccnc(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)nc1,1,0.9899485111236572,0.9899485111236572,O=C1C(NC(C=C2)=NC=C2N3CCN(C4COC4)C[C@@H]3C)=CC(C5=CC=NC(N6C(C7=CC(CC(C)(C)C8)=C8N7CC6)=O)=C5CO)=CN1C,Fenebrutinib,Data.sdf,14141,HY-19834,GDC-0853,1434048-34-6,Btk,Protein Tyrosine Kinase/RTK,C37H44N8O4,10mM,Cancer,Phase 3,C[C@H]1CN(C2COC2)CCN1c1ccc(Nc2cc(-c3ccnc(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)nc1,清洗成功,0.2314049586776859
5688,Cc1ncc(C)n2nc([C@@H]3C[C@H]3c3nc4c5cccnc5ccn4c3C)nc12,1,0.9899439811706543,0.9899439811706543,CC1=C([C@H]2[C@H](C3=NN4C(C(C)=NC=C4C)=N3)C2)N=C5C6=C(N=CC=C6)C=CN51,PDE10-IN-1,Data.sdf,6716,HY-12813,,1516896-09-5,Phosphodiesterase (PDE),Metabolic Enzyme/Protease,C21H19N7,2mM,Neurological Disease,No Development Reported,Cc1ncc(C)n2nc([C@@H]3C[C@H]3c3nc4c5cccnc5ccn4c3C)nc12,清洗成功,0.2093023255813953
8284,FC(F)(F)Cn1ncc(-c2ccncc2)c1-c1ccc(OCc2ccc3ccccc3n2)cc1,1,0.989938497543335,0.989938497543335,FC(F)(CN1N=CC(C2=CC=NC=C2)=C1C3=CC=C(OCC4=NC5=C(C=C4)C=CC=C5)C=C3)F,PDE10-IN-5,Data.sdf,9777,HY-14550A,,898562-99-7,Phosphodiesterase (PDE),Metabolic Enzyme/Protease,C26H19F3N4O,10mM,Others,No Development Reported,FC(F)(F)Cn1ncc(-c2ccncc2)c1-c1ccc(OCc2ccc3ccccc3n2)cc1,清洗成功,0.2597402597402597
15515,O=c1cc(-c2ccc(O)cc2)oc2c([C@@H]3OC[C@@H](O)[C@H](O)[C@H]3O)c(O)c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)c12,1,0.9899352192878723,0.9899352192878723,OC1=C([C@@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)CO)C(O)=C(C(C=C(C3=CC=C(O)C=C3)O4)=O)C4=C1[C@H]5[C@@H]([C@H]([C@H](O)CO5)O)O,Vicenin 3,Data.sdf,18507,HY-N4090,,59914-91-9,Angiotensin-converting Enzyme (ACE),Metabolic Enzyme/Protease,C26H28O14,10mM,Cardiovascular Disease,No Development Reported,O=c1cc(-c2ccc(O)cc2)oc2c([C@@H]3OC[C@@H](O)[C@H](O)[C@H]3O)c(O)c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)c12,清洗成功,0.2823529411764706
378,N#Cc1c(N)nc(N)nc1N[C@@H](c1nc2c(F)ccc(Cl)c2c(=O)n1-c1cccnc1)C1CC1,1,0.989934504032135,0.989934504032135,NC1=NC(N)=NC(N[C@H](C2CC2)C(N3C4=CN=CC=C4)=NC5=C(F)C=CC(Cl)=C5C3=O)=C1C#N,GS-9901,Data.sdf,431,HY-100694,,1640247-87-5,PI3K,PI3K/Akt/mTOR,C22H17ClFN9O,10mM,Inflammation/Immunology,Phase 1,N#Cc1c(N)nc(N)nc1N[C@@H](c1nc2c(F)ccc(Cl)c2c(=O)n1-c1cccnc1)C1CC1,清洗成功,0.2613636363636363
10485,CCNC(=O)c1n[nH]c(-c2cc(Cl)c(O)cc2O)c1-c1ccc(OC)cc1,1,0.9899336695671082,0.9899336695671082,O=C(C1=NNC(C2=CC(Cl)=C(O)C=C2O)=C1C3=CC=C(OC)C=C3)NCC,VER-49009,Data.sdf,12428,HY-15986,CCT 129397,558640-51-0,HSP,Cell Cycle/DNA Damage; Metabolic Enzyme/Protease,C19H18ClN3O4,10mM,Cancer,No Development Reported,CCNC(=O)c1n[nH]c(-c2cc(Cl)c(O)cc2O)c1-c1ccc(OC)cc1,清洗成功,0.3108108108108108
16152,O=c1cc(-c2ccc(O)c(O)c2)oc2c(O)c(O)ccc12,1,0.9899330139160156,0.9899330139160156,O=C1C=C(C2=CC=C(O)C(O)=C2)OC3=C(O)C(O)=CC=C13,"7,8,3a??4a??Tetrahydroxyflavone",Data.sdf,19316,HY-N8600,,3440-24-2,Xanthine Oxidase,Metabolic Enzyme/Protease,C15H10O6,10mM,Metabolic Disease,No Development Reported,O=c1cc(-c2ccc(O)c(O)c2)oc2c(O)c(O)ccc12,清洗成功,0.3181818181818182
2387,COc1ccc2c(c1)-c1nn(CCCN(C)C)c3ccc([N+](=O)[O-])c(c13)N2,1,0.9899272918701172,0.9899272918701172,O=[N+](C1=CC=C2C3=C1NC4=CC=C(OC)C=C4C3=NN2CCCN(C)C)[O-],Pyrazoloacridine,Data.sdf,2805,HY-108969,NSC 366140; PD 115934,99009-20-8,Apoptosis; Topoisomerase,Apoptosis; Cell Cycle/DNA Damage,C19H21N5O3,10mM,Cancer,Phase 2,COc1ccc2c(c1)-c1nn(CCCN(C)C)c3ccc([N+](=O)[O-])c(c13)N2,清洗成功,0.2894736842105263
7145,COC(=O)c1ccc(O)c(NC(=O)COc2ccc(C34CC5CC(CC(C5)C3)C4)cc2)c1,1,0.9899227023124695,0.9899227023124695,O=C(OC)C1=CC=C(O)C(NC(COC2=CC=C(C3(C4)CC5CC4CC(C5)C3)C=C2)=O)=C1,LW6,Data.sdf,8461,HY-13671,HIF-1?± inhibitor; LW8,934593-90-5,Apoptosis; HIF/HIF Prolyl-Hydroxylase,Apoptosis; Metabolic Enzyme/Protease,C26H29NO5,10mM,Cancer,No Development Reported,COC(=O)c1ccc(O)c(NC(=O)COc2ccc(C34CC5CC(CC(C5)C3)C4)cc2)c1,清洗成功,0.2658227848101265
11748,Cn1cc(CCn2cnc(-c3cnn(C)c3)c2-c2ccc(C#N)cc2)cn1,1,0.9899210929870605,0.9899210929870605,N#CC1=CC=C(C2=C(C3=CN(C)N=C3)N=CN2CCC4=CN(C)N=C4)C=C1,BAZ2-ICR,Data.sdf,13898,HY-19336,,1665195-94-7,Epigenetic Reader Domain,Epigenetics,C20H19N7,10mM,Cancer,No Development Reported,Cn1cc(CCn2cnc(-c3cnn(C)c3)c2-c2ccc(C#N)cc2)cn1,清洗成功,0.3235294117647059
9304,Cc1nc(N[C@H](C)c2cccc(C(F)F)c2F)c2cc3c(cc2n1)OCC[C@H]1CN(C(=O)C2(C#N)CC2)CCN31,1,0.9899188280105591,0.9899188280105591,N#CC1(C(N2C[C@]3([H])CCOC4=CC5=NC(C)=NC(N[C@@H](C6=CC=CC(C(F)F)=C6F)C)=C5C=C4N3CC2)=O)CC1,SOS1-IN-14,Data.sdf,10975,HY-151517,,2793405-20-4,Ras,GPCR/G Protein; MAPK/ERK Pathway,C29H29F3N6O2,10mM,Cancer,No Development Reported,Cc1nc(N[C@H](C)c2cccc(C(F)F)c2F)c2cc3c(cc2n1)OCC[C@H]1CN(C(=O)C2(C#N)CC2)CCN31,清洗成功,0.2222222222222222
4671,O=C(OCC1(COC(=O)c2cccnc2)CCCC(COC(=O)c2cccnc2)(COC(=O)c2cccnc2)C1O)c1cccnc1,1,0.9899181723594666,0.9899181723594666,O=C(C1=CC=CN=C1)OCC2(CCCC(COC(C3=CC=CN=C3)=O)(C2O)COC(C4=CC=CN=C4)=O)COC(C5=CC=CN=C5)=O,Nicomol,Data.sdf,5489,HY-121776,,27959-26-8,Drug Derivative,Others,C34H32N4O9,10mM,Cardiovascular Disease,No Development Reported,O=C(OCC1(COC(=O)c2cccnc2)CCCC(COC(=O)c2cccnc2)(COC(=O)c2cccnc2)C1O)c1cccnc1,清洗成功,0.3
844,Cc1c2c(nn1C)CSCc1cc(n(C)n1)CSc1cc(c3ccccc3c1)OCCCc1c(C(=O)O)n(C)c3c-2c(Cl)ccc13,1,0.9899107813835144,0.9899107813835144,O=C(O)C1=C(CCCOC2=C(C=CC=C3)C3=CC4=C2)C5=C(N1C)C(C6=C(C)N(C)N=C6CSCC7=NN(C)C(CS4)=C7)=C(Cl)C=C5,AZD-5991,Data.sdf,968,HY-101533,,2143061-81-6,Bcl-2 Family,Apoptosis,C35H34ClN5O3S2,10mM,Cancer,Phase 2,Cc1c2c(nn1C)CSCc1cc(n(C)n1)CSc1cc(c3ccccc3c1)OCCCc1c(C(=O)O)n(C)c3c-2c(Cl)ccc13,清洗成功,0.2127659574468085
5869,COc1ccc(-c2cc(=O)c3c(O)c(OC)c(OCCN4CCNC(=O)C4)cc3o2)cc1OC,1,0.9899089336395264,0.9899089336395264,COC1=C(O)C2=C(OC(C3=CC=C(OC)C(OC)=C3)=CC2=O)C=C1OCCN(C4)CCNC4=O,EMT inhibitor-2,Data.sdf,6941,HY-128859,,2232228-60-1,Cytochrome P450,Metabolic Enzyme/Protease,C24H26N2O8,10mM,Metabolic Disease,No Development Reported,COc1ccc(-c2cc(=O)c3c(O)c(OC)c(OCCN4CCNC(=O)C4)cc3o2)cc1OC,清洗成功,0.3
4009,Cc1cc(-c2nc3cnc(C4CCOCC4)cc3n2[C@@H](C)c2ccccc2)nn(C)c1=O,1,0.98990797996521,0.98990797996521,CN1C(C(C)=CC(C2=NC3=CN=C(C=C3N2[C@H](C4=CC=CC=C4)C)C5CCOCC5)=N1)=O,BRD4 Inhibitor-10,Data.sdf,4711,HY-117491,,1660117-38-3,Epigenetic Reader Domain,Epigenetics,C25H27N5O2,10mM,Cancer,Phase 1,Cc1cc(-c2nc3cnc(C4CCOCC4)cc3n2[C@@H](C)c2ccccc2)nn(C)c1=O,清洗成功,0.2528735632183908
4947,CN1CCC(Nc2nc(Nc3ccc(Oc4ccccc4)cc3)c3c(=O)[nH]cc(Br)c3n2)CC1,1,0.9899070262908936,0.9899070262908936,O=C1NC=C(C2=C1C(NC3=CC=C(C=C3)OC4=CC=CC=C4)=NC(NC5CCN(CC5)C)=N2)Br,Denfivontinib,Data.sdf,5826,HY-12333,G-749,1457983-28-6,Apoptosis; FLT3,Apoptosis; Protein Tyrosine Kinase/RTK,C25H25BrN6O2,10mM,Cancer,No Development Reported,CN1CCC(Nc2nc(Nc3ccc(Oc4ccccc4)cc3)c3c(=O)[nH]cc(Br)c3n2)CC1,清洗成功,0.2823529411764706
1256,COc1ccc(-c2cc(=O)c3ccc4ccccc4c3o2)cc1OC,1,0.9899067282676697,0.9899067282676697,O=C1C2=CC=C3C=CC=CC3=C2OC(C4=CC=C(OC)C(OC)=C4)=C1,DiMNF,Data.sdf,1462,HY-103222,"3',4'-Dimethoxy-?±NF",14756-24-2,Aryl Hydrocarbon Receptor,Immunology/Inflammation,C21H16O4,10mM,Inflammation/Immunology,No Development Reported,COc1ccc(-c2cc(=O)c3ccc4ccccc4c3o2)cc1OC,清洗成功,0.3380281690140845
16076,C[C@@H]1O[C@@H](O[C@H]2[C@H](Oc3c(-c4ccc(O)c(O)c4)oc4cc(O)cc(O)c4c3=O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,1,0.9899058938026428,0.9899058938026428,O=C(C(O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O[C@H]2[C@@H]([C@@H]([C@H]([C@@H](O2)C)O)O)O)=C(C3=CC(O)=C(C=C3)O)OC4=CC(O)=C5)C4=C5O,Quercetin 3-O-neohesperidoside,Data.sdf,19218,HY-N7976,,32453-36-4,Others,Others,C27H30O16,10mM,Inflammation/Immunology,No Development Reported,C[C@@H]1O[C@@H](O[C@H]2[C@H](Oc3c(-c4ccc(O)c(O)c4)oc4cc(O)cc(O)c4c3=O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,清洗成功,0.3146067415730337
12711,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,1,0.9899017810821533,0.9899017810821533,O=C(C(C1=O)=C(O)[C@@H](N(C)C)[C@]2([H])C[C@]3([H])CC4=C(C(C3=C(O)[C@@]21O)=O)C(O)=C(NC(CNC(C)(C)C)=O)C=C4N(C)C)N,Tigecycline,Data.sdf,15035,HY-B0117,GAR-936,220620-09-7,Antibiotic; Autophagy; Bacterial,Anti-infection; Autophagy,C29H39N5O8,10mM,Infection; Cancer,Launched,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,清洗成功,0.1578947368421052
12712,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,1,0.9899017810821533,0.9899017810821533,O=S(C)(O)=O.O=S(C)(O)=O.O=S(C)(O)=O.O=C(C(C1=O)=C(O)[C@@H](N(C)C)[C@]2([H])C[C@]3([H])CC4=C(C(C3=C(O)[C@@]21O)=O)C(O)=C(NC(CNC(C)(C)C)=O)C=C4N(C)C)N.O=S(C)(O)=O,Tigecycline (tetramesylate),Data.sdf,15036,HY-B0117C,GAR-936 tetramesylate,,Antibiotic; Autophagy; Bacterial,Anti-infection; Autophagy,C33H55N5O20S4,10mM,Infection; Cancer,Launched,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,清洗成功,0.1538461538461538
9139,C=C[C@H]1C[N@+]2(C)CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12,1,0.9898887276649475,0.9898887276649475,O[C@@H](C1=CC=NC2=C1C=C(OC)C=C2)[C@]3([H])[N@@+]4(C[C@@H]([C@@H](CC4)C3)C=C)C.[I-],Quinidine methiodide,Data.sdf,10777,HY-150123,,42982-87-6,Drug Metabolite,Metabolic Enzyme/Protease,C21H27IN2O2,10mM,Cardiovascular Disease,No Development Reported,C=C[C@H]1C[N@+]2(C)CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12,清洗成功,0.3055555555555556
875,Cc1c(-c2ccccc2)oc2ccc(OCCCCCCN3CCC(O)CC3)cc2c1=O,1,0.989881694316864,0.989881694316864,O=C1C(C)=C(C2=CC=CC=C2)OC3=CC=C(OCCCCCCN4CCC(O)CC4)C=C13,Sigma-LIGAND-1,Data.sdf,1005,HY-101626,,139652-01-0,Sigma Receptor,Neuronal Signaling,C27H33NO4,10mM,Neurological Disease,No Development Reported,Cc1c(-c2ccccc2)oc2ccc(OCCCCCCN3CCC(O)CC3)cc2c1=O,清洗成功,0.2837837837837837
876,Cc1c(-c2ccccc2)oc2ccc(OCCCCCCN3CCC(O)CC3)cc2c1=O,1,0.989881694316864,0.989881694316864,O=C1C(C)=C(C2=CC=CC=C2)OC3=CC=C(OCCCCCCN4CCC(O)CC4)C=C13.[H]Cl,Sigma-LIGAND-1 (hydrochloride),Data.sdf,1006,HY-101626A,,139652-86-1,Sigma Receptor,Neuronal Signaling,C27H34ClNO4,10mM,Neurological Disease,No Development Reported,Cc1c(-c2ccccc2)oc2ccc(OCCCCCCN3CCC(O)CC3)cc2c1=O,清洗成功,0.28
17637,Oc1ccc2c(-c3c(-c4ccccn4)nn4c3CCC4)ccnc2c1,1,0.9898806810379028,0.9898806810379028,OC1=CC=C2C(C(C(C3=CC=CC=N3)=N4)=C5N4CCC5)=CC=NC2=C1,TGF-?2RI inhibitor 2,Data.sdf,21010,HY-W028145,,476474-11-0,TGF-?2 Receptor,TGF-beta/Smad,C20H16N4O,10mM,Cancer,No Development Reported,Oc1ccc2c(-c3c(-c4ccccn4)nn4c3CCC4)ccnc2c1,清洗成功,0.2461538461538461
6986,CN1/C(=C/C=C/C=C/C2=[N+](CCCCCC(=O)NCCc3ccc(O)cc3)c3ccc(S(=O)(=O)[O-])cc3C2(C)C)C(C)(C)c2ccc(S(=O)(=O)O)cc21,1,0.9898802042007446,0.9898802042007446,O=S(C1=CC2=C(C(C)(C)/C(N2C)=C\C=C\C=C\C3=[N+](CCCCCC(NCCC4=CC=C(O)C=C4)=O)C5=C(C=C(S(=O)([O-])=O)C=C5)C3(C)C)C=C1)(O)=O,Cyanine 5 Tyramide methyl indole,Data.sdf,8287,HY-136247A,,,DNA Stain,Cell Cycle/DNA Damage,C40H47N3O8S2,10mM,Others,No Development Reported,CN1/C(=C/C=C/C=C/C2=[N+](CCCCCC(=O)NCCc3ccc(O)cc3)c3ccc(S(=O)(=O)[O-])cc3C2(C)C)C(C)(C)c2ccc(S(=O)(=O)O)cc21,清洗成功,0.1941747572815534
7024,Cn1cnnc1CC1(c2cccc(NC(=O)c3cc(CN4CCC5(CC5)C4)cc(C4CC4)n3)c2)COC1,1,0.9898799657821655,0.9898799657821655,O=C(C1=NC(C2CC2)=CC(CN(CC3)CC43CC4)=C1)NC5=CC=CC(C6(CC7=NN=CN7C)COC6)=C5,Cbl-b-IN-1,Data.sdf,8328,HY-136339,,2368841-84-1,E1/E2/E3 Enzyme; Interleukin Related,Immunology/Inflammation; Metabolic Enzyme/Protease,C29H34N6O2,10mM,Cancer; Inflammation/Immunology,No Development Reported,Cn1cnnc1CC1(c2cccc(NC(=O)c3cc(CN4CCC5(CC5)C4)cc(C4CC4)n3)c2)COC1,清洗成功,0.2457627118644068
7990,Cc1nc2ccc(Oc3ccc(O)c(C(C)(C)C)c3)cc2n1C,1,0.9898696541786194,0.9898696541786194,OC1=CC=C(OC2=CC=C3N=C(C)N(C)C3=C2)C=C1C(C)(C)C,DS20362725,Data.sdf,9435,HY-143201,,2735803-20-8,Estrogen Receptor/ERR,Vitamin D Related/Nuclear Receptor,C19H22N2O2,10mM,Metabolic Disease,No Development Reported,Cc1nc2ccc(Oc3ccc(O)c(C(C)(C)C)c3)cc2n1C,清洗成功,0.2909090909090909
2883,Cn1cncc1-c1c(F)cncc1NC(=O)c1c(N)nn2cc(F)cnc12,1,0.9898673295974731,0.9898673295974731,O=C(NC1=C(C(F)=CN=C1)C2=CN=CN2C)C3=C4N=CC(F)=CN4N=C3N,Tuvusertib,Data.sdf,3384,HY-111451,M1774; ATR inhibitor 1,1613200-51-3,ATM/ATR,Cell Cycle/DNA Damage; PI3K/Akt/mTOR,C16H12F2N8O,10mM,Cancer,Phase 2,Cn1cncc1-c1c(F)cncc1NC(=O)c1c(N)nn2cc(F)cnc12,清洗成功,0.3246753246753247
5016,N#Cc1ccc2c(c1)[C@H]1CCCN(C(=O)c3ccc4nc[nH]c4c3)[C@H]1C2,1,0.9898547530174255,0.9898547530174255,N#CC1=CC2=C(C=C1)C[C@@]3([H])[C@]2([H])CCCN3C(C4=CC=C5N=CNC5=C4)=O,BI 187004,Data.sdf,5910,HY-123800,VTP-34072,1303515-32-3,11?2-HSD,Metabolic Enzyme/Protease,C21H18N4O,10mM,Neurological Disease,Phase 2,N#Cc1ccc2c(c1)[C@H]1CCCN(C(=O)c3ccc4nc[nH]c4c3)[C@H]1C2,清洗成功,0.2771084337349397
12315,OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1,1,0.989854633808136,0.989854633808136,O/N=C1C(C=CC(C2=CN(CCO)N=C2C3=CC=NC=C3)=C4)=C4CC/1,GDC-0879,Data.sdf,14572,HY-50864,,905281-76-7,Raf,MAPK/ERK Pathway,C19H18N4O2,10mM,Cancer,No Development Reported,OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1,清洗成功,0.2711864406779661
11733,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1,1,0.9898536801338196,0.9898536801338196,O=C(C1=CC=C(F)C(C2=C(F)C=CC=C2F)=N1)NC3=C([C@@H]4C[C@H](C)C[C@H](N)C4)C=CN=C3,PIM447,Data.sdf,13882,HY-19322,LGH447,1210608-43-7,Apoptosis; Pim,Apoptosis; JAK/STAT Signaling,C24H23F3N4O,10mM,Cancer,Phase 1,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1,清洗成功,0.3295454545454545
11734,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1,1,0.9898536801338196,0.9898536801338196,O=C(C1=NC(C2=C(F)C=CC=C2F)=C(F)C=C1)NC3=C([C@H]4C[C@@H](N)C[C@@H](C)C4)C=CN=C3.Cl.Cl,PIM-447 (dihydrochloride),Data.sdf,13883,HY-19322B,LGH447 dihydrochloride,1820565-69-2,Apoptosis; Pim,Apoptosis; JAK/STAT Signaling,C24H25Cl2F3N4O,10mM,Cancer,Phase 1,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1,清洗成功,0.3258426966292135
11735,C[C@H]1C[C@@H](N)C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1,1,0.9898536801338196,0.9898536801338196,O=C(C1=NC(C2=C(F)C=CC=C2F)=C(F)C=C1)NC3=C([C@@H]4C[C@H](N)C[C@H](C)C4)C=CN=C3.Cl.Cl,"(1S,3R,5R)-PIM447 (dihydrochloride)",Data.sdf,13884,HY-19322C,"(1S,3R,5R)-LGH447 dihydrochloride",,Pim,JAK/STAT Signaling,C24H25Cl2F3N4O,10mM,Cancer,No Development Reported,C[C@H]1C[C@@H](N)C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1,清洗成功,0.3258426966292135
343,CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1,1,0.9898509979248047,0.9898509979248047,O=C(C1=C(SC2=CC3=C(C(/C=C/C4=CC=CC=N4)=NN3)C=C2)C=CC=C1)NC,Axitinib,Data.sdf,396,HY-10065,AG-013736,319460-85-0,PDGFR; VEGFR,Protein Tyrosine Kinase/RTK,C22H18N4OS,10mM,Cancer,Launched,CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1,清洗成功,0.2972972972972973
14959,O=c1cc(-c2ccc(O)cc2)oc2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)c([C@@H]3OC[C@H](O)[C@H](O)[C@H]3O)c(O)c12,1,0.989849328994751,0.989849328994751,O=C1C=C(C2=CC=C(O)C=C2)OC3=C([C@H]4[C@@H]([C@H]([C@@H]([C@@H](CO)O4)O)O)O)C(O)=C([C@H]5[C@@H]([C@H]([C@H](CO5)O)O)O)C(O)=C13,Isoschaftoside,Data.sdf,17771,HY-N1458,,52012-29-0,Fungal; Parasite,Anti-infection,C26H28O14,10mM,Cancer; Infection,No Development Reported,O=c1cc(-c2ccc(O)cc2)oc2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)c([C@@H]3OC[C@H](O)[C@H](O)[C@H]3O)c(O)c12,清洗成功,0.2823529411764706
16021,COc1cc(O)c2c(=O)c(O)c(-c3ccc(OC)c(OC)c3)oc2c1,1,0.9898409247398376,0.9898409247398376,O=C1C(O)=C(C2=CC=C(OC)C(OC)=C2)OC3=CC(OC)=CC(O)=C13,"3',4',7-Trimethoxyquercetin",Data.sdf,19152,HY-N7641,Quercetin 3a??4a??7-trimethyl ether,6068-80-0,Others,Others,C18H16O7,10mM,Others,No Development Reported,COc1cc(O)c2c(=O)c(O)c(-c3ccc(OC)c(OC)c3)oc2c1,清洗成功,0.3461538461538461
8511,Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCC(=O)NC(c2cccnc2)c2cc3ccccc3o2)C(C)(C)C)cc1,1,0.9898365139961243,0.9898365139961243,O=C(N1[C@@H](C[C@H](C1)O)C(N[C@H](C2=CC=C(C3=C(N=CS3)C)C=C2)C)=O)[C@H](C(C)(C)C)NC(CCC(NC(C4=CN=CC=C4)C5=CC6=CC=CC=C6O5)=O)=O,"(S,R,S)-AHPC-C2-amide-benzofuranylmethyl-pyridine",Data.sdf,10042,HY-147025,,2347517-69-3,HIF/HIF Prolyl-Hydroxylase; PROTACs; TGF-beta/Smad,Metabolic Enzyme/Protease; PROTAC; Stem Cell/Wnt; TGF-beta/Smad,C41H46N6O6S,10mM,Inflammation/Immunology,No Development Reported,Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCC(=O)NC(c2cccnc2)c2cc3ccccc3o2)C(C)(C)C)cc1,清洗成功,0.2232142857142857
4163,Cc1cccc(-c2n[nH]cc2-c2ccc3nccnc3c2)n1,1,0.9898320436477661,0.9898320436477661,CC1=CC=CC(C2=NNC=C2C3=CC=C4N=CC=NC4=C3)=N1,BIO-013077-01,Data.sdf,4903,HY-118810,,746667-48-1,TGF-?2 Receptor,TGF-beta/Smad,C17H13N5,10mM,Cancer,No Development Reported,Cc1cccc(-c2n[nH]cc2-c2ccc3nccnc3c2)n1,清洗成功,0.2950819672131147
18285,c1ccc2[nH]cnc2c1,1,0.989831805229187,0.989831805229187,C12=CC=CC=C1NC=N2,Benzimidazole,Data.sdf,21792,HY-Y1825,,51-17-2,Bacterial; Fungal; Influenza Virus; Parasite,Anti-infection,C7H6N2,10mM,Others,Phase 4,c1ccc2[nH]cnc2c1,清洗成功,0.2926829268292683
3717,COc1c(OCCCCN2CCN(C)CC2)cc(O)c2c(=O)cc(-c3ccccc3)oc12,1,0.9898284673690796,0.9898284673690796,O=C1C=C(C2=CC=CC=C2)OC3=C(OC)C(OCCCCN4CCN(C)CC4)=CC(O)=C13,LYG-202,Data.sdf,4376,HY-115436,,1175077-25-4,Apoptosis,Apoptosis,C25H30N2O5,10mM,Cancer,No Development Reported,COc1c(OCCCCN2CCN(C)CC2)cc(O)c2c(=O)cc(-c3ccccc3)oc12,清洗成功,0.3414634146341463
2598,CCCCn1c(-c2ccccc2)nc(-c2ccccc2)c1CN(Cc1ccc2c(c1)OCO2)Cc1ccc2c(c1)OCO2,1,0.9898277521133423,0.9898277521133423,CCCCN1C(CN(CC2=CC=C(OCO3)C3=C2)CC4=CC=C(OCO5)C5=C4)=C(C6=CC=CC=C6)N=C1C7=CC=CC=C7,NDT 9513727,Data.sdf,3047,HY-110060,,439571-48-9,Complement System,Immunology/Inflammation,C36H35N3O4,10mM,Inflammation/Immunology,No Development Reported,CCCCn1c(-c2ccccc2)nc(-c2ccccc2)c1CN(Cc1ccc2c(c1)OCO2)Cc1ccc2c(c1)OCO2,清洗成功,0.3055555555555556
2751,Cc1ccc(CCCO)c(NCc2ccc3nc(NCCCN4CCOCC4)n(Cc4nc(C)ccc4O)c3c2)c1,1,0.9898262023925781,0.9898262023925781,OC1=CC=C(C)N=C1CN2C3=CC(CNC4=CC(C)=CC=C4CCCO)=CC=C3N=C2NCCCN5CCOCC5,TMC353121,Data.sdf,3233,HY-11097,,857066-90-1,RSV,Anti-infection,C32H42N6O3,10mM,Infection,No Development Reported,Cc1ccc(CCCO)c(NCc2ccc3nc(NCCCN4CCOCC4)n(Cc4nc(C)ccc4O)c3c2)c1,清洗成功,0.2622950819672131
405,O=C1/C(=N/Nc2ccc(Cl)c([N+](=O)[O-])c2)C(c2ccccc2)=NN1c1nc(-c2ccccc2)cs1,1,0.989825427532196,0.989825427532196,O=C(N(C1=NC(C2=CC=CC=C2)=CS1)N=C/3C4=CC=CC=C4)C3=N\NC5=CC=C(Cl)C([N+]([O-])=O)=C5,C 87,Data.sdf,460,HY-100735,,332420-90-3,TNF Receptor,Apoptosis,C24H15ClN6O3S,10mM,Inflammation/Immunology,No Development Reported,O=C1/C(=N/Nc2ccc(Cl)c([N+](=O)[O-])c2)C(c2ccccc2)=NN1c1nc(-c2ccccc2)cs1,清洗成功,0.2911392405063291
14203,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1[C@H](O)C[C@@](O)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,1,0.9898195862770081,0.9898195862770081,O=C([C@@]1(O)C[C@@H](OC(/C=C/C2=CC=C(O)C(O)=C2)=O)[C@H](OC(/C=C/C3=CC=C(O)C(O)=C3)=O)[C@H](O)C1)O,"3,4-Dicaffeoylquinic acid",Data.sdf,16751,HY-N0057,"3,4-Di-O-caffeoylquinic acid; Isochlorogenic acid B",14534-61-3,Apoptosis; Endogenous Metabolite; Glycosidase; Influenza Virus,Anti-infection; Apoptosis; Metabolic Enzyme/Protease,C25H24O12,10mM,Cancer; Infection,No Development Reported,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1[C@H](O)C[C@@](O)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,清洗成功,0.3333333333333333
14204,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H]1[C@H](O)C[C@](O)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,1,0.9898195862770081,0.9898195862770081,O=C([C@]1(O)C[C@@H](OC(/C=C/C2=CC=C(O)C(O)=C2)=O)[C@@H](OC(/C=C/C3=CC=C(O)C(O)=C3)=O)[C@H](O)C1)O,"4,5-Dicaffeoylquinic acid",Data.sdf,16752,HY-N0058,Isochlorogenic acid C,57378-72-0,Apoptosis; Endogenous Metabolite; Glycosidase; HBV,Anti-infection; Apoptosis; Metabolic Enzyme/Protease,C25H24O12,10mM,Infection,No Development Reported,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H]1[C@H](O)C[C@](O)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,清洗成功,0.3333333333333333
8076,Cc1ccccc1C(=O)Nc1c(C)cc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)cc1Cl,1,0.9898148775100708,0.9898148775100708,O=C(NC1=C(C)C=C(S(=O)(N[C@@H](C2CCN(C)CC2)C)=O)C=C1Cl)C3=CC=CC=C3C,CCR8 antagonist 2,Data.sdf,9540,HY-144200,,2756350-98-6,CCR,GPCR/G Protein; Immunology/Inflammation,C23H30ClN3O3S,2mM,Cancer; Neurological Disease,No Development Reported,Cc1ccccc1C(=O)Nc1c(C)cc(S(=O)(=O)N[C@H](C)C2CCN(C)CC2)cc1Cl,清洗成功,0.2747252747252747
7803,CN(C)C(=O)c1cccc(NC(=O)c2c(Sc3c(Cl)cccc3Cl)cc(C(F)(F)F)[nH]c2=O)c1,1,0.989812433719635,0.989812433719635,O=C(C1=CC=CC(NC(C2=C(C=C(NC2=O)C(F)(F)F)SC3=C(C=CC=C3Cl)Cl)=O)=C1)N(C)C,NRX-103095,Data.sdf,9228,HY-141450,,2763260-38-2,?2-catenin,Stem Cell/Wnt,C22H16Cl2F3N3O3S,10mM,Cancer,No Development Reported,CN(C)C(=O)c1cccc(NC(=O)c2c(Sc3c(Cl)cccc3Cl)cc(C(F)(F)F)[nH]c2=O)c1,清洗成功,0.2631578947368421
6729,CCCc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(-c2ccnc(N3CCN(C)CC3)c2)cc2c1cnn2C(C)C,1,0.9898123145103455,0.9898123145103455,O=C(C1=CC(C2=CC(N3CCN(C)CC3)=NC=C2)=CC4=C1C=NN4C(C)C)NCC5=C(CCC)C=C(C)NC5=O,GSK343,Data.sdf,7987,HY-13500,,1346704-33-3,Autophagy; Histone Methyltransferase,Autophagy; Epigenetics,C31H39N7O2,10mM,Cancer,No Development Reported,CCCc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(-c2ccnc(N3CCN(C)CC3)c2)cc2c1cnn2C(C)C,清洗成功,0.3137254901960784
6063,COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(CC#N)nc34)CC2)CC1,1,0.9898120760917664,0.9898120760917664,O=C(N1CCN([C@@H]2CC[C@@H](NC3=C4C(C=CC(CC#N)=N4)=NC(NC5=CN(C)N=C5)=N3)CC2)CC1)OC,IRAK4-IN-6,Data.sdf,7171,HY-130253,,2454244-02-9,IRAK,Immunology/Inflammation,C25H32N10O2,10mM,Cancer,No Development Reported,COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(CC#N)nc34)CC2)CC1,清洗成功,0.3181818181818182
1333,Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1,1,0.989803671836853,0.989803671836853,FC1=C(OC2=NC=NN3C2=C(C(OC[C@H](O)C)=C3)C)C=CC4=C1C=C(C)N4,Brivanib,Data.sdf,1552,HY-10337,BMS-540215,649735-46-6,Autophagy; VEGFR,Autophagy; Protein Tyrosine Kinase/RTK,C19H19FN4O3,10mM,Cancer,Phase 3,Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1,清洗成功,0.2191780821917808
113,CCc1cc2c(=O)c(-c3nc4ccccc4s3)coc2c(CN2CCCCC2)c1O,1,0.9898033142089844,0.9898033142089844,O=C1C(C2=NC3=CC=CC=C3S2)=COC4=C(CN5CCCCC5)C(O)=C(CC)C=C14,SZL P1-41,Data.sdf,132,HY-100237,,222716-34-9,Apoptosis; E1/E2/E3 Enzyme,Apoptosis; Metabolic Enzyme/Protease,C24H24N2O3S,2mM,Cancer,No Development Reported,CCc1cc2c(=O)c(-c3nc4ccccc4s3)coc2c(CN2CCCCC2)c1O,清洗成功,0.2571428571428571
11789,N#Cc1cc(-c2ccc(O)c(F)c2)cc2ccc(O)cc12,1,0.9898011088371277,0.9898011088371277,N#CC1=C2C=C(O)C=CC2=CC(C3=CC=C(O)C(F)=C3)=C1,ERB-196,Data.sdf,13947,HY-19468,WAY-202196,550997-55-2,Estrogen Receptor/ERR,Vitamin D Related/Nuclear Receptor,C17H10FNO2,10mM,Inflammation/Immunology; Neurological Disease,Phase 1,N#Cc1cc(-c2ccc(O)c(F)c2)cc2ccc(O)cc12,清洗成功,0.2456140350877192
533,Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)C2(C#N)CC2)C(C)(C)C)cc1,1,0.989790141582489,0.989790141582489,O=C([C@H]1N(C([C@H](C(C)(C)C)NC(C2(CC2)C#N)=O)=O)C[C@H](O)C1)NCC3=CC=C(C4=C(C)N=CS4)C=C3,VH-298,Data.sdf,601,HY-100947,,2097381-85-4,HIF/HIF Prolyl-Hydroxylase; Ligands for E3 Ligase,Metabolic Enzyme/Protease; PROTAC,C27H33N5O4S,10mM,Cancer; Inflammation/Immunology,No Development Reported,Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)C2(C#N)CC2)C(C)(C)C)cc1,清洗成功,0.2547169811320754
2006,Cc1ccc2c(c1)C(=O)[C@@]1(O)CCN(c3ccccc3)C1=N2,1,0.9897881746292114,0.9897881746292114,O[C@]12C(N(C3=CC=CC=C3)CC2)=NC4=CC=C(C)C=C4C1=O,(+)-Blebbistatin,Data.sdf,2359,HY-107657,,1177356-70-5,Myosin,Cytoskeleton,C18H16N2O2,10mM,Others,No Development Reported,Cc1ccc2c(c1)C(=O)[C@@]1(O)CCN(c3ccccc3)C1=N2,清洗成功,0.2459016393442623
9483,CC(C)(O)CCn1ncc(-c2onc(-c3c(F)cccc3Cl)c2-c2ncccn2)c1C(F)(F)F,1,0.9897868633270264,0.9897868633270264,FC1=CC=CC(Cl)=C1C2=NOC(C3=C(C(F)(F)F)N(CCC(C)(C)O)N=C3)=C2C4=NC=CC=N4,Izumerogant,Data.sdf,11192,HY-152851,IMU-935,2299252-72-3,ROR,Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor,C22H18ClF4N5O2,10mM,Others; Cancer,Phase 1,CC(C)(O)CCn1ncc(-c2onc(-c3c(F)cccc3Cl)c2-c2ncccn2)c1C(F)(F)F,清洗成功,0.2210526315789473
2719,CN(C)CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,1,0.9897757768630981,0.9897757768630981,NC1=C2C(N([C@H]3CN(CCC3)C(CN(C)C)=O)N=C2C4=CC=C(OC5=CC=CC=C5)C=C4)=NC=N1,CHMFL-FLT3-122,Data.sdf,3190,HY-110293,,1839150-56-9,Apoptosis; FLT3,Apoptosis; Protein Tyrosine Kinase/RTK,C26H29N7O2,10mM,Cancer,No Development Reported,CN(C)CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,清洗成功,0.3157894736842105
2404,CN1Cc2cc(Cl)ccc2-n2c(nnc2[C@H]2CC[C@H](Oc3ccccn3)CC2)C1,1,0.9897753000259399,0.9897753000259399,CN1CC2=NN=C([C@H]3CC[C@H](OC4=NC=CC=C4)CC3)[N@]2[C@]5=CC=C(Cl)C=C5C1,Balovaptan,Data.sdf,2826,HY-109024,RG7314,1228088-30-9,Vasopressin Receptor,GPCR/G Protein,C22H24ClN5O,10mM,Neurological Disease; Endocrinology; Cardiovascular Disease,Phase 3,CN1Cc2cc(Cl)ccc2-n2c(nnc2[C@H]2CC[C@H](Oc3ccccn3)CC2)C1,清洗成功,0.231578947368421
7920,CC(C)(C[C@@](O)(Cc1cc2ccncc2[nH]1)C(F)(F)F)c1cc(F)ccc1O,1,0.9897744655609131,0.9897744655609131,OC1=CC=C(C=C1C(C)(C[C@](O)(C(F)(F)F)CC2=CC3=C(C=NC=C3)N2)C)F,Glucocorticoid receptor agonist,Data.sdf,9359,HY-14234,,1245526-82-2,Glucocorticoid Receptor,Immunology/Inflammation; Vitamin D Related/Nuclear Receptor,C20H20F4N2O2,10mM,Endocrinology; Metabolic Disease; Inflammation/Immunology,No Development Reported,CC(C)(C[C@@](O)(Cc1cc2ccncc2[nH]1)C(F)(F)F)c1cc(F)ccc1O,清洗成功,0.2638888888888889
7399,Cc1ccc2c(c1)C(=O)C1(O)CCN(c3ccccc3)C1=N2,1,0.9897739291191101,0.9897739291191101,O=C1C2(O)C(N(C3=CC=CC=C3)CC2)=NC4=C1C=C(C)C=C4,Blebbistatin,Data.sdf,8755,HY-13813,,674289-55-5,Myosin,Cytoskeleton,C18H16N2O2,10mM,Others,No Development Reported,Cc1ccc2c(c1)C(=O)C1(O)CCN(c3ccccc3)C1=N2,清洗成功,0.2459016393442623
9719,CN(C)C(=O)c1cc2cnc(Nc3ccc(-c4csc5c(=O)cc(N6CCOCC6)oc45)cc3)nc2n1C1CCCC1,1,0.9897698163986206,0.9897698163986206,O=C1C=C(N2CCOCC2)OC3=C1SC=C3C4=CC=C(NC5=NC6=C(C=C(N6C7CCCC7)C(N(C)C)=O)C=N5)C=C4,SRX3177,Data.sdf,11483,HY-153894,,2241237-51-2,CDK; Epigenetic Reader Domain; PI3K,Cell Cycle/DNA Damage; Epigenetics; PI3K/Akt/mTOR,C31H32N6O4S,10mM,Cancer,No Development Reported,CN(C)C(=O)c1cc2cnc(Nc3ccc(-c4csc5c(=O)cc(N6CCOCC6)oc45)cc3)nc2n1C1CCCC1,清洗成功,0.2897196261682243
7869,C[C@@H]1CN(c2ccc(-c3cc(C(=O)O)ccc3F)cc2NC(=O)c2c[nH]c(=O)cc2C(F)(F)F)C[C@H](C)N1C,1,0.9897688627243042,0.9897688627243042,O=C(C(C(C(F)(F)F)=C1)=CNC1=O)NC2=C(N3C[C@@H](N([C@@H](C3)C)C)C)C=CC(C4=CC(C(O)=O)=CC=C4F)=C2,Dimethyl-F-OICR-9429-COOH,Data.sdf,9299,HY-141799,,2407458-49-3,Ligands for Target Protein for PROTAC; WDR5,Epigenetics; PROTAC,C27H26F4N4O4,10mM,Cancer,No Development Reported,C[C@@H]1CN(c2ccc(-c3cc(C(=O)O)ccc3F)cc2NC(=O)c2c[nH]c(=O)cc2C(F)(F)F)C[C@H](C)N1C,清洗成功,0.2765957446808511
8674,O=C(Nc1ccc2[nH]c(=O)oc2c1)C(=O)N1CCC(Cc2ccc(F)cc2)CC1,1,0.9897645711898804,0.9897645711898804,O=C(NC1=CC=C2NC(OC2=C1)=O)C(N3CCC(CC4=CC=C(F)C=C4)CC3)=O,Radiprodil,Data.sdf,10229,HY-14777,RGH-896,496054-87-6,iGluR,Membrane Transporter/Ion Channel; Neuronal Signaling,C21H20FN3O4,10mM,Neurological Disease,Phase 2,O=C(Nc1ccc2[nH]c(=O)oc2c1)C(=O)N1CCC(Cc2ccc(F)cc2)CC1,清洗成功,0.2531645569620253
5673,c1ccc(Cn2nnc3c(Sc4nc5ccccc5o4)ncnc32)cc1,1,0.9897642135620117,0.9897642135620117,C1(N(CC2=CC=CC=C2)N=N3)=C3C(SC4=NC5=C(C=CC=C5)O4)=NC=N1,VAS2870,Data.sdf,6694,HY-12804,,722456-31-7,NADPH Oxidase,Metabolic Enzyme/Protease,C18H12N6OS,10mM,Cardiovascular Disease,No Development Reported,c1ccc(Cn2nnc3c(Sc4nc5ccccc5o4)ncnc32)cc1,清洗成功,0.2638888888888889
2187,COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1,1,0.9897639751434326,0.9897639751434326,O=S(C1=CC=C(C2=NC(C3=CC=NC=C3)=C(C4=CC=C5C=C(OC)C=CC5=C4)N2C)C(C)=C1)(C)=O,SB-633825,Data.sdf,2565,HY-108333,,956613-01-7,BRK; Tie,Protein Tyrosine Kinase/RTK,C28H25N3O3S,10mM,Cancer; Cardiovascular Disease,No Development Reported,COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1,清洗成功,0.3
10274,CN(CC#N)C(=O)C[C@@H](Nc1nc2ccccc2[nH]1)c1cccc(C(F)(F)F)c1,1,0.9897595643997192,0.9897595643997192,O=C(N(CC#N)C)C[C@@H](NC1=NC2=CC=CC=C2N1)C3=CC=CC(C(F)(F)F)=C3,AP30663,Data.sdf,12165,HY-157557,,,Potassium Channel,Membrane Transporter/Ion Channel,C20H18F3N5O,10mM,Cardiovascular Disease,Phase 2,CN(CC#N)C(=O)C[C@@H](Nc1nc2ccccc2[nH]1)c1cccc(C(F)(F)F)c1,清洗成功,0.323943661971831
4363,CN1CCN(c2cc(-c3ccncc3)c(-c3ccc4ccccc4c3)nn2)CC1,1,0.9897593259811401,0.9897593259811401,CN1CCN(C2=NN=C(C3=CC=C4C=CC=CC4=C3)C(C5=CC=NC=C5)=C2)CC1,MW-150,Data.sdf,5133,HY-120111,MW01-18-150SRM,1628502-91-9,Autophagy; p38 MAPK,Autophagy; MAPK/ERK Pathway,C24H23N5,10mM,Inflammation/Immunology; Neurological Disease,Phase 2,CN1CCN(c2cc(-c3ccncc3)c(-c3ccc4ccccc4c3)nn2)CC1,清洗成功,0.3333333333333333
170,CC1(N)CCN(c2cnc(-c3cccc(Cl)c3Cl)c(N)n2)CC1,1,0.9897587299346924,0.9897587299346924,NC1=NC(N2CCC(C)(N)CC2)=CN=C1C3=CC=CC(Cl)=C3Cl,SHP099,Data.sdf,197,HY-100388,,1801747-42-1,Phosphatase; SHP2,Metabolic Enzyme/Protease; Protein Tyrosine Kinase/RTK,C16H19Cl2N5,10mM,Cancer,No Development Reported,CC1(N)CCN(c2cnc(-c3cccc(Cl)c3Cl)c(N)n2)CC1,清洗成功,0.2535211267605634
171,CC1(N)CCN(c2cnc(-c3cccc(Cl)c3Cl)c(N)n2)CC1,1,0.9897587299346924,0.9897587299346924,NC1=NC(N2CCC(C)(N)CC2)=CN=C1C3=CC=CC(Cl)=C3Cl.Cl,SHP099 (monohydrochloride),Data.sdf,198,HY-100388A,,2200214-93-1,Phosphatase; SHP2,Metabolic Enzyme/Protease; Protein Tyrosine Kinase/RTK,C16H20Cl3N5,10mM,Cancer,No Development Reported,CC1(N)CCN(c2cnc(-c3cccc(Cl)c3Cl)c(N)n2)CC1,清洗成功,0.25
3793,C=CC(=O)N1CCN(c2ccc(CCC(=O)NCCCCCNC(=O)c3cccc(-c4nc(NC(=O)C5(c6ccc7c(c6)OC(F)(F)O7)CC5)ccc4C)c3)o2)C(=O)C1,1,0.9897587299346924,0.9897587299346924,O=C(N1CC(N(CC1)C2=CC=C(CCC(NCCCCCNC(C3=CC=CC(C4=NC(NC(C5(CC5)C6=CC=C7OC(F)(OC7=C6)F)=O)=CC=C4C)=C3)=O)=O)O2)=O)C=C,NJH-2-057,Data.sdf,4468,HY-115878,,2858812-70-9,CFTR,Membrane Transporter/Ion Channel,C43H44F2N6O8,10mM,Others,No Development Reported,C=CC(=O)N1CCN(c2ccc(CCC(=O)NCCCCCNC(=O)c3cccc(-c4nc(NC(=O)C5(c6ccc7c(c6)OC(F)(F)O7)CC5)ccc4C)c3)o2)C(=O)C1,清洗成功,0.2153846153846154
10234,COc1c(Cl)cccc1Nc1c(-c2ccncc2C#C[C@@]2(C)CCCN2C(=O)/C=C/CN(C)C)[nH]c2c1C(=O)NCC2,1,0.9897528886795044,0.9897528886795044,O=C(N1CCC[C@]1(C)C#CC2=C(C=CN=C2)C3=C(C4=C(N3)CCNC4=O)NC5=CC=CC(Cl)=C5OC)/C=C/CN(C)C,STX-721,Data.sdf,12108,HY-157229,,2765525-82-2,EGFR,JAK/STAT Signaling; Protein Tyrosine Kinase/RTK,C32H35ClN6O3,10mM,Others,Phase 2,COc1c(Cl)cccc1Nc1c(-c2ccncc2C#C[C@@]2(C)CCCN2C(=O)/C=C/CN(C)C)[nH]c2c1C(=O)NCC2,清洗成功,0.2203389830508474
10197,N#Cc1ccc(O[C@@H]2c3ccccc3C[C@H]2N2CCC[C@@H](N)C2)c(Cl)c1,1,0.9897454977035522,0.9897454977035522,N[C@@H](C1)CCCN1[C@@H]2CC3=CC=CC=C3[C@H]2OC4=C(Cl)C=C(C#N)C=C4,SAR7334,Data.sdf,12064,HY-15699,,1333210-07-3,TRP Channel,Membrane Transporter/Ion Channel; Neuronal Signaling,C21H22ClN3O,10mM,Neurological Disease,No Development Reported,N#Cc1ccc(O[C@@H]2c3ccccc3C[C@H]2N2CCC[C@@H](N)C2)c(Cl)c1,清洗成功,0.2261904761904762
10198,N#Cc1ccc(O[C@@H]2c3ccccc3C[C@H]2N2CCC[C@@H](N)C2)c(Cl)c1,1,0.9897454977035522,0.9897454977035522,N[C@@H](C1)CCCN1[C@@H]2CC3=CC=CC=C3[C@H]2OC4=CC=C(C#N)C=C4Cl.Cl.Cl,SAR7334 (hydrochloride),Data.sdf,12065,HY-15699A,,1333207-63-8,TRP Channel,Membrane Transporter/Ion Channel; Neuronal Signaling,C21H24Cl3N3O,10mM,Neurological Disease,No Development Reported,N#Cc1ccc(O[C@@H]2c3ccccc3C[C@H]2N2CCC[C@@H](N)C2)c(Cl)c1,清洗成功,0.2235294117647059
11346,O=S1CCON=C1c1cc2ccccc2s1,1,0.9897447228431702,0.9897447228431702,O=S1C(C2=CC3=CC=CC=C3S2)=NOCC1,Bethoxazin,Data.sdf,13422,HY-17525,,163269-30-5,Bacterial,Anti-infection,C11H9NO2S2,10mM,Infection,No Development Reported,O=S1CCON=C1c1cc2ccccc2s1,清洗成功,0.2884615384615384
1134,CS(=O)c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,1,0.9897434115409851,0.9897434115409851,O=S(C1=CC=C(C2=NC(C3=CC=C(F)C=C3)=C(C4=CC=NC=C4)N2)C=C1)C,Adezmapimod,Data.sdf,1309,HY-10256,SB 203580; RWJ 64809,152121-47-6,Autophagy; Mitophagy; Organoid; p38 MAPK,Autophagy; MAPK/ERK Pathway; Stem Cell/Wnt,C21H16FN3OS,10mM,Inflammation/Immunology; Cancer,No Development Reported,CS(=O)c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,清洗成功,0.3157894736842105
1135,CS(=O)c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,1,0.9897434115409851,0.9897434115409851,O=S(C1=CC=C(C2=NC(C3=CC=C(F)C=C3)=C(C4=CC=NC=C4)N2)C=C1)C.[H]Cl,Adezmapimod (hydrochloride),Data.sdf,1310,HY-10256A,SB 203580 (hydrochloride); RWJ 64809 (hydrochloride),869185-85-3,Autophagy; Mitophagy; Organoid; p38 MAPK,Autophagy; MAPK/ERK Pathway; Stem Cell/Wnt,C21H17ClFN3OS,10mM,Inflammation/Immunology; Cancer,No Development Reported,CS(=O)c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,清洗成功,0.3103448275862069
8752,O=c1[nH]ncc(N/N=C/c2cccc(O)c2)c1Cl,1,0.9897419214248657,0.9897419214248657,O=C1NN=CC(N/N=C/C2=CC(O)=CC=C2)=C1Cl,L82-G17,Data.sdf,10327,HY-148161,,92285-87-5,DNA/RNA Synthesis,Cell Cycle/DNA Damage,C11H9ClN4O2,10mM,Cancer,No Development Reported,O=c1[nH]ncc(N/N=C/c2cccc(O)c2)c1Cl,清洗成功,0.2711864406779661
9890,Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1,1,0.9897414445877075,0.9897414445877075,O=C(C1=CC=C(C)N(C2=CC=C(F)C=C2)C1=O)NC3=CC=C(OC4=CC5=C(N(C)N=C5)C=C4C6=CNN=C6)C(F)=C3,Merestinib,Data.sdf,11687,HY-15514,LY2801653,1206799-15-6,c-Met/HGFR; Discoidin Domain Receptor; FLT3; ROS Kinase,Protein Tyrosine Kinase/RTK,C30H22F2N6O3,10mM,Cancer,Phase 2,Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1,清洗成功,0.2929292929292929
9893,Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1,1,0.9897414445877075,0.9897414445877075,[H]Cl.[H]Cl.O=C(C1=CC=C(C)N(C2=CC=C(F)C=C2)C1=O)NC3=CC=C(OC4=CC5=C(N(C)N=C5)C=C4C6=CNN=C6)C(F)=C3,Merestinib dihydrochloride,Data.sdf,11690,HY-15514A,LY2801653 (dihydrochloride),1206801-37-7,c-Met/HGFR; Discoidin Domain Receptor; FLT3; ROS Kinase,Protein Tyrosine Kinase/RTK,C30H24Cl2F2N6O3,10mM,Cancer,Phase 2,Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1,清洗成功,0.29
7478,COc1ccc(C(OC[C@H]2O[C@@H](n3cnc4c(=O)[nH]c(/N=C\N(C)C)nc43)C[C@@H]2O)(c2ccccc2)c2ccc(OC)cc2)cc1,1,0.9897312521934509,0.9897312521934509,COC1=CC=C(C(C2=CC=CC=C2)(OC[C@@H]3[C@@H](O)C[C@@H](O3)N4C=NC5=C4N=C(/N=C\N(C)C)NC5=O)C6=CC=C(OC)C=C6)C=C1,5'-O-DMT-N2-DMF-dG,Data.sdf,8847,HY-138607,,40094-22-2,DNA/RNA Synthesis; Nucleoside Antimetabolite/Analog,Cell Cycle/DNA Damage,C34H36N6O6,10mM,Cancer; Infection,No Development Reported,COc1ccc(C(OC[C@H]2O[C@@H](n3cnc4c(=O)[nH]c(/N=C\N(C)C)nc43)C[C@@H]2O)(c2ccccc2)c2ccc(OC)cc2)cc1,清洗成功,0.2159090909090909
2752,Cc1ccc(O)c(Cn2c(NC3CCN(CCN)CC3)nc3c(C)cccc32)n1,1,0.9897279143333435,0.9897279143333435,OC1=CC=C(C)N=C1CN2C3=CC=CC(C)=C3N=C2NC4CCN(CCN)CC4,JNJ 2408068,Data.sdf,3234,HY-11098,R170591,317846-22-3,RSV,Anti-infection,C22H30N6O,10mM,Infection,No Development Reported,Cc1ccc(O)c(Cn2c(NC3CCN(CCN)CC3)nc3c(C)cccc32)n1,清洗成功,0.2340425531914893
11507,COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(CC(C)(C)O)n(-c5ccccc5)c4=O)cc3F)ccnc2c1,1,0.9897229671478271,0.9897229671478271,O=C(C1=C(C)N(CC(C)(O)C)N(C2=CC=CC=C2)C1=O)NC3=CC=C(OC4=CC=NC5=CC(OC)=CC=C45)C(F)=C3,SYN1143,Data.sdf,13611,HY-18307,,913376-84-8,c-Met/HGFR,Protein Tyrosine Kinase/RTK,C31H29FN4O5,10mM,Cancer,No Development Reported,COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(CC(C)(C)O)n(-c5ccccc5)c4=O)cc3F)ccnc2c1,清洗成功,0.3225806451612903
6170,CC(C)(O)COc1ccc2c(Oc3ccc(Nc4nccc5[nH]cc(-c6ccccc6)c(=O)c45)cc3F)ccnc2c1,1,0.9897143244743347,0.9897143244743347,O=C1C(C2=CC=CC=C2)=CNC3=C1C(NC4=CC=C(OC5=CC=NC6=CC(OCC(C)(O)C)=CC=C56)C(F)=C4)=NC=C3,MET kinase-IN-2,Data.sdf,7301,HY-131065,,2101241-90-9,c-Met/HGFR,Protein Tyrosine Kinase/RTK,C33H27FN4O4,10mM,Cancer,No Development Reported,CC(C)(O)COc1ccc2c(Oc3ccc(Nc4nccc5[nH]cc(-c6ccccc6)c(=O)c45)cc3F)ccnc2c1,清洗成功,0.2795698924731182
5896,O=C(c1cnc(NCc2cnccn2)nc1)N1CCC2(CCOCC2)C1,1,0.9897140264511108,0.9897140264511108,O=C(N1CC2(CCOCC2)CC1)C3=CN=C(NCC4=NC=CN=C4)N=C3,PFI-653,Data.sdf,6972,HY-129035,Vanin-1-IN-1,2173134-00-2,,,C18H22N6O2,10mM,Metabolic Disease; Inflammation/Immunology,No Development Reported,O=C(c1cnc(NCc2cnccn2)nc1)N1CCC2(CCOCC2)C1,清洗成功,0.2592592592592592
815,C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1,1,0.9897103905677795,0.9897103905677795,NC(C1=C2N(N=C1C3=CC=C(OC4=CC=CC=C4)C=C3)C(C5CCN(C(C=C)=O)CC5)CCN2)=O,(?±)-Zanubrutinib,Data.sdf,937,HY-101474,(?±)-BGB-3111,1633350-06-7,Btk,Protein Tyrosine Kinase/RTK,C27H29N5O3,10mM,Cancer,No Development Reported,C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1,清洗成功,0.2142857142857142
816,C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1,1,0.9897103905677795,0.9897103905677795,NC(C1=C2N(N=C1C3=CC=C(OC4=CC=CC=C4)C=C3)[C@H](C5CCN(C(C=C)=O)CC5)CCN2)=O,Zanubrutinib,Data.sdf,938,HY-101474A,BGB-3111,1691249-45-2,Btk,Protein Tyrosine Kinase/RTK,C27H29N5O3,10mM,Cancer,Launched,C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1,清洗成功,0.2142857142857142
817,C=CC(=O)N1CCC([C@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1,1,0.9897103905677795,0.9897103905677795,NC(C1=C2N(N=C1C3=CC=C(OC4=CC=CC=C4)C=C3)[C@@H](C5CCN(C(C=C)=O)CC5)CCN2)=O,(R)-Zanubrutinib,Data.sdf,939,HY-101474B,(R)-BGB-3111,1691249-44-1,Btk,Protein Tyrosine Kinase/RTK,C27H29N5O3,10mM,Others,No Development Reported,C=CC(=O)N1CCC([C@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1,清洗成功,0.2142857142857142
9363,CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21,1,0.9897043108940125,0.9897043108940125,ClC(C=C(NC1=NC=NC2=C1N(CCNC(CC(C)(C)O)=O)C=C2)C=C3)=C3OC4=CC=CC(C(F)(F)F)=C4,TAK-285,Data.sdf,11052,HY-15196,,871026-44-7,EGFR,JAK/STAT Signaling; Protein Tyrosine Kinase/RTK,C26H25ClF3N5O3,10mM,Cancer,Phase 1,CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21,清洗成功,0.2844036697247706
2955,CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)Cn1c(-c2cccc(C(F)(F)F)c2)[n+](C)c2ccccc21,1,0.9896988272666931,0.9896988272666931,CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(CN2C(C=CC=C3)=C3[N+](C)=C2C4=CC(C(F)(F)F)=CC=C4)=O.[I-],S-Gboxin,Data.sdf,3464,HY-111652,,2101317-21-7,Others,Others,C27H32F3IN2O2,10mM,Cancer,No Development Reported,CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)Cn1c(-c2cccc(C(F)(F)F)c2)[n+](C)c2ccccc21,清洗成功,0.25
7183,CN(C)CC(=O)Nc1ccc2[nH]c(=O)c3ccccc3c2c1,1,0.989685595035553,0.989685595035553,O=C(NC(C=C1C2=C3C=CC=C2)=CC=C1NC3=O)CN(C)C.Cl,PJ34 (hydrochloride),Data.sdf,8502,HY-13688,,344458-15-7,PARP,Cell Cycle/DNA Damage; Epigenetics,C17H18ClN3O2,10mM,Cancer,No Development Reported,CN(C)CC(=O)Nc1ccc2[nH]c(=O)c3ccccc3c2c1,清洗成功,0.3472222222222222
11042,CC1(C)CN(C(=O)c2ccc(-c3cccc4nc(NC(=O)C5CC5)nn34)cc2)C1,1,0.98968505859375,0.98968505859375,O=C(C1CC1)NC2=NN3C(C4=CC=C(C(N5CC(C)(C)C5)=O)C=C4)=CC=CC3=N2,Solcitinib,Data.sdf,13082,HY-16755,GSK-2586184; GLPG-0778,1206163-45-2,JAK,Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt,C22H23N5O2,10mM,Inflammation/Immunology,Phase 2,CC1(C)CN(C(=O)c2ccc(-c3cccc4nc(NC(=O)C5CC5)nn34)cc2)C1,清洗成功,0.3146067415730337
7326,CN(C)CCNc1nc2cc(O)ccc2c2c1C(=O)c1ccccc1-2,1,0.9896826148033142,0.9896826148033142,O=C(C1=C2C3=CC=C(O)C=C3N=C1NCCN(C)C)C4=C2C=CC=C4.Cl.Cl,TAS-103 (dihydrochloride),Data.sdf,8666,HY-13758A,BMS-247615 dihydrochloride,174634-09-4,Topoisomerase,Cell Cycle/DNA Damage,C20H21Cl2N3O2,10mM,Cancer,No Development Reported,CN(C)CCNc1nc2cc(O)ccc2c2c1C(=O)c1ccccc1-2,清洗成功,0.2608695652173913
1075,COC(=O)N1CCC(CN2CCC(CNC(=O)c3cccc4nc(C(C)C)[nH]c34)CC2)CC1,1,0.9896770119667053,0.9896770119667053,O=C(N1CCC(CN2CCC(CNC(C3=C4C(N=C(C(C)C)N4)=CC=C3)=O)CC2)CC1)OC,Felcisetrag,Data.sdf,1236,HY-102057,TD-8954,916075-84-8,5-HT Receptor,GPCR/G Protein; Neuronal Signaling,C25H37N5O3,10mM,Others,Phase 2,COC(=O)N1CCC(CN2CCC(CNC(=O)c3cccc4nc(C(C)C)[nH]c34)CC2)CC1,清洗成功,0.3444444444444444
1464,Cc1nc2cc(F)c(F)cc2n1-c1cncc(Nc2ccc(C(F)(F)F)cc2)n1,1,0.9896696209907532,0.9896696209907532,FC(C1=CC=C(NC2=NC(N3C4=CC(F)=C(F)C=C4N=C3C)=CN=C2)C=C1)(F)F,PTC-028,Data.sdf,1718,HY-103696,,1782970-28-8,Apoptosis; BMI1,Apoptosis; Stem Cell/Wnt,C19H12F5N5,10mM,Cancer,No Development Reported,Cc1nc2cc(F)c(F)cc2n1-c1cncc(Nc2ccc(C(F)(F)F)cc2)n1,清洗成功,0.275
4819,O=C1CCC(N2C(=O)c3cccc(OCCOCCOCCN4CCN(Cc5ccc6cc(C(=O)Nc7cc(NC(=O)c8ccc9c(c8)OCCO9)ccc7Cl)ccc6n5)CC4)c3C2=O)C(=O)N1,1,0.9896680116653442,0.9896680116653442,O=C(C1=CC=C2N=C(CN3CCN(CCOCCOCCOC4=CC=CC(C(N5C(CC6)C(NC6=O)=O)=O)=C4C5=O)CC3)C=CC2=C1)NC7=CC(NC(C8=CC=C(OCCO9)C9=C8)=O)=CC=C7Cl.OC=O,CCT367766 (formic),Data.sdf,5668,HY-122653A,,,PROTACs,PROTAC,C50H50ClN7O13,10mM,Cancer,No Development Reported,O=C1CCC(N2C(=O)c3cccc(OCCOCCOCCN4CCN(Cc5ccc6cc(C(=O)Nc7cc(NC(=O)c8ccc9c(c8)OCCO9)ccc7Cl)ccc6n5)CC4)c3C2=O)C(=O)N1,清洗成功,0.2816901408450704
15646,O=C(O[C@@H]1[C@@H](O)[C@H](Oc2cc(O)c3c(c2)O[C@H](c2ccccc2)CC3=O)O[C@@H]2COC(=O)c3cc(O)c(O)c(O)c3-c3c(cc(O)c(O)c3O)C(=O)O[C@@H]12)c1cc(O)c(O)c(O)c1,1,0.9896659851074219,0.9896659851074219,O=C1C[C@@H](C2=CC=CC=C2)OC3=CC(O[C@H]4[C@@H]([C@H]([C@@H]([C@@H](COC5=O)O4)OC(C6=CC(O)=C(O)C(O)=C6C7=C(O)C(O)=C(O)C=C75)=O)OC(C8=CC(O)=C(O)C(O)=C8)=O)O)=CC(O)=C13,"Pinocembrin 7-O-[3''-O-galloyl-4'',6''-hexahydroxydiphenoyl]-?2-D-glucoside",Data.sdf,18676,HY-N5084,,205370-59-8,Others,Others,C42H32O21,10mM,Others,No Development Reported,O=C(O[C@@H]1[C@@H](O)[C@H](Oc2cc(O)c3c(c2)O[C@H](c2ccccc2)CC3=O)O[C@@H]2COC(=O)c3cc(O)c(O)c(O)c3-c3c(cc(O)c(O)c3O)C(=O)O[C@@H]12)c1cc(O)c(O)c(O)c1,清洗成功,0.3372093023255814
4953,Cc1noc(=O)c2ccc(NC(=O)C(O)(CC(C)(C)c3cccc4c3OCC4)C(F)(F)F)cc12,1,0.9896643757820129,0.9896643757820129,O=C1C2=CC=C(C=C2C(C)=NO1)NC(C(C(F)(F)F)(O)CC(C)(C3=C4C(CCO4)=CC=C3)C)=O,ZK 216348,Data.sdf,5832,HY-123352,(+)-ZK 216348,669073-68-1,Glucocorticoid Receptor,Immunology/Inflammation; Vitamin D Related/Nuclear Receptor,C24H23F3N2O5,10mM,Endocrinology; Inflammation/Immunology,No Development Reported,Cc1noc(=O)c2ccc(NC(=O)C(O)(CC(C)(C)c3cccc4c3OCC4)C(F)(F)F)cc12,清洗成功,0.2234042553191489
4954,Cc1noc(=O)c2ccc(NC(=O)C(O)(CC(C)(C)c3cccc4c3OCC4)C(F)(F)F)cc12,1,0.9896643757820129,0.9896643757820129,O=C1C2=CC=C(C=C2C(C)=NO1)NC(C(C(F)(F)F)(O)CC(C)(C3=C4C(CCO4)=CC=C3)C)=O,(-)-ZK 216348,Data.sdf,5833,HY-123352A,,,Glucocorticoid Receptor,Immunology/Inflammation; Vitamin D Related/Nuclear Receptor,C24H23F3N2O5,10mM,Endocrinology; Inflammation/Immunology,No Development Reported,Cc1noc(=O)c2ccc(NC(=O)C(O)(CC(C)(C)c3cccc4c3OCC4)C(F)(F)F)cc12,清洗成功,0.2234042553191489
14439,O=c1cc(-c2ccc(O)c(O)c2)oc2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@H]3O[C@@H](CO)[C@@H](O)[C@@H](O)[C@@H]3O)c(O)cc(O)c12,1,0.9896636605262756,0.9896636605262756,O[C@H]1[C@@H](O)[C@H](O)[C@@]([H])(O[C@H]2[C@H](C3=C(O)C=C(O)C4=C3OC(C5=CC=C(O)C(O)=C5)=CC4=O)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@H]1CO,2"-O-beta-L-galactopyranosylorientin,Data.sdf,17081,HY-N0406,,861691-37-4,P-glycoprotein,Membrane Transporter/Ion Channel,C27H30O16,10mM,Inflammation/Immunology,No Development Reported,O=c1cc(-c2ccc(O)c(O)c2)oc2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@H]3O[C@@H](CO)[C@@H](O)[C@@H](O)[C@@H]3O)c(O)cc(O)c12,清洗成功,0.3493975903614458
6680,CN(C)c1cc2c(cc1Sc1nc3c(N)nccc3n1CCNCC(C)(C)C)OCO2,1,0.9896629452705383,0.9896629452705383,NC1=NC=CC2=C1N=C(SC3=C(N(C)C)C=C(OCO4)C4=C3)N2CCNCC(C)(C)C,Debio 0932,Data.sdf,7928,HY-13469,CUDC-305,1061318-81-7,HSP,Cell Cycle/DNA Damage; Metabolic Enzyme/Protease,C22H30N6O2S,10mM,Cancer,Phase 1,CN(C)c1cc2c(cc1Sc1nc3c(N)nccc3n1CCNCC(C)(C)C)OCO2,清洗成功,0.2682926829268293
4818,Oc1c(Cl)cc(Cl)cc1/C=N/c1ccc(Nc2ccccc2)cc1,1,0.9896605014801025,0.9896605014801025,OC1=C(/C=N/C2=CC=C(NC3=CC=CC=C3)C=C2)C=C(Cl)C=C1Cl,MitoBloCK-6,Data.sdf,5667,HY-122652,,303215-67-0,Aldose Reductase; Apoptosis,Apoptosis; Metabolic Enzyme/Protease,C19H14Cl2N2O,10mM,Cancer; Neurological Disease,No Development Reported,Oc1c(Cl)cc(Cl)cc1/C=N/c1ccc(Nc2ccccc2)cc1,清洗成功,0.2857142857142857
3297,CNC(=O)c1cc(Cl)cc(C)c1NC(=O)c1cc(Br)nn1-c1ncccc1Cl,1,0.9896602630615234,0.9896602630615234,O=C(C1=CC(Br)=NN1C2=NC=CC=C2Cl)NC3=C(C(NC)=O)C=C(Cl)C=C3C,Chlorantraniliprole,Data.sdf,3877,HY-112820,,500008-45-7,Insecticide,Others,C18H14BrCl2N5O2,10mM,Others,No Development Reported,CNC(=O)c1cc(Cl)cc(C)c1NC(=O)c1cc(Br)nn1-c1ncccc1Cl,清洗成功,0.2823529411764706
8606,CN(C)N(C)C(=O)[C@@]1(Cc2ccccc2)CCCN(C(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)C(C)(C)N)C1,1,0.9896535277366638,0.9896535277366638,[H][C@](CC1=CNC2=CC=CC=C21)(NC(C(C)(C)N)=O)C(N3CCC[C@@](C(N(C)N(C)C)=O)(CC4=CC=CC=C4)C3)=O,Anamorelin,Data.sdf,10155,HY-14734,RC-1291; ONO-7643,249921-19-5,GHSR,GPCR/G Protein,C31H42N6O3,10mM,Cancer; Endocrinology,Launched,CN(C)N(C)C(=O)[C@@]1(Cc2ccccc2)CCCN(C(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)C(C)(C)N)C1,清洗成功,0.2803738317757009
7701,C=CC(=O)N1CCC(C)(Nc2cccc(C(F)(F)F)c2)C1,1,0.9896523356437683,0.9896523356437683,O=C(N1CCC(C)(C1)NC2=CC=CC(C(F)(F)F)=C2)C=C,MYF-01-37,Data.sdf,9109,HY-139603,,2416417-65-5,YAP,Stem Cell/Wnt,C15H17F3N2O,10mM,Cancer,No Development Reported,C=CC(=O)N1CCC(C)(Nc2cccc(C(F)(F)F)c2)C1,清洗成功,0.2987012987012987
4846,CN(C)C/C=C/C(=O)Nc1cccc(C(=O)Nc2cccc(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)c2)c1,1,0.9896513223648071,0.9896513223648071,O=C(NC1=CC=CC(NC2=NC=C(Cl)C(C3=CNC4=C3C=CC=C4)=N2)=C1)C5=CC=CC(NC(/C=C/CN(C)C)=O)=C5,THZ2,Data.sdf,5704,HY-12280,,1604810-84-5,CDK,Cell Cycle/DNA Damage,C31H28ClN7O2,10mM,Cancer,No Development Reported,CN(C)C/C=C/C(=O)Nc1cccc(C(=O)Nc2cccc(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)c2)c1,清洗成功,0.3222222222222222
7208,CC1(N)CCN(c2cnc3c(-c4cccc(Cl)c4Cl)n[nH]c3n2)CC1,1,0.9896500110626221,0.9896500110626221,NC1(C)CCN(C2=CN=C3C(NN=C3C4=CC=CC(Cl)=C4Cl)=N2)CC1,IACS-13909,Data.sdf,8534,HY-137092,,2160546-07-4,Phosphatase; SHP2,Metabolic Enzyme/Protease; Protein Tyrosine Kinase/RTK,C17H18Cl2N6,10mM,Cancer,No Development Reported,CC1(N)CCN(c2cnc3c(-c4cccc(Cl)c4Cl)n[nH]c3n2)CC1,清洗成功,0.2702702702702703
449,COc1ccc(NC(=O)c2ccc(-c3ccc(-c4noc(C)n4)cc3C)cc2)cc1N1CCN(C)CC1,1,0.9896426796913147,0.9896426796913147,O=C(C1=CC=C(C2=CC=C(C3=NOC(C)=N3)C=C2C)C=C1)NC4=CC=C(OC)C(N5CCN(C)CC5)=C4.[H]Cl,GR127935 (hydrochloride),Data.sdf,509,HY-100794,,148642-42-6,5-HT Receptor,GPCR/G Protein; Neuronal Signaling,C29H32ClN5O3,10mM,Neurological Disease,No Development Reported,COc1ccc(NC(=O)c2ccc(-c3ccc(-c4noc(C)n4)cc3C)cc2)cc1N1CCN(C)CC1,清洗成功,0.3333333333333333
7270,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(CC(F)(F)F)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,1,0.9896231293678284,0.9896231293678284,O=C(NC1=CC(NC2=NC(C3=CN(CC(F)(F)F)C4=C3C=CC=C4)=CC=N2)=C(C=C1N(CCN(C)C)C)OC)C=C,Befotertinib,Data.sdf,8604,HY-137433,D-0316,1835667-63-4,EGFR,JAK/STAT Signaling; Protein Tyrosine Kinase/RTK,C29H32F3N7O2,10mM,Cancer,Phase 4,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(CC(F)(F)F)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,清洗成功,0.3406593406593406
3287,Cn1nc(CC(=O)Nc2ccc(CN3CCN(C(=O)OC(C)(C)C)CC3)cc2)c2ccccc2c1=O,1,0.9896227121353149,0.9896227121353149,O=C(N1CCN(CC2=CC=C(NC(CC3=NN(C)C(C4=C3C=CC=C4)=O)=O)C=C2)CC1)OC(C)(C)C,PH-002,Data.sdf,3865,HY-112798,,1311174-68-1,Apolipoprotein,Metabolic Enzyme/Protease,C27H33N5O4,10mM,Neurological Disease,No Development Reported,Cn1nc(CC(=O)Nc2ccc(CN3CCN(C(=O)OC(C)(C)C)CC3)cc2)c2ccccc2c1=O,清洗成功,0.3111111111111111
6301,Nc1ncc(-c2nc(N3CCOCC3)nc(N[C@@]3(CO)CCN(C(=O)OCC(F)F)C3)c2F)cn1,1,0.9896218776702881,0.9896218776702881,OC[C@]1(CN(CC1)C(OCC(F)F)=O)NC2=NC(N3CCOCC3)=NC(C4=CN=C(N)N=C4)=C2F,PF-06843195,Data.sdf,7455,HY-131972,,2067281-51-8,PI3K,PI3K/Akt/mTOR,C20H25F3N8O4,10mM,Cancer,No Development Reported,Nc1ncc(-c2nc(N3CCOCC3)nc(N[C@@]3(CO)CCN(C(=O)OCC(F)F)C3)c2F)cn1,清洗成功,0.2448979591836734
10864,O=C(CSc1nnc(-c2ccncc2)n1-c1ccccc1)c1ccc2c(c1)OCCO2,1,0.9896211624145508,0.9896211624145508,O=C(CSC1=NN=C(N1C2=CC=CC=C2)C3=CC=NC=C3)C4=CC=C5OCCOC5=C4,Antiparasitic agent-23,Data.sdf,12875,HY-164052,,556055-08-4,Parasite,Anti-infection,C23H18N4O3S,10mM,Infection,No Development Reported,O=C(CSc1nnc(-c2ccncc2)n1-c1ccccc1)c1ccc2c(c1)OCCO2,清洗成功,0.3026315789473684
6426,Cc1cc(C)c2c(n1)CN(C(=O)CC1CN(c3ccnc(C(F)(F)F)c3)C1)C2,1,0.9896160364151001,0.9896160364151001,O=C(CC1CN(C1)C2=CC(C(F)(F)F)=NC=C2)N3CC4=NC(C)=CC(C)=C4C3,Emraclidine,Data.sdf,7611,HY-132812,CVL-231,2170722-84-4,mAChR,GPCR/G Protein; Neuronal Signaling,C20H21F3N4O,10mM,Neurological Disease,Phase 2,Cc1cc(C)c2c(n1)CN(C(=O)CC1CN(c3ccnc(C(F)(F)F)c3)C1)C2,清洗成功,0.2244897959183673
12193,CC(CC(=O)Nc1ccc2nc(-c3cscn3)[nH]c2c1)c1cccc(Cl)c1,1,0.9896140694618225,0.9896140694618225,O=C(NC1=CC=C2N=C(C3=CSC=N3)NC2=C1)CC(C)C4=CC=CC(Cl)=C4,KV2 channel inhibitor-1,Data.sdf,14423,HY-44153,,689297-68-5,Potassium Channel,Membrane Transporter/Ion Channel,C20H17ClN4OS,10mM,Neurological Disease,No Development Reported,CC(CC(=O)Nc1ccc2nc(-c3cscn3)[nH]c2c1)c1cccc(Cl)c1,清洗成功,0.2929292929292929
105,Cc1nn(-c2ccccc2)c(C)c1/C=N/N1CCN(Cc2ccccc2)CC1,1,0.9896137118339539,0.9896137118339539,CC1=C(/C=N/N2CCN(CC3=CC=CC=C3)CC2)C(C)=NN1C4=CC=CC=C4,SANT-1,Data.sdf,120,HY-100224,,304909-07-7,Hedgehog; Smo,Stem Cell/Wnt,C23H27N5,10mM,Cancer,No Development Reported,Cc1nn(-c2ccccc2)c(C)c1/C=N/N1CCN(Cc2ccccc2)CC1,清洗成功,0.2647058823529412
1375,Oc1ccc(-c2c(-c3ccccc3)nn3c(C(F)(F)F)cc(C(F)(F)F)nc23)cc1,1,0.9896125197410583,0.9896125197410583,OC1=CC=C(C2=C3N=C(C(F)(F)F)C=C(C(F)(F)F)N3N=C2C4=CC=CC=C4)C=C1,PHTPP,Data.sdf,1607,HY-103456,,805239-56-9,Estrogen Receptor/ERR,Vitamin D Related/Nuclear Receptor,C20H11F6N3O,10mM,Cancer,No Development Reported,Oc1ccc(-c2c(-c3ccccc3)nn3c(C(F)(F)F)cc(C(F)(F)F)nc23)cc1,清洗成功,0.3103448275862069
1243,Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12,1,0.9896098375320435,0.9896098375320435,NC1=NC(Cl)=CC(NC2=CC(F)=C(OC3=C4C(NC=C4C)=NC=C3)C(F)=C2)=N1,BAY-549,Data.sdf,1444,HY-10319,ROCK-IN-2; Azaindole 1; TC-S 7001,867017-68-3,ROCK,Cell Cycle/DNA Damage; Cytoskeleton; Stem Cell/Wnt; TGF-beta/Smad,C18H13ClF2N6O,10mM,Cardiovascular Disease,No Development Reported,Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12,清洗成功,0.3432835820895522
5851,CN(C)C/C=C/C(=O)Nc1cccc(-c2c(-c3ccccc3)oc3ncnc(N[C@H](CO)c4ccccc4)c23)c1,1,0.9896089434623718,0.9896089434623718,O=C(NC1=CC=CC(C2=C(C3=CC=CC=C3)OC4=NC=NC(N[C@@H](C5=CC=CC=C5)CO)=C42)=C1)/C=C/CN(C)C,Gozanertinib,Data.sdf,6919,HY-128778,,1226549-49-0,EGFR,JAK/STAT Signaling; Protein Tyrosine Kinase/RTK,C32H31N5O3,10mM,Cancer,Phase 1,CN(C)C/C=C/C(=O)Nc1cccc(-c2c(-c3ccccc3)oc3ncnc(N[C@H](CO)c4ccccc4)c23)c1,清洗成功,0.3177570093457944
8240,COc1c(-c2cn(C3CCC(=O)NC3=O)nn2)csc1C(=O)N1CCCC1,1,0.9896056652069092,0.9896056652069092,O=C(C(N1N=NC(C2=CSC(C(N3CCCC3)=O)=C2OC)=C1)CC4)NC4=O,TMX-4116,Data.sdf,9731,HY-145322,,2766385-56-0,Casein Kinase; Molecular Glues,Cell Cycle/DNA Damage; PROTAC; Stem Cell/Wnt,C17H19N5O4S,10mM,Cancer,No Development Reported,COc1c(-c2cn(C3CCC(=O)NC3=O)nn2)csc1C(=O)N1CCCC1,清洗成功,0.217391304347826
3212,CCOC(=O)O[C@@H](C)n1nnnc1-c1c(-c2ccc(C(=O)N(c3ncccc3Cl)[C@@H]3CCCNC3)cc2F)cnn1C,1,0.9896042346954346,0.9896042346954346,O=C(N([C@H]1CNCCC1)C2=C(Cl)C=CC=N2)C3=CC=C(C4=C(C5=NN=NN5[C@H](C)OC(OCC)=O)N(C)N=C4)C(F)=C3.[H]Cl,PF-06815345 (hydrochloride),Data.sdf,3778,HY-112598A,,2334434-49-8,PCSK9,Metabolic Enzyme/Protease,C27H30Cl2FN9O4,10mM,Metabolic Disease; Cardiovascular Disease,Phase 1,CCOC(=O)O[C@@H](C)n1nnnc1-c1c(-c2ccc(C(=O)N(c3ncccc3Cl)[C@@H]3CCCNC3)cc2F)cnn1C,清洗成功,0.2389380530973451
14465,COc1c2c(cc3oc(C)cc(=O)c13)O[C@H](C(C)(C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C2,1,0.989601194858551,0.989601194858551,O[C@H]1[C@H](O)[C@@H](CO)O[C@@H](OC(C)([C@H]2OC3=C(C(OC)=C(C(C=C(C)O4)=O)C4=C3)C2)C)[C@@H]1O,5-O-Methylvisammioside,Data.sdf,17113,HY-N0442,4'-O-?2-D-Glucosyl-5-O-methylvisamminol,84272-85-5,Others,Others,C22H28O10,10mM,Others,No Development Reported,COc1c2c(cc3oc(C)cc(=O)c13)O[C@H](C(C)(C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C2,清洗成功,0.3048780487804878
14997,O=c1c(O[C@@H]2O[C@H](CO[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,1,0.9895989894866943,0.9895989894866943,O=C1C(O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](CO[C@H]3[C@@H]([C@H]([C@@H]([C@@H](CO)O3)O)O)O)O2)O)O)O)=C(C4=CC=C(O)C=C4)OC5=CC(O)=CC(O)=C15,Kaempferol 3-O-gentiobioside,Data.sdf,17811,HY-N1510,,22149-35-5,Glycosidase,Metabolic Enzyme/Protease,C27H30O16,10mM,Metabolic Disease,No Development Reported,O=c1c(O[C@@H]2O[C@H](CO[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,清洗成功,0.3292682926829268
7429,COc1cc2[nH]c(C)c(-c3ccc(Oc4ccc(OC(F)(F)F)cc4)cc3)c(=O)c2cc1Cl,1,0.9895946979522705,0.9895946979522705,O=C1C(C2=CC=C(OC3=CC=C(OC(F)(F)F)C=C3)C=C2)=C(C)NC4=C1C=C(Cl)C(OC)=C4,ELQ-300,Data.sdf,8793,HY-13836,,1354745-52-0,Parasite,Anti-infection,C24H17ClF3NO4,10mM,Infection,No Development Reported,COc1cc2[nH]c(C)c(-c3ccc(Oc4ccc(OC(F)(F)F)cc4)cc3)c(=O)c2cc1Cl,清洗成功,0.2647058823529412
157,Cc1cc(-c2nncc3c(C(C)(C)C)c(OCc4ncnn4C)nn23)no1,1,0.9895880222320557,0.9895880222320557,CN1N=CN=C1COC2=NN3C(C4=NOC(C)=C4)=NN=CC3=C2C(C)(C)C,MRK-016,Data.sdf,182,HY-100370,,342652-67-9,GABA Receptor,Membrane Transporter/Ion Channel; Neuronal Signaling,C17H20N8O2,10mM,Cancer,No Development Reported,Cc1cc(-c2nncc3c(C(C)(C)C)c(OCc4ncnn4C)nn23)no1,清洗成功,0.2045454545454545
6192,COc1cc(-c2c(-c3ccccc3)ncn2CCC2CCCN2C)ccc1O,1,0.9895859360694885,0.9895859360694885,OC1=CC=C(C2=C(C3=CC=CC=C3)N=CN2CCC4N(C)CCC4)C=C1OC,yGsy2p-IN-H23,Data.sdf,7326,HY-131177,,1269190-98-8,GSK-3,PI3K/Akt/mTOR; Stem Cell/Wnt,C23H27N3O2,10mM,Metabolic Disease,No Development Reported,COc1cc(-c2c(-c3ccccc3)ncn2CCC2CCCN2C)ccc1O,清洗成功,0.3116883116883117
5998,COc1cc(NC(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,1,0.9895851016044617,0.9895851016044617,O=C(OC1CCN(CCC(NC2=CC(OC)=C(CNC[C@H](O)C3=CC=C(O)C4=C3C=CC(N4)=O)C=C2Cl)=O)CC1)NC5=CC=CC=C5C6=CC=CC=C6,Batefenterol,Data.sdf,7097,HY-12980,GSK961081; TD-5959,743461-65-6,Adrenergic Receptor; mAChR,GPCR/G Protein; Neuronal Signaling,C40H42ClN5O7,10mM,Inflammation/Immunology; Endocrinology,Phase 2,COc1cc(NC(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12,清洗成功,0.2480620155038759
14276,C=C[C@H]1C[N@]2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccccc12,1,0.9895819425582886,0.9895819425582886,C=C[C@H]1C[N@](CC[C@H]1C2)[C@]2([H])[C@H](O)C3=CC=NC4=CC=CC=C34,Cinchonidine,Data.sdf,16868,HY-N0173,?±-Quinidine,485-71-2,Parasite; Serotonin Transporter,Anti-infection; Neuronal Signaling,C19H22N2O,10mM,Infection,No Development Reported,C=C[C@H]1C[N@]2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccccc12,清洗成功,0.2352941176470588
9537,Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCC(=O)N2CCC3(CC2)CCN(c2cncc(Nc4ncc(Cl)c(-c5cccc(-c6ccccc6)c5)n4)c2)C3=O)C(C)(C)C)cc1,1,0.9895794987678528,0.9895794987678528,ClC1=CN=C(N=C1C2=CC=CC(C3=CC=CC=C3)=C2)NC4=CC(N(C5=O)CCC5(CC6)CCN6C(CCCCCC(N[C@H](C(N7[C@H](C(N[C@@H](C)C8=CC=C(C9=C(C)N=CS9)C=C8)=O)C[C@@H](O)C7)=O)C(C)(C)C)=O)=O)=CN=C4,TMX-4153,Data.sdf,11264,HY-153119,,2867519-91-1,Ligands for Target Protein for PROTAC,PROTAC,C59H67ClN10O6S,10mM,Others,No Development Reported,Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCC(=O)N2CCC3(CC2)CCN(c2cncc(Nc4ncc(Cl)c(-c5cccc(-c6ccccc6)c5)n4)c2)C3=O)C(C)(C)C)cc1,清洗成功,0.2098765432098765
2866,CCc1c(N(CC)C2CCOCC2)cc2oc(C3CCN(C(C)C)CC3)cc2c1C(=O)NCc1c(C)cc(C)[nH]c1=O,1,0.9895729422569275,0.9895729422569275,CCC1=C(C(NCC2=C(C)C=C(C)NC2=O)=O)C(C=C(C3CCN(C(C)C)CC3)O4)=C4C=C1N(C5CCOCC5)CC,EBI-2511,Data.sdf,3367,HY-111418,,2098546-05-3,Histone Methyltransferase,Epigenetics,C34H48N4O4,2mM,Cancer,No Development Reported,CCc1c(N(CC)C2CCOCC2)cc2oc(C3CCN(C(C)C)CC3)cc2c1C(=O)NCc1c(C)cc(C)[nH]c1=O,清洗成功,0.2155172413793103
18191,C=C[C@H]1C[N@@]2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccccc12,1,0.9895720481872559,0.9895720481872559,O[C@@H](C1=CC=NC2=CC=CC=C12)[C@]3([H])[N@@]4C[C@H](C=C)[C@@H](CC4)C3,Cinchonine,Data.sdf,21681,HY-Y0152,"(8R,9S)-Cinchonine; LA40221",118-10-5,Apoptosis; Autophagy; Calcium Channel; Caspase; Parasite,Anti-infection; Apoptosis; Autophagy; Membrane Transporter/Ion Channel; Neuronal Signaling,C19H22N2O,10mM,Cancer; Inflammation/Immunology; Others,No Development Reported,C=C[C@H]1C[N@@]2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccccc12,清洗成功,0.2352941176470588
6001,CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1cccc(-c2ccc(OC(F)F)cc2)c1,1,0.9895706176757812,0.9895706176757812,O=S(C1=CC(C#N)=CC=C1OC2=CC(C3=CC=C(OC(F)F)C=C3)=CC=C2)(NC(NC(C)(C)C)=O)=O,NTP42,Data.sdf,7100,HY-129851,,2055599-51-2,Prostaglandin Receptor,GPCR/G Protein,C25H23F2N3O5S,10mM,Cardiovascular Disease,Phase 1,CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1cccc(-c2ccc(OC(F)F)cc2)c1,清洗成功,0.2325581395348837
13371,CC1(C)[C@H](C=C(Cl)Cl)[C@@H]1C(=O)O[C@@H](C#N)c1cccc(Oc2ccccc2)c1,1,0.9895667433738708,0.9895667433738708,O=C([C@@H]1C(C)(C)[C@@H]1/C=C(Cl)\Cl)O[C@@H](C#N)C2=CC=CC(OC3=CC=CC=C3)=C2,Alpha-Cypermethrin,Data.sdf,15780,HY-B0874,FMC 45497; Fendona; WL 85871,67375-30-8,Insecticide,Others,C22H19Cl2NO3,10mM,Others,No Development Reported,CC1(C)[C@H](C=C(Cl)Cl)[C@@H]1C(=O)O[C@@H](C#N)c1cccc(Oc2ccccc2)c1,清洗成功,0.2179487179487179
2504,CN1CC[C@@H](COC(=O)Nc2ccccc2-c2ccc(F)c(Cl)c2)C1,1,0.9895662069320679,0.9895662069320679,O=C(OC[C@H]1CN(C)CC1)NC2=CC=CC=C2C3=CC=C(F)C(Cl)=C3,Velufenacin,Data.sdf,2937,HY-109196,DA-8010,1648737-78-3,mAChR,GPCR/G Protein; Neuronal Signaling,C19H20ClFN2O2,10mM,Neurological Disease,Phase 3,CN1CC[C@@H](COC(=O)Nc2ccccc2-c2ccc(F)c(Cl)c2)C1,清洗成功,0.3372093023255814
2422,C=CC(=O)Nc1cc(Nc2nccc(-n3cc(CN(C)C)c(-c4ccccc4)n3)n2)c(OC)cc1N1CCOCC1,1,0.9895645380020142,0.9895645380020142,C=CC(NC1=CC(NC2=NC=CC(N3N=C(C4=CC=CC=C4)C(CN(C)C)=C3)=N2)=C(OC)C=C1N5CCOCC5)=O,Lazertinib,Data.sdf,2847,HY-109061,YH25448; GNS-1480,1903008-80-9,EGFR,JAK/STAT Signaling; Protein Tyrosine Kinase/RTK,C30H34N8O3,2mM,Cancer,Launched,C=CC(=O)Nc1cc(Nc2nccc(-n3cc(CN(C)C)c(-c4ccccc4)n3)n2)c(OC)cc1N1CCOCC1,清洗成功,0.3428571428571428
589,N#C/C(=C\c1ccc(O)c(O)c1)C(=O)OCCc1cccs1,1,0.9895629286766052,0.9895629286766052,O=C(OCCC1=CC=CS1)/C(C#N)=C/C2=CC=C(O)C(O)=C2,2-TEDC,Data.sdf,667,HY-101051,,132465-10-2,Lipoxygenase,Metabolic Enzyme/Protease,C16H13NO4S,10mM,Metabolic Disease; Cardiovascular Disease,No Development Reported,N#C/C(=C\c1ccc(O)c(O)c1)C(=O)OCCc1cccs1,清洗成功,0.2830188679245283
10708,COc1ccc([C@H]2Cc3[nH]c4ccccc4c3[C@@H](CCNCC3CC3)[C@@H]2N)cc1,1,0.9895586967468262,0.9895586967468262,N[C@@H]([C@@H]1CCNCC2CC2)[C@@H](C3=CC=C(OC)C=C3)CC4=C1C5=C(N4)C=CC=C5.Cl.Cl,UCM-13369 (dihydrochloride),Data.sdf,12691,HY-162265A,,,Apoptosis,Apoptosis,C25H33Cl2N3O,10mM,Cancer,No Development Reported,COc1ccc([C@H]2Cc3[nH]c4ccccc4c3[C@@H](CCNCC3CC3)[C@@H]2N)cc1,清洗成功,0.2441860465116279
5468,O=C(Nc1csc([N+](=O)[O-])c1)Nc1c(Cl)cccc1Cl,1,0.9895548820495605,0.9895548820495605,O=C(NC1=CSC([N+]([O-])=O)=C1)NC2=C(Cl)C=CC=C2Cl,DFP00173,Data.sdf,6443,HY-126073,,672286-03-2,Aquaporin,Membrane Transporter/Ion Channel,C11H7Cl2N3O3S,10mM,Cancer; Inflammation/Immunology,No Development Reported,O=C(Nc1csc([N+](=O)[O-])c1)Nc1c(Cl)cccc1Cl,清洗成功,0.3103448275862069
5962,Cc1cccc(-c2n[nH]cc2-c2ccc(F)c(-c3cnn(CCO)c3)c2)n1,1,0.9895532131195068,0.9895532131195068,FC1=C(C2=CN(CCO)N=C2)C=C(C3=CNN=C3C4=CC=CC(C)=N4)C=C1,R-268712,Data.sdf,7052,HY-12953,,879487-87-3,Anaplastic lymphoma kinase (ALK); TGF-beta/Smad; TGF-?2 Receptor,Protein Tyrosine Kinase/RTK; Stem Cell/Wnt; TGF-beta/Smad,C20H18FN5O,10mM,Cancer; Inflammation/Immunology; Cardiovascular Disease,No Development Reported,Cc1cccc(-c2n[nH]cc2-c2ccc(F)c(-c3cnn(CCO)c3)c2)n1,清洗成功,0.2840909090909091
3220,N#Cc1c(-c2cccs2)[nH]c(SCc2cccc(-c3nnn[nH]3)c2)nc1=O,1,0.9895409941673279,0.9895409941673279,N#CC1=C(C2=CC=CS2)NC(SCC3=CC=CC(C4=NN=NN4)=C3)=NC1=O,TES-991,Data.sdf,3786,HY-112619,,1883602-20-7,Others,Others,C17H11N7OS2,10mM,Metabolic Disease,No Development Reported,N#Cc1c(-c2cccs2)[nH]c(SCc2cccc(-c3nnn[nH]3)c2)nc1=O,清洗成功,0.2386363636363636
4917,CN(CC(=O)Nc1ccc(F)c(F)c1F)C(=O)c1ccc2c(c1)OCCO2,1,0.9895377159118652,0.9895377159118652,O=C(N(CC(NC1=CC=C(C(F)=C1F)F)=O)C)C2=CC=C3OCCOC3=C2,IMB-808,Data.sdf,5792,HY-123148,,870768-70-0,LXR,Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor,C18H15F3N2O4,10mM,Inflammation/Immunology,No Development Reported,CN(CC(=O)Nc1ccc(F)c(F)c1F)C(=O)c1ccc2c(c1)OCCO2,清洗成功,0.3098591549295774
2309,O=C(N1CCC(C(c2ccc3c(c2)OCO3)c2ccc3c(c2)OCO3)CC1)n1cncn1,1,0.9895370006561279,0.9895370006561279,O=C(N1CCC(C(C2=CC=C(OCO3)C3=C2)C4=CC=C(OCO5)C5=C4)CC1)N6N=CN=C6,JJKK 048,Data.sdf,2710,HY-108613,,1515855-97-6,MAGL,Metabolic Enzyme/Protease,C23H22N4O5,10mM,Cancer; Neurological Disease,No Development Reported,O=C(N1CCC(C(c2ccc3c(c2)OCO3)c2ccc3c(c2)OCO3)CC1)n1cncn1,清洗成功,0.2857142857142857
14607,COc1c2c(cc3oc(CO[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc(=O)c13)O[C@H](C(C)(C)O)C2,1,0.9895338416099548,0.9895338416099548,COC1=C(C[C@@H](C(C)(O)C)O2)C2=CC(OC(CO[C@@H]([C@@H]([C@@H](O)[C@@H]3O)O)O[C@@H]3CO)=C4)=C1C4=O,Prim-O-glucosylcimifugin,Data.sdf,17294,HY-N0635,,80681-45-4,COX; NO Synthase; TNF Receptor,Apoptosis; Immunology/Inflammation,C22H28O11,10mM,Inflammation/Immunology,No Development Reported,COc1c2c(cc3oc(CO[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc(=O)c13)O[C@H](C(C)(C)O)C2,清洗成功,0.2873563218390804
15584,O=c1c(O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,1,0.9895302653312683,0.9895302653312683,O=C1C(O[C@H]2[C@@H]([C@H]([C@@H](O)[C@@H](CO)O2)O)O[C@]3([H])O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)CO)=C(C4=CC=C(O)C=C4)OC5=CC(O)=CC(O)=C51,Panasenoside,Data.sdf,18599,HY-N4258,,31512-06-8,Glycosidase,Metabolic Enzyme/Protease,C27H30O16,10mM,Metabolic Disease,No Development Reported,O=c1c(O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,清洗成功,0.3230769230769231
11994,CC1(C)CC(=O)C2=C(C1)NC(=S)NC2c1cccc(O)c1,1,0.989529550075531,0.989529550075531,O=C1C2=C(NC(NC2C3=CC=CC(O)=C3)=S)CC(C)(C)C1,Dimethylenastron,Data.sdf,14184,HY-19944,,863774-58-7,Kinesin,Cell Cycle/DNA Damage; Cytoskeleton,C16H18N2O2S,10mM,Cancer,No Development Reported,CC1(C)CC(=O)C2=C(C1)NC(=S)NC2c1cccc(O)c1,清洗成功,0.2166666666666666
10691,C[C@@H]1CN(c2ccc(-c3cc(C(=O)NCCCCCCCNC(=O)COc4cccc5c4C(=O)N(C4CCC(=O)NC4=O)C5=O)ccc3F)cc2NC(=O)c2c[nH]c(=O)cc2C(F)(F)F)C[C@H](C)N1C,1,0.9895294308662415,0.9895294308662415,CN1[C@@H](CN(C2=C(C=C(C=C2)C3=CC(C(NCCCCCCCNC(COC4=C(C5=CC=C4)C(N(C5=O)C6C(NC(CC6)=O)=O)=O)=O)=O)=CC=C3F)NC(C7=CNC(C=C7C(F)(F)F)=O)=O)C[C@@H]1C)C,WDR5 degrader-1,Data.sdf,12670,HY-162014,,3032434-45-7,PROTACs; WDR5,Epigenetics; PROTAC,C49H52F4N8O9,10mM,Cancer,No Development Reported,C[C@@H]1CN(c2ccc(-c3cc(C(=O)NCCCCCCCNC(=O)COc4cccc5c4C(=O)N(C4CCC(=O)NC4=O)C5=O)ccc3F)cc2NC(=O)c2c[nH]c(=O)cc2C(F)(F)F)C[C@H](C)N1C,清洗成功,0.2307692307692307
3068,COc1cc(-c2nn(CCN3CCC(N(C)C)CC3)c3ncnc(N)c23)ccc1NC(=O)OC(C)(C)C,1,0.9895249605178833,0.9895249605178833,NC1=C2C(C3=CC(OC)=C(NC(OC(C)(C)C)=O)C=C3)=NN(CCN4CCC(N(C)C)CC4)C2=NC=N1,eCF506,Data.sdf,3589,HY-112096,,1914078-41-3,Src,Protein Tyrosine Kinase/RTK,C26H38N8O3,10mM,Cancer,No Development Reported,COc1cc(-c2nn(CCN3CCC(N(C)C)CC3)c3ncnc(N)c23)ccc1NC(=O)OC(C)(C)C,清洗成功,0.2596153846153846
7802,O=C(O)c1cccc(NC(=O)c2c(Sc3c(Cl)cccc3Cl)cc(C(F)(F)F)[nH]c2=O)c1,1,0.9895234704017639,0.9895234704017639,OC(C1=CC=CC(NC(C2=C(C=C(NC2=O)C(F)(F)F)SC3=C(C=CC=C3Cl)Cl)=O)=C1)=O,NRX-103094,Data.sdf,9227,HY-141449,,2763260-36-0,Molecular Glues; ?2-catenin,PROTAC; Stem Cell/Wnt,C20H11Cl2F3N2O4S,10mM,Cancer,No Development Reported,O=C(O)c1cccc(NC(=O)c2c(Sc3c(Cl)cccc3Cl)cc(C(F)(F)F)[nH]c2=O)c1,清洗成功,0.2777777777777778
5305,O=c1cc(-c2ccc(O)cc2)oc2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)c([C@@H]3OC[C@@H](O)[C@H](O)[C@H]3O)c(O)c12,1,0.9895195960998535,0.9895195960998535,OC1=C([C@H]2[C@@H]([C@H]([C@H](O)CO2)O)O)C(O)=C(C(C=C(C3=CC=C(O)C=C3)O4)=O)C4=C1[C@@H]5O[C@@H]([C@@H](O)[C@H](O)[C@H]5O)CO,Vicenin-1,Data.sdf,6255,HY-125112,,35927-38-9,Angiotensin-converting Enzyme (ACE),Metabolic Enzyme/Protease,C26H28O14,10mM,Cardiovascular Disease,No Development Reported,O=c1cc(-c2ccc(O)cc2)oc2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)c([C@@H]3OC[C@@H](O)[C@H](O)[C@H]3O)c(O)c12,清洗成功,0.2823529411764706
6049,Oc1cc(O)c2c(c1)O[C@@]1(c3ccc(O)c(O)c3)Oc3cc(O)c4c(c3[C@@H]2[C@H]1O)O[C@H](c1ccc(O)c(O)c1)[C@H](O)[C@H]4c1c(O)cc(O)c2c1O[C@H](c1ccc(O)c(O)c1)[C@H](O)C2,1,0.9895163178443909,0.9895163178443909,O[C@H]1[C@@H](C2=CC=C(O)C(O)=C2)OC3=C4C(O[C@]5(C6=CC=C(O)C(O)=C6)OC7=CC(O)=CC(O)=C7[C@@]4([H])[C@H]5O)=CC(O)=C3[C@@H]1C8=C9C(C[C@@H](O)[C@@H](C%10=CC=C(O)C(O)=C%10)O9)=C(O)C=C8O,Cinnamtannin B-1,Data.sdf,7157,HY-130237,,88082-60-4,Reactive Oxygen Species,Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?oB,C45H36O18,10mM,Cancer; Metabolic Disease,No Development Reported,Oc1cc(O)c2c(c1)O[C@@]1(c3ccc(O)c(O)c3)Oc3cc(O)c4c(c3[C@@H]2[C@H]1O)O[C@H](c1ccc(O)c(O)c1)[C@H](O)[C@H]4c1c(O)cc(O)c2c1O[C@H](c1ccc(O)c(O)c1)[C@H](O)C2,清洗成功,0.3333333333333333
3777,O=C(N/N=C/c1c(O)ccc2ccccc12)c1cc(-c2ccc3ccccc3c2)[nH]n1,1,0.989512026309967,0.989512026309967,O=C(C1=NNC(C2=CC=C3C=CC=CC3=C2)=C1)N/N=C/C4=C5C=CC=CC5=CC=C4O,SKI-I,Data.sdf,4451,HY-115735,,306301-68-8,Apoptosis; SphK,Apoptosis; Immunology/Inflammation,C25H18N4O2,10mM,Cancer,No Development Reported,O=C(N/N=C/c1c(O)ccc2ccccc12)c1cc(-c2ccc3ccccc3c2)[nH]n1,清洗成功,0.2763157894736842
3496,C=C[C@]1(C)C[C@@H](OC(=O)CSc2cccc(CO)c2)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,1,0.9895032644271851,0.9895032644271851,O=C(CSC1=CC=CC(CO)=C1)O[C@H]2[C@]3(C)[C@@H](CC[C@]4([C@H]([C@@H]([C@](C=C)(C2)C)O)C)[C@@]3([H])C(CC4)=O)C,BC-7013,Data.sdf,4113,HY-113640,,1028291-66-8,Bacterial,Anti-infection,C29H40O5S,10mM,Infection,Phase 2,C=C[C@]1(C)C[C@@H](OC(=O)CSc2cccc(CO)c2)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O,清洗成功,0.1844660194174757
15108,O=c1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,1,0.9895021319389343,0.9895021319389343,O=C1C(O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](CO)O2)O)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@@H](CO)O3)O)O)O)=C(C4=CC=C(O)C=C4)OC5=CC(O)=CC(O)=C15,Kaempferol 3-O-sophoroside,Data.sdf,17961,HY-N2055,,19895-95-5,AMPK; NF-?oB; TNF Receptor; Toll-like Receptor (TLR),Apoptosis; Epigenetics; Immunology/Inflammation; NF-?oB; PI3K/Akt/mTOR,C27H30O16,10mM,Inflammation/Immunology; Neurological Disease,No Development Reported,O=c1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,清洗成功,0.3230769230769231
10378,CN1CCN(c2ccc3nc(-c4cc(C(C)(C)C)c(OCCCC(=O)NCCCN=[N+]=[N-])c(C(C)(C)C)c4)[nH]c3c2)CC1,1,0.9894965291023254,0.9894965291023254,O=C(NCCCN=[N+]=[N-])CCCOC1=C(C(C)(C)C)C=C(C2=NC3=CC=C(N4CCN(C)CC4)C=C3N2)C=C1C(C)(C)C,MIR96-IN-1,Data.sdf,12304,HY-15843,,1311982-88-3,Apoptosis; MicroRNA,Apoptosis; Epigenetics,C33H48N8O2,10mM,Cancer,No Development Reported,CN1CCN(c2ccc3nc(-c4cc(C(C)(C)C)c(OCCCC(=O)NCCCN=[N+]=[N-])c(C(C)(C)C)c4)[nH]c3c2)CC1,清洗成功,0.2571428571428571
9066,Cc1nc(-c2cc3ccccc3oc2=O)cs1,1,0.9894953370094299,0.9894953370094299,O=C1OC2=C(C=C1C3=CSC(C)=N3)C=CC=C2,WAY-299765,Data.sdf,10687,HY-149686,,106578-02-3,Drug Derivative,Others,C13H9NO2S,10mM,Others,No Development Reported,Cc1nc(-c2cc3ccccc3oc2=O)cs1,清洗成功,0.2777777777777778
15485,C=C[C@@]1(C)Cc2occ(C)c2C(=O)[C@@H]1C(=C)C,1,0.9894822835922241,0.9894822835922241,O=C1C2=C(OC=C2C)C[C@@](C=C)(C)[C@H]1C(C)=C,Curzerenone,Data.sdf,18468,HY-N3651,,20493-56-5,Bacterial,Anti-infection,C15H18O2,10mM,Infection,No Development Reported,C=C[C@@]1(C)Cc2occ(C)c2C(=O)[C@@H]1C(=C)C,清洗成功,0.1911764705882352
12145,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cc(-c3ccc4ncccc4c3)[nH]n2)cc1,1,0.9894796013832092,0.9894796013832092,O=C(NC1=CC(C(C)(C)C)=NN1C2=CC=C(C)C=C2)NC3=NNC(C4=CC5=C(N=CC=C5)C=C4)=C3,Pyk2-IN-2,Data.sdf,14366,HY-401485,,1271418-15-5,FAK; Pyk2,Protein Tyrosine Kinase/RTK,C27H27N7O,10mM,cancer,No Development Reported,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cc(-c3ccc4ncccc4c3)[nH]n2)cc1,清洗成功,0.2967032967032967
1271,COc1ccc(-c2ccn(CC[C@](C)(C(=O)NO)S(C)(=O)=O)c(=O)c2)c(F)c1,1,0.9894781708717346,0.9894781708717346,FC1=C(C2=CC(N(CC[C@](S(C)(=O)=O)(C)C(NO)=O)C=C2)=O)C=CC(OC)=C1,PF-5081090,Data.sdf,1483,HY-103251,LpxC-4,1312473-63-4,Antibiotic; Bacterial,Anti-infection,C18H21FN2O6S,10mM,Infection,No Development Reported,COc1ccc(-c2ccn(CC[C@](C)(C(=O)NO)S(C)(=O)=O)c(=O)c2)c(F)c1,清洗成功,0.3037974683544304
9930,CN1CCC(OC(=O)N(c2ccccc2)c2ccccc2)CC1,1,0.9894759654998779,0.9894759654998779,CN1CCC(CC1)OC(N(C2=CC=CC=C2)C3=CC=CC=C3)=O,mAChR antagonist 1,Data.sdf,11738,HY-155367,,101491-79-6,mAChR,GPCR/G Protein; Neuronal Signaling,C19H22N2O2,10mM,Neurological Disease,No Development Reported,CN1CCC(OC(=O)N(c2ccccc2)c2ccccc2)CC1,清洗成功,0.2876712328767123
15301,COc1cc2ccc(=O)oc2c2ccoc12,1,0.9894758462905884,0.9894758462905884,O=C1C=CC2=C(C3=C(OC=C3)C(OC)=C2)O1,Sphondin,Data.sdf,18219,HY-N2429,,483-66-9,COX,Immunology/Inflammation,C12H8O4,10mM,Inflammation/Immunology,No Development Reported,COc1cc2ccc(=O)oc2c2ccoc12,清洗成功,0.2692307692307692
6331,CCc1cc2ncc(CN3CCN(c4ccc(C(=O)NC)nc4)CC3)cc2[nH]c1=O,1,0.9894633293151855,0.9894633293151855,O=C(C1=NC=C(N2CCN(CC3=CC(N4)=C(N=C3)C=C(CC)C4=O)CC2)C=C1)NC,Saruparib,Data.sdf,7492,HY-132167,AZD5305,2589531-76-8,PARP,Cell Cycle/DNA Damage; Epigenetics,C22H26N6O2,10mM,Cancer,Phase 3,CCc1cc2ncc(CN3CCN(c4ccc(C(=O)NC)nc4)CC3)cc2[nH]c1=O,清洗成功,0.3111111111111111
3869,COc1nn(C)cc1Nc1ncc(F)c(-c2c[nH]c3c(NC(=O)[C@@H](C)N4CCN(C)[C@H](C)C4)cccc23)n1,1,0.9894578456878662,0.9894578456878662,O=C(NC1=CC=CC2=C1NC=C2C3=C(C=NC(NC4=CN(N=C4OC)C)=N3)F)[C@H](N5CCN([C@@H](C5)C)C)C,JAK1-IN-4,Data.sdf,4552,HY-116505,,2091134-35-7,JAK,Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt,C26H32FN9O2,10mM,Cancer,No Development Reported,COc1nn(C)cc1Nc1ncc(F)c(-c2c[nH]c3c(NC(=O)[C@@H](C)N4CCN(C)[C@H](C)C4)cccc23)n1,清洗成功,0.2844036697247706
10508,Cn1cc(-c2ccc(S(=O)(=O)n3ccc(/C=C/C(=O)Nc4ccccc4N)c3)cc2)cn1,1,0.9894564747810364,0.9894564747810364,O=C(NC1=CC=CC=C1N)/C=C/C2=CN(S(=O)(C3=CC=C(C4=CN(C)N=C4)C=C3)=O)C=C2.O=S(C5=CC=C(C)C=C5)(O)=O,Domatinostat (tosylate),Data.sdf,12456,HY-16012,4SC-202,1186222-89-8,Apoptosis; HDAC,Apoptosis; Cell Cycle/DNA Damage; Epigenetics,C30H29N5O6S2,10mM,Cancer,Phase 2,Cn1cc(-c2ccc(S(=O)(=O)n3ccc(/C=C/C(=O)Nc4ccccc4N)c3)cc2)cn1,清洗成功,0.3043478260869565
10510,Cn1cc(-c2ccc(S(=O)(=O)n3ccc(/C=C/C(=O)Nc4ccccc4N)c3)cc2)cn1,1,0.9894564747810364,0.9894564747810364,O=C(NC1=CC=CC=C1N)/C=C/C2=CN(S(=O)(C3=CC=C(C4=CN(C)N=C4)C=C3)=O)C=C2,Domatinostat,Data.sdf,12458,HY-16012A,4SC-202 (free base),910462-43-0,Apoptosis; HDAC,Apoptosis; Cell Cycle/DNA Damage; Epigenetics,C23H21N5O3S,10mM,Cancer,Phase 2,Cn1cc(-c2ccc(S(=O)(=O)n3ccc(/C=C/C(=O)Nc4ccccc4N)c3)cc2)cn1,清洗成功,0.3048780487804878
10386,CN(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)C(=O)c1ccc(CN2CCC(C(N)=O)CC2)cc1,1,0.9894519448280334,0.9894519448280334,O=C(OC1CCN(CCN(C(C2=CC=C(CN3CCC(C(N)=O)CC3)C=C2)=O)C)CC1)NC4=CC=CC=C4C5=CC=CC=C5,Revefenacin,Data.sdf,12312,HY-15851,TD-4208; GSK1160724,864750-70-9,mAChR,GPCR/G Protein; Neuronal Signaling,C35H43N5O4,10mM,Inflammation/Immunology; Cardiovascular Disease,Launched,CN(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)C(=O)c1ccc(CN2CCC(C(N)=O)CC2)cc1,清洗成功,0.3009708737864077
10809,CCN(C/C=C/C#CC(C)(C)C)Cc1cccc(OCc2cc(-c3ccsc3)cs2)c1,1,0.9894422292709351,0.9894422292709351,CCN(C/C=C/C#CC(C)(C)C)CC1=CC=CC(OCC2=CC(C3=CSC=C3)=CS2)=C1,NB-598,Data.sdf,12813,HY-16343,,131060-14-5,COX,Immunology/Inflammation,C27H31NOS2,10mM,Metabolic Disease,No Development Reported,CCN(C/C=C/C#CC(C)(C)C)Cc1cccc(OCc2cc(-c3ccsc3)cs2)c1,清洗成功,0.2178217821782178
10811,CCN(C/C=C/C#CC(C)(C)C)Cc1cccc(OCc2cc(-c3ccsc3)cs2)c1,1,0.9894422292709351,0.9894422292709351,O=C(O)/C=C\C(O)=O.CC(C)(C)C#C/C=C/CN(CC)CC1=CC(OCC2=CC(C3=CSC=C3)=CS2)=CC=C1,NB-598 (Maleate),Data.sdf,12815,HY-16343C,,155294-62-5,COX,Immunology/Inflammation,C31H35NO5S2,10mM,Metabolic Disease,No Development Reported,CCN(C/C=C/C#CC(C)(C)C)Cc1cccc(OCc2cc(-c3ccsc3)cs2)c1,清洗成功,0.2164948453608247
17853,CSc1ncnc2[nH]cnc12,1,0.9894284605979919,0.9894284605979919,CSC1=NC=NC2=C1N=CN2,6-(Methylthio)purine,Data.sdf,21282,HY-W097453,6-Methylmercaptopurine,50-66-8,Endogenous Metabolite,Metabolic Enzyme/Protease,C6H6N4S,10mM,Others,No Development Reported,CSc1ncnc2[nH]cnc12,清洗成功,0.3404255319148936
10511,CC(C)Cc1cccc2nc(Cn3cccc(NC(=O)[C@H](CC/C=C/C(=O)N(C)C)NC(=O)OCc4ccccc4)c3=O)[nH]c12,1,0.9894235730171204,0.9894235730171204,CC(C)CC1=C2C(N=C(N2)CN3C(C(NC([C@H](CC/C=C/C(N(C)C)=O)NC(OCC4=CC=CC=C4)=O)=O)=CC=C3)=O)=CC=C1,TG-2-IN-4,Data.sdf,12459,HY-160132,,2410899-01-1,Glutaminase,Metabolic Enzyme/Protease,C34H40N6O5,10mM,Inflammation/Immunology,No Development Reported,CC(C)Cc1cccc2nc(Cn3cccc(NC(=O)[C@H](CC/C=C/C(=O)N(C)C)NC(=O)OCc4ccccc4)c3=O)[nH]c12,清洗成功,0.2033898305084746
4735,COC[C@@H](C)N[C@H]1CC[C@H](Nc2cc(-c3cccc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1,1,0.9894223809242249,0.9894223809242249,ClC1=CN=C(N[C@H]2CC[C@H](N[C@H](C)COC)CC2)C=C1C3=CC=CC(NCC4(C#N)CCOCC4)=N3,NVP-2,Data.sdf,5562,HY-12214A,,1263373-43-8,Apoptosis; CDK,Apoptosis; Cell Cycle/DNA Damage,C27H37ClN6O2,10mM,Cancer,No Development Reported,COC[C@@H](C)N[C@H]1CC[C@H](Nc2cc(-c3cccc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1,清洗成功,0.2660550458715596
14606,COc1c2c(cc3oc(CO)cc(=O)c13)O[C@H](C(C)(C)O)C2,1,0.9894144535064697,0.9894144535064697,O=C1C=C(CO)OC2=CC(O[C@H](C(C)(O)C)C3)=C3C(OC)=C12,Cimifugin,Data.sdf,17293,HY-N0634,Cimitin,37921-38-3,NF-?oB,NF-?oB,C16H18O6,10mM,Inflammation/Immunology,No Development Reported,COc1c2c(cc3oc(CO)cc(=O)c13)O[C@H](C(C)(C)O)C2,清洗成功,0.2876712328767123
8212,Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCCCCN2CCN(C(=O)CCC(=O)Nc3cccc(Sc4ncc(N5CCC(C)(N)CC5)nc4N)c3Cl)CC2)C(C)(C)C)cc1,1,0.9894101619720459,0.9894101619720459,ClC(C(SC1=NC=C(N2CCC(N)(CC2)C)N=C1N)=CC=C3)=C3NC(CCC(N(CC4)CCN4CCCCCCCCC(N[C@@H](C(C)(C)C)C(N5[C@@H](C[C@H](C5)O)C(N[C@H](C6=CC=C(C7=C(C)N=CS7)C=C6)C)=O)=O)=O)=O)=O,SHP2-D26,Data.sdf,9697,HY-145162,,2458219-65-1,Phosphatase; PROTACs; SHP2,Metabolic Enzyme/Protease; PROTAC; Protein Tyrosine Kinase/RTK,C56H79ClN12O6S2,10mM,Cancer,No Development Reported,Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCCCCN2CCN(C(=O)CCC(=O)Nc3cccc(Sc4ncc(N5CCC(C)(N)CC5)nc4N)c3Cl)CC2)C(C)(C)C)cc1,清洗成功,0.2
5559,CN[C@@H](C)C(=O)O[C@H]1CC(=O)N(C)c2cc(cc(OC)c2Cl)C/C(C)=C/C=C/[C@@H](OC)[C@@]2(O)C[C@H](OC(=O)N2)[C@@H](C)[C@@H]2O[C@@]12C,1,0.9894046783447266,0.9894046783447266,C[C@]12[C@H]([C@@H]([C@](O3)([H])C[C@]([C@](/C=C/C=C(C)/CC4=CC(N(C)C(C[C@]2([H])OC([C@H](C)NC)=O)=O)=C(C(OC)=C4)Cl)([H])OC)(NC3=O)O)C)O1,N-Me-L-Ala-maytansinol,Data.sdf,6562,HY-126663,,77668-69-0,ADC Cytotoxin,Antibody-drug Conjugate/ADC Related,C32H44ClN3O9,10mM,Cancer,No Development Reported,CN[C@@H](C)C(=O)O[C@H]1CC(=O)N(C)c2cc(cc(OC)c2Cl)C/C(C)=C/C=C/[C@@H](OC)[C@@]2(O)C[C@H](OC(=O)N2)[C@@H](C)[C@@H]2O[C@@]12C,清洗成功,0.180327868852459
8870,Cc1ccc2c(NC[C@](O)(CC(C)(C)c3cc(F)cc4c3OCC4)C(F)(F)F)cccc2n1,1,0.9893971681594849,0.9893971681594849,CC(C)(C1=C(OCC2)C2=CC(F)=C1)C[C@@](O)(CNC3=C4C=CC(C)=NC4=CC=C3)C(F)(F)F,Mapracorat,Data.sdf,10466,HY-14864,ZK-245186; BOL-303242X,887375-26-0,Glucocorticoid Receptor,Immunology/Inflammation; Vitamin D Related/Nuclear Receptor,C25H26F4N2O2,10mM,Endocrinology,Phase 3,Cc1ccc2c(NC[C@](O)(CC(C)(C)c3cc(F)cc4c3OCC4)C(F)(F)F)cccc2n1,清洗成功,0.2254901960784313
16035,COc1cc(OC)c2c(=O)c(OC)c(-c3ccc(OC)c(OC)c3)oc2c1,1,0.9893845915794373,0.9893845915794373,O=C1C(OC)=C(C2=CC=C(OC)C(OC)=C2)OC3=CC(OC)=CC(OC)=C13,"3,5,7,3a??4a??Pentamethoxyflavone",Data.sdf,19171,HY-N7690,,1247-97-8,Calcium Channel,Membrane Transporter/Ion Channel; Neuronal Signaling,C20H20O7,10mM,Metabolic Disease; Cardiovascular Disease,No Development Reported,COc1cc(OC)c2c(=O)c(OC)c(-c3ccc(OC)c(OC)c3)oc2c1,清洗成功,0.3
7816,Cc1nc(N2CCC3(CC2)CO[C@@H](C)[C@H]3N)c(CO)nc1Sc1ccnc(N)c1Cl,1,0.9893844723701477,0.9893844723701477,N[C@H]1C2(CO[C@H]1C)CCN(C3=NC(C)=C(SC4=CC=NC(N)=C4Cl)N=C3CO)CC2,Vociprotafib,Data.sdf,9243,HY-141523,RMC-4630; SHP2-IN-7,2172652-48-9,Phosphatase; SHP2,Metabolic Enzyme/Protease; Protein Tyrosine Kinase/RTK,C20H27ClN6O2S,10mM,Cancer,Phase 2,Cc1nc(N2CCC3(CC2)CO[C@@H](C)[C@H]3N)c(CO)nc1Sc1ccnc(N)c1Cl,清洗成功,0.203883495145631
13563,C[N+]12CCC(CC1)C(OC(=O)C(O)(c1ccccc1)c1ccccc1)C2,1,0.9893804788589478,0.9893804788589478,C[N+]1(CC2)CC(OC(C(C3=CC=CC=C3)(O)C4=CC=CC=C4)=O)C2CC1.[Br-],Clidinium (bromide),Data.sdf,15997,HY-B1132,Ro 2-3773,3485-62-9,mAChR,GPCR/G Protein; Neuronal Signaling,C22H26BrNO3,10mM,Neurological Disease,Launched,C[N+]12CCC(CC1)C(OC(=O)C(O)(c1ccccc1)c1ccccc1)C2,清洗成功,0.25
2438,O=C(O)c1ccnc(N2CC(O)(c3ccc(OCc4c(-c5c(Cl)cccc5Cl)noc4C4CC4)cc3Cl)C2)c1,1,0.9893791079521179,0.9893791079521179,ClC1=C(C2(CN(C3=CC(C(O)=O)=CC=N3)C2)O)C=CC(OCC4=C(C5CC5)ON=C4C(C(Cl)=CC=C6)=C6Cl)=C1,Cilofexor,Data.sdf,2863,HY-109083,GS-9674,1418274-28-8,Autophagy; FXR,Autophagy; Metabolic Enzyme/Protease,C28H22Cl3N3O5,10mM,Inflammation/Immunology,Phase 3,O=C(O)c1ccnc(N2CC(O)(c3ccc(OCc4c(-c5c(Cl)cccc5Cl)noc4C4CC4)cc3Cl)C2)c1,清洗成功,0.2291666666666666
2851,CNC(=O)COc1cc2cc(Nc3nc(N4CCC(C(=O)N(C)C)CC4)ncc3Cl)cc(OC)c2n(C)c1=O,1,0.989378035068512,0.989378035068512,ClC1=CN=C(N2CCC(C(N(C)C)=O)CC2)N=C1NC3=CC(C=C(OCC(NC)=O)C(N4C)=O)=C4C(OC)=C3,BI-3812,Data.sdf,3349,HY-111381,,2166387-64-8,Bcl-2 Family,Apoptosis,C26H32ClN7O5,10mM,Cancer,No Development Reported,CNC(=O)COc1cc2cc(Nc3nc(N4CCC(C(=O)N(C)C)CC4)ncc3Cl)cc(OC)c2n(C)c1=O,清洗成功,0.3168316831683168
6721,COc1ccc(CN(C(=O)c2ccccn2)C(C(=O)NC2CCCCC2)c2ccc3cc(OCC(=O)OC(C)(C)C)ccc3c2)cc1,1,0.9893723130226135,0.9893723130226135,O=C(OC(C)(C)C)COC1=CC=C2C=C(C(N(CC3=CC=C(OC)C=C3)C(C4=NC=CC=C4)=O)C(NC5CCCCC5)=O)C=CC2=C1,NY2267,Data.sdf,7979,HY-134975,,886053-73-2,c-Myc,Apoptosis,C38H43N3O6,10mM,Cancer,No Development Reported,COc1ccc(CN(C(=O)c2ccccn2)C(C(=O)NC2CCCCC2)c2ccc3cc(OCC(=O)OC(C)(C)C)ccc3c2)cc1,清洗成功,0.2696629213483146
4046,Nc1ccc(-c2ccncc2)cc1NC(=O)N1CCCC1,1,0.9893697500228882,0.9893697500228882,O=C(N1CCCC1)NC2=C(N)C=CC(C3=CC=NC=C3)=C2,BRD6688,Data.sdf,4751,HY-117709,,1404562-17-9,HDAC,Cell Cycle/DNA Damage; Epigenetics,C16H18N4O,10mM,Neurological Disease,No Development Reported,Nc1ccc(-c2ccncc2)cc1NC(=O)N1CCCC1,清洗成功,0.3108108108108108
13383,CC1(C)C(C=C(Cl)Cl)C1C(=O)OCc1cccc(Oc2ccccc2)c1,1,0.9893688559532166,0.9893688559532166,O=C(C1C(C)(C)C1/C=C(Cl)\Cl)OCC2=CC=CC(OC3=CC=CC=C3)=C2,Permethrin,Data.sdf,15794,HY-B0887,NRDC-143,52645-53-1,Mitochondrial Metabolism; Na+/K+ ATPase; Parasite; Sodium Channel,Anti-infection; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease,C21H20Cl2O3,10mM,Infection; Neurological Disease,Launched,CC1(C)C(C=C(Cl)Cl)C1C(=O)OCc1cccc(Oc2ccccc2)c1,清洗成功,0.2777777777777778
13384,CC1(C)[C@H](C=C(Cl)Cl)[C@H]1C(=O)OCc1cccc(Oc2ccccc2)c1,1,0.9893688559532166,0.9893688559532166,Cl/C(Cl)=C\[C@@H]1[C@H](C1(C)C)C(OCC2=CC(OC3=CC=CC=C3)=CC=C2)=O,(+)-trans-Permethrin,Data.sdf,15795,HY-B0887A,(+)-trans-NRDC-143; (1R)-trans-Permethrin,51877-74-8 ,Insecticide,Others,C21H20Cl2O3,10mM,Others,No Development Reported,CC1(C)[C@H](C=C(Cl)Cl)[C@H]1C(=O)OCc1cccc(Oc2ccccc2)c1,清洗成功,0.2777777777777778
13385,CC1(C)[C@@H](C=C(Cl)Cl)[C@@H]1C(=O)OCc1cccc(Oc2ccccc2)c1,1,0.9893688559532166,0.9893688559532166,Cl/C(Cl)=C\[C@H]1[C@@H](C1(C)C)C(OCC2=CC(OC3=CC=CC=C3)=CC=C2)=O,(-)-trans-Permethrin,Data.sdf,15796,HY-B0887B,(-)-trans-NRDC-143; (1S)-trans-Permethrin,54774-47-9,Insecticide,Others,C21H20Cl2O3,10mM,Others,No Development Reported,CC1(C)[C@@H](C=C(Cl)Cl)[C@@H]1C(=O)OCc1cccc(Oc2ccccc2)c1,清洗成功,0.2777777777777778
13386,CC1(C)[C@H](C(=O)OCc2cccc(Oc3ccccc3)c2)[C@@H]1C=C(Cl)Cl,1,0.9893688559532166,0.9893688559532166,Cl/C(Cl)=C\[C@H]1[C@H](C1(C)C)C(OCC2=CC(OC3=CC=CC=C3)=CC=C2)=O,1R-cis-Permethrin,Data.sdf,15797,HY-B0887C,1R-cis-NRDC-143,54774-45-7,Parasite,Anti-infection,C21H20Cl2O3,10mM,Infection,Phase 4,CC1(C)[C@H](C(=O)OCc2cccc(Oc3ccccc3)c2)[C@@H]1C=C(Cl)Cl,清洗成功,0.2777777777777778
13387,CC1(C)[C@H](C=C(Cl)Cl)[C@@H]1C(=O)OCc1cccc(Oc2ccccc2)c1,1,0.9893688559532166,0.9893688559532166,Cl/C(Cl)=C\[C@@H]1[C@@H](C1(C)C)C(OCC2=CC(OC3=CC=CC=C3)=CC=C2)=O,(-)-cis-Permethrin,Data.sdf,15798,HY-B0887D,(-)-cis-NRDC-143,54774-46-8,Insecticide,Others,C21H20Cl2O3,10mM,Others,No Development Reported,CC1(C)[C@H](C=C(Cl)Cl)[C@@H]1C(=O)OCc1cccc(Oc2ccccc2)c1,清洗成功,0.2777777777777778
3528,COc1cccc(CN(C(=O)CC(C)(C)C)[C@H]2C[C@@H](C(=O)N3CCNCC3)N(Cc3ccc4c(c3)OCO4)C2)c1,1,0.9893681406974792,0.9893681406974792,CC(C)(C)CC(N([C@@H]1CN(CC2=CC=C(OCO3)C3=C2)[C@H](C(N4CCNCC4)=O)C1)CC5=CC=CC(OC)=C5)=O,CUR61414,Data.sdf,4151,HY-113965,,334998-36-6,Apoptosis; Hedgehog; Smo,Apoptosis; Stem Cell/Wnt,C31H42N4O5,10mM,Inflammation/Immunology,No Development Reported,COc1cccc(CN(C(=O)CC(C)(C)C)[C@H]2C[C@@H](C(=O)N3CCNCC3)N(Cc3ccc4c(c3)OCO4)C2)c1,清洗成功,0.2580645161290322
10849,CNC(=O)C#CCNC(=O)c1ccc(-c2ccccc2)[nH]c1=O,1,0.9893667101860046,0.9893667101860046,CNC(C#CCNC(C1=CC=C(NC1=O)C2=CC=CC=C2)=O)=O,GSK_WRN2,Data.sdf,12860,HY-163941,,,DNA/RNA Synthesis,Cell Cycle/DNA Damage,C17H15N3O3,10mM,Cancer,No Development Reported,CNC(=O)C#CCNC(=O)c1ccc(-c2ccccc2)[nH]c1=O,清洗成功,0.2592592592592592
7150,COc1cc2cc(c1Cl)N(C)C(=O)C[C@H](OC(=O)[C@H](C)N(C)C(C)=O)[C@]1(C)O[C@H]1[C@H](C)[C@@H]1C[C@@](O)(NC(=O)O1)[C@H](OC)/C=C/C=C(\C)C2,1,0.9893665909767151,0.9893665909767151,C[C@]12[C@@]([C@@H]([C@]3([H])C[C@]([C@@H](/C=C/C=C(CC4=CC(N(C(C[C@@H]2OC([C@H](C)N(C)C(C)=O)=O)=O)C)=C(C(OC)=C4)Cl)\C)OC)(NC(O3)=O)O)C)([H])O1,Maytansine,Data.sdf,8466,HY-13674,NSC 153858,35846-53-8,Microtubule/Tubulin,Cell Cycle/DNA Damage; Cytoskeleton,C34H46ClN3O10,10mM,Cancer,Launched,COc1cc2cc(c1Cl)N(C)C(=O)C[C@H](OC(=O)[C@H](C)N(C)C(C)=O)[C@]1(C)O[C@H]1[C@H](C)[C@@H]1C[C@@](O)(NC(=O)O1)[C@H](OC)/C=C/C=C(\C)C2,清洗成功,0.1666666666666666
9857,Cc1cccc(/C=N/Nc2cc(N3CCOCC3)n3nc(-c4ccncc4)nc3n2)c1,1,0.9893531799316406,0.9893531799316406,CC1=CC=CC(/C=N/NC2=NC3=NC(C4=CC=NC=C4)=NN3C(N5CCOCC5)=C2)=C1,PIKfyve-IN-2,Data.sdf,11646,HY-154956,,2245319-25-7,PIKfyve,PI3K/Akt/mTOR,C22H22N8O,2mM,Cancer; Inflammation/Immunology,No Development Reported,Cc1cccc(/C=N/Nc2cc(N3CCOCC3)n3nc(-c4ccncc4)nc3n2)c1,清洗成功,0.247191011235955
15201,COc1cc(C)c2c(=O)cc(C[C@@H](C)O)oc2c1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1OC(=O)/C=C/c1ccc(O)cc1,1,0.9893520474433899,0.9893520474433899,O=C1C=C(C[C@H](O)C)OC2=C([C@H]3[C@@H]([C@H]([C@@H]([C@@H](CO)O3)O)O)OC(/C=C/C4=CC=C(O)C=C4)=O)C(OC)=CC(C)=C12,Aloeresin D,Data.sdf,18082,HY-N2215,,105317-67-7,Beta-secretase,Neuronal Signaling,C29H32O11,10mM,Neurological Disease,No Development Reported,COc1cc(C)c2c(=O)cc(C[C@@H](C)O)oc2c1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1OC(=O)/C=C/c1ccc(O)cc1,清洗成功,0.2653061224489796
4122,N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1,1,0.9893501400947571,0.9893501400947571,O=C(O)C1=CC(CN2CCC(C#N)(CC2)C3=NC=CC=C3)=C4C=CC=CN4C1=O,PQCA,Data.sdf,4846,HY-118342,,1144504-35-7,mAChR,GPCR/G Protein; Neuronal Signaling,C22H20N4O3,10mM,Neurological Disease,No Development Reported,N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1,清洗成功,0.2878787878787879
11943,C=CC(=O)Nc1cccc(-c2cccc3cnc(Nc4ccc(N5CCN(CCO)CC5)c(F)c4F)nc23)c1,1,0.989349901676178,0.989349901676178,OCCN1CCN(C2=C(F)C(F)=C(NC3=NC=C4C(C(C5=CC(NC(C=C)=O)=CC=C5)=CC=C4)=N3)C=C2)CC1,Olafertinib,Data.sdf,14129,HY-19815,,1660963-42-7,EGFR,JAK/STAT Signaling; Protein Tyrosine Kinase/RTK,C29H28F2N6O2,10mM,Cancer,Phase 2,C=CC(=O)Nc1cccc(-c2cccc3cnc(Nc4ccc(N5CCN(CCO)CC5)c(F)c4F)nc23)c1,清洗成功,0.287037037037037
9657,COc1cc(-c2cn(C)c(=O)c3cnc(N4CCC4)cc23)cc(OC)c1CN1CCC(CN2CCC3(CC2)CN(c2ccc4c(c2)C(=O)N(C2CCC(=O)NC2=O)C4)C3)CC1,1,0.9893487691879272,0.9893487691879272,O=C1C2=C(C(C3=CC(OC)=C(CN4CCC(CC4)CN5CCC6(CC5)CN(C6)C7=CC=C8C(C(N(C9C(NC(CC9)=O)=O)C8)=O)=C7)C(OC)=C3)=CN1C)C=C(N%10CCC%10)N=C2,PROTAC BRD9 Degrader-6,Data.sdf,11412,HY-153632,,2676211-62-2,Epigenetic Reader Domain; PROTACs,Epigenetics; PROTAC,C47H56N8O6,10mM,Cancer,No Development Reported,COc1cc(-c2cn(C)c(=O)c3cnc(N4CCC4)cc23)cc(OC)c1CN1CCC(CN2CCC3(CC2)CN(c2ccc4c(c2)C(=O)N(C2CCC(=O)NC2=O)C4)C3)CC1,清洗成功,0.2388059701492537
6575,Cn1ccc(-c2cc(Cl)c(Cl)c3[nH]c4c(c23)CN(C(=O)CO)CC4)n1,1,0.9893479347229004,0.9893479347229004,OCC(N(C1)CCC(N2)=C1C3=C2C(Cl)=C(Cl)C=C3C4=NN(C)C=C4)=O,G140,Data.sdf,7800,HY-133916,,2369751-07-3,Cyclic GMP-AMP Synthase,Immunology/Inflammation,C17H16Cl2N4O2,10mM,Inflammation/Immunology,No Development Reported,Cn1ccc(-c2cc(Cl)c(Cl)c3[nH]c4c(c23)CN(C(=O)CO)CC4)n1,清洗成功,0.2121212121212121
8009,CC(C)Oc1ccc2c(=O)[nH]c3sccc3c2c1,1,0.9893473386764526,0.9893473386764526,CC(OC1=CC2=C(C(NC3=C2C=CS3)=O)C=C1)C,ART-IN-1,Data.sdf,9459,HY-143338,,2418014-98-7,PARP,Cell Cycle/DNA Damage; Epigenetics,C14H13NO2S,10mM,Cancer,No Development Reported,CC(C)Oc1ccc2c(=O)[nH]c3sccc3c2c1,清洗成功,0.3478260869565217
14651,CC[C@]12C=CCN3CC[C@@]4(c5ccc(OC)cc5N(C)[C@H]4[C@@](O)(C(=O)OC)[C@@H]1OC(C)=O)[C@@H]32,1,0.989342451095581,0.989342451095581,CC[C@@]1(C=CCN2CC3)[C@@]2([H])[C@@]3(C4=CC=C(OC)C=C4N5C)[C@]5([H])[C@](C(OC)=O)(O)[C@@H]1OC(C)=O,Vindoline,Data.sdf,17349,HY-N0687,,2182-14-1,Microtubule/Tubulin,Cell Cycle/DNA Damage; Cytoskeleton,C25H32N2O6,10mM,Cancer,No Development Reported,CC[C@]12C=CCN3CC[C@@]4(c5ccc(OC)cc5N(C)[C@H]4[C@@](O)(C(=O)OC)[C@@H]1OC(C)=O)[C@@H]32,清洗成功,0.2592592592592592
3061,CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1,1,0.9893370866775513,0.9893370866775513,O=C(C1=CC=C(OC(F)(F)F)C=C1N)N(CC2)CCC2C3=NC=NC4=CC(N5CCN(C)CC5)=CN=C43,BAY885,Data.sdf,3581,HY-112082,,2307249-33-6,ERK,MAPK/ERK Pathway; Stem Cell/Wnt,C25H28F3N7O2,10mM,Cancer,No Development Reported,CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1,清洗成功,0.2682926829268293
9146,COc1cc(-c2cnc3cc(OCCN4CCOCC4)ccn23)cc2c1C(=O)N(CC(F)(F)F)CC2,1,0.9893324375152588,0.9893324375152588,O=C1C2=C(CCN1CC(F)(F)F)C=C(C3=CN=C4C=C(C=CN43)OCCN5CCOCC5)C=C2OC,GLPG3970,Data.sdf,10786,HY-150203,,2403733-82-2,Salt-inducible Kinase (SIK),Immunology/Inflammation,C25H27F3N4O4,10mM,Inflammation/Immunology,Phase 2,COc1cc(-c2cnc3cc(OCCN4CCOCC4)ccn23)cc2c1C(=O)N(CC(F)(F)F)CC2,清洗成功,0.2432432432432432
10327,COc1ccc(-n2ccc3c(=O)n(CC4(O)CCN(C(=O)C[C@@H](C)c5ccccc5)CC4)cnc32)cc1,1,0.9893290400505066,0.9893290400505066,COC1=CC=C(C=C1)N2C=CC3=C2N=CN(C3=O)CC4(CCN(CC4)C(C[C@H](C5=CC=CC=C5)C)=O)O,YCH2823,Data.sdf,12236,HY-158039,,,Apoptosis; Deubiquitinase,Apoptosis; Cell Cycle/DNA Damage,C29H32N4O4,10mM,Cancer,No Development Reported,COc1ccc(-n2ccc3c(=O)n(CC4(O)CCN(C(=O)C[C@@H](C)c5ccccc5)CC4)cnc32)cc1,清洗成功,0.2352941176470588
592,Cn1c(=O)oc2ccc(-c3ccc(C[C@@H](C#N)NC(=O)[C@@H]4CNCCCO4)cc3)cc21,1,0.9893208742141724,0.9893208742141724,O=C([C@H]1OCCCNC1)N[C@H](C#N)CC2=CC=C(C3=CC=C(OC(N4C)=O)C4=C3)C=C2,Brensocatib,Data.sdf,672,HY-101056,AZD7986; INS 1007,1802148-05-5,Dipeptidyl Peptidase,Metabolic Enzyme/Protease,C23H24N4O4,10mM,Inflammation/Immunology,Phase 3,Cn1c(=O)oc2ccc(-c3ccc(C[C@@H](C#N)NC(=O)[C@@H]4CNCCCO4)cc3)cc21,清洗成功,0.2323232323232323
17157,CN(C(=O)COC(=O)/C=C/c1cccc([N+](=O)[O-])c1)C1CCS(=O)(=O)C1,1,0.9893172383308411,0.9893172383308411,O=C(OCC(N(C)C(CC1)CS1(=O)=O)=O)/C=C/C2=CC=CC([N+]([O-])=O)=C2,CID 5951923,Data.sdf,20429,HY-W011044,,749872-43-3,KLF,MAPK/ERK Pathway,C16H18N2O7S,10mM,Cancer,No Development Reported,CN(C(=O)COC(=O)/C=C/c1cccc([N+](=O)[O-])c1)C1CCS(=O)(=O)C1,清洗成功,0.2253521126760563
6004,Nc1c(C(=O)c2ccccc2)sc2[nH]c(=O)c(C(=O)O)cc12,1,0.9893136620521545,0.9893136620521545,OC(C1=CC2=C(SC(C(C3=CC=CC=C3)=O)=C2N)NC1=O)=O,LDN-91946,Data.sdf,7103,HY-12989,,439946-22-2,Deubiquitinase,Cell Cycle/DNA Damage,C15H10N2O4S,10mM,Cancer; Neurological Disease,No Development Reported,Nc1c(C(=O)c2ccccc2)sc2[nH]c(=O)c(C(=O)O)cc12,清洗成功,0.3166666666666666
11985,Cc1cccc(-c2nc(CNc3ccccc3F)[nH]c2-c2ccc3ncnn3c2)n1,1,0.9893040657043457,0.9893040657043457,CC1=CC=CC(C2=C(C3=CN4C(C=C3)=NC=N4)NC(CNC5=CC=CC=C5F)=N2)=N1,Vactosertib,Data.sdf,14174,HY-19928,EW-7197; TEW-7197,1352608-82-2,TGF-?2 Receptor,TGF-beta/Smad,C22H18FN7,10mM,Cancer,Phase 2,Cc1cccc(-c2nc(CNc3ccccc3F)[nH]c2-c2ccc3ncnn3c2)n1,清洗成功,0.3134328358208955
11986,Cc1cccc(-c2nc(CNc3ccccc3F)[nH]c2-c2ccc3ncnn3c2)n1,1,0.9893040657043457,0.9893040657043457,CC1=CC=CC(C2=C(C3=CN4C(C=C3)=NC=N4)NC(CNC5=CC=CC=C5F)=N2)=N1.Cl,Vactosertib (Hydrochloride),Data.sdf,14175,HY-19928A,EW-7197 (Hydrochloride); TEW-7197 (Hydrochloride),1352610-25-3,TGF-?2 Receptor,TGF-beta/Smad,C22H19ClFN7,10mM,Cancer,Phase 2,Cc1cccc(-c2nc(CNc3ccccc3F)[nH]c2-c2ccc3ncnn3c2)n1,清洗成功,0.3088235294117647
2639,CCOC(=O)c1ccc(-c2ccc(OC(=O)N(C)Cc3cccc(-c4ccncc4)c3)cc2)cc1,1,0.9892962574958801,0.9892962574958801,CN(CC1=CC(C2=CC=NC=C2)=CC=C1)C(OC3=CC=C(C4=CC=C(C(OCC)=O)C=C4)C=C3)=O,WWL113,Data.sdf,3098,HY-110148,,947669-86-5,Carboxylesterase (CES),Metabolic Enzyme/Protease,C29H26N2O4,10mM,Metabolic Disease,No Development Reported,CCOC(=O)c1ccc(-c2ccc(OC(=O)N(C)Cc3cccc(-c4ccncc4)c3)cc2)cc1,清洗成功,0.3442622950819672
15885,COc1cc(OC)c2c(=O)cc(-c3cc(OC)c(OC)c(OC)c3)oc2c1,1,0.9892956614494324,0.9892956614494324,O=C1C=C(C2=CC(OC)=C(OC)C(OC)=C2)OC3=CC(OC)=CC(OC)=C13,"3',?4',?5',?5,?7-?Pentamethoxyflavone",Data.sdf,18975,HY-N7029,,53350-26-8,Others,Others,C20H20O7,10mM,Cancer,No Development Reported,COc1cc(OC)c2c(=O)cc(-c3cc(OC)c(OC)c(OC)c3)oc2c1,清洗成功,0.3043478260869565
15529,COc1ccc(-c2oc3c(CCC(C)(C)O)c(O)cc(O)c3c(=O)c2O)cc1,1,0.9892946481704712,0.9892946481704712,O=C1C(O)=C(C2=CC=C(OC)C=C2)OC3=C(CCC(C)(O)C)C(O)=CC(O)=C13,Wushanicaritin,Data.sdf,18524,HY-N4111,,521-45-9,Others,Others,C21H22O7,10mM,Cancer; Inflammation/Immunology,No Development Reported,COc1ccc(-c2oc3c(CCC(C)(C)O)c(O)cc(O)c3c(=O)c2O)cc1,清洗成功,0.3205128205128205
6269,Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOCCOCCOc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)cc2)C(C)(C)C)cc1,1,0.9892945289611816,0.9892945289611816,O=C(N1[C@@H](C[C@H](C1)O)C(NCC2=CC=C(C3=C(N=CS3)C)C=C2)=O)[C@H](C(C)(C)C)NC(COCCOCCOCCOC(C=C4)=CC=C4C5=CC(C(NC6=CC(Cl)=C(C=C6)OCC7=CC(F)=CC=C7)=NC=N8)=C8C=C5)=O,SJF-1521,Data.sdf,7422,HY-131865,,2230821-40-4,EGFR; PROTACs,JAK/STAT Signaling; PROTAC; Protein Tyrosine Kinase/RTK,C57H61ClFN7O9S,10mM,Others,No Development Reported,Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOCCOCCOc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)cc2)C(C)(C)C)cc1,清洗成功,0.2483660130718954
15187,COc1cc2oc(-c3ccc(O)cc3)cc(=O)c2c(O)c1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,1,0.9892828464508057,0.9892828464508057,O=C1C=C(C2=CC=C(O)C=C2)OC3=CC(OC)=C([C@H]4[C@@H]([C@H]([C@@H]([C@@H](CO)O4)O)O)O)C(O)=C13,Swertisin,Data.sdf,18065,HY-N2189,,6991/10/2,Adenosine Receptor; HBV; SGLT,Anti-infection; GPCR/G Protein; Membrane Transporter/Ion Channel,C22H22O10,10mM,Infection; Inflammation/Immunology; Neurological Disease,No Development Reported,COc1cc2oc(-c3ccc(O)cc3)cc(=O)c2c(O)c1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,清洗成功,0.325
827,Cn1nccc1Nc1nccc(-c2cc3c(s2)C(C)(C)N(CCN2CCOCC2)C3=O)n1,1,0.989282488822937,0.989282488822937,O=C(C(C=C(C1=NC(NC2=CC=NN2C)=NC=C1)S3)=C3C4(C)C)N4CCN5CCOCC5,Temuterkib,Data.sdf,949,HY-101494,LY3214996,1951483-29-6,ERK,MAPK/ERK Pathway; Stem Cell/Wnt,C22H27N7O2S,10mM,Cancer,Phase 2,Cn1nccc1Nc1nccc(-c2cc3c(s2)C(C)(C)N(CCN2CCOCC2)C3=O)n1,清洗成功,0.3333333333333333
1684,Clc1cccc(C(c2ccc3nc[nH]c3c2)n2ccnc2)c1,1,0.9892773628234863,0.9892773628234863,ClC1=CC(C(C2=CC=C3N=CNC3=C2)N4C=CN=C4)=CC=C1,Liarozole,Data.sdf,1992,HY-106019,R75251,115575-11-6,Cytochrome P450; RAR/RXR,Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor,C17H13ClN4,10mM,Cancer; Metabolic Disease; Inflammation/Immunology,Launched,Clc1cccc(C(c2ccc3nc[nH]c3c2)n2ccnc2)c1,清洗成功,0.2307692307692307
1685,Clc1cccc(C(c2ccc3nc[nH]c3c2)n2ccnc2)c1,1,0.9892773628234863,0.9892773628234863,ClC1=CC(C(C2=CC=C3N=CNC3=C2)N4C=CN=C4)=CC=C1.[H]Cl.[H]Cl,Liarozole (dihydrochloride),Data.sdf,1993,HY-106019C,R75251 (dihydrochloride),1883548-96-6,Cytochrome P450; RAR/RXR,Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor,C17H15Cl3N4,10mM,Cancer; Metabolic Disease; Inflammation/Immunology,Phase 3,Clc1cccc(C(c2ccc3nc[nH]c3c2)n2ccnc2)c1,清洗成功,0.2278481012658227
850,O=C(Oc1ccccc1)n1c(=O)oc2ccc(Cl)cc21,1,0.9892772436141968,0.9892772436141968,O=C(N1C(OC2=CC=C(Cl)C=C12)=O)OC3=CC=CC=C3,OGT-IN-1,Data.sdf,974,HY-101548,,371215-02-0,OGT,Neuronal Signaling,C14H8ClNO4,10mM,Metabolic Disease,No Development Reported,O=C(Oc1ccccc1)n1c(=O)oc2ccc(Cl)cc21,清洗成功,0.2631578947368421
2967,O=C(Nc1ccccc1-c1cc(F)c(F)c(F)c1)c1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)nc1C(F)F,1,0.9892767667770386,0.9892767667770386,O=C(C1=CN([C@H]2[C@@H]([C@H]([C@@H]([C@@H](CO)O2)O)O)O)N=C1C(F)F)NC3=CC=CC=C3C4=CC(F)=C(F)C(F)=C4,M700F048,Data.sdf,3476,HY-111741,,2056235-51-7,Fungal,Anti-infection,C23H20F5N3O6,10mM,Infection,No Development Reported,O=C(Nc1ccccc1-c1cc(F)c(F)c(F)c1)c1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)nc1C(F)F,清洗成功,0.2875
6034,Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1,1,0.9892653226852417,0.9892653226852417,CC1=NC(C2=NNC=C2C3=NC4=CC=CN=C4C=C3)=CC=C1,RepSox,Data.sdf,7139,HY-13012,E-616452; SJN 2511,446859-33-2,Organoid; TGF-?2 Receptor,Stem Cell/Wnt; TGF-beta/Smad,C17H13N5,10mM,Metabolic Disease,No Development Reported,Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1,清洗成功,0.2950819672131147
7571,CC(C)Oc1ccc(-c2ccccc2)cc1-n1c(CN2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O,1,0.9892617464065552,0.9892617464065552,O=C1C2=C(N=C(CN3CCN(CC3)C(COC4=CC=C(C=C4)Cl)=O)N1C5=C(OC(C)C)C=CC(C6=CC=CC=C6)=C5)C=CC=C2,Erastin2,Data.sdf,8961,HY-139087,,1695533-44-8,Ferroptosis,Apoptosis,C36H35ClN4O4,10mM,Metabolic Disease,No Development Reported,CC(C)Oc1ccc(-c2ccccc2)cc1-n1c(CN2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O,清洗成功,0.2735849056603773
574,CN1C[C@H](Nc2cnn(C)c(=O)c2Br)C[C@H](c2ccccc2)C1,1,0.9892584681510925,0.9892584681510925,BrC1=C(N[C@@H]2C[C@H](C3=CC=CC=C3)CN(C)C2)C=NN(C)C1=O,GSK 4027,Data.sdf,650,HY-101027,,2079896-25-4,Epigenetic Reader Domain; Histone Acetyltransferase,Epigenetics,C17H21BrN4O,10mM,Cancer; Inflammation/Immunology,No Development Reported,CN1C[C@H](Nc2cnn(C)c(=O)c2Br)C[C@H](c2ccccc2)C1,清洗成功,0.2307692307692307
575,CN1C[C@@H](Nc2cnn(C)c(=O)c2Br)C[C@@H](c2ccccc2)C1,1,0.9892584681510925,0.9892584681510925,BrC1=C(N[C@H]2C[C@@H](C3=CC=CC=C3)CN(C)C2)C=NN(C)C1=O,GSK4028,Data.sdf,651,HY-101027A,,2079886-19-2,Epigenetic Reader Domain; Histone Acetyltransferase,Epigenetics,C17H21BrN4O,10mM,Cancer; Inflammation/Immunology,No Development Reported,CN1C[C@@H](Nc2cnn(C)c(=O)c2Br)C[C@@H](c2ccccc2)C1,清洗成功,0.2307692307692307
5357,O=C1CN(/N=C/c2ccc(-c3ccc([N+](=O)[O-])cc3)o2)C(=O)N1,1,0.9892575144767761,0.9892575144767761,O=C1NC(CN1/N=C/C2=CC=C(C3=CC=C([N+]([O-])=O)C=C3)O2)=O,Dantrolene,Data.sdf,6313,HY-12542,F 368,7261-97-4,Apoptosis; Calcium Channel; Reactive Oxygen Species,Apoptosis; Immunology/Inflammation; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling; NF-?oB,C14H10N4O5,10mM,Inflammation/Immunology; Neurological Disease; Cardiovascular Disease,Launched,O=C1CN(/N=C/c2ccc(-c3ccc([N+](=O)[O-])cc3)o2)C(=O)N1,清洗成功,0.2461538461538461
2533,Oc1ccc(-c2cc(=S)ss2)cc1,1,0.9892531037330627,0.9892531037330627,S=C1SSC(C2=CC=C(O)C=C2)=C1,ADT-OH,Data.sdf,2970,HY-109582,"5-(4-Hydroxyphenyl)-3H-1,2-dithiole-3-thione; ACS 1",18274-81-2,Apoptosis; FAK,Apoptosis; Protein Tyrosine Kinase/RTK,C9H6OS3,10mM,Cancer,No Development Reported,Oc1ccc(-c2cc(=S)ss2)cc1,清洗成功,0.2619047619047619
10250,O=C(Nc1cccc(C(F)(F)F)c1)Nc1cc(S(=O)(=O)NC2CC2)ccc1-c1ccsc1,1,0.9892511963844299,0.9892511963844299,O=S(C1=CC=C(C2=CSC=C2)C(NC(NC3=CC=CC(C(F)(F)F)=C3)=O)=C1)(NC4CC4)=O,AGI-6780,Data.sdf,12131,HY-15734,,1432660-47-3,Isocitrate Dehydrogenase (IDH),Metabolic Enzyme/Protease,C21H18F3N3O3S2,10mM,Cancer,No Development Reported,O=C(Nc1cccc(C(F)(F)F)c1)Nc1cc(S(=O)(=O)NC2CC2)ccc1-c1ccsc1,清洗成功,0.3461538461538461
8608,CN(C)N(C)C(=O)[C@@]1(Cc2ccccc2)CCCN(C(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)C(C)(C)N)C1,1,0.9892497062683105,0.9892497062683105,[H][C@](CC1=CNC2=CC=CC=C21)(NC(C(C)(C)N)=O)C(N3CCC[C@@](C(N(C)N(C)C)=O)(CC4=CC=CC=C4)C3)=O.[H]Cl,Anamorelin (hydrochloride),Data.sdf,10157,HY-14734A,RC-1291 hydrochloride; ONO-7643 hydrochloride,861998-00-7,GHSR,GPCR/G Protein,C31H43ClN6O3,10mM,Cancer; Endocrinology,Launched,CN(C)N(C)C(=O)[C@@]1(Cc2ccccc2)CCCN(C(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)C(C)(C)N)C1,清洗成功,0.2777777777777778
17141,COc1ccc(C(OC[C@H]2O[C@@H](n3cnc4c(=O)[nH]cnc43)C[C@@H]2O)(c2ccccc2)c2ccc(OC)cc2)cc1,1,0.9892470240592957,0.9892470240592957,O[C@H]1C[C@H](N2C(N=CNC3=O)=C3N=C2)O[C@@H]1COC(C4=CC=C(OC)C=C4)(C5=CC=C(OC)C=C5)C6=CC=CC=C6,DMT-dI,Data.sdf,20410,HY-W010744,5'-O-DMT-dI; 2'-Deoxy-5'-O-DMT-inosine,93778-57-5,Nucleoside Antimetabolite/Analog,Cell Cycle/DNA Damage,C31H30N4O6,10mM,Others,No Development Reported,COc1ccc(C(OC[C@H]2O[C@@H](n3cnc4c(=O)[nH]cnc43)C[C@@H]2O)(c2ccccc2)c2ccc(OC)cc2)cc1,清洗成功,0.25
12299,CC(C)[C@H]1c2ccc(F)cc2CC[C@@]1(CCN(C)CCCc1nc2ccccc2[nH]1)OC(=O)C1CC1,1,0.9892452955245972,0.9892452955245972,O=C(C1CC1)O[C@@]2(CCN(CCCC3=NC4=CC=CC=C4N3)C)[C@@H](C(C)C)C5=C(C=C(F)C=C5)CC2.[H]Cl.[H]Cl,NNC 55-0396,Data.sdf,14547,HY-50722,NNC 55-0396 dihydrochloride,357400-13-6,Calcium Channel,Membrane Transporter/Ion Channel; Neuronal Signaling,C30H40Cl2FN3O2,10mM,Neurological Disease; Cardiovascular Disease,No Development Reported,CC(C)[C@H]1c2ccc(F)cc2CC[C@@]1(CCN(C)CCCc1nc2ccccc2[nH]1)OC(=O)C1CC1,清洗成功,0.2095238095238095
5720,Cn1cncc1CN(CCN(CC1CCCCC1)S(=O)(=O)c1ccccn1)c1ccc(C#N)cc1F,1,0.9892422556877136,0.9892422556877136,O=S(C1=NC=CC=C1)(N(CCN(C2=CC=C(C#N)C=C2F)CC3=CN=CN3C)CC4CCCCC4)=O,FGTI-2734,Data.sdf,6755,HY-128350,,1247018-19-4,Farnesyl Transferase,Metabolic Enzyme/Protease,C26H31FN6O2S,10mM,Cancer,No Development Reported,Cn1cncc1CN(CCN(CC1CCCCC1)S(=O)(=O)c1ccccn1)c1ccc(C#N)cc1F,清洗成功,0.2475247524752475
5721,Cn1cncc1CN(CCN(CC1CCCCC1)S(=O)(=O)c1ccccn1)c1ccc(C#N)cc1F,1,0.9892422556877136,0.9892422556877136,OS(=O)(C)=O.O=S(C1=NC=CC=C1)(N(CCN(C2=CC=C(C#N)C=C2F)CC3=CN=CN3C)CC4CCCCC4)=O,FGTI-2734 (mesylate),Data.sdf,6756,HY-128350A,,2702297-24-1,Farnesyl Transferase,Metabolic Enzyme/Protease,C27H35FN6O5S2,10mM,Cancer,No Development Reported,Cn1cncc1CN(CCN(CC1CCCCC1)S(=O)(=O)c1ccccn1)c1ccc(C#N)cc1F,清洗成功,0.25
757,CNC(=O)c1ccc(-c2cc(Cl)cc(Cl)c2Cl)c(N)n1,1,0.9892346858978271,0.9892346858978271,O=C(C1=NC(N)=C(C2=CC(Cl)=CC(Cl)=C2Cl)C=C1)NC,PF-01247324,Data.sdf,864,HY-101383,,875051-72-2,Sodium Channel,Membrane Transporter/Ion Channel,C13H10Cl3N3O,10mM,Neurological Disease,Phase 1,CNC(=O)c1ccc(-c2cc(Cl)cc(Cl)c2Cl)c(N)n1,清洗成功,0.3103448275862069
10756,OC1(c2ccccc2)CSC(=S)N1Cc1ccncc1,1,0.9892328977584839,0.9892328977584839,OC1(CSC(N1CC2=CC=NC=C2)=S)C3=CC=CC=C3,COB-187,Data.sdf,12745,HY-162675,,1862177-86-3,GSK-3,PI3K/Akt/mTOR; Stem Cell/Wnt,C15H14N2OS2,10mM,Cancer; Infection; Metabolic Disease; Neurological Disease,No Development Reported,OC1(c2ccccc2)CSC(=S)N1Cc1ccncc1,清洗成功,0.2807017543859649
1634,C=C[C@H]1CNCC[C@H]1CCC(=O)c1ccnc2ccc(OC)cc12,1,0.989222526550293,0.989222526550293,O=C(C1=CC=NC2=CC=C(OC)C=C12)CC[C@H]3[C@@H](C=C)CNCC3.[H]Cl,Viquidil (hydrochloride),Data.sdf,1931,HY-105559A,Quinotoxine (hydrochloride),52211-63-9,Others,Others,C20H25ClN2O2,10mM,Cardiovascular Disease,No Development Reported,C=C[C@H]1CNCC[C@H]1CCC(=O)c1ccnc2ccc(OC)cc12,清洗成功,0.3414634146341463
1826,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2nc(NC3CCN(C4CCCC4)CC3)sc2c1,1,0.9892215728759766,0.9892215728759766,O=C(O[C@@H]1[C@@]2([H])[C@@](OCC2)([H])OC1)N[C@@H](CC3=CC=CC=C3)[C@H](O)CN(S(=O)(C4=CC=C5N=C(NC6CCN(C7CCCC7)CC6)SC5=C4)=O)CC(C)C,TMC310911,Data.sdf,2157,HY-107123,ASC-09,1000287-05-7,HIV Protease,Anti-infection; Metabolic Enzyme/Protease,C38H53N5O7S2,10mM,Infection,Phase 2,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc2nc(NC3CCN(C4CCCC4)CC3)sc2c1,清洗成功,0.2280701754385964
7692,CC1(F)CN(C(=O)Cn2cnc3c(c(-c4ccc(F)c(Cl)c4)cn3C3CC3)c2=O)C1,1,0.9892194867134094,0.9892194867134094,O=C1C2=C(N=CN1CC(N3CC(C)(C3)F)=O)N(C4CC4)C=C2C5=CC(Cl)=C(F)C=C5,Plazinemdor,Data.sdf,9100,HY-139580,CAD-9303,2378285-59-5,iGluR,Membrane Transporter/Ion Channel; Neuronal Signaling,C21H19ClF2N4O2,10mM,Neurological Disease,Phase 1,CC1(F)CN(C(=O)Cn2cnc3c(c(-c4ccc(F)c(Cl)c4)cn3C3CC3)c2=O)C1,清洗成功,0.2736842105263158
4886,Cc1cc2cc(Oc3ccnc(Nc4cccc(CS(=O)(=O)NCCN(C)C)c4)n3)ccc2[nH]1,1,0.9892064332962036,0.9892064332962036,O=S(CC1=CC=CC(NC2=NC=CC(OC3=CC4=C(NC(C)=C4)C=C3)=N2)=C1)(NCCN(C)C)=O,Sulfatinib,Data.sdf,5753,HY-12297,Surufatinib; HMPL-012,1308672-74-3,FGFR; VEGFR,Protein Tyrosine Kinase/RTK,C24H28N6O3S,10mM,Cancer,Launched,Cc1cc2cc(Oc3ccnc(Nc4cccc(CS(=O)(=O)NCCN(C)C)c4)n3)ccc2[nH]1,清洗成功,0.3033707865168539
11156,CS(=O)(=O)Nc1cc2occ(NC=O)c(=O)c2cc1Oc1ccccc1,1,0.9892039895057678,0.9892039895057678,O=C1C2=CC(OC3=CC=CC=C3)=C(C=C2OC=C1NC([H])=O)NS(=O)(C)=O,Iguratimod,Data.sdf,13214,HY-17009,T614,123663-49-0,COX; Macrophage migration inhibitory factor (MIF),Immunology/Inflammation,C17H14N2O6S,10mM,Inflammation/Immunology,Launched,CS(=O)(=O)Nc1cc2occ(NC=O)c(=O)c2cc1Oc1ccccc1,清洗成功,0.2162162162162162
4092,CC1(C(=O)Nc2ccc(O)c(Cl)c2Cl)CCCCC1,1,0.9891982674598694,0.9891982674598694,O=C(NC1=CC=C(C(Cl)=C1Cl)O)C2(CCCCC2)C,Fenhexamid,Data.sdf,4805,HY-118065,KBR 2738,126833-17-8,Fungal,Anti-infection,C14H17Cl2NO2,10mM,Infection,No Development Reported,CC1(C(=O)Nc2ccc(O)c(Cl)c2Cl)CCCCC1,清洗成功,0.2272727272727272
5639,O=C1/C(=C/c2ccc(O)c(Br)c2)CN(Cc2ccccc2)C/C1=C\c1ccc(O)c(Br)c1,1,0.9891966581344604,0.9891966581344604,O=C1/C(CN(CC2=CC=CC=C2)C/C1=C\C3=CC=C(O)C(Br)=C3)=C/C4=CC=C(O)C(Br)=C4,CARM1-IN-1,Data.sdf,6653,HY-12759,,1020399-49-8,Histone Methyltransferase,Epigenetics,C26H21Br2NO3,10mM,Cancer,No Development Reported,O=C1/C(=C/c2ccc(O)c(Br)c2)CN(Cc2ccccc2)C/C1=C\c1ccc(O)c(Br)c1,清洗成功,0.3064516129032258
3278,Cc1cc(/C=N/NC(=O)c2cc(Br)c(O)c(Br)c2)c(C)n1-c1cccc([N+](=O)[O-])c1,1,0.9891932606697083,0.9891932606697083,O=C(N/N=C/C1=C(C)N(C2=CC=CC([N+]([O-])=O)=C2)C(C)=C1)C3=CC(Br)=C(O)C(Br)=C3,Kinesore,Data.sdf,3855,HY-112777,,363571-83-9,Kinesin; Microtubule/Tubulin,Cell Cycle/DNA Damage; Cytoskeleton,C20H16Br2N4O4,10mM,Others,No Development Reported,Cc1cc(/C=N/NC(=O)c2cc(Br)c(O)c(Br)c2)c(C)n1-c1cccc([N+](=O)[O-])c1,清洗成功,0.3382352941176471
9627,Cn1c(=O)c2c(c3cc(Nc4ccnc(F)c4Cl)ccc31)N[C@@H](C1CC1)C(F)(F)CO2,1,0.9891912341117859,0.9891912341117859,O=C1N(C)C2=C(C=C(NC3=C(Cl)C(F)=NC=C3)C=C2)C4=C1OCC(F)(F)[C@H](C5CC5)N4,CCT374705,Data.sdf,11372,HY-153521,,2640647-90-9,BCL6,Immunology/Inflammation,C21H18ClF3N4O2,10mM,Cancer,No Development Reported,Cn1c(=O)c2c(c3cc(Nc4ccnc(F)c4Cl)ccc31)N[C@@H](C1CC1)C(F)(F)CO2,清洗成功,0.2321428571428571
15461,C[C@@H]1O[C@@H](Oc2cc(O)c3c(=O)c(O)c(-c4ccc(O)cc4)oc3c2)[C@H](O)[C@H](O)[C@H]1O,1,0.9891861081123352,0.9891861081123352,O=C1C(O)=C(C2=CC=C(O)C=C2)OC3=CC(O[C@H]4[C@@H]([C@@H]([C@H]([C@H](C)O4)O)O)O)=CC(O)=C13,Kaempferol-7-O-rhamnoside,Data.sdf,18439,HY-N3431,,20196-89-8,Glycosidase,Metabolic Enzyme/Protease,C21H20O10,10mM,Metabolic Disease,No Development Reported,C[C@@H]1O[C@@H](Oc2cc(O)c3c(=O)c(O)c(-c4ccc(O)cc4)oc3c2)[C@H](O)[C@H](O)[C@H]1O,清洗成功,0.3
3543,CCOC(=O)C1(CCOc2ccccc2)CCN(Cc2ccc(O)c(Cl)c2)CC1,1,0.9891855716705322,0.9891855716705322,O=C(C1(CCN(CC1)CC2=CC=C(C(Cl)=C2)O)CCOC3=CC=CC=C3)OCC,ML359,Data.sdf,4167,HY-114086,,1069858-99-6,PDI,Cell Cycle/DNA Damage; Metabolic Enzyme/Protease,C23H28ClNO4,10mM,Cardiovascular Disease,No Development Reported,CCOC(=O)C1(CCOc2ccccc2)CCN(Cc2ccc(O)c(Cl)c2)CC1,清洗成功,0.3058823529411765
11090,COc1ccc2nccc(C(=O)CC[C@@H]3CCN(CC#Cc4cc(F)cc(F)c4F)C[C@@H]3C(=O)O)c2c1,1,0.9891788959503174,0.9891788959503174,O=C([C@H]1CN(CC#CC2=CC(F)=CC(F)=C2F)CC[C@H]1CCC(C3=CC=NC4=CC=C(OC)C=C34)=O)O,RPR-260243,Data.sdf,13137,HY-16915,,668463-35-2,Potassium Channel,Membrane Transporter/Ion Channel,C28H25F3N2O4,10mM,Cardiovascular Disease,No Development Reported,COc1ccc2nccc(C(=O)CC[C@@H]3CCN(CC#Cc4cc(F)cc(F)c4F)C[C@@H]3C(=O)O)c2c1,清洗成功,0.2608695652173913
249,COc1cc2cc(c1Cl)N(C)C(=O)C[C@H](OC(=O)[C@H](C)N(C)C(=O)CCSC)[C@]1(C)O[C@H]1[C@H](C)[C@@H]1C[C@@](O)(NC(=O)O1)[C@H](OC)/C=C/C=C(\C)C2,1,0.9891736507415771,0.9891736507415771,C[C@]1([C@@](CC(N(C2=CC3=CC(OC)=C2Cl)C)=O)([H])OC([C@H](C)N(C)C(CCSC)=O)=O)[C@H]([C@@H]([C@](OC4=O)([H])C[C@]([C@](/C=C/C=C(C)/C3)([H])OC)(N4)O)C)O1,S-methyl DM1,Data.sdf,284,HY-100504,,912569-84-7,ADC Cytotoxin; Microtubule/Tubulin,Antibody-drug Conjugate/ADC Related; Cell Cycle/DNA Damage; Cytoskeleton,C36H50ClN3O10S,10mM,Cancer,No Development Reported,COc1cc2cc(c1Cl)N(C)C(=O)C[C@H](OC(=O)[C@H](C)N(C)C(=O)CCSC)[C@]1(C)O[C@H]1[C@H](C)[C@@H]1C[C@@](O)(NC(=O)O1)[C@H](OC)/C=C/C=C(\C)C2,清洗成功,0.1610738255033557
5345,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1,1,0.9891726970672607,0.9891726970672607,COC1=CC=C(CCN2CCC(NC3=NC4=CC=CC=C4N3CC5=CC=C(F)C=C5)CC2)C=C1,Astemizole,Data.sdf,6300,HY-12532,R 43512,68844-77-9,Histamine Receptor; Potassium Channel,GPCR/G Protein; Immunology/Inflammation; Membrane Transporter/Ion Channel; Neuronal Signaling,C28H31FN4O,10mM,Inflammation/Immunology; Endocrinology,Launched,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1,清洗成功,0.2588235294117647
3616,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCCOCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCc1ccc(-c2scnc2C)cc1)C(C)(C)C,1,0.9891714453697205,0.9891714453697205,FC1=CC=C(NC(C2(CC2)C(NC3=CC(F)=C(OC4=C(C=C(OC)C(OCCCCOCCCCOCC(N[C@@H](C(C)(C)C)C(N5[C@H](C(NCC6=CC=C(C7=C(C)N=CS7)C=C6)=O)C[C@@H](O)C5)=O)=O)=C8)C8=NC=C4)C=C3)=O)=O)C=C1,SJF?±,Data.sdf,4257,HY-114404,,2254609-27-1,Autophagy; p38 MAPK; PROTACs,Autophagy; MAPK/ERK Pathway; PROTAC,C59H67F2N7O11S,10mM,Cancer,No Development Reported,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCCOCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCc1ccc(-c2scnc2C)cc1)C(C)(C)C,清洗成功,0.2229729729729729
11131,CCN(c1cc(C#CCN2CCOCC2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)[C@H]1CC[C@H](N(C)CCOC)CC1,1,0.9891703724861145,0.9891703724861145,O=C(NCC1=C(C)C=C(C)NC1=O)C2=CC(C#CCN3CCOCC3)=CC(N(CC)[C@H]4CC[C@H](N(CCOC)C)CC4)=C2C,EPZ011989,Data.sdf,13186,HY-16986,,1598383-40-4,Histone Methyltransferase,Epigenetics,C35H51N5O4,10mM,Cancer,No Development Reported,CCN(c1cc(C#CCN2CCOCC2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)[C@H]1CC[C@H](N(C)CCOC)CC1,清洗成功,0.2619047619047619
11132,CCN(c1cc(C#CCN2CCOCC2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)[C@H]1CC[C@H](N(C)CCOC)CC1,1,0.9891703724861145,0.9891703724861145,O=C(NCC1=C(C)C=C(C)NC1=O)C2=CC(C#CCN3CCOCC3)=CC(N(CC)[C@H]4CC[C@H](N(CCOC)C)CC4)=C2C.[H]Cl,EPZ011989 (hydrochloride),Data.sdf,13187,HY-16986B,,2095432-26-9,Histone Methyltransferase,Epigenetics,C35H52ClN5O4,10mM,Cancer,No Development Reported,CCN(c1cc(C#CCN2CCOCC2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)[C@H]1CC[C@H](N(C)CCOC)CC1,清洗成功,0.2598425196850393
8932,Cc1cc(-c2cnc(N)c(Oc3cnn(C4CCN(C)CC4)c3)n2)cc(C)c1C(=O)NCCN1CC[C@@H](F)C1,1,0.9891696572303772,0.9891696572303772,CC1=C(C(NCCN2CC[C@H](C2)F)=O)C(C)=CC(C3=NC(OC4=CN(C5CCN(CC5)C)N=C4)=C(N=C3)N)=C1,HPK1-IN-32,Data.sdf,10537,HY-148847,,2766481-17-6,MAP4K,MAPK/ERK Pathway,C28H37FN8O2,10mM,Cancer,No Development Reported,Cc1cc(-c2cnc(N)c(Oc3cnn(C4CCN(C)CC4)c3)n2)cc(C)c1C(=O)NCCN1CC[C@@H](F)C1,清洗成功,0.3469387755102041
11871,Cc1cc(COc2ccc([C@]3(N)CCN([C@H](CC(C)C)C(=O)NO)C3=O)cc2)c2ccccc2n1,1,0.9891694784164429,0.9891694784164429,OC=O.N[C@]1(C2=CC=C(C=C2)OCC3=CC(C)=NC4=C3C=CC=C4)C(N(CC1)[C@H](CC(C)C)C(NO)=O)=O,BMS-561392 (formate),Data.sdf,14043,HY-19667A,DPC 333 (formate),2922280-85-9,TNF Receptor,Apoptosis,C28H34N4O6,10mM,Inflammation/Immunology,No Development Reported,Cc1cc(COc2ccc([C@]3(N)CCN([C@H](CC(C)C)C(=O)NO)C3=O)cc2)c2ccccc2n1,清洗成功,0.2450980392156862
12501,CN1CC(=O)N2[C@H](c3ccc4c(c3)OCO4)c3[nH]c4ccccc4c3C[C@@H]2C1=O,1,0.9891618490219116,0.9891618490219116,O=C([C@@]1([H])CC2=C([C@@H](C3=CC=C(OCO4)C4=C3)N15)NC6=C2C=CC=C6)N(C)CC5=O,Tadalafil,Data.sdf,14802,HY-90009A,IC-351,171596-29-5,Apoptosis; Phosphodiesterase (PDE),Apoptosis; Metabolic Enzyme/Protease,C22H19N3O4,10mM,Cardiovascular Disease; Cancer,Launched,CN1CC(=O)N2[C@H](c3ccc4c(c3)OCO4)c3[nH]c4ccccc4c3C[C@@H]2C1=O,清洗成功,0.2763157894736842
12502,CN1CC(=O)N2[C@@H](c3ccc4c(c3)OCO4)c3[nH]c4ccccc4c3C[C@H]2C1=O,1,0.9891618490219116,0.9891618490219116,O=C([C@]1([H])CC2=C([C@H](C3=CC=C(OCO4)C4=C3)N15)NC6=C2C=CC=C6)N(C)CC5=O,ent-Tadalafil,Data.sdf,14803,HY-90009C,ent-IC-351,629652-72-8,Phosphodiesterase (PDE),Metabolic Enzyme/Protease,C22H19N3O4,10mM,Cancer,No Development Reported,CN1CC(=O)N2[C@@H](c3ccc4c(c3)OCO4)c3[nH]c4ccccc4c3C[C@H]2C1=O,清洗成功,0.2763157894736842
13516,CC(C)=CC1C(C(=O)OCc2cccc(Oc3ccccc3)c2)C1(C)C,1,0.9891571998596191,0.9891571998596191,O=C(C1C(C)(C)C1/C=C(C)\C)OCC2=CC=CC(OC3=CC=CC=C3)=C2,Phenothrin,Data.sdf,15944,HY-B1072,,26002-80-2,Parasite,Anti-infection,C23H26O3,10mM,Infection,Launched,CC(C)=CC1C(C(=O)OCc2cccc(Oc3ccccc3)c2)C1(C)C,清洗成功,0.2957746478873239
16010,COc1cc(O)c2c(O)c3c(=O)oc(C)cc3cc2c1,1,0.9891310930252075,0.9891310930252075,O=C1C2=C(O)C3=C(O)C=C(OC)C=C3C=C2C=C(C)O1,Toralactone,Data.sdf,19135,HY-N7617,,41743-74-2,Keap1-Nrf2,NF-?oB,C15H12O5,2mM,Cancer,No Development Reported,COc1cc(O)c2c(O)c3c(=O)oc(C)cc3cc2c1,清洗成功,0.2923076923076923
9518,Cc1c(/C=C/c2cc(CNC(C)(CO)C(=O)O)ccc2C(F)(F)F)cccc1-c1ccc2c(c1)OCCO2,1,0.9891306161880493,0.9891306161880493,CC1=C(C=CC=C1/C=C/C2=C(C=CC(CNC(CO)(C)C(O)=O)=C2)C(F)(F)F)C3=CC=C(OCCO4)C4=C3,MAX-10181,Data.sdf,11239,HY-153064,PD-1/PD-L1-IN-30,2171558-14-6,PD-1/PD-L1,Immunology/Inflammation,C29H28F3NO5,10mM,Cancer,Phase 1,Cc1c(/C=C/c2cc(CNC(C)(CO)C(=O)O)ccc2C(F)(F)F)cccc1-c1ccc2c(c1)OCCO2,清洗成功,0.2738095238095238
11403,CC(C)NC(=O)[C@H]1CC[C@@H](n2c(NC(=O)c3ccc(F)cc3)nc3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1,1,0.9891304969787598,0.9891304969787598,O=C(NC1=NC2=CC=C(CN3CCC(C(C)(O)C)CC3)C=C2N1[C@H]4CC[C@@H](C(NC(C)C)=O)CC4)C5=CC=C(F)C=C5,Belizatinib,Data.sdf,13487,HY-17603,TSR-011,1357920-84-3,Anaplastic lymphoma kinase (ALK); Trk Receptor,Neuronal Signaling; Protein Tyrosine Kinase/RTK,C33H44FN5O3,10mM,Cancer,Phase 2,CC(C)NC(=O)[C@H]1CC[C@@H](n2c(NC(=O)c3ccc(F)cc3)nc3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1,清洗成功,0.34375
11821,CCn1c(=O)c(-c2ccc(-c3cncc(C)n3)cc2Cl)cc2cnc(NCCC3CCN(C)CC3)nc21,1,0.9891294240951538,0.9891294240951538,O=C1C(C2=CC=C(C3=NC(C)=CN=C3)C=C2Cl)=CC4=CN=C(NCCC5CCN(C)CC5)N=C4N1CC,FRAX1036,Data.sdf,13983,HY-19538,,1432908-05-8,PAK,Cell Cycle/DNA Damage; Cytoskeleton,C28H32ClN7O,10mM,Cancer,No Development Reported,CCn1c(=O)c(-c2ccc(-c3cncc(C)n3)cc2Cl)cc2cnc(NCCC3CCN(C)CC3)nc21,清洗成功,0.3039215686274509
10523,CN1Cc2cc(-c3ccc(-c4cncc(NS(=O)(=O)c5ccccc5[N+](=O)[O-])c4)s3)ccc2C1=O,1,0.9891282916069031,0.9891282916069031,O=C1C2=C(CN1C)C=C(C3=CC=C(C4=CN=CC(NS(=O)(C5=C([N+]([O-])=O)C=CC=C5)=O)=C4)S3)C=C2,Perforin-IN-2,Data.sdf,12474,HY-160214,,1567836-70-7,Drug Derivative,Others,C24H18N4O5S2,10mM,Inflammation/Immunology,No Development Reported,CN1Cc2cc(-c3ccc(-c4cncc(NS(=O)(=O)c5ccccc5[N+](=O)[O-])c4)s3)ccc2C1=O,清洗成功,0.2441860465116279
5942,C[C@]1(C(=O)N(CCCC(=O)O)Cc2cccc(Cl)c2)CCN1C(=O)c1csc2ccccc12,1,0.9891246557235718,0.9891246557235718,O=C(O)CCCN(C([C@]1(C)N(C(C2=CSC3=CC=CC=C32)=O)CC1)=O)CC4=CC=CC(Cl)=C4,GLPG0974,Data.sdf,7028,HY-12940,,1391076-61-1,Free Fatty Acid Receptor,GPCR/G Protein,C25H25ClN2O4S,10mM,Metabolic Disease,Phase 2,C[C@]1(C(=O)N(CCCC(=O)O)Cc2cccc(Cl)c2)CCN1C(=O)c1csc2ccccc12,清洗成功,0.2666666666666666
5945,C[C@@]1(C(=O)N(CCCC(=O)O)Cc2cccc(Cl)c2)CCN1C(=O)c1csc2ccccc12,1,0.9891246557235718,0.9891246557235718,O=C(O)CCCN(C([C@@]1(C)N(C(C2=CSC3=CC=CC=C32)=O)CC1)=O)CC4=CC=CC(Cl)=C4,(S)-GLPG0974,Data.sdf,7031,HY-12940A,,2326220-69-1,Free Fatty Acid Receptor,GPCR/G Protein,C25H25ClN2O4S,10mM,Metabolic Disease,No Development Reported,C[C@@]1(C(=O)N(CCCC(=O)O)Cc2cccc(Cl)c2)CCN1C(=O)c1csc2ccccc12,清洗成功,0.2666666666666666
9472,COc1ncc(-c2cc(-c3ncc(CN4C[C@@H](C)O[C@@H](C)C4)o3)c3cn[nH]c3c2)cc1NS(C)(=O)=O,1,0.9891217350959778,0.9891217350959778,CS(=O)(NC1=CC(C2=CC3=C(C(C4=NC=C(CN5C[C@@H](C)O[C@@H](C)C5)O4)=C2)C=NN3)=CN=C1OC)=O,GSK2292767,Data.sdf,11181,HY-15280,,1254036-66-2,PI3K,PI3K/Akt/mTOR,C24H28N6O5S,10mM,Inflammation/Immunology,Phase 1,COc1ncc(-c2cc(-c3ncc(CN4C[C@@H](C)O[C@@H](C)C4)o3)c3cn[nH]c3c2)cc1NS(C)(=O)=O,清洗成功,0.2545454545454545
3699,Fc1cc(-c2cccc(-c3ncn[nH]3)c2)cc(F)c1CNC1Cc2ccccc2C1,1,0.989120602607727,0.989120602607727,FC1=C(CNC2CC3=C(C=CC=C3)C2)C(F)=CC(C4=CC=CC(C5=NC=NN5)=C4)=C1,GSK1521498 (free base),Data.sdf,4356,HY-115066,,1007573-18-3,Opioid Receptor,GPCR/G Protein; Neuronal Signaling,C24H20F2N4,10mM,Neurological Disease,Phase 2,Fc1cc(-c2cccc(-c3ncn[nH]3)c2)cc(F)c1CNC1Cc2ccccc2C1,清洗成功,0.240506329113924
11043,Cc1cc(C)c2[nH]c(-c3cnc(NCCCC4CCN(C)CC4)nc3C)nc2c1,1,0.9891168475151062,0.9891168475151062,CN1CCC(CCCNC2=NC=C(C3=NC4=CC(C)=CC(C)=C4N3)C(C)=N2)CC1,Toreforant,Data.sdf,13083,HY-16756,JNJ-38518168,952494-46-1,Histamine Receptor,GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling,C23H32N6,10mM,Neurological Disease; Endocrinology,Phase 2,Cc1cc(C)c2[nH]c(-c3cnc(NCCCC4CCN(C)CC4)nc3C)nc2c1,清洗成功,0.247191011235955
13253,CO[C@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]1Cc1cn(C)c3cccc2c13,1,0.9891084432601929,0.9891084432601929,CO[C@@]([C@@]1([H])C2)(C[C@@H](COC(C3=CN=CC(Br)=C3)=O)CN1C)C4=C5C2=CN(C)C5=CC=C4,Nicergoline,Data.sdf,15645,HY-B0702,,27848-84-6,Adrenergic Receptor,GPCR/G Protein; Neuronal Signaling,C24H26BrN3O3,10mM,Neurological Disease; Cardiovascular Disease,Launched,CO[C@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]1Cc1cn(C)c3cccc2c13,清洗成功,0.2233009708737864
14380,COc1ccc(-c2cc(=O)c3c(O)c(OC)c(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3o2)cc1,1,0.9891069531440735,0.9891069531440735,O=C1C=C(C2=CC=C(OC)C=C2)OC3=CC(O[C@H]4[C@@H]([C@H]([C@@H]([C@@H](CO[C@H]5[C@@H]([C@@H]([C@H]([C@H](C)O5)O)O)O)O4)O)O)O)=C(OC)C(O)=C13,Pectolinarin,Data.sdf,17000,HY-N0314,,28978-02-1,Apoptosis; Interleukin Related; Prostaglandin Receptor,Apoptosis; GPCR/G Protein; Immunology/Inflammation,C29H34O15,10mM,Inflammation/Immunology,No Development Reported,COc1ccc(-c2cc(=O)c3c(O)c(OC)c(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3o2)cc1,清洗成功,0.3033707865168539
2987,Cc1cc2ncnn2cc1Nc1ncc2c(n1)n(C1CCOCC1)c(=O)n2C,1,0.9891030788421631,0.9891030788421631,CC1=CC2=NC=NN2C=C1NC3=NC=C(N(C)C(N4C5CCOCC5)=O)C4=N3,AZD-7648,Data.sdf,3497,HY-111783,,2230820-11-6,Apoptosis; ATM/ATR; DNA-PK; PI3K,Apoptosis; Cell Cycle/DNA Damage; PI3K/Akt/mTOR,C18H20N8O2,10mM,Cancer,Phase 2,Cc1cc2ncnn2cc1Nc1ncc2c(n1)n(C1CCOCC1)c(=O)n2C,清洗成功,0.2631578947368421
11503,Cc1ccn(-c2ccc(-c3ncco3)cc2)c(=O)c1-c1ccc2nc(N)ncc2c1,1,0.9890900254249573,0.9890900254249573,O=C1C(C2=CC3=CN=C(N)N=C3C=C2)=C(C)C=CN1C4=CC=C(C5=NC=CO5)C=C4,c-Kit-IN-5-1,Data.sdf,13606,HY-18302,,1003311-62-3,c-Kit,Protein Tyrosine Kinase/RTK,C23H17N5O2,10mM,Inflammation/Immunology,No Development Reported,Cc1ccn(-c2ccc(-c3ncco3)cc2)c(=O)c1-c1ccc2nc(N)ncc2c1,清洗成功,0.2903225806451613
663,C=CC(=O)N1CCC(CNc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)CC1,1,0.9890837073326111,0.9890837073326111,C=CC(N1CCC(CNC2=NC=NC(N)=C2C3=CC=C(OC4=CC=CC=C4)C=C3)CC1)=O,Evobrutinib,Data.sdf,755,HY-101215,M2951; MSC2364447C,1415823-73-2,Btk,Protein Tyrosine Kinase/RTK,C25H27N5O2,10mM,Inflammation/Immunology; Cancer,Phase 3,C=CC(=O)N1CCC(CNc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)CC1,清洗成功,0.275
12864,CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,1,0.9890747666358948,0.9890747666358948,OC(C(/C=N/N1CCN(C)CC1)=C(NC(/C(C)=C\C=C\[C@@H]([C@@H]([C@@H](C)[C@H]2O)O)C)=O)C(O)=C3C(O)=C4C)=C3C5=C4O[C@](C)(O/C=C/[C@@H]([C@H]([C@@]([C@@H]2C)([H])OC(C)=O)C)OC)C5=O,Rifampicin,Data.sdf,15209,HY-B0272,Rifampin; Rifamycin AMP,13292-46-1,Antibiotic; Bacterial; Influenza Virus; Orthopoxvirus,Anti-infection,C43H58N4O12,10mM,Infection; Cancer,Launched,CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,清洗成功,0.1854838709677419
2854,C=CCN1CC(=O)N2[C@@H](Cc3ccc(O)cc3F)C(=O)N(Cc3cccc(N4CC(N5CCN(CC)CC5)C4)n3)C[C@@H]2N1C(=O)NCc1ccccc1,1,0.9890727400779724,0.9890727400779724,O=C(N([C@](CN1CC2=NC(N3CC(N4CCN(CC)CC4)C3)=CC=C2)([H])N5[C@@H](CC6=CC=C(O)C=C6F)C1=O)N(CC=C)CC5=O)NCC7=CC=CC=C7,E-7386,Data.sdf,3352,HY-111386,,1799824-08-0,Epigenetic Reader Domain,Epigenetics,C39H48FN9O4,10mM,Cancer,Phase 2,C=CCN1CC(=O)N2[C@@H](Cc3ccc(O)cc3F)C(=O)N(Cc3cccc(N4CC(N5CCN(CC)CC5)C4)n3)C[C@@H]2N1C(=O)NCc1ccccc1,清洗成功,0.2096774193548387
11841,CC(C)Oc1ccc(-c2c[nH]cc2CN(C)CCN)cc1,1,0.9890701770782471,0.9890701770782471,CN(CCN)CC1=CNC=C1C2=CC=C(OC(C)C)C=C2,MS023,Data.sdf,14007,HY-19615,,1831110-54-3,Histone Methyltransferase,Epigenetics,C17H25N3O,10mM,Cancer,No Development Reported,CC(C)Oc1ccc(-c2c[nH]cc2CN(C)CCN)cc1,清洗成功,0.24
11842,CC(C)Oc1ccc(-c2c[nH]cc2CN(C)CCN)cc1,1,0.9890701770782471,0.9890701770782471,CC(OC1=CC=C(C=C1)C2=CNC=C2CN(C)CCN)C.Cl.Cl,MS023 (dihydrochloride),Data.sdf,14008,HY-19615B,,1992047-64-9,Histone Methyltransferase,Epigenetics,C17H27Cl2N3O,10mM,Cancer,No Development Reported,CC(C)Oc1ccc(-c2c[nH]cc2CN(C)CCN)cc1,清洗成功,0.2368421052631578
12247,NC(=O)C1CCN(C(=O)CCc2nc3ccccc3c(=O)[nH]2)CC1,1,0.9890637993812561,0.9890637993812561,O=C(C1CCN(C(CCC(N2)=NC3=C(C=CC=C3)C2=O)=O)CC1)N,WAY-620473,Data.sdf,14490,HY-49072,,743451-55-0,Drug Derivative,Others,C17H20N4O3,10mM,Others,No Development Reported,NC(=O)C1CCN(C(=O)CCc2nc3ccccc3c(=O)[nH]2)CC1,清洗成功,0.296875
11823,CCC(=O)N1CCOc2c(cc(-c3ccc(OC)c(OC)c3)cc2OC[C@H]2CCCN(C)C2)C1,1,0.9890608787536621,0.9890608787536621,COC1=C(OC)C=C(C2=CC(OC[C@H]3CCCN(C)C3)=C(OCCN(C(CC)=O)C4)C4=C2)C=C1,I-CBP112,Data.sdf,13985,HY-19541,,1640282-31-0,Epigenetic Reader Domain; Histone Acetyltransferase,Epigenetics,C27H36N2O5,10mM,Cancer,No Development Reported,CCC(=O)N1CCOc2c(cc(-c3ccc(OC)c(OC)c3)cc2OC[C@H]2CCCN(C)C2)C1,清洗成功,0.2345679012345679
14010,CC(C)C[C@@H](N)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O,1,0.9890600442886353,0.9890600442886353,O[C@@H]1[C@@H](O[C@@](O[C@@H](C)[C@H]2O)([H])C[C@@]2(N)C)[C@@H](O[C@H](CO)[C@H]1O)OC3=C(OC4=CC=C([C@H]([C@H]5NC([C@H](N)CC(C)C)=O)O)C=C4Cl)C=C([C@](NC([C@@H](NC5=O)CC(N)=O)=O)([H])C(N[C@](C6=O)([H])C7=CC8=C(O)C=C7)=O)C=C3OC9=CC=C([C@H]([C@](C(N[C@@](C(O)=O)([H])C%10=C8C(O)=CC(O)=C%10)=O)([H])N6)O)C=C9Cl.Cl[H],Norvancomycin (hydrochloride),Data.sdf,16494,HY-B1924,Desmethyl-vancomycin hydrochloride,213997-73-0,Antibiotic; Bacterial,Anti-infection,C65H74Cl3N9O24,10mM,Infection,Launched,CC(C)C[C@@H](N)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O,清洗成功,0.1830065359477124
5129,CCOC(=O)N1CCN(C(c2ccccn2)c2c(-c3ccccc3)n(O)c3ccccc23)CC1,1,0.9890583157539368,0.9890583157539368,O=C(N1CCN(C(C2=C(C3=CC=CC=C3)N(O)C4=C2C=CC=C4)C5=NC=CC=C5)CC1)OCC,PIP-199,Data.sdf,6040,HY-124325,,622795-76-0,DNA Alkylator/Crosslinker,Cell Cycle/DNA Damage,C27H28N4O3,10mM,Cancer,No Development Reported,CCOC(=O)N1CCN(C(c2ccccn2)c2c(-c3ccccc3)n(O)c3ccccc23)CC1,清洗成功,0.2359550561797752
4518,Cc1ccc2c(c1)C(=O)[C@]1(O)CCN(c3ccc([N+](=O)[O-])cc3)C1=N2,1,0.9890553951263428,0.9890553951263428,O=C1[C@]2(C(N(CC2)C3=CC=C(C=C3)[N+]([O-])=O)=NC4=C1C=C(C=C4)C)O,para-Nitroblebbistatin,Data.sdf,5319,HY-120870,,1621326-32-6,Myosin,Cytoskeleton,C18H15N3O4,10mM,Metabolic Disease,No Development Reported,Cc1ccc2c(c1)C(=O)[C@]1(O)CCN(c3ccc([N+](=O)[O-])cc3)C1=N2,清洗成功,0.2638888888888889
8840,O=C(O)c1ccc2nc(-c3cc(Cl)cc(Cl)c3)oc2c1,1,0.9890493154525757,0.9890493154525757,O=C(C1=CC=C2N=C(C3=CC(Cl)=CC(Cl)=C3)OC2=C1)O,Tafamidis,Data.sdf,10434,HY-14852,,594839-88-0,Endoplasmic Reticulum Oxidoreductase 1 (ERO1),Anti-infection,C14H7Cl2NO3,10mM,Neurological Disease,Launched,O=C(O)c1ccc2nc(-c3cc(Cl)cc(Cl)c3)oc2c1,清洗成功,0.3015873015873015
8844,O=C(O)c1ccc2nc(-c3cc(Cl)cc(Cl)c3)oc2c1,1,0.9890491962432861,0.9890491962432861,O=C(C1=CC=C2N=C(C3=CC(Cl)=CC(Cl)=C3)OC2=C1)O.O[C@@H]([C@@H]([C@@H](CO)O)O)[C@@H](O)CNC,Tafamidis meglumine,Data.sdf,10438,HY-14852A,Fx-1006A,951395-08-7,Transthyretin (TTR),Neuronal Signaling,C21H24Cl2N2O8,10mM,Neurological Disease,Launched,O=C(O)c1ccc2nc(-c3cc(Cl)cc(Cl)c3)oc2c1,清洗成功,0.2658227848101265
10160,CC1(C)CCN(Cc2ccc3nc(Cn4cc(-c5cc(Br)cc6[nH]ncc56)nn4)cn3c2)CC1,1,0.989048421382904,0.989048421382904,BrC1=CC(C2=CN(CC3=CN4C=C(CN5CCC(C)(CC5)C)C=CC4=N3)N=N2)=C6C=NNC6=C1,STM3006,Data.sdf,12019,HY-156773,,2499664-52-5,Apoptosis; METTL3,Apoptosis; Epigenetics,C25H27BrN8,10mM,Cancer,No Development Reported,CC1(C)CCN(Cc2ccc3nc(Cn4cc(-c5cc(Br)cc6[nH]ncc56)nn4)cn3c2)CC1,清洗成功,0.3253012048192771
12954,Cc1cccc(N(C)C(=S)Oc2ccc3ccccc3c2)c1,1,0.9890450239181519,0.9890450239181519,S=C(OC1=CC=C2C=CC=CC2=C1)N(C)C3=CC=CC(C)=C3,Tolnaftate,Data.sdf,15316,HY-B0370,NP-27,2398-96-1,Fungal,Anti-infection,C19H17NOS,10mM,Infection,Launched,Cc1cccc(N(C)C(=S)Oc2ccc3ccccc3c2)c1,清洗成功,0.2698412698412698
5816,Cc1cc(C(=O)Nc2nc3cccc(Cl)c3n2[C@@H]2CCCCN(C(=O)/C=C/CN(C)C)C2)ccn1,1,0.9890416264533997,0.9890416264533997,O=C(C1=CC(C)=NC=C1)NC2=NC3=CC=CC(Cl)=C3N2[C@H]4CN(C(/C=C/CN(C)C)=O)CCCC4,Nazartinib,Data.sdf,6880,HY-12872,EGF816,1508250-71-2,EGFR,JAK/STAT Signaling; Protein Tyrosine Kinase/RTK,C26H31ClN6O2,10mM,Cancer,Phase 3,Cc1cc(C(=O)Nc2nc3cccc(Cl)c3n2[C@@H]2CCCCN(C(=O)/C=C/CN(C)C)C2)ccn1,清洗成功,0.308411214953271
14929,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](OC(=O)/C=C/c2ccc(O)c(O)c2)(C(=O)O)C[C@@H](O)[C@H]1O,1,0.9890406727790833,0.9890406727790833,O=C([C@@]1(OC(/C=C/C2=CC=C(O)C(O)=C2)=O)C[C@@H](OC(/C=C/C3=CC=C(O)C(O)=C3)=O)[C@H](O)[C@H](O)C1)O,"1,3-Dicaffeoylquinic acid",Data.sdf,17729,HY-N1412,"1,3-O-Dicaffeoylquinic acid; 1,5-Dicaffeoylquinic acid",19870-46-3,Akt; PI3K; Reactive Oxygen Species,Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?oB; PI3K/Akt/mTOR,C25H24O12,10mM,Neurological Disease,No Development Reported,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](OC(=O)/C=C/c2ccc(O)c(O)c2)(C(=O)O)C[C@@H](O)[C@H]1O,清洗成功,0.3269230769230769
10517,Cc1ccc(OCc2cccc(N)c2)c(F)c1[C@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,1,0.9890361428260803,0.9890361428260803,OCC([C@]12[C@@]3([C@@]([C@@]4([H])[C@]([C@@]5(C(CC4)=CC(C=C5)=O)C)([H])[C@H](C3)O)([H])C[C@@]1([H])O[C@H](C6=C(C(OCC7=CC(N)=CC=C7)=CC=C6C)F)O2)C)=O,Glucocorticoid receptor agonist-3,Data.sdf,12466,HY-160177,,2842165-73-3,ADC Cytotoxin; Glucocorticoid Receptor,Antibody-drug Conjugate/ADC Related; Immunology/Inflammation; Vitamin D Related/Nuclear Receptor,C36H40FNO7,10mM,Others,No Development Reported,Cc1ccc(OCc2cccc(N)c2)c(F)c1[C@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,清洗成功,0.1833333333333333
10518,Cc1ccc(OCc2cccc(N)c2)c(F)c1[C@@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,1,0.9890361428260803,0.9890361428260803,OCC([C@]12[C@@]3([C@@]([C@@]4([H])[C@]([C@@]5(C(CC4)=CC(C=C5)=O)C)([H])[C@H](C3)O)([H])C[C@@]1([H])O[C@@H](C6=C(C(OCC7=CC(N)=CC=C7)=CC=C6C)F)O2)C)=O,Glucocorticoid receptor agonist-4,Data.sdf,12467,HY-160179,,2842165-72-2,ADC Cytotoxin; Glucocorticoid Receptor,Antibody-drug Conjugate/ADC Related; Immunology/Inflammation; Vitamin D Related/Nuclear Receptor,C36H40FNO7,10mM,Inflammation/Immunology,No Development Reported,Cc1ccc(OCc2cccc(N)c2)c(F)c1[C@@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,清洗成功,0.1833333333333333
9861,N[C@@H]1c2cccnc2[C@H](OC(=O)N2CCC(n3c(=O)[nH]c4ncccc43)CC2)CC[C@H]1c1cccc(F)c1F,1,0.989031970500946,0.989031970500946,N[C@H]1[C@H](C2=C(F)C(F)=CC=C2)CC[C@@H](OC(N3CCC(N4C(C=CC=N5)=C5NC4=O)CC3)=O)C6=NC=CC=C61,Rimegepant,Data.sdf,11650,HY-15498,BMS-927711; BHV-3000,1289023-67-1,CGRP Receptor,GPCR/G Protein; Neuronal Signaling,C28H28F2N6O3,10mM,Neurological Disease,Launched,N[C@@H]1c2cccnc2[C@H](OC(=O)N2CCC(n3c(=O)[nH]c4ncccc43)CC2)CC[C@H]1c1cccc(F)c1F,清洗成功,0.2358490566037736
15640,O=c1c(-c2ccc(O)cc2)coc2cc(O)c(O)cc12,1,0.9890296459197998,0.9890296459197998,O=C1C(C2=CC=C(O)C=C2)=COC3=CC(O)=C(O)C=C13,Desmethylglycitein,Data.sdf,18668,HY-N5072,"4',6,7-Trihydroxyisoflavone",17817-31-1,CDK; PI3K; PKC,Cell Cycle/DNA Damage; Epigenetics; PI3K/Akt/mTOR; TGF-beta/Smad,C15H10O5,10mM,Cancer,No Development Reported,O=c1c(-c2ccc(O)cc2)coc2cc(O)c(O)cc12,清洗成功,0.2916666666666667
13951,CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O[C@H]3C[C@](C)(N)[C@@H](O)[C@H](C)O3)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(NCc3ccc(-c4ccc(Cl)cc4)cc3)[C@@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O,1,0.9890266060829163,0.9890266060829163,O[C@@H]1[C@@H](O[C@@](O[C@@H](C)[C@@H]2O)([H])C[C@]2(C)NCC3=CC=C(C4=CC=C(Cl)C=C4)C=C3)[C@@H](O[C@H](CO)[C@H]1O)OC5=C(OC6=CC=C([C@H]([C@H]7NC([C@H](NC)CC(C)C)=O)O)C=C6Cl)C=C([C@](NC([C@@H](NC7=O)CC(N)=O)=O)([H])C(N[C@](C8=O)([H])C9=CC%10=C(O)C=C9)=O)C=C5OC%11=CC=C([C@H]([C@](C(N[C@@](C(O)=O)([H])C%12=C%10C(O)=CC(O)=C%12)=O)([H])N8)O[C@@](O[C@@H](C)[C@@H]%13O)([H])C[C@@]%13(N)C)C=C%11Cl.O=P(O)(O)O.O=P(O)(O)O,Oritavancin (diphosphate),Data.sdf,16428,HY-B1831A,LY333328 diphosphate,192564-14-0,Antibiotic; Bacterial,Anti-infection,C86H103Cl3N10O34P2,10mM,Infection; Inflammation/Immunology,Launched,CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O[C@H]3C[C@](C)(N)[C@@H](O)[C@H](C)O3)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(NCc3ccc(-c4ccc(Cl)cc4)cc3)[C@@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O,清洗成功,0.1714285714285714
14408,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@@](OC(=O)/C=C/c2ccc(O)c(O)c2)(C(=O)O)C[C@@H](O)[C@@H]1O,1,0.9890215992927551,0.9890215992927551,O=C([C@]1(OC(/C=C/C2=CC=C(O)C(O)=C2)=O)C[C@@H](OC(/C=C/C3=CC=C(O)C(O)=C3)=O)[C@@H](O)[C@H](O)C1)O,Cynarin,Data.sdf,17039,HY-N0359,Cynarine,30964-13-7,Influenza Virus; Reactive Oxygen Species,Anti-infection; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?oB,C25H24O12,10mM,Infection; Inflammation/Immunology,No Development Reported,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@@](OC(=O)/C=C/c2ccc(O)c(O)c2)(C(=O)O)C[C@@H](O)[C@@H]1O,清洗成功,0.3269230769230769
8941,CNCCC(=O)N(C)[C@@H](C)C(=O)O[C@H]1CC(=O)N(C)c2cc(cc(OC)c2Cl)C/C(C)=C/C=C/[C@@H](OC)[C@@]2(O)C[C@H](OC(=O)N2)[C@@H](C)[C@@H]2O[C@@]12C,1,0.9890186786651611,0.9890186786651611,O=C(N(C)[C@@H](C)C(O[C@H]([C@@]1(C)[C@@H](O1)[C@@H]2C)CC(N(C)C3=C(Cl)C(OC)=CC(C/C(C)=C/C=C/[C@@H](OC)[C@]4(O)NC(O[C@H]2C4)=O)=C3)=O)=O)CCNC,Maytansinoid B,Data.sdf,10547,HY-148870,,1628543-40-7,ADC Cytotoxin,Antibody-drug Conjugate/ADC Related,C36H51ClN4O10,10mM,Cancer,No Development Reported,CNCCC(=O)N(C)[C@@H](C)C(=O)O[C@H]1CC(=O)N(C)c2cc(cc(OC)c2Cl)C/C(C)=C/C=C/[C@@H](OC)[C@@]2(O)C[C@H](OC(=O)N2)[C@@H](C)[C@@H]2O[C@@]12C,清洗成功,0.1742424242424242
11439,C[C@@H]1CN2c3c(cc4c(N5C(=O)OC[C@@H]5C)noc4c3F)CC3(C(=O)NC(=O)NC3=O)[C@H]2[C@H](C)O1,1,0.9890154004096985,0.9890154004096985,O=C(NC(C12[C@]([C@H](C)O[C@H](C)C3)([H])N3C4=C(C=C5C(ON=C5N6C(OC[C@@H]6C)=O)=C4F)C2)=O)NC1=O,Zoliflodacin,Data.sdf,13524,HY-17647,ETX0914; AZD0914,1620458-09-4,Antibiotic; Bacterial; DNA/RNA Synthesis,Anti-infection; Cell Cycle/DNA Damage,C22H22FN5O7,10mM,Infection,Phase 3,C[C@@H]1CN2c3c(cc4c(N5C(=O)OC[C@@H]5C)noc4c3F)CC3(C(=O)NC(=O)NC3=O)[C@H]2[C@H](C)O1,清洗成功,0.1636363636363636
15845,CC(C)(O)[C@@H]1Cc2c(cc3oc(CO)cc(=O)c3c2O)O1,1,0.9890127182006836,0.9890127182006836,O=C1C=C(CO)OC2=CC(O[C@H](C(C)(O)C)C3)=C3C(O)=C12,Angelicain,Data.sdf,18929,HY-N6941,Norcimifugin,49624-66-0,Others,Others,C15H16O6,10mM,Inflammation/Immunology,No Development Reported,CC(C)(O)[C@@H]1Cc2c(cc3oc(CO)cc(=O)c3c2O)O1,清洗成功,0.2328767123287671
10722,CCOc1cc(C(=O)N(C)Cc2cccc3cn[nH]c23)ccc1-c1cccc(F)c1,1,0.989011287689209,0.989011287689209,CN(C(C1=CC(OCC)=C(C2=CC(F)=CC=C2)C=C1)=O)CC3=C4C(C=NN4)=CC=C3,BAL-0028,Data.sdf,12705,HY-162333,,2842012-69-3,Interleukin Related; NOD-like Receptor (NLR),Immunology/Inflammation,C24H22FN3O2,10mM,Inflammation/Immunology,No Development Reported,CCOc1cc(C(=O)N(C)Cc2cccc3cn[nH]c23)ccc1-c1cccc(F)c1,清洗成功,0.3026315789473684
11009,O=C(Nc1ccc([N+](=O)[O-])cc1O)Nc1ccccc1Br,1,0.9890086054801941,0.9890086054801941,O=C(NC1=CC=C([N+]([O-])=O)C=C1O)NC2=CC=CC=C2Br,SB225002,Data.sdf,13048,HY-16711,,182498-32-4,CXCR,GPCR/G Protein; Immunology/Inflammation,C13H10BrN3O4,10mM,Inflammation/Immunology; Endocrinology; Cancer,No Development Reported,O=C(Nc1ccc([N+](=O)[O-])cc1O)Nc1ccccc1Br,清洗成功,0.3214285714285714
11386,CN[C@H]1C(=O)N[C@@H]2Cc3ccc(cc3)Oc3cc4cc(c3O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3NC(=O)CCCCCCCCC(C)C)Oc3ccc(cc3Cl)[C@@H](O)[C@@H]3NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@@H](NC2=O)c2cc(cc(O)c2Cl)Oc2cc1ccc2O)c1ccc(O)c(c1)-c1c(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]2O)cc(O)cc1[C@@H](C(=O)NCCCN(C)C)NC3=O,1,0.9890061616897583,0.9890061616897583,O[C@@H]([C@@H](O)[C@@H]1O)[C@H](O[C@@H]1CO)OC2=C(C3=CC([C@@](C4=O)([H])NC([C@@](NC([C@](NC([C@@](NC5=O)([H])C6)=O)([H])C(C=C7OC(C=C8[C@H]5NC)=C(C=C8)O)=C(C(O)=C7)Cl)=O)([H])C9=CC%10=C(O[C@H](O[C@H](C(O)=O)[C@@H](O)[C@@H]%11O)[C@@H]%11NC(CCCCCCCCC(C)C)=O)C(OC%12=CC=C6C=C%12)=C9)=O)=CC=C3O)C([C@@](NC([C@](N4)([H])[C@@H](C%13=CC=C(O%10)C(Cl)=C%13)O)=O)([H])C(NCCCN(C)C)=O)=CC(O)=C2.[H]Cl,Dalbavancin (hydrochloride),Data.sdf,13469,HY-17586,MDL-63397 (hydrochloride); BI-397 (hydrochloride),2227366-51-8,Antibiotic; Bacterial,Anti-infection,C88H101Cl3N10O28,10mM,Infection,Launched,CN[C@H]1C(=O)N[C@@H]2Cc3ccc(cc3)Oc3cc4cc(c3O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3NC(=O)CCCCCCCCC(C)C)Oc3ccc(cc3Cl)[C@@H](O)[C@@H]3NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@@H](NC2=O)c2cc(cc(O)c2Cl)Oc2cc1ccc2O)c1ccc(O)c(c1)-c1c(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]2O)cc(O)cc1[C@@H](C(=O)NCCCN(C)C)NC3=O,清洗成功,0.1952662721893491
475,O[C@H]1CC[C@@H](Oc2cccc3cnc(Nc4ccc5nc[nH]c5c4)nc23)CC1,1,0.988987147808075,0.988987147808075,O[C@@H](CC1)CC[C@@H]1OC2=CC=CC(C=N3)=C2N=C3NC4=CC=C(N=CN5)C5=C4,NCB-0846,Data.sdf,537,HY-100830,,1792999-26-8,MAP4K; TGF-beta/Smad; Wnt,MAPK/ERK Pathway; Stem Cell/Wnt; TGF-beta/Smad,C21H21N5O2,10mM,Cancer,No Development Reported,O[C@H]1CC[C@@H](Oc2cccc3cnc(Nc4ccc5nc[nH]c5c4)nc23)CC1,清洗成功,0.3333333333333333
314,CC(=O)Nc1cc(Oc2ccc3c(C(=O)Nc4ccc(CN5CCN(C)CC5)c(C(F)(F)F)c4)cccc3c2)ncn1,1,0.9889835715293884,0.9889835715293884,O=C(C1=C2C=CC(OC3=NC=NC(NC(C)=O)=C3)=CC2=CC=C1)NC4=CC=C(CN5CCN(C)CC5)C(C(F)(F)F)=C4,BGG463,Data.sdf,362,HY-100600,K03859,890129-26-7,CDK,Cell Cycle/DNA Damage,C30H29F3N6O3,10mM,Others,No Development Reported,CC(=O)Nc1cc(Oc2ccc3c(C(=O)Nc4ccc(CN5CCN(C)CC5)c(C(F)(F)F)c4)cccc3c2)ncn1,清洗成功,0.2884615384615384
11426,Cn1cnc([N+](=O)[O-])c1C[N+](C)(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(Cl)c(Br)c3)ncnc2cn1,1,0.9889812469482422,0.9889812469482422,BrC1=C(Cl)C=CC(NC2=NC=NC3=C2C=C(NC(/C=C/C[N+](C)(C)CC4=C([N+]([O-])=O)N=CN4C)=O)N=C3)=C1.[Br-],Tarloxotinib (bromide),Data.sdf,13511,HY-17632,TH-4000,1636180-98-7,EGFR,JAK/STAT Signaling; Protein Tyrosine Kinase/RTK,C24H24Br2ClN9O3,10mM,Cancer,Phase 2,Cn1cnc([N+](=O)[O-])c1C[N+](C)(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(Cl)c(Br)c3)ncnc2cn1,清洗成功,0.336283185840708
3612,CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1,1,0.98897784948349,0.98897784948349,COC1=C(OC)C=C(N=C(C)N=C2N[C@H](C)C3=CC(C4=C(CNC)C=CC=C4)=CS3)C2=C1,BAY-293,Data.sdf,4253,HY-114398,,2244904-70-7,Ras,GPCR/G Protein; MAPK/ERK Pathway,C25H28N4O2S,10mM,Cancer,No Development Reported,CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1,清洗成功,0.2727272727272727
5794,COc1cc(-c2cnn(C)c2)ccc1Nc1ncc2ccnc(N[C@@H](C)C(C)(C)C)c2n1,1,0.9889745712280273,0.9889745712280273,CC(C)(C)[C@@H](NC1=NC=CC2=CN=C(NC3=CC=C(C4=CN(C)N=C4)C=C3OC)N=C21)C,Mps1-IN-7,Data.sdf,6851,HY-12862,,1578244-34-4,Mps1,Cell Cycle/DNA Damage; Cytoskeleton,C24H29N7O,10mM,Cancer,No Development Reported,COc1cc(-c2cnn(C)c2)ccc1Nc1ncc2ccnc(N[C@@H](C)C(C)(C)C)c2n1,清洗成功,0.3473684210526316
7525,CN1CCN(CCC(=O)Nc2ccc3c(=O)n(CC4(O)CCN(C(=O)[C@@H](CCCNC(=O)c5ccc6c(Cl)c7c(nc6c5)CCCC7)Cc5ccccc5)CC4)cnc3c2)CC1,1,0.9889673590660095,0.9889673590660095,O=C(C(C=CC1=C2Cl)=CC1=NC3=C2CCCC3)NCCC[C@@H](CC4=CC=CC=C4)C(N5CCC(CN6C=NC7=C(C=CC(NC(CCN8CCN(C)CC8)=O)=C7)C6=O)(O)CC5)=O,XL177A,Data.sdf,8903,HY-138794,,2417089-74-6,Deubiquitinase,Cell Cycle/DNA Damage,C48H57ClN8O5,10mM,Cancer,No Development Reported,CN1CCN(CCC(=O)Nc2ccc3c(=O)n(CC4(O)CCN(C(=O)[C@@H](CCCNC(=O)c5ccc6c(Cl)c7c(nc6c5)CCCC7)Cc5ccccc5)CC4)cnc3c2)CC1,清洗成功,0.2765957446808511
7526,CN1CCN(CCC(=O)Nc2ccc3c(=O)n(CC4(O)CCN(C(=O)C(CCCNC(=O)c5ccc6c(Cl)c7c(nc6c5)CCCC7)Cc5ccccc5)CC4)cnc3c2)CC1,1,0.9889673590660095,0.9889673590660095,O=C(C(C=CC1=C2Cl)=CC1=NC3=C2CCCC3)NCCCC(CC4=CC=CC=C4)C(N5CCC(CN6C=NC7=C(C=CC(NC(CCN8CCN(C)CC8)=O)=C7)C6=O)(O)CC5)=O,(Rac)-XL177A,Data.sdf,8904,HY-138794A,,2417089-73-5,Deubiquitinase,Cell Cycle/DNA Damage,C48H57ClN8O5,10mM,Cancer,No Development Reported,CN1CCN(CCC(=O)Nc2ccc3c(=O)n(CC4(O)CCN(C(=O)C(CCCNC(=O)c5ccc6c(Cl)c7c(nc6c5)CCCC7)Cc5ccccc5)CC4)cnc3c2)CC1,清洗成功,0.2765957446808511
4074,Cn1ncc(S(=O)(=O)N2CC[C@H]3Cc4c(cnn4-c4ccc(F)cc4)C[C@]3(C(=O)c3cc(C(F)(F)F)ccn3)C2)n1,1,0.9889655113220215,0.9889655113220215,O=C([C@]12CC3=C(N(C4=CC=C(F)C=C4)N=C3)C[C@]1([H])CCN(S(=O)(C5=NN(C)N=C5)=O)C2)C6=NC=CC(C(F)(F)F)=C6,Exicorilant,Data.sdf,4783,HY-117880,CORT 125281,1781244-77-6,Glucocorticoid Receptor,Immunology/Inflammation; Vitamin D Related/Nuclear Receptor,C26H23F4N7O3S,10mM,Metabolic Disease; Endocrinology,Phase 2,Cn1ncc(S(=O)(=O)N2CC[C@H]3Cc4c(cnn4-c4ccc(F)cc4)C[C@]3(C(=O)c3cc(C(F)(F)F)ccn3)C2)n1,清洗成功,0.2211538461538461
9676,Nc1nccc(Sc2cnc(N3CCC4(CC3)Cc3ccccc3[C@H]4N)nn2)c1Cl,1,0.9889524579048157,0.9889524579048157,N[C@H]1C2(CCN(C3=NN=C(SC4=CC=NC(N)=C4Cl)C=N3)CC2)CC5=CC=CC=C51,PF-07284892,Data.sdf,11434,HY-153740,ARRY-558,2498597-94-5,SHP2,Protein Tyrosine Kinase/RTK,C21H22ClN7S,10mM,Cancer,Phase 1,Nc1nccc(Sc2cnc(N3CCC4(CC3)Cc3ccccc3[C@H]4N)nn2)c1Cl,清洗成功,0.2018348623853211
2847,Cc1nc(-c2cnn(C)c2-c2ccc(C(F)(F)F)cn2)c2c(N3CCC3)ncnn12,1,0.988947868347168,0.988947868347168,CC1=NC(C2=C(C3=CC=C(C(F)(F)F)C=N3)N(C)N=C2)=C4N1N=CN=C4N5CCC5,PF-05180999,Data.sdf,3344,HY-111371,PF-999,1394033-54-5,Phosphodiesterase (PDE),Metabolic Enzyme/Protease,C19H17F3N8,10mM,Neurological Disease,Phase 1,Cc1nc(-c2cnn(C)c2-c2ccc(C(F)(F)F)cn2)c2c(N3CCC3)ncnn12,清洗成功,0.24
12804,COc1ccc(-c2nc3ccc(C4=NNC(=O)CC4C)cc3[nH]2)cc1,1,0.9889464974403381,0.9889464974403381,O=C1CC(C)C(C2=CC=C3N=C(C4=CC=C(OC)C=C4)NC3=C2)=NN1,Pimobendan,Data.sdf,15137,HY-B0204,UD-CG115,74150-27-9,Phosphodiesterase (PDE),Metabolic Enzyme/Protease,C19H18N4O2,10mM,Cardiovascular Disease,Launched,COc1ccc(-c2nc3ccc(C4=NNC(=O)CC4C)cc3[nH]2)cc1,清洗成功,0.2985074626865671
7769,C=CC(=O)Nc1cc(Nc2nccc(-c3c4n(c5ccccc35)CCCC4)n2)c(OC)cc1N(C)CCN(C)C,1,0.9889426231384277,0.9889426231384277,O=C(NC1=CC(NC2=NC(C3=C(CCCC4)N4C5=C3C=CC=C5)=CC=N2)=C(C=C1N(CCN(C)C)C)OC)C=C,Oritinib,Data.sdf,9192,HY-139920,SH-1028,2035089-28-0,EGFR,JAK/STAT Signaling; Protein Tyrosine Kinase/RTK,C31H37N7O2,10mM,Cancer,Phase 3,C=CC(=O)Nc1cc(Nc2nccc(-c3c4n(c5ccccc35)CCCC4)n2)c(OC)cc1N(C)CCN(C)C,清洗成功,0.3085106382978723
2261,CN1c2ccc([N+](=O)[O-])cc2N=C(c2ccc(C(=O)O)cc2)c2cc3c(cc21)C(C)(C)CCC3(C)C,1,0.9889361262321472,0.9889361262321472,O=C(O)C1=CC=C(C2=NC3=CC([N+]([O-])=O)=CC=C3N(C)C4=CC5=C(C(C)(C)CCC5(C)C)C=C42)C=C1,HX531,Data.sdf,2652,HY-108521,,188844-34-0,Apoptosis; MDM-2/p53; RAR/RXR,Apoptosis; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor,C29H29N3O4,10mM,Cancer; Metabolic Disease,No Development Reported,CN1c2ccc([N+](=O)[O-])cc2N=C(c2ccc(C(=O)O)cc2)c2cc3c(cc21)C(C)(C)CCC3(C)C,清洗成功,0.2638888888888889
177,CSc1cc(C)nc(SC)c1NC(=O)CN1CCN(CCSc2nc3ccccc3[nH]2)CC1,1,0.9889300465583801,0.9889300465583801,O=C(NC1=C(SC)C=C(C)N=C1SC)CN2CCN(CCSC3=NC4=CC=CC=C4N3)CC2.[H]Cl.[H]Cl,K-604 (dihydrochloride),Data.sdf,205,HY-100400A,,217094-32-1,Acyltransferase,Metabolic Enzyme/Protease,C23H32Cl2N6OS3,10mM,Cardiovascular Disease,Phase 2,CSc1cc(C)nc(SC)c1NC(=O)CN1CCN(CCSc2nc3ccccc3[nH]2)CC1,清洗成功,0.2531645569620253
16088,O=c1c2cc(O)ccc2oc2cc(O)c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)c12,1,0.988927960395813,0.988927960395813,OC1=C(C(C2=C3)=O)C(OC2=CC=C3O)=CC(O)=C1[C@@H]([C@@H]([C@H]4O)O)O[C@@H]([C@H]4O)CO,Neolancerin,Data.sdf,19232,HY-N8088,,117221-65-5,Others,Others,C19H18O10,10mM,Cancer,No Development Reported,O=c1c2cc(O)ccc2oc2cc(O)c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)c12,清洗成功,0.3064516129032258
10937,COc1ccc(Cl)c(Nc2nc3ccccc3nc2NS(=O)(=O)c2cccc(NC(=O)C(C)(C)N)c2)c1,1,0.9889230728149414,0.9889230728149414,CC(C)(N)C(NC1=CC=CC(S(=O)(NC2=NC3=CC=CC=C3N=C2NC4=CC(OC)=CC=C4Cl)=O)=C1)=O,Pilaralisib,Data.sdf,12960,HY-16526,XL-147; SAR245408,934526-89-3,PI3K,PI3K/Akt/mTOR,C25H25ClN6O4S,10mM,Cancer,Phase 2,COc1ccc(Cl)c(Nc2nc3ccccc3nc2NS(=O)(=O)c2cccc(NC(=O)C(C)(C)N)c2)c1,清洗成功,0.3058823529411765
12495,CN(C)C/C=C/C(=O)Nc1ccc(C(=O)Nc2cccc(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)c2)cc1,1,0.988922119140625,0.988922119140625,ClC1=CN=C(NC2=CC(NC(C3=CC=C(NC(/C=C/CN(C)C)=O)C=C3)=O)=CC=C2)N=C1C4=CNC5=CC=CC=C54,THZ1,Data.sdf,14796,HY-80013,,1604810-83-4,CDK,Cell Cycle/DNA Damage,C31H28ClN7O2,10mM,Cancer,No Development Reported,CN(C)C/C=C/C(=O)Nc1ccc(C(=O)Nc2cccc(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)c2)cc1,清洗成功,0.3181818181818182
12496,CN(C)C/C=C/C(=O)Nc1ccc(C(=O)Nc2cccc(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)c2)cc1,1,0.988922119140625,0.988922119140625,ClC1=CN=C(NC2=CC(NC(C3=CC=C(NC(/C=C/CN(C)C)=O)C=C3)=O)=CC=C2)N=C1C4=CNC5=CC=CC=C54.Cl,THZ1 (Hydrochloride),Data.sdf,14797,HY-80013A,,,CDK,Cell Cycle/DNA Damage,C31H29Cl2N7O2,10mM,Cancer,No Development Reported,CN(C)C/C=C/C(=O)Nc1ccc(C(=O)Nc2cccc(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)c2)cc1,清洗成功,0.3153153153153153
14367,O=c1c2cc(O)c(O)cc2oc2cc(O)c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)c12,1,0.9889159202575684,0.9889159202575684,O[C@@H]([C@H](O)[C@@H](CO)O1)[C@@H](O)[C@@H]1C2=C(O)C3=C(C=C2O)OC4=CC(O)=C(O)C=C4C3=O,Mangiferin,Data.sdf,16982,HY-N0290,,4773-96-0,Apoptosis; Keap1-Nrf2; NF-?oB,Apoptosis; NF-?oB,C19H18O11,10mM,Cancer,No Development Reported,O=c1c2cc(O)c(O)cc2oc2cc(O)c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)c12,清洗成功,0.2631578947368421
11644,Cc1cccc(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3ncnn3c2)n1,1,0.9889158010482788,0.9889158010482788,N#CC1=CC=CC(NCC2=NC(C3=CN4C(C=C3)=NC=N4)=C(C5=NC(C)=CC=C5)N2)=C1,EW-7195,Data.sdf,13776,HY-18766,,1352609-28-9,p38 MAPK; TGF-?2 Receptor,MAPK/ERK Pathway; TGF-beta/Smad,C23H18N8,10mM,Cancer,No Development Reported,Cc1cccc(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3ncnn3c2)n1,清洗成功,0.3142857142857143
2338,O=C(CC12CC3CC(CC(C3)C1)C2)Nc1cccc2nc(NCCNCCO)ccc12,1,0.9889155626296997,0.9889155626296997,O=C(NC1=C2C=CC(NCCNCCO)=NC2=CC=C1)CC3(C4)CC5CC4CC(C5)C3.[H]Cl.[H]Cl,AZ10606120 (dihydrochloride),Data.sdf,2743,HY-108669,,607378-18-7,P2X Receptor,Membrane Transporter/Ion Channel,C25H36Cl2N4O2,10mM,Cancer; Neurological Disease,No Development Reported,O=C(CC12CC3CC(CC(C3)C1)C2)Nc1cccc2nc(NCCNCCO)ccc12,清洗成功,0.264367816091954
10800,O=C(CSc1nc2ccccc2c(=O)[nH]1)Nc1ncc(S(=O)(=O)c2ccc([N+](=O)[O-])cc2)s1,1,0.9889078736305237,0.9889078736305237,O=C1C2=C(N=C(N1)SCC(NC3=NC=C(S3)S(C4=CC=C(C=C4)[N+]([O-])=O)(=O)=O)=O)C=CC=C2,SIRT4-IN-1,Data.sdf,12802,HY-163316,,,Sirtuin,Cell Cycle/DNA Damage; Epigenetics,C19H13N5O6S3,10mM,Cancer; Metabolic Disease,No Development Reported,O=C(CSc1nc2ccccc2c(=O)[nH]1)Nc1ncc(S(=O)(=O)c2ccc([N+](=O)[O-])cc2)s1,清洗成功,0.3421052631578947
1456,CNCCOc1ccccc1C1(Nc2nccn(-c3cc(C(=O)NC4CC4)cc(F)c3C)c2=O)CC1,1,0.9889021515846252,0.9889021515846252,O=C(NC1CC1)C2=CC(N3C(C(NC4(C5=CC=CC=C5OCCNC)CC4)=NC=C3)=O)=C(C)C(F)=C2,AZD7624,Data.sdf,1707,HY-103672,,1095004-78-6,Autophagy; p38 MAPK,Autophagy; MAPK/ERK Pathway,C27H30FN5O3,10mM,Inflammation/Immunology,Phase 2,CNCCOc1ccccc1C1(Nc2nccn(-c3cc(C(=O)NC4CC4)cc(F)c3C)c2=O)CC1,清洗成功,0.2201834862385321
16079,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)c(O)c4)oc4cc(O)cc(O)c4c3=O)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,1,0.9889019727706909,0.9889019727706909,O=C(C(O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO[C@H]2[C@@H]([C@@H]([C@H]([C@@H](O2)C)O)O)O)O)O)O[C@H]3[C@@H]([C@@H]([C@H]([C@@H](O3)C)O)O)O)=C(C4=CC(O)=C(C=C4)O)OC5=CC(O)=C6)C5=C6O,Manghaslin,Data.sdf,19222,HY-N7993,,55696-57-6,Cholinesterase (ChE),Neuronal Signaling,C33H40O20,10mM,Inflammation/Immunology,No Development Reported,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)c(O)c4)oc4cc(O)cc(O)c4c3=O)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,清洗成功,0.2972972972972973
59,COc1cc2cc(c1Cl)N(C)C(=O)C[C@H](OC(=O)[C@H](C)N(C)C(=O)CCSSC)[C@]1(C)O[C@H]1[C@H](C)[C@@H]1C[C@@](O)(NC(=O)O1)[C@H](OC)/C=C/C=C(\C)C2,1,0.9888968467712402,0.9888968467712402,C[C@]12[C@@]([C@@H]([C@]3([H])C[C@]([C@@H](/C=C/C=C(CC4=CC(N(C(C[C@@H]2OC([C@H](C)N(C)C(CCSSC)=O)=O)=O)C)=C(C(OC)=C4)Cl)\C)OC)(NC(O3)=O)O)C)([H])O1,DM1-SMe,Data.sdf,68,HY-100128,,138148-68-2,ADC Cytotoxin; Microtubule/Tubulin,Antibody-drug Conjugate/ADC Related; Cell Cycle/DNA Damage; Cytoskeleton,C36H50ClN3O10S2,10mM,Cancer,No Development Reported,COc1cc2cc(c1Cl)N(C)C(=O)C[C@H](OC(=O)[C@H](C)N(C)C(=O)CCSSC)[C@]1(C)O[C@H]1[C@H](C)[C@@H]1C[C@@](O)(NC(=O)O1)[C@H](OC)/C=C/C=C(\C)C2,清洗成功,0.1589403973509933
9904,O=C(NS(=O)(=O)c1ccc2ncsc2c1)c1cc2cc(Oc3ccc(Cl)c(Cl)c3)ccc2[nH]1,1,0.9888646602630615,0.9888646602630615,O=C(C(N1)=CC2=C1C=CC(OC3=CC=C(Cl)C(Cl)=C3)=C2)NS(=O)(C4=CC=C5N=CSC5=C4)=O,Galectin-3/galectin-8-IN-1,Data.sdf,11704,HY-155191,,,Galectin,Immunology/Inflammation,C22H13Cl2N3O4S2,10mM,Cancer; Inflammation/Immunology,No Development Reported,O=C(NS(=O)(=O)c1ccc2ncsc2c1)c1cc2cc(Oc3ccc(Cl)c(Cl)c3)ccc2[nH]1,清洗成功,0.2790697674418604
11674,COc1ccc(N(C)c2nc(C)nc3ccccc23)cc1OCCCC(=O)NO,1,0.988864541053772,0.988864541053772,CN(C1=CC(OCCCC(NO)=O)=C(OC)C=C1)C2=NC(C)=NC3=CC=CC=C32,SKLB-23bb,Data.sdf,13815,HY-18947,,1815580-06-3,HDAC,Cell Cycle/DNA Damage; Epigenetics,C21H24N4O4,10mM,Cancer,No Development Reported,COc1ccc(N(C)c2nc(C)nc3ccccc23)cc1OCCCC(=O)NO,清洗成功,0.3417721518987341
5321,Cc1c(-c2cnccn2)ssc1=S,1,0.9888596534729004,0.9888596534729004,S=C1SSC(C2=NC=CN=C2)=C1C,Oltipraz,Data.sdf,6273,HY-12519,RP 35972; NSC 347901,64224-21-1,HIF/HIF Prolyl-Hydroxylase; HIV; Keap1-Nrf2; Parasite,Anti-infection; Metabolic Enzyme/Protease; NF-?oB,C8H6N2S3,10mM,Cancer,Phase 3,Cc1c(-c2cnccn2)ssc1=S,清洗成功,0.2222222222222222
6888,COC(=O)CN(Cc1cccs1)C(=O)[C@H](NS(=O)(=O)c1ccc2[nH]c(=O)ccc2c1)c1ccccc1OC,1,0.9888549447059631,0.9888549447059631,O=C(OC)CN(C([C@@H](C1=CC=CC=C1OC)NS(=O)(C2=CC3=C(NC(C=C3)=O)C=C2)=O)=O)CC4=CC=CS4,OSMI-2,Data.sdf,8171,HY-135784,,2260542-60-5,Acyltransferase; OGT,Metabolic Enzyme/Protease; Neuronal Signaling,C26H25N3O7S2,10mM,Metabolic Disease,No Development Reported,COC(=O)CN(Cc1cccs1)C(=O)[C@H](NS(=O)(=O)c1ccc2[nH]c(=O)ccc2c1)c1ccccc1OC,清洗成功,0.2452830188679245
5165,COc1cc2cc(c1Cl)N(C)C(=O)C[C@H](OC(=O)[C@H](C)N(C)C(=O)CCC(C)(C)S)[C@]1(C)O[C@H]1[C@H](C)[C@@H]1C[C@@](O)(NC(=O)O1)[C@H](OC)/C=C/C=C(\C)C2,1,0.988840639591217,0.988840639591217,C[C@]1([C@H](CC(N(C(C=C2C=C3OC)=C3Cl)C)=O)OC([C@H](C)N(C)C(CCC(C)(S)C)=O)=O)[C@H]([C@@H]([C@](OC4=O)([H])C[C@]([C@](/C=C/C=C(C)/C2)([H])OC)(N4)O)C)O1,DM4,Data.sdf,6085,HY-12454,,796073-69-3,ADC Cytotoxin; Microtubule/Tubulin,Antibody-drug Conjugate/ADC Related; Cell Cycle/DNA Damage; Cytoskeleton,C38H54ClN3O10S,10mM,Cancer,No Development Reported,COc1cc2cc(c1Cl)N(C)C(=O)C[C@H](OC(=O)[C@H](C)N(C)C(=O)CCC(C)(C)S)[C@]1(C)O[C@H]1[C@H](C)[C@@H]1C[C@@](O)(NC(=O)O1)[C@H](OC)/C=C/C=C(\C)C2,清洗成功,0.1666666666666666
8646,CCN(c1cc(-c2ccc(CN3CCN(CCCCCCCOc4cccc5c4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)cc2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCOCC1,1,0.9888394474983215,0.9888394474983215,CCN(C1CCOCC1)C2=C(C(C(NCC3=C(C=C(NC3=O)C)C)=O)=CC(C4=CC=C(C=C4)CN5CCN(CC5)CCCCCCCOC6=C7C(N(C(C7=CC=C6)=O)C8CCC(NC8=O)=O)=O)=C2)C,PROTAC EZH2 Degrader-1,Data.sdf,10198,HY-147525,,2641601-67-2,Histone Methyltransferase; PROTACs,Epigenetics; PROTAC,C54H67N7O8,10mM,Cancer,No Development Reported,CCN(c1cc(-c2ccc(CN3CCN(CCCCCCCOc4cccc5c4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)cc2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCOCC1,清洗成功,0.2867647058823529
2434,Cc1ccc2c(Nc3cccc(Cl)c3F)nccc2c1NC(=O)c1csc2c(N)ncnc12,1,0.9888250231742859,0.9888250231742859,O=C(C(C1=NC=N2)=CSC1=C2N)NC(C3=C4C(NC(C=CC=C5Cl)=C5F)=NC=C3)=C(C=C4)C,Belvarafenib,Data.sdf,2859,HY-109080,HM95573; GDC-5573; RG6185,1446113-23-0,Raf,MAPK/ERK Pathway,C23H16ClFN6OS,10mM,Cancer,Phase 2,Cc1ccc2c(Nc3cccc(Cl)c3F)nccc2c1NC(=O)c1csc2c(N)ncnc12,清洗成功,0.2659574468085106
10009,Cc1c(-c2ccccc2)ccc2nc(-c3cccc(CNCCO)c3)[nH]c12,1,0.9888240694999695,0.9888240694999695,CC1=C2NC(C3=CC(CNCCO)=CC=C3)=NC2=CC=C1C4=CC=CC=C4,VISTA-IN-2,Data.sdf,11839,HY-155971,,2614183-36-5,Autophagy,Autophagy,C23H23N3O,10mM,Cancer; Inflammation/Immunology,No Development Reported,Cc1c(-c2ccccc2)ccc2nc(-c3cccc(CNCCO)c3)[nH]c12,清洗成功,0.2647058823529412
11791,COc1cc2cc(c1Cl)N(C)C(=O)C[C@H](O)[C@]1(C)O[C@H]1[C@H](C)[C@@H]1C[C@@](O)(NC(=O)O1)[C@H](OC)/C=C/C=C(\C)C2,1,0.9888203740119934,0.9888203740119934,C[C@]1([C@H](CC(N(C(C=C2C=C3OC)=C3Cl)C)=O)O)[C@H]([C@@H]([C@](OC4=O)([H])C[C@]([C@](/C=C/C=C(C)/C2)([H])OC)(N4)O)C)O1,Maytansinol,Data.sdf,13949,HY-19474,Ansamitocin P-0,57103-68-1,ADC Cytotoxin; Apoptosis; Microtubule/Tubulin,Antibody-drug Conjugate/ADC Related; Apoptosis; Cell Cycle/DNA Damage; Cytoskeleton,C28H37ClN2O8,10mM,Cancer,No Development Reported,COc1cc2cc(c1Cl)N(C)C(=O)C[C@H](O)[C@]1(C)O[C@H]1[C@H](C)[C@@H]1C[C@@](O)(NC(=O)O1)[C@H](OC)/C=C/C=C(\C)C2,清洗成功,0.1654135338345864
17896,Sc1nnc(-c2ccncc2)o1,1,0.9888178110122681,0.9888178110122681,C1=C(C=CN=C1)C2=NN=C(O2)S,"5-(Pyridin-4-yl)-1,3,4-oxadiazole-2-thiol",Data.sdf,21331,HY-W104752,,15264-63-8,Bacterial; Fungal,Anti-infection,C7H5N3OS,10mM,Cancer; Infection; Metabolic Disease; Inflammation/Immunology; Neurological Disease,No Development Reported,Sc1nnc(-c2ccncc2)o1,清洗成功,0.2894736842105263
15157,COc1ccc(-c2coc3cc(OC)ccc3c2=O)cc1,1,0.9888168573379517,0.9888168573379517,O=C1C(C2=CC=C(OC)C=C2)=COC3=CC(OC)=CC=C13,"4',7-Dimethoxyisoflavone",Data.sdf,18025,HY-N2145,Dimethoxydaidzein,1157-39-7,Endogenous Metabolite; Fungal,Anti-infection; Metabolic Enzyme/Protease,C17H14O4,10mM,Infection,No Development Reported,COc1ccc(-c2coc3cc(OC)ccc3c2=O)cc1,清洗成功,0.3469387755102041
5793,Cn1ncc2cc(-c3ccc(S(=O)(=O)CC(C)(C)C(=O)N[C@H](C#N)CC(N)=O)cc3)ccc21,1,0.9888131022453308,0.9888131022453308,O=C(N[C@H](C#N)CC(N)=O)C(C)(C)CS(=O)(C1=CC=C(C2=CC3=C(N(C)N=C3)C=C2)C=C1)=O,Legumain inhibitor 1,Data.sdf,6850,HY-128617,,2361157-34-6,Legumain,Neuronal Signaling,C23H25N5O4S,10mM,Cancer,No Development Reported,Cn1ncc2cc(-c3ccc(S(=O)(=O)CC(C)(C)C(=O)N[C@H](C#N)CC(N)=O)cc3)ccc21,清洗成功,0.3214285714285714
6262,C=CC(=O)N[C@H]1COC[C@H]1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)c(=O)n(C)c2n1,1,0.9888112545013428,0.9888112545013428,CN1C2=NC(N[C@@H]3COC[C@@H]3NC(C=C)=O)=NC=C2C=C(C4=C(Cl)C(OC)=CC(OC)=C4Cl)C1=O,FGFR4-IN-5,Data.sdf,7408,HY-131704,,1628793-01-0,FGFR,Protein Tyrosine Kinase/RTK,C23H23Cl2N5O5,10mM,Cancer,No Development Reported,C=CC(=O)N[C@H]1COC[C@H]1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)c(=O)n(C)c2n1,清洗成功,0.2989690721649484
12237,Cc1c2c(nc3ccccc13)CC(C)(C)CC2=O,1,0.988810658454895,0.988810658454895,O=C1C2=C(C)C3=C(C=CC=C3)N=C2CC(C)(C1)C,WAY-629450,Data.sdf,14480,HY-48957,,851901-67-2,Drug Derivative,Others,C16H17NO,10mM,Others,No Development Reported,Cc1c2c(nc3ccccc13)CC(C)(C)CC2=O,清洗成功,0.2452830188679245
9643,N#Cc1cc(F)ccc1-c1cc(-c2cnc3nc(C(F)(F)F)ccn23)ccc1F,1,0.9888090491294861,0.9888090491294861,N#CC1=CC(F)=CC=C1C2=C(F)C=CC(C3=CN=C4N=C(C(F)(F)F)C=CN43)=C2,MRK-898,Data.sdf,11395,HY-153584,,461450-30-6,GABA Receptor,Membrane Transporter/Ion Channel; Neuronal Signaling,C20H9F5N4,10mM,Neurological Disease,No Development Reported,N#Cc1cc(F)ccc1-c1cc(-c2cnc3nc(C(F)(F)F)ccn23)ccc1F,清洗成功,0.2602739726027397
10867,O=C(Nc1cccc(Br)c1)c1c(O)c2ccccc2[nH]c1=O,1,0.9888068437576294,0.9888068437576294,O=C(C1=C(O)C2=C(C=CC=C2)NC1=O)NC3=CC(Br)=CC=C3,EGFR T790M/L858R-IN-8,Data.sdf,12878,HY-164056,,333419-97-9,EGFR,JAK/STAT Signaling; Protein Tyrosine Kinase/RTK,C16H11BrN2O3,2mM,Cancer,No Development Reported,O=C(Nc1cccc(Br)c1)c1c(O)c2ccccc2[nH]c1=O,清洗成功,0.296875
3008,Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOCCOCCOCCOc2cc3nccc(Nc4ccc5scnc5c4)c3cc2S(=O)(=O)C(C)(C)C)C(C)(C)C)cc1,1,0.9888054132461548,0.9888054132461548,CC1=C(SC=N1)C2=CC=C(CNC([C@H]3N(C([C@H](C(C)(C)C)NC(COCCOCCOCCOCCOC4=CC5=C(C(NC6=CC=C(SC=N7)C7=C6)=CC=N5)C=C4S(C(C)(C)C)(=O)=O)=O)=O)C[C@H](O)C3)=O)C=C2,PROTAC RIPK degrader-2,Data.sdf,3522,HY-111866,,1801547-16-9,PROTACs; RIP kinase,Apoptosis; PROTAC,C52H65N7O11S3,10mM,Cancer; Metabolic Disease,No Development Reported,Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOCCOCCOCCOc2cc3nccc(Nc4ccc5scnc5c4)c3cc2S(=O)(=O)C(C)(C)C)C(C)(C)C)cc1,清洗成功,0.2
1325,Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1,1,0.9888043999671936,0.9888043999671936,O=C(O[C@@H](COC1=CN2C(C(OC3=C(C4=C(NC(C)=C4)C=C3)F)=NC=N2)=C1C)C)[C@@H](N)C,Brivanib (alaninate),Data.sdf,1544,HY-10336,BMS-582664,649735-63-7,Autophagy; VEGFR,Autophagy; Protein Tyrosine Kinase/RTK,C22H24FN5O4,10mM,Cancer,Phase 3,Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1,清洗成功,0.21875
4106,CCOC(=O)c1c(COc2ccccc2)oc2ccc(O)cc12,1,0.9887977242469788,0.9887977242469788,O=C(OCC)C1=C(OC2=CC=C(C=C12)O)COC3=CC=CC=C3,T16A(inh)-C01,Data.sdf,4826,HY-118170,,171506-87-9,Chloride Channel,Membrane Transporter/Ion Channel,C18H16O5,10mM,Others,No Development Reported,CCOC(=O)c1c(COc2ccccc2)oc2ccc(O)cc12,清洗成功,0.3333333333333333
10153,O=C(NC[C@]1(O)CC[C@H](COc2ccccc2F)CC1)c1ccc(O)c(F)c1,1,0.9887972474098206,0.9887972474098206,O=C(NC[C@]1(O)CC[C@H](COC2=CC=CC=C2F)CC1)C3=CC(F)=C(O)C=C3,HSD17B13-IN-2,Data.sdf,12011,HY-156735,,863564-24-3,17?2-HSD,Metabolic Enzyme/Protease,C21H23F2NO4,10mM,Cancer,No Development Reported,O=C(NC[C@]1(O)CC[C@H](COc2ccccc2F)CC1)c1ccc(O)c(F)c1,清洗成功,0.2873563218390804
9160,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,1,0.9887939095497131,0.9887939095497131,O=C1C(N(C)N=C2CCC)=C2N=C(C3=CC(S(=O)(N4CCN(C)CC4)=O)=CC=C3OCC)N1,Sildenafil,Data.sdf,10801,HY-15025,UK-92480,139755-83-2,Apoptosis; Autophagy; Bacterial; Phosphodiesterase (PDE),Anti-infection; Apoptosis; Autophagy; Metabolic Enzyme/Protease,C22H30N6O4S,10mM,Cardiovascular Disease; Cancer,Launched,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,清洗成功,0.23
9164,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,1,0.9887939095497131,0.9887939095497131,O=C1C(N(C)N=C2CCC)=C2N=C(C3=CC(S(=O)(N4CCN(C)CC4)=O)=CC=C3OCC)N1.O=C(CC(C(O)=O)(O)CC(O)=O)O,Sildenafil (citrate),Data.sdf,10805,HY-15025A,UK-92480 (citrate),171599-83-0,Apoptosis; Autophagy; Bacterial; Phosphodiesterase (PDE),Anti-infection; Apoptosis; Autophagy; Metabolic Enzyme/Protease,C28H38N6O11S,10mM,Cardiovascular Disease; Cancer,Launched,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,清洗成功,0.2252252252252252
5657,CCCS(=O)c1ccc2nc(NC(=O)OC)[nH]c2c1,1,0.988787829875946,0.988787829875946,O=C(OC)NC1=NC2=CC=C(S(CCC)=O)C=C2N1,Albendazole sulfoxide,Data.sdf,6674,HY-12785,Ricobendazole; Albendazole oxide,54029-12-8,Parasite,Anti-infection,C12H15N3O3S,10mM,Infection,Launched,CCCS(=O)c1ccc2nc(NC(=O)OC)[nH]c2c1,清洗成功,0.2835820895522388
2078,CNC1C(=O)NC2Cc3ccc(cc3)Oc3cc4cc(c3O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3NC(=O)CCCCCCCCC(C)C)Oc3ccc(cc3Cl)C(O)C3NC(=O)C(NC(=O)C4NC(=O)C(NC2=O)c2cc(cc(O)c2Cl)Oc2cc1ccc2O)c1ccc(O)c(c1)-c1c(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]2O)cc(O)cc1C(C(=O)O)NC3=O,1,0.9887852668762207,0.9887852668762207,ClC1=CC(C(O)C(C(NC(C(O)=O)C(C=C(O)C=C2O[C@@H]3[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)=C2C4=C(O)C=CC(C5NC(C6NC(C(C7=C(Cl)C(O)=CC(O8)=C7)NC(C9NC(C(C%10=CC8=C(O)C=C%10)NC)=O)=O)=O)=O)=C4)=O)NC5=O)=CC=C1OC%11=CC6=CC(OC%12=CC=C(C9)C=C%12)=C%11O[C@@H]%13O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]%13NC(CCCCCCCCC(C)C)=O,A40926,Data.sdf,2441,HY-107833,,102961-72-8,Antibiotic; Bacterial,Anti-infection,C83H88Cl2N8O29,2mM,Infection,Launched,CNC1C(=O)NC2Cc3ccc(cc3)Oc3cc4cc(c3O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3NC(=O)CCCCCCCCC(C)C)Oc3ccc(cc3Cl)C(O)C3NC(=O)C(NC(=O)C4NC(=O)C(NC2=O)c2cc(cc(O)c2Cl)Oc2cc1ccc2O)c1ccc(O)c(c1)-c1c(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]2O)cc(O)cc1C(C(=O)O)NC3=O,清洗成功,0.2101910828025477
4544,CCOC(=O)c1c(N)sc(C(=O)Nc2cccc([N+](=O)[O-])c2)c1C,1,0.9887837767601013,0.9887837767601013,O=C(OCC)C1=C(SC(C(NC2=CC=CC([N+]([O-])=O)=C2)=O)=C1C)N,DC-S239,Data.sdf,5351,HY-121093,,303141-21-1,Histone Methyltransferase,Epigenetics,C15H15N3O5S,10mM,Cancer,No Development Reported,CCOC(=O)c1c(N)sc(C(=O)Nc2cccc([N+](=O)[O-])c2)c1C,清洗成功,0.2985074626865671
9314,CN1CC[C@@H](Oc2ccc(F)c(-c3nc4c(o3)C(=O)c3ccccc3C4=O)c2Cl)C1,1,0.9887810945510864,0.9887810945510864,O=C(C1=C2OC(C3=C(F)C=CC(O[C@H]4CN(C)CC4)=C3Cl)=N1)C5=C(C=CC=C5)C2=O,OTUB1/USP8-IN-1,Data.sdf,10986,HY-151563,,2858800-98-1,Deubiquitinase,Cell Cycle/DNA Damage,C22H16ClFN2O4,10mM,Cancer,No Development Reported,CN1CC[C@@H](Oc2ccc(F)c(-c3nc4c(o3)C(=O)c3ccccc3C4=O)c2Cl)C1,清洗成功,0.2823529411764706
9315,CN1CC[C@@H](Oc2ccc(F)c(-c3nc4c(o3)C(=O)c3ccccc3C4=O)c2Cl)C1,1,0.9887810945510864,0.9887810945510864,O=C(C1=C2OC(C3=C(F)C=CC(O[C@H]4CN(C)CC4)=C3Cl)=N1)C5=C(C=CC=C5)C2=O.OC(C(F)(F)F)=O,OTUB1/USP8-IN-1 (TFA),Data.sdf,10987,HY-151563A,,,Deubiquitinase,Cell Cycle/DNA Damage,C24H17ClF4N2O6,10mM,Cancer,No Development Reported,CN1CC[C@@H](Oc2ccc(F)c(-c3nc4c(o3)C(=O)c3ccccc3C4=O)c2Cl)C1,清洗成功,0.2717391304347826
15063,O=c1c(-c2ccc(O)c(O)c2)coc2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)ccc12,1,0.988777220249176,0.988777220249176,O=C1C(C2=CC=C(O)C(O)=C2)=COC3=C([C@H]4[C@@H]([C@H]([C@@H]([C@@H](CO)O4)O)O)O)C(O)=CC=C13,3'-Hydroxypuerarin,Data.sdf,17905,HY-N1980,,117060-54-5,Reactive Oxygen Species,Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?oB,C21H20O10,10mM,Inflammation/Immunology,No Development Reported,O=c1c(-c2ccc(O)c(O)c2)coc2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)ccc12,清洗成功,0.2784810126582278
7597,COc1cc(/C=C(\C#N)C(=O)NCCCCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)NCc2ccc(-c3scnc3C)cc2)C(C)(C)C)ccc1OCc1ccc(C(F)(F)F)cc1C(F)(F)F,1,0.9887420535087585,0.9887420535087585,COC(C=C1/C=C(C#N)/C(NCCCCC(N[C@@H](C(C)(C)C)C(N2[C@@H](C[C@H](C2)O)C(NCC3=CC=C(C4=C(C)N=CS4)C=C3)=O)=O)=O)=O)=C(C=C1)OCC5=C(C=C(C=C5)C(F)(F)F)C(F)(F)F,PROTAC ERR?± Degrader-3,Data.sdf,8992,HY-139185,,2306388-65-6,Estrogen Receptor/ERR; PROTACs,PROTAC; Vitamin D Related/Nuclear Receptor,C47H50F6N6O7S,10mM,Cancer,No Development Reported,COc1cc(/C=C(\C#N)C(=O)NCCCCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)NCc2ccc(-c3scnc3C)cc2)C(C)(C)C)ccc1OCc1ccc(C(F)(F)F)cc1C(F)(F)F,清洗成功,0.2222222222222222
1555,COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc(-c3ccc(-c4cnc([C@@H]5CCCN5C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]4)cc3)cc2)[nH]1)C(C)C,1,0.9887415766716003,0.9887415766716003,O=C(N1CCC[C@H]1C2=NC=C(C3=CC=C(C4=CC=C(C=C4)C5=CN=C(N5)[C@@H]6CCCN6C([C@H](C(C)C)NC(OC)=O)=O)C=C3)N2)[C@H](C(C)C)NC(OC)=O.[H]Cl.[H]Cl,Daclatasvir (dihydrochloride),Data.sdf,1838,HY-10465,BMS-790052 (dihydrochloride); EBP 883 (dihydrochloride),1009119-65-6,HCV,Anti-infection,C40H52Cl2N8O6,10mM,Infection,Launched,COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc(-c3ccc(-c4cnc([C@@H]5CCCN5C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]4)cc3)cc2)[nH]1)C(C)C,清洗成功,0.2470588235294117
1556,COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc(-c3ccc(-c4cnc([C@@H]5CCCN5C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]4)cc3)cc2)[nH]1)C(C)C,1,0.9887415766716003,0.9887415766716003,O=C([C@@H](NC(OC)=O)C(C)C)N1CCC[C@H]1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C5=CN=C([C@@H]6CCCN6C([C@@H](NC(OC)=O)C(C)C)=O)N5)C=C4,Daclatasvir,Data.sdf,1839,HY-10466,BMS-790052; EBP 883,1009119-64-5,HCV,Anti-infection,C40H50N8O6,10mM,Infection,Launched,COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc(-c3ccc(-c4cnc([C@@H]5CCCN5C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]4)cc3)cc2)[nH]1)C(C)C,清洗成功,0.25
2765,CN[C@H]1CC[C@H](N(Cc2cc(-c3ccncc3)ccc2OC)C(=O)c2sc3c(F)ccc(F)c3c2Cl)CC1,1,0.9887412190437317,0.9887412190437317,O=C(C1=C(Cl)C2=C(F)C=CC(F)=C2S1)N(CC3=CC(C4=CC=NC=C4)=CC=C3OC)[C@H]5CC[C@H](NC)CC5,Hedgehog agonist 1,Data.sdf,3248,HY-111040,,946002-48-8,Hedgehog,Stem Cell/Wnt,C29H28ClF2N3O2S,10mM,Neurological Disease,No Development Reported,CN[C@H]1CC[C@H](N(Cc2cc(-c3ccncc3)ccc2OC)C(=O)c2sc3c(F)ccc(F)c3c2Cl)CC1,清洗成功,0.2613636363636363
4728,Cc1c(-c2cc(NS(=O)(=O)c3ccccc3Cl)n(C)n2)sc2ccc(Cl)cc12,1,0.9887396693229675,0.9887396693229675,O=S(C1=CC=CC=C1Cl)(NC2=CC(C3=C(C)C4=CC(Cl)=CC=C4S3)=NN2C)=O,ML-60218,Data.sdf,5555,HY-122122,,577784-91-9,DNA/RNA Synthesis,Cell Cycle/DNA Damage,C19H15Cl2N3O2S2,10mM,Cancer; Infection,No Development Reported,Cc1c(-c2cc(NS(=O)(=O)c3ccccc3Cl)n(C)n2)sc2ccc(Cl)cc12,清洗成功,0.25
12194,CSc1cccc(NC(=O)CCc2c(C)nc3c4cccnc4nn3c2C)c1,1,0.988739013671875,0.988739013671875,O=C(NC1=CC=CC(SC)=C1)CCC2=C(C)N3C(N=C2C)=C(C=CC=N4)C4=N3,Pantothenate kinase-IN-2,Data.sdf,14424,HY-44170,,902614-04-4,PANK,Metabolic Enzyme/Protease,C21H21N5OS,10mM,Metabolic Disease,No Development Reported,CSc1cccc(NC(=O)CCc2c(C)nc3c4cccnc4nn3c2C)c1,清洗成功,0.2926829268292683
4893,CC(C)(Cc1ccc(Oc2ncccc2C#N)cc1)NC[C@H](O)COc1ccccc1-c1cccs1,1,0.9887224435806274,0.9887224435806274,N#CC1=CC=CN=C1OC2=CC=C(C=C2)CC(NC[C@@H](COC3=CC=CC=C3C4=CC=CS4)O)(C)C,Lubabegron,Data.sdf,5762,HY-123012,LY-488756,391920-32-4,Adrenergic Receptor,GPCR/G Protein; Neuronal Signaling,C29H29N3O3S,10mM,Others,No Development Reported,CC(C)(Cc1ccc(Oc2ncccc2C#N)cc1)NC[C@H](O)COc1ccccc1-c1cccs1,清洗成功,0.2527472527472527
3877,O=C(Nc1cc(O)cc(-c2cccs2)c1)Nc1ccc2ccccc2c1,1,0.9887158274650574,0.9887158274650574,O=C(NC1=CC2=CC=CC=C2C=C1)NC3=CC(O)=CC(C4=CC=CS4)=C3,FzM1,Data.sdf,4561,HY-116553,,1680196-54-6,Wnt; ?2-catenin,Stem Cell/Wnt,C21H16N2O2S,10mM,Cancer,No Development Reported,O=C(Nc1cc(O)cc(-c2cccs2)c1)Nc1ccc2ccccc2c1,清洗成功,0.3389830508474576
5070,COCCO[C@H]1CC[C@H](Nc2cc(=O)n(C)c3ccc(-c4cncs4)cc23)CC1,1,0.988714873790741,0.988714873790741,O=C1N(C)C2=C(C=C(C3=CN=CS3)C=C2)C(N[C@H]4CC[C@H](OCCOC)CC4)=C1,CD38 inhibitor 1,Data.sdf,5970,HY-123999,,1700637-55-3,CD38,Immunology/Inflammation,C22H27N3O3S,10mM,Metabolic Disease,No Development Reported,COCCO[C@H]1CC[C@H](Nc2cc(=O)n(C)c3ccc(-c4cncs4)cc23)CC1,清洗成功,0.2777777777777778
1570,Nc1nccc(Oc2ccc(NC(=O)c3c[nH]cc(-c4ccc(F)cc4)c3=O)cc2F)c1Cl,1,0.9887136816978455,0.9887136816978455,ClC1=C(OC2=CC=C(NC(C3=CNC=C(C4=CC=C(F)C=C4)C3=O)=O)C=C2F)C=CN=C1N,BMS-794833,Data.sdf,1854,HY-10497,,1174046-72-0,c-Met/HGFR; VEGFR,Protein Tyrosine Kinase/RTK,C23H15ClF2N4O3,10mM,Cancer,No Development Reported,Nc1nccc(Oc2ccc(NC(=O)c3c[nH]cc(-c4ccc(F)cc4)c3=O)cc2F)c1Cl,清洗成功,0.35
2446,Cn1nc(C(=O)N(Cc2ccccc2)Cc2ccc(C(=O)O)cc2)c2c1-c1cc(Cl)ccc1OC2,1,0.9887059926986694,0.9887059926986694,CN1C(C2=CC(Cl)=CC=C2OC3)=C3C(C(N(CC4=CC=CC=C4)CC5=CC=C(C(O)=O)C=C5)=O)=N1,Nidufexor,Data.sdf,2873,HY-109096,LMB763,1773489-72-7,Autophagy; FXR,Autophagy; Metabolic Enzyme/Protease,C27H22ClN3O4,10mM,Inflammation/Immunology,Phase 2,Cn1nc(C(=O)N(Cc2ccccc2)Cc2ccc(C(=O)O)cc2)c2c1-c1cc(Cl)ccc1OC2,清洗成功,0.2439024390243902
1186,CCn1c(-c2nc3cc(C(=O)N4CCC[C@@H](N)C4)cc(OC)c3n2C)cc2cccnc21,1,0.9887049794197083,0.9887049794197083,O=C(N1C[C@H](N)CCC1)C2=CC(OC)=C3C(N=C(C4=CC5=CC=CN=C5N4CC)N3C)=C2.[H]Cl,GSK199,Data.sdf,1375,HY-103058,,1549811-53-1,Protein Arginine Deiminase,Epigenetics,C24H29ClN6O2,10mM,Cancer; Inflammation/Immunology; Cardiovascular Disease,No Development Reported,CCn1c(-c2nc3cc(C(=O)N4CCC[C@@H](N)C4)cc(OC)c3n2C)cc2cccnc21,清洗成功,0.3297872340425531
2865,CN(C)C1CCN(c2ccc(Nc3cc4c(N5CCC(CO)CC5)nc(Nc5ccc(F)cc5)nc4cn3)nc2)CC1,1,0.9887033104896545,0.9887033104896545,OCC(CC1)CCN1C2=NC(NC3=CC=C(F)C=C3)=NC(C=N4)=C2C=C4NC5=NC=C(N6CCC(N(C)C)CC6)C=C5,EGFR-IN-5,Data.sdf,3366,HY-111415,,2225887-26-1,EGFR,JAK/STAT Signaling; Protein Tyrosine Kinase/RTK,C31H38FN9O,10mM,Cancer,No Development Reported,CN(C)C1CCN(c2ccc(Nc3cc4c(N5CCC(CO)CC5)nc(Nc5ccc(F)cc5)nc4cn3)nc2)CC1,清洗成功,0.3092783505154639
5538,COc1cc(OC)c2c(=O)c(OCCCCN3CCN(C(=O)c4ccncc4)CC3)c(-c3cc(OC)c(OC)c(OC)c3)oc2c1,1,0.988698422908783,0.988698422908783,O=C1C(OCCCCN2CCN(C(C3=CC=NC=C3)=O)CC2)=C(C4=CC(OC)=C(OC)C(OC)=C4)OC5=CC(OC)=CC(OC)=C15,Telomerase-IN-2,Data.sdf,6533,HY-126482,,1610878-54-0,Telomerase,Cell Cycle/DNA Damage,C34H39N3O9,10mM,Cancer,No Development Reported,COc1cc(OC)c2c(=O)c(OCCCCN3CCN(C(=O)c4ccncc4)CC3)c(-c3cc(OC)c(OC)c(OC)c3)oc2c1,清洗成功,0.2524271844660194
4539,C#CCN(C)Cc1cc2cc(OCCCC3CCN(Cc4ccccc4)CC3)ccc2n1C,1,0.9886981248855591,0.9886981248855591,C#CCN(C)CC1=CC2=C(C=CC(OCCCC3CCN(CC3)CC4=CC=CC=C4)=C2)N1C,ASS234,Data.sdf,5346,HY-121072,,1334106-34-1,Cholinesterase (ChE); Monoamine Oxidase,Neuronal Signaling,C29H37N3O,10mM,Neurological Disease,No Development Reported,C#CCN(C)Cc1cc2cc(OCCCC3CCN(Cc4ccccc4)CC3)ccc2n1C,清洗成功,0.29
10254,COc1cc2cc(c1Cl)N(C)C(=O)C[C@H](OC(=O)C(C)C)[C@]1(C)O[C@H]1[C@H](C)[C@@H]1C[C@@](O)(NC(=O)O1)[C@H](OC)/C=C/C=C(\C)C2,1,0.9886959791183472,0.9886959791183472,ClC1=C(N(C)C(C[C@H](OC(C(C)C)=O)[C@@](O2)(C)[C@]2([H])[C@H](C)[C@]3([H])C[C@](NC(O3)=O)(O)[C@H](OC)/C=C/C=C(C)/C4)=O)C=C4C=C1OC,Ansamitocin P-3,Data.sdf,12137,HY-15739,Antibiotic C 15003P3; Maytansinol isobutyrate,66584-72-3,ADC Cytotoxin; Antibiotic; Bacterial; Microtubule/Tubulin,Antibody-drug Conjugate/ADC Related; Anti-infection; Cell Cycle/DNA Damage; Cytoskeleton,C32H43ClN2O9,10mM,Cancer; Infection,No Development Reported,COc1cc2cc(c1Cl)N(C)C(=O)C[C@H](OC(=O)C(C)C)[C@]1(C)O[C@H]1[C@H](C)[C@@H]1C[C@@](O)(NC(=O)O1)[C@H](OC)/C=C/C=C(\C)C2,清洗成功,0.1764705882352941
6375,CNC(=O)c1ccccc1Nc1cc(Nc2ccc(N3CCN(CC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)N[C@@H](C)c4ccc(-c5scnc5C)cc4)C(C)(C)C)CC3)cc2OC)ncc1C(F)(F)F,1,0.9886958599090576,0.9886958599090576,O=C([C@H]1N(C([C@@H](NC(CN2CCN(C3=CC=C(NC4=NC=C(C(F)(F)F)C(NC5=CC=CC=C5C(NC)=O)=C4)C(OC)=C3)CC2)=O)C(C)(C)C)=O)C[C@H](O)C1)N[C@H](C6=CC=C(C7=C(C)N=CS7)C=C6)C,GSK215,Data.sdf,7542,HY-132296,,2743427-26-9,FAK; PROTACs,PROTAC; Protein Tyrosine Kinase/RTK,C50H59F3N10O6S,10mM,Cancer,No Development Reported,CNC(=O)c1ccccc1Nc1cc(Nc2ccc(N3CCN(CC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)N[C@@H](C)c4ccc(-c5scnc5C)cc4)C(C)(C)C)CC3)cc2OC)ncc1C(F)(F)F,清洗成功,0.3333333333333333
982,CC(C)S(=O)(=O)c1ccc2nccc(Nc3ccc4scnc4c3)c2c1,1,0.9886947274208069,0.9886947274208069,O=S(C1=CC=C2N=CC=C(C2=C1)NC3=CC=C4SC=NC4=C3)(C(C)C)=O,GSK-872,Data.sdf,1127,HY-101872,,1346546-69-7,RIP kinase,Apoptosis,C19H17N3O2S2,10mM,Inflammation/Immunology,No Development Reported,CC(C)S(=O)(=O)c1ccc2nccc(Nc3ccc4scnc4c3)c2c1,清洗成功,0.2784810126582278
983,CC(C)S(=O)(=O)c1ccc2nccc(Nc3ccc4scnc4c3)c2c1,1,0.9886947274208069,0.9886947274208069,O=S(C1=CC=C2N=CC=C(C2=C1)NC3=CC=C4SC=NC4=C3)(C(C)C)=O.[H]Cl,GSK-872 (hydrochloride),Data.sdf,1128,HY-101872A,,2703752-81-0,RIP kinase,Apoptosis,C19H18ClN3O2S2,10mM,Inflammation/Immunology,No Development Reported,CC(C)S(=O)(=O)c1ccc2nccc(Nc3ccc4scnc4c3)c2c1,清洗成功,0.275
9062,CN(C)C/C=C/C(=O)Nc1ccc(C(=O)N[C@H]2CC[C@H](Nc3cc(-c4cccc(NCc5cccc(F)c5)n4)c(Cl)cn3)CC2)cc1,1,0.9886940121650696,0.9886940121650696,O=C(N[C@H]1CC[C@H](NC2=NC=C(Cl)C(C3=NC(NCC4=CC=CC(F)=C4)=CC=C3)=C2)CC1)C5=CC=C(NC(/C=C/CN(C)C)=O)C=C5,XPW1,Data.sdf,10680,HY-149673,,2700286-66-2,CDK,Cell Cycle/DNA Damage,C36H39ClFN7O2,10mM,Cancer,No Development Reported,CN(C)C/C=C/C(=O)Nc1ccc(C(=O)N[C@H]2CC[C@H](Nc3cc(-c4cccc(NCc5cccc(F)c5)n4)c(Cl)cn3)CC2)cc1,清洗成功,0.3050847457627119
15411,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)cc4)oc4cc(O)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@H]2O)[C@H](O)[C@H](O)[C@H]1O,1,0.9886915683746338,0.9886915683746338,O=C(C(O[C@@H]1O[C@@H]([C@@H]([C@@H]([C@H]1O)O)O)CO[C@H]2[C@@H]([C@@H]([C@H]([C@@H](O2)C)O)O)O)=C(C3=CC=C(C=C3)O)OC4=CC(O)=C5)C4=C5O,Biorobin,Data.sdf,18362,HY-N2938,Kaempferol 3-O-robinobioside,17297-56-2,Others,Others,C27H30O15,10mM,Cancer,No Development Reported,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)cc4)oc4cc(O)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@H]2O)[C@H](O)[C@H](O)[C@H]1O,清洗成功,0.3134328358208955
8541,CN1CCN(c2ncc(Oc3cc(CN4CCC(CC(=O)O)CC4)cc(-c4cc(Cl)cc(Cl)c4)n3)cn2)CC1,1,0.988689124584198,0.988689124584198,O=C(O)CC1CCN(CC2=CC(C3=CC(Cl)=CC(Cl)=C3)=NC(OC4=CN=C(N5CCN(C)CC5)N=C4)=C2)CC1,BOS-318,Data.sdf,10078,HY-147140,,2387633-15-8,Furin,Metabolic Enzyme/Protease,C28H32Cl2N6O3,10mM,Inflammation/Immunology,No Development Reported,CN1CCN(c2ncc(Oc3cc(CN4CCC(CC(=O)O)CC4)cc(-c4cc(Cl)cc(Cl)c4)n3)cn2)CC1,清洗成功,0.268041237113402
8020,O[C@@](Cc1nc(CC2(C(F)(F)F)CC2)c[nH]1)(c1ccc(-n2cccn2)cc1)C(F)(F)F,1,0.9886863231658936,0.9886863231658936,O[C@](CC1=NC(CC2(C(F)(F)F)CC2)=CN1)(C(F)(F)F)C3=CC=C(N4C=CC=N4)C=C3,MK-5046,Data.sdf,9471,HY-14342,,1022152-70-0,Bombesin Receptor,GPCR/G Protein,C20H18F6N4O,10mM,Metabolic Disease,No Development Reported,O[C@@](Cc1nc(CC2(C(F)(F)F)CC2)c[nH]1)(c1ccc(-n2cccn2)cc1)C(F)(F)F,清洗成功,0.2258064516129032
8021,O[C@](Cc1nc(CC2(C(F)(F)F)CC2)c[nH]1)(c1ccc(-n2cccn2)cc1)C(F)(F)F,1,0.9886863231658936,0.9886863231658936,O[C@@](CC1=NC(CC2(C(F)(F)F)CC2)=CN1)(C(F)(F)F)C3=CC=C(N4C=CC=N4)C=C3,(R)-MK-5046,Data.sdf,9472,HY-14342A,,1021736-25-3,Bombesin Receptor,GPCR/G Protein,C20H18F6N4O,10mM,Metabolic Disease,No Development Reported,O[C@](Cc1nc(CC2(C(F)(F)F)CC2)c[nH]1)(c1ccc(-n2cccn2)cc1)C(F)(F)F,清洗成功,0.2258064516129032
2840,O=C(c1cc(Br)c(O)c(Br)c1)N1CCOc2ccncc21,1,0.9886794686317444,0.9886794686317444,O=C(N1C2=C(OCC1)C=CN=C2)C3=CC(Br)=C(C(Br)=C3)O,Epaminurad,Data.sdf,3332,HY-111345,UR-1102; URC-102,1198153-15-9,OAT; URAT1,Membrane Transporter/Ion Channel,C14H10Br2N2O3,10mM,Metabolic Disease; Inflammation/Immunology,Phase 3,O=C(c1cc(Br)c(O)c(Br)c1)N1CCOc2ccncc21,清洗成功,0.2307692307692307
5646,COc1cc(O)ccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,1,0.9886695742607117,0.9886695742607117,OC1=CC=C(OCCNCC(O)COC2=CC=CC(N3)=C2C4=C3C=CC=C4)C(OC)=C1,Carvedilol metabolite 4-Hydroxyphenyl Carvedilol,Data.sdf,6660,HY-12767,4-Hydroxyphenyl Carvedilol; 4-Hydroxycarvedilol,142227-49-4,Drug Metabolite,Metabolic Enzyme/Protease,C24H26N2O5,10mM,Cancer; Cardiovascular Disease; Inflammation/Immunology,No Development Reported,COc1cc(O)ccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,清洗成功,0.2816901408450704
16795,CCOC(=O)Cn1cccc1-c1nc(-c2ccc(OC)cc2)c(-c2ccc(OC)cc2)s1,1,0.9886625409126282,0.9886625409126282,O=C(OCC)CN1C(C2=NC(C3=CC=C(OC)C=C3)=C(C4=CC=C(OC)C=C4)S2)=CC=C1,Pamicogrel,Data.sdf,19988,HY-U00175,KBT3022,101001-34-7,COX,Immunology/Inflammation,C25H24N2O4S,10mM,Cardiovascular Disease,No Development Reported,CCOC(=O)Cn1cccc1-c1nc(-c2ccc(OC)cc2)c(-c2ccc(OC)cc2)s1,清洗成功,0.2711864406779661
9832,COc1ccc(-c2cnc3c(cc(C4CCN(C(C)=O)CC4)n3C)n2)cc1,1,0.9886616468429565,0.9886616468429565,CC(N1CCC(C2=CC3=NC(C4=CC=C(OC)C=C4)=CN=C3N2C)CC1)=O,Gcase activator 2,Data.sdf,11619,HY-154823,,2759897-35-1,Glycosidase,Metabolic Enzyme/Protease,C21H24N4O2,10mM,Metabolic Disease,No Development Reported,COc1ccc(-c2cnc3c(cc(C4CCN(C(C)=O)CC4)n3C)n2)cc1,清洗成功,0.3424657534246575
5220,COc1cn(-c2ccc(-n3cccn3)cc2F)nc(-c2ccnn2-c2ccccc2)c1=O,1,0.9886491298675537,0.9886491298675537,FC1=CC(N2N=CC=C2)=CC=C1N3N=C(C4=CC=NN4C5=CC=CC=C5)C(C(OC)=C3)=O,Balipodect,Data.sdf,6146,HY-12472,TAK-063,1238697-26-1,Phosphodiesterase (PDE),Metabolic Enzyme/Protease,C23H17FN6O2,10mM,Neurological Disease,Phase 2,COc1cn(-c2ccc(-n3cccn3)cc2F)nc(-c2ccnn2-c2ccccc2)c1=O,清洗成功,0.2317073170731707
14973,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)cc4)oc4cc(O)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,1,0.9886431097984314,0.9886431097984314,O=C1C(O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](CO[C@H]3[C@@H]([C@@H]([C@H]([C@H](C)O3)O)O)O)O2)O)O)O)=C(C4=CC=C(O)C=C4)OC5=CC(O)=CC(O)=C15,Nicotiflorin,Data.sdf,17785,HY-N1475,,17650-84-9,Others,Others,C27H30O15,10mM,Neurological Disease,No Development Reported,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)cc4)oc4cc(O)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,清洗成功,0.3134328358208955
6993,Cc1nc(-c2cnc(NC(C)C)n(C)c2=O)ccc1Oc1ccnc(-c2cnn(C)c2)c1,1,0.988642156124115,0.988642156124115,O=C1N(C)C(NC(C)C)=NC=C1C2=NC(C)=C(OC3=CC(C4=CN(C)N=C4)=NC=C3)C=C2,Vimseltinib,Data.sdf,8296,HY-136256,DCC-3014,1628606-05-2,c-Fms; c-Kit,Protein Tyrosine Kinase/RTK,C23H25N7O2,10mM,Cancer,Launched,Cc1nc(-c2cnc(NC(C)C)n(C)c2=O)ccc1Oc1ccnc(-c2cnn(C)c2)c1,清洗成功,0.2941176470588235
7151,CC1(C)CC(=O)c2s/c(=N\c3ccccc3)oc2C1,1,0.9886419177055359,0.9886419177055359,O=C1CC(C)(C)CC2=C1S/C(O2)=N\C3=CC=CC=C3,BOT-64,Data.sdf,8467,HY-136741,,113760-29-5,IKK,NF-?oB,C15H15NO2S,10mM,Inflammation/Immunology,No Development Reported,CC1(C)CC(=O)c2s/c(=N\c3ccccc3)oc2C1,清洗成功,0.2698412698412698
8458,CO/N=C(/COc1ccc2c(C)cc(=O)oc2c1)c1nccs1,1,0.9886419177055359,0.9886419177055359,CO/N=C(C1=NC=CS1)/COC2=CC=C3C(C)=CC(OC3=C2)=O,Antimicrobial agent-2,Data.sdf,9982,HY-146460,,2412592-33-5,Reactive Oxygen Species,Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?oB,C16H14N2O4S,10mM,Infection,No Development Reported,CO/N=C(/COc1ccc2c(C)cc(=O)oc2c1)c1nccs1,清洗成功,0.3442622950819672
6350,CN1CCC(c2c[nH]c3ccc(O)cc23)CC1,1,0.9886198043823242,0.9886198043823242,OC1=CC2=C(NC=C2C3CCN(C)CC3)C=C1,BRL 54443,Data.sdf,7514,HY-13221,,57477-39-1,5-HT Receptor,GPCR/G Protein; Neuronal Signaling,C14H18N2O,10mM,Cardiovascular Disease,No Development Reported,CN1CCC(c2c[nH]c3ccc(O)cc23)CC1,清洗成功,0.2647058823529412
9073,Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21,1,0.9886155724525452,0.9886155724525452,O=C1C(OC2=CC=C(F)C=C2F)=CC3=CN=C(NC4CCOCC4)N=C3N1C.Cl,R1487 (Hydrochloride),Data.sdf,10697,HY-14975,,449808-64-4,Autophagy; p38 MAPK,Autophagy; MAPK/ERK Pathway,C19H19ClF2N4O3,10mM,Cancer,Phase 1,Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21,清洗成功,0.3068181818181818
1192,Cn1nc(CC(=O)Nc2cc(S(=O)(=O)Nc3cccc(Cl)c3)ccc2O)c2ccccc2c1=O,1,0.9886106848716736,0.9886106848716736,O=C(NC1=CC(S(=O)(NC2=CC=CC(Cl)=C2)=O)=CC=C1O)CC3=NN(C)C(C4=C3C=CC=C4)=O,EZ-482,Data.sdf,1381,HY-103076,,1016456-76-0,Apolipoprotein,Metabolic Enzyme/Protease,C23H19ClN4O5S,10mM,Neurological Disease,No Development Reported,Cn1nc(CC(=O)Nc2cc(S(=O)(=O)Nc3cccc(Cl)c3)ccc2O)c2ccccc2c1=O,清洗成功,0.2631578947368421
14407,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H]1[C@H](O)C[C@](OC(=O)/C=C/c2ccc(O)c(O)c2)(C(=O)O)C[C@H]1O,1,0.9886075854301453,0.9886075854301453,OC1=CC=C(/C=C/C(O[C@H]2[C@H](O)C[C@@](C(O)=O)(OC(/C=C/C3=CC(O)=C(O)C=C3)=O)C[C@H]2O)=O)C=C1O,"1,4-Dicaffeoylquinic acid",Data.sdf,17038,HY-N0358,"1,4-DCQA",1182-34-9,Interleukin Related; TNF Receptor,Apoptosis; Immunology/Inflammation,C25H24O12,10mM,Inflammation/Immunology,No Development Reported,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H]1[C@H](O)C[C@](OC(=O)/C=C/c2ccc(O)c(O)c2)(C(=O)O)C[C@H]1O,清洗成功,0.3469387755102041
15387,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)cc4)oc4cc(O)cc(O)c4c3=O)[C@H](O[C@@H]3OC[C@@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,1,0.9886011481285095,0.9886011481285095,O=C1C(O[C@H]2[C@@H]([C@H]([C@H](O)[C@@H](CO[C@H]3[C@@H]([C@@H]([C@@H](O)[C@H](C)O3)O)O)O2)O)O[C@@]4([H])[C@@H]([C@H]([C@H](O)CO4)O)O)=C(C5=CC=C(O)C=C5)OC6=CC(O)=CC(O)=C61,Camelliaside B,Data.sdf,18329,HY-N2605,,131573-90-5,Others,Others,C32H38O19,10mM,Inflammation/Immunology,No Development Reported,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)cc4)oc4cc(O)cc(O)c4c3=O)[C@H](O[C@@H]3OC[C@@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,清洗成功,0.2625
5234,O=C(NC[C@H]1[C@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@@H]12)c1ccc2[nH]nnc2c1,1,0.9885799288749695,0.9885799288749695,O=C(N1C[C@]2([H])[C@H](CNC(C3=CC=C(NN=N4)C4=C3)=O)[C@]2([H])C1)OCC5=CC(C(F)(F)F)=CC(C(F)(F)F)=C5,BI-2545,Data.sdf,6164,HY-124772,,2162961-71-7,Phosphodiesterase (PDE),Metabolic Enzyme/Protease,C23H19F6N5O3,10mM,Inflammation/Immunology,No Development Reported,O=C(NC[C@H]1[C@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@@H]12)c1ccc2[nH]nnc2c1,清洗成功,0.2537313432835821
14306,C[C@H]1O[C@@H](O[C@H]2[C@H](Oc3c(-c4ccc(O)cc4)oc4cc(O)cc(O)c4c3=O)O[C@@H](CO)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,1,0.988576352596283,0.988576352596283,C[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H]2[C@H](O)[C@@H](O)[C@H](CO)O[C@H]2OC3=C(C4=CC=C(O)C=C4)OC5=CC(O)=CC(O)=C5C3=O)O1,Kaempferol-3-O-glucorhamnoside,Data.sdf,16904,HY-N0208,,40437-72-7,NF-?oB; p38 MAPK,MAPK/ERK Pathway; NF-?oB,C27H30O15,10mM,Inflammation/Immunology,No Development Reported,C[C@H]1O[C@@H](O[C@H]2[C@H](Oc3c(-c4ccc(O)cc4)oc4cc(O)cc(O)c4c3=O)O[C@@H](CO)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,清洗成功,0.3068181818181818
14911,COc1ccc(-c2cc(=O)c3c(O)c(OC)c(O)c(OC)c3o2)cc1,1,0.9885624647140503,0.9885624647140503,O=C1C=C(C2=CC=C(OC)C=C2)OC3=C(OC)C(O)=C(OC)C(O)=C13,Nevadensin,Data.sdf,17703,HY-N1377,,10176-66-6,Bacterial; Carboxylesterase (CES),Anti-infection; Metabolic Enzyme/Protease,C18H16O7,10mM,Infection; Metabolic Disease; Inflammation/Immunology; Cardiovascular Disease,No Development Reported,COc1ccc(-c2cc(=O)c3c(O)c(OC)c(O)c(OC)c3o2)cc1,清洗成功,0.3478260869565217
2792,CC1(CCCc2cc(=O)oc3[nH]c(=O)[nH]c(=O)c23)CC1,1,0.9885593056678772,0.9885593056678772,O=C1NC2=C(C(CCCC3(C)CC3)=CC(O2)=O)C(N1)=O,SCH-900271,Data.sdf,3282,HY-111143,,915210-50-3,nAChR,Membrane Transporter/Ion Channel; Neuronal Signaling,C14H16N2O4,10mM,Metabolic Disease,Phase 2,CC1(CCCc2cc(=O)oc3[nH]c(=O)[nH]c(=O)c23)CC1,清洗成功,0.2372881355932203
12025,CN(C)CCCC(=O)Nc1ccc(C(=O)Nc2cccc(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)c2)cc1,1,0.9885357022285461,0.9885357022285461,ClC1=CN=C(NC2=CC(NC(C3=CC=C(NC(CCCN(C)C)=O)C=C3)=O)=CC=C2)N=C1C4=CNC5=CC=CC=C54,THZ1-R,Data.sdf,14218,HY-19988,,1621523-07-6,CDK,Cell Cycle/DNA Damage,C31H30ClN7O2,10mM,Cancer,No Development Reported,CN(C)CCCC(=O)Nc1ccc(C(=O)Nc2cccc(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)c2)cc1,清洗成功,0.3333333333333333
7097,CN(CCc1nc2ccccc2n1CC(=O)Nc1ccc2c(c1)CCC2)C(=O)c1ccccc1,1,0.9885326623916626,0.9885326623916626,O=C(NC1=CC=C2C(CCC2)=C1)CN3C4=CC=CC=C4N=C3CCN(C)C(C5=CC=CC=C5)=O,GSK717,Data.sdf,8409,HY-136555,,1595278-21-9,NOD-like Receptor (NLR),Immunology/Inflammation,C28H28N4O2,10mM,Inflammation/Immunology,No Development Reported,CN(CCc1nc2ccccc2n1CC(=O)Nc1ccc2c(c1)CCC2)C(=O)c1ccccc1,清洗成功,0.2823529411764706
14529,C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2c2c(O)cc(O)c3c(=O)cc(-c4ccc(O)cc4)oc23)[C@H](O)[C@H](O)[C@H]1O,1,0.9885304570198059,0.9885304570198059,OC1=CC(O)=C2C(OC(C3=CC=C(O)C=C3)=CC2=O)=C1[C@H](O[C@H](CO)[C@@H](O)[C@@H]4O)[C@@H]4O[C@@](O[C@@H](C)[C@H](O)[C@H]5O)([H])[C@@H]5O,Vitexin-2"-O-rhamnoside,Data.sdf,17199,HY-N0534,,64820-99-1,Others,Others,C27H30O14,10mM,Cardiovascular Disease,No Development Reported,C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2c2c(O)cc(O)c3c(=O)cc(-c4ccc(O)cc4)oc23)[C@H](O)[C@H](O)[C@H]1O,清洗成功,0.3218390804597701
6421,CC(C)(C)/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1,1,0.9885199666023254,0.9885199666023254,NC1=C2C(N([C@H]3CN(CCC3)C(/C(C#N)=C/C(C)(C)C)=O)N=C2C4=C(C=C(C=C4)OC5=CC=CC=C5)F)=NC=N1,Atuzabrutinib,Data.sdf,7605,HY-132808,SAR 444727; PRN473,1581714-49-9,Btk,Protein Tyrosine Kinase/RTK,C30H30FN7O2,10mM,Inflammation/Immunology,Phase 2,CC(C)(C)/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1,清洗成功,0.2666666666666666
10379,COc1cc(/C=C(\C#N)C(N)=O)cc(CSc2nc3ccccc3s2)c1O,1,0.9885121583938599,0.9885121583938599,O=C(N)/C(C#N)=C/C1=CC(OC)=C(O)C(CSC2=NC3=CC=CC=C3S2)=C1,AG-825,Data.sdf,12305,HY-15844,Tyrphostin AG-825,149092-50-2,Adrenergic Receptor; Apoptosis; EGFR,Apoptosis; GPCR/G Protein; JAK/STAT Signaling; Neuronal Signaling; Protein Tyrosine Kinase/RTK,C19H15N3O3S2,10mM,Cancer; Inflammation/Immunology; Neurological Disease; Cardiovascular Disease,No Development Reported,COc1cc(/C=C(\C#N)C(N)=O)cc(CSc2nc3ccccc3s2)c1O,清洗成功,0.2941176470588235
16211,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)C(C)(C)C,1,0.988506555557251,0.988506555557251,O=C([C@@H]1CCC(N1)=O)N[C@@H](CC2=CN=CN2)C(N[C@H](C(N[C@@H](CO)C(N[C@H](C(N[C@H](C(C)(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(N)=N)C(N3[C@@H](CCC3)C(NCC)=O)=O)=O)=O)=O)CC4=CC=C(C=C4)O)=O)=O)CC5=CNC6=CC=CC=C56)=O,Lecirelin,Data.sdf,19386,HY-P0051,,61012-19-9,GnRH Receptor,GPCR/G Protein,C59H84N16O12,10mM,Cancer; Endocrinology,No Development Reported,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)C(C)(C)C,清洗成功,0.2198581560283688
8785,Cc1cc(C)c(CNC(=O)c2cc(-c3ccc(N4CCN(CCNC(=O)CCOCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)nc3)cc3c2cnn3C(C)C)c(=O)[nH]1,1,0.988500714302063,0.988500714302063,O=C(C1=CC(C2=CC=C(N3CCN(CCNC(CCOCCNC4=CC=CC(C(N5C(CC6)C(NC6=O)=O)=O)=C4C5=O)=O)CC3)N=C2)=CC7=C1C=NN7C(C)C)NCC8=C(C)C=C(C)NC8=O,MS177,Data.sdf,10372,HY-148333,,2225938-86-1,Apoptosis; Histone Methyltransferase; PROTACs,Apoptosis; Epigenetics; PROTAC,C48H55N11O8,10mM,Cancer,No Development Reported,Cc1cc(C)c(CNC(=O)c2cc(-c3ccc(N4CCN(CCNC(=O)CCOCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)nc3)cc3c2cnn3C(C)C)c(=O)[nH]1,清洗成功,0.2589928057553957
5565,CN(C)c1ccc(C2Nc3ccc4ccccc4c3C3=C2C(=O)CC(C)(C)C3)cc1Br,1,0.9884986281394958,0.9884986281394958,O=C1C(C(C2=CC=C(N(C)C)C(Br)=C2)NC3=C4C5=CC=CC=C5C=C3)=C4CC(C)(C)C1,Glutaminase C-IN-1,Data.sdf,6570,HY-12682,Compound 968,311795-38-7,Glutaminase,Metabolic Enzyme/Protease,C27H27BrN2O,10mM,Cancer,No Development Reported,CN(C)c1ccc(C2Nc3ccc4ccccc4c3C3=C2C(=O)CC(C)(C)C3)cc1Br,清洗成功,0.2419354838709677
2453,Cc1cc(C)c(CNC(=O)c2cc(Cl)c3c(c2C)O[C@@](C)([C@H]2CC[C@H](N(C)C)CC2)O3)c(=O)[nH]1,1,0.9884971380233765,0.9884971380233765,CC1=C(O[C@@](C)([C@]2([H])CC[C@@H](N(C)C)CC2)O3)C3=C(Cl)C=C1C(NCC(C4=O)=C(C=C(C)N4)C)=O,Valemetostat,Data.sdf,2880,HY-109108,DS-3201,1809336-39-7,Histone Methyltransferase,Epigenetics,C26H34ClN3O4,10mM,Cancer,Launched,Cc1cc(C)c(CNC(=O)c2cc(Cl)c3c(c2C)O[C@@](C)([C@H]2CC[C@H](N(C)C)CC2)O3)c(=O)[nH]1,清洗成功,0.217391304347826
2454,Cc1cc(C)c(CNC(=O)c2cc(Cl)c3c(c2C)O[C@@](C)([C@H]2CC[C@H](N(C)C)CC2)O3)c(=O)[nH]1,1,0.9884971380233765,0.9884971380233765,O=S(C1=CC=C(C)C=C1)(O)=O.CC2=C(O[C@@](C)([C@]3([H])CC[C@@H](N(C)C)CC3)O4)C4=C(Cl)C=C2C(NCC(C5=O)=C(C=C(C)N5)C)=O,Valemetostat (tosylate),Data.sdf,2881,HY-109108A,DS-3201 (tosylate),1809336-93-3,Histone Methyltransferase,Epigenetics,C33H42ClN3O7S,10mM,Cancer,Launched,Cc1cc(C)c(CNC(=O)c2cc(Cl)c3c(c2C)O[C@@](C)([C@H]2CC[C@H](N(C)C)CC2)O3)c(=O)[nH]1,清洗成功,0.2142857142857142
4337,N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1,1,0.9884961843490601,0.9884961843490601,O=C(NCC1=CC=CC=C1)/C(C#N)=C/C2=CC=C(O)C(O)=C2,AG490,Data.sdf,5100,HY-12000,Tyrphostin AG490; Tyrphostin B42,133550-30-8,Autophagy; EGFR; JAK; STAT,Autophagy; Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt,C17H14N2O3,10mM,Cancer,No Development Reported,N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1,清洗成功,0.3114754098360656
1841,C[C@@H]1O[C@@H](O[C@H]2[C@H](Oc3c(-c4ccc(O)cc4)oc4cc(O)cc(O)c4c3=O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,1,0.9884909391403198,0.9884909391403198,O=C1C(O[C@H](O[C@@H]2CO)[C@@H]([C@H]([C@@H]2O)O)O[C@H](O[C@H]3C)[C@@H]([C@@H]([C@H]3O)O)O)=C(C(C=C4)=CC=C4O)OC5=CC(O)=CC(O)=C15,Kaempferol 3-neohesperidoside,Data.sdf,2175,HY-107207,Kaempferol 3-O-neohesperidoside,32602-81-6,Insulin Receptor,Protein Tyrosine Kinase/RTK,C27H30O15,10mM,Metabolic Disease,No Development Reported,C[C@@H]1O[C@@H](O[C@H]2[C@H](Oc3c(-c4ccc(O)cc4)oc4cc(O)cc(O)c4c3=O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,清洗成功,0.3068181818181818
1918,N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1,1,0.9884900450706482,0.9884900450706482,O=C(NCC1=CC=CC=C1)/C(C#N)=C/C2=CC=C(O)C(O)=C2,(E/Z)-AG490,Data.sdf,2259,HY-107459,(E/Z)-Tyrphostin AG490; (E/Z)-Tyrphostin B42,134036-52-5,EGFR; JAK; STAT,Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt,C17H14N2O3,10mM,Cancer,No Development Reported,N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1,清洗成功,0.3114754098360656
8996,O=c1cc(COc2ccccc2Cl)nc2scc(-c3ccccc3)n12,1,0.9884893298149109,0.9884893298149109,O=C1C=C(N=C2SC=C(N12)C3=CC=CC=C3)COC4=C(C=CC=C4)Cl,SLC26A3-IN-2,Data.sdf,10609,HY-149276,,950348-60-4,GLUT,Membrane Transporter/Ion Channel,C19H13ClN2O2S,10mM,Metabolic Disease,No Development Reported,O=c1cc(COc2ccccc2Cl)nc2scc(-c3ccccc3)n12,清洗成功,0.3043478260869565
3675,CNc1cnn(-c2cccc(C(F)(F)F)c2)c(=O)c1Cl,1,0.9884871244430542,0.9884871244430542,O=C1C(Cl)=C(C=NN1C2=CC=CC(C(F)(F)F)=C2)NC,Norflurazon,Data.sdf,4326,HY-114849,SAN 9789,27314-13-2,,,C12H9ClF3N3O,10mM,Others,No Development Reported,CNc1cnn(-c2cccc(C(F)(F)F)c2)c(=O)c1Cl,清洗成功,0.3174603174603174
3163,COc1cc(C(N)=O)nc(-c2cccc(C#C[C@]3(O)CCN(C)C3=O)c2)c1,1,0.9884859323501587,0.9884859323501587,O=C(N)C1=NC(C2=CC=CC(C#C[C@]3(O)CCN(C)C3=O)=C2)=CC(OC)=C1,NIK SMI1,Data.sdf,3718,HY-112433,,1660114-31-7,NF-?oB,NF-?oB,C20H19N3O4,10mM,Inflammation/Immunology,No Development Reported,COc1cc(C(N)=O)nc(-c2cccc(C#C[C@]3(O)CCN(C)C3=O)c2)c1,清洗成功,0.2708333333333333
3164,COc1cc(C(N)=O)nc(-c2cccc(C#C[C@@]3(O)CCN(C)C3=O)c2)c1,1,0.9884859323501587,0.9884859323501587,O=C(N)C1=NC(C2=CC=CC(C#C[C@@]3(O)CCN(C)C3=O)=C2)=CC(OC)=C1,(S)-NIK SMI1,Data.sdf,3719,HY-112433A,,2984765-48-0,NF-?oB,NF-?oB,C20H19N3O4,10mM,Inflammation/Immunology,No Development Reported,COc1cc(C(N)=O)nc(-c2cccc(C#C[C@@]3(O)CCN(C)C3=O)c2)c1,清洗成功,0.2708333333333333
649,CNc1ccc(-c2ccc3cc(OCC(O)CF)ccc3n2)cc1,1,0.9884824156761169,0.9884824156761169,OC(COC1=CC=C2N=C(C3=CC=C(NC)C=C3)C=CC2=C1)CF,THK-5117,Data.sdf,738,HY-101182,,1374107-54-6,Microtubule/Tubulin,Cell Cycle/DNA Damage; Cytoskeleton,C19H19FN2O2,10mM,Neurological Disease,No Development Reported,CNc1ccc(-c2ccc3cc(OCC(O)CF)ccc3n2)cc1,清洗成功,0.2608695652173913
5682,Cn1nccc1-c1ccccc1Oc1ccc(S(=O)(=O)Nc2nccs2)cc1C#N,1,0.9884777665138245,0.9884777665138245,O=S(C1=CC=C(OC2=CC=CC=C2C3=CC=NN3C)C(C#N)=C1)(NC4=NC=CS4)=O,PF-04856264,Data.sdf,6709,HY-12811,,1235397-05-3,Sodium Channel,Membrane Transporter/Ion Channel,C20H15N5O3S2,10mM,Neurological Disease,No Development Reported,Cn1nccc1-c1ccccc1Oc1ccc(S(=O)(=O)Nc2nccs2)cc1C#N,清洗成功,0.2127659574468085
12030,CN(C(=O)CNC(=O)/C=C/c1cccc(Cl)c1)C1CCS(=O)(=O)CC1,1,0.9884738326072693,0.9884738326072693,O=C(NCC(N(C)C(CC1)CCS1(=O)=O)=O)/C=C/C2=CC=CC(Cl)=C2,ML264,Data.sdf,14224,HY-19994,,1550008-55-3,KLF,MAPK/ERK Pathway,C17H21ClN2O4S,10mM,Cancer,No Development Reported,CN(C(=O)CNC(=O)/C=C/c1cccc(Cl)c1)C1CCS(=O)(=O)CC1,清洗成功,0.2461538461538461
9978,COc1cc2nccc(Nc3ccc4scnc4c3)c2cc1P(C)(C)=O,1,0.9884729981422424,0.9884729981422424,O=P(C)(C1=C(OC)C=C2N=CC=C(NC3=CC=C(SC=N4)C4=C3)C2=C1)C,Zharp2-1,Data.sdf,11801,HY-155782,,2772600-18-5,RIP kinase,Apoptosis,C19H18N3O2PS,10mM,Inflammation/Immunology,No Development Reported,COc1cc2nccc(Nc3ccc4scnc4c3)c2cc1P(C)(C)=O,清洗成功,0.2650602409638554
2249,COC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCc1c(-c2ccccc2)[nH]c2c(F)cc(F)cc12,1,0.9884716272354126,0.9884716272354126,N=C(N)NCCC[C@@H](C(OC)=O)NC(CCCC1=C(C2=CC=CC=C2)NC3=C1C=C(F)C=C3F)=O,L-803087,Data.sdf,2638,HY-108497,,217480-26-7,Somatostatin Receptor,GPCR/G Protein; Neuronal Signaling,C25H29F2N5O3,10mM,Cancer; Neurological Disease,No Development Reported,COC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCc1c(-c2ccccc2)[nH]c2c(F)cc(F)cc12,清洗成功,0.2386363636363636
4796,COC(=O)[C@@H](Nc1nc(CN2CCN(C(c3ccc(Cl)cc3)c3ccc(Cl)cc3)CC2)nc2ccccc12)C(C)C,1,0.9884689450263977,0.9884689450263977,CC(C)[C@@H](C(OC)=O)NC1=C2C=CC=CC2=NC(CN3CCN(C(C4=CC=C(Cl)C=C4)C5=CC=C(Cl)C=C5)CC3)=N1,P53R3,Data.sdf,5637,HY-122578,,922150-12-7,MDM-2/p53,Apoptosis,C32H35Cl2N5O2,10mM,Cancer,No Development Reported,COC(=O)[C@@H](Nc1nc(CN2CCN(C(c3ccc(Cl)cc3)c3ccc(Cl)cc3)CC2)nc2ccccc12)C(C)C,清洗成功,0.2584269662921348
354,O=c1ccc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2[nH]1,1,0.9884682297706604,0.9884682297706604,O=C1NC2=C(C=CC(OCCCCN3CCN(C4=CC=CC(Cl)=C4Cl)CC3)=C2)C=C1,Dehydroaripiprazole,Data.sdf,407,HY-100665,OPC-14857; DM-14857,129722-25-4,5-HT Receptor,GPCR/G Protein; Neuronal Signaling,C23H25Cl2N3O2,10mM,Neurological Disease,No Development Reported,O=c1ccc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2[nH]1,清洗成功,0.2619047619047619
7893,NS(=O)(=O)c1ccc(NC(=O)c2c(O)c3c4c(sc3[nH]c2=O)CCCC4)cc1,1,0.9884595274925232,0.9884595274925232,O=C(C1=C(O)C2=C(SC3=C2CCCC3)NC1=O)NC4=CC=C(S(=O)(N)=O)C=C4,M435-1279,Data.sdf,9328,HY-141891,,1359431-16-5,E1/E2/E3 Enzyme,Metabolic Enzyme/Protease,C18H17N3O5S2,10mM,Cancer,No Development Reported,NS(=O)(=O)c1ccc(NC(=O)c2c(O)c3c4c(sc3[nH]c2=O)CCCC4)cc1,清洗成功,0.3194444444444444
2846,N#Cc1c(-c2cccs2)nc(SCc2cccc(CC(=O)O)c2)[nH]c1=O,1,0.9884562492370605,0.9884562492370605,O=C1C(C#N)=C(C2=CC=CS2)N=C(SCC3=CC=CC(CC(O)=O)=C3)N1,TES-1025,Data.sdf,3343,HY-111365,,1883602-21-8,Others,Others,C18H13N3O3S2,10mM,Metabolic Disease,No Development Reported,N#Cc1c(-c2cccs2)nc(SCc2cccc(CC(=O)O)c2)[nH]c1=O,清洗成功,0.2435897435897435
12310,CC(C)(N)C(=O)N[C@H](COCc1ccccc1)C(=O)N1CCC2(CC1)CN(S(C)(=O)=O)c1ccccc12,1,0.9884540438652039,0.9884540438652039,CC(N)(C(N[C@@H](C(N1CCC2(CN(C3=C2C=CC=C3)S(=O)(C)=O)CC1)=O)COCC4=CC=CC=C4)=O)C.CS(=O)(O)=O,Ibutamoren (Mesylate),Data.sdf,14561,HY-50844,MK-677; MK-0677,159752-10-0,GHSR,GPCR/G Protein,C28H40N4O8S2,10mM,Endocrinology,Phase 2,CC(C)(N)C(=O)N[C@H](COCc1ccccc1)C(=O)N1CCC2(CC1)CN(S(C)(=O)=O)c1ccccc12,清洗成功,0.2111111111111111
10212,Cc1cc(OCc2nnc(SC3CCCC3)n2-c2cccnc2)ccc1-c1ccc(S(C)(=O)=O)cc1,1,0.9884490370750427,0.9884490370750427,CC(C=C(OCC1=NN=C(SC2CCCC2)N1C3=CC=CN=C3)C=C4)=C4C5=CC=C(S(=O)(C)=O)C=C5,NMS-873,Data.sdf,12085,HY-15713,,1418013-75-8,p97,Cell Cycle/DNA Damage,C27H28N4O3S2,10mM,Cancer,No Development Reported,Cc1cc(OCc2nnc(SC3CCCC3)n2-c2cccnc2)ccc1-c1ccc(S(C)(=O)=O)cc1,清洗成功,0.2790697674418604
6508,CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O[Na])CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1,1,0.9884483218193054,0.9884483218193054,ClC1=CC2=C(C=C1)C=CC(/C=C/C3=CC([C@H](SCC4(CC(O[Na])=O)CC4)CCC5=CC=CC=C5C(C)(O)C)=CC=C3)=N2,Montelukast (sodium),Data.sdf,7715,HY-13315,MK0476,151767-02-1,Leukotriene Receptor,GPCR/G Protein,C35H35ClNNaO3S,10mM,Inflammation/Immunology; Cancer,Launched,CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O[Na])CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1,清洗成功,0.1981132075471698
6021,Oc1cc(O)c2ccc(-c3ccc(O)c(O)c3)[o+]c2c1,1,0.9884431958198547,0.9884431958198547,OC1=CC2=[O+]C(C3=CC=C(O)C(O)=C3)=CC=C2C(O)=C1.[Cl-],Luteolinidin (chloride),Data.sdf,7122,HY-129997,,1154-78-5,CD38; NADPH Oxidase; Tyrosinase,Immunology/Inflammation; Metabolic Enzyme/Protease,C15H11ClO5,10mM,Cardiovascular Disease,No Development Reported,Oc1cc(O)c2ccc(-c3ccc(O)c(O)c3)[o+]c2c1,清洗成功,0.2941176470588235
8729,Cc1cccc(C)c1N(CC(=O)Nc1ccc(-c2ncon2)cc1)C(=O)C1CCS(=O)(=O)CC1,1,0.9884429574012756,0.9884429574012756,O=C(C(CC1)CCS1(=O)=O)N(C2=C(C)C=CC=C2C)CC(NC3=CC=C(C4=NOC=N4)C=C3)=O,Amenamevir,Data.sdf,10300,HY-14809,ASP2151,841301-32-4,HSV,Anti-infection,C24H26N4O5S,10mM,Infection,Launched,Cc1cccc(C)c1N(CC(=O)Nc1ccc(-c2ncon2)cc1)C(=O)C1CCS(=O)(=O)CC1,清洗成功,0.2323232323232323
12821,CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1,1,0.988439679145813,0.988439679145813,O=C(OC)NC1=NC2=CC=C(SCCC)C=C2N1,Albendazole,Data.sdf,15161,HY-B0223,SKF-62979,54965-21-8,Antibiotic; Apoptosis; Autophagy; Bacterial; HIF/HIF Prolyl-Hydroxylase; Microtubule/Tubulin; Parasite; Reactive Oxygen Species; VEGFR,Anti-infection; Apoptosis; Autophagy; Cell Cycle/DNA Damage; Cytoskeleton; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?oB; Protein Tyrosine Kinase/RTK,C12H15N3O2S,10mM,Cancer; Infection,Launched,CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1,清洗成功,0.2878787878787879
11840,CC(C)C[C@H](NC(=O)c1cc2ccccc2s1)C(=O)N1CCN(C(=O)[C@H](CO)NS(=O)(=O)c2ccc(Cl)cc2Cl)CC1,1,0.9884279370307922,0.9884279370307922,O=C(C1=CC2=CC=CC=C2S1)N[C@H](C(N3CCN(C([C@@H](NS(=O)(C4=CC=C(Cl)C=C4Cl)=O)CO)=O)CC3)=O)CC(C)C,GSK1016790A,Data.sdf,14005,HY-19608,,942206-85-1,Calcium Channel; TRP Channel,Membrane Transporter/Ion Channel; Neuronal Signaling,C28H32Cl2N4O6S2,10mM,Metabolic Disease; Cardiovascular Disease,No Development Reported,CC(C)C[C@H](NC(=O)c1cc2ccccc2s1)C(=O)N1CCN(C(=O)[C@H](CO)NS(=O)(=O)c2ccc(Cl)cc2Cl)CC1,清洗成功,0.2631578947368421
3648,COc1cccc(CC(C)C(=O)Nc2ccc3nc(-c4cscn4)[nH]c3c2)c1,1,0.9884267449378967,0.9884267449378967,O=C(NC1=CC=C2N=C(C3=CSC=N3)NC2=C1)C(C)CC4=CC=CC(OC)=C4,RY785,Data.sdf,4292,HY-114608,,1393748-80-5,Sodium Channel,Membrane Transporter/Ion Channel,C21H20N4O2S,10mM,Neurological Disease,No Development Reported,COc1cccc(CC(C)C(=O)Nc2ccc3nc(-c4cscn4)[nH]c3c2)c1,清洗成功,0.3291139240506329
13141,Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O,1,0.9884257316589355,0.9884257316589355,O=C(C1=C2C(C(C(C)=C(C3=CC=CC=C3)O2)=O)=CC=C1)OCCN4CCCCC4.Cl,Flavoxate (hydrochloride),Data.sdf,15521,HY-B0549A,Rec-7-0040; DW61,3717-88-2,Calcium Channel; mAChR; Phosphodiesterase (PDE),GPCR/G Protein; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling,C24H26ClNO4,10mM,Neurological Disease,Launched,Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O,清洗成功,0.2777777777777778
529,CN(C)CCCSc1ccccc1NC(=O)/C=C/c1ccccc1,1,0.9884251356124878,0.9884251356124878,O=C(NC1=CC=CC=C1SCCCN(C)C)/C=C/C2=CC=CC=C2.[H]Cl,Cinanserin (hydrochloride),Data.sdf,597,HY-100943,SQ 10643,54-84-2,5-HT Receptor; Influenza Virus,Anti-infection; GPCR/G Protein; Neuronal Signaling,C20H25ClN2OS,10mM,Infection; Inflammation/Immunology,No Development Reported,CN(C)CCCSc1ccccc1NC(=O)/C=C/c1ccccc1,清洗成功,0.2307692307692307
4969,NCc1ccc2c(c1)nc(CN1C(=O)C3(CC3)c3ccc(F)cc31)n2CCCC(F)(F)F,1,0.9884234070777893,0.9884234070777893,O=C1C2(C3=C(N1CC4=NC5=C(C=CC(CN)=C5)N4CCCC(F)(F)F)C=C(C=C3)F)CC2,Sisunatovir,Data.sdf,5856,HY-123475,RV521,1903763-82-5,RSV,Anti-infection,C23H22F4N4O,10mM,Infection,Phase 3,NCc1ccc2c(c1)nc(CN1C(=O)C3(CC3)c3ccc(F)cc31)n2CCCC(F)(F)F,清洗成功,0.2682926829268293
4970,NCc1ccc2c(c1)nc(CN1C(=O)C3(CC3)c3ccc(F)cc31)n2CCCC(F)(F)F,1,0.9884234070777893,0.9884234070777893,O=C(N(C1=C2C=CC(F)=C1)CC3=NC4=CC(CN)=CC=C4N3CCCC(F)(F)F)C52CC5.[H]Cl,Sisunatovir (hydrochloride),Data.sdf,5857,HY-123475A,RV521 (hydrochloride),1903763-83-6,RSV,Anti-infection,C23H23ClF4N4O,10mM,Infection,Phase 3,NCc1ccc2c(c1)nc(CN1C(=O)C3(CC3)c3ccc(F)cc31)n2CCCC(F)(F)F,清洗成功,0.2650602409638554
204,O=C(O)c1cn(C2CC2)c2cc(N3CCC(O)(COc4ccc(N5C[C@H](CO)OC5=O)cc4F)CC3)c(F)cc2c1=O,1,0.9884198904037476,0.9884198904037476,O=C(C1=CN(C2CC2)C3=C(C=C(F)C(N4CCC(O)(COC5=CC=C(N6C(O[C@@H](CO)C6)=O)C=C5F)CC4)=C3)C1=O)O,Cadazolid,Data.sdf,235,HY-100436,ACT-179811,1025097-10-2,Antibiotic; Bacterial,Anti-infection,C29H29F2N3O8,10mM,Infection,Phase 3,O=C(O)c1cn(C2CC2)c2cc(N3CCC(O)(COc4ccc(N5C[C@H](CO)OC5=O)cc4F)CC3)c(F)cc2c1=O,清洗成功,0.28
11676,CC(C)n1cc(-c2ccc3c(c2)N(C)CC3)c2c(NS(=O)(=O)c3ccn(C)n3)ccnc21,1,0.9884147644042969,0.9884147644042969,CC(C)N1C=C(C2=CC=C(CCN3C)C3=C2)C4=C1N=CC=C4NS(C5=NN(C)C=C5)(=O)=O,GSK2795039,Data.sdf,13817,HY-18950,,1415925-18-6,Apoptosis; NADPH Oxidase; Reactive Oxygen Species,Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?oB,C23H26N6O2S,10mM,Cancer,No Development Reported,CC(C)n1cc(-c2ccc3c(c2)N(C)CC3)c2c(NS(=O)(=O)c3ccn(C)n3)ccnc21,清洗成功,0.2444444444444444
10048,CN(C)C/C=C/C(=O)Nc1cccc(C(=O)Nc2ccc(Nc3nccc(-c4cccnc4)n3)cc2)c1,1,0.9884068369865417,0.9884068369865417,O=C(C1=CC(NC(/C=C/CN(C)C)=O)=CC=C1)NC(C=C2)=CC=C2NC3=NC=CC(C4=CN=CC=C4)=N3,JNK-IN-7,Data.sdf,11884,HY-15617,JNK inhibitor,1408064-71-0,JNK,MAPK/ERK Pathway,C28H27N7O2,10mM,Cancer,No Development Reported,CN(C)C/C=C/C(=O)Nc1cccc(C(=O)Nc2ccc(Nc3nccc(-c4cccnc4)n3)cc2)c1,清洗成功,0.3209876543209876
5776,Cc1cc(C)c(CNC(=O)c2cc(-c3ccc(N4CCN(C)CC4)nc3)cc3c2c(C)cn3C(C)C)c(=O)[nH]1,1,0.9884058237075806,0.9884058237075806,O=C(C1=CC(C2=CC=C(N3CCN(C)CC3)N=C2)=CC4=C1C(C)=CN4C(C)C)NCC5=C(C)C=C(C)NC5=O,GSK503,Data.sdf,6823,HY-12856,,1346572-63-1,Histone Methyltransferase,Epigenetics,C31H38N6O2,10mM,Cancer,No Development Reported,Cc1cc(C)c(CNC(=O)c2cc(-c3ccc(N4CCN(C)CC4)nc3)cc3c2c(C)cn3C(C)C)c(=O)[nH]1,清洗成功,0.3225806451612903
8575,C=C(C)C(=O)Nc1ccc(-c2c(-c3ccc(Oc4nccc(C)n4)c(F)c3)c3c(N)ncnc3n2C)cc1,1,0.9883982539176941,0.9883982539176941,O=C(C(C)=C)NC1=CC=C(C2=C(C3=C(N)N=CN=C3N2C)C4=CC(F)=C(OC5=NC=CC(C)=N5)C=C4)C=C1,Lirafugratinib,Data.sdf,10116,HY-147250,RLY-4008,2549174-42-5,FGFR,Protein Tyrosine Kinase/RTK,C28H24FN7O2,10mM,Cancer,Phase 2,C=C(C)C(=O)Nc1ccc(-c2c(-c3ccc(Oc4nccc(C)n4)c(F)c3)c3c(N)ncnc3n2C)cc1,清洗成功,0.3103448275862069
4175,N#Cc1cc(S(=O)(=O)Nc2ncns2)ccc1Oc1ccc(-c2cccc(C(F)(F)F)c2)cc1-c1ccnc(CNCCC2CCNCC2)c1,1,0.9883971810340881,0.9883971810340881,N#CC1=CC(S(=O)(NC2=NC=NS2)=O)=CC=C1OC3=CC=C(C4=CC(C(F)(F)F)=CC=C4)C=C3C5=CC(CNCCC6CCNCC6)=NC=C5.[H]Cl.[H]Cl.[H]Cl,PF-06456384 (trihydrochloride),Data.sdf,4916,HY-118952A,,1834610-75-1,Sodium Channel,Membrane Transporter/Ion Channel,C35H35Cl3F3N7O3S2,10mM,Neurological Disease,No Development Reported,N#Cc1cc(S(=O)(=O)Nc2ncns2)ccc1Oc1ccc(-c2cccc(C(F)(F)F)c2)cc1-c1ccnc(CNCCC2CCNCC2)c1,清洗成功,0.2222222222222222
6153,COc1cc(-c2nc(-c3ccccc3)c(-c3cccs3)[nH]2)cc(OC)c1O,1,0.9883971810340881,0.9883971810340881,COC1=CC(C2=NC(C3=CC=CC=C3)=C(N2)C4=CC=CS4)=CC(OC)=C1O,DPTIP,Data.sdf,7280,HY-131002,,351353-48-5,Phospholipase,Metabolic Enzyme/Protease,C21H18N2O3S,10mM,Inflammation/Immunology,No Development Reported,COc1cc(-c2nc(-c3ccccc3)c(-c3cccs3)[nH]2)cc(OC)c1O,清洗成功,0.3064516129032258
9396,Oc1ccc(/C=N/c2ccc3[nH]c(=S)[nH]c3c2)c(O)c1,1,0.988393247127533,0.988393247127533,S=C1NC2=CC=C(C=C2N1)/N=C/C3=CC=C(C=C3O)O,?±-Glucosidase-IN-22,Data.sdf,11091,HY-152158,,2870693-28-8,Glycosidase,Metabolic Enzyme/Protease,C14H11N3O2S,10mM,Metabolic Disease,No Development Reported,Oc1ccc(/C=N/c2ccc3[nH]c(=S)[nH]c3c2)c(O)c1,清洗成功,0.28125
8576,C=C(C)C(=O)Nc1ccc(-c2c(-c3ccc(Oc4nccc(C)n4)c(F)c3)c3c(N)ncnc3n2C)cc1,1,0.9883908033370972,0.9883908033370972,O=C(C(C)=C)NC1=CC=C(C2=C(C3=C(N)N=CN=C3N2C)C4=CC(F)=C(OC5=NC=CC(C)=N5)C=C4)C=C1.Cl,Lirafugratinib (hydrochloride),Data.sdf,10117,HY-147250A,RLY-4008 (hydrochloride),2688040-45-9,FGFR,Protein Tyrosine Kinase/RTK,C28H25ClFN7O2,10mM,Cancer,Phase 2,C=C(C)C(=O)Nc1ccc(-c2c(-c3ccc(Oc4nccc(C)n4)c(F)c3)c3c(N)ncnc3n2C)cc1,清洗成功,0.3068181818181818
18170,COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1,1,0.9883744716644287,0.9883744716644287,COCCN[C@@H]1CC[C@@H](NC2=NC=C(Cl)C(C3=CSC(NCC4(C#N)CCOCC4)=N3)=C2)CC1,JSH-150,Data.sdf,21653,HY-X0150,,2247481-21-4,CDK,Cell Cycle/DNA Damage,C24H33ClN6O2S,10mM,Cancer,No Development Reported,COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1,清洗成功,0.2545454545454545
10985,CC(C)(C)OC(=O)N1CCC(OCc2nc(-c3ccncc3)no2)CC1,1,0.9883566498756409,0.9883566498756409,O=C(OC(C)(C)C)N1CCC(CC1)OCC2=NC(C3=CC=NC=C3)=NO2,PSN632408,Data.sdf,13019,HY-16673,,857652-30-3,GPR119,GPCR/G Protein; Neuronal Signaling,C18H24N4O4,10mM,Metabolic Disease,No Development Reported,CC(C)(C)OC(=O)N1CCC(OCc2nc(-c3ccncc3)no2)CC1,清洗成功,0.3243243243243243
10541,O=C1CCC(N2Cc3cc(Nc4noc5ccccc45)ccc3C2=O)C(=O)N1,1,0.9883366227149963,0.9883366227149963,O=C1N(C2C(NC(CC2)=O)=O)CC3=C1C=CC(NC4=NOC5=C4C=CC=C5)=C3,SJ3149,Data.sdf,12495,HY-160444,,3026986-17-1,Casein Kinase; Molecular Glues,Cell Cycle/DNA Damage; PROTAC; Stem Cell/Wnt,C20H16N4O4,10mM,Cancer,No Development Reported,O=C1CCC(N2Cc3cc(Nc4noc5ccccc45)ccc3C2=O)C(=O)N1,清洗成功,0.2444444444444444
134,CC(C)(C)S(=O)(=O)c1ccc2nccc(Nc3n[nH]c4ccc(F)cc34)c2c1,1,0.9883354902267456,0.9883354902267456,FC1=CC2=C(NN=C2NC3=CC=NC4=CC=C(S(=O)(C(C)(C)C)=O)C=C34)C=C1,GSK583,Data.sdf,157,HY-100339,,1346547-00-9,RIP kinase,Apoptosis,C20H19FN4O2S,10mM,Endocrinology,No Development Reported,CC(C)(C)S(=O)(=O)c1ccc2nccc(Nc3n[nH]c4ccc(F)cc34)c2c1,清洗成功,0.2727272727272727
5073,Cc1ccsc1C(=O)N/N=C/c1ccc2ccccc2c1O,1,0.9883289337158203,0.9883289337158203,O=C(N/N=C/C1=C(C2=CC=CC=C2C=C1)O)C3=C(C=CS3)C,PCNA-I1,Data.sdf,5974,HY-124012,,444930-42-1,DNA/RNA Synthesis,Cell Cycle/DNA Damage,C17H14N2O2S,10mM,Cancer,No Development Reported,Cc1ccsc1C(=O)N/N=C/c1ccc2ccccc2c1O,清洗成功,0.2741935483870967
11458,N#Cc1c(-c2ccccc2)cc(-c2cc(Br)ccc2O)[nH]c1=O,1,0.9883246421813965,0.9883246421813965,OC1=C(C(N2)=CC(C3=CC=CC=C3)=C(C#N)C2=O)C=C(Br)C=C1,TCS PIM-1 1,Data.sdf,13550,HY-18086,SC 204330,491871-58-0,Pim,JAK/STAT Signaling,C18H11BrN2O2,10mM,Cancer,No Development Reported,N#Cc1c(-c2ccccc2)cc(-c2cc(Br)ccc2O)[nH]c1=O,清洗成功,0.2857142857142857
12109,O=C(N[C@@H]1CC[C@@H](c2cccc(F)c2F)CN(CC(F)(F)F)C1=O)N1CCC(n2c(=O)[nH]c3ncccc32)CC1,1,0.988323450088501,0.988323450088501,O=C1NC2=C(N1C3CCN(C(N[C@@H]4CC[C@@H](C5=CC=CC(F)=C5F)CN(CC(F)(F)F)C4=O)=O)CC3)C=CC=N2,Telcagepant,Data.sdf,14320,HY-32709,MK-0974,781649-09-0,CGRP Receptor,GPCR/G Protein; Neuronal Signaling,C26H27F5N6O3,10mM,Neurological Disease,Phase 3,O=C(N[C@@H]1CC[C@@H](c2cccc(F)c2F)CN(CC(F)(F)F)C1=O)N1CCC(n2c(=O)[nH]c3ncccc32)CC1,清洗成功,0.2407407407407407
6197,Cc1c(COc2cc(OCc3cccc(C#N)c3)c(CN3CCCCC3C(=O)O)cc2Cl)cccc1-c1ccc2c(c1)OCCO2,1,0.9883226752281189,0.9883226752281189,O=C(C1N(CCCC1)CC2=CC(Cl)=C(C=C2OCC3=CC=CC(C#N)=C3)OCC4=CC=CC(C5=CC=C6OCCOC6=C5)=C4C)O,BMS-1166-N-piperidine-COOH,Data.sdf,7331,HY-131187,,2447066-00-2,Ligands for Target Protein for PROTAC,PROTAC,C37H35ClN2O6,10mM,Cancer,No Development Reported,Cc1c(COc2cc(OCc3cccc(C#N)c3)c(CN3CCCCC3C(=O)O)cc2Cl)cccc1-c1ccc2c(c1)OCCO2,清洗成功,0.233009708737864
807,Cn1c(CSc2nc3ccccc3s2)n[nH]c1=S,1,0.9883224368095398,0.9883224368095398,S=C1NN=C(CSC2=NC3=CC=CC=C3S2)N1C,Ceefourin 1,Data.sdf,922,HY-101453,,315702-40-0,P-glycoprotein,Membrane Transporter/Ion Channel,C11H10N4S3,10mM,Cancer,No Development Reported,Cn1c(CSc2nc3ccccc3s2)n[nH]c1=S,清洗成功,0.2962962962962963
885,COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc2cc(F)c([C@H]3CC[C@H](c4cc5[nH]c([C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)[C@@H](C)OC)nc5cc4F)N3c3cc(F)c(N4CCC(c5ccc(F)cc5)CC4)c(F)c3)cc2[nH]1)[C@@H](C)OC,1,0.9883214831352234,0.9883214831352234,FC(C=C(N=C([C@H](CCC1)N1C([C@H]([C@@H](C)OC)NC(OC)=O)=O)N2)C2=C3)=C3[C@@H]4N(C5=CC(F)=C(N6CCC(C7=CC=C(F)C=C7)CC6)C(F)=C5)[C@@H](C(C=C(NC([C@H](CCC8)N8C([C@H]([C@@H](C)OC)NC(OC)=O)=O)=N9)C9=C%10)=C%10F)CC4,Pibrentasvir,Data.sdf,1015,HY-101662,ABT-530,1353900-92-1,HCV,Anti-infection,C57H65F5N10O8,10mM,Infection,Launched,COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc2cc(F)c([C@H]3CC[C@H](c4cc5[nH]c([C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)[C@@H](C)OC)nc5cc4F)N3c3cc(F)c(N4CCC(c5ccc(F)cc5)CC4)c(F)c3)cc2[nH]1)[C@@H](C)OC,清洗成功,0.1981981981981982
14180,O=c1c(-c2ccc(O)cc2)coc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc12,1,0.9883204698562622,0.9883204698562622,OC1=CC=C(C2=COC(C=C(O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)C=C4)=C4C2=O)C=C1,Daidzin,Data.sdf,16719,HY-N0018,Daidzoside; NPI-031D; Daidzein 7-O-glucoside,552-66-9,Aldehyde Dehydrogenase (ALDH); Mitochondrial Metabolism; Reverse Transcriptase,Anti-infection; Metabolic Enzyme/Protease,C21H20O9,10mM,Others; Cardiovascular Disease; Cancer,Launched,O=c1c(-c2ccc(O)cc2)coc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc12,清洗成功,0.3421052631578947
5342,CCN(CC)CCCNC(=O)Cn1nc(C)n2c(c(C)c3sccc32)c1=O,1,0.9883171916007996,0.9883171916007996,O=C1N(CC(NCCCN(CC)CC)=O)N=C(C)N2C1=C(C)C3=C2C=CS3,NV03,Data.sdf,6297,HY-125292,,2448341-58-8,Histone Methyltransferase; Ligands for E3 Ligase,Epigenetics; PROTAC,C19H27N5O2S,10mM,Cancer,No Development Reported,CCN(CC)CCCNC(=O)Cn1nc(C)n2c(c(C)c3sccc32)c1=O,清洗成功,0.2441860465116279
11605,CC(C)(O)CNc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,1,0.9883162379264832,0.9883162379264832,CC(O)(C)CNC1=NC(C2=NC(C(F)(F)F)=CC=C2)=NC(NC3=CC(C(F)(F)F)=NC=C3)=N1,Enasidenib,Data.sdf,13729,HY-18690,AG-221,1446502-11-9,Isocitrate Dehydrogenase (IDH),Metabolic Enzyme/Protease,C19H17F6N7O,10mM,Cancer,Launched,CC(C)(O)CNc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,清洗成功,0.2933333333333333
11606,CC(C)(O)CNc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,1,0.9883162379264832,0.9883162379264832,CS(=O)(O)=O.CC(O)(C)CNC1=NC(C2=NC(C(F)(F)F)=CC=C2)=NC(NC3=CC(C(F)(F)F)=NC=C3)=N1,Enasidenib (mesylate),Data.sdf,13730,HY-18690A,AG-221 (mesylate),1650550-25-6,Isocitrate Dehydrogenase (IDH),Metabolic Enzyme/Protease,C20H21F6N7O4S,10mM,Cancer,Launched,CC(C)(O)CNc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,清洗成功,0.2823529411764706
6517,Cc1cc(NC(=O)c2cccc(NC(=O)/C=C/CN(C)C)c2)ccc1Nc1nccc(-c2cccnc2)n1,1,0.9883114695549011,0.9883114695549011,CC1=CC(NC(C2=CC=CC(NC(/C=C/CN(C)C)=O)=C2)=O)=CC=C1NC3=NC=CC(C4=CN=CC=C4)=N3,JNK-IN-8,Data.sdf,7724,HY-13319,JNK Inhibitor XVI,1410880-22-6,JNK,MAPK/ERK Pathway,C29H29N7O2,10mM,Cancer,No Development Reported,Cc1cc(NC(=O)c2cccc(NC(=O)/C=C/CN(C)C)c2)ccc1Nc1nccc(-c2cccnc2)n1,清洗成功,0.3103448275862069
1526,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/C1CCCN1C,1,0.9882981181144714,0.9882981181144714,O=C(NC1=C(OCC)C=C2N=CC(C#N)=C(NC3=CC=C(OCC4=NC=CC=C4)C(Cl)=C3)C2=C1)/C=C/C5N(C)CCC5,(Rac)-Pyrotinib,Data.sdf,1793,HY-104065A,(Rac)-SHR-1258,1246089-97-3,Drug Isomer,Others,C32H31ClN6O3,2mM,Cancer,No Development Reported,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/C1CCCN1C,清洗成功,0.3362068965517241
1624,CN1CC[C@@]23C=C[C@H](O)C[C@@H]2Oc2c(OC(=O)C45C[C@H]6C[C@@H](C4)C[C@@H](C5)C6)ccc(c23)C1,1,0.9882887601852417,0.9882887601852417,O=C(C12C[C@H](C3)C[C@H](C[C@H]3C2)C1)OC4=CC=C5C6=C4O[C@]7([H])[C@@]6(CCN(C)C5)C=C[C@H](O)C7.[H]Cl,P11149,Data.sdf,1919,HY-105327,,164724-79-2,Cholinesterase (ChE),Neuronal Signaling,C27H34ClNO4,10mM,Neurological Disease,No Development Reported,CN1CC[C@@]23C=C[C@H](O)C[C@@H]2Oc2c(OC(=O)C45C[C@H]6C[C@@H](C4)C[C@@H](C5)C6)ccc(c23)C1,清洗成功,0.1818181818181818
14930,CC(C)(O)CCc1c(O)cc(O)c2c(=O)c(O)c(-c3ccc(O)cc3)oc12,1,0.9882860779762268,0.9882860779762268,O=C1C(O)=C(C2=CC=C(O)C=C2)OC3=C(CCC(C)(O)C)C(O)=CC(O)=C13,Noricaritin,Data.sdf,17730,HY-N1413,,5240-95-9,Others,Others,C20H20O7,10mM,Inflammation/Immunology; Cancer,No Development Reported,CC(C)(O)CCc1c(O)cc(O)c2c(=O)c(O)c(-c3ccc(O)cc3)oc12,清洗成功,0.3035714285714285
4867,C[C@H](CC(=O)N1CCC(O)(Cn2cnc3cc(NC(=O)CCN4CCN(C)CC4)ccc3c2=O)CC1)c1ccccc1,1,0.9882835149765015,0.9882835149765015,O=C(NC1=CC(N=CN2CC3(O)CCN(C(C[C@H](C4=CC=CC=C4)C)=O)CC3)=C(C=C1)C2=O)CCN5CCN(C)CC5,XL 188,Data.sdf,5727,HY-122886,,2305045-76-3,Deubiquitinase,Cell Cycle/DNA Damage,C32H42N6O4,10mM,Cancer,No Development Reported,C[C@H](CC(=O)N1CCC(O)(Cn2cnc3cc(NC(=O)CCN4CCN(C)CC4)ccc3c2=O)CC1)c1ccccc1,清洗成功,0.2649572649572649
10094,COc1ccc(C#N)cc1-c1ccnc(Nc2ccc(N3CCOCC3)c(OC)c2)c1,1,0.9882832765579224,0.9882832765579224,N#CC1=CC(C2=CC(NC3=CC=C(N4CCOCC4)C(OC)=C3)=NC=C2)=C(OC)C=C1,TINK-IN-1,Data.sdf,11942,HY-156502,,1417795-25-5,MAP4K,MAPK/ERK Pathway,C24H24N4O3,10mM,Cancer,No Development Reported,COc1ccc(C#N)cc1-c1ccnc(Nc2ccc(N3CCOCC3)c(OC)c2)c1,清洗成功,0.2873563218390804
10719,O=C1CCC(N2Cc3cc(CNCC4CCN(c5ncc(-c6cccc(Cl)c6)cc5C(F)(F)F)CC4)ccc3C2=O)C(=O)N1,1,0.9882808327674866,0.9882808327674866,ClC1=CC(C2=CC(C(F)(F)F)=C(N3CCC(CNCC4=CC(CN(C5C(NC(CC5)=O)=O)C6=O)=C6C=C4)CC3)N=C2)=CC=C1.O=C(O)C(F)(F)F,MYC degrader 1 (TFA),Data.sdf,12702,HY-162318A,,,c-Myc; Molecular Glues,Apoptosis; PROTAC,C34H32ClF6N5O5,10mM,Cancer,No Development Reported,O=C1CCC(N2Cc3cc(CNCC4CCN(c5ncc(-c6cccc(Cl)c6)cc5C(F)(F)F)CC4)ccc3C2=O)C(=O)N1,清洗成功,0.2336448598130841
12007,COc1cc2c(cc1OC)-c1cc3nc4ccccc4nc3n1C(C)(C)C2,1,0.9882791042327881,0.9882791042327881,CC(CC1=CC(OC)=C(OC)C=C12)(C)N3C2=CC4=NC5=CC=CC=C5N=C43,YM-90709,Data.sdf,14198,HY-19969,,163769-88-8,Interleukin Related,Immunology/Inflammation,C22H21N3O2,10mM,Inflammation/Immunology,No Development Reported,COc1cc2c(cc1OC)-c1cc3nc4ccccc4nc3n1C(C)(C)C2,清洗成功,0.265625
420,O=C(N[C@@H](Cc1ccc(O)cc1)C(=O)O)c1cc(-c2ccccc2)c(=O)n2c1sc1ccc(OC3CCCCC3)cc12,1,0.9882774949073792,0.9882774949073792,OC(C=C1)=CC=C1C[C@@H](C(O)=O)NC(C(C=C2C3=CC=CC=C3)=C4SC5=CC=C(OC6CCCCC6)C=C5N4C2=O)=O,HeE1-2Tyr,Data.sdf,478,HY-100749,,2245195-67-7,Dengue Virus; Flavivirus; SARS-CoV,Anti-infection,C33H30N2O6S,10mM,Infection,No Development Reported,O=C(N[C@@H](Cc1ccc(O)cc1)C(=O)O)c1cc(-c2ccccc2)c(=O)n2c1sc1ccc(OC3CCCCC3)cc12,清洗成功,0.2473118279569892
10860,Cc1cc(-c2c[nH]nc2-c2cccc(OCc3cccc(C#N)c3)c2)cc(C)n1,1,0.9882684946060181,0.9882684946060181,N#CC1=CC=CC(COC2=CC=CC(C3=NNC=C3C4=CC(C)=NC(C)=C4)=C2)=C1,Lolamicin,Data.sdf,12871,HY-164036,,2930690-12-1,Antibiotic; Bacterial,Anti-infection,C24H20N4O,10mM,Infection,No Development Reported,Cc1cc(-c2c[nH]nc2-c2cccc(OCc3cccc(C#N)c3)c2)cc(C)n1,清洗成功,0.3472222222222222
13211,COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1,1,0.9882670044898987,0.9882670044898987,CN(C)CCN1C2=CC=CC=C2S[C@@H](C3=CC=C(OC)C=C3)[C@@H](OC(C)=O)C1=O,Diltiazem,Data.sdf,15598,HY-B0632,,42399-41-7,Calcium Channel,Membrane Transporter/Ion Channel; Neuronal Signaling,C22H26N2O4S,10mM,Cardiovascular Disease; Cancer,Launched,COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1,清洗成功,0.2857142857142857
8252,Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CN2CCN(c3cc(-c4ccccc4O)nnc3N)CC2)C(C)(C)C)cc1,1,0.9882644414901733,0.9882644414901733,O=C(N(C[C@@H]1O)[C@@H](C1)C(N[C@H](C2=CC=C(C(SC=N3)=C3C)C=C2)C)=O)[C@H](C(C)(C)C)NC(CN4CCN(C(C=C(C(C=CC=C5)=C5O)N=N6)=C6N)CC4)=O,AU-15330,Data.sdf,9743,HY-145388,,2380274-50-8,Epigenetic Reader Domain; PROTACs,Epigenetics; PROTAC,C39H49N9O5S,10mM,Cancer,No Development Reported,Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CN2CCN(c3cc(-c4ccccc4O)nnc3N)CC2)C(C)(C)C)cc1,清洗成功,0.2142857142857142
8253,Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@H](O)CN2C(=O)[C@@H](NC(=O)CN2CCN(c3cc(-c4ccccc4O)nnc3N)CC2)C(C)(C)C)cc1,1,0.9882644414901733,0.9882644414901733,O=C(N(C[C@H]1O)[C@@H](C1)C(N[C@H](C2=CC=C(C(SC=N3)=C3C)C=C2)C)=O)[C@H](C(C)(C)C)NC(CN4CCN(C(C=C(C(C=CC=C5)=C5O)N=N6)=C6N)CC4)=O,AU-16235,Data.sdf,9744,HY-145388B,,2380275-40-9,Drug Isomer,Others,C39H49N9O5S,10mM,Cancer,No Development Reported,Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@H](O)CN2C(=O)[C@@H](NC(=O)CN2CCN(c3cc(-c4ccccc4O)nnc3N)CC2)C(C)(C)C)cc1,清洗成功,0.2142857142857142
941,CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1,1,0.9882609248161316,0.9882609248161316,N#CC1=CC2=C(NCCC3=CC=C4C=C(C(N5CCN(C)CC5)=O)C=CC4=C3)N=CN=C2C=C1,Senexin B,Data.sdf,1078,HY-101800,SNX2-1-165; BCD-115,1449228-40-3,CDK,Cell Cycle/DNA Damage,C27H26N6O,10mM,Cancer,Phase 1,CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1,清洗成功,0.3214285714285714
3300,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C4CC4)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,1,0.9882566332817078,0.9882566332817078,COC(C=C(N(C)CCN(C)C)C(NC(C=C)=O)=C1)=C1NC2=NC(C3=CN(C4CC4)C5=C3C=CC=C5)=CC=N2.CS(=O)(O)=O,Almonertinib (mesylate),Data.sdf,3881,HY-112823A,HS-10296 (mesylate),2134096-06-1,EGFR,JAK/STAT Signaling; Protein Tyrosine Kinase/RTK,C31H39N7O5S,10mM,Cancer,Launched,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C4CC4)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,清洗成功,0.3431372549019608
4446,CC(C)(C)NC(=O)CN1CCC(CNC(=O)c2cc(F)cc(Cl)c2)CC1,1,0.9882535934448242,0.9882535934448242,O=C(C1=CC(F)=CC(Cl)=C1)NCC2CCN(CC2)CC(NC(C)(C)C)=O,Ulixacaltamide,Data.sdf,5238,HY-120546,Z944; PRAX-944,1199236-64-0,Calcium Channel,Membrane Transporter/Ion Channel; Neuronal Signaling,C19H27ClFN3O2,10mM,Inflammation/Immunology; Neurological Disease,Phase 3,CC(C)(C)NC(=O)CN1CCC(CNC(=O)c2cc(F)cc(Cl)c2)CC1,清洗成功,0.3058823529411765
9705,COc1ccc(NC(=O)CSc2nc(=O)c3ccccc3[nH]2)c(OC)c1,1,0.9882327914237976,0.9882327914237976,O=C1N=C(NC2=C1C=CC=C2)SCC(NC3=CC=C(C=C3OC)OC)=O,Z16078526,Data.sdf,11467,HY-153813,,852222-94-7,Mitochondrial Metabolism; p38 MAPK,MAPK/ERK Pathway; Metabolic Enzyme/Protease,C18H17N3O4S,10mM,Others,No Development Reported,COc1ccc(NC(=O)CSc2nc(=O)c3ccccc3[nH]2)c(OC)c1,清洗成功,0.3043478260869565
7713,Cc1nc2ccc(Oc3ccc(F)cc3)cc2c(=O)n1C[C@H]1CCCN(C(C)C)C1,1,0.9882280230522156,0.9882280230522156,O=C1N(C[C@@H]2CN(C(C)C)CCC2)C(C)=NC3=C1C=C(OC4=CC=C(F)C=C4)C=C3,YIL781,Data.sdf,9125,HY-13964,,875258-85-8,GHSR,GPCR/G Protein,C24H28FN3O2,10mM,Metabolic Disease,No Development Reported,Cc1nc2ccc(Oc3ccc(F)cc3)cc2c(=O)n1C[C@H]1CCCN(C(C)C)C1,清洗成功,0.2911392405063291
7716,Cc1nc2ccc(Oc3ccc(F)cc3)cc2c(=O)n1C[C@H]1CCCN(C(C)C)C1,1,0.9882280230522156,0.9882280230522156,O=C1N(C[C@@H]2CN(C(C)C)CCC2)C(C)=NC3=C1C=C(OC4=CC=C(F)C=C4)C=C3.[H]Cl,YIL781 (hydrochloride),Data.sdf,9128,HY-13964A,,1640226-17-0,GHSR,GPCR/G Protein,C24H29ClFN3O2,10mM,Metabolic Disease,No Development Reported,Cc1nc2ccc(Oc3ccc(F)cc3)cc2c(=O)n1C[C@H]1CCCN(C(C)C)C1,清洗成功,0.2875
866,COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,1,0.9882263541221619,0.9882263541221619,CN1CCN(CC1)CCCOC2=C(C=C3C(NC4=CC(OC)=C(C=C4Cl)Cl)=C(C=NC3=C2)C#N)OC,Bosutinib,Data.sdf,991,HY-10158,SKI-606,380843-75-4,Autophagy; Bcr-Abl; Src,Autophagy; Protein Tyrosine Kinase/RTK,C26H29Cl2N5O3,10mM,Cancer,Launched,COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,清洗成功,0.303030303030303
869,COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,1,0.9882263541221619,0.9882263541221619,CN1CCN(CC1)CCCOC2=C(C=C3C(NC4=CC(OC)=C(C=C4Cl)Cl)=C(C=NC3=C2)C#N)OC.O,Bosutinib (hydrate),Data.sdf,995,HY-10158A,SKI-606 (hydrate),918639-08-4,Bcr-Abl; Src,Protein Tyrosine Kinase/RTK,C26H31Cl2N5O4,10mM,Cancer,Launched,COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,清洗成功,0.303030303030303
16039,CC(=O)O[C@@H]1C[C@H](O)[C@@]23COC(O)[C@]1(C)[C@@H]2C[C@@H](O)[C@@]1(C)[C@@H]2C(=O)C[C@@H](c4ccoc4)[C@]2(C)[C@@H](OC(C)=O)C(=O)[C@@H]13,1,0.9882211089134216,0.9882211089134216,O[C@@H](C[C@H]1OC(C)=O)[C@]([C@](C[C@H]2O)([H])[C@@]31C)(COC3O)[C@](C([C@@H]4OC(C)=O)=O)([H])[C@@]2([C@@](C5=O)([H])[C@@]4([C@@](C6=COC=C6)([H])C5)C)C,Isotoosendanin,Data.sdf,19175,HY-N7694,,97871-44-8,Others,Others,C30H38O11,10mM,Inflammation/Immunology,No Development Reported,CC(=O)O[C@@H]1C[C@H](O)[C@@]23COC(O)[C@]1(C)[C@@H]2C[C@@H](O)[C@@]1(C)[C@@H]2C(=O)C[C@@H](c4ccoc4)[C@]2(C)[C@@H](OC(C)=O)C(=O)[C@@H]13,清洗成功,0.1666666666666666
5185,CN1CCN(Cc2ccc(NC(=O)Cc3ccc(Oc4cc(NC(=O)C5CC5)ncn4)cc3)cc2C(F)(F)F)CC1,1,0.9882127642631531,0.9882127642631531,O=C(NC1=CC=C(CN2CCN(C)CC2)C(C(F)(F)F)=C1)CC3=CC=C(OC4=NC=NC(NC(C5CC5)=O)=C4)C=C3,WS6,Data.sdf,6106,HY-12461,,1421227-53-3,EGFR; FLT3; GABA Receptor; IKK; PI3K,JAK/STAT Signaling; Membrane Transporter/Ion Channel; Neuronal Signaling; NF-?oB; PI3K/Akt/mTOR; Protein Tyrosine Kinase/RTK,C29H31F3N6O3,10mM,Metabolic Disease; Inflammation/Immunology; Neurological Disease,No Development Reported,CN1CCN(Cc2ccc(NC(=O)Cc3ccc(Oc4cc(NC(=O)C5CC5)ncn4)cc3)cc2C(F)(F)F)CC1,清洗成功,0.3232323232323232
8471,COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1,1,0.9882127642631531,0.9882127642631531,CN(C)CCN1C2=CC=CC=C2S[C@@H](C3=CC=C(OC)C=C3)[C@@H](OC(C)=O)C1=O.Cl,Diltiazem (hydrochloride),Data.sdf,9996,HY-14656,CRD-401,33286-22-5,Calcium Channel,Membrane Transporter/Ion Channel; Neuronal Signaling,C22H27ClN2O4S,10mM,Cardiovascular Disease; Cancer,Launched,COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1,清洗成功,0.282051282051282
14955,C[C@@H]1O[C@@H](Oc2cc(O)c3c(=O)c(O)c(-c4ccc(O)c(O)c4)oc3c2)[C@H](O)[C@H](O)[C@H]1O,1,0.9882070422172546,0.9882070422172546,O=C1C(O)=C(C2=CC=C(O)C(O)=C2)OC3=CC(O[C@H]4[C@@H]([C@@H]([C@H]([C@H](C)O4)O)O)O)=CC(O)=C13,Vincetoxicoside B,Data.sdf,17765,HY-N1448,,22007-72-3,Fungal,Anti-infection,C21H20O11,10mM,Infection,No Development Reported,C[C@@H]1O[C@@H](Oc2cc(O)c3c(=O)c(O)c(-c4ccc(O)c(O)c4)oc3c2)[C@H](O)[C@H](O)[C@H]1O,清洗成功,0.3114754098360656
10354,O=C(CSc1nc2c(c(=O)n1-c1ccccc1)SCC2)Nc1ccc(-c2ccccc2)cn1,1,0.9882034659385681,0.9882034659385681,O=C(NC1=NC=C(C2=CC=CC=C2)C=C1)CSC3=NC(CCS4)=C4C(N3C5=CC=CC=C5)=O,IWP L6,Data.sdf,12272,HY-15825,Porcn Inhibitor III,1427782-89-5,Porcupine,Stem Cell/Wnt,C25H20N4O2S2,10mM,Cancer,No Development Reported,O=C(CSc1nc2c(c(=O)n1-c1ccccc1)SCC2)Nc1ccc(-c2ccccc2)cn1,清洗成功,0.2394366197183098
11030,O=C1c2cc(-c3ccc(OC(F)(F)F)cc3)ccc2OCCN1Cc1ncccn1,1,0.988192617893219,0.988192617893219,O=C1N(CC2=NC=CC=N2)CCOC3=CC=C(C4=CC=C(OC(F)(F)F)C=C4)C=C13.[H]Cl,Eleclazine (hydrochloride),Data.sdf,13069,HY-16738A,GS 6615 (hydrochloride),1448754-43-5,Potassium Channel; Sodium Channel,Membrane Transporter/Ion Channel,C21H17ClF3N3O3,10mM,Cardiovascular Disease,Phase 3,O=C1c2cc(-c3ccc(OC(F)(F)F)cc3)ccc2OCCN1Cc1ncccn1,清洗成功,0.2473118279569892
17138,COc1ccc(C(OC[C@H]2O[C@@H](n3cnc4c(=O)[nH]c(NC(=O)C(C)C)nc43)C[C@@H]2O)(c2ccccc2)c2ccc(OC)cc2)cc1,1,0.9881750345230103,0.9881750345230103,O[C@H]1C[C@H](N2C(N=C(NC(C(C)C)=O)NC3=O)=C3N=C2)O[C@@H]1COC(C4=CC=C(OC)C=C4)(C5=CC=C(OC)C=C5)C6=CC=CC=C6,5'-O-DMT-N2-ibu-dG,Data.sdf,20406,HY-W010702,"N2-Isobutyryl-5a??O-(4,4a??dimethoxytrityl)-2a??deoxyguanosine",68892-41-1,DNA/RNA Synthesis,Cell Cycle/DNA Damage,C35H37N5O7,10mM,Others,No Development Reported,COc1ccc(C(OC[C@H]2O[C@@H](n3cnc4c(=O)[nH]c(NC(=O)C(C)C)nc43)C[C@@H]2O)(c2ccccc2)c2ccc(OC)cc2)cc1,清洗成功,0.2474226804123711
9826,COc1ccc(-c2cccc(C(=O)N(C)Cc3ccncc3)c2)cc1S(=O)(=O)Nc1cccc(NCCNC(=O)c2cccc(C)c2)c1,1,0.9881733059883118,0.9881733059883118,O=C(C1=CC(C2=CC=C(OC)C(S(=O)(NC3=CC=CC(NCCNC(C4=CC=CC(C)=C4)=O)=C3)=O)=C2)=CC=C1)N(C)CC5=CC=NC=C5,RTIOXA-43,Data.sdf,11610,HY-154789,,2832067-72-6,Orexin Receptor (OX Receptor),GPCR/G Protein; Neuronal Signaling,C37H37N5O5S,10mM,Neurological Disease,No Development Reported,COc1ccc(-c2cccc(C(=O)N(C)Cc3ccncc3)c2)cc1S(=O)(=O)Nc1cccc(NCCNC(=O)c2cccc(C)c2)c1,清洗成功,0.2745098039215686
473,CCn1cnc2c(Nc3cccc(NC(=O)C#Cc4ccc(C)cc4)c3)nc(N[C@H]3CC[C@H](O)CC3)nc21,1,0.9881654977798462,0.9881654977798462,O=C(NC1=CC=CC(NC2=C3N=CN(CC)C3=NC(N[C@H]4CC[C@H](O)CC4)=N2)=C1)C#CC5=CC=C(C)C=C5,TN1,Data.sdf,535,HY-100826,,289479-94-3,Others,Others,C29H31N7O2,10mM,Cardiovascular Disease,Phase 2,CCn1cnc2c(Nc3cccc(NC(=O)C#Cc4ccc(C)cc4)c3)nc(N[C@H]3CC[C@H](O)CC3)nc21,清洗成功,0.3125
6125,Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCCCCCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)C(C)(C)C)cc1,1,0.9881644248962402,0.9881644248962402,O=C([C@H]1N(C([C@@H](NC(CCCCCCCCCCNC2=CC=CC(C(N3C(CC4)C(NC4=O)=O)=O)=C2C3=O)=O)C(C)(C)C)=O)C[C@H](O)C1)NCC5=CC=C(C6=C(C)N=CS6)C=C5,TD-165,Data.sdf,7247,HY-130714,,2305936-56-3,PROTACs,PROTAC,C46H59N7O8S,10mM,Cancer,No Development Reported,Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCCCCCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)C(C)(C)C)cc1,清洗成功,0.225563909774436
14673,CC(C)=CCc1cc(-c2coc3cc(O)ccc3c2=O)ccc1O,1,0.9881630539894104,0.9881630539894104,O=C1C(C2=CC=C(O)C(C/C=C(C)\C)=C2)=COC3=CC(O)=CC=C13,Neobavaisoflavone,Data.sdf,17381,HY-N0720,,41060-15-5,Apoptosis; DNA/RNA Synthesis,Apoptosis; Cell Cycle/DNA Damage,C20H18O4,10mM,Cancer,No Development Reported,CC(C)=CCc1cc(-c2coc3cc(O)ccc3c2=O)ccc1O,清洗成功,0.3484848484848485
18144,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CC1=NC(C)(Cc3nc(Cn4c(=O)c5c(nc(N6CCC[C@@H](N)C6)n5CC#CC)n(C)c4=O)nc4ccccc34)c3ccccc3N1)c(=O)n2C,1,0.9881511926651001,0.9881511926651001,O=C(N(C1=C(C2=O)N(C(N3C[C@@H](CCC3)N)=N1)CC#CC)C)N2CC4=NC(CC5(N=C(NC6=C5C=CC=C6)CN7C(N(C8=C(C7=O)N(C(N9C[C@@H](CCC9)N)=N8)CC#CC)C)=O)C)=C%10C=CC=CC%10=N4,Linagliptin methyldimer,Data.sdf,21625,HY-W744745,,1418133-47-7,Dipeptidyl Peptidase,Metabolic Enzyme/Protease,C50H56N16O4,10mM,Others,No Development Reported,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(CC1=NC(C)(Cc3nc(Cn4c(=O)c5c(nc(N6CCC[C@@H](N)C6)n5CC#CC)n(C)c4=O)nc4ccccc34)c3ccccc3N1)c(=O)n2C,清洗成功,0.2201834862385321
10875,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)c(O)c4)oc4cc(O)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H](O)[C@H]1O,1,0.9881503582000732,0.9881503582000732,O=C(C(O[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)CO[C@H]3[C@@H]([C@@H]([C@H]([C@@H](O3)C)O)O)O)=C(C4=CC(O)=C(C=C4)O)OC5=CC(O)=C6)C5=C6O,?±-Glucosylrutin,Data.sdf,12887,HY-164159,,130603-71-3,Reactive Oxygen Species,Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?oB,C33H40O21,10mM,Inflammation/Immunology,No Development Reported,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)c(O)c4)oc4cc(O)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H](O)[C@H]1O,清洗成功,0.3085106382978723
5591,CCOC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(-c2ccccc2)cc1,1,0.9881427884101868,0.9881427884101868,O=C(C1=C(C)NC2=C(C(CC(C)(C)C2)=O)C1C3=CC=C(C4=CC=CC=C4)C=C3)OCC,ITD-1,Data.sdf,6600,HY-12704,,1099644-42-4,TGF-?2 Receptor,TGF-beta/Smad,C27H29NO3,10mM,Cardiovascular Disease,No Development Reported,CCOC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(-c2ccccc2)cc1,清洗成功,0.2682926829268293
15615,COc1cc(OC)c2c(=O)cc(-c3ccccc3)oc2c1,1,0.9881368279457092,0.9881368279457092,O=C1C=C(C2=CC=CC=C2)OC3=CC(OC)=CC(OC)=C13,"5,7-Dimethoxyflavone",Data.sdf,18640,HY-N5011,,21392-57-4,Cytochrome P450,Metabolic Enzyme/Protease,C17H14O4,10mM,Cancer; Metabolic Disease; Inflammation/Immunology,No Development Reported,COc1cc(OC)c2c(=O)cc(-c3ccccc3)oc2c1,清洗成功,0.3043478260869565
11217,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,1,0.9881290793418884,0.9881290793418884,O=C(OC)N[C@@H](C(C)(C)C)C(NN(CC1=CC=C(C2=NC=CC=C2)C=C1)C[C@H](O)[C@H](CC3=CC=CC=C3)NC([C@H](C(C)(C)C)NC(OC)=O)=O)=O,Atazanavir,Data.sdf,13280,HY-17367,BMS-232632,198904-31-3,Cytochrome P450; Endogenous Metabolite; HIV; HIV Protease; P-glycoprotein; SARS-CoV; Toll-like Receptor (TLR),Anti-infection; Immunology/Inflammation; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease,C38H52N6O7,10mM,Cancer; Infection; Cardiovascular Disease,Launched,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,清洗成功,0.2815533980582524
11218,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,1,0.9881290793418884,0.9881290793418884,O=C(OC)N[C@@H](C(C)(C)C)C(NN(CC1=CC=C(C2=NC=CC=C2)C=C1)C[C@H](O)[C@H](CC3=CC=CC=C3)NC([C@H](C(C)(C)C)NC(OC)=O)=O)=O.O=S(O)(O)=O,Atazanavir (sulfate),Data.sdf,13281,HY-17367A,BMS-232632 sulfate,229975-97-7,Cytochrome P450; Endogenous Metabolite; HIV; HIV Protease; P-glycoprotein; SARS-CoV; Toll-like Receptor (TLR),Anti-infection; Immunology/Inflammation; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease,C38H54N6O11S,10mM,Cancer; Infection; Cardiovascular Disease,Launched,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,清洗成功,0.2710280373831775
7380,COc1ccc(N(C(=O)Oc2cc(C(=O)Nc3cccc(C(F)(F)F)c3)ccc2C)c2ccnc(Nc3ccc(N4CCN(C)CC4)cc3)n2)c(OC)c1,1,0.9881270527839661,0.9881270527839661,O=C(OC1=CC(C(NC2=CC(C(F)(F)F)=CC=C2)=O)=CC=C1C)N(C3=NC(NC4=CC=C(N(CC5)CCN5C)C=C4)=NC=C3)C(C=CC(OC)=C6)=C6OC,WH-4-025,Data.sdf,8731,HY-138001,,1876463-35-2,Salt-inducible Kinase (SIK),Immunology/Inflammation,C39H38F3N7O5,10mM,Cancer,No Development Reported,COc1ccc(N(C(=O)Oc2cc(C(=O)Nc3cccc(C(F)(F)F)c3)ccc2C)c2ccnc(Nc3ccc(N4CCN(C)CC4)cc3)n2)c(OC)c1,清洗成功,0.3043478260869565
8627,Clc1cccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)c1,1,0.988126277923584,0.988126277923584,ClC1=CC(N2CCN(CC2)CC3=NC4=C(N3)C=CC=C4)=CC=C1,Dopamine D4 receptor antagonist-1,Data.sdf,10177,HY-147398,,444724-92-9,Dopamine Receptor,GPCR/G Protein; Neuronal Signaling,C18H19ClN4,10mM,Neurological Disease,No Development Reported,Clc1cccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)c1,清洗成功,0.2898550724637681
6863,COc1cc(/C=C(\C#N)C(=O)c2ccc(O)c(O)c2)cc(I)c1O,1,0.988118588924408,0.988118588924408,N#C/C(C(C1=CC=C(O)C(O)=C1)=O)=C\C2=CC(OC)=C(O)C(I)=C2,I-OMe-Tyrphostin AG 538,Data.sdf,8141,HY-135680,I-OMe-AG 538,1094048-77-7,IGF-1R,Protein Tyrosine Kinase/RTK,C17H12INO5,10mM,Cancer; Metabolic Disease,No Development Reported,COc1cc(/C=C(\C#N)C(=O)c2ccc(O)c(O)c2)cc(I)c1O,清洗成功,0.3333333333333333
1904,CN1c2cc3c(cc2N=C(c2ccc(C(=O)O)cc2)c2ccccc21)C(C)(C)CCC3(C)C,1,0.9881086945533752,0.9881086945533752,O=C(O)C1=CC=C(C2=NC3=CC4=C(C(C)(C)CCC4(C)C)C=C3N(C)C5=CC=CC=C52)C=C1,LE135,Data.sdf,2245,HY-107436,,155877-83-1,RAR/RXR; TRP Channel,Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling; Vitamin D Related/Nuclear Receptor,C29H30N2O2,10mM,Cancer; Neurological Disease,No Development Reported,CN1c2cc3c(cc2N=C(c2ccc(C(=O)O)cc2)c2ccccc21)C(C)(C)CCC3(C)C,清洗成功,0.2337662337662337
11683,CC(=O)Nc1cc(Oc2ccc3c(nc(Nc4ccc(F)cc4F)n3C)c2C)ccn1,1,0.9880848526954651,0.9880848526954651,CC(NC1=CC(OC2=CC=C(N(C)C(NC3=CC=C(F)C=C3F)=N4)C4=C2C)=CC=N1)=O,CHZ868,Data.sdf,13825,HY-18960,,1895895-38-1,JAK,Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt,C22H19F2N5O2,10mM,Cancer,No Development Reported,CC(=O)Nc1cc(Oc2ccc3c(nc(Nc4ccc(F)cc4F)n3C)c2C)ccn1,清洗成功,0.2777777777777778
9064,O=S(=O)(NC1CCN(Cc2ccccc2)CC1)c1ccc2ccccc2c1,1,0.9880810976028442,0.9880810976028442,O=S(NC1CCN(CC1)CC2=CC=CC=C2)(C3=CC4=C(C=CC=C4)C=C3)=O,WAY-639228,Data.sdf,10684,HY-149683,,179051-05-9,Drug Derivative,Others,C22H24N2O2S,10mM,Others,No Development Reported,O=S(=O)(NC1CCN(Cc2ccccc2)CC1)c1ccc2ccccc2c1,清洗成功,0.2676056338028169
5789,CCCOc1ccc(NC(=O)CN2CCN(C)CC2)cc1-c1nc(CC)c(CC)c(=O)[nH]1,1,0.9880794882774353,0.9880794882774353,CCCOC1=C(C2=NC(CC)=C(CC)C(N2)=O)C=C(NC(CN3CCN(C)CC3)=O)C=C1,TPN171,Data.sdf,6843,HY-128593,,1229018-87-4,Phosphodiesterase (PDE),Metabolic Enzyme/Protease,C24H35N5O3,10mM,Cardiovascular Disease,No Development Reported,CCCOc1ccc(NC(=O)CN2CCN(C)CC2)cc1-c1nc(CC)c(CC)c(=O)[nH]1,清洗成功,0.2673267326732673
8691,NC(=O)c1cccc2c1O/C(=C\c1ccc(O)cc1)C(=O)N2,1,0.9880757331848145,0.9880757331848145,O=C(C1=C(C(NC/2=O)=CC=C1)OC2=C/C3=CC=C(O)C=C3)N,PARP1-IN-11,Data.sdf,10249,HY-147886,,2482484-87-5,PARP,Cell Cycle/DNA Damage; Epigenetics,C16H12N2O4,10mM,Cancer,No Development Reported,NC(=O)c1cccc2c1O/C(=C\c1ccc(O)cc1)C(=O)N2,清洗成功,0.3442622950819672
11843,C=CC(=O)Nc1cccc(-n2c(=O)cc(C)c3cnc(Nc4ccc(OCCN(C)C)cc4OC)nc32)c1,1,0.988061785697937,0.988061785697937,COC(C=C(OCCN(C)C)C=C1)=C1NC2=NC=C3C(N(C4=CC=CC(NC(C=C)=O)=C4)C(C=C3C)=O)=N2.OC(C(F)(F)F)=O,EGFR-IN-1 (TFA),Data.sdf,14009,HY-19617B,,2753348-63-7,EGFR,JAK/STAT Signaling; Protein Tyrosine Kinase/RTK,C30H31F3N6O6,10mM,Cancer,No Development Reported,C=CC(=O)Nc1cccc(-n2c(=O)cc(C)c3cnc(Nc4ccc(OCCN(C)C)cc4OC)nc32)c1,清洗成功,0.3008849557522124
10622,Cc1[nH]c2ccccc2c1C1C(C#N)=C(N)Oc2c1cc(/C=C/C(=O)c1cccs1)cc2C(C)(C)C,1,0.988041877746582,0.988041877746582,O=C(C1=CC=CS1)/C=C/C2=CC(C(C3=C(C)NC4=C3C=CC=C4)C(C#N)=C(N)O5)=C5C(C(C)(C)C)=C2,DNA relaxation-IN-1,Data.sdf,12586,HY-161152,,2190506-29-5,DNA/RNA Synthesis,Cell Cycle/DNA Damage,C30H27N3O2S,10mM,Cancer,No Development Reported,Cc1[nH]c2ccccc2c1C1C(C#N)=C(N)Oc2c1cc(/C=C/C(=O)c1cccs1)cc2C(C)(C)C,清洗成功,0.22
13686,Nc1cc(-c2ccncc2)c[nH]c1=O,1,0.9880414009094238,0.9880414009094238,O=C1C(N)=CC(C2=CC=NC=C2)=CN1,Amrinone,Data.sdf,16136,HY-B1294,Inamrinone,60719-84-8,Phosphodiesterase (PDE),Metabolic Enzyme/Protease,C10H9N3O,10mM,Cardiovascular Disease,Launched,Nc1cc(-c2ccncc2)c[nH]c1=O,清洗成功,0.3260869565217391
9917,Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1,1,0.9880409240722656,0.9880409240722656,NC1=C(Br)C([C@H]2CNCCC2)=NC3=C(C4=CN(C)N=C4)C=NN13,SCH900776,Data.sdf,11719,HY-15532,MK-8776,891494-63-6,Checkpoint Kinase (Chk),Cell Cycle/DNA Damage,C15H18BrN7,10mM,Cancer,Phase 2,Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1,清洗成功,0.325
9918,Cn1cc(-c2cnn3c(N)c(Br)c([C@H]4CCCNC4)nc23)cn1,1,0.9880409240722656,0.9880409240722656,NC1=C(Br)C([C@@H]2CNCCC2)=NC3=C(C4=CN(C)N=C4)C=NN13,SCH900776 (S-isomer),Data.sdf,11720,HY-15532B,MK-8776 S-isomer,891494-64-7,Drug Isomer,Others,C15H18BrN7,10mM,Cancer,Phase 2,Cn1cc(-c2cnn3c(N)c(Br)c([C@H]4CCCNC4)nc23)cn1,清洗成功,0.325
2022,COC1(C[S@@](=O)c2ccccc2)CCN(CCc2c[nH]c3ccc(F)cc23)CC1,1,0.9880166053771973,0.9880166053771973,O=[S@](CC1(OC)CCN(CCC2=CNC3=C2C=C(F)C=C3)CC1)C4=CC=CC=C4,GR 159897,Data.sdf,2376,HY-107691,,158848-32-9,Neurokinin Receptor,GPCR/G Protein; Neuronal Signaling,C23H27FN2O2S,10mM,Cancer; Endocrinology; Neurological Disease,No Development Reported,COC1(C[S@@](=O)c2ccccc2)CCN(CCc2c[nH]c3ccc(F)cc23)CC1,清洗成功,0.2470588235294117
9568,CNCc1cc(-c2ccccc2F)n(S(=O)(=O)c2cccc(OCCCOC)c2)c1,1,0.988010585308075,0.988010585308075,O=S(C1=CC(OCCCOC)=CC=C1)(N2C=C(CNC)C=C2C3=C(F)C=CC=C3)=O.Cl,P-CAB agent 2 (hydrochloride),Data.sdf,11300,HY-153219,,2209911-80-6,Potassium Channel,Membrane Transporter/Ion Channel,C22H26ClFN2O4S,10mM,Endocrinology,No Development Reported,CNCc1cc(-c2ccccc2F)n(S(=O)(=O)c2cccc(OCCCOC)c2)c1,清洗成功,0.2421052631578947
9569,CNCc1cc(-c2ccccc2F)n(S(=O)(=O)c2cccc(OCCCOC)c2)c1,1,0.988010585308075,0.988010585308075,O=S(C1=CC(OCCCOC)=CC=C1)(N2C=C(CNC)C=C2C3=C(F)C=CC=C3)=O,P-CAB agent 2,Data.sdf,11301,HY-153219A,,1978371-23-1,Potassium Channel,Membrane Transporter/Ion Channel,C22H25FN2O4S,10mM,Endocrinology,No Development Reported,CNCc1cc(-c2ccccc2F)n(S(=O)(=O)c2cccc(OCCCOC)c2)c1,清洗成功,0.2446808510638297
14425,Oc1ccc2c(c1)[C@H]1Oc3cc4c(cc3[C@H]1CO2)OCO4,1,0.9880099892616272,0.9880099892616272,OC1=CC=C2OC[C@]3([H])C4=CC5=C(OCO5)C=C4O[C@]3([H])C2=C1,Maackiain,Data.sdf,17060,HY-N0381,DL-?Maackiain,19908-48-6,Apoptosis; Parasite,Anti-infection; Apoptosis,C16H12O5,10mM,Infection,No Development Reported,Oc1ccc2c(c1)[C@H]1Oc3cc4c(cc3[C@H]1CO2)OCO4,清洗成功,0.2790697674418604
4934,O=C(C1CC1)N1CC[C@@H](Cc2n[nH]c(=O)n2-c2ccc(-c3ccc4occc4c3)cc2)C1,1,0.9880064129829407,0.9880064129829407,O=C(N1C[C@H](CC2=NNC(N2C3=CC=C(C4=CC=C(OC=C5)C5=C4)C=C3)=O)CC1)C6CC6,GSK2194069,Data.sdf,5810,HY-12325,,1332331-08-4,Fatty Acid Synthase (FASN),Metabolic Enzyme/Protease,C25H24N4O3,10mM,Cancer,No Development Reported,O=C(C1CC1)N1CC[C@@H](Cc2n[nH]c(=O)n2-c2ccc(-c3ccc4occc4c3)cc2)C1,清洗成功,0.3243243243243243
3096,CC(C)(/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1)N1CCN(C2COC2)CC1,1,0.9879977703094482,0.9879977703094482,NC1=C2C(C3=C(C=C(OC4=CC=CC=C4)C=C3)F)=NN([C@H]5CN(CCC5)C(/C(C#N)=C/C(C)(N6CCN(C7COC7)CC6)C)=O)C2=NC=N1,(E)-Rilzabrutinib,Data.sdf,3624,HY-112166,(E)-PRN1008,1575596-29-0,Btk,Protein Tyrosine Kinase/RTK,C36H40FN9O3,10mM,Cancer; Metabolic Disease,Phase 3,CC(C)(/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1)N1CCN(C2COC2)CC1,清洗成功,0.2376237623762376
17959,O/N=c1\nc[nH]c2nc[nH]c12,1,0.9879969954490662,0.9879969954490662,O/N=C1N=CNC2=C\1NC=N2,6-N-Hydroxylaminopurine,Data.sdf,21403,HY-W131303,,5667-20-9,DNA/RNA Synthesis,Cell Cycle/DNA Damage,C5H5N5O,10mM,Others,No Development Reported,O/N=c1\nc[nH]c2nc[nH]c12,清洗成功,0.303030303030303
5606,COC(=O)c1cc(Cl)c(O)c(S(=O)(=O)Nc2cc(-c3ccccc3)c(F)cc2F)c1,1,0.9879943132400513,0.9879943132400513,O=C(OC)C1=CC(S(=O)(NC2=CC(C3=CC=CC=C3)=C(F)C=C2F)=O)=C(O)C(Cl)=C1,NDI-091143,Data.sdf,6616,HY-127111,,2375840-87-0,ATP Citrate Lyase,Metabolic Enzyme/Protease,C20H14ClF2NO5S,10mM,Cancer,No Development Reported,COC(=O)c1cc(Cl)c(O)c(S(=O)(=O)Nc2cc(-c3ccccc3)c(F)cc2F)c1,清洗成功,0.273972602739726
6528,Cc1nc2cnc3ccc(C#Cc4cccnc4)cc3c2n1-c1ccc(C(C)(C)C#N)cc1,1,0.9879883527755737,0.9879883527755737,CC1=NC2=C(C3=CC(C#CC4=CC=CN=C4)=CC=C3N=C2)N1C5=CC=C(C=C5)C(C#N)(C)C,NVP-BAG956,Data.sdf,7738,HY-13333,BAG 956,853910-02-8,PI3K,PI3K/Akt/mTOR,C28H21N5,10mM,Cancer,No Development Reported,Cc1nc2cnc3ccc(C#Cc4cccnc4)cc3c2n1-c1ccc(C(C)(C)C#N)cc1,清洗成功,0.2631578947368421
6016,CC(C)(C)OC(=O)N(CC1CC1)c1cc(-c2nc(C(=O)Nc3cn(-c4ccc(C(=O)O)cc4)nc3C(F)(F)F)co2)ccn1,1,0.9879860281944275,0.9879860281944275,FC(F)(F)C1=NN(C=C1NC(C2=COC(C3=CC=NC(N(C(OC(C)(C)C)=O)CC4CC4)=C3)=N2)=O)C5=CC=C(C(O)=O)C=C5,PROTAC IRAK4 ligand-1,Data.sdf,7116,HY-129967,,2357108-39-3,Ligands for Target Protein for PROTAC,PROTAC,C29H27F3N6O6,10mM,Cancer,No Development Reported,CC(C)(C)OC(=O)N(CC1CC1)c1cc(-c2nc(C(=O)Nc3cn(-c4ccc(C(=O)O)cc4)nc3C(F)(F)F)co2)ccn1,清洗成功,0.2589285714285714
10925,N#Cc1ccc(N2CCN(CCCc3cc4cccc(F)c4c(=O)[nH]3)CC2)cc1,1,0.9879734516143799,0.9879734516143799,N#CC1=CC=C(N2CCN(CCCC3=CC4=C(C(N3)=O)C(F)=CC=C4)CC2)C=C1.Cl,PARP1-IN-33,Data.sdf,12947,HY-164926,,2640677-68-3,PARP,Cell Cycle/DNA Damage; Epigenetics,C23H24ClFN4O,10mM,Neurological Disease,No Development Reported,N#Cc1ccc(N2CCN(CCCc3cc4cccc(F)c4c(=O)[nH]3)CC2)cc1,清洗成功,0.2613636363636363
6263,C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)n[nH]c(=O)c32)C1,1,0.9879472851753235,0.9879472851753235,O=C1C(N([C@H]2CN(C(C=C)=O)CCC2)N=C3C4=CC=C(OC5=CC=CC=C5)C=C4)=C3C(N)=NN1,BTK inhibitor 17,Data.sdf,7409,HY-131705,,1858206-76-4,Btk,Protein Tyrosine Kinase/RTK,C25H24N6O3,10mM,Inflammation/Immunology,No Development Reported,C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)n[nH]c(=O)c32)C1,清洗成功,0.253012048192771
2870,c1cc(-c2cnc3[nH]ccc(N4CCC[C@@]5(CCCCN5)C4)c2-3)ncn1,1,0.9879470467567444,0.9879470467567444,C12=C(N3CCC[C@@]4(CCCCN4)C3)C=CNC1=NC=C2C5=NC=NC=C5,BDP9066,Data.sdf,3371,HY-111424,,2226507-04-4,Ras,GPCR/G Protein; MAPK/ERK Pathway,C20H24N6,10mM,Cancer,No Development Reported,c1cc(-c2cnc3[nH]ccc(N4CCC[C@@]5(CCCCN5)C4)c2-3)ncn1,清洗成功,0.2162162162162162
4444,CCC1=CC2CN(C1)Cc1c([nH]c3ccccc13)[C@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,1,0.9879441261291504,0.9879441261291504,CC[C@@]1(C=CCN2CC3)[C@@]2([H])[C@@]3(C(C=C([C@@](C4=C5C(C=CC=C6)=C6N4)(CC(C=C(CC)C7)([H])CN7C5)C(OC)=O)C(OC)=C8)=C8N9C)[C@]9([H])[C@](C(OC)=O)(O)[C@@H]1OC(C)=O.O=C(O)[C@H](O)[C@@H](O)C(O)=O.O=C(O)[C@H](O)[C@@H](O)C(O)=O,Vinorelbine (ditartrate),Data.sdf,5236,HY-12053A,KW-2307; Nor-5'-anhydrovinblastine ditartrate,125317-39-7,Autophagy; Microtubule/Tubulin,Autophagy; Cell Cycle/DNA Damage; Cytoskeleton,C53H66N4O20,10mM,Cancer,Launched,CCC1=CC2CN(C1)Cc1c([nH]c3ccccc13)[C@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,清洗成功,0.1956521739130435
2147,Cc1nc2ccc(CN(C)c3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)s3)cc2c(=O)[nH]1,1,0.9879422783851624,0.9879422783851624,CC(NC1=O)=NC2=C1C=C(CN(C)C3=CC=C(C(N[C@H](C(O)=O)CCC(O)=O)=O)S3)C=C2,Raltitrexed,Data.sdf,2520,HY-10821,ZD1694; D1694; ICI-D1694,112887-68-0,Nucleoside Antimetabolite/Analog; Thymidylate Synthase,Apoptosis; Cell Cycle/DNA Damage,C21H22N4O6S,10mM,Cancer,Launched,Cc1nc2ccc(CN(C)c3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)s3)cc2c(=O)[nH]1,清洗成功,0.2325581395348837
1309,CCCCCOc1c(OC)ccc2cc(C(=O)NCc3ccc4c(c3)OCO4)c(=O)[nH]c12,1,0.9879239201545715,0.9879239201545715,O=C(C1=CC2=C(NC1=O)C(OCCCCC)=C(OC)C=C2)NCC3=CC=C(OCO4)C4=C3,JTE-907,Data.sdf,1527,HY-103325,,282089-49-0,Cannabinoid Receptor,GPCR/G Protein; Neuronal Signaling,C24H26N2O6,10mM,Inflammation/Immunology,No Development Reported,CCCCCOc1c(OC)ccc2cc(C(=O)NCc3ccc4c(c3)OCO4)c(=O)[nH]c12,清洗成功,0.3271028037383177
7755,COc1cc(NC(=O)Nc2cccc(CNC(=O)O[C@H]3CCOC3)c2)ccc1-c1cnco1,1,0.9879167675971985,0.9879167675971985,O=C(O[C@@H]1COCC1)NCC2=CC=CC(NC(NC3=CC=C(C4=CN=CO4)C(OC)=C3)=O)=C2,Merimepodib,Data.sdf,9178,HY-13986,VX-497; MMPD,198821-22-6,Dengue Virus; Flavivirus; HBV; HCV,Anti-infection,C23H24N4O6,10mM,Infection; Cancer,Launched,COc1cc(NC(=O)Nc2cccc(CNC(=O)O[C@H]3CCOC3)c2)ccc1-c1cnco1,清洗成功,0.2790697674418604
7757,COc1cc(NC(=O)Nc2cccc(CNC(=O)O[C@@H]3CCOC3)c2)ccc1-c1cnco1,1,0.9879167675971985,0.9879167675971985,COC1=C(C2=CN=CO2)C=CC(NC(NC3=CC(CNC(O[C@@H]4CCOC4)=O)=CC=C3)=O)=C1,(R)-Merimepodib,Data.sdf,9180,HY-13986A,(R)-VX-497; (R)-MMPD,2748420-50-8,IMPDH,Metabolic Enzyme/Protease,C23H24N4O6,10mM,Infection,No Development Reported,COc1cc(NC(=O)Nc2cccc(CNC(=O)O[C@@H]3CCOC3)c2)ccc1-c1cnco1,清洗成功,0.2790697674418604
6437,C=CC(=O)Nc1cc(Nc2nccc(Nc3cc(Cl)c(F)cc3C(C)(C)O)n2)c(OC)cc1N1CC[C@@H](N(C)C)C1,1,0.9879157543182373,0.9879157543182373,C=CC(NC1=C(N2C[C@@H](CC2)N(C)C)C=C(C(NC3=NC=CC(NC4=C(C=C(C(Cl)=C4)F)C(C)(O)C)=N3)=C1)OC)=O,Sunvozertinib,Data.sdf,7624,HY-132842,DZD9008,2370013-12-8,Btk; EGFR,JAK/STAT Signaling; Protein Tyrosine Kinase/RTK,C29H35ClFN7O3,10mM,Cancer,Phase 3,C=CC(=O)Nc1cc(Nc2nccc(Nc3cc(Cl)c(F)cc3C(C)(C)O)n2)c(OC)cc1N1CC[C@@H](N(C)C)C1,清洗成功,0.2956521739130435
6438,C=CC(=O)Nc1cc(Nc2nccc(Nc3cc(Cl)c(F)cc3C(C)(C)O)n2)c(OC)cc1N1CC[C@H](N(C)C)C1,1,0.9879157543182373,0.9879157543182373,C=CC(NC1=C(N2C[C@H](CC2)N(C)C)C=C(C(NC3=NC=CC(NC4=C(C=C(C(Cl)=C4)F)C(C)(O)C)=N3)=C1)OC)=O,(S)-Sunvozertinib,Data.sdf,7625,HY-132842A,(S)-DZD9008,2370013-49-1,Btk; EGFR,JAK/STAT Signaling; Protein Tyrosine Kinase/RTK,C29H35ClFN7O3,10mM,Cancer,No Development Reported,C=CC(=O)Nc1cc(Nc2nccc(Nc3cc(Cl)c(F)cc3C(C)(C)O)n2)c(OC)cc1N1CC[C@H](N(C)C)C1,清洗成功,0.2956521739130435
3259,O=C1CC(c2ccccc2)c2cnn(-c3nc4ccccc4s3)c2N1,1,0.9879105091094971,0.9879105091094971,O=C1CC(C2=CC=CC=C2)C3=C(N(C4=NC5=CC=CC=C5S4)N=C3)N1,Neurotoxin Inhibitor,Data.sdf,3834,HY-112722,,951571-70-3,Others,Others,C19H14N4OS,10mM,Neurological Disease,No Development Reported,O=C1CC(c2ccccc2)c2cnn(-c3nc4ccccc4s3)c2N1,清洗成功,0.2666666666666666
6092,N#Cc1cc(Cl)cc(Oc2c(Br)ccc(CC(=O)Nc3ccc(S(N)(=O)=O)cc3Cl)c2F)c1,1,0.9879091382026672,0.9879091382026672,ClC1=CC(OC2=C(F)C(CC(NC3=CC=C(S(=O)(N)=O)C=C3Cl)=O)=CC=C2Br)=CC(C#N)=C1,Depulfavirine,Data.sdf,7211,HY-13053,Ro-0335,867365-76-2,Reverse Transcriptase,Anti-infection,C21H13BrCl2FN3O4S,10mM,Cancer,No Development Reported,N#Cc1cc(Cl)cc(Oc2c(Br)ccc(CC(=O)Nc3ccc(S(N)(=O)=O)cc3Cl)c2F)c1,清洗成功,0.2637362637362637
8683,O=C(O)/C=C/c1ccc(-c2ccc(O)c(C34CC5CC(CC(C5)C3)C4)c2)c(/C=N/O)c1,1,0.9879043698310852,0.9879043698310852,O=C(O)/C=C/C1=CC=C(C2=CC=C(O)C(C34CC5CC(C4)CC(C5)C3)=C2)C(/C=N/O)=C1,POLA1 inhibitor 1,Data.sdf,10239,HY-147812,,2217671-41-3,DNA/RNA Synthesis,Cell Cycle/DNA Damage,C26H27NO4,10mM,Cancer,No Development Reported,O=C(O)/C=C/c1ccc(-c2ccc(O)c(C34CC5CC(CC(C5)C3)C4)c2)c(/C=N/O)c1,清洗成功,0.2615384615384615
6065,CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1,1,0.9878993630409241,0.9878993630409241,O=C1N(C2=CC=CC=C2)C([C@@H](NC3=C4N=CNC4=NC=N3)CC)=NC5=C1C(F)=CC=C5,Idelalisib,Data.sdf,7175,HY-13026,CAL-101; GS-1101,870281-82-6,Autophagy; PI3K,Autophagy; PI3K/Akt/mTOR,C22H18FN7O,10mM,Cancer,Launched,CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1,清洗成功,0.3472222222222222
15318,CC(=O)Cc1cc(=O)c2c(C)cc(O)c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c2o1,1,0.9878891110420227,0.9878891110420227,OC1=CC(C)=C(C(C=C(CC(C)=O)O2)=O)C2=C1[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)CO,Aloesin,Data.sdf,18241,HY-N2460,Aloeresin,30861-27-9,Apoptosis; Tyrosinase,Apoptosis; Metabolic Enzyme/Protease,C19H22O9,10mM,Cancer; Infection; Inflammation/Immunology,No Development Reported,CC(=O)Cc1cc(=O)c2c(C)cc(O)c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c2o1,清洗成功,0.2948717948717949
5788,Cc1cc(C)c2[nH]c(=O)c(-c3[nH]cnc3-c3ccccc3)cc2c1,1,0.9878660440444946,0.9878660440444946,CC1=CC(C)=C(NC(C(C2=C(C3=CC=CC=C3)N=CN2)=C4)=O)C4=C1,DIPQUO,Data.sdf,6842,HY-128591,,1269365-82-3,Phosphatase,Metabolic Enzyme/Protease,C20H17N3O,10mM,Metabolic Disease,No Development Reported,Cc1cc(C)c2[nH]c(=O)c(-c3[nH]cnc3-c3ccccc3)cc2c1,清洗成功,0.3454545454545454
10843,O=C(Cc1ccc(-c2ccccc2)cc1)NC1CCN(Cc2ccccc2)CC1,1,0.9878623485565186,0.9878623485565186,O=C(CC1=CC=C(C2=CC=CC=C2)C=C1)NC3CCN(CC3)CC4=CC=CC=C4,E6-272,Data.sdf,12854,HY-163901,,945142-65-4,Apoptosis; HPV,Anti-infection; Apoptosis,C26H28N2O,10mM,Infection,No Development Reported,O=C(Cc1ccc(-c2ccccc2)cc1)NC1CCN(Cc2ccccc2)CC1,清洗成功,0.2962962962962963
7415,Cc1cccc(CC(=O)N2CCc3c2ccc(-c2cn(C)c4ncnc(N)c24)c3F)n1,1,0.9878579378128052,0.9878579378128052,CC1=CC=CC(CC(N2CCC3=C2C=CC(C4=CN(C)C5=NC=NC(N)=C54)=C3F)=O)=N1,GSK2656157,Data.sdf,8775,HY-13820,,1337532-29-2,Apoptosis; Autophagy; PERK,Apoptosis; Autophagy; Cell Cycle/DNA Damage,C23H21FN6O,10mM,Cancer,No Development Reported,Cc1cccc(CC(=O)N2CCc3c2ccc(-c2cn(C)c4ncnc(N)c24)c3F)n1,清洗成功,0.2580645161290322
10907,CONC(=O)Nc1ccc(-c2sc3c(c2CN(C)C)c(=O)n(-c2ccc(OC)nn2)c(=O)n3Cc2c(F)cccc2F)cc1,1,0.9878473281860352,0.9878473281860352,O=C(NOC)NC1=CC=C(C(S2)=C(CN(C)C)C(C(N3C4=NN=C(OC)C=C4)=O)=C2N(CC5=C(F)C=CC=C5F)C3=O)C=C1,Relugolix,Data.sdf,12927,HY-16474,TAK-385,737789-87-6,GnRH Receptor,GPCR/G Protein,C29H27F2N7O5S,10mM,Cancer; Endocrinology,Launched,CONC(=O)Nc1ccc(-c2sc3c(c2CN(C)C)c(=O)n(-c2ccc(OC)nn2)c(=O)n3Cc2c(F)cccc2F)cc1,清洗成功,0.2527472527472527
7932,CC1(C)Oc2ccc(C#N)cc2[C@H](N(Cc2ncc[nH]2)c2ccc(Cl)cc2)[C@H]1O,1,0.9878432750701904,0.9878432750701904,CC(O1)(C)[C@H](O)[C@@H](N(CC2=NC=CN2)C3=CC=C(Cl)C=C3)C4=C1C=CC(C#N)=C4,BMS-191095,Data.sdf,9373,HY-14256,,166095-21-2,Potassium Channel,Membrane Transporter/Ion Channel,C22H21ClN4O2,10mM,Neurological Disease; Cardiovascular Disease,Phase 1,CC1(C)Oc2ccc(C#N)cc2[C@H](N(Cc2ncc[nH]2)c2ccc(Cl)cc2)[C@H]1O,清洗成功,0.2705882352941176
1619,COc1ccc2[nH]cc(CCNC(=O)c3cc(=O)cco3)c2c1,1,0.9878429174423218,0.9878429174423218,O=C(C1=CC(C=CO1)=O)NCCC2=CNC3=CC=C(OC)C=C23,Piromelatine,Data.sdf,1910,HY-105285,Neu-P11,946846-83-9,5-HT Receptor; Melatonin Receptor; P2X Receptor; Sodium Channel; TRP Channel,GPCR/G Protein; Membrane Transporter/Ion Channel; Neuronal Signaling,C17H16N2O4,10mM,Neurological Disease,Phase 3,COc1ccc2[nH]cc(CCNC(=O)c3cc(=O)cco3)c2c1,清洗成功,0.3378378378378378
8582,Cc1ccc(NC(=O)N2CC[C@@H](CC(F)(F)F)C2)cc1-c1cc(N[C@H](C)CO)nc(N2CCOCC2)c1,1,0.9878355860710144,0.9878355860710144,CC1=CC=C(NC(N2C[C@@H](CC2)CC(F)(F)F)=O)C=C1C3=CC(N[C@H](C)CO)=NC(N4CCOCC4)=C3,Exarafenib,Data.sdf,10123,HY-147268,RAF/KIN_2787,2639957-39-2,p38 MAPK; Raf,MAPK/ERK Pathway,C26H34F3N5O3,10mM,Cancer,Phase 1,Cc1ccc(NC(=O)N2CC[C@@H](CC(F)(F)F)C2)cc1-c1cc(N[C@H](C)CO)nc(N2CCOCC2)c1,清洗成功,0.26
8853,O=C(O)C1CC(OCCOc2ccc(-c3cc(=O)c4cccc(Cl)c4o3)cc2)C1,1,0.9878336191177368,0.9878336191177368,O=C1C=C(C2=CC=C(OCCOC3CC(C(O)=O)C3)C=C2)OC4=C1C=CC=C4Cl,ccc_R08,Data.sdf,10448,HY-148560,,2919019-72-8,DNA/RNA Synthesis; HBV,Anti-infection; Cell Cycle/DNA Damage,C22H19ClO6,10mM,Infection,No Development Reported,O=C(O)C1CC(OCCOc2ccc(-c3cc(=O)c4cccc(Cl)c4o3)cc2)C1,清洗成功,0.275
8854,O=c1cc(-c2ccc(OCCO[C@H]3C[C@H](C(=O)O)C3)cc2)oc2c(Cl)cccc12,1,0.9878336191177368,0.9878336191177368,O=C1C=C(C2=CC=C(C=C2)OCCO[C@@H]3C[C@H](C3)C(O)=O)OC4=C(Cl)C=CC=C41,trans-ccc_R08,Data.sdf,10449,HY-148560A,,2413192-49-9,HBV,Anti-infection,C22H19ClO6,10mM,Infection,No Development Reported,O=c1cc(-c2ccc(OCCO[C@H]3C[C@H](C(=O)O)C3)cc2)oc2c(Cl)cccc12,清洗成功,0.275
8855,O=c1cc(-c2ccc(OCCO[C@H]3C[C@@H](C(=O)O)C3)cc2)oc2c(Cl)cccc12,1,0.9878336191177368,0.9878336191177368,O=C1C=C(C2=CC=C(C=C2)OCCO[C@H]3C[C@H](C3)C(O)=O)OC4=C(Cl)C=CC=C41,cis-ccc_R08,Data.sdf,10450,HY-148560B,,2413192-48-8,HBV,Anti-infection,C22H19ClO6,10mM,Infection,No Development Reported,O=c1cc(-c2ccc(OCCO[C@H]3C[C@@H](C(=O)O)C3)cc2)oc2c(Cl)cccc12,清洗成功,0.275
5327,O=C1N/C(=N\CCc2ccccc2)S/C1=C/c1c[nH]c2ncccc12,1,0.9878217577934265,0.9878217577934265,O=C1N/C(S/C1=C/C2=CNC3=C2C=CC=N3)=N\CCC4=CC=CC=C4,DJ4,Data.sdf,6279,HY-125221,,1681020-24-5,ROCK,Cell Cycle/DNA Damage; Cytoskeleton; Stem Cell/Wnt; TGF-beta/Smad,C19H16N4OS,10mM,Cancer,No Development Reported,O=C1N/C(=N\CCc2ccccc2)S/C1=C/c1c[nH]c2ncccc12,清洗成功,0.3375
8714,Cc1ccc(-n2cc3cnnc(N4CCC(C(=O)NCCCN(C)C)CC4)c3n2)cc1,1,0.9878196716308594,0.9878196716308594,O=C(C1CCN(CC1)C2=NN=CC3=CN(C4=CC=C(C)C=C4)N=C32)NCCCN(C)C,TLR9-IN-1,Data.sdf,10280,HY-148045,,2226366-86-3,Toll-like Receptor (TLR),Immunology/Inflammation,C23H31N7O,10mM,Inflammation/Immunology,No Development Reported,Cc1ccc(-n2cc3cnnc(N4CCC(C(=O)NCCCN(C)C)CC4)c3n2)cc1,清洗成功,0.2558139534883721
12493,C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-c5ccc(NS(C)(=O)=O)cc5)cc4c32)ccc1C,1,0.9878146648406982,0.9878146648406982,O=C1N(C2=C(C=C1)C=NC3=CC=C(C4=CC=C(NS(=O)(C)=O)C=C4)C=C32)C5=CC=C(C)C(NC(C=C)=O)=C5,BMX-IN-1,Data.sdf,14794,HY-80002,BMX kinase inhibitor,1431525-23-3,BMX Kinase; Btk,Protein Tyrosine Kinase/RTK,C29H24N4O4S,10mM,Cancer,No Development Reported,C=CC(=O)Nc1cc(-n2c(=O)ccc3cnc4ccc(-c5ccc(NS(C)(=O)=O)cc5)cc4c32)ccc1C,清洗成功,0.3333333333333333
3614,CN1CCN(c2nc3c(F)cccc3c(=O)n2-c2ccc(Oc3ccc(F)cc3)cc2)CC1,1,0.9878137111663818,0.9878137111663818,O=C1N(C2=CC=C(OC3=CC=C(F)C=C3)C=C2)C(N4CCN(C)CC4)=NC5=C(F)C=CC=C51,TRPV4 agonist-1 (free base),Data.sdf,4255,HY-114400,,2314467-59-7,TRP Channel,Membrane Transporter/Ion Channel; Neuronal Signaling,C25H22F2N4O2,10mM,Inflammation/Immunology,No Development Reported,CN1CCN(c2nc3c(F)cccc3c(=O)n2-c2ccc(Oc3ccc(F)cc3)cc2)CC1,清洗成功,0.2588235294117647
9089,Cc1cc(=O)c(C(=O)NCc2c(F)cc(-c3cccc(S(=O)(=O)F)c3)cc2F)nn1-c1ccccc1,1,0.9878042936325073,0.9878042936325073,FC1=C(C(F)=CC(C2=CC(S(=O)(F)=O)=CC=C2)=C1)CNC(C3=NN(C(C)=CC3=O)C4=CC=CC=C4)=O,Anticancer agent 126,Data.sdf,10719,HY-149873,,3033748-20-5,WDR5,Epigenetics,C25H18F3N3O4S,10mM,Cancer,No Development Reported,Cc1cc(=O)c(C(=O)NCc2c(F)cc(-c3cccc(S(=O)(=O)F)c3)cc2F)nn1-c1ccccc1,清洗成功,0.2473118279569892
5490,CC(=O)N1CCC(c2cc(-c3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)c3c(N)ncnn23)CC1,1,0.9877958297729492,0.9877958297729492,O=C(C1=CC=CN(C2=CC=C(F)C=C2)C1=O)NC3=CC=C(C4=C5C(N)=NC=NN5C(C6CCN(C(C)=O)CC6)=C4)C(F)=C3,TAM-IN-2,Data.sdf,6468,HY-126216,,2135642-56-5,TAM Receptor,Protein Tyrosine Kinase/RTK,C31H27F2N7O3,2mM,Cancer,No Development Reported,CC(=O)N1CCC(c2cc(-c3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)c3c(N)ncnn23)CC1,清洗成功,0.2636363636363636
11816,CC(=O)c1nc(-c2ccc(C[C@@H](CNC(=O)CN(C)C)NC(=O)c3ccc(OC(C)C)c(Cl)c3)cc2)cn1C,1,0.9877937436103821,0.9877937436103821,ClC1=CC(C(N[C@@H](CC2=CC=C(C3=CN(C)C(C(C)=O)=N3)C=C2)CNC(CN(C)C)=O)=O)=CC=C1OC(C)C,PF-2771,Data.sdf,13977,HY-19530,,2070009-55-9,Kinesin,Cell Cycle/DNA Damage; Cytoskeleton,C29H36ClN5O4,10mM,Cancer,No Development Reported,CC(=O)c1nc(-c2ccc(C[C@@H](CNC(=O)CN(C)C)NC(=O)c3ccc(OC(C)C)c(Cl)c3)cc2)cn1C,清洗成功,0.2708333333333333
8497,Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1,1,0.9877881407737732,0.9877881407737732,IC1=CC=CC(CSC(O2)=NN=C2C3=CC=NC=C3)=C1,GSK3?2 inhibitor II,Data.sdf,10025,HY-14679,,478482-75-6,GSK-3,PI3K/Akt/mTOR; Stem Cell/Wnt,C14H10IN3OS,10mM,Neurological Disease,No Development Reported,Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1,清洗成功,0.2666666666666666
12260,NCCCCN(Cc1nc2ccccc2[nH]1)[C@H]1CCCc2cccnc21,1,0.9877792000770569,0.9877792000770569,[H]Cl.[H]Cl.[H]Cl.NCCCCN(CC1=NC2=CC=CC=C2N1)[C@@H]3C4=NC=CC=C4CCC3,Mavorixafor (trihydrochloride),Data.sdf,14505,HY-50101A,AMD-070 (trihydrochloride); AMD-11070 (trihydrochloride),2309699-17-8,CXCR; HIV,Anti-infection; GPCR/G Protein; Immunology/Inflammation,C21H30Cl3N5,10mM,Infection; Endocrinology; Cancer,Launched,NCCCCN(Cc1nc2ccccc2[nH]1)[C@H]1CCCc2cccnc21,清洗成功,0.2222222222222222
12261,NCCCCN(Cc1nc2ccccc2[nH]1)[C@H]1CCCc2cccnc21,1,0.9877792000770569,0.9877792000770569,NCCCCN(CC1=NC2=CC=CC=C2N1)[C@H]3CCCC4=C3N=CC=C4.[H]Cl,Mavorixafor (hydrochloride),Data.sdf,14506,HY-50101C,AMD-070 (hydrochloride); AMD-11070 (hydrochloride),880549-30-4,CXCR; HIV,Anti-infection; GPCR/G Protein; Immunology/Inflammation,C21H28ClN5,10mM,Cancer; Infection,Launched,NCCCCN(Cc1nc2ccccc2[nH]1)[C@H]1CCCc2cccnc21,清洗成功,0.2222222222222222
11414,CC[C@@H](Oc1cccc(CN(CCCOc2ccc(OC)cc2)c2nc3ccccc3o2)c1)C(=O)O,1,0.9877598881721497,0.9877598881721497,CC[C@@H](OC1=CC=CC(CN(C2=NC3=CC=CC=C3O2)CCCOC4=CC=C(OC)C=C4)=C1)C(O)=O,Pemafibrate,Data.sdf,13499,HY-17618,(R)-K-13675,848259-27-8,PPAR,Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor,C28H30N2O6,10mM,Inflammation/Immunology; Cardiovascular Disease,Launched,CC[C@@H](Oc1cccc(CN(CCCOc2ccc(OC)cc2)c2nc3ccccc3o2)c1)C(=O)O,清洗成功,0.3037974683544304
10468,O=C(CCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1)Oc1cc(O)cc(/C=C/c2ccc(O)cc2)c1,1,0.9877588152885437,0.9877588152885437,O=C(CCC[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3)OC4=CC(O)=CC(/C=C/C5=CC=C(C=C5)O)=C4.[Br-],TPP-resveratrol,Data.sdf,12409,HY-159734,,,Apoptosis,Apoptosis,C36H32BrO4P,10mM,Cancer,No Development Reported,O=C(CCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1)Oc1cc(O)cc(/C=C/c2ccc(O)cc2)c1,清洗成功,0.2884615384615384
7731,Cc1ccc(/C=N/n2c(SCC3CC3)nnc2-c2ccccn2)o1,1,0.9877538084983826,0.9877538084983826,CC(O1)=CC=C1/C=N/N2C(SCC3CC3)=NN=C2C4=CC=CC=N4,Transketolase-IN-1,Data.sdf,9149,HY-139731,,2763650-87-7,Transketolase,Metabolic Enzyme/Protease,C17H17N5OS,10mM,Others,No Development Reported,Cc1ccc(/C=N/n2c(SCC3CC3)nnc2-c2ccccn2)o1,清洗成功,0.2285714285714285
16345,CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)NCC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O,1,0.9877426624298096,0.9877426624298096,OC(C=C1)=CC=C1C[C@H](N)C(N[C@@H](C(C)C)C(N[C@@H](CCSC)C(NCC(N[C@@H](CC2=CN=CN2)C(N[C@@H](CC3=CC=CC=C3)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](C(N[C@@H](CC(O)=O)C(N[C@@H](CCCNC(N)=N)C(N[C@H](C(NCC(O)=O)=O)CC4=CC=CC=C4)=O)=O)=O)CC5=CNC6=CC=CC=C56)=O)=O)=O)=O)=O)=O)=O,[D-Trp8]-?3-MSH,Data.sdf,19523,HY-P1217,,321351-81-9,Melanocortin Receptor,GPCR/G Protein; Neuronal Signaling,C74H99N21O16S,2mM,Inflammation/Immunology,No Development Reported,CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)NCC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O,清洗成功,0.2809917355371901
14600,C[C@@H]1O[C@@H](Oc2cc(O)c3c(=O)c(O[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)c(-c4ccc(O)cc4)oc3c2)[C@H](O)[C@H](O)[C@H]1O,1,0.9877419471740723,0.9877419471740723,O=C1C(O[C@H](O[C@@H](C)[C@H](O)[C@H]2O)[C@@H]2O)=C(C3=CC=C(O)C=C3)OC4=CC(O[C@H](O[C@@H](C)[C@H](O)[C@H]5O)[C@@H]5O)=CC(O)=C14,Kaempferitrin,Data.sdf,17287,HY-N0628,Lespedin; Lespenephryl,482-38-2,Insulin Receptor,Protein Tyrosine Kinase/RTK,C27H30O14,10mM,Cancer; Metabolic Disease; Endocrinology,No Development Reported,C[C@@H]1O[C@@H](Oc2cc(O)c3c(=O)c(O[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)c(-c4ccc(O)cc4)oc3c2)[C@H](O)[C@H](O)[C@H]1O,清洗成功,0.2950819672131147
7146,O=S(=O)(Nc1nc2cc(Cl)ccc2o1)c1cc(Cl)ccc1Cl,1,0.9877205491065979,0.9877205491065979,O=S(C1=CC(Cl)=CC=C1Cl)(NC2=NC3=CC(Cl)=CC=C3O2)=O,FBPase-1 inhibitor-1,Data.sdf,8462,HY-136717,,883973-99-7,FBPase,Metabolic Enzyme/Protease,C13H7Cl3N2O3S,10mM,Metabolic Disease,No Development Reported,O=S(=O)(Nc1nc2cc(Cl)ccc2o1)c1cc(Cl)ccc1Cl,清洗成功,0.2678571428571428
10116,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCCCC(=O)O,1,0.9877035617828369,0.9877035617828369,O=C(CCCCCOC1=CC2=NC=CC(OC3=CC=C(NC(C4(CC4)C(NC5=CC=C(C=C5)F)=O)=O)C=C3F)=C2C=C1OC)O,Canlitinib,Data.sdf,11967,HY-156603,,2222730-78-9,c-Met/HGFR,Protein Tyrosine Kinase/RTK,C33H31F2N3O7,10mM,Cancer,No Development Reported,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCCCC(=O)O,清洗成功,0.2555555555555555
1064,Cc1cnc(N2CC3(CCOCC3)C2)c(C(=O)Nc2ccc(C(=O)N3CCc4cc(C(=O)Nc5c(C)cccc5F)sc4-c4ccccc43)cc2)c1,1,0.9876967072486877,0.9876967072486877,O=C(C(S1)=CC2=C1C3=CC=CC=C3N(C(C4=CC=C(NC(C5=CC(C)=CN=C5N6CC7(CCOCC7)C6)=O)C=C4)=O)CC2)NC8=C(C)C=CC=C8F,PC786,Data.sdf,1224,HY-102038,,1902114-15-1,RSV,Anti-infection,C41H38FN5O4S,10mM,Infection,Phase 2,Cc1cnc(N2CC3(CCOCC3)C2)c(C(=O)Nc2ccc(C(=O)N3CCc4cc(C(=O)Nc5c(C)cccc5F)sc4-c4ccccc43)cc2)c1,清洗成功,0.2393162393162393
6400,O=C(O)[C@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](Oc2cccc(Cl)c2F)CC1,1,0.9876954555511475,0.9876954555511475,FC(C(Cl)=CC=C1)=C1O[C@H](CC2)CC[C@@]2(C(O)=O)CC3=CC=CC(NC4=NC=CS4)=N3,MK-5108,Data.sdf,7571,HY-13252,VX-689,1010085-13-8,Aurora Kinase; Autophagy,Autophagy; Cell Cycle/DNA Damage; Epigenetics,C22H21ClFN3O3S,10mM,Cancer,Phase 1,O=C(O)[C@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](Oc2cccc(Cl)c2F)CC1,清洗成功,0.2209302325581395
3707,NC(=O)C1CN(CC(=O)Nc2c(Cl)cccc2Cl)CCN1CCCC(c1ccc(F)cc1)c1cccnc1,1,0.9876910448074341,0.9876910448074341,O=C(NC1=C(Cl)C=CC=C1Cl)CN2CC(C(N)=O)N(CCCC(C3=CC=C(F)C=C3)C4=CC=CN=C4)CC2.[H]Cl.[H]Cl,Soluflazine,Data.sdf,4366,HY-115366,,112415-83-5,Nucleoside Transporters,Membrane Transporter/Ion Channel,C28H32Cl4FN5O2,10mM,Neurological Disease,No Development Reported,NC(=O)C1CN(CC(=O)Nc2c(Cl)cccc2Cl)CCN1CCCC(c1ccc(F)cc1)c1cccnc1,清洗成功,0.2421052631578947
5201,COc1ccc(-n2ncc3cnc(Nc4cc(OC)c(OC)c(OCCCN5CCN(C)CC5)c4)nc32)cc1,1,0.9876765012741089,0.9876765012741089,COC1=CC=C(N2N=CC3=CN=C(NC4=CC(OCCCN5CCN(C)CC5)=C(OC)C(OC)=C4)N=C32)C=C1,TBK1/IKK?μ-IN-4,Data.sdf,6124,HY-124652,,1381930-17-1,IKK,NF-?oB,C28H35N7O4,10mM,Cancer,No Development Reported,COc1ccc(-n2ncc3cnc(Nc4cc(OC)c(OC)c(OCCCN5CCN(C)CC5)c4)nc32)cc1,清洗成功,0.3452380952380952
1566,CC(C)[C@@H](CN1CC[C@@](C)(c2cccc(O)c2)[C@@H](C)C1)NC(=O)[C@H]1Cc2ccc(O)cc2CN1,1,0.9876621961593628,0.9876621961593628,O=C([C@@H]1NCC2=C(C=CC(O)=C2)C1)N[C@@H](C(C)C)CN3C[C@H](C)[C@](C)(C4=CC=CC(O)=C4)CC3.[H]Cl.[H]Cl,JDTic (dihydrochloride),Data.sdf,1850,HY-10487,,785835-79-2,Opioid Receptor,GPCR/G Protein; Neuronal Signaling,C28H41Cl2N3O3,10mM,Neurological Disease,Phase 1,CC(C)[C@@H](CN1CC[C@@](C)(c2cccc(O)c2)[C@@H](C)C1)NC(=O)[C@H]1Cc2ccc(O)cc2CN1,清洗成功,0.2058823529411764
6662,CC(C)(C)c1ccc(S(=O)(=O)Nc2ccc3sc(/C=C/C(=O)NO)cc3c2)cc1,1,0.987626850605011,0.987626850605011,O=C(NO)/C=C/C1=CC2=CC(NS(=O)(C3=CC=C(C(C)(C)C)C=C3)=O)=CC=C2S1,KH-3,Data.sdf,7904,HY-134601,,1215115-03-9,HuR,Epigenetics,C21H22N2O4S2,10mM,Cancer,No Development Reported,CC(C)(C)c1ccc(S(=O)(=O)Nc2ccc3sc(/C=C/C(=O)NO)cc3c2)cc1,清洗成功,0.3125
7969,CC(N/C(=N\C#N)Nc1ccncc1)C(C)(C)C,1,0.9876254200935364,0.9876254200935364,CC(C(C)(C)C)N/C(NC1=CC=NC=C1)=N\C#N,Pinacidil,Data.sdf,9413,HY-14290,P-1134,60560-33-0,Potassium Channel,Membrane Transporter/Ion Channel,C13H19N5,10mM,Cardiovascular Disease,Launched,CC(N/C(=N\C#N)Nc1ccncc1)C(C)(C)C,清洗成功,0.2352941176470588
10571,Cc1cc(C#N)cc2c(=O)n(C)c(-c3cc(Br)nn3-c3ncccc3Cl)nc12,1,0.987618088722229,0.987618088722229,N#CC(C=C12)=CC(C)=C2N=C(C3=CC(Br)=NN3C4=NC=CC=C4Cl)N(C)C1=O,J9Z38,Data.sdf,12527,HY-160758,,1414864-34-8,Insecticide,Others,C19H12BrClN6O,10mM,Others,No Development Reported,Cc1cc(C#N)cc2c(=O)n(C)c(-c3cc(Br)nn3-c3ncccc3Cl)nc12,清洗成功,0.2432432432432432
9025,CN(C)c1cccc(Nc2cc(-c3ccccc3)nc(C3CCNCC3)n2)c1,1,0.987608790397644,0.987608790397644,CN(C)C1=CC(NC2=CC(C3=CC=CC=C3)=NC(C4CCNCC4)=N2)=CC=C1,ARN22089,Data.sdf,10642,HY-149464,,2248691-29-2,Ras,GPCR/G Protein; MAPK/ERK Pathway,C23H27N5,10mM,Cancer,No Development Reported,CN(C)c1cccc(Nc2cc(-c3ccccc3)nc(C3CCNCC3)n2)c1,清洗成功,0.282051282051282
8890,N#Cc1cc(-c2n[nH]c(-c3ccncc3)n2)ccn1,1,0.9875582456588745,0.9875582456588745,N#CC1=NC=CC(C2=NNC(C3=CC=NC=C3)=N2)=C1,Topiroxostat,Data.sdf,10491,HY-14874,FYX-051,577778-58-6,Cytochrome P450; Xanthine Oxidase,Metabolic Enzyme/Protease,C13H8N6,10mM,Metabolic Disease,Launched,N#Cc1cc(-c2n[nH]c(-c3ccncc3)n2)ccn1,清洗成功,0.2857142857142857
8319,Cc1cc(-c2nc(-c3ccnc(N)c3F)ccc2O)nc(N)n1,1,0.987557053565979,0.987557053565979,FC1=C(C2=CC=C(O)C(C3=CC(C)=NC(N)=N3)=N2)C=CN=C1N,Tanuxiciclib,Data.sdf,9816,HY-145599,,1983983-64-7,CDK,Cell Cycle/DNA Damage,C15H13FN6O,10mM,Cancer,No Development Reported,Cc1cc(-c2nc(-c3ccnc(N)c3F)ccc2O)nc(N)n1,清洗成功,0.265625
628,Cc1nnc2c3ccccc3c(N[C@@H](C)[C@H](c3ccccc3)N(C)C)nn12,1,0.9875487089157104,0.9875487089157104,C[C@@H]([C@H](C1=CC=CC=C1)N(C)C)NC(C2=C3C=CC=C2)=NN4C3=NN=C4C,L-Moses,Data.sdf,713,HY-101125,L-45,2079885-05-3,Epigenetic Reader Domain,Epigenetics,C21H24N6,10mM,Cancer,No Development Reported,Cc1nnc2c3ccccc3c(N[C@@H](C)[C@H](c3ccccc3)N(C)C)nn12,清洗成功,0.2191780821917808
629,Cc1nnc2c3ccccc3c(N[C@@H](C)[C@H](c3ccccc3)N(C)C)nn12,1,0.9875487089157104,0.9875487089157104,C[C@@H]([C@H](C1=CC=CC=C1)N(C)C)NC(C2=C3C=CC=C2)=NN4C3=NN=C4C.[H]Cl.[H]Cl,L-Moses (dihydrochloride),Data.sdf,714,HY-101125A,L-45 (dihydrochloride),2922480-38-2,Epigenetic Reader Domain,Epigenetics,C21H26Cl2N6,10mM,Cancer,No Development Reported,Cc1nnc2c3ccccc3c(N[C@@H](C)[C@H](c3ccccc3)N(C)C)nn12,清洗成功,0.2162162162162162
630,Cc1nnc2c3ccccc3c(N[C@H](C)[C@@H](c3ccccc3)N(C)C)nn12,1,0.9875487089157104,0.9875487089157104,C[C@H]([C@@H](C1=CC=CC=C1)N(C)C)NC(C2=C3C=CC=C2)=NN4C3=NN=C4C,D-Moses,Data.sdf,715,HY-101125B,D-45,2084850-77-9,Others,Others,C21H24N6,10mM,Cancer,No Development Reported,Cc1nnc2c3ccccc3c(N[C@H](C)[C@@H](c3ccccc3)N(C)C)nn12,清洗成功,0.2191780821917808
7623,Fc1ccc2nc(CNc3nc(N4CCNCC4)nc4c(C5CC5)cnn34)[nH]c2c1F,1,0.9875446557998657,0.9875446557998657,FC1=C2C(N=C(CNC3=NC(N4CCNCC4)=NC5=C(C6CC6)C=NN53)N2)=CC=C1F,CDK12-IN-6,Data.sdf,9025,HY-139329,,2651196-71-1,CDK,Cell Cycle/DNA Damage,C20H21F2N9,10mM,Cancer,No Development Reported,Fc1ccc2nc(CNc3nc(N4CCNCC4)nc4c(C5CC5)cnn34)[nH]c2c1F,清洗成功,0.2346938775510204
7419,C=CCn1c(=O)c2cnc(Nc3ccc4c(c3)CN(C)CC43CC3)nc2n1-c1cccc(C(C)(C)O)n1,1,0.9875444173812866,0.9875444173812866,CN1CC2(CC2)C(C(C1)=C3)=CC=C3NC4=NC=C(C5=O)C(N(C6=CC=CC(C(C)(O)C)=N6)N5CC=C)=N4,WEE1-IN-3,Data.sdf,8781,HY-138239,,2272976-28-8,Wee1,Cell Cycle/DNA Damage,C28H31N7O2,10mM,Cancer,No Development Reported,C=CCn1c(=O)c2cnc(Nc3ccc4c(c3)CN(C)CC43CC3)nc2n1-c1cccc(C(C)(C)O)n1,清洗成功,0.2772277227722772
159,CNCC(=O)OCc1cccnc1N(C)C(=O)OC(C)[n+]1cnn(C[C@](O)(c2cc(F)ccc2F)[C@@H](C)c2nc(-c3ccc(C#N)cc3)cs2)c1,1,0.9875427484512329,0.9875427484512329,O[C@@](CN(N=C1)C=[N+]1C(C)OC(N(C(N=CC=C2)=C2COC(CNC)=O)C)=O)(C(C=C3F)=C(C=C3)F)[C@H](C4=NC(C(C=C5)=CC=C5C#N)=CS4)C.O=[S]([O-])(O)=O,Isavuconazonium (sulfate),Data.sdf,184,HY-100373,BAL8557-002,946075-13-4,Fungal,Anti-infection,C35H36F2N8O9S2,10mM,Infection,Launched,CNCC(=O)OCc1cccnc1N(C)C(=O)OC(C)[n+]1cnn(C[C@](O)(c2cc(F)ccc2F)[C@@H](C)c2nc(-c3ccc(C#N)cc3)cs2)c1,清洗成功,0.1836734693877551
4853,Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCN(CCCCCCNC(=O)CNc4cccc5c4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)cc2)n1,1,0.9875379800796509,0.9875379800796509,O=C(NC1=CC=CC(C(N=C2NC3=CC=C(C(N4CCN(CCCCCCNC(CNC5=CC=CC(C(N6C(CC7)C(NC7=O)=O)=O)=C5C6=O)=O)CC4)=O)C=C3)=CN(C)C2=O)=C1C)C8=CC=C(C(C)(C)C)C=C8,DD-03-171,Data.sdf,5712,HY-122830,,2366132-45-6,Btk; PROTACs,PROTAC; Protein Tyrosine Kinase/RTK,C55H62N10O8,10mM,Cancer,No Development Reported,Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(C(=O)N3CCN(CCCCCCNC(=O)CNc4cccc5c4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)cc2)n1,清洗成功,0.2297297297297297
14202,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](O)[C@H]1O,1,0.9875319600105286,0.9875319600105286,O=C([C@@]1(O)C[C@@H](OC(/C=C/C2=CC=C(O)C(O)=C2)=O)[C@H](O)[C@H](O)C1)O,Chlorogenic acid,Data.sdf,16749,HY-N0055,3-O-Caffeoylquinic acid; Heriguard; NSC-407296,327-97-9,Bacterial; Endogenous Metabolite; HIF/HIF Prolyl-Hydroxylase; Influenza Virus; Reactive Oxygen Species,Anti-infection; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?oB,C16H18O9,10mM,Cancer; Infection; Inflammation/Immunology; Cardiovascular Disease,No Development Reported,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](O)[C@H]1O,清洗成功,0.34
4586,CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1,1,0.9875307083129883,0.9875307083129883,CN1CC(CCC1)CN2C3=C(SC4=CC=CC=C24)C=CC=C3,Mepazine,Data.sdf,5396,HY-121282,Pecazine,60-89-9,Apoptosis; MALT1,Apoptosis; Metabolic Enzyme/Protease; NF-?oB,C19H22N2S,10mM,Cancer,No Development Reported,CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1,清洗成功,0.2432432432432432
4587,CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1,1,0.9875307083129883,0.9875307083129883,CN1CC(CN2C3=C(C=CC=C3)SC4=CC=CC=C24)CCC1.[H]Cl,Mepazine (hydrochloride),Data.sdf,5397,HY-121282A,Pecazine (hydrochloride),2975-36-2,Apoptosis; MALT1,Apoptosis; Metabolic Enzyme/Protease; NF-?oB,C19H23ClN2S,10mM,Cancer,No Development Reported,CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1,清洗成功,0.24
5283,CC1=C(C(=O)OCCN(Cc2ccccc2)c2ccccc2)C(c2cccc([N+](=O)[O-])c2)C(P2(=O)OCC(C)(C)CO2)=C(C)N1,1,0.9875277876853943,0.9875277876853943,CC1=C(P2(OCC(C)(C)CO2)=O)C(C3=CC([N+]([O-])=O)=CC=C3)C(C(OCCN(C4=CC=CC=C4)CC5=CC=CC=C5)=O)=C(C)N1,Efonidipine,Data.sdf,6230,HY-12502,NZ-105; (?±)-Efonidipine,111011-63-3,Calcium Channel,Membrane Transporter/Ion Channel; Neuronal Signaling,C34H38N3O7P,10mM,Cardiovascular Disease,Launched,CC1=C(C(=O)OCCN(Cc2ccccc2)c2ccccc2)C(c2cccc([N+](=O)[O-])c2)C(P2(=O)OCC(C)(C)CO2)=C(C)N1,清洗成功,0.2043010752688172
5287,CC1=C(C(=O)OCCN(Cc2ccccc2)c2ccccc2)C(c2cccc([N+](=O)[O-])c2)C(P2(=O)OCC(C)(C)CO2)=C(C)N1,1,0.9875276684761047,0.9875276684761047,CC1=C(P2(OCC(C)(C)CO2)=O)C(C3=CC([N+]([O-])=O)=CC=C3)C(C(OCCN(C4=CC=CC=C4)CC5=CC=CC=C5)=O)=C(C)N1.[H]Cl.CCO,Efonidipine (hydrochloride monoethanolate),Data.sdf,6234,HY-12502A,NZ-105 hydrochloride monoethanolate,111011-76-8,Calcium Channel,Membrane Transporter/Ion Channel; Neuronal Signaling,C36H45ClN3O8P,10mM,Cardiovascular Disease,Launched,CC1=C(C(=O)OCCN(Cc2ccccc2)c2ccccc2)C(c2cccc([N+](=O)[O-])c2)C(P2(=O)OCC(C)(C)CO2)=C(C)N1,清洗成功,0.2019230769230769
17217,CSc1ccc2c(c1)Nc1ccccc1S2,1,0.9875273108482361,0.9875273108482361,CSC1=CC(NC2=CC=CC=C2S3)=C3C=C1,2-Methylthiophenothiazine,Data.sdf,20510,HY-W011996,,7643/8/5,Microtubule/Tubulin,Cell Cycle/DNA Damage; Cytoskeleton,C13H11NS2,10mM,cancer,No Development Reported,CSc1ccc2c(c1)Nc1ccccc1S2,清洗成功,0.2115384615384615
14675,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@@](O)(C(=O)O)C[C@@H](O)[C@@H]1O,1,0.9875105619430542,0.9875105619430542,O=C([C@]1(O)C[C@@H](OC(/C=C/C2=CC=C(O)C(O)=C2)=O)[C@@H](O)[C@H](O)C1)O,Neochlorogenic acid,Data.sdf,17383,HY-N0722,trans-5-O-Caffeoylquinic acid,906-33-2,COX; Interleukin Related; NF-?oB; TNF Receptor,Apoptosis; Immunology/Inflammation; NF-?oB,C16H18O9,10mM,Inflammation/Immunology; Cancer,No Development Reported,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@@](O)(C(=O)O)C[C@@H](O)[C@@H]1O,清洗成功,0.34
7930,Cc1[nH]c(=O)c(C#N)cc1-c1ccncc1,1,0.9875072836875916,0.9875072836875916,CC(N1)=C(C2=CC=NC=C2)C=C(C#N)C1=O,Milrinone,Data.sdf,9369,HY-14252,Win 47203,78415-72-2,Phosphodiesterase (PDE),Metabolic Enzyme/Protease,C12H9N3O,10mM,Cardiovascular Disease,Launched,Cc1[nH]c(=O)c(C#N)cc1-c1ccncc1,清洗成功,0.3265306122448979
12638,CCN(C(=O)C1CC1)c1cc(-c2ccc(N3CCN(CC4CC4)CC3)nc2C)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C,1,0.9875026345252991,0.9875026345252991,O=C(NCC1=C(C)C=C(C)NC1=O)C2=CC(C3=CC=C(N4CCN(CC5CC5)CC4)N=C3C)=CC(N(C(C6CC6)=O)CC)=C2C,EZH2-IN-2,Data.sdf,14956,HY-A0298,,2238821-31-1,Histone Methyltransferase,Epigenetics,C36H46N6O3,10mM,Cancer,No Development Reported,CCN(C(=O)C1CC1)c1cc(-c2ccc(N3CCN(CC4CC4)CC3)nc2C)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C,清洗成功,0.2583333333333333
17890,Nc1cnn(-c2ccccc2)c(=O)c1Cl,1,0.9874926805496216,0.9874926805496216,O=C1C(Cl)=C(C=NN1C2=CC=CC=C2)N,Chloridazon,Data.sdf,21325,HY-W103488,,1698-60-8,,,C10H8ClN3O,10mM,Others,No Development Reported,Nc1cnn(-c2ccccc2)c(=O)c1Cl,清洗成功,0.3125
3883,CS(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(C(N)=O)CC1)c1ccccc1S2,1,0.9874899983406067,0.9874899983406067,O=C(N)C1CCN(CC1)CCCN2C3=C(SC4=CC=C(C=C24)S(=O)(C)=O)C=CC=C3,Metopimazine,Data.sdf,4568,HY-116578,EXP999; RP9965,14008-44-7,Drug Derivative,Others,C22H27N3O3S2,10mM,Inflammation/Immunology,No Development Reported,CS(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(C(N)=O)CC1)c1ccccc1S2,清洗成功,0.28
7748,C=CC(=O)Nc1cc(Nc2ncc(Cl)c(-c3c[nH]c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,1,0.9874843955039978,0.9874843955039978,C=CC(NC1=CC(NC2=NC=C(Cl)C(C3=CNC4=C3C=CC=C4)=N2)=C(OC)C=C1N(CCN(C)C)C)=O,Mutant EGFR inhibitor,Data.sdf,9171,HY-13984,,1421373-62-7,EGFR,JAK/STAT Signaling; Protein Tyrosine Kinase/RTK,C27H30ClN7O2,10mM,Cancer,No Development Reported,C=CC(=O)Nc1cc(Nc2ncc(Cl)c(-c3c[nH]c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,清洗成功,0.3267326732673267
3124,C=CC(=O)N1CCCC(c2ccnc(Nc3cc(C(=O)Nc4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)n2)C1,1,0.9874787330627441,0.9874787330627441,FC(F)(F)C1=CC(NC(C2=CC(NC3=NC=CC(C4CN(C(C=C)=O)CCC4)=N3)=C(C)C=C2)=O)=CC(N5C=NC(C)=C5)=C1,M443,Data.sdf,3661,HY-112274,,1820684-31-8,Mixed Lineage Kinase,MAPK/ERK Pathway,C31H30F3N7O2,10mM,Cancer,No Development Reported,C=CC(=O)N1CCCC(c2ccnc(Nc3cc(C(=O)Nc4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)n2)C1,清洗成功,0.2540983606557377
3027,Cc1ccc2c(Nc3cccc(OC(F)(F)F)c3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12,1,0.9874691963195801,0.9874691963195801,FC(F)(F)OC1=CC(NC2=NC=CC3=C2C=CC(C)=C3NC4=NC=CC=C4C5=C6N=CNC6=NC=N5)=CC=C1,LUT014,Data.sdf,3544,HY-111940,,2274819-46-2,Raf,MAPK/ERK Pathway,C27H19F3N8O,10mM,Inflammation/Immunology,Phase 2,Cc1ccc2c(Nc3cccc(OC(F)(F)F)c3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12,清洗成功,0.3157894736842105
6090,Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCCCOc2ccc(-c3ccc(N4C(=S)N(c5ccc(C#N)c(C(F)(F)F)c5)C(=O)C4(C)C)cc3)cc2)C(C)(C)C)cc1,1,0.9874623417854309,0.9874623417854309,O=C(NCC1=CC=C(C2=C(C)N=CS2)C=C1)[C@H]3N(C([C@H](C(C)(C)C)NC(COCCCCOC4=CC=C(C5=CC=C(N(C(N6C7=CC=C(C#N)C(C(F)(F)F)=C7)=S)C(C)(C)C6=O)C=C5)C=C4)=O)=O)C[C@H](O)C3,ARCC-4,Data.sdf,7207,HY-130492,,1973403-00-7,Androgen Receptor; PROTACs,PROTAC; Vitamin D Related/Nuclear Receptor,C53H56F3N7O7S2,10mM,Cancer,No Development Reported,Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCCCOc2ccc(-c3ccc(N4C(=S)N(c5ccc(C#N)c(C(F)(F)F)c5)C(=O)C4(C)C)cc3)cc2)C(C)(C)C)cc1,清洗成功,0.1862068965517241
16072,COc1ccc2cc([N+](=O)[O-])c3c(C(=O)O)cc4c(c3c2c1)OCO4,1,0.9874516129493713,0.9874516129493713,O=C(C1=C2C([N+]([O-])=O)=CC3=CC=C(OC)C=C3C2=C(OCO4)C4=C1)O,Aristolochic acid III,Data.sdf,19214,HY-N7951,,7267-92-7,Others,Others,C17H11NO7,10mM,Others,No Development Reported,COc1ccc2cc([N+](=O)[O-])c3c(C(=O)O)cc4c(c3c2c1)OCO4,清洗成功,0.2837837837837837
11071,O=C1CCC(N2C(=O)c3cc(F)c(N4CCC(N5CCN(c6ccc(N(C(=O)NCc7ccccc7)[C@H]7CC[C@H](Nc8ncc9ccccc9n8)CC7)cn6)CC5)CC4)cc3C2=O)C(=O)N1,1,0.9874442219734192,0.9874442219734192,O=C(NCC1=CC=CC=C1)N(C2=CN=C(N3CCN(C4CCN(C5=C(F)C=C(C(N(C6CCC(NC6=O)=O)C7=O)=O)C7=C5)CC4)CC3)C=C2)[C@H](CC8)CC[C@@H]8NC9=NC=C%10C(C=CC=C%10)=N9,YJ1206,Data.sdf,13113,HY-168555,,3053716-98-3,Apoptosis; CDK; PROTACs,Apoptosis; Cell Cycle/DNA Damage; PROTAC,C49H52FN11O5,10mM,Cancer,No Development Reported,O=C1CCC(N2C(=O)c3cc(F)c(N4CCC(N5CCN(c6ccc(N(C(=O)NCc7ccccc7)[C@H]7CC[C@H](Nc8ncc9ccccc9n8)CC7)cn6)CC5)CC4)cc3C2=O)C(=O)N1,清洗成功,0.2307692307692307
8295,CCn1c(CN[C@@H](C)C(N)=O)nc2ccc(Oc3ccc(C)cc3)cc21,1,0.9874247908592224,0.9874247908592224,CCN1C2=CC(OC3=CC=C(C=C3)C)=CC=C2N=C1CN[C@@H](C)C(N)=O,Bliretrigine,Data.sdf,9789,HY-145558,,1233229-75-8,Sodium Channel,Membrane Transporter/Ion Channel,C20H24N4O2,10mM,Neurological Disease,No Development Reported,CCn1c(CN[C@@H](C)C(N)=O)nc2ccc(Oc3ccc(C)cc3)cc21,清洗成功,0.3026315789473684
3901,O=c1nc(Oc2cnn(Cc3ccccc3)c2)[nH]c2cnccc12,1,0.9874098896980286,0.9874098896980286,O=C1C2=C(NC(OC3=CN(N=C3)CC4=CC=CC=C4)=N1)C=NC=C2,GSK467,Data.sdf,4587,HY-116761,,1628332-52-4,Histone Demethylase,Epigenetics,C17H13N5O2,10mM,Cancer,No Development Reported,O=c1nc(Oc2cnn(Cc3ccccc3)c2)[nH]c2cnccc12,清洗成功,0.3387096774193548
5938,COc1ccc(-c2c(-c3ccc(C#N)c(F)c3)nc(N3CCC(N)CC3)n(C)c2=O)cc1F,1,0.9874026775360107,0.9874026775360107,N#CC1=CC=C(C(N=C(N2CCC(N)CC2)N3C)=C(C4=CC=C(OC)C(F)=C4)C3=O)C=C1F.O=S(C5=CC=CC=C5)(O)=O,Pulrodemstat (benzenesulfonate),Data.sdf,7023,HY-129388B,CC-90011 (benzenesulfonate); LSD1-IN-7 (benzenesulfonate),2097523-60-7,Histone Demethylase,Epigenetics,C30H29F2N5O5S,10mM,Cancer,Phase 2,COc1ccc(-c2c(-c3ccc(C#N)c(F)c3)nc(N3CCC(N)CC3)n(C)c2=O)cc1F,清洗成功,0.2427184466019417
6505,Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C1CCN(CCOCCOCCOc2ccc3c(c2)CN(C2CCC(=O)NC2=O)C3=O)CC1,1,0.987389087677002,0.987389087677002,O=C(C(N(CC1=C2C=CC(OCCOCCOCCN3CCC(N4N=C(C5=CC=C(OC6=CC=CC=C6)C=C5)C7=C(N)N=CN=C74)CC3)=C1)C2=O)CC8)NC8=O,SJF620,Data.sdf,7710,HY-133137,,2376187-16-3,Btk; PROTACs,PROTAC; Protein Tyrosine Kinase/RTK,C41H44N8O7,10mM,Cancer,No Development Reported,Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C1CCN(CCOCCOCCOc2ccc3c(c2)CN(C2CCC(=O)NC2=O)C3=O)CC1,清洗成功,0.2659574468085106
4050,C=CCn1nc(-c2ccc(O)cc2O)c2cccc(C(F)(F)F)c21,1,0.9873884320259094,0.9873884320259094,OC1=CC=C(C(O)=C1)C2=NN(C3=C2C=CC=C3C(F)(F)F)CC=C,WAY-169916,Data.sdf,4755,HY-117726,,669764-18-5,Estrogen Receptor/ERR; NF-?oB,NF-?oB; Vitamin D Related/Nuclear Receptor,C17H13F3N2O2,10mM,Inflammation/Immunology,No Development Reported,C=CCn1nc(-c2ccc(O)cc2O)c2cccc(C(F)(F)F)c21,清洗成功,0.2419354838709677
8103,Cc1cnc2c(-c3ccc(C(=O)N(c4ncccc4C)[C@@H]4CCCNC4)cc3F)cnn2c1,1,0.987385630607605,0.987385630607605,CC1=CN2N=CC(C3=CC=C(C=C3F)C(N([C@@H]4CCCNC4)C5=C(C=CC=N5)C)=O)=C2N=C1,CD33 splicing modulator 1,Data.sdf,9569,HY-144399,,2762547-05-5,Transmembrane Glycoprotein,Immunology/Inflammation,C25H25FN6O,10mM,Neurological Disease,No Development Reported,Cc1cnc2c(-c3ccc(C(=O)N(c4ncccc4C)[C@@H]4CCCNC4)cc3F)cnn2c1,清洗成功,0.28
3875,CSC(=O)c1cccc2nnsc12,1,0.9873823523521423,0.9873823523521423,O=C(SC)C1=C2SN=NC2=CC=C1,Acibenzolar-S-methyl,Data.sdf,4559,HY-116541,ASM,135158-54-2,Bacterial; Fungal,Anti-infection,C8H6N2OS2,10mM,Infection,No Development Reported,CSC(=O)c1cccc2nnsc12,清洗成功,0.25
4739,COc1cc(OC)c(-c2cn3ccc(N4CC[C@H](NCc5ccncc5)C4)cc3n2)cc1Cl,1,0.9873666763305664,0.9873666763305664,COC1=C(Cl)C=C(C2=CN3C=CC(N4C[C@@H](NCC5=CC=NC=C5)CC4)=CC3=N2)C(OC)=C1,OTS186935,Data.sdf,5568,HY-122181,,2093400-18-9,Histone Methyltransferase,Epigenetics,C25H26ClN5O2,10mM,Cancer,No Development Reported,COc1cc(OC)c(-c2cn3ccc(N4CC[C@H](NCc5ccncc5)C4)cc3n2)cc1Cl,清洗成功,0.2708333333333333
4170,COc1cccc(-c2cc3c(cc4n3C(=S)N(CCCN3CCOCC3)C4=O)s2)c1,1,0.987343430519104,0.987343430519104,O=C(C1=CC2=C(C=C(S2)C3=CC=CC(OC)=C3)N1C4=S)N4CCCN5CCOCC5,IW927,Data.sdf,4911,HY-118922,,389142-48-7,TNF Receptor,Apoptosis,C22H23N3O3S2,10mM,Inflammation/Immunology,No Development Reported,COc1cccc(-c2cc3c(cc4n3C(=S)N(CCCN3CCOCC3)C4=O)s2)c1,清洗成功,0.2625
6172,CCN(CC)c1cc2oc(=O)c(-c3nc4ccccc4o3)cc2cc1C,1,0.9873399138450623,0.9873399138450623,CCN(CC)C1=C(C)C=C2C(OC(C(C3=NC(C=CC=C4)=C4O3)=C2)=O)=C1,EMI56,Data.sdf,7303,HY-131067,,2414374-41-5,EGFR,JAK/STAT Signaling; Protein Tyrosine Kinase/RTK,C21H20N2O3,10mM,Cancer,No Development Reported,CCN(CC)c1cc2oc(=O)c(-c3nc4ccccc4o3)cc2cc1C,清洗成功,0.2533333333333333
5815,CCOCC1(COCC)CCC(c2n[nH]cc2CN(C)CCNC)CC1,1,0.9873377084732056,0.9873377084732056,CNCCN(CC1=CNN=C1C2CCC(COCC)(COCC)CC2)C.Cl.Cl,GSK3368715 (dihydrochloride),Data.sdf,6877,HY-128717A,EPZ019997 (dihydrochloride),1628925-77-8,Histone Methyltransferase,Epigenetics,C20H40Cl2N4O2,10mM,Cancer,Phase 1,CCOCC1(COCC)CCC(c2n[nH]cc2CN(C)CCNC)CC1,清洗成功,0.1724137931034483
4898,CN(C(=O)CC1CCCC1)c1ccc(Cl)c(COc2cccc3cnccc23)c1Cl,1,0.987330436706543,0.987330436706543,O=C(CC1CCCC1)N(C)C2=CC=C(C(COC3=CC=CC4=C3C=CN=C4)=C2Cl)Cl,AS1708727,Data.sdf,5770,HY-123046,,1253226-93-5,Autophagy,Autophagy,C24H24Cl2N2O2,10mM,Cancer; Metabolic Disease,No Development Reported,CN(C(=O)CC1CCCC1)c1ccc(Cl)c(COc2cccc3cnccc23)c1Cl,清洗成功,0.2682926829268293
8788,C[C@H](c1c[nH]c(=O)c2cc(F)c(F)cc12)N(C)C(=O)Nc1ccc(F)c(C#N)c1,1,0.9873283505439758,0.9873283505439758,FC1=C(C#N)C=C(NC(N(C)[C@H](C)C2=CNC(C3=C2C=C(F)C(F)=C3)=O)=O)C=C1,AB-836,Data.sdf,10375,HY-148348,,2445597-31-7,HBV,Anti-infection,C20H15F3N4O2,10mM,Infection,Phase 1,C[C@H](c1c[nH]c(=O)c2cc(F)c(F)cc12)N(C)C(=O)Nc1ccc(F)c(C#N)c1,清洗成功,0.2297297297297297
7330,Nc1nc(S)c2nc[nH]c2n1,1,0.9873220324516296,0.9873220324516296,SC1=NC(N)=NC2=C1N=CN2,6-Thioguanine,Data.sdf,8671,HY-13765,Thioguanine; 2-Amino-6-purinethiol,154-42-7,Apoptosis; Autophagy; Deubiquitinase; DNA Methyltransferase; Endogenous Metabolite; SARS-CoV,Anti-infection; Apoptosis; Autophagy; Cell Cycle/DNA Damage; Epigenetics; Metabolic Enzyme/Protease,C5H5N5S,10mM,Cancer; Infection; Inflammation/Immunology,Launched,Nc1nc(S)c2nc[nH]c2n1,清洗成功,0.2857142857142857
8089,Cc1ccc(NC(=O)c2ccc3cnccc3c2)cc1C(=O)Nc1cnc(Nc2cccc(NC3CCN(C(=O)/C=C/CN(C)C)CC3)c2)nc1,1,0.9873148202896118,0.9873148202896118,O=C(C1=CC2=C(C=NC=C2)C=C1)NC3=CC=C(C)C(C(NC4=CN=C(NC5=CC=CC(NC6CCN(C(/C=C/CN(C)C)=O)CC6)=C5)N=C4)=O)=C3,BLK-IN-2,Data.sdf,9554,HY-144288,,2694871-86-6,Btk,Protein Tyrosine Kinase/RTK,C39H41N9O3,10mM,Cancer,No Development Reported,Cc1ccc(NC(=O)c2ccc3cnccc3c2)cc1C(=O)Nc1cnc(Nc2cccc(NC3CCN(C(=O)/C=C/CN(C)C)CC3)c2)nc1,清洗成功,0.3298969072164948
2523,Cc1ccc2c([nH]c(=O)c3c(=O)cc(C(=O)OCCC(C)C)oc32)c1C,1,0.9873107671737671,0.9873107671737671,O=C(C(O1)=CC(C2=C1C3=C(NC2=O)C(C)=C(C)C=C3)=O)OCCC(C)C,Repirinast,Data.sdf,2959,HY-109544,MY-5116,73080-51-0,Histamine Receptor,GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling,C20H21NO5,10mM,Inflammation/Immunology,Launched,Cc1ccc2c([nH]c(=O)c3c(=O)cc(C(=O)OCCC(C)C)oc32)c1C,清洗成功,0.2253521126760563
997,CC(=O)N1CCN(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C#N)C(=O)C1(C)C,1,0.9873083233833313,0.9873083233833313,NC1=NC=NN2C1=C(C(F)(F)F)C=C2C3=CC=C(C#N)C(N4CCN(C(C)=O)C(C)(C)C4=O)=C3,PI3K?′-IN-1,Data.sdf,1145,HY-101921,,1911564-39-0,PI3K,PI3K/Akt/mTOR,C22H20F3N7O2,10mM,Inflammation/Immunology,No Development Reported,CC(=O)N1CCN(c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2C#N)C(=O)C1(C)C,清洗成功,0.2527472527472527
17067,CS(=O)(=O)c1ccc2nc(N)sc2c1,1,0.9873018264770508,0.9873018264770508,NC1=NC2=CC=C(S(=O)(C)=O)C=C2S1,TbPTR1 inhibitor 2,Data.sdf,20323,HY-W009689,,17557-67-4,Parasite,Anti-infection,C8H8N2O2S2,10mM,Infection,No Development Reported,CS(=O)(=O)c1ccc2nc(N)sc2c1,清洗成功,0.3396226415094339
2063,COc1cccc2oc(-c3ccccc3)cc(=O)c12,1,0.9872995018959045,0.9872995018959045,O=C1C=C(C2=CC=CC=C2)OC3=CC=CC(OC)=C13,5-Methoxyflavone,Data.sdf,2421,HY-107790,,42079-78-7,DNA/RNA Synthesis,Cell Cycle/DNA Damage,C16H12O3,10mM,Neurological Disease,No Development Reported,COc1cccc2oc(-c3ccccc3)cc(=O)c12,清洗成功,0.3134328358208955
5704,CCOC(=O)C(C)Oc1cccc2c(=O)n(CC(=O)NCc3ccc4c(c3)OCO4)ccc12,1,0.987295925617218,0.987295925617218,CC(OC1=CC=CC2=C1C=CN(CC(NCC3=CC=C(OCO4)C4=C3)=O)C2=O)C(OCC)=O,SID7970631,Data.sdf,6732,HY-128207,,868224-75-3,,GPCR/G Protein,C24H24N2O7,10mM,Cancer,No Development Reported,CCOC(=O)C(C)Oc1cccc2c(=O)n(CC(=O)NCc3ccc4c(c3)OCO4)ccc12,清洗成功,0.3333333333333333
392,C[C@H](NC(=O)c1c(N)nn2cccnc12)c1cc2cccc(C#Cc3cnn(C)c3)c2c(=O)n1-c1ccccc1,1,0.9872937798500061,0.9872937798500061,O=C(C1=C2N=CC=CN2N=C1N)N[C@H](C3=CC4=C(C(N3C5=CC=CC=C5)=O)C(C#CC6=CN(C)N=C6)=CC=C4)C,Eganelisib,Data.sdf,446,HY-100716,IPI-549,1693758-51-8,PI3K,PI3K/Akt/mTOR,C30H24N8O2,10mM,Cancer,Phase 2,C[C@H](NC(=O)c1c(N)nn2cccnc12)c1cc2cccc(C#Cc3cnn(C)c3)c2c(=O)n1-c1ccccc1,清洗成功,0.2525252525252525
8901,Cc1cc2ncc(C(=O)NCC(C)(C)NCC(=O)N3CCC[C@H]3C#N)cn2n1,1,0.9872680306434631,0.9872680306434631,O=C(C1=CN2C(N=C1)=CC(C)=N2)NCC(C)(NCC(N3[C@H](C#N)CCC3)=O)C,Anagliptin,Data.sdf,10503,HY-14877,SK-0403,739366-20-2,Dipeptidyl Peptidase,Metabolic Enzyme/Protease,C19H25N7O2,10mM,Metabolic Disease; Cardiovascular Disease,Launched,Cc1cc2ncc(C(=O)NCC(C)(C)NCC(=O)N3CCC[C@H]3C#N)cn2n1,清洗成功,0.24
6126,Cc1cc(Nc2ncc(F)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc1N1CCN(C)CC1,1,0.987245500087738,0.987245500087738,[H][C@@]1([C@H]([C@H]2C(N)=O)NC3=NC(NC4=CC=C(C(C)=C4)N5CCN(CC5)C)=NC=C3F)C[C@]2(C=C1)[H],Cenisertib,Data.sdf,7248,HY-13072,AS-703569; R-763,871357-89-0,Akt; Aurora Kinase; Bcr-Abl; FLT3; STAT,Cell Cycle/DNA Damage; Epigenetics; JAK/STAT Signaling; PI3K/Akt/mTOR; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt,C24H30FN7O,10mM,Cancer,Phase 1,Cc1cc(Nc2ncc(F)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc1N1CCN(C)CC1,清洗成功,0.348314606741573
4537,Cc1nc2c(s1)C(=O)C=C(NCCN(C)C)C2=O,1,0.9872421026229858,0.9872421026229858,O=C(C(NCCN(C)C)=CC1=O)C2=C1SC(C)=N2,BN-82685,Data.sdf,5344,HY-121065,IRC-083065,477603-18-2,Phosphatase,Metabolic Enzyme/Protease,C12H15N3O2S,10mM,Cancer,No Development Reported,Cc1nc2c(s1)C(=O)C=C(NCCN(C)C)C2=O,清洗成功,0.2413793103448276
4699,C[C@@H]1CCCN1CCc1cc2cc(-c3ccc(C#N)cc3)ccc2o1,1,0.987212598323822,0.987212598323822,C[C@H]1N(CCC2=CC3=C(C=CC(C4=CC=C(C#N)C=C4)=C3)O2)CCC1,ABT-239,Data.sdf,5519,HY-12195,,460746-46-7,Histamine Receptor; TRP Channel,GPCR/G Protein; Immunology/Inflammation; Membrane Transporter/Ion Channel; Neuronal Signaling,C22H22N2O,10mM,Neurological Disease; Endocrinology,Phase 1,C[C@@H]1CCCN1CCc1cc2cc(-c3ccc(C#N)cc3)ccc2o1,清洗成功,0.2666666666666666
7243,O=C(N/N=C/c1ccc(O)c([N+](=O)[O-])c1)c1cc(O)cc(O)c1,1,0.9872117638587952,0.9872117638587952,O=C(N/N=C/C1=CC=C(O)C([N+]([O-])=O)=C1)C2=CC(O)=CC(O)=C2,Neuraminidase-IN-1,Data.sdf,8574,HY-137334,,2379438-80-7,Influenza Virus,Anti-infection,C14H11N3O6,10mM,Infection,No Development Reported,O=C(N/N=C/c1ccc(O)c([N+](=O)[O-])c1)c1cc(O)cc(O)c1,清洗成功,0.3333333333333333
6174,CN1C(=O)C(Cc2ccc3ccccc3c2)N=C(c2ccc(O)cc2)c2cc(Cl)ccc21,1,0.9871679544448853,0.9871679544448853,O=C1N(C)C2=CC=C(Cl)C=C2C(C3=CC=C(O)C=C3)=NC1CC4=CC=C5C=CC=CC5=C4,Bz 423,Data.sdf,7305,HY-13108,BZ48,216691-95-1,Bcl-2 Family,Apoptosis,C27H21ClN2O2,10mM,Inflammation/Immunology,No Development Reported,CN1C(=O)C(Cc2ccc3ccccc3c2)N=C(c2ccc(O)cc2)c2cc(Cl)ccc21,清洗成功,0.2592592592592592
2459,C[C@H](NP(=O)(OC[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)C[C@@H]1O)Oc1cccc2ccccc12)C(=O)OCc1ccccc1,1,0.9871615767478943,0.9871615767478943,O=P(OC[C@H]1O[C@@H](N(C=C(F)C2=O)C(N2)=O)C[C@@H]1O)(N[C@@H](C)C(OCC3=CC=CC=C3)=O)OC4=CC=CC5=C4C=CC=C5,Fosifloxuridine nafalbenamide,Data.sdf,2886,HY-109115,NUC-3373,1332837-31-6,Thymidylate Synthase,Apoptosis,C29H29FN3O9P,10mM,Cancer,Phase 2,C[C@H](NP(=O)(OC[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)C[C@@H]1O)Oc1cccc2ccccc12)C(=O)OCc1ccccc1,清洗成功,0.2123893805309734
1174,COc1cc2c(Nc3cc(Cl)c(OC)c(Cl)c3)c(C#N)cnc2cc1OCCCN1CCN(C)CC1,1,0.9871562719345093,0.9871562719345093,N#CC1=C(NC2=CC(Cl)=C(OC)C(Cl)=C2)C3=CC(OC)=C(OCCCN4CCN(C)CC4)C=C3N=C1,Bosutinib isomer,Data.sdf,1361,HY-103029,,1391063-17-4,Wee1,Cell Cycle/DNA Damage,C26H29Cl2N5O3,10mM,Cancer,No Development Reported,COc1cc2c(Nc3cc(Cl)c(OC)c(Cl)c3)c(C#N)cnc2cc1OCCCN1CCN(C)CC1,清洗成功,0.3061224489795918
10733,CN(C)CCCNc1nc2cc([N+](=O)[O-])ccc2nc1NCc1ccc(-c2ccccc2)cc1,1,0.9871519804000854,0.9871519804000854,CN(C)CCCNC1=NC2=CC([N+]([O-])=O)=CC=C2N=C1NCC3=CC=C(C4=CC=CC=C4)C=C3,ZBP1/RIP3/MLKL activator 1,Data.sdf,12718,HY-162424,,,Mixed Lineage Kinase; Necroptosis; RIP kinase,Apoptosis; MAPK/ERK Pathway,C26H28N6O2,10mM,Cancer,No Development Reported,CN(C)CCCNc1nc2cc([N+](=O)[O-])ccc2nc1NCc1ccc(-c2ccccc2)cc1,清洗成功,0.3
12318,Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1,1,0.9871504306793213,0.9871504306793213,O=C(C1=CC=C(C(C(F)(F)F)=C1)CN2C[C@@H](N(C)C)CC2)NC3=CC=C(C)C(NC4=NC=CC(C5=CN=CN=C5)=N4)=C3,Bafetinib,Data.sdf,14575,HY-50868,INNO-406; NS-187,859212-16-1,Apoptosis; Bcr-Abl; Src,Apoptosis; Protein Tyrosine Kinase/RTK,C30H31F3N8O,10mM,Cancer,Phase 2,Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1,清洗成功,0.3113207547169811
11903,CSc1nc2nnc([N+](=O)[O-])c(=O)n2[n-]1,1,0.9871390461921692,0.9871390461921692,O=C1N([N-]C(SC)=N2)C2=NN=C1[N+]([O-])=O.[H]O[H].[H]O[H].[Na+],Triazavirin,Data.sdf,14084,HY-19743,,928659-17-0,DNA/RNA Synthesis; Influenza Virus; Nucleoside Antimetabolite/Analog,Anti-infection; Cell Cycle/DNA Damage,C5H7N6NaO5S,10mM,Infection,Phase 4,CSc1nc2nnc([N+](=O)[O-])c(=O)n2[n-]1,清洗成功,0.1791044776119403
7993,Cn1cnc(Cn2c(=O)[nH]/c(=N\c3cc4cn(C)nc4cc3Cl)n(Cc3cc(F)c(F)cc3F)c2=O)n1,1,0.9871333837509155,0.9871333837509155,FC1=C(CN2C(N(CC3=NN(C)C=N3)C(N/C2=N\C4=CC5=CN(C)N=C5C=C4Cl)=O)=O)C=C(F)C(F)=C1.O=C(O)/C=C/C(O)=O,Ensitrelvir (fumarate),Data.sdf,9438,HY-143216A,S-217622 (fumarate),2757470-18-9,SARS-CoV; Virus Protease,Anti-infection,C26H21ClF3N9O6,10mM,Infection,Phase 3,Cn1cnc(Cn2c(=O)[nH]/c(=N\c3cc4cn(C)nc4cc3Cl)n(Cc3cc(F)c(F)cc3F)c2=O)n1,清洗成功,0.2178217821782178
7992,Cn1cnc(Cn2c(=O)[nH]/c(=N\c3cc4cn(C)nc4cc3Cl)n(Cc3cc(F)c(F)cc3F)c2=O)n1,1,0.987133264541626,0.987133264541626,FC1=C(CN2C(N(CC3=NN(C)C=N3)C(N/C2=N\C4=CC5=CN(C)N=C5C=C4Cl)=O)=O)C=C(F)C(F)=C1,Ensitrelvir,Data.sdf,9437,HY-143216,S-217622,2647530-73-0,SARS-CoV; Virus Protease,Anti-infection,C22H17ClF3N9O2,10mM,Infection,Phase 3,Cn1cnc(Cn2c(=O)[nH]/c(=N\c3cc4cn(C)nc4cc3Cl)n(Cc3cc(F)c(F)cc3F)c2=O)n1,清洗成功,0.2234042553191489
8388,CC(C)(O)c1ccc(C2=CNC3=NC(=O)CN(CC4CCOCC4)C3=N2)cn1,1,0.9871237277984619,0.9871237277984619,O=C1N=C2NC=C(C3=CC=C(C(C)(C)O)N=C3)N=C2N(CC4CCOCC4)C1,CC214-2,Data.sdf,9896,HY-145931,,1228012-18-7,Autophagy; mTOR,Autophagy; PI3K/Akt/mTOR,C20H25N5O3,10mM,Cancer,No Development Reported,CC(C)(O)c1ccc(C2=CNC3=NC(=O)CN(CC4CCOCC4)C3=N2)cn1,清洗成功,0.2682926829268293
11427,CC(C)(C)[C@@H]1NC(=O)O[C@@H]2CCC[C@H]2OC/C=C/C(F)(F)c2nc3ccccc3nc2O[C@@H]2C[C@@H](C(=O)N[C@]3(C(=O)NS(=O)(=O)C4(C)CC4)C[C@H]3C(F)F)N(C2)C1=O,1,0.9871223568916321,0.9871223568916321,O=C([C@H]1N(C([C@@H](NC(O[C@@]2([H])[C@@]3([H])CCC2)=O)C(C)(C)C)=O)C[C@@](OC4=NC5=CC=CC=C5N=C4C(F)(/C=C/CO3)F)([H])C1)N[C@]6([C@H](C(F)F)C6)C(NS(=O)(C7(CC7)C)=O)=O,Glecaprevir,Data.sdf,13512,HY-17634,ABT-493,1365970-03-1,HCV; HCV Protease; SARS-CoV,Anti-infection; Metabolic Enzyme/Protease,C38H46F4N6O9S,10mM,Infection,Launched,CC(C)(C)[C@@H]1NC(=O)O[C@@H]2CCC[C@H]2OC/C=C/C(F)(F)c2nc3ccccc3nc2O[C@@H]2C[C@@H](C(=O)N[C@]3(C(=O)NS(=O)(=O)C4(C)CC4)C[C@H]3C(F)F)N(C2)C1=O,清洗成功,0.1705426356589147
2103,CCOc1cc2ncc(-c3cc(N)nc(F)c3)n2cc1S(=O)(=O)C(C)(C)C,1,0.9871122241020203,0.9871122241020203,O=S(C1=CN2C(C3=CC(N)=NC(F)=C3)=CN=C2C=C1OCC)(C(C)(C)C)=O,RIPK-IN-4,Data.sdf,2470,HY-107978,,2141969-56-2,RIP kinase,Apoptosis,C18H21FN4O3S,10mM,Inflammation/Immunology,No Development Reported,CCOc1cc2ncc(-c3cc(N)nc(F)c3)n2cc1S(=O)(=O)C(C)(C)C,清洗成功,0.2727272727272727
4157,NC(=S)N/N=C(/c1cccc(O)c1)c1cccc(Br)c1,1,0.987106442451477,0.987106442451477,S=C(N/N=C(C1=CC(O)=CC=C1)\C2=CC(Br)=CC=C2)N,KGP94,Data.sdf,4896,HY-118762,,1131456-28-4,Cathepsin,Metabolic Enzyme/Protease,C14H12BrN3OS,10mM,Cancer,No Development Reported,NC(=S)N/N=C(/c1cccc(O)c1)c1cccc(Br)c1,清洗成功,0.2978723404255319
10711,CNCCn1c(=O)c2cc(OC)c(OC)cc2c2cnc3cc4c(cc3c21)OCO4,1,0.9871000051498413,0.9871000051498413,O=C1N(CCNC)C2=C(C=NC(C2=C3)=CC4=C3OCO4)C5=CC(OC)=C(OC)C=C15,Genz-644282,Data.sdf,12694,HY-16228,,529488-28-6,Topoisomerase,Cell Cycle/DNA Damage,C22H21N3O5,2mM,Cancer,Phase 1,CNCCn1c(=O)c2cc(OC)c(OC)cc2c2cnc3cc4c(cc3c21)OCO4,清洗成功,0.2716049382716049
15462,COc1ccc(-c2oc3cc(OC)cc(OC)c3c(=O)c2O)cc1,1,0.9870985150337219,0.9870985150337219,COC1=C2C(OC(C3=CC=C(OC)C=C3)=C(O)C2=O)=CC(OC)=C1,"3-Hydroxy-5,7,4a??trimethoxyflavone",Data.sdf,18440,HY-N3432,,1098-92-6,Others,Others,C18H16O6,10mM,Others,No Development Reported,COc1ccc(-c2oc3cc(OC)cc(OC)c3c(=O)c2O)cc1,清洗成功,0.3015873015873015
3633,CC(C)Oc1ccc(C(=O)Cn2ccnc2)cc1-n1c(CN2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O,1,0.9870944619178772,0.9870944619178772,O=C1N(C2=CC(C(CN3C=CN=C3)=O)=CC=C2OC(C)C)C(CN4CCN(C(COC5=CC=C(Cl)C=C5)=O)CC4)=NC6=CC=CC=C61,Imidazole ketone erastin,Data.sdf,4275,HY-114481,IKE,1801530-11-9,Ferroptosis,Apoptosis,C35H35ClN6O5,10mM,Cancer,No Development Reported,CC(C)Oc1ccc(C(=O)Cn2ccnc2)cc1-n1c(CN2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O,清洗成功,0.2413793103448276
1627,O=C1Nc2ccc(I)cc2/C1=C/c1cc(Br)c(O)c(Br)c1,1,0.9870812296867371,0.9870812296867371,O=C1NC2=C(/C1=C/C3=CC(Br)=C(C(Br)=C3)O)C=C(C=C2)I,GW 5074,Data.sdf,1923,HY-10542,,220904-83-6,Apoptosis; Raf,Apoptosis; MAPK/ERK Pathway,C15H8Br2INO2,10mM,Cancer,No Development Reported,O=C1Nc2ccc(I)cc2/C1=C/c1cc(Br)c(O)c(Br)c1,清洗成功,0.3389830508474576
15658,O=c1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)cc2)oc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)cc(O)c12,1,0.9870720505714417,0.9870720505714417,O=C1C(O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](CO)O2)O)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@@H](CO)O3)O)O)O)=C(C4=CC=C(O)C=C4)OC5=CC(O[C@H]6[C@@H]([C@H]([C@@H]([C@@H](CO)O6)O)O)O)=CC(O)=C15,Kaempferol 3-sophoroside-7-glucoside,Data.sdf,18695,HY-N5117,,55136-76-0,Others,Others,C33H40O21,10mM,Metabolic Disease,No Development Reported,O=c1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)cc2)oc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)cc(O)c12,清洗成功,0.3214285714285714
4376,OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1,1,0.9870676398277283,0.9870676398277283,OCCN1N=CC(C2=NC3=C(N=C2)N=NN3CC4=CC5=CC=CN=C5C=C4)=C1.CS(=O)(O)=O,PF-04217903 (mesylate),Data.sdf,5151,HY-12017A,,956906-93-7,c-Met/HGFR,Protein Tyrosine Kinase/RTK,C20H20N8O4S,10mM,Cancer,Phase 1,OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1,清洗成功,0.3411764705882353
639,O=c1cc(N2CCOCC2)oc2c(-c3ccc4c(c3)OCCO4)csc12,1,0.9870558977127075,0.9870558977127075,O=C1C=C(N2CCOCC2)OC3=C1SC=C3C4=CC=C(OCCO5)C5=C4,SF2523,Data.sdf,725,HY-101146,,1174428-47-7,DNA-PK; Epigenetic Reader Domain; PI3K,Cell Cycle/DNA Damage; Epigenetics; PI3K/Akt/mTOR,C19H17NO5S,10mM,Cancer,No Development Reported,O=c1cc(N2CCOCC2)oc2c(-c3ccc4c(c3)OCCO4)csc12,清洗成功,0.3043478260869565
4442,FC(F)(F)c1c(CN2CCC(c3ccccc3)CC2)ccn2c(CC3CC3)nnc12,1,0.9870461225509644,0.9870461225509644,FC(C1=C(CN2CCC(C3=CC=CC=C3)CC2)C=CN4C1=NN=C4CC5CC5)(F)F,JNJ-46281222,Data.sdf,5234,HY-120530,,1254980-38-5,mGluR,GPCR/G Protein; Neuronal Signaling,C23H25F3N4,10mM,Neurological Disease,No Development Reported,FC(F)(F)c1c(CN2CCC(c3ccccc3)CC2)ccn2c(CC3CC3)nnc12,清洗成功,0.208955223880597
8172,N[C@@H]1c2ccccc2OC12CCN(c1cnc3c(N4CCCc5ncccc54)n[nH]c3n1)CC2,1,0.9870296716690063,0.9870296716690063,N[C@H]1C2(CCN(C3=CN=C(C(N4C5=CC=CN=C5CCC4)=NN6)C6=N3)CC2)OC7=CC=CC=C71,Migoprotafib,Data.sdf,9649,HY-144903,GDC-1971,2377352-49-1,ERK; p38 MAPK; Phosphatase; SHP2,MAPK/ERK Pathway; Metabolic Enzyme/Protease; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt,C25H26N8O,10mM,Cancer,Phase 1,N[C@@H]1c2ccccc2OC12CCN(c1cnc3c(N4CCCc5ncccc54)n[nH]c3n1)CC2,清洗成功,0.2121212121212121
975,CN(C)CC1CCOC1(c1ccccc1)c1ccccc1,1,0.9870265126228333,0.9870265126228333,CN(C)CC1CCOC1(C2=CC=CC=C2)C3=CC=CC=C3.[H]Cl,Blarcamesine (hydrochloride),Data.sdf,1119,HY-101864,Anavex 2-73,195615-84-0,Sigma Receptor,Neuronal Signaling,C19H24ClNO,10mM,Neurological Disease; Cancer,Phase 2,CN(C)CC1CCOC1(c1ccccc1)c1ccccc1,清洗成功,0.3064516129032258
861,COCCNc1cc(NC(=O)N2CCCc3cc(CN4CCN(C)CC4=O)c(C=O)nc32)ncc1C#N,1,0.9870229959487915,0.9870229959487915,CN1CC(N(CC2=CC(CCCN3C(NC4=CC(NCCOC)=C(C#N)C=N4)=O)=C3N=C2C=O)CC1)=O,Roblitinib,Data.sdf,985,HY-101568,FGF-401,1708971-55-4,FGFR,Protein Tyrosine Kinase/RTK,C25H30N8O4,2mM,Cancer,Phase 2,COCCNc1cc(NC(=O)N2CCCc3cc(CN4CCN(C)CC4=O)c(C=O)nc32)ncc1C#N,清洗成功,0.2454545454545454
1018,N#CC(C#N)=Cc1cc(O)c(O)c([N+](=O)[O-])c1,1,0.9870188236236572,0.9870188236236572,N#C/C(C#N)=C/C1=CC([N+]([O-])=O)=C(O)C(O)=C1,Tyrphostin AG 1288,Data.sdf,1170,HY-101961,AG 1288,116313-73-6,c-Kit,Protein Tyrosine Kinase/RTK,C10H5N3O4,10mM,Inflammation/Immunology,No Development Reported,N#CC(C#N)=Cc1cc(O)c(O)c([N+](=O)[O-])c1,清洗成功,0.2698412698412698
10615,CNC(=O)Nc1ccc(-c2cc(-c3ccnc(Nc4ccc(Cl)c(S(=O)(=O)N5CCNCC5)c4)n3)ccn2)cc1,1,0.9869949221611023,0.9869949221611023,ClC1=C(S(N2CCNCC2)(=O)=O)C=C(NC3=NC=CC(C4=CC(C5=CC=C(NC(NC)=O)C=C5)=NC=C4)=N3)C=C1,KVS0001,Data.sdf,12578,HY-161111,,3056394-59-0,Ser/Thr Kinase,Metabolic Enzyme/Protease,C27H27ClN8O3S,10mM,cancer,No Development Reported,CNC(=O)Nc1ccc(-c2cc(-c3ccnc(Nc4ccc(Cl)c(S(=O)(=O)N5CCNCC5)c4)n3)ccn2)cc1,清洗成功,0.3466666666666667
1887,CCOC(=O)C(C)Oc1cccc2c(=O)n(CC(=O)Nc3ccc4c(c3)OCCO4)ccc12,1,0.9869895577430725,0.9869895577430725,CCOC(C(C)OC1=C2C(C(N(CC(NC3=CC=C(OCCO4)C4=C3)=O)C=C2)=O)=CC=C1)=O,SID 7969543,Data.sdf,2225,HY-107404,,868224-64-0,,GPCR/G Protein,C24H24N2O7,10mM,Endocrinology,No Development Reported,CCOC(=O)C(C)Oc1cccc2c(=O)n(CC(=O)Nc3ccc4c(c3)OCCO4)ccc12,清洗成功,0.268041237113402
11855,CNc1ncc2cc(-c3ccc(-c4cccc(C)n4)cc3Cl)c(=O)n(C[C@H]3OC[C@H](N)CO3)c2n1,1,0.9869861006736755,0.9869861006736755,ClC(C=C(C1=NC(C)=CC=C1)C=C2)=C2C3=CC4=CN=C(NC)N=C4N(C[C@@H]5OC[C@@H](N)CO5)C3=O,G-5555,Data.sdf,14026,HY-19635,,1648863-90-4,PAK,Cell Cycle/DNA Damage; Cytoskeleton,C25H25ClN6O3,10mM,Cancer,No Development Reported,CNc1ncc2cc(-c3ccc(-c4cccc(C)n4)cc3Cl)c(=O)n(C[C@H]3OC[C@H](N)CO3)c2n1,清洗成功,0.2475247524752475
11856,CNc1ncc2cc(-c3ccc(-c4cccc(C)n4)cc3Cl)c(=O)n(C[C@H]3OC[C@H](N)CO3)c2n1,1,0.9869861006736755,0.9869861006736755,ClC(C=C(C1=NC(C)=CC=C1)C=C2)=C2C3=CC4=CN=C(NC)N=C4N(C[C@@H]5OC[C@@H](N)CO5)C3=O.[H]Cl,G-5555 (hydrochloride),Data.sdf,14027,HY-19635A,,2319590-15-1,PAK,Cell Cycle/DNA Damage; Cytoskeleton,C25H26Cl2N6O3,10mM,Cancer,No Development Reported,CNc1ncc2cc(-c3ccc(-c4cccc(C)n4)cc3Cl)c(=O)n(C[C@H]3OC[C@H](N)CO3)c2n1,清洗成功,0.2450980392156862
3986,O=C(O)c1cc2sccc2[nH]1,1,0.9869809746742249,0.9869809746742249,O=C(C1=CC2=C(C=CS2)N1)O,DAO-IN-2,Data.sdf,4683,HY-117292,,39793-31-2,Others,Others,C7H5NO2S,10mM,Neurological Disease,No Development Reported,O=C(O)c1cc2sccc2[nH]1,清洗成功,0.2666666666666666
1999,C[N+](C)(C)CC#CCOC(=O)Nc1cccc(Cl)c1,1,0.9869650602340698,0.9869650602340698,O=C(NC1=CC(Cl)=CC=C1)OCC#CC[N+](C)(C)C.[Cl-],McN-A-343,Data.sdf,2352,HY-107648,,55-45-8,mAChR,GPCR/G Protein; Neuronal Signaling,C14H18Cl2N2O2,10mM,Inflammation/Immunology,No Development Reported,C[N+](C)(C)CC#CCOC(=O)Nc1cccc(Cl)c1,清洗成功,0.3283582089552239
8109,CC(C)(C)c1[nH]cnc1/C=c1\[nH]c(=O)/c(=C/c2ccccc2)[nH]c1=O,1,0.9869539141654968,0.9869539141654968,O=C(N/C1=C\C2=C(NC=N2)C(C)(C)C)/C(NC1=O)=C/C3=CC=CC=C3,Plinabulin,Data.sdf,9577,HY-14444,NPI-2358,714272-27-2,Microtubule/Tubulin,Cell Cycle/DNA Damage; Cytoskeleton,C19H20N4O2,10mM,Cancer,Phase 3,CC(C)(C)c1[nH]cnc1/C=c1\[nH]c(=O)/c(=C/c2ccccc2)[nH]c1=O,清洗成功,0.2830188679245283
9782,C[C@@H]1CN(Cc2ncccn2)C[C@H]1c1nc2c(cnn2C2CCOCC2)c(=O)[nH]1,1,0.9869486093521118,0.9869486093521118,O=C1C2=C(N(C3CCOCC3)N=C2)N=C([C@@H]4CN(CC5=NC=CC=N5)C[C@H]4C)N1,Edelinontrine,Data.sdf,11558,HY-15441,PF-04447943,1082744-20-4,Phosphodiesterase (PDE),Metabolic Enzyme/Protease,C20H25N7O2,10mM,Neurological Disease,Phase 2,C[C@@H]1CN(Cc2ncccn2)C[C@H]1c1nc2c(cnn2C2CCOCC2)c(=O)[nH]1,清洗成功,0.2421052631578947
8038,C#CCN(Cc1cc2c(=O)[nH]c(C)nc2cc1Br)c1ccc(C(=O)NCc2cccnc2)cc1,1,0.9869376420974731,0.9869376420974731,O=C(NCC1=CC=CN=C1)C2=CC=C(N(CC3=CC4=C(N=C(C)NC4=O)C=C3Br)CC#C)C=C2,CB30865,Data.sdf,9496,HY-14373,ZM 242421,206275-15-2,NAMPT,Metabolic Enzyme/Protease,C26H22BrN5O2,10mM,Cancer,No Development Reported,C#CCN(Cc1cc2c(=O)[nH]c(C)nc2cc1Br)c1ccc(C(=O)NCc2cccnc2)cc1,清洗成功,0.2987012987012987
10266,c1ccc(Cn2c(-c3ccc(OC[C@H](C4CCNCC4)n4c(-c5ccccc5)nc5ccccc54)cc3)nc3ccccc32)cc1,1,0.9869324564933777,0.9869324564933777,C1(C2=CC=C(OC[C@@H](N3C4=CC=CC=C4N=C3C5=CC=CC=C5)C6CCNCC6)C=C2)=NC7=CC=CC=C7N1CC8=CC=CC=C8,Deltarasin,Data.sdf,12151,HY-15747,,1440898-61-2,Phosphodiesterase (PDE); Ras,GPCR/G Protein; MAPK/ERK Pathway; Metabolic Enzyme/Protease,C40H37N5O,10mM,Cancer,No Development Reported,c1ccc(Cn2c(-c3ccc(OC[C@H](C4CCNCC4)n4c(-c5ccccc5)nc5ccccc54)cc3)nc3ccccc32)cc1,清洗成功,0.2692307692307692
9453,COC(=O)N1CC[C@@H]2[C@H]1CCC[C@@]2(O)C#Cc1cccc(C)c1,1,0.9869306087493896,0.9869306087493896,CC1=CC(C#C[C@]2(O)CCC[C@]3([H])[C@@]2([H])CCN3C(OC)=O)=CC=C1,Mavoglurant,Data.sdf,11156,HY-15257,AFQ056,543906-09-8,mGluR,GPCR/G Protein; Neuronal Signaling,C19H23NO3,10mM,Neurological Disease,Phase 3,COC(=O)N1CC[C@@H]2[C@H]1CCC[C@@]2(O)C#Cc1cccc(C)c1,清洗成功,0.25
17665,Cc1nc2ccccc2o1,1,0.9869285225868225,0.9869285225868225,CC1=NC2=CC=CC=C2O1,2-Methylbenzoxazole,Data.sdf,21047,HY-W038287,,95-21-6,Endogenous Metabolite,Metabolic Enzyme/Protease,C8H7NO,10mM,Metabolic Disease,No Development Reported,Cc1nc2ccccc2o1,清洗成功,0.2941176470588235
1028,Cc1ccc(-c2nc(N)nc3c2nnn3Cc2cccc(CO[C@H]3CCOC3)n2)o1,1,0.9869150519371033,0.9869150519371033,NC1=NC(C2=CC=C(C)O2)=C(N=NN3CC4=NC(CO[C@@H]5COCC5)=CC=C4)C3=N1,Ciforadenant,Data.sdf,1181,HY-101978,CPI-444; V81444,1202402-40-1,Adenosine Receptor,GPCR/G Protein,C20H21N7O3,10mM,Cancer,Phase 2,Cc1ccc(-c2nc(N)nc3c2nnn3Cc2cccc(CO[C@H]3CCOC3)n2)o1,清洗成功,0.2083333333333333
7781,CC(C)CCNc1ncccc1C(=O)N1CCN(Cc2ccccc2)CC1,1,0.9868867993354797,0.9868867993354797,O=C(N1CCN(CC2=CC=CC=C2)CC1)C3=CC=CN=C3NCCC(C)C,NSI-189,Data.sdf,9205,HY-13999,,1270138-40-3,Trk Receptor,Neuronal Signaling; Protein Tyrosine Kinase/RTK,C22H30N4O,10mM,Neurological Disease,Phase 2,CC(C)CCNc1ncccc1C(=O)N1CCN(Cc2ccccc2)CC1,清洗成功,0.2857142857142857
7783,CC(C)CCNc1ncccc1C(=O)N1CCN(Cc2ccccc2)CC1,1,0.9868867993354797,0.9868867993354797,O=C(N1CCN(CC1)CC2=CC=CC=C2)C3=CC=CN=C3NCCC(C)C.O=P(O)(O)O,NSI-189 (phosphate),Data.sdf,9207,HY-13999A1,,1270138-41-4,Trk Receptor,Neuronal Signaling; Protein Tyrosine Kinase/RTK,C22H33N4O5P,10mM,Neurological Disease,Phase 2,CC(C)CCNc1ncccc1C(=O)N1CCN(Cc2ccccc2)CC1,清洗成功,0.2873563218390804
3988,CCC(Sc1nc2c(cnn2-c2cccc(F)c2)c(=O)[nH]1)C(N)=O,1,0.9868865609169006,0.9868865609169006,CCC(SC1=NC(N(C2=CC=CC(F)=C2)N=C3)=C3C(N1)=O)C(N)=O,HS148,Data.sdf,4687,HY-117364,,1892595-16-2,DAPK,Apoptosis,C15H14FN5O2S,2mM,Others,No Development Reported,CCC(Sc1nc2c(cnn2-c2cccc(F)c2)c(=O)[nH]1)C(N)=O,清洗成功,0.25
5570,O=C(c1ccc(NS(=O)(=O)c2cccc3cccnc23)cc1)N1CCN(CC2CC2)CC1,1,0.986855685710907,0.986855685710907,O=S(C1=C2N=CC=CC2=CC=C1)(NC3=CC=C(C(N4CCN(CC5CC5)CC4)=O)C=C3)=O,Mitapivat,Data.sdf,6577,HY-12689,AG-348,1260075-17-9,Pyruvate Kinase,Metabolic Enzyme/Protease,C24H26N4O3S,10mM,Metabolic Disease,Launched,O=C(c1ccc(NS(=O)(=O)c2cccc3cccnc23)cc1)N1CCN(CC2CC2)CC1,清洗成功,0.2708333333333333
688,CC1(C)CCC2(CC1)N[C@@H](C(=O)N[C@@H]1CC[C@@H](C(N)=O)OC1)[C@H](c1ccnc(Cl)c1F)[C@]21C(=O)Nc2cc(Cl)ccc21,1,0.9868419766426086,0.9868419766426086,CC1=CC=C(S(=O)(O)=O)C=C1.O=C2NC3=CC(Cl)=CC=C3[C@]24C5(N[C@H]([C@@H]4C6=CC=NC(Cl)=C6F)C(N[C@@H]7CC[C@H](OC7)C(N)=O)=O)CCC(C)(CC5)C.[H]O[H],Milademetan (tosylate hydrate),Data.sdf,786,HY-101266B,DS-3032b; DS-3032 (tosylate hydrate),2095625-97-9,Apoptosis; E1/E2/E3 Enzyme; MDM-2/p53,Apoptosis; Metabolic Enzyme/Protease,C37H44Cl2FN5O8S,10mM,Cancer,Phase 2,CC1(C)CCC2(CC1)N[C@@H](C(=O)N[C@@H]1CC[C@@H](C(N)=O)OC1)[C@H](c1ccnc(Cl)c1F)[C@]21C(=O)Nc2cc(Cl)ccc21,清洗成功,0.192
17856,COc1ccc(C(OC[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)C[C@@H]2O)(c2ccccc2)c2ccc(OC)cc2)cc1,1,0.9868414402008057,0.9868414402008057,COC1=CC=C(C(C2=CC=C(OC)C=C2)(OC[C@@H]3[C@@H](O)C[C@@H](O3)N4C=CC(NC4=O)=O)C5=CC=CC=C5)C=C1,"5'-O-(4,4'-Dimethoxytrityl)-2'-deoxyuridine",Data.sdf,21287,HY-W097792,5'-O-DMT-dU,23669-79-6,DNA/RNA Synthesis,Cell Cycle/DNA Damage,C30H30N2O7,10mM,Others,No Development Reported,COc1ccc(C(OC[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)C[C@@H]2O)(c2ccccc2)c2ccc(OC)cc2)cc1,清洗成功,0.2361111111111111
13733,CN(C)c1ccc2nc3ccc(=[N+](C)C)cc-3sc2c1,1,0.9868301749229431,0.9868301749229431,CN(C1=CC(SC2=C/C(C=CC2=N3)=[N+](C)\C)=C3C=C1)C.O.[Cl-],Methylene blue (trihydrate),Data.sdf,16186,HY-B1359,C.I. Basic Blue 9 trihydrate,7220-79-3,Guanylate Cyclase; Monoamine Oxidase; NO Synthase; Parasite,Anti-infection; GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling,C16H24ClN3O3S,10mM,Cancer; Infection; Neurological Disease,Launched,CN(C)c1ccc2nc3ccc(=[N+](C)C)cc-3sc2c1,清洗成功,0.2678571428571428
5162,CC(=O)Oc1cc(OC(C)=O)c2c(=O)c(OC(C)=O)c(-c3ccc(OC(C)=O)c(OC(C)=O)c3)oc2c1,1,0.9868263006210327,0.9868263006210327,O=C1C(OC(C)=O)=C(C2=CC=C(OC(C)=O)C(OC(C)=O)=C2)OC3=CC(OC(C)=O)=CC(OC(C)=O)=C13,Quercetin pentaacetate,Data.sdf,6080,HY-124512,Pentaacetylquercetin,1064-06-8,RSV,Anti-infection,C25H20O12,10mM,Infection; Inflammation/Immunology,No Development Reported,CC(=O)Oc1cc(OC(C)=O)c2c(=O)c(OC(C)=O)c(-c3ccc(OC(C)=O)c(OC(C)=O)c3)oc2c1,清洗成功,0.2368421052631578
10444,Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1,1,0.9868228435516357,0.9868228435516357,O=C1C=C(C2=NC(NC3=CC=NN3C)=NC=C2)C=CN1[C@@H](C4=CC=C(Cl)C(F)=C4)CO,Ravoxertinib,Data.sdf,12377,HY-15947,GDC-0994,1453848-26-4,ERK,MAPK/ERK Pathway; Stem Cell/Wnt,C21H18ClFN6O2,10mM,Cancer,Phase 1,Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1,清洗成功,0.2926829268292683
10445,Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1,1,0.9868228435516357,0.9868228435516357,O=C1C=C(C2=NC(NC3=CC=NN3C)=NC=C2)C=CN1[C@@H](C4=CC=C(Cl)C(F)=C4)CO.Cl[H],Ravoxertinib hydrochloride,Data.sdf,12378,HY-15947A,GDC-0994 (hydrochloride),2070009-58-2,ERK,MAPK/ERK Pathway; Stem Cell/Wnt,C21H19Cl2FN6O2,10mM,Cancer,Phase 1,Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1,清洗成功,0.2891566265060241
3311,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OCC(F)(F)F)nc1N(C)CCN(C)C,1,0.9868213534355164,0.9868213534355164,C=CC(NC1=CC(NC2=NC=CC(C3=CN(C)C4=C3C=CC=C4)=N2)=C(OCC(F)(F)F)N=C1N(CCN(C)C)C)=O,Firmonertinib,Data.sdf,3895,HY-112870,Alflutinib; Furmonertinib; AST2818,1869057-83-9,EGFR,JAK/STAT Signaling; Protein Tyrosine Kinase/RTK,C28H31F3N8O2,10mM,Cancer,Launched,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OCC(F)(F)F)nc1N(C)CCN(C)C,清洗成功,0.3235294117647059
17713,Nc1ccc2nccnc2c1Br,1,0.9868201613426208,0.9868201613426208,NC1=CC=C2N=CC=NC2=C1Br,6-Amino-5-bromoquinoxaline,Data.sdf,21108,HY-W041703,5-Bromoquinoxalin-6-amine,50358-63-9,Androgen Receptor,Vitamin D Related/Nuclear Receptor,C8H6BrN3,10mM,others,No Development Reported,Nc1ccc2nccnc2c1Br,清洗成功,0.275
3580,Cc1c(-c2cccc(S(=O)(=O)N(C)C)c2)c2ncccc2n1C/C(F)=C/CN,1,0.986793577671051,0.986793577671051,CC(N1C/C(F)=C/CN)=C(C2=CC=CC(S(N(C)C)(=O)=O)=C2)C3=C1C=CC=N3.Cl,PXS-5153A (monohydrochloride),Data.sdf,4214,HY-114286A,,,Monoamine Oxidase,Neuronal Signaling,C20H24ClFN4O2S,10mM,Inflammation/Immunology,No Development Reported,Cc1c(-c2cccc(S(=O)(=O)N(C)C)c2)c2ncccc2n1C/C(F)=C/CN,清洗成功,0.2317073170731707
4364,N=c1c2c(-c3ccccc3)c(-c3ccccc3)n(Cc3ccccc3)c2ncn1[C@H]1CC[C@H](O)CC1,1,0.9867711663246155,0.9867711663246155,O[C@H]1CC[C@H](N(C=NC2=C3C(C4=CC=CC=C4)=C(C5=CC=CC=C5)N2CC6=CC=CC=C6)C3=N)CC1,Metarrestin,Data.sdf,5134,HY-120118,ML246,1443414-10-5,DNA/RNA Synthesis,Cell Cycle/DNA Damage,C31H30N4O,10mM,Cancer,Phase 1,N=c1c2c(-c3ccccc3)c(-c3ccccc3)n(Cc3ccccc3)c2ncn1[C@H]1CC[C@H](O)CC1,清洗成功,0.2985074626865671
10692,Cc1cnc(N[C@H]2CC[C@H](N)CC2)nc1-c1cnc2ccc(-c3ccccc3)cn12,1,0.9867660999298096,0.9867660999298096,CC1=CN=C(N[C@@H]2CC[C@@H](N)CC2)N=C1C3=CN=C(C=C4)N3C=C4C5=CC=CC=C5,CDDD11-8,Data.sdf,12671,HY-162037,,2241659-94-7,CDK; FLT3,Cell Cycle/DNA Damage; Protein Tyrosine Kinase/RTK,C24H26N6,10mM,Cancer,No Development Reported,Cc1cnc(N[C@H]2CC[C@H](N)CC2)nc1-c1cnc2ccc(-c3ccccc3)cn12,清洗成功,0.3333333333333333
9022,CN(C)CCN1CCCC(C(=O)Nc2nc3c(F)cc(F)cc3s2)C1,1,0.986759603023529,0.986759603023529,O=C(C1CN(CCC1)CCN(C)C)NC2=NC3=C(S2)C=C(F)C=C3F,MCUF-651,Data.sdf,10638,HY-149453,,2747162-85-0,Guanylate Cyclase,GPCR/G Protein,C17H22F2N4OS,10mM,Cardiovascular Disease,No Development Reported,CN(C)CCN1CCCC(C(=O)Nc2nc3c(F)cc(F)cc3s2)C1,清洗成功,0.3134328358208955
5053,Cn1ncc(-c2nc(N[C@H]3CC[C@H](N)CC3)ncc2Cl)c1CC1CC1,1,0.9867578148841858,0.9867578148841858,N[C@H]1CC[C@H](NC2=NC=C(Cl)C(C3=C(CC4CC4)N(C)N=C3)=N2)CC1,BTX-A51,Data.sdf,5951,HY-123954,Casein Kinase inhibitor A51,2079068-74-7,Apoptosis; Casein Kinase; CDK,Apoptosis; Cell Cycle/DNA Damage; Stem Cell/Wnt,C18H25ClN6,10mM,Cancer,Phase 1,Cn1ncc(-c2nc(N[C@H]3CC[C@H](N)CC3)ncc2Cl)c1CC1CC1,清洗成功,0.3108108108108108
11612,COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,1,0.9867559671401978,0.9867559671401978,CN1N=CC(C2=NC3=CC(N(C4=CC(OC)=CC(OC)=C4)CCNC(C)C)=CC=C3N=C2)=C1,Erdafitinib,Data.sdf,13740,HY-18708,JNJ-42756493,1346242-81-6,Apoptosis; FGFR,Apoptosis; Protein Tyrosine Kinase/RTK,C25H30N6O2,10mM,Cancer,Launched,COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,清洗成功,0.3170731707317073
17748,N#Cc1cc(I)c(O)c([N+](=O)[O-])c1,1,0.9867450594902039,0.9867450594902039,N#CC1=CC([N+]([O-])=O)=C(O)C(I)=C1,Nitroxynil,Data.sdf,21150,HY-W049875,,1689-89-0,Parasite,Anti-infection,C7H3IN2O3,10mM,Infection,No Development Reported,N#Cc1cc(I)c(O)c([N+](=O)[O-])c1,清洗成功,0.2363636363636363
5100,CCOC(=O)c1cc2cc(O)ccc2n1CC(=O)NCCN1CCCCC1,1,0.9867232441902161,0.9867232441902161,O=C(C(N1CC(NCCN2CCCCC2)=O)=CC3=C1C=CC(O)=C3)OCC.CC(O)=O,KY-02327 (acetate),Data.sdf,6008,HY-124156A,,2989396-34-9,Wnt,Stem Cell/Wnt,C22H31N3O6,10mM,Metabolic Disease,No Development Reported,CCOC(=O)c1cc2cc(O)ccc2n1CC(=O)NCCN1CCCCC1,清洗成功,0.3088235294117647
1621,CN(C)CC1CCOC1(c1ccccc1)c1ccccc1,1,0.9867163896560669,0.9867163896560669,CN(C)CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)OCC1,Blarcamesine,Data.sdf,1912,HY-105296,,195615-83-9,mAChR; Sigma Receptor,GPCR/G Protein; Neuronal Signaling,C19H23NO,10mM,Cancer,Phase 2,CN(C)CC1CCOC1(c1ccccc1)c1ccccc1,清洗成功,0.2903225806451613
11860,COCCNCc1ccc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccc(F)cc5)cc4F)c3s2)nc1,1,0.9867079257965088,0.9867079257965088,O=C(NC(NC1=CC=C(OC2=C3C(C=C(C4=NC=C(CNCCOC)C=C4)S3)=NC=C2)C(F)=C1)=S)CC5=CC=C(F)C=C5.Cl,Glesatinib (hydrochloride),Data.sdf,14031,HY-19642A,MGCD265 hydrochloride,1123838-51-6,c-Met/HGFR; TAM Receptor,Protein Tyrosine Kinase/RTK,C31H28ClF2N5O3S2,10mM,Cancer,Phase 2,COCCNCc1ccc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccc(F)cc5)cc4F)c3s2)nc1,清洗成功,0.2673267326732673
4306,COc1ccc(-c2coc3cc(O)c(O)cc3c2=O)cc1,1,0.9866915941238403,0.9866915941238403,O=C1C(C2=CC=C(C=C2)OC)=COC3=CC(O)=C(C=C13)O,Texasin,Data.sdf,5063,HY-119822,,897-46-1,Others,Others,C16H12O5,10mM,Others,No Development Reported,COc1ccc(-c2coc3cc(O)c(O)cc3c2=O)cc1,清洗成功,0.3061224489795918
3605,COc1ccc2[nH]c(=O)c(C(c3nnnn3CCc3ccccc3)N3CCN(C4CCCCC4)CC3)cc2c1,1,0.9866853952407837,0.9866853952407837,O=C1NC2=C(C=C(OC)C=C2)C=C1C(N3CCN(C4CCCCC4)CC3)C5=NN=NN5CCC6=CC=CC=C6,GT 949,Data.sdf,4246,HY-114381,,460330-27-2,EAAT,Membrane Transporter/Ion Channel,C30H37N7O2,10mM,Neurological Disease,No Development Reported,COc1ccc2[nH]c(=O)c(C(c3nnnn3CCc3ccccc3)N3CCN(C4CCCCC4)CC3)cc2c1,清洗成功,0.2947368421052631
4398,N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N,1,0.9866846203804016,0.9866846203804016,NC1=CC=CC=C1S/C(N)=C(/C(C#N)=C(SC2=C(C=CC=C2)N)\N)C#N.CCO,U0126-EtOH,Data.sdf,5181,HY-12031,,1173097-76-1,Autophagy; Influenza Virus; MEK; Mitophagy,Anti-infection; Autophagy; MAPK/ERK Pathway,C20H22N6OS2,10mM,Cancer,No Development Reported,N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N,清洗成功,0.2131147540983606
4399,N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N,1,0.9866846203804016,0.9866846203804016,NC1=CC=CC=C1S/C(N)=C(C#N)/C(C#N)=C(N)/SC2=CC=CC=C2N,U0126,Data.sdf,5182,HY-12031A,,109511-58-2,Autophagy; Influenza Virus; MEK; Mitophagy,Anti-infection; Autophagy; MAPK/ERK Pathway,C18H16N6S2,10mM,Cancer,No Development Reported,N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N,清洗成功,0.2115384615384615
8311,O=C(O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2n[nH]c3ncc(F)cc23)nc(C2CC2)c1F,1,0.9866710305213928,0.9866710305213928,FC1=CN=C2C(C(C3=NC(N[C@@H]4[C@H](C5CCC4CC5)C(O)=O)=C(F)C(C6CC6)=N3)=NN2)=C1,Onradivir,Data.sdf,9807,HY-145586,ZSP1273,2200336-20-3,Influenza Virus,Anti-infection,C22H22F2N6O2,10mM,Infection,Phase 3,O=C(O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2n[nH]c3ncc(F)cc23)nc(C2CC2)c1F,清洗成功,0.2903225806451613
6656,CNC(=O)N1CCc2c(c(N3CCCc4cc(-c5cnn(C)c5)c(C(F)F)cc43)nn2C2CCN(C(=O)CCOCCOCCOCCOCCNc3ccc4c(c3)C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)C1,1,0.986659049987793,0.986659049987793,CNC(N(CC1)CC2=C1N(N=C2N3C(C=C(C(F)F)C(C4=CN(C)N=C4)=C5)=C5CCC3)C6CCN(C(CCOCCOCCOCCOCCNC7=CC8=C(C(N(C9C(NC(CC9)=O)=O)C8=O)=O)C=C7)=O)CC6)=O,dCBP-1,Data.sdf,7898,HY-134582,,2484739-25-3,Epigenetic Reader Domain; PROTACs,Epigenetics; PROTAC,C51H63F2N11O10,10mM,Cancer,No Development Reported,CNC(=O)N1CCc2c(c(N3CCCc4cc(-c5cnn(C)c5)c(C(F)F)cc43)nn2C2CCN(C(=O)CCOCCOCCOCCOCCNc3ccc4c(c3)C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)C1,清洗成功,0.2608695652173913
1246,CC(Sc1nc2ccccc2[nH]1)C(=O)N/N=C/c1cc(Br)ccc1O,1,0.9866565465927124,0.9866565465927124,CC(SC1=NC2=CC=CC=C2N1)C(N/N=C/C3=CC(Br)=CC=C3O)=O,KH7,Data.sdf,1447,HY-103194,,330676-02-3,Adenylate Cyclase,GPCR/G Protein,C17H15BrN4O2S,10mM,Others,No Development Reported,CC(Sc1nc2ccccc2[nH]1)C(=O)N/N=C/c1cc(Br)ccc1O,清洗成功,0.3037974683544304
1274,O=C(Oc1coc(CSc2ncccn2)cc1=O)c1ccc([N+](=O)[O-])cc1,1,0.9866487383842468,0.9866487383842468,O=C1C=C(CSC2=NC=CC=N2)OC=C1OC(C3=CC=C([N+]([O-])=O)C=C3)=O,ML221,Data.sdf,1486,HY-103254,,877636-42-5,Apelin Receptor (APJ); Arrestin,GPCR/G Protein,C17H11N3O6S,10mM,Neurological Disease,No Development Reported,O=C(Oc1coc(CSc2ncccn2)cc1=O)c1ccc([N+](=O)[O-])cc1,清洗成功,0.2467532467532467
8164,NCC(=O)Nc1cc(N)ccc1Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1,1,0.9866417646408081,0.9866417646408081,O=C(CN)NC1=CC(N)=CC=C1OC2=CC=CC(C3=NC4=C(C(N5CCOCC5)=N3)OC6=NC=CC=C64)=C2,RIDR-PI-103,Data.sdf,9641,HY-144876,,2581114-71-6,Reactive Oxygen Species,Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?oB,C27H25N7O4,10mM,Cancer,No Development Reported,NCC(=O)Nc1cc(N)ccc1Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1,清洗成功,0.2568807339449541
3503,O=C(O)CS(=O)CC(=O)Nc1ccc2c(c1)OCO2,1,0.9866319298744202,0.9866319298744202,O=C(O)CS(CC(NC1=CC=C(OCO2)C2=C1)=O)=O,ASN03576800,Data.sdf,4122,HY-113761,,957513-35-8,Filovirus,Anti-infection,C11H11NO6S,10mM,Infection,No Development Reported,O=C(O)CS(=O)CC(=O)Nc1ccc2c(c1)OCO2,清洗成功,0.3454545454545454
8681,COC(=O)c1ccc(OC)c(NC(=O)COc2ccc(C(C)(C)CC(C)(C)C)cc2)c1,1,0.9866182208061218,0.9866182208061218,O=C(OC)C1=CC=C(OC)C(NC(COC2=CC=C(C(C)(C)CC(C)(C)C)C=C2)=O)=C1,MDH1-IN-2,Data.sdf,10236,HY-147791,,2143463-35-6,Others,Others,C25H33NO5,10mM,Cancer,No Development Reported,COC(=O)c1ccc(OC)c(NC(=O)COc2ccc(C(C)(C)CC(C)(C)C)cc2)c1,清洗成功,0.3194444444444444
5108,CNC(=O)c1cc2c(Oc3ccc(NC(=S)NC(=O)Cc4ccccc4)cc3F)ccnc2cc1OC,1,0.9866161346435547,0.9866161346435547,O=C(C1=C(OC)C=C2N=CC=C(OC3=CC=C(NC(NC(CC4=CC=CC=C4)=O)=S)C=C3F)C2=C1)NC,Pamufetinib,Data.sdf,6019,HY-12423,TAS-115,1190836-34-0,c-Met/HGFR; VEGFR,Protein Tyrosine Kinase/RTK,C27H23FN4O4S,10mM,Cancer,Phase 3,CNC(=O)c1cc2c(Oc3ccc(NC(=S)NC(=O)Cc4ccccc4)cc3F)ccnc2cc1OC,清洗成功,0.2584269662921348
5111,CNC(=O)c1cc2c(Oc3ccc(NC(=S)NC(=O)Cc4ccccc4)cc3F)ccnc2cc1OC,1,0.9866161346435547,0.9866161346435547,CS(=O)(O)=O.O=C(C1=C(OC)C=C2N=CC=C(OC3=CC=C(NC(NC(CC4=CC=CC=C4)=O)=S)C=C3F)C2=C1)NC,Pamufetinib (mesylate),Data.sdf,6022,HY-12423A,TAS-115 (mesylate),1688673-09-7,c-Met/HGFR; VEGFR,Protein Tyrosine Kinase/RTK,C28H27FN4O7S2,10mM,Cancer,Phase 3,CNC(=O)c1cc2c(Oc3ccc(NC(=S)NC(=O)Cc4ccccc4)cc3F)ccnc2cc1OC,清洗成功,0.2605042016806723
4299,O=C1C=C2CC3(O)COc4c(ccc(O)c4O)C3=C2C=C1O,1,0.9866144061088562,0.9866144061088562,O=C1C=C2CC3(C(C4=CC=C(C(O)=C4OC3)O)=C2C=C1O)O,Hematein,Data.sdf,5054,HY-119751,,475-25-2,Akt; Apoptosis; Casein Kinase; Wnt,Apoptosis; Cell Cycle/DNA Damage; PI3K/Akt/mTOR; Stem Cell/Wnt,C16H12O6,10mM,Cancer,No Development Reported,O=C1C=C2CC3(O)COc4c(ccc(O)c4O)C3=C2C=C1O,清洗成功,0.2777777777777778
15057,O=c1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)c(O)c2)oc2cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc(O)c12,1,0.9865913987159729,0.9865913987159729,O=C1C(O[C@@H]([C@@H]([C@@H](O)[C@@H]2O)O)O[C@@H]2CO)=C(C3=CC(O)=C(O)C=C3)OC4=CC(O[C@@H]([C@@H]([C@@H](O)[C@@H]5O)O)O[C@@H]5CO[C@@H]([C@@H]([C@@H](O)[C@@H]6O)O)O[C@@H]6CO)=CC(O)=C14,Quercetin-3-O-?2-D-glucose-7-O-?2-D-gentiobiosiden,Data.sdf,17895,HY-N1968,Quercetin-3-O-beta-D-glucose-7-O-beta-D-gentiobioside,60778-02-1,Others,Others,C33H40O22,10mM,Others,No Development Reported,O=c1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)c(O)c2)oc2cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc(O)c12,清洗成功,0.3333333333333333
15854,CC(C)=CCc1c(O)cc2oc3cc(O)c(O)c(CCC(C)(C)O)c3c(=O)c2c1O,1,0.9865895509719849,0.9865895509719849,CC(C)(O)CCC1=C(O)C(O)=CC(OC2=CC(O)=C(C/C=C(C)/C)C(O)=C23)=C1C3=O,Garcinone C,Data.sdf,18938,HY-N6954,,76996-27-5,ATM/ATR; CDK; Hedgehog; STAT,Cell Cycle/DNA Damage; JAK/STAT Signaling; PI3K/Akt/mTOR; Stem Cell/Wnt,C23H26O7,10mM,Cancer; Inflammation/Immunology,No Development Reported,CC(C)=CCc1c(O)cc2oc3cc(O)c(O)c(CCC(C)(C)O)c3c(=O)c2c1O,清洗成功,0.3235294117647059
8321,COC1CN([C@H]2CC[C@H]([C@@]3(C)Oc4c(Cl)cc(C(=O)NCc5c(SC)cc(C)[nH]c5=O)c(C)c4O3)CC2)C1,1,0.9865795969963074,0.9865795969963074,CC1=C2C(O[C@@](O2)([C@]3([H])CC[C@](N4CC(C4)OC)([H])CC3)C)=C(C=C1C(NCC5=C(C=C(NC5=O)C)SC)=O)Cl,Tulmimetostat,Data.sdf,9818,HY-145602,CPI-0209,2567686-02-4,Histone Methyltransferase,Epigenetics,C28H36ClN3O5S,10mM,Cancer,Phase 2,COC1CN([C@H]2CC[C@H]([C@@]3(C)Oc4c(Cl)cc(C(=O)NCc5c(SC)cc(C)[nH]c5=O)c(C)c4O3)CC2)C1,清洗成功,0.2258064516129032
3113,c1cc2c(cc1-c1noc(CC3CCN(C4CCC4)CC3)n1)OCO2,1,0.986562967300415,0.986562967300415,N1(C2CCC2)CCC(CC3=NC(C4=CC=C(OCO5)C5=C4)=NO3)CC1,H3R antagonist 1,Data.sdf,3643,HY-112219,,1448422-61-4,Histamine Receptor,GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling,C19H23N3O3,10mM,Inflammation/Immunology; Endocrinology,No Development Reported,c1cc2c(cc1-c1noc(CC3CCN(C4CCC4)CC3)n1)OCO2,清洗成功,0.3442622950819672
3114,c1cc2c(cc1-c1noc(CC3CCN(C4CCC4)CC3)n1)OCO2,1,0.986562967300415,0.986562967300415,[H]Cl.N1(C2CCC2)CCC(CC3=NC(C4=CC=C(OCO5)C5=C4)=NO3)CC1,H3R antagonist 1 (hydrochloride),Data.sdf,3644,HY-112219A,,2319790-07-1,Histamine Receptor,GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling,C19H24ClN3O3,10mM,Inflammation/Immunology; Endocrinology,No Development Reported,c1cc2c(cc1-c1noc(CC3CCN(C4CCC4)CC3)n1)OCO2,清洗成功,0.3387096774193548
12387,Cc1cccc(Oc2nc3c(C)cccn3c(=O)c2/C=C(\C#N)c2nc3ccccc3s2)c1,1,0.9865455627441406,0.9865455627441406,N#C/C(C1=NC2=CC=CC=C2S1)=C\C3=C(N=C4C(C)=CC=CN4C3=O)OC5=CC=CC(C)=C5,CCG-63802,Data.sdf,14664,HY-70074,,620112-78-9,RGS Protein,GPCR/G Protein,C26H18N4O2S,2mM,Cancer; Inflammation/Immunology,No Development Reported,Cc1cccc(Oc2nc3c(C)cccn3c(=O)c2/C=C(\C#N)c2nc3ccccc3s2)c1,清洗成功,0.24
17702,O=[N+]([O-])c1cccc(Br)c1O,1,0.9865034818649292,0.9865034818649292,C1=C([N+]([O-])=O)C(=C(Br)C=C1)O,2-Bromo-6-nitrophenol,Data.sdf,21094,HY-W040886,,13073-25-1,Drug Intermediate,Others,C6H4BrNO3,10mM,Others,No Development Reported,O=[N+]([O-])c1cccc(Br)c1O,清洗成功,0.2745098039215686
8243,N#Cc1ccc(Cn2nccc2-c2cc(F)c3nnn(-c4ccc5cn[nH]c5c4)c3c2)cc1,1,0.986492931842804,0.986492931842804,N#CC1=CC=C(CN2N=CC=C2C3=CC4=C(N=NN4C5=CC6=C(C=NN6)C=C5)C(F)=C3)C=C1,CD73-IN-5,Data.sdf,9734,HY-145334,,2412019-99-7,CD73,Immunology/Inflammation,C24H15FN8,10mM,Cancer,No Development Reported,N#Cc1ccc(Cn2nccc2-c2cc(F)c3nnn(-c4ccc5cn[nH]c5c4)c3c2)cc1,清洗成功,0.2857142857142857
246,N#C/C(=C\c1ccc(O)c(O)c1)C(=O)N1CCc2ccccc21,1,0.986491322517395,0.986491322517395,O=C(/C(C#N)=C/C1=CC=C(O)C(O)=C1)N2CCC3=CC=CC=C32,Tyrphostin AG 528,Data.sdf,280,HY-100499,Tyrphostin B66; AG 528,133550-49-9,EGFR,JAK/STAT Signaling; Protein Tyrosine Kinase/RTK,C18H14N2O3,10mM,Cancer,No Development Reported,N#C/C(=C\c1ccc(O)c(O)c1)C(=O)N1CCc2ccccc21,清洗成功,0.2692307692307692
12020,Cn1ncc(C#N)c1-c1ccc2c(c1)CN([C@H](CN)Cc1cccc(F)c1)C2=O,1,0.9864662289619446,0.9864662289619446,N#CC1=C(C2=CC3=C(C(N([C@@H](CC4=CC=CC(F)=C4)CN)C3)=O)C=C2)N(C)N=C1,AKT-IN-6,Data.sdf,14211,HY-19982,,1430056-54-4,Akt,PI3K/Akt/mTOR,C22H20FN5O,10mM,Cancer,No Development Reported,Cn1ncc(C#N)c1-c1ccc2c(c1)CN([C@H](CN)Cc1cccc(F)c1)C2=O,清洗成功,0.2795698924731182
17516,Cn1cnc2[nH]c(=O)[nH]c(=O)c21,1,0.9864640235900879,0.9864640235900879,CN1C=NC2=C1C(=O)NC(=O)N2,7-Methylxanthine,Data.sdf,20864,HY-W017163,,552-62-5,Adenosine Receptor; Endogenous Metabolite,GPCR/G Protein; Metabolic Enzyme/Protease,C6H6N4O2,10mM,Metabolic Disease,Phase 2,Cn1cnc2[nH]c(=O)[nH]c(=O)c21,清洗成功,0.3076923076923077
5723,CCCOC(=O)N1CCN(C(=O)c2ccc3c(Cl)cc(-c4ccc(C5(N)CC5)cc4)nc3c2)C[C@H]1C,1,0.9864553213119507,0.9864553213119507,O=C(N1[C@H](C)CN(C(C2=CC=C3C(Cl)=CC(C4=CC=C(C5(N)CC5)C=C4)=NC3=C2)=O)CC1)OCCC,SMYD3-IN-1,Data.sdf,6758,HY-128352,,2095160-79-3,Histone Methyltransferase,Epigenetics,C28H31ClN4O3,10mM,Cancer,No Development Reported,CCCOC(=O)N1CCN(C(=O)c2ccc3c(Cl)cc(-c4ccc(C5(N)CC5)cc4)nc3c2)C[C@H]1C,清洗成功,0.2475247524752475
3805,Cn1cc(-c2cnc3cnn(S(=O)(=O)c4cnc5ccc(-c6cnn(C)c6)cn45)c3c2)cn1,1,0.9864488244056702,0.9864488244056702,O=S(N1N=CC2=NC=C(C3=CN(C)N=C3)C=C21)(C4=CN=C5C=CC(C6=CN(C)N=C6)=CN54)=O,Glumetinib,Data.sdf,4482,HY-116000,Gumarontinib; SCC244,1642581-63-2,c-Met/HGFR,Protein Tyrosine Kinase/RTK,C21H17N9O2S,10mM,Cancer,Phase 2,Cn1cc(-c2cnc3cnn(S(=O)(=O)c4cnc5ccc(-c6cnn(C)c6)cn45)c3c2)cn1,清洗成功,0.3026315789473684
7636,CC(C)(O)c1cc2nn(CCS(C)(=O)=O)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1,1,0.9864243865013123,0.9864243865013123,O=C(C1=CC=CC(C(F)(F)F)=N1)NC2=CC3=CN(CCS(=O)(C)=O)N=C3C=C2C(C)(C)O,Zabedosertib,Data.sdf,9039,HY-139374,BAY 1834845,1931994-81-8,IRAK,Immunology/Inflammation,C20H21F3N4O4S,10mM,Inflammation/Immunology,Phase 2,CC(C)(O)c1cc2nn(CCS(C)(=O)=O)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1,清洗成功,0.3012048192771084
15830,CC1(C)O[C@]23[C@H](OC(=O)c4cccnc4)[C@H]1C[C@H](OC(=O)c1ccccc1)[C@]2(C)[C@@H](OC(=O)c1ccccc1)CC[C@]3(C)O,1,0.9864200949668884,0.9864200949668884,C[C@@]12[C@@]3([C@@](O)(CC[C@@H]2OC(C4=CC=CC=C4)=O)C)[C@@]([H])([C@@](C(C)(C)O3)([H])C[C@@H]1OC(C5=CC=CC=C5)=O)OC(C6=CN=CC=C6)=O,Regelidine,Data.sdf,18912,HY-N6912,,114542-54-0,Others,Others,C35H37NO8,2mM,Metabolic Disease,No Development Reported,CC1(C)O[C@]23[C@H](OC(=O)c4cccnc4)[C@H]1C[C@H](OC(=O)c1ccccc1)[C@]2(C)[C@@H](OC(=O)c1ccccc1)CC[C@]3(C)O,清洗成功,0.2278481012658227
13435,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,1,0.9864193797111511,0.9864193797111511,CSC(C=C1N2CCC3N(C)CCCC3)=CC=C1SC4=C2C=CC=C4.[H]Cl,Thioridazine (hydrochloride),Data.sdf,15857,HY-B0965,,130-61-0,5-HT Receptor; Apoptosis; Autophagy; Bacterial; Dopamine Receptor,Anti-infection; Apoptosis; Autophagy; GPCR/G Protein; Neuronal Signaling,C21H27ClN2S2,10mM,Cancer; Infection; Neurological Disease,Launched,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,清洗成功,0.2465753424657534
13436,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,1,0.9864193797111511,0.9864193797111511,CSC(C=C1N2CCC3N(C)CCCC3)=CC=C1SC4=C2C=CC=C4,Thioridazine,Data.sdf,15858,HY-B0965A,,50-52-2,5-HT Receptor; Apoptosis; Autophagy; Bacterial; Dopamine Receptor,Anti-infection; Apoptosis; Autophagy; GPCR/G Protein; Neuronal Signaling,C21H26N2S2,10mM,Neurological Disease; Cancer,Launched,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,清洗成功,0.25
8047,O=C(O)c1cccc2cc(CNC(=O)c3cnn4cccnc34)oc12,1,0.986416220664978,0.986416220664978,O=C(C1=CC=CC2=C1OC(CNC(C3=C4N=CC=CN4N=C3)=O)=C2)O,STING agonist-7,Data.sdf,9505,HY-143896,,2767442-46-4,STING,Immunology/Inflammation,C17H12N4O4,10mM,Cancer,No Development Reported,O=C(O)c1cccc2cc(CNC(=O)c3cnn4cccnc34)oc12,清洗成功,0.2894736842105263
11885,Nc1ncccc1-c1nc2ccc(-c3ccccc3)nc2n1-c1ccc(C2(N)CCC2)cc1,1,0.9863983988761902,0.9863983988761902,NC1=NC=CC=C1C2=NC3=CC=C(C4=CC=CC=C4)N=C3N2C5=CC=C(C6(N)CCC6)C=C5,Miransertib,Data.sdf,14063,HY-19719,ARQ-092,1313881-70-7,Akt; Parasite,Anti-infection; PI3K/Akt/mTOR,C27H24N6,10mM,Cancer; Infection,Phase 2,Nc1ncccc1-c1nc2ccc(-c3ccccc3)nc2n1-c1ccc(C2(N)CCC2)cc1,清洗成功,0.3116883116883117
11886,Nc1ncccc1-c1nc2ccc(-c3ccccc3)nc2n1-c1ccc(C2(N)CCC2)cc1,1,0.9863983988761902,0.9863983988761902,NC1=NC=CC=C1C2=NC3=CC=C(C4=CC=CC=C4)N=C3N2C5=CC=C(C6(N)CCC6)C=C5.[H]Cl,Miransertib (hydrochloride),Data.sdf,14064,HY-19719A,ARQ-092 (hydrochloride),1313883-00-9,Akt; Parasite,Anti-infection; PI3K/Akt/mTOR,C27H25ClN6,10mM,Cancer; Infection,Phase 2,Nc1ncccc1-c1nc2ccc(-c3ccccc3)nc2n1-c1ccc(C2(N)CCC2)cc1,清洗成功,0.3076923076923077
10382,CC(Sc1nc2c(cnn2-c2cccc(Cl)c2)c(=O)[nH]1)C(N)=O,1,0.9863899350166321,0.9863899350166321,CC(SC1=NC(N(C2=CC=CC(Cl)=C2)N=C3)=C3C(N1)=O)C(N)=O,HS38,Data.sdf,12308,HY-15847,,1030203-81-6,DAPK,Apoptosis,C14H12ClN5O2S,10mM,Cardiovascular Disease,No Development Reported,CC(Sc1nc2c(cnn2-c2cccc(Cl)c2)c(=O)[nH]1)C(N)=O,清洗成功,0.2602739726027397
1002,COc1cc2c(NC3CCN(C)CC3)cc(-c3ccc(C)o3)nc2cc1OCCCN1CCCC1,1,0.9863828420639038,0.9863828420639038,CN(CC1)CCC1NC2=CC(C3=CC=C(C)O3)=NC4=CC(OCCCN5CCCC5)=C(OC)C=C42,CM-272,Data.sdf,1150,HY-101925,,1846570-31-7,Apoptosis; DNA Methyltransferase; Histone Methyltransferase,Apoptosis; Epigenetics,C28H38N4O3,10mM,Cancer,No Development Reported,COc1cc2c(NC3CCN(C)CC3)cc(-c3ccc(C)o3)nc2cc1OCCCN1CCCC1,清洗成功,0.2954545454545454
7619,COc1cccc2[nH]c(C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]3CCNC3=O)C(=O)c3nc4ccccc4s3)cc12,1,0.9863678812980652,0.9863678812980652,COC1=C2C(NC(C(N[C@@H](CC(C)C)C(N[C@@H](C[C@H]3C(NCC3)=O)C(C4=NC5=CC=CC=C5S4)=O)=O)=O)=C2)=CC=C1,YH-53,Data.sdf,9020,HY-139311,,1471484-62-4,SARS-CoV,Anti-infection,C30H33N5O5S,10mM,Infection,No Development Reported,COc1cccc2[nH]c(C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]3CCNC3=O)C(=O)c3nc4ccccc4s3)cc12,清洗成功,0.2580645161290322
11031,O=c1ccc2ncc(=O)n3c2n1C[C@H]3CN1CCC(NCc2cc3c(cn2)OCCC3)CC1,1,0.9863632321357727,0.9863632321357727,O=C(C=NC(C=C1)=C23)N3[C@H](CN4CCC(NCC5=CC(CCCO6)=C6C=N5)CC4)CN2C1=O,Gepotidacin,Data.sdf,13070,HY-16742,GSK2140944,1075236-89-3,Antibiotic; Bacterial; Topoisomerase,Anti-infection; Cell Cycle/DNA Damage,C24H28N6O3,10mM,Infection,Launched,O=c1ccc2ncc(=O)n3c2n1C[C@H]3CN1CCC(NCc2cc3c(cn2)OCCC3)CC1,清洗成功,0.2375
11032,O=c1ccc2ncc(=O)n3c2n1C[C@@H]3CN1CCC(NCc2cc3c(cn2)OCCC3)CC1,1,0.9863632321357727,0.9863632321357727,O=C(C=NC(C=C1)=C23)N3[C@@H](CN4CCC(NCC5=CC(CCCO6)=C6C=N5)CC4)CN2C1=O,Gepotidacin (S enantiomer),Data.sdf,13071,HY-16742A,GSK2140944 (S enantiomer),2319789-82-5,Bacterial,Anti-infection,C24H28N6O3,10mM,Infection,No Development Reported,O=c1ccc2ncc(=O)n3c2n1C[C@@H]3CN1CCC(NCc2cc3c(cn2)OCCC3)CC1,清洗成功,0.2375
11033,O=c1ccc2ncc(=O)n3c2n1C[C@H]3CN1CCC(NCc2cc3c(cn2)OCCC3)CC1,1,0.9863632321357727,0.9863632321357727,O=C(C=NC(C=C1)=C23)N3[C@H](CN4CCC(NCC5=CC(CCCO6)=C6C=N5)CC4)CN2C1=O.CS(=O)(O)=O.O.O,Gepotidacin (mesylate hydrate),Data.sdf,13072,HY-16742B,,1624306-20-2,Antibiotic; Bacterial; Topoisomerase,Anti-infection; Cell Cycle/DNA Damage,C25H36N6O8S,10mM,Infection,Phase 3,O=c1ccc2ncc(=O)n3c2n1C[C@H]3CN1CCC(NCc2cc3c(cn2)OCCC3)CC1,清洗成功,0.2260869565217391
15818,CC(=O)O[C@H]1Cc2c(cc3oc(C)cc(=O)c3c2O)OC1(C)C,1,0.986339807510376,0.986339807510376,OC1=C(C[C@H](OC(C)=O)C(C)(C)O2)C2=CC(OC(C)=C3)=C1C3=O,3'-?O-?Acetylhamaudol,Data.sdf,18899,HY-N6892,,30358-88-4,Others,Others,C17H18O6,10mM,Cancer,No Development Reported,CC(=O)O[C@H]1Cc2c(cc3oc(C)cc(=O)c3c2O)OC1(C)C,清洗成功,0.28
4667,O=C(Nc1ccc(Cl)cc1)C1CN(C(=O)c2cccc(-c3ccco3)c2)CC(F)(F)C1,1,0.9863292574882507,0.9863292574882507,O=C(C1CN(C(C2=CC=CC(C3=CC=CO3)=C2)=O)CC(F)(F)C1)NC4=CC=C(Cl)C=C4,CCG-222740,Data.sdf,5485,HY-121750,,1922098-69-8,Ras; ROCK,Cell Cycle/DNA Damage; Cytoskeleton; GPCR/G Protein; MAPK/ERK Pathway; Stem Cell/Wnt; TGF-beta/Smad,C23H19ClF2N2O3,10mM,Cancer,No Development Reported,O=C(Nc1ccc(Cl)cc1)C1CN(C(=O)c2cccc(-c3ccco3)c2)CC(F)(F)C1,清洗成功,0.2564102564102564
3327,O=S(=O)(N[C@H]1CCC[C@@H](N2c3ccccc3Oc3ccccc32)[C@@H]1O)c1ccc(OC(F)(F)F)cc1,1,0.9863237142562866,0.9863237142562866,O=S(C1=CC=C(OC(F)(F)F)C=C1)(N[C@@H]2[C@@H](O)[C@H](N3C4=C(C=CC=C4)OC5=CC=CC=C35)CCC2)=O,"(1S,2S,3R)-DT-061",Data.sdf,3913,HY-112929B,,1809427-20-0,Phosphatase,Metabolic Enzyme/Protease,C25H23F3N2O5S,10mM,Cancer,No Development Reported,O=S(=O)(N[C@H]1CCC[C@@H](N2c3ccccc3Oc3ccccc32)[C@@H]1O)c1ccc(OC(F)(F)F)cc1,清洗成功,0.2266666666666666
4210,CC1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2O1,1,0.9863234758377075,0.9863234758377075,O=C(C1=NC=C(N)C=C1)N2CCC3(CCN(CC4=C5CC(C)(C)OC5=CC=C4)CC3)CC2,AZ084,Data.sdf,4953,HY-119217,,929300-19-6,CCR,GPCR/G Protein; Immunology/Inflammation,C26H34N4O2,10mM,Inflammation/Immunology; Endocrinology; Cancer,No Development Reported,CC1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2O1,清洗成功,0.2736842105263158
11776,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNCc1cccc(F)c1)C(C)(C)C)S(=O)(=O)c1cccc(N)c1,1,0.9862980842590332,0.9862980842590332,O=S(C1=CC(N)=CC=C1)(N(C[C@@H](O)[C@H](CC2=CC=CC=C2)NC([C@H](C(C)(C)C)NC(CNCC3=CC=CC(F)=C3)=O)=O)CC(C)C)=O,DPC-681,Data.sdf,13932,HY-19400,DPH-153893,284661-68-3,HIV; HIV Protease,Anti-infection; Metabolic Enzyme/Protease,C35H48FN5O5S,10mM,Infection,Phase 1,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNCc1cccc(F)c1)C(C)(C)C)S(=O)(=O)c1cccc(N)c1,清洗成功,0.2421052631578947
6710,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)N3CCc4cc(Cn5nc(-c6ccc7oc(N)nc7c6)c6c(N)ncnc65)ccc4C3)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,1,0.9862827658653259,0.9862827658653259,NC1=C2C(C3=CC=C(OC(N)=N4)C4=C3)=NN(C2=NC=N1)CC5=CC=C(CN(CC6)C(CCOCCOCCOCCOCCOCCOCCOCCOCCNC(O[C@H]7[C@@H](C[C@@H](CC7)C[C@H]([C@@]8([H])OC([C@@]9([H])N(CCCC9)C(C([C@@]%10(O[C@](CC[C@H]%10C)([H])C[C@@H](/C(C)=C/C=C/C=C/[C@H](C[C@H](C([C@@H]([C@@H](/C(C)=C/[C@H](C(C8)=O)C)O)OC)=O)C)C)OC)O)=O)=O)=O)C)OC)=O)=O)C6=C5,(32-Carbonyl)-RMC-5552,Data.sdf,7964,HY-134903,,2382768-55-8,mTOR,PI3K/Akt/mTOR,C93H134N10O24,10mM,Cancer,No Development Reported,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)N3CCc4cc(Cn5nc(-c6ccc7oc(N)nc7c6)c6c(N)ncnc65)ccc4C3)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,清洗成功,0.1761658031088082
6815,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)ccn(C3CC3)c12,1,0.9862810373306274,0.9862810373306274,O=C1C=CN(C2CC2)C3=C1C=C(F)C(N(C4)C[C@]5([H])[C@@]4([H])CCCN5)=C3OC,Decarboxy Moxifloxacin,Data.sdf,8090,HY-135398,,1322062-57-6,Bacterial,Anti-infection,C20H24FN3O2,10mM,Inflammation/Immunology; Infection,No Development Reported,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)ccn(C3CC3)c12,清洗成功,0.2533333333333333
10490,CN1CCN(CC(=O)N(C)c2ccc(N/C(=C3\C(=O)Nc4cc(C(=O)O)ccc43)c3ccccc3)cc2)CC1,1,0.986275315284729,0.986275315284729,O=C(C1=CC(NC/2=O)=C(C=C1)C2=C(NC3=CC=C(N(C)C(CN4CCN(C)CC4)=O)C=C3)/C5=CC=CC=C5)O,BIBF 1202,Data.sdf,12433,HY-15992,,894783-71-2,VEGFR,Protein Tyrosine Kinase/RTK,C30H31N5O4,10mM,Cancer,No Development Reported,CN1CCN(CC(=O)N(C)c2ccc(N/C(=C3\C(=O)Nc4cc(C(=O)O)ccc43)c3ccccc3)cc2)CC1,清洗成功,0.2727272727272727
2331,O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1,1,0.9862682819366455,0.9862682819366455,O=C(NC1=CC=C(O)C=C1)CCCC2=CC=C(C3=CC=CC=C3F)C=C2,CMPD1,Data.sdf,2736,HY-108643,,41179-33-3,MAPKAPK2 (MK2),MAPK/ERK Pathway,C22H20FNO2,10mM,Cancer,No Development Reported,O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1,清洗成功,0.3380281690140845
14332,C[C@@H]1O[C@@H](Oc2cc(O)c3c(=O)c(O)c(-c4ccc(O)cc4)oc3c2O)[C@H](O)[C@H](O)[C@H]1O,1,0.9862620234489441,0.9862620234489441,O=C1C(O)=C(C2=CC=C(O)C=C2)OC3=C(O)C(O[C@H]4[C@@H]([C@@H]([C@H]([C@H](C)O4)O)O)O)=CC(O)=C13,Rhodionin,Data.sdf,16935,HY-N0241,,85571-15-9,Cholinesterase (ChE),Neuronal Signaling,C21H20O11,10mM,Metabolic Disease,No Development Reported,C[C@@H]1O[C@@H](Oc2cc(O)c3c(=O)c(O)c(-c4ccc(O)cc4)oc3c2O)[C@H](O)[C@H](O)[C@H]1O,清洗成功,0.275
8282,FC(F)(F)Cn1cc(-c2ccncc2)c(-c2ccc(OCc3ccc4ccccc4n3)cc2)n1,1,0.9862515330314636,0.9862515330314636,FC(F)(F)CN1C=C(C2=CC=NC=C2)C(C(C=C3)=CC=C3OCC4=NC5=CC=CC=C5C=C4)=N1,TP-10,Data.sdf,9775,HY-14550,,898563-00-3,Phosphodiesterase (PDE),Metabolic Enzyme/Protease,C26H19F3N4O,10mM,Neurological Disease; Cardiovascular Disease,Phase 2,FC(F)(F)Cn1cc(-c2ccncc2)c(-c2ccc(OCc3ccc4ccccc4n3)cc2)n1,清洗成功,0.2394366197183098
8567,c1ccc(CSc2nnc(COc3ccccc3)n2-c2ccccc2)cc1,1,0.986247181892395,0.986247181892395,C1(COC2=CC=CC=C2)=NN=C(SCC3=CC=CC=C3)N1C4=CC=CC=C4,MIND4-19,Data.sdf,10108,HY-147233,,129544-85-0,Sirtuin,Cell Cycle/DNA Damage; Epigenetics,C22H19N3OS,10mM,Neurological Disease,No Development Reported,c1ccc(CSc2nnc(COc3ccccc3)n2-c2ccccc2)cc1,清洗成功,0.25
4001,COc1cc2c(NCC3CCN(C)CC3)cc(-c3ccc(C)o3)nc2cc1OCCCN1CCCC1,1,0.9862400889396667,0.9862400889396667,CN1CCC(CNC2=CC(C3=CC=C(C)O3)=NC4=CC(OCCCN5CCCC5)=C(OC)C=C24)CC1.Cl.Cl.Cl,CM-579 trihydrochloride,Data.sdf,4702,HY-117421A,,2448471-08-5,DNA Methyltransferase; Histone Methyltransferase,Epigenetics,C29H43Cl3N4O3,10mM,Cancer,No Development Reported,COc1cc2c(NCC3CCN(C)CC3)cc(-c3ccc(C)o3)nc2cc1OCCCN1CCCC1,清洗成功,0.2631578947368421
7558,O=C(/C=C/c1ccco1)Nc1ccc2oc(-c3ccncc3)nc2c1,1,0.9862398505210876,0.9862398505210876,O=C(NC1=CC=C(OC(C2=CC=NC=C2)=N3)C3=C1)/C=C/C4=CC=CO4,SW157765,Data.sdf,8945,HY-139047,,332063-87-3,GLUT,Membrane Transporter/Ion Channel,C19H13N3O3,10mM,Cancer,No Development Reported,O=C(/C=C/c1ccco1)Nc1ccc2oc(-c3ccncc3)nc2c1,清洗成功,0.3283582089552239
11151,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1,1,0.9862115383148193,0.9862115383148193,CS(=O)(O)=O.O=C(C1=NC2=C(C=CC=C2)C=C1)N[C@@H](CC(N)=O)C(N[C@@H](CC3=CC=CC=C3)[C@H](O)CN4[C@@H](C[C@@]5([H])[C@@](CCCC5)([H])C4)C(NC(C)(C)C)=O)=O,Saquinavir (mesylate),Data.sdf,13209,HY-17003,Ro 31-8959/003,149845-06-7,Autophagy; HIV; HIV Protease,Anti-infection; Autophagy; Metabolic Enzyme/Protease,C39H54N6O8S,10mM,Infection; Cancer,Launched,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1,清洗成功,0.2181818181818181
11154,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1,1,0.9862115383148193,0.9862115383148193,O=C(N[C@@H](CC(N)=O)C(N[C@@H](CC1=CC=CC=C1)[C@H](O)CN2[C@H](C(NC(C)(C)C)=O)C[C@@](CCCC3)([H])[C@@]3([H])C2)=O)C4=NC5=CC=CC=C5C=C4,Saquinavir,Data.sdf,13212,HY-17007,Ro 31-8959,127779-20-8,HIV; HIV Protease; SARS-CoV,Anti-infection; Metabolic Enzyme/Protease,C38H50N6O5,10mM,Infection; Cancer,Launched,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1,清洗成功,0.2264150943396226
16096,COc1cc2oc(CCc3ccccc3)cc(=O)c2cc1OC,1,0.9861992597579956,0.9861992597579956,O=C1C=C(CCC2=CC=CC=C2)OC3=CC(OC)=C(OC)C=C13,"6,7-Dimethoxy-2-(2-phenylethyl)chromone",Data.sdf,19241,HY-N8123,,84294-87-1,Others,Others,C19H18O4,10mM,Others,No Development Reported,COc1cc2oc(CCc3ccccc3)cc(=O)c2cc1OC,清洗成功,0.2727272727272727
16593,CC(=O)N1CC2(CCN(C(=O)[C@@H](CCCCN)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H](N)Cc3ccccc3)CC2)C1,1,0.9861944913864136,0.9861944913864136,CC(N1CC2(CCN(CC2)C([C@@H](CCCCN)NC([C@@H](CC(C)C)NC([C@H](NC([C@H](N)CC3=CC=CC=C3)=O)CC4=CC=CC=C4)=O)=O)=O)C1)=O.CC(O)=O,Anrikefon (acetate),Data.sdf,19779,HY-P3445A,HSK21542 (acetate),2584931-05-3,Opioid Receptor,GPCR/G Protein; Neuronal Signaling,C41H61N7O7,10mM,Neurological Disease,Phase 4,CC(=O)N1CC2(CCN(C(=O)[C@@H](CCCCN)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H](N)Cc3ccccc3)CC2)C1,清洗成功,0.2241379310344827
10522,CNc1cc[n+](CCNC(=O)c2ccn3c(-c4c(C)noc4C)cnc3c2)cc1,1,0.986191987991333,0.986191987991333,O=C(C1=CC2=NC=C(C3=C(C)ON=C3C)N2C=C1)NCC[N+]4=CC=C(NC)C=C4.[Cl-],BAY-6096,Data.sdf,12473,HY-160210,,2313483-41-7,Adrenergic Receptor,GPCR/G Protein; Neuronal Signaling,C21H23ClN6O2,2mM,Cardiovascular Disease,No Development Reported,CNc1cc[n+](CCNC(=O)c2ccn3c(-c4c(C)noc4C)cnc3c2)cc1,清洗成功,0.2386363636363636
9417,COc1ccc(C2(C(=O)N3C[C@H](F)C[C@@H]3C(=O)Nc3ccc4[nH]ncc4n3)CCC(F)(F)CC2)cc1,1,0.986187219619751,0.986187219619751,COC1=CC=C(C=C1)C2(CCC(F)(CC2)F)C(N3C[C@@H](C[C@@H]3C(NC4=NC5=C(NN=C5)C=C4)=O)F)=O,DS-9300,Data.sdf,11115,HY-152241,,2259641-46-6,Histone Acetyltransferase,Epigenetics,C25H26F3N5O3,10mM,Cancer,No Development Reported,COc1ccc(C2(C(=O)N3C[C@H](F)C[C@@H]3C(=O)Nc3ccc4[nH]ncc4n3)CCC(F)(F)CC2)cc1,清洗成功,0.2282608695652173
8391,Oc1cc(CNC(=S)/C=C/c2ccc(O)c(O)c2Br)cc(O)c1O,1,0.9861806035041809,0.9861806035041809,OC(C=C1CNC(/C=C/C2=C(C(O)=C(C=C2)O)Br)=S)=C(C(O)=C1)O,NT219,Data.sdf,9899,HY-145935,,1198078-60-2,Insulin Receptor; STAT,JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt,C16H14BrNO5S,10mM,Cancer,Phase 2,Oc1cc(CNC(=S)/C=C/c2ccc(O)c(O)c2Br)cc(O)c1O,清洗成功,0.2321428571428571
7942,N#Cc1ccc(N2CCN([C@H]3C=C(c4cc5ncccc5c(=O)[nH]4)CC3)CC2)cc1,1,0.986174464225769,0.986174464225769,N#CC1=CC=C(N2CCN([C@H]3C=C(C4=CC5=C(C(N4)=O)C=CC=N5)CC3)CC2)C=C1,PARP1-IN-7,Data.sdf,9384,HY-142657,,2084112-75-2,PARP,Cell Cycle/DNA Damage; Epigenetics,C24H23N5O,10mM,Cancer,No Development Reported,N#Cc1ccc(N2CCN([C@H]3C=C(c4cc5ncccc5c(=O)[nH]4)CC3)CC2)cc1,清洗成功,0.2916666666666667
9593,CC(C)(O)C#Cc1cccc(COc2cc(-c3cnc(C4CCNCC4)s3)cnc2N)c1,1,0.9861677289009094,0.9861677289009094,OC(C)(C)C#CC1=CC=CC(COC2=C(N)N=CC(C3=CN=C(C4CCNCC4)S3)=C2)=C1,HPK1-IN-34,Data.sdf,11333,HY-153362,,2380300-99-0,MAP4K,MAPK/ERK Pathway,C25H28N4O2S,10mM,Cancer,No Development Reported,CC(C)(O)C#Cc1cccc(COc2cc(-c3cnc(C4CCNCC4)s3)cnc2N)c1,清洗成功,0.2391304347826087
12183,NCCN1CCN(C/C=C/C(=O)N2CCC[C@@H](n3nc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)C2)CC1,1,0.9861656427383423,0.9861656427383423,NCCN1CCN(C/C=C/C(N2C[C@H](N3N=C(C4=CC=C(OC5=CC=CC=C5)C=C4)C6=C(N)N=CN=C63)CCC2)=O)CC1,Ibrutinib-MPEA,Data.sdf,14410,HY-43521,,1710768-30-1,Btk,Protein Tyrosine Kinase/RTK,C32H39N9O2,10mM,Cancer,No Development Reported,NCCN1CCN(C/C=C/C(=O)N2CCC[C@@H](n3nc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)C2)CC1,清洗成功,0.2823529411764706
9596,CC(C)(O)c1cc2nc([C@H]3CC[C@H](CN4CC5(CC(CCNc6cccc7c6C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)C4)CC3)sc2cc1NC(=O)c1cccc(C(F)(F)F)n1,1,0.9861652851104736,0.9861652851104736,O=C(N1C2C(NC(CC2)=O)=O)C3=CC=CC(NCCC(C4)CC4(C5)CN5C[C@H]6CC[C@H](C(SC7=C8)=NC7=CC(C(C)(O)C)=C8NC(C9=CC=CC(C(F)(F)F)=N9)=O)CC6)=C3C1=O,Zomiradomide,Data.sdf,11336,HY-153368,KT-413,2655656-99-6,IRAK; PROTACs,Immunology/Inflammation; PROTAC,C45H48F3N7O6S,10mM,Cancer,Phase 1,CC(C)(O)c1cc2nc([C@H]3CC[C@H](CN4CC5(CC(CCNc6cccc7c6C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)C4)CC3)sc2cc1NC(=O)c1cccc(C(F)(F)F)n1,清洗成功,0.2109375
1180,Cn1c(CNc2cccc(C(=O)NCc3ccccc3C(F)(F)F)c2)nnc1-c1ccncc1,1,0.9861575365066528,0.9861575365066528,O=C(C1=CC(NCC2=NN=C(C3=CC=NC=C3)N2C)=CC=C1)NCC4=CC=CC=C4C(F)(F)F,CMPD101,Data.sdf,1368,HY-103045,,865608-11-3,PKC; ROCK,Cell Cycle/DNA Damage; Cytoskeleton; Epigenetics; Stem Cell/Wnt; TGF-beta/Smad,C24H21F3N6O,10mM,Cardiovascular Disease,No Development Reported,Cn1c(CNc2cccc(C(=O)NCc3ccccc3C(F)(F)F)c2)nnc1-c1ccncc1,清洗成功,0.3382352941176471
11456,O=C(Nc1ccccc1)N1CCC(Cc2cnc3ccccc3c2)CC1,1,0.9861516356468201,0.9861516356468201,O=C(NC1=CC=CC=C1)N(CC2)CCC2CC3=CN=C4C(C=CC=C4)=C3,PF 750,Data.sdf,13547,HY-18081,,959151-50-9,Autophagy; FAAH,Autophagy; Metabolic Enzyme/Protease; Neuronal Signaling,C22H23N3O,10mM,Metabolic Disease,No Development Reported,O=C(Nc1ccccc1)N1CCC(Cc2cnc3ccccc3c2)CC1,清洗成功,0.3108108108108108
1216,CN(C)CCn1cc(S(=O)(=O)c2cccc(F)c2)c2cccnc21,1,0.9861505627632141,0.9861505627632141,CN(C)CCN1C=C(S(=O)(C2=CC=CC(F)=C2)=O)C3=CC=CN=C31.[H]Cl.[H]Cl,WAY208466 (dihydrochloride),Data.sdf,1411,HY-103133,,1207064-61-6,5-HT Receptor,GPCR/G Protein; Neuronal Signaling,C17H20Cl2FN3O2S,10mM,Neurological Disease,No Development Reported,CN(C)CCn1cc(S(=O)(=O)c2cccc(F)c2)c2cccnc21,清洗成功,0.3134328358208955
9013,C=Cc1cc2c(Nc3ccc4scnc4c3)ncnc2cn1,1,0.9861314296722412,0.9861314296722412,C=CC1=NC=C2N=CN=C(NC3=CC(N=CS4)=C4C=C3)C2=C1,RIPK3-IN-3,Data.sdf,10627,HY-149393,,3052303-53-1,Mixed Lineage Kinase; RIP kinase,Apoptosis; MAPK/ERK Pathway,C16H11N5S,10mM,cancer,No Development Reported,C=Cc1cc2c(Nc3ccc4scnc4c3)ncnc2cn1,清洗成功,0.320754716981132
7304,Nc1ccc(Sc2nc3ccccc3s2)c(Cl)c1,1,0.9861112833023071,0.9861112833023071,NC1=CC=C(SC2=NC3=CC=CC=C3S2)C(Cl)=C1,KRAS inhibitor-9,Data.sdf,8644,HY-137497,,300809-71-6,Apoptosis; Ras,Apoptosis; GPCR/G Protein; MAPK/ERK Pathway,C13H9ClN2S2,10mM,Cancer,No Development Reported,Nc1ccc(Sc2nc3ccccc3s2)c(Cl)c1,清洗成功,0.3
8186,COCCCc1ccc2oc(-c3ccc(OC)c(OC)c3)cc2c1,1,0.9861084818840027,0.9861084818840027,COCCCC1=CC=C(OC(C2=CC=C(OC)C(OC)=C2)=C3)C3=C1,MDR-1339,Data.sdf,9668,HY-14503,DWK-1339,1018946-38-7,Amyloid-?2,Neuronal Signaling,C20H22O4,10mM,Neurological Disease,No Development Reported,COCCCc1ccc2oc(-c3ccc(OC)c(OC)c3)cc2c1,清洗成功,0.3076923076923077
17433,O=c1[nH]c2ccccc2o1,1,0.9861040711402893,0.9861040711402893,O=C1OC2=CC=CC=C2N1,2-Benzoxazolinone,Data.sdf,20766,HY-W015818,"2-Benzoxazolone; 1,3-Benzoxazol-2(3H)-one; 2-Hydroxybenzoxazole",59-49-4,Parasite,Anti-infection,C7H5NO2,10mM,Infection,No Development Reported,O=c1[nH]c2ccccc2o1,清洗成功,0.3255813953488372
1577,CN(c1nc2ccccc2s1)C1CCN(CC(O)COc2ccc(F)cc2)CC1,1,0.9860775470733643,0.9860775470733643,CN(C1CCN(CC(O)COC2=CC=C(F)C=C2)CC1)C3=NC4=C(C=CC=C4)S3,Sabeluzole,Data.sdf,1865,HY-105022,R 58735,104383-17-7,Tau Protein,Neuronal Signaling,C22H26FN3O2S,10mM,Neurological Disease,Phase 3,CN(c1nc2ccccc2s1)C1CCN(CC(O)COc2ccc(F)cc2)CC1,清洗成功,0.25
10549,C[C@H](CC(=O)N1CCC(O)(Cn2cnc3cc(N)ccc3c2=O)CC1)c1ccccc1,1,0.9860661625862122,0.9860661625862122,O=C1C2=CC=C(N)C=C2N=CN1CC3(CCN(CC3)C(C[C@H](C4=CC=CC=C4)C)=O)O,USP7-IN-13,Data.sdf,12504,HY-160515,,2305046-93-7,Deubiquitinase,Cell Cycle/DNA Damage,C24H28N4O3,10mM,Cancer,No Development Reported,C[C@H](CC(=O)N1CCC(O)(Cn2cnc3cc(N)ccc3c2=O)CC1)c1ccccc1,清洗成功,0.2957746478873239
7154,COC(=O)c1sccc1N/N=C(\C#N)S(C)(=O)=O,1,0.9860618710517883,0.9860618710517883,O=C(C1=C(N/N=C(C#N)/S(=O)(C)=O)C=CS1)OC,HIF-2?±-IN-4,Data.sdf,8470,HY-136748,,882268-69-1,HIF/HIF Prolyl-Hydroxylase,Metabolic Enzyme/Protease,C9H9N3O4S2,10mM,Cancer,No Development Reported,COC(=O)c1sccc1N/N=C(\C#N)S(C)(=O)=O,清洗成功,0.2413793103448276
7761,CN(C)c1ccc(/N=N/c2ccccn2)c(O)c1,1,0.9860485792160034,0.9860485792160034,OC1=CC(N(C)C)=CC=C1/N=N/C2=NC=CC=C2.CS(O)(=O)=O,ERGi-USU-6 (mesylate),Data.sdf,9184,HY-139893,,2756327-67-8,Others,Others,C14H18N4O4S,10mM,Cancer,No Development Reported,CN(C)c1ccc(/N=N/c2ccccn2)c(O)c1,清洗成功,0.216867469879518
1400,CC(C)(O)c1ccn2c(-c3ccc(F)c(-c4ccc(F)cc4C#N)c3)cnc2c1F,1,0.9860440492630005,0.9860440492630005,N#CC1=CC(F)=CC=C1C2=CC(C3=CN=C4C(F)=C(C(C)(O)C)C=CN43)=CC=C2F,TP003,Data.sdf,1641,HY-103512,,628690-75-5,GABA Receptor,Membrane Transporter/Ion Channel; Neuronal Signaling,C23H16F3N3O,10mM,Neurological Disease,No Development Reported,CC(C)(O)c1ccn2c(-c3ccc(F)c(-c4ccc(F)cc4C#N)c3)cnc2c1F,清洗成功,0.2337662337662337
6171,CCN(CC)c1ccc2cc(-c3nc4cc(C)ccc4o3)c(=O)oc2c1,1,0.98602294921875,0.98602294921875,CCN(CC)C1=CC=C2C(OC(C(C3=NC(C=C(C)C=C4)=C4O3)=C2)=O)=C1,EMI48,Data.sdf,7302,HY-131066,,34564-13-1,EGFR,JAK/STAT Signaling; Protein Tyrosine Kinase/RTK,C21H20N2O3,10mM,Cancer,No Development Reported,CCN(CC)c1ccc2cc(-c3nc4cc(C)ccc4o3)c(=O)oc2c1,清洗成功,0.2295081967213114
4358,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,1,0.9860141277313232,0.9860141277313232,CC1=CC=C(C=C1S(N)(=O)=O)NC2=NC=CC(N(C3=CC4=NN(C(C)=C4C=C3)C)C)=N2.Cl,Pazopanib (Hydrochloride),Data.sdf,5127,HY-12009,GW786034 (Hydrochloride),635702-64-6,Autophagy; c-Fms; c-Kit; FGFR; PDGFR; VEGFR,Autophagy; Protein Tyrosine Kinase/RTK,C21H24ClN7O2S,10mM,Cancer,Launched,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,清洗成功,0.3411764705882353
5054,Cn1ncc(-c2nc(N[C@H]3CC[C@H](N)CC3)ncc2F)c1CC1CC1,1,0.9860081076622009,0.9860081076622009,N[C@H]1CC[C@H](NC2=NC=C(F)C(C3=C(CC4CC4)N(C)N=C3)=N2)CC1,Casein Kinase inhibitor A86,Data.sdf,5952,HY-123955,,2079069-01-3,Apoptosis; Casein Kinase; CDK,Apoptosis; Cell Cycle/DNA Damage; Stem Cell/Wnt,C18H25FN6,10mM,Cancer,No Development Reported,Cn1ncc(-c2nc(N[C@H]3CC[C@H](N)CC3)ncc2F)c1CC1CC1,清洗成功,0.3098591549295774
6622,Cc1ccc(Cn2nc(C(=O)N[C@@H]3C(C)(C)[C@@H]4CC[C@@]3(C)C4)cc2-c2ccc(Cl)c(C)c2)cc1,1,0.9860056638717651,0.9860056638717651,O=C(C1=NN(CC2=CC=C(C)C=C2)C(C3=CC=C(Cl)C(C)=C3)=C1)N[C@H]4[C@@](C5)(C)CC[C@@]5([H])C4(C)C,SR144528,Data.sdf,7859,HY-13439,,192703-06-3,Cannabinoid Receptor,GPCR/G Protein; Neuronal Signaling,C29H34ClN3O,10mM,Neurological Disease,No Development Reported,Cc1ccc(Cn2nc(C(=O)N[C@@H]3C(C)(C)[C@@H]4CC[C@@]3(C)C4)cc2-c2ccc(Cl)c(C)c2)cc1,清洗成功,0.2272727272727272
5707,C=CC(=O)Nc1cccc(C)c1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1,1,0.9860019683837891,0.9860019683837891,C=CC(NC1=CC=CC(C)=C1NC2=NC=C3C=C(C4=C(Cl)C(OC)=CC(OC)=C4Cl)C=CC3=N2)=O,BLU9931,Data.sdf,6735,HY-12823,,1538604-68-0,FGFR,Protein Tyrosine Kinase/RTK,C26H22Cl2N4O3,10mM,Cancer,No Development Reported,C=CC(=O)Nc1cccc(C)c1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1,清洗成功,0.313953488372093
6471,O=C(NCc1cc(F)cc(F)c1)[C@@]1(O)CCN(c2ccc3[nH]ccc3c2)C1=O,1,0.9859675765037537,0.9859675765037537,O=C([C@]1(O)C(N(C2=CC3=C(NC=C3)C=C2)CC1)=O)NCC4=CC(F)=CC(F)=C4,M8891,Data.sdf,7669,HY-133016,,1464842-09-8,MetAP,Metabolic Enzyme/Protease,C20H17F2N3O3,10mM,Cancer; Cardiovascular Disease,Phase 1,O=C(NCc1cc(F)cc(F)c1)[C@@]1(O)CCN(c2ccc3[nH]ccc3c2)C1=O,清洗成功,0.3214285714285714
6472,O=C(NCc1cc(F)cc(F)c1)[C@]1(O)CCN(c2ccc3[nH]ccc3c2)C1=O,1,0.9859675765037537,0.9859675765037537,O=C([C@@]1(O)C(N(C2=CC3=C(NC=C3)C=C2)CC1)=O)NCC4=CC(F)=CC(F)=C4,(R)-M8891,Data.sdf,7670,HY-133016A,,2575547-29-2,MetAP,Metabolic Enzyme/Protease,C20H17F2N3O3,10mM,Others,No Development Reported,O=C(NCc1cc(F)cc(F)c1)[C@]1(O)CCN(c2ccc3[nH]ccc3c2)C1=O,清洗成功,0.3214285714285714
1093,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,1,0.9859543442726135,0.9859543442726135,O=S(C1=CC(NC2=NC=CC(N(C3=CC4=NN(C(C)=C4C=C3)C)C)=N2)=CC=C1C)(N)=O,Pazopanib,Data.sdf,1256,HY-10208,GW786034,444731-52-6,Autophagy; c-Kit; FGFR; PDGFR; VEGFR,Autophagy; Protein Tyrosine Kinase/RTK,C21H23N7O2S,10mM,Cancer,Launched,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,清洗成功,0.3452380952380952
12286,N#Cc1ccc(NC(=O)Nc2ccccc2Br)c2[nH]nnc12,1,0.985948920249939,0.985948920249939,N#CC1=C(N=NN2)C2=C(C=C1)NC(NC(C=CC=C3)=C3Br)=O,SB-265610,Data.sdf,14533,HY-50688,,211096-49-0,CXCR,GPCR/G Protein; Immunology/Inflammation,C14H9BrN6O,10mM,Inflammation/Immunology,Phase 2,N#Cc1ccc(NC(=O)Nc2ccccc2Br)c2[nH]nnc12,清洗成功,0.2962962962962963
4942,C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12,1,0.9859431982040405,0.9859431982040405,O=C(C1=CC([C@H](NC2=CC(F)=CC(F)=C2)C)=C3C(C(C=C(N4CCOCC4)O3)=O)=C1)N(C)C,AZD8186,Data.sdf,5819,HY-12330,,1627494-13-6,PI3K,PI3K/Akt/mTOR,C24H25F2N3O4,10mM,Cancer,Phase 2,C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12,清洗成功,0.2272727272727272
5492,CN1CCN(c2ncc(Sc3cccc(NC(=O)CN)c3)c(OCc3ccccc3)n2)CC1,1,0.9858910441398621,0.9858910441398621,O=C(NC1=CC=CC(SC2=CN=C(N3CCN(C)CC3)N=C2OCC4=CC=CC=C4)=C1)CN,HSP70-IN-1,Data.sdf,6470,HY-12622,,1268273-90-0,HSP,Cell Cycle/DNA Damage; Metabolic Enzyme/Protease,C24H28N6O2S,10mM,Cancer,No Development Reported,CN1CCN(c2ncc(Sc3cccc(NC(=O)CN)c3)c(OCc3ccccc3)n2)CC1,清洗成功,0.2826086956521739
13818,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,1,0.9858888983726501,0.9858888983726501,O=S(C(C=C1N2CCC3N(C)CCCC3)=CC=C1SC4=C2C=CC=C4)C,Mesoridazine,Data.sdf,16278,HY-B1482A,TPS-23,5588-33-0,Potassium Channel,Membrane Transporter/Ion Channel,C21H26N2OS2,10mM,Neurological Disease,Launched,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,清洗成功,0.2816901408450704
10924,COc1ccc(CSc2nnc(-c3ccc4ncsc4c3)o2)cc1C(F)(F)F,1,0.985878586769104,0.985878586769104,FC(F)(C1=CC(CSC2=NN=C(C3=CC4=C(N=CS4)C=C3)O2)=CC=C1OC)F,GSK-3?2 inhibitor 22,Data.sdf,12946,HY-164907,,1005199-84-7,GSK-3,PI3K/Akt/mTOR; Stem Cell/Wnt,C18H12F3N3O2S2,10mM,Neurological Disease,No Development Reported,COc1ccc(CSc2nnc(-c3ccc4ncsc4c3)o2)cc1C(F)(F)F,清洗成功,0.328125
12383,Cc1cc(NC(=O)Nc2ccc(N(C)C)cc2)c2cc(F)cc(F)c2n1,1,0.9858719706535339,0.9858719706535339,O=C(NC1=CC(C)=NC2=C(C=C(C=C21)F)F)NC3=CC=C(C=C3)N(C)C,SB-408124,Data.sdf,14660,HY-70068,,288150-92-5,Orexin Receptor (OX Receptor),GPCR/G Protein; Neuronal Signaling,C19H18F2N4O,10mM,Neurological Disease; Endocrinology,No Development Reported,Cc1cc(NC(=O)Nc2ccc(N(C)C)cc2)c2cc(F)cc(F)c2n1,清洗成功,0.3066666666666666
12424,Cc1cc(NC(=O)Nc2ccc(N(C)C)cc2)c2cc(F)cc(F)c2n1,1,0.9858594536781311,0.9858594536781311,O=C(NC1=CC=C(C=C1)N(C)C)NC2=CC(C)=NC(C2=CC(F)=C3)=C3F.[H]Cl,SB-408124 (Hydrochloride),Data.sdf,14710,HY-76612,,1431697-90-3,Orexin Receptor (OX Receptor),GPCR/G Protein; Neuronal Signaling,C19H19ClF2N4O,2mM,Neurological Disease; Endocrinology,No Development Reported,Cc1cc(NC(=O)Nc2ccc(N(C)C)cc2)c2cc(F)cc(F)c2n1,清洗成功,0.3026315789473684
9431,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)SCF,1,0.9858585000038147,0.9858585000038147,C[C@@]12[C@](C(SCF)=O)(OC(C3=CC=CO3)=O)[C@H](C)C[C@@]1([H])[C@]4([H])C[C@H](F)C5=CC(C=C[C@]5(C)[C@@]4(F)[C@@H](O)C2)=O,Fluticasone furoate,Data.sdf,11131,HY-15234,,397864-44-7,Glucocorticoid Receptor,Immunology/Inflammation; Vitamin D Related/Nuclear Receptor,C27H29F3O6S,10mM,Inflammation/Immunology,Launched,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)SCF,清洗成功,0.1639344262295081
7951,N#Cc1cc(NC(=O)C(=O)O)c(Cl)c(NC(=O)C(=O)O)c1,1,0.9858530759811401,0.9858530759811401,OC(C(NC1=C(Cl)C(NC(C(O)=O)=O)=CC(C#N)=C1)=O)=O,Lodoxamide,Data.sdf,9395,HY-14270,U-42585E (free acid),53882-12-5,Histamine Receptor,GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling,C11H6ClN3O6,10mM,Inflammation/Immunology; Endocrinology,Launched,N#Cc1cc(NC(=O)C(=O)O)c(Cl)c(NC(=O)C(=O)O)c1,清洗成功,0.28
12290,COc1ccc(CC(=O)NC(N/C(=N/C#N)Nc2cccc3ncccc23)C(C)(C)C)cc1OC,1,0.9858512282371521,0.9858512282371521,N#C/N=C(NC(NC(CC1=CC(OC)=C(C=C1)OC)=O)C(C)(C)C)\NC2=CC=CC3=NC=CC=C23,A-740003,Data.sdf,14537,HY-50697,,861393-28-4,P2X Receptor,Membrane Transporter/Ion Channel,C26H30N6O3,10mM,Neurological Disease,No Development Reported,COc1ccc(CC(=O)NC(N/C(=N/C#N)Nc2cccc3ncccc23)C(C)(C)C)cc1OC,清洗成功,0.2921348314606741
10043,[O-][n+]1c(CN2CCCCC2)nc2cccc3c2c1-c1ccccc1-3,1,0.9858443737030029,0.9858443737030029,[O-][N+](C(CN1CCCCC1)=N2)=C3C4=C(C=CC=C4)C5=C3C2=CC=C5,NSC194598,Data.sdf,11878,HY-156135,,5358-76-9,RET,Protein Tyrosine Kinase/RTK,C20H19N3O,10mM,Others,No Development Reported,[O-][n+]1c(CN2CCCCC2)nc2cccc3c2c1-c1ccccc1-3,清洗成功,0.2777777777777778
10774,N#Cc1cc(NC(=O)C(=O)O)c(Cl)c(NC(=O)C(=O)O)c1,1,0.9858377575874329,0.9858377575874329,N#CC1=CC(NC(C(O)=O)=O)=C(Cl)C(NC(C(O)=O)=O)=C1.OCC(CO)(N)CO.OCC(CO)(N)CO,Lodoxamide (tromethamine),Data.sdf,12769,HY-16289,U-42585E,63610-09-3,Histamine Receptor,GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling,C19H28ClN5O12,10mM,Inflammation/Immunology; Endocrinology,Launched,N#Cc1cc(NC(=O)C(=O)O)c(Cl)c(NC(=O)C(=O)O)c1,清洗成功,0.2698412698412698
4786,COc1cc(-c2[o+]c3cc(O)cc(O)c3cc2O)cc(OC)c1O,1,0.9858328104019165,0.9858328104019165,OC1=CC(O)=C2C=C(C(C3=CC(OC)=C(C(OC)=C3)O)=[O+]C2=C1)O.[Cl-],Malvidin (chloride),Data.sdf,5626,HY-122496,Syringidin,643-84-5,Apoptosis,Apoptosis,C17H15ClO7,10mM,Cancer,No Development Reported,COc1cc(-c2[o+]c3cc(O)cc(O)c3cc2O)cc(OC)c1O,清洗成功,0.2537313432835821
4325,Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)ncc2nccn12,1,0.9858314990997314,0.9858314990997314,CC1=[C@]([C@]2=C(C)N=CC3=NC=CN32)C=CC(OC4=C(C=CO5)C5=CC=N4)=C1,PF-06256142,Data.sdf,5087,HY-119943,,1609583-14-3,Dopamine Receptor,GPCR/G Protein; Neuronal Signaling,C21H16N4O2,10mM,Neurological Disease,No Development Reported,Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)ncc2nccn12,清洗成功,0.2352941176470588
4326,Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)ncc2nccn12,1,0.9858314990997314,0.9858314990997314,CC1=C(C2=C(C)N=CC3=NC=CN32)C=CC(OC4=C(C=CO5)C5=CC=N4)=C1,(Rac)-PF-06256142,Data.sdf,5088,HY-119943A,,1609580-97-3,Dopamine Receptor,GPCR/G Protein; Neuronal Signaling,C21H16N4O2,10mM,Neurological Disease,No Development Reported,Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)ncc2nccn12,清洗成功,0.2352941176470588
4327,Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)ncc2nccn12,1,0.9858314990997314,0.9858314990997314,CC1=CC(OC2=C(C=CO3)C3=CC=N2)=CC=[C@]1[C@]4=C(C)N=CC5=NC=CN54,(R)-PF-06256142,Data.sdf,5089,HY-119943B,,1609583-15-4,Dopamine Receptor,GPCR/G Protein; Neuronal Signaling,C21H16N4O2,10mM,Neurological Disease,No Development Reported,Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)ncc2nccn12,清洗成功,0.2352941176470588
8350,Cc1ccc(NS(=O)(=O)c2cccc(C#N)c2)c2[nH]cc(C#N)c12,1,0.9858182072639465,0.9858182072639465,O=S(C1=CC(C#N)=CC=C1)(NC2=C(NC=C3C#N)C3=C(C)C=C2)=O,E7820,Data.sdf,9849,HY-14571,ER68203-00,289483-69-8,Integrin; Molecular Glues,Cytoskeleton; PROTAC,C17H12N4O2S,10mM,Cancer,Phase 2,Cc1ccc(NS(=O)(=O)c2cccc(C#N)c2)c2[nH]cc(C#N)c12,清洗成功,0.3333333333333333
428,COc1ccc(-c2cc(C(F)(F)F)n3nc(-c4cccs4)cc3n2)cc1OC,1,0.985815167427063,0.985815167427063,COC1=C(OC)C=C(C2=NC3=CC(C4=CC=CS4)=NN3C(C(F)(F)F)=C2)C=C1,FUBP1-IN-1,Data.sdf,487,HY-100758,,883003-62-1,Others,Others,C19H14F3N3O2S,10mM,Cancer,No Development Reported,COc1ccc(-c2cc(C(F)(F)F)n3nc(-c4cccs4)cc3n2)cc1OC,清洗成功,0.3246753246753247
15751,CC(=O)Nc1c2sscc-2n(C)c1=O,1,0.985791802406311,0.985791802406311,CC(NC1=C2C(N(C)C1=O)=CSS2)=O,Thiolutin,Data.sdf,18824,HY-N6712,Acetopyrrothin,1987/11/6,Antibiotic; Bacterial; Deubiquitinase; Endogenous Metabolite,Anti-infection; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease,C8H8N2O2S2,10mM,Infection; Metabolic Disease,No Development Reported,CC(=O)Nc1c2sscc-2n(C)c1=O,清洗成功,0.2666666666666666
14072,c1ccc(Cc2nc3ccccc3[nH]2)cc1,1,0.9857609868049622,0.9857609868049622,C1(CC2=CC=CC=C2)=NC3=CC=CC=C3N1,Bendazol,Data.sdf,16567,HY-B2141,,621-72-7,HIF/HIF Prolyl-Hydroxylase; NO Synthase,Immunology/Inflammation; Metabolic Enzyme/Protease,C14H12N2,10mM,Metabolic Disease; Cardiovascular Disease; Others,Launched,c1ccc(Cc2nc3ccccc3[nH]2)cc1,清洗成功,0.3181818181818182
8061,CCOC(=O)c1cnn2ccc(-c3c[nH]nc3-c3ccc(F)cc3)cc12,1,0.9857390522956848,0.9857390522956848,O=C(C1=C2C=C(C3=CNN=C3C4=CC=C(F)C=C4)C=CN2N=C1)OCC,ALK5-IN-8,Data.sdf,9524,HY-144043,,2705900-81-6,TGF-?2 Receptor,TGF-beta/Smad,C19H15FN4O2,10mM,Cancer,No Development Reported,CCOC(=O)c1cnn2ccc(-c3c[nH]nc3-c3ccc(F)cc3)cc12,清洗成功,0.2823529411764706
9118,CN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4ccnc(N)n4)cc3)cc2C(F)(F)F)CC1,1,0.9857124090194702,0.9857124090194702,NC1=NC(OC2=CC=C(NC(NC3=CC(C(F)(F)F)=C(CN4CCN(C)CC4)C=C3)=O)C=C2)=CC=N1,AUZ 454,Data.sdf,10754,HY-15004,K03861,853299-07-7,CDK,Cell Cycle/DNA Damage,C24H26F3N7O2,10mM,Cancer,No Development Reported,CN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4ccnc(N)n4)cc3)cc2C(F)(F)F)CC1,清洗成功,0.3068181818181818
324,CCc1c(C)nc(SCC(=O)Nc2nc(-c3ccc(OC)cc3)cs2)[nH]c1=O,1,0.9857038855552673,0.9857038855552673,O=C(NC1=NC(C2=CC=C(OC)C=C2)=CS1)CSC3=NC(C)=C(CC)C(N3)=O,T16Ainh-A01,Data.sdf,373,HY-100612,,552309-42-9,Chloride Channel,Membrane Transporter/Ion Channel,C19H20N4O3S2,10mM,Others,No Development Reported,CCc1c(C)nc(SCC(=O)Nc2nc(-c3ccc(OC)cc3)cs2)[nH]c1=O,清洗成功,0.2916666666666667
7782,Cc1[nH]c(/C=C2\C(=O)Nc3cc(NC(=O)Nc4cc(C(C)(C)C)on4)ccc32)c(C)c1NC(=O)CN1CCN(C)CC1,1,0.985694944858551,0.985694944858551,O=C1NC2=CC(NC(NC3=NOC(C(C)(C)C)=C3)=O)=CC=C2/C1=C/C4=C(C)C(NC(CN5CCN(C)CC5)=O)=C(C)N4,CSF1R-IN-3,Data.sdf,9206,HY-139990,,2760584-90-3,c-Fms,Protein Tyrosine Kinase/RTK,C30H38N8O4,10mM,Cancer,No Development Reported,Cc1[nH]c(/C=C2\C(=O)Nc3cc(NC(=O)Nc4cc(C(C)(C)C)on4)ccc32)c(C)c1NC(=O)CN1CCN(C)CC1,清洗成功,0.3461538461538461
13016,CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](Oc2ccc3c(O)c(NC(=O)c4ccc(O)c(CC=C(C)C)c4)c(=O)oc3c2C)OC1(C)C,1,0.9856927394866943,0.9856927394866943,CC1=C(O2)C(C(O)=C(NC(C3=CC(C/C=C(C)/C)=C(O)C=C3)=O)C2=O)=CC=C1O[C@H]4[C@@H]([C@@H]([C@@H](OC)C(C)(C)O4)OC(N)=O)O,Novobiocin,Data.sdf,15381,HY-B0425,Albamycin; Cathomycin,303-81-1,Antibiotic; Apoptosis; Bacterial; DNA/RNA Synthesis; HSP; Orthopoxvirus,Anti-infection; Apoptosis; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease,C31H36N2O11,10mM,Cancer; Infection,Launched,CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](Oc2ccc3c(O)c(NC(=O)c4ccc(O)c(CC=C(C)C)c4)c(=O)oc3c2C)OC1(C)C,清洗成功,0.2264150943396226
8044,O=C(Nc1cccnc1)N1CCC(Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1,1,0.9856775999069214,0.9856775999069214,O=C(N1CCC(CC2=CC=CC(OC3=NC=C(C=C3)C(F)(F)F)=C2)CC1)NC4=CN=CC=C4,PF-3845,Data.sdf,9502,HY-14380,,1196109-52-0,Autophagy; FAAH,Autophagy; Metabolic Enzyme/Protease; Neuronal Signaling,C24H23F3N4O2,10mM,Inflammation/Immunology; Cancer,No Development Reported,O=C(Nc1cccnc1)N1CCC(Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1,清洗成功,0.313953488372093
10959,CC(C)=CC(=O)CCC(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1,1,0.9856747984886169,0.9856747984886169,C/C(C)=C/C(CCC(N1CCN(CC2=CC3=NC(C4=CC=CC5=C4C=NN5)=NC(N6CCOCC6)=C3S2)CC1)=O)=O,CNX-1351,Data.sdf,12991,HY-16596,,1276105-89-5,PI3K,PI3K/Akt/mTOR,C30H35N7O3S,10mM,Cancer,No Development Reported,CC(C)=CC(=O)CCC(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1,清洗成功,0.2545454545454545
4246,O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1,1,0.985673725605011,0.985673725605011,O=C1NC2=C(CC1)C=C(C=C2)NC3=CC(OC4CCOCC4)=C(C=C3Cl)[N+]([O-])=O,TP-021,Data.sdf,4991,HY-119402,BCL6-IN-8c,2130878-25-8,Bcl-2 Family,Apoptosis,C20H20ClN3O5,10mM,Cancer,No Development Reported,O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1,清洗成功,0.2718446601941747
17931,COc1ccc(C(OC[C@H]2O[C@@H](n3cnc4c(=O)nc(NC(=O)C(C)C)[nH]c43)[C@H](F)[C@@H]2O)(c2ccccc2)c2ccc(OC)cc2)cc1,1,0.985629141330719,0.985629141330719,F[C@@H]1[C@H](O)[C@@H](COC(C2=CC=C(OC)C=C2)(C3=CC=C(OC)C=C3)C4=CC=CC=C4)O[C@H]1N(C=N5)C(NC(NC(C(C)C)=O)=N6)=C5C6=O,DMT-2'-F-iBu-G,Data.sdf,21371,HY-W115309,5'-DMT-2'-F-ibu-dG,144089-96-3,Nucleoside Antimetabolite/Analog,Cell Cycle/DNA Damage,C35H36FN5O7,10mM,Others,No Development Reported,COc1ccc(C(OC[C@H]2O[C@@H](n3cnc4c(=O)nc(NC(=O)C(C)C)[nH]c43)[C@H](F)[C@@H]2O)(c2ccccc2)c2ccc(OC)cc2)cc1,清洗成功,0.2323232323232323
6510,CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1,1,0.9856232404708862,0.9856232404708862,O=C(O)CC1(CS[C@@H](C2=CC=CC(/C=C/C3=NC4=CC(Cl)=CC=C4C=C3)=C2)CCC5=CC=CC=C5C(C)(O)C)CC1,Montelukast,Data.sdf,7717,HY-13315A,MK0476 (free base),158966-92-8,Leukotriene Receptor,GPCR/G Protein,C35H36ClNO3S,10mM,Inflammation/Immunology; Cancer,Launched,CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1,清洗成功,0.202127659574468
1324,COc1ccc(/C=C/C(=O)c2c(-c3ccccc3)c3cc(C)ccc3[nH]c2=O)cc1,1,0.9856079816818237,0.9856079816818237,O=C1NC2=C(C=C(C)C=C2)C(C3=CC=CC=C3)=C1C(/C=C/C4=CC=C(OC)C=C4)=O,Ceranib1,Data.sdf,1543,HY-103359,,328076-61-5,Ceramidase,Metabolic Enzyme/Protease,C26H21NO3,10mM,Cancer,No Development Reported,COc1ccc(/C=C/C(=O)c2c(-c3ccccc3)c3cc(C)ccc3[nH]c2=O)cc1,清洗成功,0.3492063492063492
5281,CN(CCC#N)C1CCN(C(=O)Cn2cc(NC(=O)c3cnn4cccnc34)c(-c3cc(Cl)ccc3OC(F)F)n2)CC1,1,0.9856045842170715,0.9856045842170715,O=C(C1=C2N=CC=CN2N=C1)NC3=CN(CC(N4CCC(N(CCC#N)C)CC4)=O)N=C3C5=CC(Cl)=CC=C5OC(F)F,iJak-381,Data.sdf,6228,HY-125019,,1831144-46-7,JAK; STAT,Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt,C28H28ClF2N9O3,10mM,Inflammation/Immunology,No Development Reported,CN(CCC#N)C1CCN(C(=O)Cn2cc(NC(=O)c3cnn4cccnc34)c(-c3cc(Cl)ccc3OC(F)F)n2)CC1,清洗成功,0.2461538461538461
3751,CC(C)(C)c1ccc2occ(/C=N/NC(=O)c3cccnc3)c(=O)c2c1,1,0.9856022000312805,0.9856022000312805,O=C(N/N=C/C1=COC(C=CC(C(C)(C)C)=C2)=C2C1=O)C3=CC=CN=C3,Erasin,Data.sdf,4417,HY-115594,,,Apoptosis; STAT,Apoptosis; JAK/STAT Signaling; Stem Cell/Wnt,C20H19N3O3,10mM,Cancer,No Development Reported,CC(C)(C)c1ccc2occ(/C=N/NC(=O)c3cccnc3)c(=O)c2c1,清洗成功,0.2839506172839506
481,O=C(Nc1cccc(-c2nncn2C2CC2)c1)c1cc(-n2cnc(C3CC3)c2)ccn1,1,0.9855959415435791,0.9855959415435791,O=C(C1=NC=CC(N2C=C(C3CC3)N=C2)=C1)NC4=CC=CC(C5=NN=CN5C6CC6)=C4,GS-444217,Data.sdf,543,HY-100844,,1262041-49-5,Apoptosis; MAP3K,Apoptosis; MAPK/ERK Pathway,C23H21N7O,10mM,Cancer,No Development Reported,O=C(Nc1cccc(-c2nncn2C2CC2)c1)c1cc(-n2cnc(C3CC3)c2)ccn1,清洗成功,0.253012048192771
32,Oc1cc(CNC(=S)/C=C/c2cc(O)c(O)c(Br)c2)cc(O)c1O,1,0.9855814576148987,0.9855814576148987,S=C(NCC1=CC(O)=C(O)C(O)=C1)/C=C/C2=CC(O)=C(O)C(Br)=C2,NT157,Data.sdf,34,HY-100037,Tyrphostin NT157,1384426-12-3,Insulin Receptor; STAT,JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt,C16H14BrNO5S,10mM,Cancer; Endocrinology,No Development Reported,Oc1cc(CNC(=S)/C=C/c2cc(O)c(O)c(Br)c2)cc(O)c1O,清洗成功,0.2888888888888888
10706,Nc1ncnc2cc(-c3cccc(S(N)(=O)=O)c3)sc12,1,0.9855725169181824,0.9855725169181824,NC1=C2C(C=C(C3=CC(S(N)(=O)=O)=CC=C3)S2)=NC=N1,OSM-S-106,Data.sdf,12689,HY-162238,,2650846-59-4,Parasite,Anti-infection,C12H10N4O2S2,10mM,Infection,No Development Reported,Nc1ncnc2cc(-c3cccc(S(N)(=O)=O)c3)sc12,清洗成功,0.2916666666666667
9270,COc1ccc2cc(C(=O)NCCC3CCN(Cc4ccccc4)CC3)ccc2c1,1,0.9855696558952332,0.9855696558952332,O=C(NCCC1CCN(CC2=CC=CC=C2)CC1)C3=CC=C4C=C(OC)C=CC4=C3,AChE/BChE-IN-10,Data.sdf,10933,HY-151368,,2924824-48-4,Cholinesterase (ChE),Neuronal Signaling,C26H30N2O2,10mM,Neurological Disease,No Development Reported,COc1ccc2cc(C(=O)NCCC3CCN(Cc4ccccc4)CC3)ccc2c1,清洗成功,0.3333333333333333
8518,Cc1ccc(C)c(Cn2c(C(O)c3ccncc3)nc3ccccc32)c1,1,0.9855642914772034,0.9855642914772034,OC(C1=NC2=C(N1CC3=CC(C)=CC=C3C)C=CC=C2)C4=CC=NC=C4,UCB-5307,Data.sdf,10050,HY-147045,,1515887-44-1,TNF Receptor,Apoptosis,C22H21N3O,10mM,Inflammation/Immunology,No Development Reported,Cc1ccc(C)c(Cn2c(C(O)c3ccncc3)nc3ccccc32)c1,清洗成功,0.2535211267605634
2948,COCc1c(F)c(F)c(COC(=O)[C@@H]2[C@@H](/C=C(/C)C#N)C2(C)C)c(F)c1F,1,0.9855430126190186,0.9855430126190186,O=C([C@H]1C(C)(C)[C@@H]1/C=C(C#N)/C)OCC2=C(F)C(F)=C(COC)C(F)=C2F,Epsilon-momfluorothrin,Data.sdf,3453,HY-111634,,1065124-65-3,Constitutive Androstane Receptor,Vitamin D Related/Nuclear Receptor,C19H19F4NO3,10mM,Cancer,No Development Reported,COCc1c(F)c(F)c(COC(=O)[C@@H]2[C@@H](/C=C(/C)C#N)C2(C)C)c(F)c1F,清洗成功,0.1818181818181818
1071,CCOC(=O)c1cccc(NC(=O)CCCCCCCSc2nnc(Cc3nn(C)c(=O)c4ccccc34)n2C)c1,1,0.9855330586433411,0.9855330586433411,CN1C(CC2=NN(C)C(C3=CC=CC=C32)=O)=NN=C1SCCCCCCCC(NC4=CC=CC(C(OCC)=O)=C4)=O,IL-15-IN-1,Data.sdf,1231,HY-102049,,1831830-20-6,Interleukin Related,Immunology/Inflammation,C30H36N6O4S,10mM,Inflammation/Immunology,No Development Reported,CCOC(=O)c1cccc(NC(=O)CCCCCCCSc2nnc(Cc3nn(C)c(=O)c4ccccc34)n2C)c1,清洗成功,0.2653061224489796
15628,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)cc4)oc4cc(O)cc(O)c4c3=O)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)[C@@H](O)[C@H]2O)[C@H](O)[C@H](O)[C@H]1O,1,0.9855310916900635,0.9855310916900635,O=C1C(O[C@H]2[C@@H]([C@H]([C@@H](O)[C@@H](CO[C@H]3[C@@H]([C@@H]([C@@H](O)[C@H](C)O3)O)O)O2)O)O[C@@]4([H])[C@@H]([C@@H]([C@@H](O)[C@H](C)O4)O)O)=C(C5=CC=C(O)C=C5)OC6=CC(O)=CC(O)=C61,Mauritianin,Data.sdf,18654,HY-N5038,,109008-28-8,Topoisomerase,Cell Cycle/DNA Damage,C33H40O19,10mM,Cancer,No Development Reported,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)cc4)oc4cc(O)cc(O)c4c3=O)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)[C@@H](O)[C@H]2O)[C@H](O)[C@H](O)[C@H]1O,清洗成功,0.2876712328767123
5522,Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1,1,0.9855302572250366,0.9855302572250366,O=C(C1=CC(CC2=CC=C3N=CC(Cl)=CC3=C2)=NC=C1)NCC4=C(C)C=C(N)N=C4C,LSP-249,Data.sdf,6510,HY-126378,,1801253-04-2,Kallikrein,Immunology/Inflammation,C24H22ClN5O,10mM,Inflammation/Immunology,No Development Reported,Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1,清洗成功,0.2708333333333333
9181,CO[C@@H]1[C@H](OC(=O)Oc2ccc([N+](=O)[O-])cc2)CC[C@]2(CO2)[C@H]1[C@@]1(C)O[C@@H]1CC=C(C)C,1,0.9855185747146606,0.9855185747146606,O=C(O[C@H]1[C@@H](OC)[C@@]([C@]2(C)[C@@H](C/C=C(C)\C)O2)([H])[C@]3(OC3)CC1)OC4=CC=C([N+]([O-])=O)C=C4,TSPO ligand-2,Data.sdf,10827,HY-150409,,1160640-95-8,AUTACs,Autophagy; PROTAC,C23H29NO8,10mM,Cancer,No Development Reported,CO[C@@H]1[C@H](OC(=O)Oc2ccc([N+](=O)[O-])cc2)CC[C@]2(CO2)[C@H]1[C@@]1(C)O[C@@H]1CC=C(C)C,清洗成功,0.225
1924,CC(C)OC(=O)Nc1ccc2nc(-c3cscn3)[nH]c2c1,1,0.9855145215988159,0.9855145215988159,CC(C)OC(NC1=CC2=C(N=C(C3=CSC=N3)N2)C=C1)=O,Cambendazole,Data.sdf,2267,HY-107483,,26097-80-3,Parasite,Anti-infection,C14H14N4O2S,10mM,Infection,No Development Reported,CC(C)OC(=O)Nc1ccc2nc(-c3cscn3)[nH]c2c1,清洗成功,0.2804878048780488
13042,C=C1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@H]12,1,0.9855103492736816,0.9855103492736816,O[C@@](C(O)=C(C(C1=C2C=CC=C1O)=O)[C@](C2=C)([H])[C@@H]3O)(C(C(C(N)=O)=C4O)=O)[C@]3([H])[C@@H]4N(C)C.Cl,Methacycline (hydrochloride),Data.sdf,15410,HY-B0449,,3963-95-9,Antibiotic; Bacterial,Anti-infection,C22H23ClN2O8,10mM,Infection,Launched,C=C1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@H]12,清洗成功,0.2191780821917808
11524,O=C(NCC1(c2nc(-c3ccccc3)cs2)CCOCC1)c1cccc(-c2noc(C(F)(F)F)n2)c1,1,0.9855020046234131,0.9855020046234131,O=C(NCC1(C2=NC(C3=CC=CC=C3)=CS2)CCOCC1)C4=CC=CC(C5=NOC(C(F)(F)F)=N5)=C4,TMP269,Data.sdf,13635,HY-18360,,1314890-29-3,HDAC,Cell Cycle/DNA Damage; Epigenetics,C25H21F3N4O3S,10mM,Cancer,No Development Reported,O=C(NCC1(c2nc(-c3ccccc3)cs2)CCOCC1)c1cccc(-c2noc(C(F)(F)F)n2)c1,清洗成功,0.2352941176470588
7249,Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCOCCOCCNc2nccc(-c3sc(C(C)(C)C)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3F)n2)C(C)(C)C)cc1,1,0.9854921698570251,0.9854921698570251,CC(C)(C)C(S1)=NC(C2=CC=CC(NS(C3=C(F)C=CC=C3F)(=O)=O)=C2F)=C1C4=NC(NCCOCCOCCC(N[C@@H](C(C)(C)C)C(N5C[C@H](O)C[C@H]5C(N[C@@H](C)C6=CC=C(C7=C(C)N=CS7)C=C6)=O)=O)=O)=NC=C4,DD-03-156,Data.sdf,8581,HY-137346,"(S,R,S)-AHPC-Me-PEG2-dabrafenib",2769753-69-5,CDK; LIM Kinase (LIMK); PROTACs,Cell Cycle/DNA Damage; PROTAC,C53H62F3N9O8S3,10mM,Cancer,No Development Reported,Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCOCCOCCNc2nccc(-c3sc(C(C)(C)C)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3F)n2)C(C)(C)C)cc1,清洗成功,0.2214285714285714
9490,CC(C)(C)NS(=O)(=O)c1cncc(-c2cc(F)c3nc(N)nn3c2)c1,1,0.9854893088340759,0.9854893088340759,FC1=CC(C2=CC(S(=O)(NC(C)(C)C)=O)=CN=C2)=CN3C1=NC(N)=N3,CZC24832,Data.sdf,11205,HY-15294,,1159824-67-5,PI3K,PI3K/Akt/mTOR,C15H17FN6O2S,10mM,Inflammation/Immunology; Cancer,No Development Reported,CC(C)(C)NS(=O)(=O)c1cncc(-c2cc(F)c3nc(N)nn3c2)c1,清洗成功,0.2580645161290322
1447,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)C1C(C)(C)C1(C)C)C(=O)OCC#N,1,0.9854888319969177,0.9854888319969177,O=C(C1C(C)(C)C1(C)C)O[C@]2([C@@]3([C@@]([C@@]4([H])[C@@](F)([C@@]5(C([C@@H](F)C4)=CC(C=C5)=O)C)[C@@H](O)C3)([H])C[C@H]2C)C)C(OCC#N)=O,GW-870086,Data.sdf,1696,HY-103662,,827319-43-7,Glucocorticoid Receptor,Immunology/Inflammation; Vitamin D Related/Nuclear Receptor,C31H39F2NO6,10mM,Inflammation/Immunology; Endocrinology,Phase 2,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)C1C(C)(C)C1(C)C)C(=O)OCC#N,清洗成功,0.1339285714285714
10068,Cc1cccn2c(=O)c3cc(C(=O)NCCN4CCN(C)CC4)c(=N)n(CCc4cccs4)c3nc12,1,0.9854876399040222,0.9854876399040222,O=C(C1=CC2=C(N(CCC3=CC=CS3)C1=N)N=C4C(C)=CC=CN4C2=O)NCCN5CCN(CC5)C,SPOP-IN-1,Data.sdf,11909,HY-156382,,2136270-56-7,Akt; E1/E2/E3 Enzyme; ERK,MAPK/ERK Pathway; Metabolic Enzyme/Protease; PI3K/Akt/mTOR; Stem Cell/Wnt,C26H31N7O2S,2mM,Cancer,No Development Reported,Cc1cccn2c(=O)c3cc(C(=O)NCCN4CCN(C)CC4)c(=N)n(CCc4cccs4)c3nc12,清洗成功,0.2755102040816326
6996,Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCOCCCCCOCCCCCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)C(C)(C)C)cc1,1,0.9854781627655029,0.9854781627655029,O=C(N1C(CCC2=O)C(N2)=O)C(C(C1=O)=CC=C3)=C3NCCCCCCOCCCCCOCCCCC(N[C@@H](C(C)(C)C)C(N(C[C@@H]4O)[C@@H](C4)C(NCC5=CC=C(C(SC=N6)=C6C)C=C5)=O)=O)=O,CRBN-6-5-5-VHL,Data.sdf,8299,HY-136262,,2362575-45-7,E1/E2/E3 Enzyme; PROTACs,Metabolic Enzyme/Protease; PROTAC,C51H69N7O10S,10mM,Cancer,No Development Reported,Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCOCCCCCOCCCCCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)C(C)(C)C)cc1,清洗成功,0.217391304347826
2440,CC1(C)CC=C(c2nc(C3CC(C)(C)OC(C)(C)C3)ccc2NC(=O)c2ncc(C#N)[nH]2)CC1,1,0.9854734539985657,0.9854734539985657,O=C(C1=NC=C(C#N)N1)NC2=C(C3=CCC(C)(C)CC3)N=C(C(CC(C)(C)O4)CC4(C)C)C=C2,Edicotinib,Data.sdf,2867,HY-109086,JNJ-40346527; JNJ-527,1142363-52-7,c-Fms,Protein Tyrosine Kinase/RTK,C27H35N5O2,10mM,Inflammation/Immunology; Neurological Disease; Cancer,Phase 2,CC1(C)CC=C(c2nc(C3CC(C)(C)OC(C)(C)C3)ccc2NC(=O)c2ncc(C#N)[nH]2)CC1,清洗成功,0.2043010752688172
15436,C[C@@H]1O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc(O)c3c2=O)[C@H](O)[C@H](O)[C@H]1O,1,0.9854651093482971,0.9854651093482971,O=C1C(O[C@H]2[C@@H]([C@@H]([C@@H](O)[C@H](C)O2)O)O)=C(C3=CC=C(O)C=C3)OC4=CC(O[C@H]5[C@@H]([C@@H]([C@@H](O)[C@H](C)O5)O)O[C@]6([H])O[C@@H]([C@@H](O)[C@H](O)[C@H]6O)CO)=CC(O)=C41,Grosvenorine,Data.sdf,18393,HY-N3031,,156980-60-8,Bacterial,Anti-infection,C33H40O19,10mM,Infection,No Development Reported,C[C@@H]1O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc(O)c3c2=O)[C@H](O)[C@H](O)[C@H]1O,清洗成功,0.3146067415730337
8105,Cc1cc(N(C)C(=O)[C@H]2CC[C@H](Oc3cccc(CO)c3)CC2)ccc1CN1CCN[C@@H](C)C1,1,0.9854423999786377,0.9854423999786377,O=C([C@H]1CC[C@H](OC2=CC=CC(CO)=C2)CC1)N(C)C3=CC=C(CN4C[C@H](C)NCC4)C(C)=C3,DS-3801b,Data.sdf,9571,HY-144401,,1369412-66-7,Motilin Receptor,GPCR/G Protein,C28H39N3O3,10mM,Metabolic Disease,No Development Reported,Cc1cc(N(C)C(=O)[C@H]2CC[C@H](Oc3cccc(CO)c3)CC2)ccc1CN1CCN[C@@H](C)C1,清洗成功,0.2571428571428571
9691,CCn1c2ccccc2c2cc(NC(=O)CSc3nccc(=O)[nH]3)ccc21,1,0.9854404330253601,0.9854404330253601,O=C1C=CN=C(N1)SCC(NC2=CC=C3C(C4=C(N3CC)C=CC=C4)=C2)=O,PK095,Data.sdf,11452,HY-153767,,380314-37-4,MDM-2/p53,Apoptosis,C20H18N4O2S,10mM,Cancer,No Development Reported,CCn1c2ccccc2c2cc(NC(=O)CSc3nccc(=O)[nH]3)ccc21,清洗成功,0.2784810126582278
606,O=[N+]([O-])c1ccc(Sc2cccc[n+]2[O-])c2nonc12,1,0.9854335784912109,0.9854335784912109,[O-][N+]1=CC=CC=C1SC2=CC=C([N+]([O-])=O)C3=NON=C32,NSC 228155,Data.sdf,688,HY-101084,,113104-25-9,EGFR; Epigenetic Reader Domain; Histone Acetyltransferase,Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK,C11H6N4O4S,10mM,Cancer,No Development Reported,O=[N+]([O-])c1ccc(Sc2cccc[n+]2[O-])c2nonc12,清洗成功,0.2272727272727272
7276,CC(C)(C)CNCCn1c(Sc2cc3c(cc2I)OCO3)nc2c(N)ncnc21,1,0.9854103326797485,0.9854103326797485,IC1=C(SC2=NC3=C(N)N=CN=C3N2CCNCC(C)(C)C)C=C4OCOC4=C1,Icapamespib,Data.sdf,8611,HY-137441,PU-HZ151,1000999-96-1,HSP,Cell Cycle/DNA Damage; Metabolic Enzyme/Protease,C19H23IN6O2S,10mM,Neurological Disease; Cancer,Phase 1,CC(C)(C)CNCCn1c(Sc2cc3c(cc2I)OCO3)nc2c(N)ncnc21,清洗成功,0.2948717948717949
11196,Cc1cc(CNC(C)(C)C)cc(C)c1-c1ncn(C)c1-c1ccc(C#N)c2ccccc12,1,0.9853984117507935,0.9853984117507935,N#CC1=C2C=CC=CC2=C(C3=C(C4=C(C)C=C(CNC(C)(C)C)C=C4C)N=CN3C)C=C1,NSD2-PWWP1-IN-1,Data.sdf,13258,HY-171119,,2797183-30-1,Histone Methyltransferase,Epigenetics,C28H30N4,10mM,Cancer,No Development Reported,Cc1cc(CNC(C)(C)C)cc(C)c1-c1ncn(C)c1-c1ccc(C#N)c2ccccc12,清洗成功,0.2608695652173913
15204,C[C@@H]1O[C@@H](Oc2cc(O)c3c(=O)c(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)c(-c4ccc(O)cc4)oc3c2)[C@H](O)[C@H](O)[C@H]1O,1,0.9853912591934204,0.9853912591934204,O=C1C(O[C@H](O[C@@H]2CO)[C@@H]([C@H]([C@@H]2O)O)O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]([C@H]3O)CO)=C(C(C=C4)=CC=C4O)OC5=CC(O[C@H](O[C@H]6C)[C@@H]([C@@H]([C@H]6O)O)O)=CC(O)=C15,Kaempferol 3-sophoroside 7-rhamnoside,Data.sdf,18087,HY-N2226,,93098-79-4,Others,Others,C33H40O20,10mM,Others,No Development Reported,C[C@@H]1O[C@@H](Oc2cc(O)c3c(=O)c(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)c(-c4ccc(O)cc4)oc3c2)[C@H](O)[C@H](O)[C@H]1O,清洗成功,0.3146067415730337
6459,C=CC(=O)N1CC2(CCN(c3nc(OC4CCN(CCCOC)CC4)nc4c(OCC(F)(F)F)c(-c5c(C)ccc6[nH]ncc56)c(C5CC5)cc34)CC2)C1,1,0.9853783845901489,0.9853783845901489,C=CC(N1CC2(CCN(C3=C4C=C(C5CC5)C(C6=C(C)C=CC7=C6C=NN7)=C(OCC(F)(F)F)C4=NC(OC8CCN(CCCOC)CC8)=N3)CC2)C1)=O,ASP2453,Data.sdf,7653,HY-132966,,2241719-73-1,Ras,GPCR/G Protein; MAPK/ERK Pathway,C40H48F3N7O4,10mM,Cancer,No Development Reported,C=CC(=O)N1CC2(CCN(c3nc(OC4CCN(CCCOC)CC4)nc4c(OCC(F)(F)F)c(-c5c(C)ccc6[nH]ncc56)c(C5CC5)cc34)CC2)C1,清洗成功,0.2539682539682539
7177,CC(=O)NCCCC[C@H](NC(=O)OC(C)(C)C)C(=O)Nc1ccc2c(C(F)(F)F)cc(=O)oc2c1,1,0.9853734374046326,0.9853734374046326,O=C(OC(C)(C)C)N[C@H](C(NC1=CC=C(C(O2)=C1)C(C(F)(F)F)=CC2=O)=O)CCCCNC(C)=O,BATCP,Data.sdf,8496,HY-136859,,787549-23-9,HDAC,Cell Cycle/DNA Damage; Epigenetics,C23H28F3N3O6,10mM,Cancer,No Development Reported,CC(=O)NCCCC[C@H](NC(=O)OC(C)(C)C)C(=O)Nc1ccc2c(C(F)(F)F)cc(=O)oc2c1,清洗成功,0.2747252747252747
1159,O=C(CN1C(=O)C2(CCCC2)NC[C@H]1c1cc(F)cc(F)c1)Nc1ccc2c(c1)C[C@@]1(C2)C(=O)Nc2ncccc21,1,0.9853674173355103,0.9853674173355103,O=C1C2(NC[C@@H](C3=CC(F)=CC(F)=C3)N1CC(NC4=CC5=C(C[C@@]6(C(NC7=C6C=CC=N7)=O)C5)C=C4)=O)CCCC2,MK-3207,Data.sdf,1343,HY-10301,,957118-49-9,CGRP Receptor,GPCR/G Protein; Neuronal Signaling,C31H29F2N5O3,10mM,Neurological Disease,Phase 2,O=C(CN1C(=O)C2(CCCC2)NC[C@H]1c1cc(F)cc(F)c1)Nc1ccc2c(c1)C[C@@]1(C2)C(=O)Nc2ncccc21,清洗成功,0.2427184466019417
1165,O=C(CN1C(=O)C2(CCCC2)NC[C@H]1c1cc(F)cc(F)c1)Nc1ccc2c(c1)C[C@@]1(C2)C(=O)Nc2ncccc21,1,0.9853674173355103,0.9853674173355103,O=C1C2(NC[C@@H](C3=CC(F)=CC(F)=C3)N1CC(NC4=CC5=C(C[C@@]6(C(NC7=C6C=CC=N7)=O)C5)C=C4)=O)CCCC2.Cl,MK-3207 (Hydrochloride),Data.sdf,1352,HY-10302,,957116-20-0,CGRP Receptor,GPCR/G Protein; Neuronal Signaling,C31H30ClF2N5O3,10mM,Neurological Disease,Phase 2,O=C(CN1C(=O)C2(CCCC2)NC[C@H]1c1cc(F)cc(F)c1)Nc1ccc2c(c1)C[C@@]1(C2)C(=O)Nc2ncccc21,清洗成功,0.2403846153846154
832,COC(=O)c1sc(-c2cccs2)cc1NC(=O)/C=C/C(=O)O,1,0.9853643774986267,0.9853643774986267,O=C(C1=C(NC(/C=C/C(O)=O)=O)C=C(C2=CC=CS2)S1)OC,HTS01037,Data.sdf,954,HY-101503,,682741-29-3,FABP,Metabolic Enzyme/Protease,C14H11NO5S2,10mM,Metabolic Disease,No Development Reported,COC(=O)c1sc(-c2cccs2)cc1NC(=O)/C=C/C(=O)O,清洗成功,0.2622950819672131
4151,Cc1c2c(c(O)c3c(O)cccc13)C(=O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]1C2,1,0.985353410243988,0.985353410243988,O=C(C(C1=O)=C(O)[C@@H](N(C)C)[C@]2([H])CC3=C(C([C@@]21O)=O)C(O)=C4C(O)=CC=CC4=C3C)N.[H]Cl,Anhydrotetracycline (hydrochloride),Data.sdf,4887,HY-118660,,13803-65-1,Antibiotic; Bacterial,Anti-infection,C22H23ClN2O7,10mM,Infection,No Development Reported,Cc1c2c(c(O)c3c(O)cccc13)C(=O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]1C2,清洗成功,0.2054794520547945
6929,CC1(C)CC[C@]2(C(=O)n3cnc(-c4cccnc4)c3)CC[C@]3(C)[C@H](C(=O)C=C4[C@@]5(C)C=C(C#N)C(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,1,0.9853475093841553,0.9853475093841553,CC(C)([C@](CC[C@@]([C@@]1(CC[C@]2(CCC(C)(C[C@]2([C@]13[H])[H])C)C(N4C=C(C5=CC=CN=C5)N=C4)=O)C)6C)7[H])C(C(C#N)=C[C@]7(C)C6=CC3=O)=O,CDDO-3P-Im,Data.sdf,8220,HY-135953,,1883650-95-0,Apoptosis,Apoptosis,C39H46N4O3,10mM,Cancer,No Development Reported,CC1(C)CC[C@]2(C(=O)n3cnc(-c4cccnc4)c3)CC[C@]3(C)[C@H](C(=O)C=C4[C@@]5(C)C=C(C#N)C(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,清洗成功,0.2156862745098039
7931,CC1(C)Oc2ccc(C#N)cc2[C@@H](N2CCCC2=O)[C@@H]1O,1,0.9853461980819702,0.9853461980819702,CC(O1)(C)[C@@H](O)[C@H](N2CCCC2=O)C3=C1C=CC(C#N)=C3,Levcromakalim,Data.sdf,9372,HY-14255,(-)-Cromakalim; BRL 38227,94535-50-9,Potassium Channel,Membrane Transporter/Ion Channel,C16H18N2O3,10mM,Cardiovascular Disease,No Development Reported,CC1(C)Oc2ccc(C#N)cc2[C@@H](N2CCCC2=O)[C@@H]1O,清洗成功,0.3194444444444444
7997,CCC(Sc1nc(N)nc2nc[nH]c12)C(=O)Nc1ccc(O)c(OC)c1,1,0.9853435754776001,0.9853435754776001,O=C(C(CC)SC1=NC(N)=NC2=C1NC=N2)NC3=CC=C(C(OC)=C3)O,Enpp-1-IN-12,Data.sdf,9445,HY-143256,,2631703-41-6,Phosphodiesterase (PDE),Metabolic Enzyme/Protease,C16H18N6O3S,10mM,Cancer,No Development Reported,CCC(Sc1nc(N)nc2nc[nH]c12)C(=O)Nc1ccc(O)c(OC)c1,清洗成功,0.2962962962962963
11041,[O-][n+]1cccc(-c2nc3c(Cl)cccc3cc2[C@@H](Nc2ncnc3cccnc23)C(F)(F)F)c1,1,0.9853290915489197,0.9853290915489197,FC(F)(F)[C@H](NC1=C2C(C=CC=N2)=NC=N1)C3=CC4=CC=CC(Cl)=C4N=C3C5=CC=C[N+]([O-])=C5,Seletalisib,Data.sdf,13081,HY-16754,UCB5857,1362850-20-1,PI3K,PI3K/Akt/mTOR,C23H14ClF3N6O,10mM,Inflammation/Immunology,Phase 2,[O-][n+]1cccc(-c2nc3c(Cl)cccc3cc2[C@@H](Nc2ncnc3cccnc23)C(F)(F)F)c1,清洗成功,0.2352941176470588
9393,CCCn1c(=O)c(-c2ccc(C(=O)NCc3cccnc3)cc2)nc2ccc(NC(=O)CCCCCCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)c3ccc(-c4scnc4C)cc3)C(C)(C)C)cc21,1,0.9853255152702332,0.9853255152702332,O=C(C(C1=CC=C(C=C1)C(NCC2=CN=CC=C2)=O)=NC3=C4C=C(C=C3)NC(CCCCCCCCCCC(N[C@@H](C(C)(C)C)C(N5C[C@H](O)C[C@H]5C(N[C@@H](C)C6=CC=C(C7=C(C)N=CS7)C=C6)=O)=O)=O)=O)N4CCC,Nampt degrader-2,Data.sdf,11088,HY-152154,,3035008-40-0,NAMPT; PROTACs,Metabolic Enzyme/Protease; PROTAC,C59H73N9O7S,10mM,Cancer,No Development Reported,CCCn1c(=O)c(-c2ccc(C(=O)NCc3cccnc3)cc2)nc2ccc(NC(=O)CCCCCCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)c3ccc(-c4scnc4C)cc3)C(C)(C)C)cc21,清洗成功,0.23841059602649
10743,COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OC4COC4)c(C)c3)nc2c1,1,0.985321581363678,0.985321581363678,O=C1NC(C2=CC(C)=C(OC3COC3)C(C)=C2)=NC4=C1C(OC)=CC(OC)=C4,BBC0403,Data.sdf,12729,HY-162514,,2644662-83-7,Epigenetic Reader Domain,Epigenetics,C21H22N2O5,10mM,Inflammation/Immunology,No Development Reported,COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OC4COC4)c(C)c3)nc2c1,清洗成功,0.2692307692307692
2682,CCN1CCN(c2ccc(C(C)(C)NC(=O)c3cc4[nH]c5ccccc5c(=O)c4cc3F)cn2)CC1,1,0.985317051410675,0.985317051410675,O=C1C2=CC(F)=C(C(NC(C)(C3=CN=C(N4CCN(CC)CC4)C=C3)C)=O)C=C2NC5=CC=CC=C15,BMS-566419,Data.sdf,3146,HY-110217,,566161-24-8,IMPDH,Metabolic Enzyme/Protease,C28H30FN5O2,10mM,Others,No Development Reported,CCN1CCN(c2ccc(C(C)(C)NC(=O)c3cc4[nH]c5ccccc5c(=O)c4cc3F)cn2)CC1,清洗成功,0.3069306930693069
5202,Cc1cc(=O)c2c(O)cc(OCC3CS3)cc2o1,1,0.9853147268295288,0.9853147268295288,O=C1C=C(C)OC2=C1C(O)=CC(OCC3SC3)=C2,HSP27 inhibitor J2,Data.sdf,6125,HY-124653,J2,2133499-85-9,HSP,Cell Cycle/DNA Damage; Metabolic Enzyme/Protease,C13H12O4S,10mM,Cancer,No Development Reported,Cc1cc(=O)c2c(O)cc(OCC3CS3)cc2o1,清洗成功,0.3235294117647059
14903,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)cc4)oc4cc(O[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@H]2O)[C@H](O)[C@H](O)[C@H]1O,1,0.9853124022483826,0.9853124022483826,O=C1C(O[C@H]2[C@@H]([C@H]([C@H]([C@@H](CO[C@H]3[C@@H]([C@@H]([C@H]([C@H](C)O3)O)O)O)O2)O)O)O)=C(C4=CC=C(O)C=C4)OC5=CC(O[C@H]6[C@@H]([C@@H]([C@H]([C@H](C)O6)O)O)O)=CC(O)=C15,Robinin,Data.sdf,17690,HY-N1346,,301-19-9,Apoptosis; Toll-like Receptor (TLR),Apoptosis; Immunology/Inflammation,C33H40O19,10mM,Inflammation/Immunology; Cancer,No Development Reported,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)cc4)oc4cc(O[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@H]2O)[C@H](O)[C@H](O)[C@H]1O,清洗成功,0.2727272727272727
5131,CC(=O)NCCSc1nc2cscc2c(=O)n1-c1ccc(OCC(F)(F)F)cc1,1,0.9853060245513916,0.9853060245513916,CC(NCCSC1=NC2=CSC=C2C(N1C3=CC=C(OCC(F)(F)F)C=C3)=O)=O,T-3364366,Data.sdf,6043,HY-124346,,1356354-09-0,Stearoyl-CoA Desaturase (SCD),Metabolic Enzyme/Protease,C18H16F3N3O3S2,10mM,Metabolic Disease,No Development Reported,CC(=O)NCCSc1nc2cscc2c(=O)n1-c1ccc(OCC(F)(F)F)cc1,清洗成功,0.2597402597402597
18066,Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1,1,0.9853024482727051,0.9853024482727051,O=S1(CCN(CC1)CC2=CC=C(C3=CC=CC4=NC(N)=NN43)C=C2)=O,GS-829845,Data.sdf,21540,HY-W394903,,1257705-09-1,Drug Metabolite; JAK,Epigenetics; JAK/STAT Signaling; Metabolic Enzyme/Protease; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt,C17H19N5O2S,10mM,Cancer,No Development Reported,Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1,清洗成功,0.325
2579,CC1(C)Oc2ccc(C#N)cc2[C@H](N2CCCC2=O)[C@H]1O,1,0.9853007197380066,0.9853007197380066,O[C@@H]1[C@@H](N2C(CCC2)=O)C3=CC(C#N)=CC=C3OC1(C)C,Cromakalim,Data.sdf,3026,HY-110011,BRL 34915,94470-67-4,Potassium Channel,Membrane Transporter/Ion Channel,C16H18N2O3,10mM,Inflammation/Immunology,No Development Reported,CC1(C)Oc2ccc(C#N)cc2[C@H](N2CCCC2=O)[C@H]1O,清洗成功,0.3194444444444444
4714,CNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1cccc(CN(C)C)c1)c1ccccc1,1,0.9852893948554993,0.9852893948554993,O=C(C1=CC(NC/2=O)=C(C=C1)C2=C(NC3=CC=CC(CN(C)C)=C3)/C4=CC=CC=C4)NC,MEK inhibitor,Data.sdf,5536,HY-12202,,334951-92-7,MEK,MAPK/ERK Pathway,C26H26N4O2,10mM,Cancer,No Development Reported,CNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1cccc(CN(C)C)c1)c1ccccc1,清洗成功,0.3181818181818182
7392,CCN(CC)c1ccc2cc(-c3nc4ccccc4o3)c(=O)oc2c1,1,0.9852893948554993,0.9852893948554993,O=C1C(C2=NC3=CC=CC=C3O2)=CC4=CC=C(N(CC)CC)C=C4O1,EMI1,Data.sdf,8745,HY-138072,,35773-42-3,EGFR,JAK/STAT Signaling; Protein Tyrosine Kinase/RTK,C20H18N2O3,10mM,Cancer,No Development Reported,CCN(CC)c1ccc2cc(-c3nc4ccccc4o3)c(=O)oc2c1,清洗成功,0.2571428571428571
3812,COC(=O)C[C@H]1[C@]2(C)C3=C(C)[C@H](c4ccoc4)C[C@H]3O[C@@H]2[C@@H]2OC(=O)[C@]3(C)C=CC(=O)[C@@]1(C)[C@@H]23,1,0.9852553606033325,0.9852553606033325,C[C@]12[C@@]3([H])[C@](OC([C@@]3(C=CC2=O)C)=O)([H])[C@]4([H])[C@]([C@@H]1CC(OC)=O)(C5=C(C)[C@@](C6=COC=C6)([H])C[C@@]5([H])O4)C,Nimbolide,Data.sdf,4489,HY-116035,,25990-37-8,Apoptosis; CDK; NF-?oB,Apoptosis; Cell Cycle/DNA Damage; NF-?oB,C27H30O7,10mM,Cancer,No Development Reported,COC(=O)C[C@H]1[C@]2(C)C3=C(C)[C@H](c4ccoc4)C[C@H]3O[C@@H]2[C@@H]2OC(=O)[C@]3(C)C=CC(=O)[C@@]1(C)[C@@H]23,清洗成功,0.1698113207547169
1701,COc1ccc(C(C)(C)NC(=O)[C@H]2CC[C@H]3[C@@H]4CC[C@H]5NC(=O)C=C[C@]5(C)[C@H]4CC[C@]23C)cc1,1,0.9852317571640015,0.9852317571640015,C[C@@]12[C@](CC[C@@H]2C(NC(C)(C3=CC=C(C=C3)OC)C)=O)([H])[C@@]4([H])[C@@](CC1)([H])[C@@]5([C@@](NC(C=C5)=O)([H])CC4)C,Lapisteride,Data.sdf,2013,HY-106174,CS 891,142139-60-4,5 alpha Reductase,Metabolic Enzyme/Protease,C29H40N2O3,10mM,Cancer,No Development Reported,COc1ccc(C(C)(C)NC(=O)[C@H]2CC[C@H]3[C@@H]4CC[C@H]5NC(=O)C=C[C@]5(C)[C@H]4CC[C@]23C)cc1,清洗成功,0.2368421052631578
6621,NC1=N[C@@](c2cccc(-c3cncnc3)c2)(c2ccnc(C(F)F)c2)c2cccc(F)c21,1,0.9851483106613159,0.9851483106613159,FC1=C2C([C@](C3=CC=CC(C4=CN=CN=C4)=C3)(C5=CC(C(F)F)=NC=C5)N=C2N)=CC=C1,AZD3839 (free base),Data.sdf,7858,HY-13438,,1227163-84-9,Beta-secretase,Neuronal Signaling,C24H16F3N5,10mM,Neurological Disease,Phase 1,NC1=N[C@@](c2cccc(-c3cncnc3)c2)(c2ccnc(C(F)F)c2)c2cccc(F)c21,清洗成功,0.2317073170731707
9882,Cc1cc(N(C)CCOCCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)NCc2ccc(-c3scnc3C)cc2)C(C)(C)C)nc(Nc2ccc(NC(=O)Cc3ccccc3)cc2)n1,1,0.985142171382904,0.985142171382904,O=C(CCOCCN(C1=CC(C)=NC(NC2=CC=C(NC(CC3=CC=CC=C3)=O)C=C2)=N1)C)N[C@@H](C(C)(C)C)C(N4[C@H](C(NCC5=CC=C(C6=C(C)N=CS6)C=C5)=O)C[C@@H](O)C4)=O,PROTAC TG2 degrader-2,Data.sdf,11678,HY-155102,,,Glutaminase; PROTACs,Metabolic Enzyme/Protease; PROTAC,C47H57N9O6S,10mM,Cancer,No Development Reported,Cc1cc(N(C)CCOCCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)NCc2ccc(-c3scnc3C)cc2)C(C)(C)C)nc(Nc2ccc(NC(=O)Cc3ccccc3)cc2)n1,清洗成功,0.2465753424657534
15349,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)cc4)oc4cc(O)cc(O)c4c3=O)[C@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,1,0.9851258993148804,0.9851258993148804,O=C1C(O[C@H]2[C@@H]([C@H]([C@H](O)[C@@H](CO[C@H]3[C@@H]([C@@H]([C@@H](O)[C@H](C)O3)O)O)O2)O)O[C@]4([H])O[C@@H]([C@H](O)[C@H](O)[C@H]4O)CO)=C(C5=CC=C(O)C=C5)OC6=CC(O)=CC(O)=C61,Camelliaside A,Data.sdf,18281,HY-N2524,,135095-52-2,Others,Others,C33H40O20,10mM,Inflammation/Immunology,No Development Reported,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)cc4)oc4cc(O)cc(O)c4c3=O)[C@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,清洗成功,0.2872340425531915
3520,CNc1ccc(-c2cc3cc(O)ccc3o2)c(F)n1,1,0.9851205945014954,0.9851205945014954,OC1=CC=C(OC(C2=CC=C(NC)N=C2F)=C3)C3=C1,AZD4694,Data.sdf,4142,HY-113938,NAV4694,1054629-49-0,Amyloid-?2,Neuronal Signaling,C14H11FN2O2,10mM,Cardiovascular Disease,No Development Reported,CNc1ccc(-c2cc3cc(O)ccc3o2)c(F)n1,清洗成功,0.34
16677,CC(C)C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O,1,0.9851169586181641,0.9851169586181641,OC(C=C1)=CC=C1C[C@H](NC([C@H](CO)NC([C@@H](NC([C@H](NC([C@H]2NC(CC2)=O)=O)CC3=CN=CN3)=O)CC4=CNC5=CC=CC=C45)=O)=O)C(N[C@@H](C(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(N)=N)C(N6[C@@H](CCC6)C(NCC(N)=O)=O)=O)=O)=O)CC7=CNC8=CC=CC=C78)=O,"(D-His2,D-Trp6)-LHRH",Data.sdf,19865,HY-P4534,(D-His2)-Triptorelin,321709-34-6,GnRH Receptor,GPCR/G Protein,C64H82N18O13,10mM,Others,No Development Reported,CC(C)C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O,清洗成功,0.2313432835820895
6703,CONC(=O)Nc1ccc(-n2nc3c(c2CN(C)C)c(=O)n(-c2ccc(OC)nn2)c(=O)n3Cc2c(F)cccc2F)cc1,1,0.9851130247116089,0.9851130247116089,O=C(NOC)NC1=CC=C(N2N=C(C(C(N3C4=NN=C(OC)C=C4)=O)=C2CN(C)C)N(CC5=C(F)C=CC=C5F)C3=O)C=C1,GnRH antagonist 2,Data.sdf,7955,HY-134864,,1709823-61-9,GnRH Receptor,GPCR/G Protein,C28H27F2N9O5,10mM,Endocrinology,No Development Reported,CONC(=O)Nc1ccc(-n2nc3c(c2CN(C)C)c(=O)n(-c2ccc(OC)nn2)c(=O)n3Cc2c(F)cccc2F)cc1,清洗成功,0.2277227722772277
15659,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)cc4)oc4cc(O)cc(O)c4c3=O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,1,0.9850989580154419,0.9850989580154419,O=C1C(O[C@H]2[C@@H]([C@H]([C@H](O)[C@@H](CO[C@H]3[C@@H]([C@@H]([C@@H](O)[C@H](C)O3)O)O)O2)O)O[C@]4([H])O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)CO)=C(C5=CC=C(O)C=C5)OC6=CC(O)=CC(O)=C61,Kaempferol-3-O-(2''-O-?2-D-glucopyl)-?2-D-rutinoside,Data.sdf,18696,HY-N5119,,55696-58-7,Others,Others,C33H40O20,2mM,Others,No Development Reported,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)cc4)oc4cc(O)cc(O)c4c3=O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,清洗成功,0.2872340425531915
10095,Cc1c(-c2ccnn2C)cc(C(=O)NCc2ccc(S(C)(=O)=O)cn2)c(=O)n1-c1cccc(C(F)(F)F)c1,1,0.9850732684135437,0.9850732684135437,O=C(C1=CC(C2=CC=NN2C)=C(C)N(C3=CC=CC(C(F)(F)F)=C3)C1=O)NCC4=NC=C(S(=O)(C)=O)C=C4,Alvelestat,Data.sdf,11943,HY-15651,AZD9668,848141-11-7,Elastase,Metabolic Enzyme/Protease,C25H22F3N5O4S,10mM,Inflammation/Immunology,Phase 2,Cc1c(-c2ccnn2C)cc(C(=O)NCc2ccc(S(C)(=O)=O)cn2)c(=O)n1-c1cccc(C(F)(F)F)c1,清洗成功,0.268041237113402
1796,[N-]=[N+]=N[C@H]1C[C@H](n2ccc(=O)[nH]c2=O)O[C@@H]1CO,1,0.9850705862045288,0.9850705862045288,OC[C@H]([C@@H](N=[N+]=[N-])C1)O[C@H]1N(C=C2)C(NC2=O)=O,3a??Azido-2a??3a??dideoxyuridine,Data.sdf,2127,HY-106850,AzdU; AzddU; CS-87,84472-85-5,HIV,Anti-infection,C9H11N5O4,10mM,Infection,No Development Reported,[N-]=[N+]=N[C@H]1C[C@H](n2ccc(=O)[nH]c2=O)O[C@@H]1CO,清洗成功,0.1910112359550561
8155,COc1ccc(-c2nc(SC)nc(N/N=C/c3cc(OC)c(OC)c(OC)c3)c2C#N)cc1,1,0.9850599765777588,0.9850599765777588,N#CC1=C(N/N=C/C2=CC(OC)=C(OC)C(OC)=C2)N=C(SC)N=C1C3=CC=C(OC)C=C3,PI3K/AKT-IN-1,Data.sdf,9629,HY-144806,,3033069-84-7,Akt; Apoptosis; PI3K,Apoptosis; PI3K/Akt/mTOR,C23H23N5O4S,10mM,Cancer,No Development Reported,COc1ccc(-c2nc(SC)nc(N/N=C/c3cc(OC)c(OC)c(OC)c3)c2C#N)cc1,清洗成功,0.2777777777777778
9717,CCOC(=O)c1ccc(C#Cc2ccc3c(c2)C(C)(C)CCS3)nc1,1,0.9850591421127319,0.9850591421127319,O=C(C1=CC=C(C#CC2=CC=C3C(C(C)(C)CCS3)=C2)N=C1)OCC,Tazarotene,Data.sdf,11481,HY-15388,AGN 190168,118292-40-3,Autophagy; RAR/RXR,Autophagy; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor,C21H21NO2S,10mM,Inflammation/Immunology; Cancer,Launched,CCOC(=O)c1ccc(C#Cc2ccc3c(c2)C(C)(C)CCS3)nc1,清洗成功,0.2666666666666666
16374,CCCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](N)Cc1ccc(O)cc1)C(C)C)C(N)=O,1,0.9850553274154663,0.9850553274154663,CCCC[C@@H](C(N)=O)NC([C@@H](NC([C@@H](NC(CCNC([C@H](C(C)C)NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](CC1=CC=C(O)C=C1)N)=O)CCC(N)=O)=O)CC2=CNC3=C2C=CC=C3)=O)C)=O)=O)=O)CC4=CN=CN4)=O)CC5=CC=CC=C5)=O.O=C(O)C(F)(F)F,BA 1 (TFA),Data.sdf,19553,HY-P1423A,,,Bombesin Receptor,GPCR/G Protein,C59H77F3N14O13,10mM,Cancer; Metabolic Disease,No Development Reported,CCCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CCNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](N)Cc1ccc(O)cc1)C(C)C)C(N)=O,清洗成功,0.2809917355371901
3097,N[C@@H]1CCCN(c2c(Br)cnc3[nH]cc(NC(=O)C4CC4)c23)C1,1,0.9850541949272156,0.9850541949272156,O=C(C1CC1)NC2=CNC3=NC=C(Br)C(N4C[C@H](N)CCC4)=C32,GDC-0575,Data.sdf,3625,HY-112167,ARRY-575; RG7741,1196541-47-5,Checkpoint Kinase (Chk),Cell Cycle/DNA Damage,C16H20BrN5O,10mM,Cancer,Phase 1,N[C@@H]1CCCN(c2c(Br)cnc3[nH]cc(NC(=O)C4CC4)c23)C1,清洗成功,0.3289473684210526
3098,N[C@@H]1CCCN(c2c(Br)cnc3[nH]cc(NC(=O)C4CC4)c23)C1,1,0.9850541949272156,0.9850541949272156,O=C(C1CC1)NC2=CNC3=NC=C(Br)C(N4C[C@H](N)CCC4)=C32.[H]Cl.[H]Cl,GDC-0575 (dihydrochloride),Data.sdf,3626,HY-112167A,ARRY-575 (dihydrochloride); RG7741 (dihydrochloride),1657014-42-0,Checkpoint Kinase (Chk),Cell Cycle/DNA Damage,C16H22BrCl2N5O,10mM,Cancer,Phase 1,N[C@@H]1CCCN(c2c(Br)cnc3[nH]cc(NC(=O)C4CC4)c23)C1,清洗成功,0.3246753246753247
8178,O=C(Nc1cccc(-c2ccn[nH]2)c1)c1ccc(C(F)(F)F)[nH]c1=O,1,0.9850499033927917,0.9850499033927917,O=C(C1=CC=C(NC1=O)C(F)(F)F)NC2=CC(C3=CC=NN3)=CC=C2,NRX-1532,Data.sdf,9656,HY-144982,,,?2-catenin,Stem Cell/Wnt,C16H11F3N4O2,10mM,Cancer,No Development Reported,O=C(Nc1cccc(-c2ccn[nH]2)c1)c1ccc(C(F)(F)F)[nH]c1=O,清洗成功,0.3013698630136986
4225,CCOc1ccc(-c2nn3ncccc3c2-c2ccc(S(C)(=O)=O)cc2)cc1,1,0.985040545463562,0.985040545463562,O=S(C1=CC=C(C=C1)C2=C3C=CC=NN3N=C2C4=CC=C(C=C4)OCC)(C)=O,GW-406381,Data.sdf,4969,HY-119304,,221148-46-5,COX,Immunology/Inflammation,C21H19N3O3S,10mM,Inflammation/Immunology; Neurological Disease,Phase 3,CCOc1ccc(-c2nn3ncccc3c2-c2ccc(S(C)(=O)=O)cc2)cc1,清洗成功,0.3174603174603174
9622,COC(=O)C[C@@H]1N=C(c2ccc(-c3ccc(C(=O)NCc4ccc(S(=O)(=O)Nc5ccc(C)c6c(C#N)c[nH]c56)cc4)cc3)cc2)c2c(sc(C)c2C)-n2c(C)nnc21,1,0.9850401878356934,0.9850401878356934,CC1=C(C)SC2=C1C(C3=CC=C(C4=CC=C(C=C4)C(NCC5=CC=C(C=C5)S(NC6=C7C(C(C#N)=CN7)=C(C=C6)C)(=O)=O)=O)C=C3)=N[C@@H](CC(OC)=O)C8=NN=C(C)N28,PROTAC BRD4 Degrader-19,Data.sdf,11366,HY-153459,,2684292-71-3,Epigenetic Reader Domain; PROTACs,Epigenetics; PROTAC,C44H38N8O5S2,10mM,Cancer,No Development Reported,COC(=O)C[C@@H]1N=C(c2ccc(-c3ccc(C(=O)NCc4ccc(S(=O)(=O)Nc5ccc(C)c6c(C#N)c[nH]c56)cc4)cc3)cc2)c2c(sc(C)c2C)-n2c(C)nnc21,清洗成功,0.2424242424242424
10028,COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1,1,0.9850104451179504,0.9850104451179504,O=C(OC)N[C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C3=CC(Cl)=CC(NS(=O)(C)=O)=C3F)=N1,Encorafenib,Data.sdf,11861,HY-15605,LGX818,1269440-17-6,Raf,MAPK/ERK Pathway,C22H27ClFN7O4S,10mM,Cancer,Launched,COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1,清洗成功,0.3023255813953488
16104,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](O[C@H]3[C@H](Oc4c(-c5ccc(O)cc5)oc5cc(O)cc(O)c5c4=O)O[C@H](CO)[C@@H](O)[C@@H]3O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,1,0.985005795955658,0.985005795955658,O=C1C(O[C@H](O[C@@H]2CO)[C@@H]([C@H]([C@@H]2O)O)O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]([C@H]3O)CO[C@H](O[C@H]4C)[C@@H]([C@@H]([C@H]4O)O)O)=C(C(C=C5)=CC=C5O)OC6=CC(O)=CC(O)=C16,Kaempferol-3-O-?±-L-rhamnopyranosyl-(1a??)-?2-D-glucopyranosyl-(1a??)-?2-D-glucopyranoside,Data.sdf,19250,HY-N8163,,476617-49-9,Others,Others,C33H40O20,10mM,Others,No Development Reported,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](O[C@H]3[C@H](Oc4c(-c5ccc(O)cc5)oc5cc(O)cc(O)c5c4=O)O[C@H](CO)[C@@H](O)[C@@H]3O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,清洗成功,0.2872340425531915
10144,Cc1c([C@@H](NC(=O)Nc2cnc(N)nc2)C(F)(F)F)oc2c(F)cc(F)cc12,1,0.9849990010261536,0.9849990010261536,NC1=NC=C(C=N1)NC(N[C@H](C2=C(C3=CC(F)=CC(F)=C3O2)C)C(F)(F)F)=O,Tersolisib,Data.sdf,12001,HY-156681,STX-478,2883540-92-7,PI3K,PI3K/Akt/mTOR,C16H12F5N5O2,10mM,Cancer,Phase 2,Cc1c([C@@H](NC(=O)Nc2cnc(N)nc2)C(F)(F)F)oc2c(F)cc(F)cc12,清洗成功,0.2784810126582278
10145,Cc1c([C@H](NC(=O)Nc2cnc(N)nc2)C(F)(F)F)oc2c(F)cc(F)cc12,1,0.9849990010261536,0.9849990010261536,NC1=NC=C(C=N1)NC(N[C@@H](C2=C(C3=CC(F)=CC(F)=C3O2)C)C(F)(F)F)=O,(S)-Tersolisib,Data.sdf,12002,HY-156681A,(S)-STX-478,2883540-91-6,PI3K,PI3K/Akt/mTOR,C16H12F5N5O2,10mM,Cancer,No Development Reported,Cc1c([C@H](NC(=O)Nc2cnc(N)nc2)C(F)(F)F)oc2c(F)cc(F)cc12,清洗成功,0.2784810126582278
8213,COc1cc(C(=O)N2CCC(c3nc4ccccc4n3Cc3cccc(F)c3)CC2)ccc1OCc1cccc(F)c1,1,0.9849908947944641,0.9849908947944641,O=C(N1CCC(CC1)C2=NC3=C(N2CC4=CC(F)=CC=C4)C=CC=C3)C5=CC=C(C(OC)=C5)OCC6=CC(F)=CC=C6,AZ194,Data.sdf,9698,HY-145169,,2241651-99-8,Sodium Channel,Membrane Transporter/Ion Channel,C34H31F2N3O3,10mM,Neurological Disease,No Development Reported,COc1cc(C(=O)N2CCC(c3nc4ccccc4n3Cc3cccc(F)c3)CC2)ccc1OCc1cccc(F)c1,清洗成功,0.2980769230769231
4855,Nc1nc2cc(-c3ccc4ncc(C(=O)N5CCOCC5)n4c3)ccc2o1,1,0.9849863648414612,0.9849863648414612,O=C(C1=CN=C2C=CC(C3=CC=C(OC(N)=N4)C4=C3)=CN21)N5CCOCC5,Serabelisib,Data.sdf,5714,HY-12285,MLN1117; INK1117; TAK-117,1268454-23-4,PI3K,PI3K/Akt/mTOR,C19H17N5O3,10mM,Cancer,Phase 2,Nc1nc2cc(-c3ccc4ncc(C(=O)N5CCOCC5)n4c3)ccc2o1,清洗成功,0.3333333333333333
15653,CC(C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@@H]1Cc2cc3ccc(=O)oc3cc2O1,1,0.9849829077720642,0.9849829077720642,O=C1C=CC2=CC3=C(O[C@H](C(C)(O[C@H]4[C@@H]([C@H]([C@@H]([C@@H](CO)O4)O)O)O)C)C3)C=C2O1,Marmesinin,Data.sdf,18688,HY-N5110,(-)-Marmesinin; Ammijin,495-30-7,Others,Others,C20H24O9,10mM,Neurological Disease,No Development Reported,CC(C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@@H]1Cc2cc3ccc(=O)oc3cc2O1,清洗成功,0.2891566265060241
11613,Nc1nccc(Oc2ccc(NC(=O)c3cn(COP(=O)(O)O)cc(-c4ccc(F)cc4)c3=O)cc2F)c1Cl,1,0.9849638342857361,0.9849638342857361,O=C(C1=CN(COP(O)(O)=O)C=C(C2=CC=C(F)C=C2)C1=O)NC3=CC=C(OC4=C(Cl)C(N)=NC=C4)C(F)=C3,SCR-1481B1 (free base),Data.sdf,13741,HY-18711,Metatinib (free base); c-Met inhibitor 2 (free base),1174161-69-3,c-Met/HGFR; VEGFR,Protein Tyrosine Kinase/RTK,C24H18ClF2N4O7P,10mM,cancer,No Development Reported,Nc1nccc(Oc2ccc(NC(=O)c3cn(COP(=O)(O)O)cc(-c4ccc(F)cc4)c3=O)cc2F)c1Cl,清洗成功,0.3111111111111111
11614,Nc1nccc(Oc2ccc(NC(=O)c3cn(COP(=O)(O)O)cc(-c4ccc(F)cc4)c3=O)cc2F)c1Cl,1,0.9849638342857361,0.9849638342857361,O=C(C1=CN(COP(O)(O)=O)C=C(C2=CC=C(F)C=C2)C1=O)NC3=CC=C(C(F)=C3)OC4=C(Cl)C(N)=NC=C4.OCC(CO)(CO)N.OCC(CO)(CO)N,SCR-1481B1,Data.sdf,13742,HY-18711A,Metatinib (anhydrous); c-Met inhibitor 2,1174161-86-4,c-Met/HGFR; VEGFR,Protein Tyrosine Kinase/RTK,C32H40ClF2N6O13P,10mM,Cancer,No Development Reported,Nc1nccc(Oc2ccc(NC(=O)c3cn(COP(=O)(O)O)cc(-c4ccc(F)cc4)c3=O)cc2F)c1Cl,清洗成功,0.3052631578947368
2782,Cc1cc(-c2nc3sc4c(c3c(=O)[nH]2)CCN(C)C4)cc(C)c1O,1,0.9849446415901184,0.9849446415901184,CN1CCC2=C(SC(N=C(C3=CC(C)=C(O)C(C)=C3)N4)=C2C4=O)C1,FL-411,Data.sdf,3271,HY-111102,BRD4-IN-1,2118944-88-8,Epigenetic Reader Domain,Epigenetics,C18H19N3O2S,10mM,Cancer,No Development Reported,Cc1cc(-c2nc3sc4c(c3c(=O)[nH]2)CCN(C)C4)cc(C)c1O,清洗成功,0.2567567567567567
5408,Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOc2ccc(-c3cc(Nc4ccc(OC(F)(F)F)cc4)ncn3)cc2)C(C)(C)C)cc1,1,0.9849344491958618,0.9849344491958618,FC(F)(F)OC1=CC=C(NC2=CC(C3=CC=C(OCCOCC(N[C@@H](C(C)(C)C)C(N4[C@H](C(NCC5=CC=C(C6=C(C)N=CS6)C=C5)=O)C[C@@H](O)C4)=O)=O)C=C3)=NC=N2)C=C1,GMB-475,Data.sdf,6373,HY-125834,,2490599-18-1,Apoptosis; Bcr-Abl; JAK; PROTACs; STAT,Apoptosis; Epigenetics; JAK/STAT Signaling; PROTAC; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt,C43H46F3N7O7S,10mM,Cancer,No Development Reported,Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOc2ccc(-c3cc(Nc4ccc(OC(F)(F)F)cc4)ncn3)cc2)C(C)(C)C)cc1,清洗成功,0.2230769230769231
2474,O=C(Nc1cc(Nc2ccc(Cl)c(Cl)c2)nc2ccccc12)C1CCCCC1,1,0.984933078289032,0.984933078289032,O=C(NC1=CC(NC2=CC=C(Cl)C(Cl)=C2)=NC3=CC=CC=C31)C4CCCCC4,LUF6096,Data.sdf,2902,HY-10915,,1116652-18-6,Adenosine Receptor,GPCR/G Protein,C22H21Cl2N3O,10mM,Cardiovascular Disease,No Development Reported,O=C(Nc1cc(Nc2ccc(Cl)c(Cl)c2)nc2ccccc12)C1CCCCC1,清洗成功,0.3333333333333333
5038,O=c1[nH]c(N2CCC3(CC2)CN(CCO)c2cc(F)cc(F)c23)nc2c1CCCC2,1,0.9849292635917664,0.9849292635917664,O=C1NC(N2CCC3(CC2)CN(CCO)C4=C3C(F)=CC(F)=C4)=NC5=C1CCCC5,RK-287107,Data.sdf,5934,HY-123892,,2171386-10-8,PARP,Cell Cycle/DNA Damage; Epigenetics,C22H26F2N4O2,10mM,Cancer,No Development Reported,O=c1[nH]c(N2CCC3(CC2)CN(CCO)c2cc(F)cc(F)c23)nc2c1CCCC2,清洗成功,0.1888888888888888
11969,NC(=O)C1(NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](Cc2csc3ccccc23)NC(=O)C2CCNCC2)CCNCC1,1,0.9849289059638977,0.9849289059638977,NC(C1(NC([C@@H](NC([C@H](NC([C@H](NC(C2CCNCC2)=O)CC3=CSC4=CC=CC=C34)=O)CC5=CNC6=CC=CC=C56)=O)CC7=CC=CC=C7)=O)CCNCC1)=O.OC(C(F)(F)F)=O,Relamorelin (TFA),Data.sdf,14156,HY-19884B,RM-131 (TFA); BIM-28131 (TFA),2863659-22-5,GHSR,GPCR/G Protein,C45H51F3N8O7S,10mM,Metabolic Disease,Phase 3,NC(=O)C1(NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](Cc2csc3ccccc23)NC(=O)C2CCNCC2)CCNCC1,清洗成功,0.2692307692307692
10693,O=c1[nH]c(CCl)nc2cc(-c3ccc(Cl)cc3)sc12,1,0.9849219918251038,0.9849219918251038,ClC1=CC=C(C2=CC3=C(C(NC(CCl)=N3)=O)S2)C=C1,N6F11,Data.sdf,12673,HY-162065,,851398-76-0,Ferroptosis,Apoptosis,C13H8Cl2N2OS,10mM,Cancer,No Development Reported,O=c1[nH]c(CCl)nc2cc(-c3ccc(Cl)cc3)sc12,清洗成功,0.2985074626865671
5843,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(C(=O)CCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCc3ccc(-c4scnc4C)cc3)C(C)(C)C)CC2)n1,1,0.9849137663841248,0.9849137663841248,O=C(N1CCN(C2=NC(C)=NC(NC3=NC=C(C(NC4=C(C=CC=C4Cl)C)=O)S3)=C2)CC1)CCCCCCC(N[C@@H](C(C)(C)C)C(N5[C@@H](C[C@@H](O)C5)C(NCC6=CC=C(C7=C(N=CS7)C)C=C6)=O)=O)=O,SIAIS178,Data.sdf,6910,HY-128756,,2376047-73-1,Bcr-Abl; PROTACs,PROTAC; Protein Tyrosine Kinase/RTK,C50H62ClN11O6S2,10mM,Cancer,No Development Reported,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(C(=O)CCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCc3ccc(-c4scnc4C)cc3)C(C)(C)C)CC2)n1,清洗成功,0.2198581560283688
2555,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,1,0.9848649501800537,0.9848649501800537,O=C(N)C1=C(C=C2N=CC=C(C2=C1)OC3=CC=C(C(Cl)=C3)NC(NC4CC4)=O)OC,Lenvatinib,Data.sdf,2999,HY-10981,E7080,417716-92-8,c-Kit; FGFR; PDGFR; RET; VEGFR,Protein Tyrosine Kinase/RTK,C21H19ClN4O4,10mM,Cancer,Launched,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,清洗成功,0.3292682926829268
2556,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,1,0.9848649501800537,0.9848649501800537,O=C(C1=C(OC)C=C2N=CC=C(OC3=CC=C(NC(NC4CC4)=O)C(Cl)=C3)C2=C1)N.OS(=O)(C)=O,Lenvatinib (mesylate),Data.sdf,3000,HY-10981A,E7080 (mesylate),857890-39-2,c-Kit; FGFR; PDGFR; RET; VEGFR,Protein Tyrosine Kinase/RTK,C22H23ClN4O7S,10mM,Cancer,Launched,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,清洗成功,0.313953488372093
13709,CCC1(C)CC(=O)NC(=O)C1,1,0.9848620891571045,0.9848620891571045,O=C(CC(C)(CC)C1)NC1=O,Bemegride,Data.sdf,16162,HY-B1326,3-Ethyl-3-methylglutarimide; Bemegrid,64-65-3,GABA Receptor,Membrane Transporter/Ion Channel; Neuronal Signaling,C8H13NO2,10mM,Neurological Disease,Launched,CCC1(C)CC(=O)NC(=O)C1,清洗成功,0.1739130434782608
14750,CC(C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1Cc2cc3ccc(=O)oc3cc2O1,1,0.9848508834838867,0.9848508834838867,CC(C)([C@H]1CC2=CC(C=CC3=O)=C(O3)C=C2O1)O[C@@H]([C@@H]([C@@H](O)[C@@H]4O)O)O[C@@H]4CO,Nodakenin,Data.sdf,17479,HY-N0825,,495-31-8,Cholinesterase (ChE),Neuronal Signaling,C20H24O9,10mM,Inflammation/Immunology,No Development Reported,CC(C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1Cc2cc3ccc(=O)oc3cc2O1,清洗成功,0.2891566265060241
1268,CN1C(=O)C=C[C@]2(C)[C@H]3CC[C@]4(C)[C@@H](C(=O)Nc5ccccc5Cl)CC[C@H]4[C@@H]3CC[C@@H]12,1,0.9848474860191345,0.9848474860191345,O=C([C@H]1CC[C@]2([H])[C@]1(C)CC[C@]3([H])[C@@]4(C)C=CC(N(C)[C@]4([H])CC[C@]32[H])=O)NC5=CC=CC=C5Cl,Cl-4AS-1,Data.sdf,1478,HY-103245,,188589-66-4,Androgen Receptor,Vitamin D Related/Nuclear Receptor,C26H33ClN2O2,10mM,Cancer,No Development Reported,CN1C(=O)C=C[C@]2(C)[C@H]3CC[C@]4(C)[C@@H](C(=O)Nc5ccccc5Cl)CC[C@H]4[C@@H]3CC[C@@H]12,清洗成功,0.2117647058823529
3618,Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1cccc(OCCOCCOCCNc3cccc4nnn(C5CCC(=O)NC5=O)c(=O)c34)c1)c1nnc(C)n1-2,1,0.9848019480705261,0.9848019480705261,O=C(NC1=CC(OCCOCCOCCNC2=C3C(N=NN(C(CC4)C(NC4=O)=O)C3=O)=CC=C2)=CC=C1)C[C@H]5C6=NN=C(C)N6C7=C(C(C)=C(C)S7)C(C8=CC=C(Cl)C=C8)=N5,TD-428,Data.sdf,4259,HY-114407,,2334525-50-5,Epigenetic Reader Domain; PROTACs,Epigenetics; PROTAC,C43H43ClN10O7S,10mM,Cancer,No Development Reported,Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1cccc(OCCOCCOCCNc3cccc4nnn(C5CCC(=O)NC5=O)c(=O)c34)c1)c1nnc(C)n1-2,清洗成功,0.2131147540983606
14500,CC[C@]1(O)C[C@H]2C[N@@](CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,1,0.9847886562347412,0.9847886562347412,CC[C@@]1(C=CCN2CC3)[C@@]2([H])[C@@]3(C4=CC([C@](C5=C6C7=CC=CC=C7N5)(C[C@](C[C@](CC)(O)C8)([H])C[N@@]8CC6)C(OC)=O)=C(OC)C=C4N9C=O)[C@]9([H])[C@](C(OC)=O)(O)[C@@H]1OC(C)=O.O=S(O)(O)=O,Vincristine (sulfate),Data.sdf,17159,HY-N0488,Leurocristine (sulfate); NSC-67574 (sulfate); 22-Oxovincaleukoblastine (sulfate),2068-78-2,Apoptosis; Microtubule/Tubulin,Apoptosis; Cell Cycle/DNA Damage; Cytoskeleton,C46H58N4O14S,10mM,Cancer,Launched,CC[C@]1(O)C[C@H]2C[N@@](CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,清洗成功,0.2
2238,Cc1ccc2[nH]c(N)nc(=O)c2c1Sc1ccncc1,1,0.9847655296325684,0.9847655296325684,[H]Cl.O=C1N=C(N)NC2=C1C(SC3=CC=NC=C3)=C(C)C=C2.[H]Cl,Nolatrexed dihydrochloride,Data.sdf,2626,HY-108474,AG 337,152946-68-4,Thymidylate Synthase,Apoptosis,C14H14Cl2N4OS,10mM,Cancer,Phase 3,Cc1ccc2[nH]c(N)nc(=O)c2c1Sc1ccncc1,清洗成功,0.25
8879,O=c1ccccn1-c1ccc(N[C@H]2CC[C@H](Nc3ncc(OC(F)F)cn3)C2)nc1,1,0.9847375750541687,0.9847375750541687,O=C1N(C=CC=C1)C2=CN=C(N[C@@H]3C[C@H](CC3)NC4=NC=C(OC(F)F)C=N4)C=C2,AZD0780,Data.sdf,10475,HY-148673,PCSK9-IN-12,2455427-91-3,PCSK9,Metabolic Enzyme/Protease,C20H20F2N6O2,10mM,Metabolic Disease; Cardiovascular Disease,Phase 2,O=c1ccccn1-c1ccc(N[C@H]2CC[C@H](Nc3ncc(OC(F)F)cn3)C2)nc1,清洗成功,0.2527472527472527
10697,COc1ccc2c(c1)nc(NCCCCNC(=O)CC(C)C)c1nnc(C)n12,1,0.9847372174263,0.9847372174263,CC1=NN=C2C(NCCCCNC(CC(C)C)=O)=NC3=CC(OC)=CC=C3N21,DW71177,Data.sdf,12677,HY-162088,,2241311-72-6,Epigenetic Reader Domain,Epigenetics,C20H28N6O2,10mM,Inflammation/Immunology,No Development Reported,COc1ccc2c(c1)nc(NCCCCNC(=O)CC(C)C)c1nnc(C)n12,清洗成功,0.3461538461538461
14843,CNCCc1cc2c(c3c1ccc1cc4c(cc13)OCO4)OCO2,1,0.984710156917572,0.984710156917572,CNCCC1=C2C=CC3=CC(OCO4)=C4C=C3C2=C5OCOC5=C1,Seconeolitsine,Data.sdf,17600,HY-N10495,,2650074-56-7,Antibiotic; Bacterial; Topoisomerase,Anti-infection; Cell Cycle/DNA Damage,C19H17NO4,10mM,Infection,No Development Reported,CNCCc1cc2c(c3c1ccc1cc4c(cc13)OCO4)OCO2,清洗成功,0.25
6673,O=C(O)c1ccccc1NS(=O)(=O)c1cccc(-c2cnn(Cc3ccccc3)c2)c1,1,0.9847041368484497,0.9847041368484497,O=C(O)C1=CC=CC=C1NS(=O)(C2=CC=CC(C3=CN(CC4=CC=CC=C4)N=C3)=C2)=O,NITD-2,Data.sdf,7921,HY-134665,,1197896-79-9,Dengue Virus; DNA/RNA Synthesis; Flavivirus,Anti-infection; Cell Cycle/DNA Damage,C23H19N3O4S,10mM,Infection,No Development Reported,O=C(O)c1ccccc1NS(=O)(=O)c1cccc(-c2cnn(Cc3ccccc3)c2)c1,清洗成功,0.3026315789473684
4236,Cn1cc(-c2ccc3c(c2)ncn3-c2cc(NS(=O)(=O)C3CC3)cc(-c3ccc(F)cc3F)c2)cn1,1,0.9847033619880676,0.9847033619880676,CN(N=C1)C=C1C2=CC=C3C(N=CN3C4=CC(C5=CC=C(F)C=C5F)=CC(NS(C6CC6)(=O)=O)=C4)=C2,ODM-203,Data.sdf,4980,HY-119367,,1430723-35-5,FGFR; VEGFR,Protein Tyrosine Kinase/RTK,C26H21F2N5O2S,10mM,Cancer,Phase 1,Cn1cc(-c2ccc3c(c2)ncn3-c2cc(NS(=O)(=O)C3CC3)cc(-c3ccc(F)cc3F)c2)cn1,清洗成功,0.3103448275862069
12388,Cc1cccn2c(=O)c(/C=C(\C#N)c3nc4ccccc4s3)c(Oc3ccc(F)cc3)nc12,1,0.9847024083137512,0.9847024083137512,N#C/C(C1=NC2=CC=CC=C2S1)=C\C3=C(N=C4C(C)=CC=CN4C3=O)OC5=CC=C(C=C5)F,CCG-63808,Data.sdf,14665,HY-70075,,620113-73-7,RGS Protein,GPCR/G Protein,C25H15FN4O2S,2mM,Cancer,No Development Reported,Cc1cccn2c(=O)c(/C=C(\C#N)c3nc4ccccc4s3)c(Oc3ccc(F)cc3)nc12,清洗成功,0.2432432432432432
6633,O=C(O)c1cccc(-c2cnc(Nc3ccccc3F)o2)c1,1,0.9846900701522827,0.9846900701522827,O=C(O)C1=CC=CC(C2=CN=C(NC3=CC=CC=C3F)O2)=C1,NF-?o?? activator 2,Data.sdf,7871,HY-134477,,2375281-44-8,NF-?oB,NF-?oB,C16H11FN2O3,10mM,Neurological Disease,No Development Reported,O=C(O)c1cccc(-c2cnc(Nc3ccccc3F)o2)c1,清洗成功,0.3235294117647059
9585,CS(=O)(=O)c1ccc(C#N)cc1-c1cc(=O)c2c(F)cc(F)cc2[nH]1,1,0.9846241474151611,0.9846241474151611,FC1=C2C(NC(C3=C(S(C)(=O)=O)C=CC(C#N)=C3)=CC2=O)=CC(F)=C1,FX-909,Data.sdf,11323,HY-153344,,2924573-90-8,PPAR,Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor,C17H10F2N2O3S,10mM,Cancer,Phase 1,CS(=O)(=O)c1ccc(C#N)cc1-c1cc(=O)c2c(F)cc(F)cc2[nH]1,清洗成功,0.273972602739726
2970,COc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(Br)ccc3nc2OC)c2cccc(OC)c2F)cc(OC)n1,1,0.9846200942993164,0.9846200942993164,COC1=C(F)C([C@H](C2=CC3=CC(Br)=CC=C3N=C2OC)[C@](O)(C4=CC(OC)=NC(OC)=C4)CCN(C)C)=CC=C1,TBAJ-587,Data.sdf,3479,HY-111747,,2252316-16-6,Bacterial,Anti-infection,C30H33BrFN3O5,10mM,Infection; Cardiovascular Disease,Phase 1,COc1cc([C@](O)(CCN(C)C)[C@@H](c2cc3cc(Br)ccc3nc2OC)c2cccc(OC)c2F)cc(OC)n1,清洗成功,0.2150537634408602
10559,O=[N+]([O-])c1ccc(Sc2ccncn2)c([N+](=O)[O-])c1,1,0.9846092462539673,0.9846092462539673,[O-][N+](C1=CC=C(C([N+]([O-])=O)=C1)SC2=CC=NC=N2)=O,NSC-311068,Data.sdf,12515,HY-160638,,73768-68-0,TET Protein,Epigenetics,C10H6N4O4S,10mM,Cancer,No Development Reported,O=[N+]([O-])c1ccc(Sc2ccncn2)c([N+](=O)[O-])c1,清洗成功,0.3103448275862069
6109,Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCC(=O)N2CCN(CC[C@H](CSc3ccccc3)Nc3ccc(S(=O)(=O)NC(=O)c4ccc(N5CCN(CC6=C(c7ccc(Cl)cc7)CCC(C)(C)C6)CC5)cc4)cc3S(=O)(=O)C(F)(F)F)CC2)C(C)(C)C)cc1,1,0.9845987558364868,0.9845987558364868,CC1(C)CCC(C2=CC=C(Cl)C=C2)=C(C1)CN3CCN(C4=CC=C(C(NS(=O)(C5=CC(S(C(F)(F)F)(=O)=O)=C(N[C@@H](CSC6=CC=CC=C6)CCN7CCN(C(CCCCCC(N[C@@H](C(C)(C)C)C(N8[C@@H](C[C@@H](O)C8)C(N[C@H](C9=CC=C(C%10=C(N=CS%10)C)C=C9)C)=O)=O)=O)=O)CC7)C=C5)=O)=O)C=C4)CC3,DT2216,Data.sdf,7229,HY-130604,,2365172-42-3,Apoptosis; Bcl-2 Family; PROTACs,Apoptosis; PROTAC,C77H96ClF3N10O10S4,10mM,Cancer,Phase 2,Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCC(=O)N2CCN(CC[C@H](CSc3ccccc3)Nc3ccc(S(=O)(=O)NC(=O)c4ccc(N5CCN(CC6=C(c7ccc(Cl)cc7)CCC(C)(C)C6)CC5)cc4)cc3S(=O)(=O)C(F)(F)F)CC2)C(C)(C)C)cc1,清洗成功,0.1878787878787878
2235,Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)n1c(C)nc2ccccc21,1,0.9845935702323914,0.9845935702323914,O=S(N1C2=CC=CC=C2N=C1C)(C3=CC([N+]([O-])=O)=CC=C3C)=O,BI-6015,Data.sdf,2621,HY-108469,,93987-29-2,,GPCR/G Protein,C15H13N3O4S,10mM,Cancer; Metabolic Disease,No Development Reported,Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)n1c(C)nc2ccccc21,清洗成功,0.3424657534246575
17462,Oc1nc2cc(Cl)c(O)cc2o1,1,0.9845908880233765,0.9845908880233765,ClC1=CC(N=C2O)=C(O2)C=C1O,6-Hydroxy Chlorzoxazone,Data.sdf,20797,HY-W016221,,1750-45-4,Drug Metabolite,Metabolic Enzyme/Protease,C7H4ClNO3,10mM,Inflammation/Immunology,No Development Reported,Oc1nc2cc(Cl)c(O)cc2o1,清洗成功,0.2452830188679245
9335,Cn1ccc2cc(-c3cnc4ccc(C(=O)N5CCCCC5)cc4n3)ccc2c1=O,1,0.9845749139785767,0.9845749139785767,CN1C=CC2=CC(C3=CN=C4C=CC(C(N5CCCCC5)=O)=CC4=N3)=CC=C2C1=O,15-PGDH-IN-1,Data.sdf,11016,HY-151807,,2241676-74-2,15-PGDH,Metabolic Enzyme/Protease,C24H22N4O2,10mM,Metabolic Disease,No Development Reported,Cn1ccc2cc(-c3cnc4ccc(C(=O)N5CCCCC5)cc4n3)ccc2c1=O,清洗成功,0.3108108108108108
8114,CCCc1cc(-c2nc(-c3ccc(C)cc3)cs2)ccn1,1,0.9845597743988037,0.9845597743988037,CCCC1=NC=CC(C2=NC(C3=CC=C(C)C=C3)=CS2)=C1,Fatostatin,Data.sdf,9584,HY-14452,125B11,125256-00-0,Fatty Acid Synthase (FASN),Metabolic Enzyme/Protease,C18H18N2S,10mM,Cancer,No Development Reported,CCCc1cc(-c2nc(-c3ccc(C)cc3)cs2)ccn1,清洗成功,0.288135593220339
8115,CCCc1cc(-c2nc(-c3ccc(C)cc3)cs2)ccn1,1,0.9845597743988037,0.9845597743988037,CCCC1=NC=CC(C2=NC(C3=CC=C(C)C=C3)=CS2)=C1.[H]Br,Fatostatin (hydrobromide),Data.sdf,9585,HY-14452A,125B11 (hydrobromide),298197-04-3,Fatty Acid Synthase (FASN),Metabolic Enzyme/Protease,C18H19BrN2S,10mM,Cancer,No Development Reported,CCCc1cc(-c2nc(-c3ccc(C)cc3)cs2)ccn1,清洗成功,0.2833333333333333
11197,Cc1cc(CN2CCCCC2)cc(C)c1-c1ncn(C)c1-c1ccc(C#N)c2ccccc12,1,0.9845204949378967,0.9845204949378967,N#CC1=C2C=CC=CC2=C(C3=C(C4=C(C)C=C(CN5CCCCC5)C=C4C)N=CN3C)C=C1,NSD2-PWWP1-IN-2,Data.sdf,13259,HY-171120,,2797183-32-3,Histone Methyltransferase,Epigenetics,C29H30N4,10mM,Cancer,No Development Reported,Cc1cc(CN2CCCCC2)cc(C)c1-c1ncn(C)c1-c1ccc(C#N)c2ccccc12,清洗成功,0.2857142857142857
11838,COc1ccc2[nH]c3ccc4cc[n+](CCN5CCC(C6CCN(CC[n+]7ccc8ccc9[nH]c%10ccc(OC)cc%10c9c8c7)CC6)CC5)cc4c3c2c1,1,0.9845182299613953,0.9845182299613953,COC1=CC2=C(NC3=C2C4=C[N+](CCN5CCC(C6CCN(CC[N+]7=CC=C8C=CC(NC9=C%10C=C(OC)C=C9)=C%10C8=C7)CC6)CC5)=CC=C4C=C3)C=C1.[Cl-].[Cl-],Ditercalinium (chloride),Data.sdf,14003,HY-19587,NSC335153,74517-42-3,DNA/RNA Synthesis,Cell Cycle/DNA Damage,C46H50Cl2N6O2,2mM,Cancer,No Development Reported,COc1ccc2[nH]c3ccc4cc[n+](CCN5CCC(C6CCN(CC[n+]7ccc8ccc9[nH]c%10ccc(OC)cc%10c9c8c7)CC6)CC5)cc4c3c2c1,清洗成功,0.3108108108108108
1990,Cc1ccc(NC(=O)C(C)C)cc1C1CCN(Cc2ccc(Oc3ccc(F)c(F)c3)cc2)CC1,1,0.9844774007797241,0.9844774007797241,Cl[H].FC1=CC(OC(C=C2)=CC=C2CN3CCC(CC3)C4=CC(NC(C(C)C)=O)=CC=C4C)=CC=C1F,SNAP 94847 (hydrochloride),Data.sdf,2342,HY-107625A,,1781934-47-1,MCHR1 (GPR24),GPCR/G Protein; Neuronal Signaling,C29H33ClF2N2O2,10mM,Neurological Disease,No Development Reported,Cc1ccc(NC(=O)C(C)C)cc1C1CCN(Cc2ccc(Oc3ccc(F)c(F)c3)cc2)CC1,清洗成功,0.2795698924731182
1257,O=C(NC(=S)Nc1cc([N+](=O)[O-])cc(Cl)c1O)c1ccccc1,1,0.9844713807106018,0.9844713807106018,O=C(NC(NC1=CC([N+]([O-])=O)=CC(Cl)=C1O)=S)C2=CC=CC=C2,PIT-1,Data.sdf,1464,HY-103224,,53501-41-0,PI3K,PI3K/Akt/mTOR,C14H10ClN3O4S,10mM,Cancer,No Development Reported,O=C(NC(=S)Nc1cc([N+](=O)[O-])cc(Cl)c1O)c1ccccc1,清洗成功,0.2916666666666667
6775,C=CCc1cccc(/C=N/NC(=O)CN2CCN(Cc3ccccc3)CC2)c1O,1,0.9844293594360352,0.9844293594360352,O=C(N/N=C/C1=CC=CC(CC=C)=C1O)CN2CCN(CC3=CC=CC=C3)CC2,PAC-1,Data.sdf,8039,HY-13523,Procaspase activating compound 1,315183-21-2,Apoptosis; Autophagy; Caspase,Apoptosis; Autophagy,C23H28N4O2,10mM,Cancer,Phase 2,C=CCc1cccc(/C=N/NC(=O)CN2CCN(Cc3ccccc3)CC2)c1O,清洗成功,0.2608695652173913
8656,COc1ccc(-n2c(=S)sc3c(Cl)nc(C)nc32)c(OC)c1,1,0.9844173192977905,0.9844173192977905,COC1=CC=C(C(OC)=C1)N2C(SC3=C2N=C(N=C3Cl)C)=S,CDK1/Cyc B-IN-1,Data.sdf,10209,HY-147646,,2459916-56-2,Apoptosis; CDK,Apoptosis; Cell Cycle/DNA Damage,C14H12ClN3O2S2,10mM,Cancer,No Development Reported,COc1ccc(-n2c(=S)sc3c(Cl)nc(C)nc32)c(OC)c1,清洗成功,0.2837837837837837
10761,CN1CCN(c2ccc(Nc3ncc(I)c(Oc4cccc(N(C)C)c4)n3)cc2C(F)(F)F)CC1,1,0.984411358833313,0.984411358833313,FC(C1=CC(NC2=NC=C(I)C(OC3=CC=CC(N(C)C)=C3)=N2)=CC=C1N4CCN(C)CC4)(F)F,KHKI-01215,Data.sdf,12752,HY-162709,,,Apoptosis; YAP,Apoptosis; Stem Cell/Wnt,C24H26F3IN6O,10mM,Cancer,No Development Reported,CN1CCN(c2ccc(Nc3ncc(I)c(Oc4cccc(N(C)C)c4)n3)cc2C(F)(F)F)CC1,清洗成功,0.3260869565217391
7331,COc1cc(C(=O)N2C[C@H](N)CC[C@@H]2C)cc2nc(-c3cc4cccnc4n3CC3CC3)n(C)c12,1,0.9844106435775757,0.9844106435775757,O=C(N1[C@@H](C)CC[C@@H](N)C1)C2=CC(OC)=C3C(N=C(C4=CC5=CC=CN=C5N4CC6CC6)N3C)=C2.[H]Cl,BMS-P5,Data.sdf,8672,HY-137655,,1549811-36-0,Protein Arginine Deiminase,Epigenetics,C27H33ClN6O2,10mM,Cancer,No Development Reported,COc1cc(C(=O)N2C[C@H](N)CC[C@@H]2C)cc2nc(-c3cc4cccnc4n3CC3CC3)n(C)c12,清洗成功,0.2450980392156862
7332,COc1cc(C(=O)N2C[C@H](N)CC[C@@H]2C)cc2nc(-c3cc4cccnc4n3CC3CC3)n(C)c12,1,0.9844106435775757,0.9844106435775757,O=C(N1[C@@H](C)CC[C@@H](N)C1)C2=CC(OC)=C3C(N=C(C4=CC5=CC=CN=C5N4CC6CC6)N3C)=C2,BMS-P5 (free base),Data.sdf,8673,HY-137655A,,1550371-22-6,Protein Arginine Deiminase,Epigenetics,C27H32N6O2,10mM,Cancer,No Development Reported,COc1cc(C(=O)N2C[C@H](N)CC[C@@H]2C)cc2nc(-c3cc4cccnc4n3CC3CC3)n(C)c12,清洗成功,0.2475247524752475
5353,CN[C@@H](C)C(=O)N[C@H]1CCO[C@H]2CC(C)(C)[C@H](C(=O)N[C@@H]3CCCc4ccccc43)N2C1=O,1,0.9843894839286804,0.9843894839286804,O=C([C@H]1C(C)(C)C[C@](N21)([H])OCC[C@H](NC([C@@H](NC)C)=O)C2=O)N[C@@H]3CCCC4=C3C=CC=C4,(7R)-SBP-0636457,Data.sdf,6309,HY-125378A,(7R)-SBI-0636457; (7R)-SB1-0636457,1422180-61-7,IAP,Apoptosis,C25H36N4O4,10mM,Cancer,No Development Reported,CN[C@@H](C)C(=O)N[C@H]1CCO[C@H]2CC(C)(C)[C@H](C(=O)N[C@@H]3CCCc4ccccc43)N2C1=O,清洗成功,0.203883495145631
15247,O[C@]12CO[C@H](c3ccc4c(c3)OCO4)[C@H]1CO[C@@H]2c1ccc2c(c1)OCO2,1,0.9843878746032715,0.9843878746032715,O[C@@]12[C@@](CO[C@@H]2C3=CC=C(OCO4)C4=C3)([H])[C@@H](C5=CC=C(OCO6)C6=C5)OC1,Paulownin,Data.sdf,18145,HY-N2324,(+)-Paulownin,13040-46-5,Others,Others,C20H18O7,10mM,Metabolic Disease,No Development Reported,O[C@]12CO[C@H](c3ccc4c(c3)OCO4)[C@H]1CO[C@@H]2c1ccc2c(c1)OCO2,清洗成功,0.2769230769230769
12089,O=c1ccc2cc3ccoc3c(O)c2o1,1,0.9843854308128357,0.9843854308128357,O=C1OC(C(C=C1)=C2)=C(O)C3=C2C=CO3,Xanthotoxol,Data.sdf,14293,HY-30152,8-Hydroxypsoralen,2009-24-7,5-HT Receptor; Endogenous Metabolite; Reactive Oxygen Species,GPCR/G Protein; Immunology/Inflammation; Metabolic Enzyme/Protease; Neuronal Signaling; NF-?oB,C11H6O4,10mM,Inflammation/Immunology; Neurological Disease,No Development Reported,O=c1ccc2cc3ccoc3c(O)c2o1,清洗成功,0.2765957446808511
10395,CCC(Sc1nnc2c(n1)[nH]c1ccccc12)C(=O)N1c2ccccc2Sc2ccccc21,1,0.9843676686286926,0.9843676686286926,CCC(SC1=NN=C2C(NC3=C2C=CC=C3)=N1)C(N4C5=C(C=CC=C5)SC6=CC=CC=C46)=O,Inauhzin,Data.sdf,12322,HY-15869,INZ,309271-94-1,MDM-2/p53; Sirtuin,Apoptosis; Cell Cycle/DNA Damage; Epigenetics,C25H19N5OS2,10mM,Cancer,No Development Reported,CCC(Sc1nnc2c(n1)[nH]c1ccccc12)C(=O)N1c2ccccc2Sc2ccccc21,清洗成功,0.3108108108108108
56,Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C,1,0.984336256980896,0.984336256980896,O=S(C1=CC=C(NC2=NC(C3=CN=C(N3C(C)C)C)=CC=N2)C=C1)(C)=O,AZD-5438,Data.sdf,64,HY-10012,,602306-29-6,CDK,Cell Cycle/DNA Damage,C18H21N5O2S,10mM,Cancer,Phase 1,Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C,清洗成功,0.328125
4257,CN(C)CC(Oc1ccccc1)Oc1ccccc1,1,0.9843066930770874,0.9843066930770874,CN(C)CC(OC1=CC=CC=C1)OC2=CC=CC=C2,Medifoxamine,Data.sdf,5003,HY-119468,,32359-34-5,Dopamine Receptor,GPCR/G Protein; Neuronal Signaling,C16H19NO2,10mM,Neurological Disease,Phase 4,CN(C)CC(Oc1ccccc1)Oc1ccccc1,清洗成功,0.25
4177,CC1(C)Oc2ccc(S(=O)(=O)N3CCCCC3)cc2[C@@H](N(Cc2ncc[nH]2)c2ccc(Cl)cc2)[C@@H]1O,1,0.9843063354492188,0.9843063354492188,O[C@@H]1C(C)(OC2=CC=C(C=C2[C@H]1N(CC3=NC=CN3)C4=CC=C(C=C4)Cl)S(=O)(N5CCCCC5)=O)C.Cl,BMS-199264 (hydrochloride),Data.sdf,4918,HY-118960,,186180-83-6,ATP Synthase,Membrane Transporter/Ion Channel,C26H32Cl2N4O4S,10mM,Cardiovascular Disease,No Development Reported,CC1(C)Oc2ccc(S(=O)(=O)N3CCCCC3)cc2[C@@H](N(Cc2ncc[nH]2)c2ccc(Cl)cc2)[C@@H]1O,清洗成功,0.2553191489361702
10874,Fc1cc2nc(-c3cccc(Nc4ccc(-c5cccnn5)cc4)c3)[nH]c2cc1F,1,0.9842999577522278,0.9842999577522278,FC1=C(F)C=C2NC(C3=CC(NC4=CC=C(C5=CC=CN=N5)C=C4)=CC=C3)=NC2=C1,Antiviral agent 57,Data.sdf,12885,HY-164139,,3027227-86-4,SARS-CoV,Anti-infection,C23H15F2N5,10mM,Infection,No Development Reported,Fc1cc2nc(-c3cccc(Nc4ccc(-c5cccnn5)cc4)c3)[nH]c2cc1F,清洗成功,0.2602739726027397
14008,CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1OC(C)=O,1,0.9842965006828308,0.9842965006828308,O[C@H]1[C@](O[C@H](C)[C@@H](O[C@@](O[C@@H](C)[C@@H]2OC(CC(C)C)=O)([H])C[C@]2(O)C)[C@@H]1N(C)C)([H])O[C@@H]([C@H](C[C@H]([C@H](/C=C/C=C/C3)O)C)CC=O)[C@H]([C@](CC(O[C@@H]3C)=O)([H])OC(C)=O)OC,Josamycin,Data.sdf,16492,HY-B1920,EN-141,16846-24-5,Antibiotic; Bacterial,Anti-infection,C42H69NO15,10mM,Infection,Launched,CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1OC(C)=O,清洗成功,0.1702127659574468
5217,Cc1nc2ccccc2n1CCC(=O)N/N=C/c1c(O)ccc2ccccc12,1,0.9842957258224487,0.9842957258224487,O=C(N/N=C/C1=C2C=CC=CC2=CC=C1O)CCN3C4=CC=CC=C4N=C3C,Divin,Data.sdf,6143,HY-124712,,1443321-11-6,Bacterial,Anti-infection,C22H20N4O2,10mM,Infection,No Development Reported,Cc1nc2ccccc2n1CCC(=O)N/N=C/c1c(O)ccc2ccccc12,清洗成功,0.2916666666666667
16401,CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)O,1,0.984281599521637,0.984281599521637,O=C(N[C@@H](CC1=CC=C(C=C1)O)C(N[C@@H](CO)C(N[C@@H](CCSC)C(N[C@@H](CCC(O)=O)C(N[C@@H](CC2=CNC=N2)C(N[C@@H](CC3=CC=CC=C3)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC4=CNC5=CC=CC=C45)C(NCC(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CO)N,"Adrenocorticotropic Hormone (ACTH) (1-10), human",Data.sdf,19581,HY-P1518,,2791/5/1,Melanocortin Receptor,GPCR/G Protein; Neuronal Signaling,C59H78N16O16S,10mM,Metabolic Disease,No Development Reported,CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)O,清洗成功,0.2521008403361344
3126,CS(=O)(=O)N1CCN(C(=O)c2cnc3ccc(F)cc3c2-c2ccc(C3(C#N)CC3)cc2)CC1,1,0.9842543601989746,0.9842543601989746,FC1=CC2=C(C3=CC=C(C4(CC4)C#N)C=C3)C(C(N5CCN(S(C)(=O)=O)CC5)=O)=CN=C2C=C1,NCT-506,Data.sdf,3663,HY-112278,,2231098-99-8,Aldehyde Dehydrogenase (ALDH),Metabolic Enzyme/Protease,C25H23FN4O3S,10mM,Cancer,No Development Reported,CS(=O)(=O)N1CCN(C(=O)c2cnc3ccc(F)cc3c2-c2ccc(C3(C#N)CC3)cc2)CC1,清洗成功,0.2758620689655172
8355,CCOC(=O)Nc1nc2ccc(-c3cc(Cc4n[nH]c(=O)c5ccccc45)ccc3F)cc2[nH]1,1,0.9842367172241211,0.9842367172241211,O=C(NC1=NC2=C(N1)C=C(C3=C(F)C=CC(CC4=NNC(C5=C4C=CC=C5)=O)=C3)C=C2)OCC,AMXI-5001,Data.sdf,9854,HY-145734,,2170491-77-5,Microtubule/Tubulin,Cell Cycle/DNA Damage; Cytoskeleton,C25H20FN5O3,10mM,Cancer,Phase 2,CCOC(=O)Nc1nc2ccc(-c3cc(Cc4n[nH]c(=O)c5ccccc45)ccc3F)cc2[nH]1,清洗成功,0.3222222222222222
8356,CCOC(=O)Nc1nc2ccc(-c3cc(Cc4n[nH]c(=O)c5ccccc45)ccc3F)cc2[nH]1,1,0.9842367172241211,0.9842367172241211,[H]Cl.O=C(NC1=NC2=C(N1)C=C(C3=C(F)C=CC(CC4=NNC(C5=C4C=CC=C5)=O)=C3)C=C2)OCC,AMXI-5001 (hydrochloride),Data.sdf,9855,HY-145734A,,,Microtubule/Tubulin,Cell Cycle/DNA Damage; Cytoskeleton,C25H21ClFN5O3,10mM,Cancer,Phase 2,CCOC(=O)Nc1nc2ccc(-c3cc(Cc4n[nH]c(=O)c5ccccc45)ccc3F)cc2[nH]1,清洗成功,0.3186813186813186
6444,Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCCCCCCOc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)C(C)(C)C)cc1,1,0.984219491481781,0.984219491481781,O=C([C@H]1N(C([C@@H](NC(CCCCCCCCCCOC2=CC=CC(C(N3C(CC4)C(NC4=O)=O)=O)=C2C3=O)=O)C(C)(C)C)=O)C[C@H](O)C1)NCC5=CC=C(C6=C(C)N=CS6)C=C5.OC(C(F)(F)F)=O,ZXH-4-130 (TFA),Data.sdf,7631,HY-132857A,,2711006-67-4,PROTACs,PROTAC,C48H59F3N6O11S,10mM,Neurological Disease,No Development Reported,Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCCCCCCOc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)C(C)(C)C)cc1,清洗成功,0.2
9714,C[C@]1(c2ccc(Cl)cn2)Oc2cccc(C3CCN(Cc4nc5ccc(C(=O)O)cc5n4C[C@@H]4CCO4)CC3)c2O1,1,0.984218418598175,0.984218418598175,C[C@@]1(C2=CC=C(C=N2)Cl)OC3=C(C4CCN(CC4)CC(N(C5=C6)C[C@@H]7CCO7)=NC5=CC=C6C(O)=O)C=CC=C3O1,Lotiglipron,Data.sdf,11477,HY-153865,PF-07081532,2401892-75-7,GLP Receptor,GPCR/G Protein,C31H31ClN4O5,10mM,Metabolic Disease,Phase 2,C[C@]1(c2ccc(Cl)cn2)Oc2cccc(C3CCN(Cc4nc5ccc(C(=O)O)cc5n4C[C@@H]4CCO4)CC3)c2O1,清洗成功,0.2457627118644068
10128,O=C1CCC(N2Cc3cc(CNC(=O)C(=O)c4ccc(C5(C(F)(F)F)CC5)cc4)ccc3C2=O)C(=O)N1,1,0.9842126965522766,0.9842126965522766,O=C(C(C1=CC=C(C2(C(F)(F)F)CC2)C=C1)=O)NCC3=CC=C4C(N(C5C(NC(CC5)=O)=O)CC4=C3)=O,Sontigidomide,Data.sdf,11980,HY-156641,,2560577-69-5,Others,Others,C26H22F3N3O5,10mM,Cancer,No Development Reported,O=C1CCC(N2Cc3cc(CNC(=O)C(=O)c4ccc(C5(C(F)(F)F)CC5)cc4)ccc3C2=O)C(=O)N1,清洗成功,0.2156862745098039
8427,O=[N+]([O-])c1ccc2c(c1)c(OCC1CCCCC1)nn2Cc1ccccc1,1,0.9842098951339722,0.9842098951339722,O=[N+](C1=CC2=C(N(CC3=CC=CC=C3)N=C2OCC4CCCCC4)C=C1)[O-],PGN36,Data.sdf,9941,HY-146134,,1564253-75-3,Cannabinoid Receptor,GPCR/G Protein; Neuronal Signaling,C21H23N3O3,10mM,Inflammation/Immunology,No Development Reported,O=[N+]([O-])c1ccc2c(c1)c(OCC1CCCCC1)nn2Cc1ccccc1,清洗成功,0.275
7382,NC(=O)c1sc(-c2ccsc2)cc1N,1,0.9841964840888977,0.9841964840888977,O=C(C1=C(N)C=C(C2=CSC=C2)S1)N,SC-514,Data.sdf,8733,HY-13802,GK 01140,354812-17-2,IKK,NF-?oB,C9H8N2OS2,10mM,Cancer,No Development Reported,NC(=O)c1sc(-c2ccsc2)cc1N,清洗成功,0.3454545454545454
16790,CCOC(=O)c1cc(=O)c2c(OCC(COc3cccc4oc(C(=O)OCC)cc(=O)c34)OC(=O)[C@@H](N)CCCCN)cccc2o1,1,0.9841946363449097,0.9841946363449097,N[C@@H](CCCCN)C(OC(COC1=C2C(C=C(C(OCC)=O)OC2=CC=C1)=O)COC3=C4C(C=C(C(OCC)=O)OC4=CC=C3)=O)=O.[H]Cl.[H]Cl,KY-556,Data.sdf,19983,HY-U00148,N556,110816-78-9,Drug Derivative,Others,C33H38Cl2N2O12,10mM,Inflammation/Immunology,No Development Reported,CCOC(=O)c1cc(=O)c2c(OCC(COc3cccc4oc(C(=O)OCC)cc(=O)c34)OC(=O)[C@@H](N)CCCCN)cccc2o1,清洗成功,0.2391304347826087
11819,CC(C)N1CCN(Cc2cnc(-c3cc(-c4cccc5[nH]ccc45)cc4[nH]ncc34)o2)CC1,1,0.9841906428337097,0.9841906428337097,CC(N1CCN(CC2=CN=C(C3=CC(C4=CC=CC5=C4C=CN5)=CC6=C3C=NN6)O2)CC1)C,Nemiralisib,Data.sdf,13980,HY-19535A,GSK2269557 (free base),1254036-71-9,PI3K,PI3K/Akt/mTOR,C26H28N6O,10mM,Cancer,Phase 2,CC(C)N1CCN(Cc2cnc(-c3cc(-c4cccc5[nH]ccc45)cc4[nH]ncc34)o2)CC1,清洗成功,0.2625
4042,COc1cc(-c2cn(C)c(=O)c3cnccc23)cc(OC)c1CN(C)CC(=O)NCCOCCOCCNc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O,1,0.9841318726539612,0.9841318726539612,O=C(NCCOCCOCCNC1=CC=CC(C(N2C(CC3)C(NC3=O)=O)=O)=C1C2=O)CN(CC4=C(OC)C=C(C(C5=CC=NC=C65)=CN(C)C6=O)C=C4OC)C,dBRD9,Data.sdf,4747,HY-117690,,2170679-45-3,Epigenetic Reader Domain; PROTACs,Epigenetics; PROTAC,C40H45N7O10,10mM,Cancer,No Development Reported,COc1cc(-c2cn(C)c(=O)c3cnccc23)cc(OC)c1CN(C)CC(=O)NCCOCCOCCNc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O,清洗成功,0.2459016393442623
16659,CSCC[C@H](N)C(=O)NCC(=O)N1CCC[C@H]1C(=O)Nc1ccc2c(C)cc(=O)oc2c1,1,0.9841219186782837,0.9841219186782837,CC(C1=CC=C(NC([C@H]2N(CCC2)C(CNC([C@@H](N)CCSC)=O)=O)=O)C=C1O3)=CC3=O,Met-Gly-Pro-AMC,Data.sdf,19847,HY-P4344,,1926163-52-1,MetAP,Metabolic Enzyme/Protease,C22H28N4O5S,10mM,Others,No Development Reported,CSCC[C@H](N)C(=O)NCC(=O)N1CCC[C@H]1C(=O)Nc1ccc2c(C)cc(=O)oc2c1,清洗成功,0.2531645569620253
6909,CCNCCN(CC)c1nc(Nc2ccc3ncoc3c2)nc(N[C@@H](C)C2CCCCC2)n1,1,0.9840819835662842,0.9840819835662842,CCNCCN(CC)C1=NC(NC2=CC=C3N=COC3=C2)=NC(N[C@H](C4CCCCC4)C)=N1,LS-102,Data.sdf,8196,HY-135844,,1456891-34-1,E1/E2/E3 Enzyme,Metabolic Enzyme/Protease,C24H36N8O,10mM,Inflammation/Immunology,No Development Reported,CCNCCN(CC)c1nc(Nc2ccc3ncoc3c2)nc(N[C@@H](C)C2CCCCC2)n1,清洗成功,0.2873563218390804
8679,COC(=O)N(C)c1c(N)nc(-c2nn(Cc3ccccc3F)c3ncccc23)nc1N,1,0.9840782880783081,0.9840782880783081,FC1=CC=CC=C1CN2C3=NC=CC=C3C(C4=NC(N)=C(C(N)=N4)N(C)C(OC)=O)=N2,Riociguat,Data.sdf,10234,HY-14779,BAY 632521,625115-55-1,Guanylate Cyclase,GPCR/G Protein,C20H19FN8O2,10mM,Cardiovascular Disease,Launched,COC(=O)N(C)c1c(N)nc(-c2nn(Cc3ccccc3F)c3ncccc23)nc1N,清洗成功,0.2804878048780488
7328,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](c6cccs6)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,1,0.9840535521507263,0.9840535521507263,O=C1OC[C@]2([H])[C@H](O[C@H]3[C@@H]([C@H]([C@@H]([C@@H](CO4)O3)O[C@@H]4C5=CC=CS5)O)O)C6=C(C=C7OCOC7=C6)[C@@H](C8=CC(OC)=C(O)C(OC)=C8)[C@]21[H],Teniposide,Data.sdf,8669,HY-13761,VM26,29767-20-2,Topoisomerase,Cell Cycle/DNA Damage,C32H32O13S,10mM,Cancer,Launched,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](c6cccs6)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,清洗成功,0.2075471698113207
6116,COc1ccc(-c2coc3cc(O)ccc3c2=O)cc1S(=O)(=O)O[Na],1,0.9840410947799683,0.9840410947799683,OC1=CC=C(C2=C1)C(C(C3=CC(S(=O)(O[Na])=O)=C(OC)C=C3)=CO2)=O,Sodium formononetin-3'-sulfonate,Data.sdf,7237,HY-13063,Sul-F,949021-68-5,Reactive Oxygen Species,Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?oB,C16H11NaO7S,10mM,Cardiovascular Disease,No Development Reported,COc1ccc(-c2coc3cc(O)ccc3c2=O)cc1S(=O)(=O)O[Na],清洗成功,0.2692307692307692
5177,CC(C)(C#Cc1ccc(-c2ccc(Cl)c3c(NS(=O)(=O)C4CC4)nn(CC(F)F)c23)c([C@H](Cc2cc(F)cc(F)c2)NC(=O)Cn2nc(C(F)F)c3c2C(F)(F)[C@@H]2C[C@H]32)n1)S(C)(=O)=O,1,0.984039843082428,0.984039843082428,O=C(N[C@H](C1=NC(C#CC(S(=O)(C)=O)(C)C)=CC=C1C2=CC=C(Cl)C3=C2N(CC(F)F)N=C3NS(=O)(C4CC4)=O)CC5=CC(F)=CC(F)=C5)CN6N=C(C(F)F)C7=C6C(F)(F)[C@@]8([H])[C@]7([H])C8,CA inhibitor 1,Data.sdf,6098,HY-124594,GS-6207 analog,2189684-45-3,HIV,Anti-infection,C41H36ClF8N7O5S2,10mM,Infection,No Development Reported,CC(C)(C#Cc1ccc(-c2ccc(Cl)c3c(NS(=O)(=O)C4CC4)nn(CC(F)F)c23)c([C@H](Cc2cc(F)cc(F)c2)NC(=O)Cn2nc(C(F)F)c3c2C(F)(F)[C@@H]2C[C@H]32)n1)S(C)(=O)=O,清洗成功,0.1703703703703703
4476,CN(C)CCCCCCOc1ccc(-n2ccnc2)cc1,1,0.9840326905250549,0.9840326905250549,CN(CCCCCCOC1=CC=C(C=C1)N2C=CN=C2)C.Cl.Cl,CAY 10462 (dihydrochloride),Data.sdf,5271,HY-120648A,,502656-68-0,Cytochrome P450,Metabolic Enzyme/Protease,C17H27Cl2N3O,10mM,Cardiovascular Disease,No Development Reported,CN(C)CCCCCCOc1ccc(-n2ccnc2)cc1,清洗成功,0.2394366197183098
7335,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1,1,0.984015703201294,0.984015703201294,[H]Cl.O=C1[C@](O)(CC)C2=C(CO1)C(N3CC4=CC5=C(CN(C)C)C(O)=CC=C5N=C4C3=C2)=O,Topotecan (hydrochloride),Data.sdf,8676,HY-13768A,SKF 104864A (hydrochloride); NSC 609669 (hydrochloride),119413-54-6,Apoptosis; Autophagy; Topoisomerase,Apoptosis; Autophagy; Cell Cycle/DNA Damage,C23H24ClN3O5,10mM,Cancer,Launched,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1,清洗成功,0.216867469879518
8183,Cc1ccc2c(c1)C(=O)N(C)c1cnc(Nc3cccc(S(=O)(=O)N4CCC(O)CC4)c3)nc1N2C,1,0.9840131998062134,0.9840131998062134,O=C1N(C)C2=CN=C(NC3=CC=CC(S(=O)(N4CCC(O)CC4)=O)=C3)N=C2N(C)C5=CC=C(C)C=C15,PI3K?′/?3-IN-1,Data.sdf,9662,HY-144993,,1980884-01-2,PI3K,PI3K/Akt/mTOR,C25H28N6O4S,2mM,Cancer,No Development Reported,Cc1ccc2c(c1)C(=O)N(C)c1cnc(Nc3cccc(S(=O)(=O)N4CCC(O)CC4)c3)nc1N2C,清洗成功,0.3186813186813186
4286,C=C(C)[C@H]1Cc2c(ccc3c2O[C@@H]2COc4cc(OC)c(OC)cc4[C@]2(O)C3=O)O1,1,0.9839887022972107,0.9839887022972107,O=C1[C@@]2([C@]([H])(OC3=C1C=CC4=C3C[C@@H](O4)C(C)=C)COC5=C2C=C(C(OC)=C5)OC)O,Rotenolone,Data.sdf,5040,HY-119694,,509-96-6,Others,Others,C23H22O7,10mM,Cancer,No Development Reported,C=C(C)[C@H]1Cc2c(ccc3c2O[C@@H]2COc4cc(OC)c(OC)cc4[C@]2(O)C3=O)O1,清洗成功,0.2352941176470588
2867,COCCOc1cc(CC2CCN(CCc3ccc4c(c3)C(=O)CCO4)CC2)ccc1Br,1,0.9839870929718018,0.9839870929718018,BrC1=CC=C(CC2CCN(CCC3=CC(C(CCO4)=O)=C4C=C3)CC2)C=C1OCCOC,DSP-1053,Data.sdf,3368,HY-111419,,1176326-76-3,5-HT Receptor; Serotonin Transporter,GPCR/G Protein; Neuronal Signaling,C26H32BrNO4,10mM,Neurological Disease,Phase 1,COCCOc1cc(CC2CCN(CCc3ccc4c(c3)C(=O)CCO4)CC2)ccc1Br,清洗成功,0.2526315789473684
7702,N#Cc1ccc(COc2ccc(-c3cccc4nc(NC(=O)C5CC5)nn34)cc2)cn1,1,0.9839587807655334,0.9839587807655334,O=C(C1CC1)NC2=NN3C(C4=CC=C(OCC5=CC=C(C#N)N=C5)C=C4)=CC=CC3=N2,GLPG0634 analog,Data.sdf,9111,HY-13961,,1206101-20-3,JAK,Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt,C23H18N6O2,10mM,Cancer,No Development Reported,N#Cc1ccc(COc2ccc(-c3cccc4nc(NC(=O)C5CC5)nn34)cc2)cn1,清洗成功,0.2666666666666666
3509,C=CCn1c(CSc2ccccc2[N+](=O)[O-])n[nH]c1=S,1,0.9839493632316589,0.9839493632316589,S=C1N(C(CSC2=CC=CC=C2[N+]([O-])=O)=NN1)CC=C,DSHS00884,Data.sdf,4129,HY-113794,SSYA10-001,675104-49-1,Filovirus,Anti-infection,C12H12N4O2S2,10mM,Infection,No Development Reported,C=CCn1c(CSc2ccccc2[N+](=O)[O-])n[nH]c1=S,清洗成功,0.2625
13335,Cc1c(COC(=O)[C@@H]2[C@H](/C=C(\Cl)C(F)(F)F)C2(C)C)cccc1-c1ccccc1,1,0.983932614326477,0.983932614326477,O=C([C@H]1C(C)(C)[C@H]1/C=C(Cl)/C(F)(F)F)OCC2=C(C)C(C3=CC=CC=C3)=CC=C2,Bifenthrin,Data.sdf,15742,HY-B0824,,82657-04-3,Sodium Channel,Membrane Transporter/Ion Channel,C23H22ClF3O2,10mM,Neurological Disease,No Development Reported,Cc1c(COC(=O)[C@@H]2[C@H](/C=C(\Cl)C(F)(F)F)C2(C)C)cccc1-c1ccccc1,清洗成功,0.2195121951219512
1807,CC(=O)N(C)Cc1ccc2c(c1)OCO2,1,0.9839223623275757,0.9839223623275757,CC(N(C)CC1=CC2=C(OCO2)C=C1)=O,SY-640,Data.sdf,2138,HY-106947,,168705-70-2,Endogenous Metabolite,Metabolic Enzyme/Protease,C11H13NO3,10mM,Metabolic Disease,No Development Reported,CC(=O)N(C)Cc1ccc2c(c1)OCO2,清洗成功,0.3454545454545454
17541,Cc1cc2nc[nH]c2cc1C,1,0.9838946461677551,0.9838946461677551,CC1=CC2=C(C=C1C)N=CN2,"5,6-Dimethyl-1H-benzo[d]imidazole",Data.sdf,20894,HY-W017511,,582-60-5,Endogenous Metabolite,Metabolic Enzyme/Protease,C9H10N2,10mM,Metabolic Disease,No Development Reported,Cc1cc2nc[nH]c2cc1C,清洗成功,0.2586206896551724
9767,Cc1c(NC(=O)c2cc3c(s2)CCCC3)cccc1-c1cn(C)c(=O)c(Nc2ccc([C@@H]3C(=O)N(C)CCN3C)cc2)n1,1,0.9838926792144775,0.9838926792144775,O=C(C1=CC(CCCC2)=C2S1)NC3=CC=CC(C(N=C4NC5=CC=C([C@H]6N(C)CCN(C)C6=O)C=C5)=CN(C)C4=O)=C3C,GDC-0834,Data.sdf,11543,HY-15427,,1133432-49-1,Btk,Protein Tyrosine Kinase/RTK,C33H36N6O3S,10mM,Inflammation/Immunology,No Development Reported,Cc1c(NC(=O)c2cc3c(s2)CCCC3)cccc1-c1cn(C)c(=O)c(Nc2ccc([C@@H]3C(=O)N(C)CCN3C)cc2)n1,清洗成功,0.2475247524752475
9768,Cc1c(NC(=O)c2cc3c(s2)CCCC3)cccc1-c1cn(C)c(=O)c(Nc2ccc([C@H]3C(=O)N(C)CCN3C)cc2)n1,1,0.9838926792144775,0.9838926792144775,CC1=C(C(N=C2NC3=CC=C([C@@H]4N(C)CCN(C)C4=O)C=C3)=CN(C)C2=O)C=CC=C1NC(C5=CC6=C(CCCC6)S5)=O,GDC-0834 (S-enantiomer),Data.sdf,11544,HY-15427B,,1133432-50-4,Btk,Protein Tyrosine Kinase/RTK,C33H36N6O3S,10mM,Others,No Development Reported,Cc1c(NC(=O)c2cc3c(s2)CCCC3)cccc1-c1cn(C)c(=O)c(Nc2ccc([C@H]3C(=O)N(C)CCN3C)cc2)n1,清洗成功,0.2475247524752475
5507,COc1cc(F)cc([C@@H](CO)NC(=O)[C@@H](C)N2Cc3ccc(-c4nc(NC5CCOCC5)ncc4Cl)cc3C2=O)c1,1,0.9838813543319702,0.9838813543319702,ClC(C(C1=CC2=C(CN([C@H](C)C(N[C@H](CO)C3=CC(F)=CC(OC)=C3)=O)C2=O)C=C1)=N4)=CN=C4NC5CCOCC5,ASTX029,Data.sdf,6488,HY-126288,,2095719-92-7,Apoptosis; ERK,Apoptosis; MAPK/ERK Pathway; Stem Cell/Wnt,C29H31ClFN5O5,10mM,Cancer,Phase 2,COc1cc(F)cc([C@@H](CO)NC(=O)[C@@H](C)N2Cc3ccc(-c4nc(NC5CCOCC5)ncc4Cl)cc3C2=O)c1,清洗成功,0.2608695652173913
6329,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1cc3c(cc1c2CNC(=O)CN)OCO3,1,0.9838799834251404,0.9838799834251404,NCC(NCC1=C2C(C(N3C2)=CC([C@](O)(C(OC4)=O)CC)=C4C3=O)=NC5=CC(OCO6)=C6C=C51)=O,Gly-7-MAD-MDCPT,Data.sdf,7490,HY-132164,,2378427-68-8,ADC Cytotoxin; Topoisomerase,Antibody-drug Conjugate/ADC Related; Cell Cycle/DNA Damage,C24H22N4O7,10mM,Cancer,No Development Reported,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1cc3c(cc1c2CNC(=O)CN)OCO3,清洗成功,0.2065217391304347
4817,On1ncc2cc(CCc3nn[nH]n3)ccc21,1,0.9838444590568542,0.9838444590568542,ON1N=CC2=C1C=CC(CCC3=NNN=N3)=C2,UU-T01,Data.sdf,5666,HY-122649,,1417162-83-4,?2-catenin,Stem Cell/Wnt,C10H10N6O,10mM,Cancer,No Development Reported,On1ncc2cc(CCc3nn[nH]n3)ccc21,清洗成功,0.1875
8448,O=C(Nc1scc(-c2ccc(Cl)cc2)c1C(=O)O)c1cc(F)ccc1F,1,0.9838437438011169,0.9838437438011169,O=C(C1=C(SC=C1C2=CC=C(C=C2)Cl)NC(C3=C(C=CC(F)=C3)F)=O)O,DFBTA,Data.sdf,9970,HY-146334,,2966044-07-3,Chloride Channel,Membrane Transporter/Ion Channel,C18H10ClF2NO3S,10mM,Inflammation/Immunology,No Development Reported,O=C(Nc1scc(-c2ccc(Cl)cc2)c1C(=O)O)c1cc(F)ccc1F,清洗成功,0.3333333333333333
7158,S=c1[nH]cnc2nc[nH]c12,1,0.9838332533836365,0.9838332533836365,S=C1NC=NC2=C1NC=N2,6-Mercaptopurine,Data.sdf,8474,HY-13677,Mercaptopurine; 6-MP,50-44-2,Autophagy; Endogenous Metabolite; Nucleoside Antimetabolite/Analog,Autophagy; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease,C5H4N4S,10mM,Cancer,Launched,S=c1[nH]cnc2nc[nH]c12,清洗成功,0.3448275862068966
7162,S=c1[nH]cnc2nc[nH]c12,1,0.9838332533836365,0.9838332533836365,S=C1NC=NC2=C1NC=N2.O,6-Mercaptopurine hydrate,Data.sdf,8478,HY-13677A,Mercaptopurine hydrate; 6-MP hydrate,6112-76-1,Nucleoside Antimetabolite/Analog,Cell Cycle/DNA Damage,C5H6N4OS,10mM,Cancer,Launched,S=c1[nH]cnc2nc[nH]c12,清洗成功,0.3333333333333333
11739,C[C@@H]1CN(c2ccc(S(C)(=O)=O)cc2F)CCN1c1nccc(C(=O)N[C@@H]2[C@@H]3C[C@@H]4C[C@H]2C[C@@](O)(C4)C3)n1,1,0.9838019609451294,0.9838019609451294,O=C(C1=NC(N2[C@H](C)CN(C3=CC=C(S(=O)(C)=O)C=C3F)CC2)=NC=C1)N[C@@H]4[C@]5([H])C[C@@]6([H])C[C@](C5)(O)C[C@]4([H])C6,SKI2852,Data.sdf,13888,HY-19325,,1346554-47-9,11?2-HSD,Metabolic Enzyme/Protease,C27H34FN5O4S,10mM,Metabolic Disease,No Development Reported,C[C@@H]1CN(c2ccc(S(C)(=O)=O)cc2F)CCN1c1nccc(C(=O)N[C@@H]2[C@@H]3C[C@@H]4C[C@H]2C[C@@](O)(C4)C3)n1,清洗成功,0.2450980392156862
11512,O=c1cc(NCCCN[C@@H]2CCOc3c(Br)cc(Br)cc32)[nH]c2ccsc12,1,0.9837994575500488,0.9837994575500488,BrC1=C(OCC2)C([C@@H]2NCCCNC3=CC(C(SC=C4)=C4N3)=O)=CC(Br)=C1,CRS3123,Data.sdf,13619,HY-18324,REP-3123,1013915-71-3,Antibiotic,Anti-infection,C19H19Br2N3O2S,10mM,Inflammation/Immunology,Phase 2,O=c1cc(NCCCN[C@@H]2CCOc3c(Br)cc(Br)cc32)[nH]c2ccsc12,清洗成功,0.2
13486,CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21,1,0.9837127923965454,0.9837127923965454,O=C(OCC1=CC=CC=C1)NC[C@H](C[C@@]23[H])CN(C)[C@]2([H])CC4=CN(C)C5=CC=CC3=C54,Metergoline,Data.sdf,15911,HY-B1033,,17692-51-2,5-HT Receptor; Dopamine Receptor; Sodium Channel,GPCR/G Protein; Membrane Transporter/Ion Channel; Neuronal Signaling,C25H29N3O2,10mM,Neurological Disease,Launched,CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21,清洗成功,0.2244897959183673
10416,COc1cc(-n2c(S)nc3ccccc3c2=O)c(Cl)cc1Cl,1,0.9836838245391846,0.9836838245391846,O=C1N(C2=C(Cl)C=C(Cl)C(OC)=C2)C(S)=NC3=C1C=CC=C3,Mdivi-1,Data.sdf,12344,HY-15886,Mitochondrial division inhibitor 1,338967-87-6,Apoptosis; Autophagy; Dynamin; Mitophagy,Apoptosis; Autophagy; Cytoskeleton,C15H10Cl2N2O2S,10mM,Cancer,No Development Reported,COc1cc(-n2c(S)nc3ccccc3c2=O)c(Cl)cc1Cl,清洗成功,0.3064516129032258
11578,CC(C)(C)c1cc(Br)cc([C@H](CC(=O)O)NC(=O)CNC(=O)c2cc(O)cc(NC3=NCC(O)CN3)c2)c1,1,0.9836671352386475,0.9836671352386475,O=C(CNC(C1=CC(NC2=NCC(O)CN2)=CC(O)=C1)=O)N[C@H](C3=CC(C(C)(C)C)=CC(Br)=C3)CC(O)=O,CWHM-12,Data.sdf,13699,HY-18644,,1564286-55-0,Integrin,Cytoskeleton,C26H32BrN5O6,10mM,Cancer,No Development Reported,CC(C)(C)c1cc(Br)cc([C@H](CC(=O)O)NC(=O)CNC(=O)c2cc(O)cc(NC3=NCC(O)CN3)c2)c1,清洗成功,0.1836734693877551
8499,COC(=O)c1ccc(C[NH+]2CCC(O)(Cn3cnc4c(-c5ccc(C[NH3+])cc5)n(C)nc4c3=O)CC2)c(Cl)c1,1,0.9836656451225281,0.9836656451225281,OC1(CN(C=NC2=C(C3=CC=C(C[NH3+])C=C3)N(C)N=C24)C4=O)CC[NH+](CC5=CC=C(C(OC)=O)C=C5Cl)CC1.O=C([O-])C(F)(F)F.O=C([O-])C(F)(F)F,USP7-IN-9,Data.sdf,10029,HY-146887,,2444374-01-8,Apoptosis; Deubiquitinase,Apoptosis; Cell Cycle/DNA Damage,C32H33ClF6N6O8,10mM,Cancer,No Development Reported,COC(=O)c1ccc(C[NH+]2CCC(O)(Cn3cnc4c(-c5ccc(C[NH3+])cc5)n(C)nc4c3=O)CC2)c(Cl)c1,清洗成功,0.2129629629629629
1779,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@H]1C(=O)COC(=O)C(C)(C)C,1,0.9836549162864685,0.9836549162864685,Cl[C@@]1([C@]2(C=C3)C)[C@](C[C@H](F)C2=CC3=O)([H])[C@@]4([H])[C@@](C)([C@@H](C(COC(C(C)(C)C)=O)=O)[C@H](C)C4)C[C@@H]1O,Clocortolone pivalate,Data.sdf,2105,HY-106714,,34097-16-0,Drug Metabolite,Metabolic Enzyme/Protease,C27H36ClFO5,10mM,Inflammation/Immunology,Launched,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@H]1C(=O)COC(=O)C(C)(C)C,清洗成功,0.1792452830188679
10590,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1cc(F)c(C)c3c1c2[C@@H](NC(=O)OCc1ccc(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)c(NC(=O)CN)c1)CC3,1,0.9836093187332153,0.9836093187332153,NCC(NC(C=C1COC(N[C@@H]2C3=C4C(C(N5C4)=CC([C@](O)(C(OC6)=O)CC)=C6C5=O)=NC7=CC(F)=C(C)C(CC2)=C73)=O)=C(C=C1)O[C@@H]8O[C@@H]([C@H]([C@@H]([C@H]8O)O)O)C(O)=O)=O.OC=O,NH2-Gly-PAB-Exatecan-D-glucuronic acid (formic),Data.sdf,12549,HY-160885A,,,ADC Cytotoxin,Antibody-drug Conjugate/ADC Related,C41H42FN5O16,10mM,Cancer,No Development Reported,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1cc(F)c(C)c3c1c2[C@@H](NC(=O)OCc1ccc(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)c(NC(=O)CN)c1)CC3,清洗成功,0.1798561151079136
13416,CCOC(=O)COc1ccc2c(=O)cc(-c3ccccc3)oc2c1,1,0.9836037158966064,0.9836037158966064,O=C(OCC)COC1=CC=C2C(C=C(C3=CC=CC=C3)OC2=C1)=O,Efloxate,Data.sdf,15831,HY-B0930,Angorlisin,119-41-5,Bacterial,Anti-infection,C19H16O5,10mM,Infection; Cardiovascular Disease,Launched,CCOC(=O)COc1ccc2c(=O)cc(-c3ccccc3)oc2c1,清洗成功,0.273972602739726
2403,C[C@@H]1[C@H](c2c(F)ccc(F)c2F)C[C@H](NC(=O)c2cnc3c(c2)C[C@@]2(C3)C(=O)Nc3ncccc32)C(=O)N1CC(F)(F)F,1,0.9835778474807739,0.9835778474807739,O=C1[C@]2(CC3=CC(C(N[C@H]4C[C@](C5=C(C(F)=CC=C5F)F)([H])[C@H](N(C4=O)CC(F)(F)F)C)=O)=CN=C3C2)C6=CC=CN=C6N1,Atogepant,Data.sdf,2825,HY-109022,MK-8031; AGN-241689,1374248-81-3,CGRP Receptor,GPCR/G Protein; Neuronal Signaling,C29H23F6N5O3,10mM,Neurological Disease,Launched,C[C@@H]1[C@H](c2c(F)ccc(F)c2F)C[C@H](NC(=O)c2cnc3c(c2)C[C@@]2(C3)C(=O)Nc3ncccc32)C(=O)N1CC(F)(F)F,清洗成功,0.2110091743119266
9198,COc1cccc(NC(=S)N/N=C/c2cc(C)ccc2O)c1,1,0.9835602045059204,0.9835602045059204,CC1=CC=C(O)C(/C=N/NC(NC2=CC=CC(OC)=C2)=S)=C1,ALR2-IN-1,Data.sdf,10848,HY-150630,,2799695-54-6,Aldose Reductase,Metabolic Enzyme/Protease,C16H17N3O2S,10mM,Metabolic Disease,No Development Reported,COc1cccc(NC(=S)N/N=C/c2cc(C)ccc2O)c1,清洗成功,0.3088235294117647
9378,O=C(Nc1nc2cccc(C3CCC4(CC3)CN(C(=O)[C@@H]3CC3(F)F)C4)n2n1)C1CC1,1,0.983526885509491,0.983526885509491,O=C(NC1=NN2C(C=CC=C2C3CCC4(CC3)CN(C4)C([C@@H]5CC5(F)F)=O)=N1)C6CC6,TUL01101,Data.sdf,11069,HY-152080,,2411222-97-2,JAK,Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt,C22H25F2N5O2,10mM,Inflammation/Immunology,No Development Reported,O=C(Nc1nc2cccc(C3CCC4(CC3)CN(C(=O)[C@@H]3CC3(F)F)C4)n2n1)C1CC1,清洗成功,0.247191011235955
2609,N#CC(c1ccnc(NCCc2cccnc2)n1)c1nc2ccccc2s1,1,0.9835048317909241,0.9835048317909241,N#CC(C1=CC=NC(NCCC2=CC=CN=C2)=N1)C3=NC4=CC=CC=C4S3,AS601245,Data.sdf,3062,HY-11010,,345987-15-7,JNK,MAPK/ERK Pathway,C20H16N6S,10mM,Cancer; Inflammation/Immunology; Neurological Disease,No Development Reported,N#CC(c1ccnc(NCCc2cccnc2)n1)c1nc2ccccc2s1,清洗成功,0.32
16837,Cc1cccc(S(=O)(=O)N(C)[C@H](C)CCN2CCC(C)CC2)c1,1,0.9834836721420288,0.9834836721420288,O=S(C1=CC=CC(C)=C1)(N(C)[C@H](C)CCN2CCC(C)CC2)=O,SB 258719,Data.sdf,20038,HY-U00443,,195199-95-2,5-HT Receptor,GPCR/G Protein; Neuronal Signaling,C18H30N2O2S,10mM,Cancer; Neurological Disease,No Development Reported,Cc1cccc(S(=O)(=O)N(C)[C@H](C)CCN2CCC(C)CC2)c1,清洗成功,0.2352941176470588
2592,CCc1cc(-c2n[nH]c(C)c2-c2ccc3c(c2)OCCO3)c(O)cc1O,1,0.9834529757499695,0.9834529757499695,CC1=C(C2=CC3=C(OCCO3)C=C2)C(C4=CC(CC)=C(O)C=C4O)=NN1,CCT018159,Data.sdf,3041,HY-110042,,171009-07-7,Apoptosis; HSP,Apoptosis; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease,C20H20N2O4,10mM,Cancer,No Development Reported,CCc1cc(-c2n[nH]c(C)c2-c2ccc3c(c2)OCCO3)c(O)cc1O,清洗成功,0.3142857142857143
3718,O=c1cc(NCCCN[C@@H]2CCOc3c(Br)cc(Br)cc32)[nH]c2ccsc12,1,0.9834501147270203,0.9834501147270203,O=C1C2=C(C=CS2)NC(NCCCN[C@@H]3CCOC4=C(Br)C=C(Br)C=C34)=C1.[H]Cl.[H]Cl,CRS3123 (dihydrochloride),Data.sdf,4377,HY-115440,REP-3123 (dihydrochloride),1013915-99-5,Antibiotic; Bacterial,Anti-infection,C19H21Br2Cl2N3O2S,10mM,Infection,Phase 2,O=c1cc(NCCCN[C@@H]2CCOc3c(Br)cc(Br)cc32)[nH]c2ccsc12,清洗成功,0.1978021978021978
5197,C[C@H]1CN(c2cccc3nc(-c4nc(-c5cc(C(=O)N(C)C)ccn5)cnc4N)n(C)c23)CCN1,1,0.9834429621696472,0.9834429621696472,O=C(C1=CC(C2=NC(C3=NC4=CC=CC(N5C[C@H](C)NCC5)=C4N3C)=C(N)N=C2)=NC=C1)N(C)C,MNK inhibitor 9,Data.sdf,6118,HY-124638,,1889336-59-7,MNK,MAPK/ERK Pathway,C25H29N9O,10mM,Cancer,No Development Reported,C[C@H]1CN(c2cccc3nc(-c4nc(-c5cc(C(=O)N(C)C)ccn5)cnc4N)n(C)c23)CCN1,清洗成功,0.2574257425742574
8184,Cc1ccc2c(-c3nc(Nc4cc(CN5C[C@@H](C)N[C@@H](C)C5)cc(C5CC5)c4)ncc3Cl)c[nH]c2c1,1,0.9834259748458862,0.9834259748458862,ClC1=CN=C(NC2=CC(C3CC3)=CC(CN4C[C@H](N[C@H](C4)C)C)=C2)N=C1C5=CNC6=CC(C)=CC=C56,Tuspetinib,Data.sdf,9666,HY-145015,HM43239,2294874-49-8,Apoptosis; FLT3,Apoptosis; Protein Tyrosine Kinase/RTK,C29H33ClN6,10mM,Cancer,Phase 2,Cc1ccc2c(-c3nc(Nc4cc(CN5C[C@@H](C)N[C@@H](C)C5)cc(C5CC5)c4)ncc3Cl)c[nH]c2c1,清洗成功,0.2872340425531915
704,Cc1nccc2c1c(=O)n(C)c1cc(OC[C@@H](N)CC(C)C)c(C#N)cc21,1,0.9834184050559998,0.9834184050559998,N#CC1=C(OC[C@@H](N)CC(C)C)C=C(C(C2=CC=NC(C)=C32)=C1)N(C)C3=O,BMT-090605,Data.sdf,807,HY-101290,,1551403-51-0,AAK1; Cyclin G-associated Kinase (GAK),Cell Cycle/DNA Damage; Neuronal Signaling,C21H24N4O2,10mM,Neurological Disease,No Development Reported,Cc1nccc2c1c(=O)n(C)c1cc(OC[C@@H](N)CC(C)C)c(C#N)cc21,清洗成功,0.2898550724637681
705,Cc1nccc2c1c(=O)n(C)c1cc(OC[C@@H](N)CC(C)C)c(C#N)cc21,1,0.9834184050559998,0.9834184050559998,N#CC1=C(OC[C@@H](N)CC(C)C)C=C(C(C2=CC=NC(C)=C32)=C1)N(C)C3=O.[H]Cl,BMT-090605 (hydrochloride),Data.sdf,808,HY-101290A,,2231664-45-0,AAK1; Cyclin G-associated Kinase (GAK),Cell Cycle/DNA Damage; Neuronal Signaling,C21H25ClN4O2,10mM,Neurological Disease,No Development Reported,Cc1nccc2c1c(=O)n(C)c1cc(OC[C@@H](N)CC(C)C)c(C#N)cc21,清洗成功,0.2857142857142857
132,CCc1cc2c(ccc3cnn(C[C@H](C)N)c32)o1,1,0.9833986759185791,0.9833986759185791,C[C@H](N)CN(N=C1)C2=C1C=CC3=C2C=C(CC)O3,YM348,Data.sdf,153,HY-100330,,372163-84-3,5-HT Receptor,GPCR/G Protein; Neuronal Signaling,C14H17N3O,10mM,Metabolic Disease,No Development Reported,CCc1cc2c(ccc3cnn(C[C@H](C)N)c32)o1,清洗成功,0.2456140350877192
5375,C[C@H](N)Cn1ncc2ccc(O)cc21,1,0.983345627784729,0.983345627784729,OC1=CC2=C(C=C1)C=NN2C[C@@H](N)C,AL-34662,Data.sdf,6336,HY-125641,,210580-75-9,5-HT Receptor; Adrenergic Receptor,GPCR/G Protein; Neuronal Signaling,C10H13N3O,10mM,Cardiovascular Disease,No Development Reported,C[C@H](N)Cn1ncc2ccc(O)cc21,清洗成功,0.25
15510,O=C(O[C@@H]1[C@@H](O)[C@H](Oc2cc(O)c(C(=O)CCc3ccccc3)c(O)c2)O[C@@H]2COC(=O)c3cc(O)c(O)c(O)c3-c3c(cc(O)c(O)c3O)C(=O)O[C@@H]12)c1cc(O)c(O)c(O)c1,1,0.9833390712738037,0.9833390712738037,OC1=CC(C(OC[C@@H]2[C@@H]3[C@H](OC(C4=CC(O)=C(O)C(O)=C4)=O)[C@@H](O)[C@H](OC5=CC(O)=C(C(CCC6=CC=CC=C6)=O)C(O)=C5)O2)=O)=C(C7=C(C(O3)=O)C=C(O)C(O)=C7O)C(O)=C1O,Thonningianin A,Data.sdf,18502,HY-N4084,,271579-11-4,Apoptosis,Apoptosis,C42H34O21,10mM,Cancer,No Development Reported,O=C(O[C@@H]1[C@@H](O)[C@H](Oc2cc(O)c(C(=O)CCc3ccccc3)c(O)c2)O[C@@H]2COC(=O)c3cc(O)c(O)c(O)c3-c3c(cc(O)c(O)c3O)C(=O)O[C@@H]12)c1cc(O)c(O)c(O)c1,清洗成功,0.2840909090909091
11582,CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F,1,0.9833366274833679,0.9833366274833679,O=S(NC)(NC1=NC=CC(CC2=C(C)C3=CC=C(OC4=NC=CC=N4)C=C3OC2=O)=C1F)=O,Avutometinib,Data.sdf,13703,HY-18652,Ro 5126766; CH5126766,946128-88-7,MEK; Raf,MAPK/ERK Pathway,C21H18FN5O5S,10mM,Cancer,Phase 3,CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F,清洗成功,0.2441860465116279
3052,Cc1n[nH]c2c1C(c1cc(CO)cc(-c3ccccc3)c1)(C(C)C)C(C#N)=C(N)O2,1,0.983335018157959,0.983335018157959,OCC1=CC(C2=CC=CC=C2)=CC(C3(C(C(C)=NN4)=C4OC(N)=C3C#N)C(C)C)=C1,SHIN1,Data.sdf,3572,HY-112066,RZ-2994,2146095-85-2,SHMT,Metabolic Enzyme/Protease,C24H24N4O2,10mM,Cancer,No Development Reported,Cc1n[nH]c2c1C(c1cc(CO)cc(-c3ccccc3)c1)(C(C)C)C(C#N)=C(N)O2,清洗成功,0.2816901408450704
3053,Cc1n[nH]c2c1[C@](c1cc(CO)cc(-c3ccccc3)c1)(C(C)C)C(C#N)=C(N)O2,1,0.983335018157959,0.983335018157959,OCC1=CC(C2=CC=CC=C2)=CC([C@@]3(C(C(C)=NN4)=C4OC(N)=C3C#N)C(C)C)=C1,(+)-SHIN1,Data.sdf,3573,HY-112066A,(+)-RZ-2994,2443966-90-1,SHMT,Metabolic Enzyme/Protease,C24H24N4O2,10mM,Others,No Development Reported,Cc1n[nH]c2c1[C@](c1cc(CO)cc(-c3ccccc3)c1)(C(C)C)C(C#N)=C(N)O2,清洗成功,0.2816901408450704
3054,Cc1n[nH]c2c1[C@@](c1cc(CO)cc(-c3ccccc3)c1)(C(C)C)C(C#N)=C(N)O2,1,0.983335018157959,0.983335018157959,OCC1=CC(C2=CC=CC=C2)=CC([C@]3(C(C(C)=NN4)=C4OC(N)=C3C#N)C(C)C)=C1,(-)-SHIN1,Data.sdf,3574,HY-112066B,(-)-RZ-2994,2444764-09-2,Drug Isomer,Others,C24H24N4O2,10mM,Others,No Development Reported,Cc1n[nH]c2c1[C@@](c1cc(CO)cc(-c3ccccc3)c1)(C(C)C)C(C#N)=C(N)O2,清洗成功,0.2816901408450704
9881,N#Cc1c(-c2ccc(F)cc2)csc1OCc1ccc(CN)cc1,1,0.9833327531814575,0.9833327531814575,FC1=CC=C(C2=CSC(OCC3=CC=C(CN)C=C3)=C2C#N)C=C1.Cl,PD-L1-IN-3,Data.sdf,11677,HY-155101,,2953044-29-4,PD-1/PD-L1,Immunology/Inflammation,C19H16ClFN2OS,10mM,Cancer,No Development Reported,N#Cc1c(-c2ccc(F)cc2)csc1OCc1ccc(CN)cc1,清洗成功,0.2586206896551724
7639,CCN(Cc1nc2c(N)nc3cc(-c4cc[nH]n4)ccc3c2[nH]1)C(C)=O,1,0.9833322763442993,0.9833322763442993,O=C(C)N(CC)CC1=NC2=C(N1)C3=C(C=C(C4=NNC=C4)C=C3)N=C2N,BMS-986299,Data.sdf,9042,HY-139396,,2242952-69-6,NOD-like Receptor (NLR),Immunology/Inflammation,C18H19N7O,10mM,Cancer; Inflammation/Immunology,Phase 1,CCN(Cc1nc2c(N)nc3cc(-c4cc[nH]n4)ccc3c2[nH]1)C(C)=O,清洗成功,0.253012048192771
13723,Cc1cc(CC(C)CC(C)(C)C)n(O)c(=O)c1,1,0.9832826852798462,0.9832826852798462,O=C1C=C(C)C=C(CC(C)CC(C)(C)C)N1O.NCCO,Piroctone olamine,Data.sdf,16176,HY-B1345,Piroctone ethanolamine,68890-66-4,Fungal,Anti-infection,C16H30N2O3,10mM,Infection,Launched,Cc1cc(CC(C)CC(C)(C)C)n(O)c(=O)c1,清洗成功,0.1707317073170731
8796,N#CC(C(=O)Nc1cccc(C(F)(F)F)c1)C(=S)Nc1ccccc1Cl,1,0.983272135257721,0.983272135257721,O=C(NC1=CC=CC(C(F)(F)F)=C1)C(C#N)C(NC2=CC=CC=C2Cl)=S,DP00477,Data.sdf,10385,HY-148383,,169120-56-3,"Indoleamine 2,3-Dioxygenase (IDO)",Metabolic Enzyme/Protease,C17H11ClF3N3OS,10mM,Cancer,No Development Reported,N#CC(C(=O)Nc1cccc(C(F)(F)F)c1)C(=S)Nc1ccccc1Cl,清洗成功,0.323943661971831
980,C[C@H]1CN(c2c(NC(=O)c3ccc(F)c(-c4c(F)cccc4F)n3)cnc3c2CC[C@H]3O)C[C@@H](N)[C@@H]1O,1,0.9832586050033569,0.9832586050033569,O=C(C1=NC(C2=C(F)C=CC=C2F)=C(F)C=C1)NC3=CN=C4C(CC[C@H]4O)=C3N5C[C@@H](N)[C@H](O)[C@@H](C)C5,Uzansertib,Data.sdf,1125,HY-101870,INCB053914,1620012-39-6,Pim,JAK/STAT Signaling,C26H26F3N5O3,10mM,Cancer,Phase 2,C[C@H]1CN(c2c(NC(=O)c3ccc(F)c(-c4c(F)cccc4F)n3)cnc3c2CC[C@H]3O)C[C@@H](N)[C@@H]1O,清洗成功,0.27
981,C[C@H]1CN(c2c(NC(=O)c3ccc(F)c(-c4c(F)cccc4F)n3)cnc3c2CC[C@H]3O)C[C@@H](N)[C@@H]1O,1,0.9832586050033569,0.9832586050033569,O=C(C1=NC(C2=C(F)C=CC=C2F)=C(F)C=C1)NC3=CN=C4C(CC[C@H]4O)=C3N5C[C@@H](N)[C@H](O)[C@@H](C)C5.OP(O)(O)=O,Uzansertib (phosphate),Data.sdf,1126,HY-101870B,INCB053914 (phosphate),2088852-47-3,Pim,JAK/STAT Signaling,C26H29F3N5O7P,10mM,Cancer,Phase 2,C[C@H]1CN(c2c(NC(=O)c3ccc(F)c(-c4c(F)cccc4F)n3)cnc3c2CC[C@H]3O)C[C@@H](N)[C@@H]1O,清洗成功,0.2621359223300971
4425,Cc1cccc(-c2nc(C(C)(C)C)[nH]c2-c2ccc3nccnc3c2)n1,1,0.9832473397254944,0.9832473397254944,CC(C)(C1=NC(C2=CC=CC(C)=N2)=C(C3=CC=C4N=CC=NC4=C3)N1)C,SB 525334,Data.sdf,5213,HY-12043,,356559-20-1,TGF-?2 Receptor,TGF-beta/Smad,C21H21N5,10mM,Cancer,No Development Reported,Cc1cccc(-c2nc(C(C)(C)C)[nH]c2-c2ccc3nccnc3c2)n1,清洗成功,0.2580645161290322
3116,CC(C)(C)[C@H](NC(=O)c1ccc(N)c(Cl)c1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C=O)CC(=O)O,1,0.9832340478897095,0.9832340478897095,O=C(N[C@H](C=O)CC(O)=O)[C@H]1N(C([C@H](C(C)(C)C)NC(C2=CC=C(N)C(Cl)=C2)=O)=O)CCC1,VRT-043198,Data.sdf,3646,HY-112226,,244133-31-1,Caspase; Drug Metabolite,Apoptosis; Metabolic Enzyme/Protease,C22H29ClN4O6,10mM,Inflammation/Immunology,No Development Reported,CC(C)(C)[C@H](NC(=O)c1ccc(N)c(Cl)c1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C=O)CC(=O)O,清洗成功,0.2454545454545454
16783,Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1,1,0.9832210540771484,0.9832210540771484,O=C1C(CCN2CCC(OC3=CC=CC=C34)=C4C2)=C(C)N=C5N1C=CC=C5,Lusaperidone,Data.sdf,19975,HY-U00117,R107474,214548-46-6,Adrenergic Receptor,GPCR/G Protein; Neuronal Signaling,C22H21N3O2,2mM,Neurological Disease; Endocrinology,No Development Reported,Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1,清洗成功,0.2463768115942029
930,C[C@]1(C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CO)NC(=O)c2cccc(=O)[nH]2)CO1,1,0.9831854701042175,0.9831854701042175,O=C(N[C@@H](CO)C(N[C@@H](CC1=CC=CC=C1)C([C@]2(CO2)C)=O)=O)C(N3)=CC=CC3=O,KZR-504,Data.sdf,1066,HY-101786,,1629052-78-3,Proteasome,Metabolic Enzyme/Protease,C21H23N3O6,10mM,Inflammation/Immunology,No Development Reported,C[C@]1(C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CO)NC(=O)c2cccc(=O)[nH]2)CO1,清洗成功,0.2875
2726,Cc1nc2ccc(NCc3cccc(C(F)(F)F)c3)cc2n(CCNC(=O)CO)c1=O,1,0.9831783175468445,0.9831783175468445,O=C(NCCN1C(C(C)=NC2=C1C=C(NCC3=CC=CC(C(F)(F)F)=C3)C=C2)=O)CO,CVT-12012,Data.sdf,3201,HY-11034,,1018675-35-8,Stearoyl-CoA Desaturase (SCD),Metabolic Enzyme/Protease,C21H21F3N4O3,10mM,Metabolic Disease,No Development Reported,Cc1nc2ccc(NCc3cccc(C(F)(F)F)c3)cc2n(CCNC(=O)CO)c1=O,清洗成功,0.3253012048192771
3501,Cn1c(=O)c2cc(C(=O)NCCCN3CCCCCC3)sc2c2ccccc21,1,0.9831764698028564,0.9831764698028564,O=C(C(S1)=CC2=C1C3=C(N(C)C2=O)C=CC=C3)NCCCN4CCCCCC4,MMV019313,Data.sdf,4120,HY-113752,,902630-14-2,Parasite,Anti-infection,C22H27N3O2S,10mM,Infection,No Development Reported,Cn1c(=O)c2cc(C(=O)NCCCN3CCCCCC3)sc2c2ccccc21,清洗成功,0.3066666666666666
8202,Cn1cnc2ccc(Oc3c(F)ccc(NS(=O)(=O)N4CC[C@@H](F)C4)c3C#N)cc2c1=O,1,0.983169436454773,0.983169436454773,N#CC1=C(C(F)=CC=C1NS(=O)(N2C[C@@H](CC2)F)=O)OC3=CC=C(N=CN(C4=O)C)C4=C3,B-Raf IN 2,Data.sdf,9687,HY-145120,,2649372-20-1,Raf,MAPK/ERK Pathway,C20H17F2N5O4S,10mM,Cancer,No Development Reported,Cn1cnc2ccc(Oc3c(F)ccc(NS(=O)(=O)N4CC[C@@H](F)C4)c3C#N)cc2c1=O,清洗成功,0.231578947368421
7228,Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCC3)cc2)c2ccc(O)cc12,1,0.9831565022468567,0.9831565022468567,OC1=CC2=C(N(CC3=CC=C(OCCN4CCCCC4)C=C3)C(C5=CC=C(O)C=C5)=C2C)C=C1,Pipendoxifene,Data.sdf,8557,HY-13724,ERA-923,198480-55-6,Estrogen Receptor/ERR,Vitamin D Related/Nuclear Receptor,C29H32N2O3,10mM,Cancer,Phase 2,Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCC3)cc2)c2ccc(O)cc12,清洗成功,0.3048780487804878
7231,Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCC3)cc2)c2ccc(O)cc12,1,0.9831565022468567,0.9831565022468567,OC1=CC2=C(N(CC3=CC=C(OCCN4CCCCC4)C=C3)C(C5=CC=C(O)C=C5)=C2C)C=C1.Cl,Pipendoxifene hydrochloride,Data.sdf,8560,HY-13724B,,245124-69-0,Estrogen Receptor/ERR,Vitamin D Related/Nuclear Receptor,C29H33ClN2O3,10mM,Cancer,Phase 2,Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCC3)cc2)c2ccc(O)cc12,清洗成功,0.3012048192771084
10283,Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1,1,0.9831268787384033,0.9831268787384033,O=S(C1=CC=C(C2=C(C)ON=C2C3=CC=CC=C3)C=C1)(N)=O,Valdecoxib,Data.sdf,12177,HY-15762,SC 65872,181695-72-7,COX; Endogenous Metabolite,Immunology/Inflammation; Metabolic Enzyme/Protease,C16H14N2O3S,10mM,Inflammation/Immunology; Cancer,Launched,Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1,清洗成功,0.2950819672131147
12720,CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn4c3c2OCN4C)CC1,1,0.983121395111084,0.983121395111084,O=C(C(C1=O)=CN2N(C)COC3=C(N4CCN(C)CC4)C(F)=CC1=C32)O,Marbofloxacin,Data.sdf,15044,HY-B0126,,115550-35-1,Antibiotic; Bacterial,Anti-infection,C17H19FN4O4,2mM,Infection,No Development Reported,CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn4c3c2OCN4C)CC1,清洗成功,0.2409638554216867
255,COc1cc(C(=O)N2CC[C@@H](O)[C@@H](N)C2)cc2nc(-c3cc4ccccc4n3CC3CC3)n(C)c12,1,0.9831027388572693,0.9831027388572693,O=C(N1C[C@H](N)[C@H](O)CC1)C2=CC(OC)=C3C(N=C(C(N4CC5CC5)=CC6=C4C=CC=C6)N3C)=C2.[H]Cl,GSK484 (hydrochloride),Data.sdf,290,HY-100514,,1652591-81-5,Protein Arginine Deiminase,Epigenetics,C27H32ClN5O3,10mM,Cancer; Inflammation/Immunology; Cardiovascular Disease,No Development Reported,COc1cc(C(=O)N2CC[C@@H](O)[C@@H](N)C2)cc2nc(-c3cc4ccccc4n3CC3CC3)n(C)c12,清洗成功,0.2755102040816326
4717,COc1ccc(-c2ocnc2C(=O)NCCCn2cncn2)cc1Cl,1,0.9830915331840515,0.9830915331840515,O=C(C1=C(C2=CC=C(OC)C(Cl)=C2)OC=N1)NCCCN3N=CN=C3,PF-04802367,Data.sdf,5540,HY-122026,PF-367,1962178-27-3,GSK-3,PI3K/Akt/mTOR; Stem Cell/Wnt,C16H16ClN5O3,10mM,Neurological Disease,No Development Reported,COc1ccc(-c2ocnc2C(=O)NCCCn2cncn2)cc1Cl,清洗成功,0.2613636363636363
3619,OC[C@H]1O[C@H](Sc2ccc(Cl)c(Cl)c2)[C@H](O)[C@@H](n2cc(-c3cc(F)c(F)c(F)c3)nn2)[C@H]1O,1,0.9830374121665955,0.9830374121665955,O[C@H]([C@@H](N1N=NC(C2=CC(F)=C(F)C(F)=C2)=C1)[C@H]([C@@H](CO)O3)O)[C@H]3SC4=CC=C(Cl)C(Cl)=C4,GB1107,Data.sdf,4260,HY-114409,,1978336-61-6,Galectin,Immunology/Inflammation,C20H16Cl2F3N3O4S,10mM,Cancer,No Development Reported,OC[C@H]1O[C@H](Sc2ccc(Cl)c(Cl)c2)[C@H](O)[C@@H](n2cc(-c3cc(F)c(F)c(F)c3)nn2)[C@H]1O,清洗成功,0.2073170731707317
1151,COC(=O)N1CC2(CC2)C[C@H](C(=O)NO)[C@H]1C(=O)N1CCN(c2ccccc2)CC1,1,0.9830295443534851,0.9830295443534851,O=C(N(CC1)CCN1C2=CC=CC=C2)[C@H]([C@H](C3)C(NO)=O)N(CC43CC4)C(OC)=O,Aderbasib,Data.sdf,1331,HY-10293,INCB007839; INCB7839,791828-58-5,MMP,Metabolic Enzyme/Protease,C21H28N4O5,10mM,Cancer,Phase 2,COC(=O)N1CC2(CC2)C[C@H](C(=O)NO)[C@H]1C(=O)N1CCN(c2ccccc2)CC1,清洗成功,0.2588235294117647
3108,COCc1ccc(-c2ccc3ncc(C(N)=O)c(N[C@@H](C)C4CCOCC4)c3c2)cn1,1,0.9830243587493896,0.9830243587493896,O=C(C1=C(N[C@@H](C)C2CCOCC2)C3=CC(C4=CC=C(COC)N=C4)=CC=C3N=C1)N,AZ31,Data.sdf,3638,HY-112198,,2088113-98-6,ATM/ATR,Cell Cycle/DNA Damage; PI3K/Akt/mTOR,C24H28N4O3,10mM,Cancer,No Development Reported,COCc1ccc(-c2ccc3ncc(C(N)=O)c(N[C@@H](C)C4CCOCC4)c3c2)cn1,清洗成功,0.3010752688172043
11437,CC[C@H](Nc1ncnc2nc[nH]c12)c1oc2ccccc2c(=O)c1-c1cccc(F)c1,1,0.9829930663108826,0.9829930663108826,O=C1C(C2=CC=CC(F)=C2)=C([C@@H](NC3=C4NC=NC4=NC=N3)CC)OC5=CC=CC=C15,Tenalisib,Data.sdf,13522,HY-17645,RP6530,1639417-53-0,PI3K,PI3K/Akt/mTOR,C23H18FN5O2,10mM,Cancer,Phase 2,CC[C@H](Nc1ncnc2nc[nH]c12)c1oc2ccccc2c(=O)c1-c1cccc(F)c1,清洗成功,0.3157894736842105
2591,Cc1ccc(NC(=O)c2cccc(C(C)(C)C#N)c2)cc1Nc1ccc2ncn(C)c(=O)c2c1,1,0.982948362827301,0.982948362827301,O=C1N(C)C=NC2=C1C=C(C=C2)NC3=C(C)C=CC(NC(C4=CC(C(C#N)(C)C)=CC=C4)=O)=C3,AZ 628,Data.sdf,3040,HY-11004,,878739-06-1,Apoptosis; Raf,Apoptosis; MAPK/ERK Pathway,C27H25N5O2,10mM,Cancer,No Development Reported,Cc1ccc(NC(=O)c2cccc(C(C)(C)C#N)c2)cc1Nc1ccc2ncn(C)c(=O)c2c1,清洗成功,0.2758620689655172
16407,CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C,1,0.9829326868057251,0.9829326868057251,O=C(N[C@@H](CC1=CC=C(C=C1)O)C(N[C@@H](CO)C(N[C@@H](CCSC)C(N[C@@H](CCC(O)=O)C(N[C@@H](CC2=CNC=N2)C(N[C@@H](CC3=CC=CC=C3)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC4=CNC5=CC=CC=C45)C(NCC(N[C@@H](CCCCN)C(N6[C@@H](CCC6)C(N[C@@H](C(C)C)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CO)N,ACTH (1-13),Data.sdf,19587,HY-P1555,Adrenocorticotropic Hormone (1-13),22006-64-0,Others,Others,C75H106N20O19S,10mM,Inflammation/Immunology,No Development Reported,CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C,清洗成功,0.2066666666666666
11075,CCOC(=O)c1cnn(-c2ccc(C(=O)NC(c3ccccc3)C(C)(C)C)cn2)c1,1,0.982920229434967,0.982920229434967,CC(C)(C)C(NC(C1=CC=C(N2N=CC(C(OCC)=O)=C2)N=C1)=O)C3=CC=CC=C3,AH2-14c,Data.sdf,13117,HY-168708,,,Apoptosis; Histone Demethylase,Apoptosis; Epigenetics,C23H26N4O3,10mM,Cancer,No Development Reported,CCOC(=O)c1cnn(-c2ccc(C(=O)NC(c3ccccc3)C(C)(C)C)cn2)c1,清洗成功,0.3043478260869565
6958,CC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCc1ccc(-c2scnc2C)cc1O)C(C)(C)C,1,0.9829009175300598,0.9829009175300598,O=C(N(C[C@@H]1O)[C@@H](C1)C(NCC(C=CC(C(SC=N2)=C2C)=C3)=C3O)=O)[C@H](C(C)(C)C)NC(C)=O,VH032-OH,Data.sdf,8257,HY-136164,,2244684-42-0,Ligands for E3 Ligase,PROTAC,C24H32N4O5S,10mM,Cancer,No Development Reported,CC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCc1ccc(-c2scnc2C)cc1O)C(C)(C)C,清洗成功,0.2149532710280373
16339,CC(=O)N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)N[C@@H]1CSSC[C@@H](C(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O,1,0.9828757643699646,0.9828757643699646,O=C([C@@H](NC([C@@H](CSSC[C@H](NC([C@](NC([C@@H](NC1=O)CCCCN)=O)([H])[C@H](O)C)=O)C(N[C@@H](C(N)=O)CC2=CC=C(C=C2)O)=O)NC([C@@H](NC(C)=O)CC3=CC=C(C=C3)[N+]([O-])=O)=O)=O)CC4=CC=C(C=C4)O)N[C@@H]1CC5=CNC6=CC=CC=C56,CYN 154806,Data.sdf,19517,HY-P1202,,183658-72-2,Somatostatin Receptor,GPCR/G Protein; Neuronal Signaling,C56H68N12O14S2,10mM,Endocrinology,No Development Reported,CC(=O)N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)N[C@@H]1CSSC[C@@H](C(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O,清洗成功,0.2076923076923077
16340,CC(=O)N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)N[C@@H]1CSSC[C@@H](C(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O,1,0.9828757643699646,0.9828757643699646,O=C([C@@H](NC([C@@H](CSSC[C@H](NC([C@](NC([C@@H](NC1=O)CCCCN)=O)([H])[C@H](O)C)=O)C(N[C@@H](C(N)=O)CC2=CC=C(C=C2)O)=O)NC([C@@H](NC(C)=O)CC3=CC=C(C=C3)[N+]([O-])=O)=O)=O)CC4=CC=C(C=C4)O)N[C@@H]1CC5=CNC6=CC=CC=C56.OC(C(F)(F)F)=O,CYN 154806 (TFA),Data.sdf,19518,HY-P1202A,,2828432-46-6,Somatostatin Receptor,GPCR/G Protein; Neuronal Signaling,C58H69F3N12O16S2,10mM,Endocrinology,No Development Reported,CC(=O)N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)N[C@@H]1CSSC[C@@H](C(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O,清洗成功,0.1985294117647058
4116,Cc1c(OCC(F)(F)F)ccnc1CS(=O)c1nc2ccc(O)cc2[nH]1,1,0.9828536510467529,0.9828536510467529,OC1=CC=C2N=C(NC2=C1)S(CC3=NC=CC(OCC(F)(F)F)=C3C)=O,5-Hydroxylansoprazole,Data.sdf,4839,HY-118283,AG1908,131926-98-2,Proton Pump,Membrane Transporter/Ion Channel,C16H14F3N3O3S,10mM,Metabolic Disease,No Development Reported,Cc1c(OCC(F)(F)F)ccnc1CS(=O)c1nc2ccc(O)cc2[nH]1,清洗成功,0.2923076923076923
9580,Oc1ccc(Cl)cc1/C=N\N/C(=N/N=C/c1cc(Cl)ccc1O)N/N=C/c1cc(Cl)ccc1O,1,0.9828484058380127,0.9828484058380127,OC(C=C1)=C(C=C1Cl)/C=N/N=C(N/N=C\C(C=C2Cl)=C(C=C2)O)\N/N=C/C(C=C3Cl)=C(C=C3)O.[H]Cl,CWI1-2 (hydrochloride),Data.sdf,11317,HY-153274A,,2408590-37-2,Apoptosis,Apoptosis,C22H18Cl4N6O3,10mM,Cancer,No Development Reported,Oc1ccc(Cl)cc1/C=N\N/C(=N/N=C/c1cc(Cl)ccc1O)N/N=C/c1cc(Cl)ccc1O,清洗成功,0.25
9579,Oc1ccc(Cl)cc1/C=N\N/C(=N/N=C/c1cc(Cl)ccc1O)N/N=C/c1cc(Cl)ccc1O,1,0.9828482866287231,0.9828482866287231,OC(C=C1)=C(C=C1Cl)/C=N/N=C(N/N=C\C(C=C2Cl)=C(C=C2)O)\N/N=C/C(C=C3Cl)=C(C=C3)O,CWI1-2,Data.sdf,11316,HY-153274,,2408590-36-1,Apoptosis,Apoptosis,C22H17Cl3N6O3,10mM,Cancer,No Development Reported,Oc1ccc(Cl)cc1/C=N\N/C(=N/N=C/c1cc(Cl)ccc1O)N/N=C/c1cc(Cl)ccc1O,清洗成功,0.2539682539682539
6303,C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1C[C@H]1O[C@@H](c3ccc(Cc4cccc(N)c4)cc3)O[C@]12C(=O)CO,1,0.9828442335128784,0.9828442335128784,OCC([C@]12[C@@]3([C@@]([C@@]4([H])[C@]([C@@]5(C(CC4)=CC(C=C5)=O)C)([H])[C@H](C3)O)([H])C[C@@]1([H])O[C@](C6=CC=C(C=C6)CC7=CC(N)=CC=C7)([H])O2)C)=O,Glucocorticoid receptor agonist-1,Data.sdf,7457,HY-131974,,2166375-82-0,ADC Cytotoxin; Glucocorticoid Receptor,Antibody-drug Conjugate/ADC Related; Immunology/Inflammation; Vitamin D Related/Nuclear Receptor,C35H39NO6,10mM,Inflammation/Immunology,No Development Reported,C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1C[C@H]1O[C@@H](c3ccc(Cc4cccc(N)c4)cc3)O[C@]12C(=O)CO,清洗成功,0.1981132075471698
11086,COc1ccc(-n2c(SCCCN3C(=O)c4cccc5cccc(c45)C3=O)nnc2-c2ccncc2)cc1,1,0.9828381538391113,0.9828381538391113,O=C1N(CCCSC2=NN=C(C3=CC=NC=C3)N2C4=CC=C(OC)C=C4)C(C5=CC=CC6=CC=CC1=C56)=O,WIKI4,Data.sdf,13132,HY-16910,,838818-26-1,PARP; Wnt; ?2-catenin,Cell Cycle/DNA Damage; Epigenetics; Stem Cell/Wnt,C29H23N5O3S,10mM,Cancer,No Development Reported,COc1ccc(-n2c(SCCCN3C(=O)c4cccc5cccc(c45)C3=O)nnc2-c2ccncc2)cc1,清洗成功,0.2597402597402597
3223,Cn1cc(-c2ccc(N(C(=O)NCc3ccccc3)[C@H]3CC[C@H](Nc4ccc(C#N)cn4)CC3)cc2)ccc1=O,1,0.9828197360038757,0.9828197360038757,O=C(NCC1=CC=CC=C1)N([C@H]2CC[C@@H](CC2)NC3=CC=C(C=N3)C#N)C4=CC=C(C5=CN(C(C=C5)=O)C)C=C4,CDK12-IN-2,Data.sdf,3789,HY-112626,,2244987-03-7,CDK,Cell Cycle/DNA Damage,C32H32N6O2,10mM,Cancer,No Development Reported,Cn1cc(-c2ccc(N(C(=O)NCc3ccccc3)[C@H]3CC[C@H](Nc4ccc(C#N)cn4)CC3)cc2)ccc1=O,清洗成功,0.2692307692307692
4923,CC1(C)C(C(=O)OC(C#N)c2cccc(Oc3ccccc3)c2)C1(C)C,1,0.9828160405158997,0.9828160405158997,O=C(C1C(C)(C)C1(C)C)OC(C#N)C2=CC=CC(OC3=CC=CC=C3)=C2,Fenpropathrin,Data.sdf,5798,HY-123178,,39515-41-8,Insecticide,Others,C22H23NO3,10mM,Neurological Disease,No Development Reported,CC1(C)C(C(=O)OC(C#N)c2cccc(Oc3ccccc3)c2)C1(C)C,清洗成功,0.2428571428571428
10217,N#CC1(CS(=O)(=O)N2Cc3ccc(Cl)cc3[C@H](C(=O)Nc3cncc4ccccc34)C2)CC1,1,0.9827760457992554,0.9827760457992554,N#CC1(CC1)CS(=O)(N2CC3=C([C@@H](C2)C(NC4=C5C=CC=CC5=CN=C4)=O)C=C(C=C3)Cl)=O,MAT-POS-e194df51-1,Data.sdf,12090,HY-157154,,2765433-05-2,SARS-CoV,Anti-infection,C24H21ClN4O3S,10mM,Infection,No Development Reported,N#CC1(CS(=O)(=O)N2Cc3ccc(Cl)cc3[C@H](C(=O)Nc3cncc4ccccc34)C2)CC1,清洗成功,0.2222222222222222
2931,COCCN1CCOc2c1cnn1c(-c3ccc4cccc(NCC5CCNCC5)c4n3)nnc21,1,0.9827523827552795,0.9827523827552795,COCCN1C2=C(C3=NN=C(C4=NC5=C(NCC6CCNCC6)C=CC=C5C=C4)N3N=C2)OCC1,PIM1-IN-1,Data.sdf,3436,HY-111552,,1417630-95-5,Pim,JAK/STAT Signaling,C25H30N8O2,10mM,Cancer,No Development Reported,COCCN1CCOc2c1cnn1c(-c3ccc4cccc(NCC5CCNCC5)c4n3)nnc21,清洗成功,0.2551020408163265
12793,CNS(=O)(=O)CCc1ccc2[nH]cc(C3CCN(C)CC3)c2c1,1,0.9827248454093933,0.9827248454093933,O=S(CCC1=CC2=C(NC=C2C3CCN(C)CC3)C=C1)(NC)=O.Cl,Naratriptan (hydrochloride),Data.sdf,15126,HY-B0197A,GR-85548A hydrochloride,143388-64-1,5-HT Receptor,GPCR/G Protein; Neuronal Signaling,C17H26ClN3O2S,10mM,Neurological Disease,Launched,CNS(=O)(=O)CCc1ccc2[nH]cc(C3CCN(C)CC3)c2c1,清洗成功,0.2375
3040,Cc1nc(-c2nc(-c3ccc(OC(F)(F)F)cc3)no2)nn1Cc1cccc(N2CCC(S(C)(=O)=O)CC2)c1,1,0.9827151894569397,0.9827151894569397,FC(F)(F)OC1=CC=C(C2=NOC(C3=NN(CC4=CC(N5CCC(S(=O)(C)=O)CC5)=CC=C4)C(C)=N3)=N2)C=C1.Cl,IACS-010759 (hydrochloride),Data.sdf,3557,HY-112037A,IACS-10759 (hydrochloride),1807523-99-4,Apoptosis; Mitochondrial Metabolism; Oxidative Phosphorylation,Apoptosis; Metabolic Enzyme/Protease,C25H26ClF3N6O4S,10mM,Cancer,Phase 1,Cc1nc(-c2nc(-c3ccc(OC(F)(F)F)cc3)no2)nn1Cc1cccc(N2CCC(S(C)(=O)=O)CC2)c1,清洗成功,0.24
2880,c1ccc(Cn2nnc3c(Sc4ncco4)ncnc32)cc1,1,0.9827026128768921,0.9827026128768921,C12=NC=NC(SC3=NC=CO3)=C1N=NN2CC4=CC=CC=C4,VAS 3947,Data.sdf,3381,HY-111447,,869853-70-3,Apoptosis; NADPH Oxidase,Apoptosis; Metabolic Enzyme/Protease,C14H10N6OS,10mM,Cancer; Cardiovascular Disease,No Development Reported,c1ccc(Cn2nnc3c(Sc4ncco4)ncnc32)cc1,清洗成功,0.2571428571428571
14614,COc1cc2oc(-c3ccc(O)cc3)cc(=O)c2c(O)c1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,1,0.9827017188072205,0.9827017188072205,COC1=C([C@H](O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H]2O[C@]([C@@H]([C@@H](O)[C@@H]3O)O)([H])O[C@@H]3CO)C(O)=C4C(OC(C5=CC=C(O)C=C5)=CC4=O)=C1,Spinosin,Data.sdf,17306,HY-N0651,,72063-39-9,Amyloid-?2,Neuronal Signaling,C28H32O15,10mM,Neurological Disease,No Development Reported,COc1cc2oc(-c3ccc(O)cc3)cc(=O)c2c(O)c1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,清洗成功,0.3411764705882353
9991,Cc1c(Br)cc(NCC(=O)N/N=C/c2cc([N+](=O)[O-])ccc2O)cc1Br,1,0.9826928377151489,0.9826928377151489,BrC1=CC(NCC(N/N=C/C2=CC([N+]([O-])=O)=CC=C2O)=O)=CC(Br)=C1C,L67,Data.sdf,11815,HY-15586,DNA Ligase Inhibitor,325970-71-6,Apoptosis; Caspase; DNA/RNA Synthesis; Reactive Oxygen Species,Apoptosis; Cell Cycle/DNA Damage; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?oB,C16H14Br2N4O4,10mM,Cancer,No Development Reported,Cc1c(Br)cc(NCC(=O)N/N=C/c2cc([N+](=O)[O-])ccc2O)cc1Br,清洗成功,0.2835820895522388
10313,CCCCC1(CCCC)CN(c2ccccc2)c2cc(SC)c(OCC(=O)N[C@@H](C(=O)NCC(=O)O)c3ccccc3)cc2S(=O)(=O)C1,1,0.9826744198799133,0.9826744198799133,O=C(O)CNC([C@@H](C1=CC=CC=C1)NC(COC2=C(SC)C=C(C3=C2)N(C4=CC=CC=C4)CC(CCCC)(CCCC)CS3(=O)=O)=O)=O,Elobixibat,Data.sdf,12216,HY-15790,A 3309; AZD 7806,439087-18-0,Apical Sodium-Dependent Bile Acid Transporter; Interleukin Related; TNF Receptor,Apoptosis; Immunology/Inflammation; Membrane Transporter/Ion Channel,C36H45N3O7S2,10mM,Metabolic Disease; Inflammation/Immunology; Cancer,Launched,CCCCC1(CCCC)CN(c2ccccc2)c2cc(SC)c(OCC(=O)N[C@@H](C(=O)NCC(=O)O)c3ccccc3)cc2S(=O)(=O)C1,清洗成功,0.2
10314,CCCCC1(CCCC)CN(c2ccccc2)c2cc(SC)c(OCC(=O)N[C@@H](C(=O)NCC(=O)O)c3ccccc3)cc2S(=O)(=O)C1,1,0.9826744198799133,0.9826744198799133,O=C(O)CNC([C@@H](C1=CC=CC=C1)NC(COC2=C(SC)C=C(C3=C2)N(C4=CC=CC=C4)CC(CCCC)(CCCC)CS3(=O)=O)=O)=O.O,Elobixibat (hydrate),Data.sdf,12217,HY-15790A,A 3309 (hydrate); AZD 7806 (hydrate),1633824-78-8,Apical Sodium-Dependent Bile Acid Transporter,Membrane Transporter/Ion Channel,C36H47N3O8S2,10mM,Metabolic Disease,Launched,CCCCC1(CCCC)CN(c2ccccc2)c2cc(SC)c(OCC(=O)N[C@@H](C(=O)NCC(=O)O)c3ccccc3)cc2S(=O)(=O)C1,清洗成功,0.1979166666666666
47,COc1ccc2c3c([nH]c2c1)[C@H](CC(C)C)N1C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)[C@@H]1C3,1,0.9826565980911255,0.9826565980911255,O=C1N2[C@]([H])(C3=C(C[C@]2(C(N[C@H]1CCC(OC(C)(C)C)=O)=O)[H])C4=CC=C(OC)C=C4N3)CC(C)C,Ko 143,Data.sdf,53,HY-10010,,461054-93-3,BCRP,Membrane Transporter/Ion Channel,C26H35N3O5,10mM,Cancer,No Development Reported,COc1ccc2c3c([nH]c2c1)[C@H](CC(C)C)N1C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)[C@@H]1C3,清洗成功,0.275
15445,COc1cc(O)c2c(=O)c(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)c(-c3ccc(OC)c(O)c3)oc2c1,1,0.9825994968414307,0.9825994968414307,O=C1C(O[C@@H]([C@@H]([C@H]2O)O)O[C@@H]([C@H]2O)CO[C@H](O[C@H]3C)[C@@H]([C@@H]([C@H]3O)O)O)=C(C(C=C4)=CC(O)=C4OC)OC5=CC(OC)=CC(O)=C15,Ombuoside,Data.sdf,18409,HY-N3138,,20188-85-6,Bacterial,Anti-infection,C29H34O16,10mM,Infection,No Development Reported,COc1cc(O)c2c(=O)c(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)c(-c3ccc(OC)c(O)c3)oc2c1,清洗成功,0.3258426966292135
8189,Cc1cccc(N(C)C(=O)[C@H]2C[C@@H](O)CN2c2nc(C)cc(C(F)(F)F)c2C#N)c1,1,0.9825692176818848,0.9825692176818848,O=C([C@@H]1N(C2=NC(C)=CC(C(F)(F)F)=C2C#N)C[C@H](O)C1)N(C)C3=CC=CC(C)=C3,ART615,Data.sdf,9671,HY-145056,,3031765-75-7,DNA/RNA Synthesis,Cell Cycle/DNA Damage,C21H21F3N4O2,10mM,Cancer,No Development Reported,Cc1cccc(N(C)C(=O)[C@H]2C[C@@H](O)CN2c2nc(C)cc(C(F)(F)F)c2C#N)c1,清洗成功,0.2828282828282828
7604,Cc1ccc(OCCN(C)C(=O)Cn2cc(NC(=O)CCOc3ccccc3)cn2)cc1,1,0.9825577139854431,0.9825577139854431,O=C(N(C)CCOC1=CC=C(C)C=C1)CN2N=CC(NC(CCOC3=CC=CC=C3)=O)=C2,IXA4,Data.sdf,9001,HY-139214,,1185329-96-7,IRE1,Cell Cycle/DNA Damage,C24H28N4O4,10mM,Neurological Disease,No Development Reported,Cc1ccc(OCCN(C)C(=O)Cn2cc(NC(=O)CCOc3ccccc3)cn2)cc1,清洗成功,0.247191011235955
11697,O=C(OC(C(F)(F)F)C(F)(F)F)N1CCC(C(O)(c2ccc3c(c2)OCO3)c2ccc3c(c2)OCO3)CC1,1,0.9825491905212402,0.9825491905212402,O=C(N1CCC(C(C2=CC=C(OCO3)C3=C2)(C4=CC=C(OCO5)C5=C4)O)CC1)OC(C(F)(F)F)C(F)(F)F,KML29,Data.sdf,13841,HY-18977,,1380424-42-9,MAGL,Metabolic Enzyme/Protease,C24H21F6NO7,10mM,Metabolic Disease; Inflammation/Immunology,No Development Reported,O=C(OC(C(F)(F)F)C(F)(F)F)N1CCC(C(O)(c2ccc3c(c2)OCO3)c2ccc3c(c2)OCO3)CC1,清洗成功,0.240506329113924
4780,O=C1OC2(c3ccc(O)cc3Oc3cc(O)ccc32)c2cccc3cccc1c23,1,0.9825479388237,0.9825479388237,O=C1C2=CC=CC3=C2C(C4(C5=C(OC6=C4C=CC(O)=C6)C=C(O)C=C5)O1)=CC=C3,Resorcinolnaphthalein,Data.sdf,5617,HY-122445,,41307-63-5,Angiotensin-converting Enzyme (ACE),Metabolic Enzyme/Protease,C24H14O5,10mM,Inflammation/Immunology; Cardiovascular Disease,No Development Reported,O=C1OC2(c3ccc(O)cc3Oc3cc(O)ccc32)c2cccc3cccc1c23,清洗成功,0.320754716981132
6799,CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N(C)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,1,0.9825294017791748,0.9825294017791748,C[C@H](C(N)=O)NC([C@H]1N(C([C@H](CCCCNC(C)C)NC([C@H](CC(C)C)NC([C@@H](CC(N)=O)NC([C@H](CC2=CC=C(C=C2)O)N(C([C@H](CO)NC([C@@H](CC3=CC=CN=C3)NC([C@@H](CC4=CC=C(Cl)C=C4)NC([C@@H](CC5=CC=C6C=CC=CC6=C5)NC(C)=O)=O)=O)=O)=O)C)=O)=O)=O)=O)CCC1)=O,Abarelix,Data.sdf,8071,HY-13534,R3827; PPI 149,183552-38-7,GnRH Receptor,GPCR/G Protein,C72H95ClN14O14,10mM,Cancer; Endocrinology,Launched,CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N(C)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,清洗成功,0.1910828025477707
7156,CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)CF,1,0.9824995994567871,0.9824995994567871,O=C(CF)[C@@H](NC([C@H](CC(C)C)NC([C@H](CC(C)C)NC(OCC1=CC=CC=C1)=O)=O)=O)CC(C=C2)=CC=C2O,Z-LLY-FMK,Data.sdf,8472,HY-136750,Calpain Inhibitor IV,133410-84-1,Apoptosis; Proteasome,Apoptosis; Metabolic Enzyme/Protease,C30H40FN3O6,10mM,Cancer,No Development Reported,CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)CF,清洗成功,0.2528735632183908
6519,Cc1ccccc1-c1cc(N2CC[N+](C)(COP(=O)(O)O)CC2)ncc1N(C)C(=O)C(C)(C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,1,0.9824762344360352,0.9824762344360352,O=C(C(C)(C)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1)N(C)C2=CN=C(N3CC[N+](COP(O)(O)=O)(CC3)C)C=C2C4=C(C)C=CC=C4.[H]Cl.[Cl-],Fosnetupitant (chloride monohydrochloride ),Data.sdf,7726,HY-133206A,Pronetupitant (chloride monohydrochloride ),1643757-72-5,Neurokinin Receptor,GPCR/G Protein; Neuronal Signaling,C31H37Cl2F6N4O5P,10mM,Cancer,No Development Reported,Cc1ccccc1-c1cc(N2CC[N+](C)(COP(=O)(O)O)CC2)ncc1N(C)C(=O)C(C)(C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,清洗成功,0.2162162162162162
14006,CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O[C@H]2CC[C@H](N(C)C)[C@@H](C)O2)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1OC(C)=O,1,0.9824333190917969,0.9824333190917969,O[C@H]1[C@](O[C@H](C)[C@@H](O[C@@](O[C@@H](C)[C@@H]2O)([H])C[C@]2(O)C)[C@@H]1N(C)C)([H])O[C@@H]([C@H](C[C@H]([C@H](/C=C/C=C/C3)O[C@](CC[C@@H]4N(C)C)([H])O[C@@H]4C)C)CC=O)[C@H]([C@](CC(O[C@@H]3C)=O)([H])OC(C)=O)OC,Acetylspiramycin,Data.sdf,16490,HY-B1916,Spiramycin B; Spiramycin II; Foromacidin B,24916-51-6,Antibiotic; Bacterial; Parasite,Anti-infection,C45H76N2O15,10mM,Infection,Launched,CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O[C@H]2CC[C@H](N(C)C)[C@@H](C)O2)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1OC(C)=O,清洗成功,0.1690140845070422
3115,O=C(NCc1ncccc1F)c1coc(CCNCCc2nc3ccccc3[nH]2)n1,1,0.9824223518371582,0.9824223518371582,O=C(C1=COC(CCNCCC2=NC3=CC=CC=C3N2)=N1)NCC4=NC=CC=C4F,VIT-2763,Data.sdf,3645,HY-112220,,2095668-10-1,Ferroportin,Membrane Transporter/Ion Channel,C21H21FN6O2,10mM,Metabolic Disease,Phase 2,O=C(NCc1ncccc1F)c1coc(CCNCCc2nc3ccccc3[nH]2)n1,清洗成功,0.247191011235955
8111,COc1cc2ccn(C/C=C/C(=O)NCCC(C)C)c(=O)c2cc1OC,1,0.9824005365371704,0.9824005365371704,O=C1C2=CC(OC)=C(OC)C=C2C=CN1C/C=C/C(NCCC(C)C)=O,Immunoproteasome inhibitor 1,Data.sdf,9580,HY-144452,,2755772-63-3,Proteasome,Metabolic Enzyme/Protease,C20H26N2O4,10mM,Cancer,No Development Reported,COc1cc2ccn(C/C=C/C(=O)NCCC(C)C)c(=O)c2cc1OC,清洗成功,0.2741935483870967
9563,CCOc1ccc(-n2c([C@@H](C)N(Cc3cccnc3)C(=O)Cc3ccc(F)c(C(F)(F)F)c3)nc3ncccc3c2=O)cc1,1,0.9823980927467346,0.9823980927467346,O=C(N([C@@H](C1=NC2=NC=CC=C2C(N1C3=CC=C(OCC)C=C3)=O)C)CC4=CC=CN=C4)CC5=CC=C(F)C(C(F)(F)F)=C5,NBI-74330,Data.sdf,11295,HY-15320,,855527-92-3,CXCR,GPCR/G Protein; Immunology/Inflammation,C32H27F4N5O3,10mM,Inflammation/Immunology; Endocrinology,No Development Reported,CCOc1ccc(-n2c([C@@H](C)N(Cc3cccnc3)C(=O)Cc3ccc(F)c(C(F)(F)F)c3)nc3ncccc3c2=O)cc1,清洗成功,0.2403846153846154
8746,Nc1nc(-n2cc(C(=O)O)c(=O)c3cc(F)c(N4CC(O)C4)c(Cl)c32)c(F)cc1F,1,0.9823610782623291,0.9823610782623291,O=C(C1=CN(C2=NC(N)=C(F)C=C2F)C3=C(C=C(F)C(N4CC(O)C4)=C3Cl)C1=O)O,Delafloxacin,Data.sdf,10321,HY-14814,RX-3341; WQ-3034; ABT492,189279-58-1,Antibiotic; Bacterial,Anti-infection,C18H12ClF3N4O4,10mM,Infection,Launched,Nc1nc(-n2cc(C(=O)O)c(=O)c3cc(F)c(N4CC(O)C4)c(Cl)c32)c(F)cc1F,清洗成功,0.2650602409638554
8749,Nc1nc(-n2cc(C(=O)O)c(=O)c3cc(F)c(N4CC(O)C4)c(Cl)c32)c(F)cc1F,1,0.9823610782623291,0.9823610782623291,O=C(C1=CN(C2=NC(N)=C(F)C=C2F)C3=C(C=C(F)C(N4CC(O)C4)=C3Cl)C1=O)O.O[C@H]([C@H]([C@@H]([C@@H](CO)O)O)O)CNC,Delafloxacin (meglumine),Data.sdf,10324,HY-14814A,ABT492 meglumine; RX-3341 meglumine; WQ-3034 meglumine,352458-37-8,Antibiotic; Bacterial,Anti-infection,C25H29ClF3N5O9,10mM,Infection,Launched,Nc1nc(-n2cc(C(=O)O)c(=O)c3cc(F)c(N4CC(O)C4)c(Cl)c32)c(F)cc1F,清洗成功,0.2424242424242424
1922,CCCOc1ccn2c(C(C)=O)cc(-c3cccc(OC)c3)c2c1,1,0.9823424220085144,0.9823424220085144,CC(C1=CC(C2=CC=CC(OC)=C2)=C3C=C(OCCC)C=CN13)=O,GSK8573,Data.sdf,2263,HY-107477,,1693766-04-9,Epigenetic Reader Domain,Epigenetics,C20H21NO3,10mM,Cancer,No Development Reported,CCCOc1ccn2c(C(C)=O)cc(-c3cccc(OC)c3)c2c1,清洗成功,0.3396226415094339
3659,Cc1ccc(O)c(-c2cc(-c3ccccc3)[nH]n2)c1,1,0.9823424220085144,0.9823424220085144,OC(C=CC(C)=C1)=C1C2=NNC(C3=CC=CC=C3)=C2,VRT-532,Data.sdf,4309,HY-114725,CFpot-532,38214-71-0,CFTR,Membrane Transporter/Ion Channel,C16H14N2O,10mM,Inflammation/Immunology,No Development Reported,Cc1ccc(O)c(-c2cc(-c3ccccc3)[nH]n2)c1,清洗成功,0.2857142857142857
16051,O=C(O[C@@H]1[C@H]2OC(=O)c3cc(O)c(O)c(O)c3Oc3cc4c(c(O)c3O)-c3c(cc(O)c(O)c3O)C(=O)OC[C@H]3O[C@@H](O)[C@H](OC(=O)c5cc(O)c(O)c(O)c5Oc5cc6c(c(O)c5O)-c5c(cc(O)c(O)c5O)C(=O)O[C@@H]1[C@@H](COC6=O)O[C@H]2O)[C@@H](OC(=O)c1cc(O)c(O)c(O)c1)[C@@H]3OC4=O)c1cc(O)c(O)c(O)c1,1,0.9823130965232849,0.9823130965232849,O=C1C2=CC(OC3=C(C4=O)C=C(O)C(O)=C3O)=C(O)C(O)=C2C5=C(C(OC[C@@H](O[C@@H](O)[C@H](OC(C6=C(OC7=C(O)C(O)=C(C8=C9C=C(O)C(O)=C8O)C(C(OC[C@H]%10O[C@@H](O)[C@H](O4)[C@@H](OC(C%11=CC(O)=C(O)C(O)=C%11)=O)[C@@H]%10OC9=O)=O)=C7)C(O)=C(O)C(O)=C6)=O)[C@H]%12OC(C%13=CC(O)=C(O)C(O)=C%13)=O)[C@H]%12O1)=O)C=C(O)C(O)=C5O,Oenothein B,Data.sdf,19188,HY-N7765,,104987-36-2,Apoptosis; Bacterial; Fungal; HCV,Anti-infection; Apoptosis,C68H48O44,10mM,Cancer; Infection; Inflammation/Immunology,No Development Reported,O=C(O[C@@H]1[C@H]2OC(=O)c3cc(O)c(O)c(O)c3Oc3cc4c(c(O)c3O)-c3c(cc(O)c(O)c3O)C(=O)OC[C@H]3O[C@@H](O)[C@H](OC(=O)c5cc(O)c(O)c(O)c5Oc5cc6c(c(O)c5O)-c5c(cc(O)c(O)c5O)C(=O)O[C@@H]1[C@@H](COC6=O)O[C@H]2O)[C@@H](OC(=O)c1cc(O)c(O)c(O)c1)[C@@H]3OC4=O)c1cc(O)c(O)c(O)c1,清洗成功,0.3157894736842105
15671,COc1cc2oc(-c3ccc(O)c(O)c3)c(OC)c(=O)c2c(O)c1OC,1,0.9822966456413269,0.9822966456413269,O=C1C2=C(O)C(OC)=C(OC)C=C2OC(C3=CC(O)=C(O)C=C3)=C1OC,Chrysosplenol D,Data.sdf,18712,HY-N6007,,14965-20-9,Apoptosis,Apoptosis,C18H16O8,10mM,Cancer; Infection; Inflammation/Immunology,No Development Reported,COc1cc2oc(-c3ccc(O)c(O)c3)c(OC)c(=O)c2c(O)c1OC,清洗成功,0.3142857142857143
16811,CN(C)CCCNc1c2ccccc2nc2cccc([N+](=O)[O-])c12,1,0.9822539687156677,0.9822539687156677,O=[N+](C1=CC=CC2=NC3=CC=CC=C3C(NCCCN(C)C)=C21)[O-],Nitracrine,Data.sdf,20005,HY-U00279,,4533-39-5,DNA/RNA Synthesis,Cell Cycle/DNA Damage,C18H20N4O2,10mM,Cancer,No Development Reported,CN(C)CCCNc1c2ccccc2nc2cccc([N+](=O)[O-])c12,清洗成功,0.2666666666666666
4968,COc1ccc(S(=O)(=O)Nc2nc(-c3cccc([N+](=O)[O-])c3)cs2)cc1OC,1,0.9822373986244202,0.9822373986244202,O=S(C1=CC=C(OC)C(OC)=C1)(NC2=NC(C3=CC=CC([N+]([O-])=O)=C3)=CS2)=O,Ro 61-8048,Data.sdf,5855,HY-12347,,199666-03-0,KMO,Metabolic Enzyme/Protease,C17H15N3O6S2,10mM,Neurological Disease,No Development Reported,COc1ccc(S(=O)(=O)Nc2nc(-c3cccc([N+](=O)[O-])c3)cs2)cc1OC,清洗成功,0.2816901408450704
10530,Cc1cc(NC(=O)C2CCN(c3nc4ccccc4n3Cc3cccc(F)c3)CC2)ccc1Br,1,0.9822320938110352,0.9822320938110352,O=C(C1CCN(CC1)C2=NC3=C(N2CC4=CC(F)=CC=C4)C=CC=C3)NC5=CC=C(C(C)=C5)Br,iPAF1C,Data.sdf,12483,HY-160267,,950403-60-8,DNA/RNA Synthesis; HIV,Anti-infection; Cell Cycle/DNA Damage,C27H26BrFN4O,10mM,infection,No Development Reported,Cc1cc(NC(=O)C2CCN(c3nc4ccccc4n3Cc3cccc(F)c3)CC2)ccc1Br,清洗成功,0.2736842105263158
3039,Cc1nc(-c2nc(-c3ccc(OC(F)(F)F)cc3)no2)nn1Cc1cccc(N2CCC(S(C)(=O)=O)CC2)c1,1,0.9822059869766235,0.9822059869766235,FC(F)(F)OC1=CC=C(C2=NOC(C3=NN(CC4=CC(N5CCC(S(=O)(C)=O)CC5)=CC=C4)C(C)=N3)=N2)C=C1,IACS-010759,Data.sdf,3556,HY-112037,IACS-10759,1570496-34-2,Apoptosis; Mitochondrial Metabolism; Oxidative Phosphorylation,Apoptosis; Metabolic Enzyme/Protease,C25H25F3N6O4S,10mM,Cancer,Phase 1,Cc1nc(-c2nc(-c3ccc(OC(F)(F)F)cc3)no2)nn1Cc1cccc(N2CCC(S(C)(=O)=O)CC2)c1,清洗成功,0.2424242424242424
10792,Cc1cc(-c2cnn(C)c2)ncc1Nc1ncc2c(n1)n(C1CCOCC1)c(=O)n2C,1,0.9821828007698059,0.9821828007698059,O=C1N(C)C2=CN=C(NC3=C(C)C=C(C4=CN(C)N=C4)N=C3)N=C2N1C5CCOCC5,DNA-PK-IN-12,Data.sdf,12792,HY-163134,,2792146-91-7,DNA-PK,Cell Cycle/DNA Damage; PI3K/Akt/mTOR,C21H24N8O2,2mM,Cancer,No Development Reported,Cc1cc(-c2cnn(C)c2)ncc1Nc1ncc2c(n1)n(C1CCOCC1)c(=O)n2C,清洗成功,0.2842105263157894
8478,CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1,1,0.9821702241897583,0.9821702241897583,CC(C)(C)C1=NC(C2=C(F)C(NS(C3=C(F)C=CC=C3F)(=O)=O)=CC=C2)=C(C4=CC=NC(N)=N4)S1,Dabrafenib,Data.sdf,10004,HY-14660,GSK2118436A; GSK2118436,1195765-45-7,Raf,MAPK/ERK Pathway,C23H20F3N5O2S2,10mM,Cancer,Launched,CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1,清洗成功,0.3048780487804878
8479,CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1,1,0.9821702241897583,0.9821702241897583,CC(C)(C)C1=NC(C2=C(F)C(NS(C3=C(F)C=CC=C3F)(=O)=O)=CC=C2)=C(C4=CC=NC(N)=N4)S1.CS(=O)(O)=O,Dabrafenib (Mesylate),Data.sdf,10005,HY-14660A,GSK2118436 Mesylate; GSK 2118436B,1195768-06-9,Raf,MAPK/ERK Pathway,C24H24F3N5O5S3,10mM,Cancer,Launched,CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1,清洗成功,0.2941176470588235
11636,COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OC(=O)N1CCN(C)C[C@H]1C,1,0.9821571111679077,0.9821571111679077,ClC1=CC=CC(NC2=NC=NC3=CC(OC)=C(OC(N4[C@H](C)CN(C)CC4)=O)C=C23)=C1F,Zorifertinib,Data.sdf,13768,HY-18750,AZD3759,1626387-80-1,Apoptosis; EGFR,Apoptosis; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK,C22H23ClFN5O3,10mM,Cancer,Phase 3,COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OC(=O)N1CCN(C)C[C@H]1C,清洗成功,0.35
5686,COCCn1nnnc1C(c1cc2cc(OC)ccc2[nH]c1=O)N(CCc1ccccc1)Cc1ccccc1,1,0.9821408987045288,0.9821408987045288,O=C1NC2=C(C=C(OC)C=C2)C=C1C(C3=NN=NN3CCOC)N(CCC4=CC=CC=C4)CC5=CC=CC=C5,ASN04421891,Data.sdf,6714,HY-128128,,570365-12-7,Transmembrane Glycoprotein,Immunology/Inflammation,C30H32N6O3,10mM,Neurological Disease,No Development Reported,COCCn1nnnc1C(c1cc2cc(OC)ccc2[nH]c1=O)N(CCc1ccccc1)Cc1ccccc1,清洗成功,0.2916666666666667
19,C[C@H]1C[C@@H](n2c(Nc3ccc(OC(F)(F)F)cc3)nc3cc(CCC(=O)O)ccc32)CC(C)(C)C1,1,0.982137143611908,0.982137143611908,O=C(O)CCC1=CC=C2C(N=C(NC3=CC=C(OC(F)(F)F)C=C3)N2[C@H]4CC(C)(C)C[C@@H](C)C4)=C1,BAY-1436032,Data.sdf,19,HY-100020,,1803274-65-8,Isocitrate Dehydrogenase (IDH),Metabolic Enzyme/Protease,C26H30F3N3O3,10mM,Cancer,Phase 1,C[C@H]1C[C@@H](n2c(Nc3ccc(OC(F)(F)F)cc3)nc3cc(CCC(=O)O)ccc32)CC(C)(C)C1,清洗成功,0.2804878048780488
10856,O=C(O)c1ccc2nc(CN3CCC(c4cccc(OCc5ccc(C6COC6)cc5F)n4)CC3)n(C[C@@H]3CCO3)c2c1,1,0.9820927381515503,0.9820927381515503,O=C(C1=CC=C2C(N(C(CN3CCC(C4=NC(OCC5=C(C=C(C=C5)C6COC6)F)=CC=C4)CC3)=N2)C[C@@H]7CCO7)=C1)O,DD202-114,Data.sdf,12867,HY-163996,,2886728-09-0,GLP Receptor,GPCR/G Protein,C33H35FN4O5,10mM,Metabolic Disease,No Development Reported,O=C(O)c1ccc2nc(CN3CCC(c4cccc(OCc5ccc(C6COC6)cc5F)n4)CC3)n(C[C@@H]3CCO3)c2c1,清洗成功,0.2232142857142857
9637,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1ccnc2ccc(OCCCCN)cc12,1,0.9820330739021301,0.9820330739021301,O=C(N1[C@@H](CC(F)(C1)F)C#N)CNC(C2=CC=NC3=C2C=C(OCCCCN)C=C3)=O.O=C(O)C(F)(F)F,NH2-UAMC1110 (TFA),Data.sdf,11384,HY-153552A,,2990021-73-1,FAP,Immunology/Inflammation,C23H24F5N5O5,10mM,Cancer,No Development Reported,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1ccnc2ccc(OCCCCN)cc12,清洗成功,0.2244897959183673
13592,CC1CC(OC(=O)C(O)c2ccccc2)CC(C)(C)C1,1,0.9820215702056885,0.9820215702056885,O=C(OC1CC(C)(C)CC(C)C1)C(O)C2=CC=CC=C2,Cyclandelate,Data.sdf,16029,HY-B1170,"3,5,5-Trimethylcyclohexyl mandelate",456-59-7,Others,Others,C17H24O3,10mM,Cardiovascular Disease,Launched,CC1CC(OC(=O)C(O)c2ccccc2)CC(C)(C)C1,清洗成功,0.2
2323,O=C(CSC1=NCCS1)c1ccc(O)c(O)c1,1,0.9820111393928528,0.9820111393928528,OC1=CC=C(C(CSC2=NCCS2)=O)C=C1O,RETRA,Data.sdf,2728,HY-108636,,1036069-26-7,MDM-2/p53,Apoptosis,C11H11NO3S2,10mM,Cancer,No Development Reported,O=C(CSC1=NCCS1)c1ccc(O)c(O)c1,清洗成功,0.2575757575757575
962,COc1ccccc1[C@H](Cn1c(=O)n(C(C)(C)C(N)=O)c(=O)c2c(C)c(-c3ncco3)sc21)OC1CCOCC1,1,0.9819988012313843,0.9819988012313843,O=C(N)C(C)(C)N(C(N(C[C@@H](C1=CC=CC=C1OC)OC2CCOCC2)C3=C4C(C)=C(C5=NC=CO5)S3)=O)C4=O,ND-646,Data.sdf,1103,HY-101842,,1434639-57-2,Acetyl-CoA Carboxylase,Metabolic Enzyme/Protease,C28H32N4O7S,10mM,Cancer,No Development Reported,COc1ccccc1[C@H](Cn1c(=O)n(C(C)(C)C(N)=O)c(=O)c2c(C)c(-c3ncco3)sc21)OC1CCOCC1,清洗成功,0.2075471698113207
8420,CN1CCN(C(=O)COc2ccc(C(=O)/C=C/c3ccccc3C(F)(F)F)cc2)CC1,1,0.9819846749305725,0.9819846749305725,O=C(C1=CC=C(C=C1)OCC(N2CCN(CC2)C)=O)/C=C/C3=C(C=CC=C3)C(F)(F)F.Cl,Nrf2 activator-4,Data.sdf,9932,HY-146086,,2383016-68-8,Keap1-Nrf2; Reactive Oxygen Species,Immunology/Inflammation; Metabolic Enzyme/Protease; NF-?oB,C23H24ClF3N2O3,10mM,Inflammation/Immunology; Neurological Disease,No Development Reported,CN1CCN(C(=O)COc2ccc(C(=O)/C=C/c3ccccc3C(F)(F)F)cc2)CC1,清洗成功,0.2333333333333333
15048,COc1ccc(-c2oc3c4c(cc(O)c3c(=O)c2O)OC(C)(C)CC4)cc1,1,0.9819774031639099,0.9819774031639099,O=C1C2=C(O)C=C3C(CCC(C)(C)O3)=C2OC(C4=CC=C(OC)C=C4)=C1O,?2-Anhydroicaritin,Data.sdf,17876,HY-N1940,Cycloicaritin,38226-86-7,Interleukin Related; MMP; TNF Receptor,Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease,C21H20O6,10mM,Inflammation/Immunology; Cancer,No Development Reported,COc1ccc(-c2oc3c4c(cc(O)c3c(=O)c2O)OC(C)(C)CC4)cc1,清洗成功,0.2894736842105263
15546,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)c(O)c(O)c12,1,0.9819643497467041,0.9819643497467041,O=C1C(O)=C(C2=CC=C(O)C(O)=C2)OC3=CC(O)=C(O)C(O)=C13,Quercetagetin,Data.sdf,18547,HY-N4149,6-Hydroxyquercetin,90-18-6,Pim,JAK/STAT Signaling,C15H10O8,10mM,Cancer; Inflammation/Immunology,No Development Reported,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)c(O)c(O)c12,清洗成功,0.3478260869565217
11328,COc1ccnc(CS(=O)c2nc3ccc(OC(F)F)cc3[n-]2)c1OC,1,0.9819056987762451,0.9819056987762451,O=S(C1=NC2=CC=C(OC(F)F)C=C2[N-]1)CC3=NC=CC(OC)=C3OC.[Na+],Pantoprazole (sodium),Data.sdf,13403,HY-17507A,BY1023 (sodium); SKF96022 (sodium),138786-67-1,Apoptosis; Autophagy; Bacterial; Proton Pump,Anti-infection; Apoptosis; Autophagy; Membrane Transporter/Ion Channel,C16H14F2N3NaO4S,10mM,Cancer; Inflammation/Immunology,Launched,COc1ccnc(CS(=O)c2nc3ccc(OC(F)F)cc3[n-]2)c1OC,清洗成功,0.2361111111111111
10336,CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccc4F)cc3oc2=O)c1F,1,0.9819011092185974,0.9819011092185974,FC1=C(OC2=CC=C(C(C)=C(CC3=C(F)C(NS(NC)(=O)=O)=NC=C3)C(O4)=O)C4=C2)N=CC=C1,NST-628,Data.sdf,12250,HY-158115,,3002056-30-3,MEK; Molecular Glues; Raf,MAPK/ERK Pathway; PROTAC,C22H18F2N4O5S,10mM,Cancer,Phase 1,CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccc4F)cc3oc2=O)c1F,清洗成功,0.2244897959183673
18004,N#CCCN(C(=O)CCl)c1ccc2c(c1)OCCO2,1,0.9818980097770691,0.9818980097770691,O=C(N(CCC#N)C1=CC=C(OCCO2)C2=C1)CCl,EN106,Data.sdf,21459,HY-W229874,,757192-67-9,E1/E2/E3 Enzyme,Metabolic Enzyme/Protease,C13H13ClN2O3,10mM,Cancer,No Development Reported,N#CCCN(C(=O)CCl)c1ccc2c(c1)OCCO2,清洗成功,0.2678571428571428
10449,Cc1nnc(-c2sc(NC(=O)[C@H](C(C)C)n3c(=O)[nH]c4ccccc4c3=O)nc2C)o1,1,0.9818883538246155,0.9818883538246155,O=C(C1=CC=CC=C1N2)N([C@@H](C(C)C)C(NC3=NC(C)=C(C4=NN=C(C)O4)S3)=O)C2=O,Kif15-IN-2,Data.sdf,12382,HY-15949,,672926-33-9,Kinesin,Cell Cycle/DNA Damage; Cytoskeleton,C20H20N6O4S,10mM,Cancer; Inflammation/Immunology; Cardiovascular Disease,No Development Reported,Cc1nnc(-c2sc(NC(=O)[C@H](C(C)C)n3c(=O)[nH]c4ccccc4c3=O)nc2C)o1,清洗成功,0.25
3942,N[C@H]1CC[C@H](Nc2nc(Nc3ccc(C(=O)N4CCCCC4)cc3)c3ncn(-c4cccc(F)c4)c3n2)CC1,1,0.9818772077560425,0.9818772077560425,O=C(C1=CC=C(NC2=C3N=CN(C4=CC=CC(F)=C4)C3=NC(N[C@H]5CC[C@H](N)CC5)=N2)C=C1)N6CCCCC6,Purfalcamine,Data.sdf,4633,HY-117015,,1038620-68-6,Parasite,Anti-infection,C29H33FN8O,10mM,Infection,No Development Reported,N[C@H]1CC[C@H](Nc2nc(Nc3ccc(C(=O)N4CCCCC4)cc3)c3ncn(-c4cccc(F)c4)c3n2)CC1,清洗成功,0.2736842105263158
14143,COc1ccc2nc(SCc3ncc(C)c(OC)c3C)[nH]c2c1,1,0.9818674325942993,0.9818674325942993,CC(C(OC)=C(C)C=N1)=C1CSC2=NC3=CC=C(OC)C=C3N2,Omeprazole sulfide,Data.sdf,16659,HY-G0006,Ufiprazole,73590-85-9,Drug Metabolite,Metabolic Enzyme/Protease,C17H19N3O2S,10mM,Others,No Development Reported,COc1ccc2nc(SCc3ncc(C)c(OC)c3C)[nH]c2c1,清洗成功,0.3278688524590163
6315,CCO[C@@H]1OC(=O)C[C@@H]1NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)c1ccc(N)c(Cl)c1)C(C)(C)C,1,0.9818546772003174,0.9818546772003174,ClC1=C(N)C=CC(C(N[C@@H](C(C)(C)C)C(N2[C@H](C(N[C@H]3CC(O[C@H]3OCC)=O)=O)CCC2)=O)=O)=C1,Belnacasan,Data.sdf,7471,HY-13205,VX-765,273404-37-8,Caspase,Apoptosis,C24H33ClN4O6,10mM,Inflammation/Immunology,Phase 2,CCO[C@@H]1OC(=O)C[C@@H]1NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)c1ccc(N)c(Cl)c1)C(C)(C)C,清洗成功,0.2413793103448276
10315,CC[C@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3cc4c(cc3nc2-1)OCO4,1,0.9818320274353027,0.9818320274353027,CC[C@]1(C2=C(COC1=O)C(N3C(C4=NC5=CC6=C(OCO6)C=C5C=C4C3)=C2)=O)O,(R)-FL118,Data.sdf,12219,HY-15792,"10,11-(Methylenedioxy)-20(R)-camptothecin",151636-76-9,Drug Derivative,Others,C21H16N2O6,2mM,Cancer,Phase 1,CC[C@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3cc4c(cc3nc2-1)OCO4,清洗成功,0.225
3106,Cc1cc(-n2nc3c(c2-n2ccn(-c4ccc5c(cnn5C)c4F)c2=O)[C@H](C)N(C(=O)c2cc4cc([C@H]5CCOC(C)(C)C5)ccc4n2[C@@]2(c4noc(=O)[nH]4)C[C@@H]2C)CC3)cc(C)c1F,1,0.9818319082260132,0.9818319082260132,C[C@@H]1[C@](N2C3=CC=C([C@]4([H])CC(C)(OCC4)C)C=C3C=C2C(N5[C@H](C6=C(N7C(N(C8=CC=C(N(N=C9)C)C9=C8F)C=C7)=O)N(C%10=CC(C)=C(C(C)=C%10)F)N=C6CC5)C)=O)(C(N%11)=NOC%11=O)C1,Orforglipron,Data.sdf,3635,HY-112185,LY3502970; GLP-1 receptor agonist 1,2212020-52-3,GCGR,GPCR/G Protein,C48H48F2N10O5,10mM,Metabolic Disease,Phase 3,Cc1cc(-n2nc3c(c2-n2ccn(-c4ccc5c(cnn5C)c4F)c2=O)[C@H](C)N(C(=O)c2cc4cc([C@H]5CCOC(C)(C)C5)ccc4n2[C@@]2(c4noc(=O)[nH]4)C[C@@H]2C)CC3)cc(C)c1F,清洗成功,0.1804511278195488
3625,CC(C)Cn1ncc2cc(Oc3ccc(F)cc3F)c(C(=O)NCCN(C)C)cc21,1,0.9818074703216553,0.9818074703216553,O=C(C1=CC2=C(C=C1OC3=CC=C(F)C=C3F)C=NN2CC(C)C)NCCN(C)C,p38?± inhibitor 1,Data.sdf,4266,HY-114423,,1034189-82-6,Autophagy; p38 MAPK,Autophagy; MAPK/ERK Pathway,C22H26F2N4O2,10mM,Inflammation/Immunology,No Development Reported,CC(C)Cn1ncc2cc(Oc3ccc(F)cc3F)c(C(=O)NCCN(C)C)cc21,清洗成功,0.2580645161290322
3006,CN(C)CCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,1,0.9818045496940613,0.9818045496940613,FC(C(C=C1N2CCCN3CCN(CCN(C)C)CC3)=CC=C1SC4=C2C=CC=C4)(F)F.[H]Cl.[H]Cl.[H]Cl,ZZW-115 (hydrochloride),Data.sdf,3520,HY-111838A,,10122-45-9,Apoptosis,Apoptosis,C24H34Cl3F3N4S,10mM,Cancer,No Development Reported,CN(C)CCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,清洗成功,0.2432432432432432
2211,C[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1,1,0.9817724227905273,0.9817724227905273,O=C1N(C2=CC=CC=C2)C([C@@H](NC3=C4N=CNC4=NC=N3)C)=NC5=C1C(F)=CC=C5,PI3K?′-IN-15,Data.sdf,2592,HY-108418,,870281-17-7,PI3K,PI3K/Akt/mTOR,C21H16FN7O,10mM,Cancer,No Development Reported,C[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1,清洗成功,0.3428571428571428
2212,C[C@@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1,1,0.9817724227905273,0.9817724227905273,O=C1N(C2=CC=CC=C2)C([C@H](NC3=C4N=CNC4=NC=N3)C)=NC5=C1C(F)=CC=C5,(R)-PI3K?′-IN-15,Data.sdf,2593,HY-108418A,,1707193-37-0,Others,Others,C21H16FN7O,10mM,Cancer,No Development Reported,C[C@@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1,清洗成功,0.3428571428571428
4082,O=C(O)c1ccc(CN(CC2CC2)C(=O)c2ccc(Oc3ccccc3F)cc2)cc1,1,0.9817720651626587,0.9817720651626587,O=C(O)C1=CC=C(CN(CC2CC2)C(C3=CC=C(OC4=CC=CC=C4F)C=C3)=O)C=C1,TAK-615,Data.sdf,4793,HY-117959,,1664335-55-0,LPL Receptor,GPCR/G Protein,C25H22FNO4,10mM,Inflammation/Immunology,No Development Reported,O=C(O)c1ccc(CN(CC2CC2)C(=O)c2ccc(Oc3ccccc3F)cc2)cc1,清洗成功,0.2674418604651162
8255,CCOC(=O)C[C@@H](c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1)c1cc(OC)c2c(c1)nnn2C,1,0.9817469120025635,0.9817469120025635,CCOC(C[C@@H](C1=CC(CN2S(=O)(C3=CC=CC=C3O[C@@H](C2)C)=O)=C(C=C1)C)C4=CC(OC)=C(N(N=N5)C)C5=C4)=O,Nrf2 activator-1,Data.sdf,9746,HY-145390,,2230697-41-1,Keap1-Nrf2,NF-?oB,C30H34N4O6S,10mM,Inflammation/Immunology,No Development Reported,CCOC(=O)C[C@@H](c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1)c1cc(OC)c2c(c1)nnn2C,清洗成功,0.2123893805309734
3806,Cc1nc(N2CCC3(CC2)CO[C@@H](C)[C@H]3N)c(CO)nc1-c1cccc(Cl)c1Cl,1,0.9817453026771545,0.9817453026771545,ClC1=C(C(C2=NC(CO)=C(N=C2C)N3CCC4(CC3)CO[C@H]([C@H]4N)C)=CC=C1)Cl,RMC-4550,Data.sdf,4483,HY-116009,,2172651-73-7,Phosphatase; SHP2,Metabolic Enzyme/Protease; Protein Tyrosine Kinase/RTK,C21H26Cl2N4O2,10mM,Cancer,No Development Reported,Cc1nc(N2CCC3(CC2)CO[C@@H](C)[C@H]3N)c(CO)nc1-c1cccc(Cl)c1Cl,清洗成功,0.2125
7912,Cc1cc(F)c(NC(=O)c2cccc(C(C)(C)C#N)c2)cc1-c1cnc2c(=O)n(C)ncc2c1,1,0.9817370176315308,0.9817370176315308,N#CC(C)(C)C1=CC(C(NC2=C(F)C=C(C)C(C3=CN=C4C(C=NN(C)C4=O)=C3)=C2)=O)=CC=C1,GNE-9815,Data.sdf,9350,HY-142160,,2729996-45-4,Raf,MAPK/ERK Pathway,C26H22FN5O2,10mM,Cancer,No Development Reported,Cc1cc(F)c(NC(=O)c2cccc(C(C)(C)C#N)c2)cc1-c1cnc2c(=O)n(C)ncc2c1,清洗成功,0.2959183673469387
2234,CS(=O)(=O)N(Cc1ccco1)CC(O)Cn1c2ccccc2c2ccccc21,1,0.9817337989807129,0.9817337989807129,CS(=O)(N(CC(O)CN1C2=C(C3=C1C=CC=C3)C=CC=C2)CC4=CC=CO4)=O,KL001,Data.sdf,2620,HY-108468,,309928-48-1,Cryptochrome,Metabolic Enzyme/Protease,C21H22N2O4S,10mM,Metabolic Disease,Phase 1,CS(=O)(=O)N(Cc1ccco1)CC(O)Cn1c2ccccc2c2ccccc21,清洗成功,0.2368421052631578
9546,Cc1cccc(CC(=O)N2CCc3cc(-c4cn(C)c5ncnc(N)c45)ccc32)n1,1,0.9817146062850952,0.9817146062850952,O=C(CC1=NC(C)=CC=C1)N2C3=C(CC2)C=C(C4=CN(C)C5=C4C(N)=NC=N5)C=C3,PERK-IN-6,Data.sdf,11278,HY-153160,,1337532-14-5,PERK,Cell Cycle/DNA Damage,C23H22N6O,10mM,Cancer,No Development Reported,Cc1cccc(CC(=O)N2CCc3cc(-c4cn(C)c5ncnc(N)c45)ccc32)n1,清洗成功,0.2758620689655172
7087,CC1(C)CC(=O)C2=C(C1)OC1=C(C(=O)CC(C)(C)C1)C2c1ccc(O)cc1O,1,0.9816877245903015,0.9816877245903015,O=C1C(C(C2=CC=C(O)C=C2O)C3=C(CC(C)(C)CC3=O)O4)=C4CC(C)(C)C1,CIL62,Data.sdf,8396,HY-136509,,117593-36-9,Necroptosis,Apoptosis,C23H26O5,10mM,Cancer,No Development Reported,CC1(C)CC(=O)C2=C(C1)OC1=C(C(=O)CC(C)(C)C1)C2c1ccc(O)cc1O,清洗成功,0.2962962962962963
10557,Cc1cccc(Oc2ccc(C(=O)N(C)c3cccc(C)c3)cc2)c1,1,0.9816871285438538,0.9816871285438538,CC1=CC(N(C(C2=CC=C(OC3=CC=CC(C)=C3)C=C2)=O)C)=CC=C1,11?2-HSD2-IN-2,Data.sdf,12512,HY-160618,,1834601-37-4,11?2-HSD,Metabolic Enzyme/Protease,C22H21NO2,10mM,Metabolic Disease,No Development Reported,Cc1cccc(Oc2ccc(C(=O)N(C)c3cccc(C)c3)cc2)c1,清洗成功,0.25
2604,CN(C)CCCNc1nc(CN2CCN(C(c3ccc(Cl)cc3)c3ccc(Cl)cc3)CC2)nc2ccccc12,1,0.9816189408302307,0.9816189408302307,CN(C)CCCNC1=C2C=CC=CC2=NC(CN3CCN(C(C4=CC=C(Cl)C=C4)C5=CC=C(Cl)C=C5)CC3)=N1,SCH529074,Data.sdf,3056,HY-110088,,922150-11-6,MDM-2/p53,Apoptosis,C31H36Cl2N6,10mM,Cancer,No Development Reported,CN(C)CCCNc1nc(CN2CCN(C(c3ccc(Cl)cc3)c3ccc(Cl)cc3)CC2)nc2ccccc12,清洗成功,0.2293577981651376
1142,CO[C@@H]1C[C@H](C(=O)Nc2ccc(-n3ccccc3=O)cc2F)N(C(=O)Nc2ccc(Cl)cc2)C1,1,0.981577455997467,0.981577455997467,O=C(NC(C=C1)=CC=C1Cl)N2[C@H](C[C@@H](OC)C2)C(NC3=CC=C(C=C3F)N(C=CC=C4)C4=O)=O,Eribaxaban,Data.sdf,1321,HY-10267,PD-0348292,536748-46-6,Factor Xa,Metabolic Enzyme/Protease,C24H22ClFN4O4,10mM,Cardiovascular Disease,Phase 2,CO[C@@H]1C[C@H](C(=O)Nc2ccc(-n3ccccc3=O)cc2F)N(C(=O)Nc2ccc(Cl)cc2)C1,清洗成功,0.225
8256,CCOC(=O)C[C@H](c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1)c1cc(OC)c2c(c1)nnn2C,1,0.9815714955329895,0.9815714955329895,CCOC(C[C@H](C1=CC(CN2S(=O)(C3=CC=CC=C3O[C@@H](C2)C)=O)=C(C=C1)C)C4=CC(OC)=C(N(N=N5)C)C5=C4)=O,"(R,R)-Nrf2 activator-1",Data.sdf,9747,HY-145390A,,,Keap1-Nrf2,NF-?oB,C30H34N4O6S,10mM,Inflammation/Immunology,No Development Reported,CCOC(=O)C[C@H](c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1)c1cc(OC)c2c(c1)nnn2C,清洗成功,0.2123893805309734
17992,CS(=O)(=O)c1ccc(Nc2ccc3c(c2)OCO3)c([N+](=O)[O-])c1,1,0.9815695285797119,0.9815695285797119,O=[N+](C1=CC(S(=O)(C)=O)=CC=C1NC2=CC3=C(OCO3)C=C2)[O-],MSNBA,Data.sdf,21447,HY-W179181,,852702-51-3,GLUT,Membrane Transporter/Ion Channel,C14H12N2O6S,10mM,Metabolic Disease,No Development Reported,CS(=O)(=O)c1ccc(Nc2ccc3c(c2)OCO3)c([N+](=O)[O-])c1,清洗成功,0.3389830508474576
6564,COc1cc2nc[nH]c(=O)c2cc1OCCCN1CCOCC1,1,0.9815669059753418,0.9815669059753418,O=C1NC=NC2=C1C=C(OCCCN3CCOCC3)C(OC)=C2,Gefitinib impurity 5,Data.sdf,7783,HY-133779,,199327-61-2,Drug Metabolite,Metabolic Enzyme/Protease,C16H21N3O4,2mM,Others; Cancer,No Development Reported,COc1cc2nc[nH]c(=O)c2cc1OCCCN1CCOCC1,清洗成功,0.3488372093023256
1601,Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1,1,0.981549859046936,0.981549859046936,CC1=CN=C2C(NCCN)=NC3=CC=C(C=C3N21)C.Cl,BMS-345541 (hydrochloride),Data.sdf,1892,HY-10518,,547757-23-3,IKK,NF-?oB,C14H18ClN5,10mM,Cancer,No Development Reported,Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1,清洗成功,0.2333333333333333
1606,Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1,1,0.981549859046936,0.981549859046936,CC1=CN=C2C(NCCN)=NC3=CC=C(C)C=C3N21,BMS-345541,Data.sdf,1897,HY-10519,,445430-58-0,IKK,NF-?oB,C14H17N5,10mM,Cancer,No Development Reported,Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1,清洗成功,0.2372881355932203
10367,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1sc(-c2ncco2)nc1-c1ccccc1)C1CCCCC1,1,0.9815317392349243,0.9815317392349243,O=C([C@H](CCC1)N1C([C@H](C2CCCCC2)NC([C@H](C)NC)=O)=O)NC3=C(C4=CC=CC=C4)N=C(C5=NC=CO5)S3,CUDC-427,Data.sdf,12290,HY-15835,GDC-0917,1446182-94-0,IAP,Apoptosis,C29H36N6O4S,10mM,Cancer,Phase 1,CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1sc(-c2ncco2)nc1-c1ccccc1)C1CCCCC1,清洗成功,0.25
16779,CC(C)(C)CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C,1,0.9815294146537781,0.9815294146537781,O=C([C@]([C@@]1([H])C[C@@]2([H])[C@@](CCC3=CC4=O)([H])[C@@](F)([C@]3(C=C4)C)[C@@H](O)C5)(OC(C)(C)O1)[C@]25C)COC(CC(C)(C)C)=O,Triamcinolone hexacetonide,Data.sdf,19971,HY-U00103,,5611-51-8,Others,Others,C30H41FO7,10mM,Inflammation/Immunology,Launched,CC(C)(C)CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C,清洗成功,0.1545454545454545
2059,CCn1cc(-n2c(C3CC3)c(Sc3cccc(C(=O)O)c3F)c3ccc(Cl)c(F)c32)cn1,1,0.9815277457237244,0.9815277457237244,O=C(O)C1=CC=CC(SC2=C(C3CC3)N(C4=CN(CC)N=C4)C5=C2C=CC(Cl)=C5F)=C1F,PAT-505,Data.sdf,2417,HY-107781,,1782070-22-7,Phosphodiesterase (PDE),Metabolic Enzyme/Protease,C23H18ClF2N3O2S,10mM,Inflammation/Immunology,No Development Reported,CCn1cc(-n2c(C3CC3)c(Sc3cccc(C(=O)O)c3F)c3ccc(Cl)c(F)c32)cn1,清洗成功,0.2391304347826087
3042,Cc1nc2ccc(F)cc2n1-c1nc(N)c(F)c(Nc2ccc(C(F)(F)F)cc2)n1,1,0.9815186262130737,0.9815186262130737,NC1=C(F)C(NC2=CC=C(C(F)(F)F)C=C2)=NC(N3C4=CC(F)=CC=C4N=C3C)=N1,Unesbulin,Data.sdf,3559,HY-112041,PTC596,1610964-64-1,Apoptosis; BMI1,Apoptosis; Stem Cell/Wnt,C19H13F5N6,10mM,Cancer,Phase 3,Cc1nc2ccc(F)cc2n1-c1nc(N)c(F)c(Nc2ccc(C(F)(F)F)cc2)n1,清洗成功,0.3066666666666666
10989,CC1(C)CCC(C)(C)c2c1cc(C(=O)Nc1cc(F)c(C(=O)O)c(F)c1)c(O)c2Cl,1,0.9815086722373962,0.9815086722373962,O=C(O)C1=C(F)C=C(NC(C2=C(O)C(Cl)=C3C(C)(C)CCC(C)(C)C3=C2)=O)C=C1F,AGN-195183,Data.sdf,13023,HY-16684,IRX-5183; VTP-195183; NRX-195183,367273-07-2,Autophagy; RAR/RXR,Autophagy; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor,C22H22ClF2NO4,10mM,Cancer,Phase 2,CC1(C)CCC(C)(C)c2c1cc(C(=O)Nc1cc(F)c(C(=O)O)c(F)c1)c(O)c2Cl,清洗成功,0.2567567567567567
12295,CNC(=O)c1cccc(NC(=O)N2CCC(Oc3ccccc3Cl)CC2)c1,1,0.9814980030059814,0.9814980030059814,O=C(N1CCC(OC2=C(Cl)C=CC=C2)CC1)NC3=CC=CC(C(NC)=O)=C3,A939572,Data.sdf,14543,HY-50709,,1032229-33-6,Stearoyl-CoA Desaturase (SCD),Metabolic Enzyme/Protease,C20H22ClN3O3,10mM,Cancer,No Development Reported,CNC(=O)c1cccc(NC(=O)N2CCC(Oc3ccccc3Cl)CC2)c1,清洗成功,0.2727272727272727
1661,C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1,1,0.9814667105674744,0.9814667105674744,O=C([C@@H]1CC[C@]([C@H](N)C)([H])CC1)NC2=CC=NC=C2.[H]Cl.[H]Cl,Y-27632 (dihydrochloride),Data.sdf,1963,HY-10583,,129830-38-2,Organoid; ROCK,Cell Cycle/DNA Damage; Cytoskeleton; Stem Cell/Wnt; TGF-beta/Smad,C14H23Cl2N3O,10mM,Cancer; Neurological Disease,Launched,C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1,清洗成功,0.35
10047,C[C@@H](Nc1ncc(-c2ccc3oc(=O)n(C)c3c2)nn1)c1ccc(F)cc1,1,0.9814289808273315,0.9814289808273315,O=C1OC2=CC=C(C3=CN=C(N[C@@H](C4=CC=C(F)C=C4)C)N=N3)C=C2N1C,GPR55 agonist 4,Data.sdf,11883,HY-156157,,3006105-55-8,GPR55,GPCR/G Protein; Neuronal Signaling,C19H16FN5O2,10mM,Cancer,No Development Reported,C[C@@H](Nc1ncc(-c2ccc3oc(=O)n(C)c3c2)nn1)c1ccc(F)cc1,清洗成功,0.3333333333333333
5147,Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCN(Cc3ccon3)CC2)n1,1,0.9814164638519287,0.9814164638519287,NC1=NC=CC(C2=C(C3=CC=C(F)C=C3)N=CN2C4CCN(CC5=NOC=C5)CC4)=N1,PF-5006739,Data.sdf,6062,HY-12443,,1293395-67-1,Casein Kinase,Cell Cycle/DNA Damage; Stem Cell/Wnt,C22H22FN7O,10mM,Neurological Disease,No Development Reported,Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCN(Cc3ccon3)CC2)n1,清洗成功,0.2795698924731182
11699,CC(C)=CC(=O)O[C@H]1Cc2cc3ccc(=O)oc3cc2OC1(C)C,1,0.9814072847366333,0.9814072847366333,C/C(C)=C\C(O[C@H](C(C)(C)O1)CC2=C1C=C(O3)C(C=CC3=O)=C2)=O,Decursin,Data.sdf,13844,HY-18981,(+)-Decursin,5928-25-6,Apoptosis; CXCR; PKC,Apoptosis; Epigenetics; GPCR/G Protein; Immunology/Inflammation; TGF-beta/Smad,C19H20O5,10mM,Cancer; Inflammation/Immunology; Neurological Disease,No Development Reported,CC(C)=CC(=O)O[C@H]1Cc2cc3ccc(=O)oc3cc2OC1(C)C,清洗成功,0.2272727272727272
7107,Cc1cnc(NC2CCOCC2)nc1-n1cnc(C(=O)N[C@H](CN)c2cc(F)cc(Cl)c2)c1,1,0.9813841581344604,0.9813841581344604,O=C(C1=CN(C2=NC(NC3CCOCC3)=NC=C2C)C=N1)N[C@@H](C4=CC(F)=CC(Cl)=C4)CN,ASN007,Data.sdf,8420,HY-136579,ERK-IN-3,2055597-12-9,ERK,MAPK/ERK Pathway; Stem Cell/Wnt,C22H25ClFN7O2,10mM,Cancer,Phase 1,Cc1cnc(NC2CCOCC2)nc1-n1cnc(C(=O)N[C@H](CN)c2cc(F)cc(Cl)c2)c1,清洗成功,0.2647058823529412
7108,Cc1cnc(NC2CCOCC2)nc1-n1cnc(C(=O)N[C@H](CN)c2cc(F)cc(Cl)c2)c1,1,0.9813841581344604,0.9813841581344604,O=C(C1=CN(C2=NC(NC3CCOCC3)=NC=C2C)C=N1)N[C@@H](C4=CC(F)=CC(Cl)=C4)CN.O=S(C5=CC=CC=C5)(O)=O,ASN007 (benzenesulfonate),Data.sdf,8421,HY-136579A,ERK-IN-3 (benzenesulfonate),2055597-39-0,ERK,MAPK/ERK Pathway; Stem Cell/Wnt,C28H31ClFN7O5S,10mM,Cancer,Phase 1,Cc1cnc(NC2CCOCC2)nc1-n1cnc(C(=O)N[C@H](CN)c2cc(F)cc(Cl)c2)c1,清洗成功,0.2818181818181818
7059,CCOc1ccc2nccc([C@@H](O)[C@@H]3C[C@@H]4CC[N@]3C[C@@H]4CC)c2c1,1,0.9813532829284668,0.9813532829284668,O[C@@H]([C@@](C[C@@H]1CC2)([H])[N@@]2C[C@@H]1CC)C3=CC=NC(C=C4)=C3C=C4OCC.Cl,Ethylhydrocupreine (hydrochloride),Data.sdf,8365,HY-136429A,Optochin (hydrochloride),3413-58-9,Bacterial; Parasite,Anti-infection,C21H29ClN2O2,10mM,Infection,No Development Reported,CCOc1ccc2nccc([C@@H](O)[C@@H]3C[C@@H]4CC[N@]3C[C@@H]4CC)c2c1,清洗成功,0.25
9923,Nc1nccc(NCC2CCN(Cc3ccccc3)CC2)n1,1,0.9813527464866638,0.9813527464866638,NC1=NC=CC(NCC2CCN(CC2)CC3=CC=CC=C3)=N1,AChE/BuChE-IN-4,Data.sdf,11726,HY-155349,,1997158-25-4,Cholinesterase (ChE),Neuronal Signaling,C17H23N5,10mM,Neurological Disease,No Development Reported,Nc1nccc(NCC2CCN(Cc3ccccc3)CC2)n1,清洗成功,0.3253012048192771
7668,CCOCOc1ccc2oc(-c3ccc(N(C)C(=O)OC(C)(C)C)nc3[N+](=O)[O-])cc2c1,1,0.9813501834869385,0.9813501834869385,O=C(N(C)C1=NC([N+]([O-])=O)=C(C2=CC3=CC(OCOCC)=CC=C3O2)C=C1)OC(C)(C)C,AZD4694 Precursor,Data.sdf,9075,HY-139516,AZ13040214; NAV4614,1211333-20-8,Amyloid-?2,Neuronal Signaling,C22H25N3O7,10mM,Others,No Development Reported,CCOCOc1ccc2oc(-c3ccc(N(C)C(=O)OC(C)(C)C)nc3[N+](=O)[O-])cc2c1,清洗成功,0.2065217391304347
14326,CC(C)=CCc1cc2c(cc1O)O[C@H](c1ccc(O)cc1)CC2=O,1,0.9813403487205505,0.9813403487205505,O=C1C[C@@H](C2=CC=C(O)C=C2)OC3=CC(O)=C(C/C=C(C)\C)C=C13,Bavachin,Data.sdf,16928,HY-N0233,Corylifolin,19879-32-4,Estrogen Receptor/ERR,Vitamin D Related/Nuclear Receptor,C20H20O4,10mM,Cancer,No Development Reported,CC(C)=CCc1cc2c(cc1O)O[C@H](c1ccc(O)cc1)CC2=O,清洗成功,0.2898550724637681
1147,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,1,0.9813165664672852,0.9813165664672852,O=C1N(C2=C(C(N1CC3=NC(C)=C4C=CC=CC4=N3)=O)N(CC#CC)C(N5CCC[C@@H](N)C5)=N2)C,Linagliptin,Data.sdf,1327,HY-10284,BI 1356,668270-12-0,Autophagy; Dipeptidyl Peptidase; Ferroptosis,Apoptosis; Autophagy; Metabolic Enzyme/Protease,C25H28N8O2,10mM,Metabolic Disease,Launched,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,清洗成功,0.2777777777777778
920,C=CC(=O)N1CCN(CCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1,1,0.981316089630127,0.981316089630127,O=C1C(C2=C(Cl)C(OC)=CC(OC)=C2Cl)=CC3=CN=C(NC)N=C3N1CCCN4CCN(C(C=C)=O)CC4,PRN1371,Data.sdf,1053,HY-101768,,1802929-43-6,c-Fms; FGFR,Protein Tyrosine Kinase/RTK,C26H30Cl2N6O4,10mM,Cancer,Phase 1,C=CC(=O)N1CCN(CCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1,清洗成功,0.27
2359,CNC(=O)COc1cc2cc(Nc3nc(N4C[C@H](C)C[C@H](C)C4)ncc3Cl)ccc2n(C)c1=O,1,0.981306791305542,0.981306791305542,ClC1=CN=C(N2C[C@H](C)C[C@H](C)C2)N=C1NC3=CC(C=C(OCC(NC)=O)C(N4C)=O)=C4C=C3,BI-3802,Data.sdf,2766,HY-108705,,2166387-65-9,Bcl-2 Family; Molecular Glues,Apoptosis; PROTAC,C24H29ClN6O3,10mM,Cancer,No Development Reported,CNC(=O)COc1cc2cc(Nc3nc(N4C[C@H](C)C[C@H](C)C4)ncc3Cl)ccc2n(C)c1=O,清洗成功,0.3068181818181818
16607,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1,1,0.9812772870063782,0.9812772870063782,O=C(N1[C@@H](CCC1)C(NCC)=O)[C@H](CC(C)C)NC([C@@H](NC([C@@H](CCCNC(N)=N)NC([C@@H](NC([C@H](CO)NC([C@@H](NC([C@@H](NC([C@H]2NC(CC2)=O)=O)CC3=CN=CN3)=O)CC4=CNC5=CC=CC=C45)=O)=O)CC6=CC=C(C=C6)O)=O)=O)CC7=CNC8=CC=CC=C78)=O.CC(O)=O,sGnRH-A (acetate),Data.sdf,19794,HY-P3582A,,,GnRH Receptor,GPCR/G Protein,C66H87N17O14,10mM,Endocrinology,No Development Reported,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1,清洗成功,0.2279411764705882
1804,CC(=O)NC1(c2ccccc2)CCN(CC[C@H](CN(C)C(=O)c2ccccc2)c2ccc(Cl)c(Cl)c2)CC1,1,0.9812746644020081,0.9812746644020081,CC(NC1(C2=CC=CC=C2)CCN(CC[C@@H](C3=CC(Cl)=C(Cl)C=C3)CN(C)C(C4=CC=CC=C4)=O)CC1)=O,Saredutant,Data.sdf,2135,HY-106910,SR 48968; SR 48968C,142001-63-6,Neurokinin Receptor,GPCR/G Protein; Neuronal Signaling,C31H35Cl2N3O2,10mM,Neurological Disease; Endocrinology,Phase 3,CC(=O)NC1(c2ccccc2)CCN(CC[C@H](CN(C)C(=O)c2ccccc2)c2ccc(Cl)c(Cl)c2)CC1,清洗成功,0.2660550458715596
16821,CNc1cccc(NC(=O)NC2N=C(c3ccccn3)c3ccccc3N(CC(=O)C(C)(C)C)C2=O)c1,1,0.9812657237052917,0.9812657237052917,O=C(NC1=CC=CC(NC)=C1)NC2C(N(CC(C(C)(C)C)=O)C3=CC=CC=C3C(C4=NC=CC=C4)=N2)=O,(Rac)-Sograzepide,Data.sdf,20016,HY-U00360,(Rac)-Netazepide; (Rac)-YF 476; (Rac)-YM-220,168161-71-5,Cholecystokinin Receptor,GPCR/G Protein; Neuronal Signaling,C28H30N6O3,10mM,Metabolic Disease,No Development Reported,CNc1cccc(NC(=O)NC2N=C(c3ccccn3)c3ccccc3N(CC(=O)C(C)(C)C)C2=O)c1,清洗成功,0.2584269662921348
8825,CNc1cccc(NC(=O)N[C@@H]2N=C(c3ccccn3)c3ccccc3N(CC(=O)C(C)(C)C)C2=O)c1,1,0.9812503457069397,0.9812503457069397,O=C(NC1=CC=CC(NC)=C1)N[C@H]2C(N(CC(C(C)(C)C)=O)C3=CC=CC=C3C(C4=NC=CC=C4)=N2)=O,Sograzepide,Data.sdf,10419,HY-14850,Netazepide; YF 476; YM-220,155488-25-8,Cholecystokinin Receptor,GPCR/G Protein; Neuronal Signaling,C28H30N6O3,10mM,Metabolic Disease; Endocrinology,Phase 2,CNc1cccc(NC(=O)N[C@@H]2N=C(c3ccccn3)c3ccccc3N(CC(=O)C(C)(C)C)C2=O)c1,清洗成功,0.2584269662921348
3930,NNC(=O)CSc1ccccc1[N+](=O)[O-],1,0.9812328815460205,0.9812328815460205,O=C(NN)CSC1=CC=CC=C1[N+]([O-])=O,MAC13772,Data.sdf,4617,HY-116872,,4871-40-3,Bacterial,Anti-infection,C8H9N3O3S,10mM,Infection,No Development Reported,NNC(=O)CSc1ccccc1[N+](=O)[O-],清洗成功,0.2807017543859649
4392,CNC(=O)C[C@H]1COc2cc(F)ccc2N1C(=O)c1ccc2c(c1)NC(=O)CO2,1,0.9811993837356567,0.9811993837356567,FC1=CC2=C(N(C(C3=CC=C(OCC(N4)=O)C4=C3)=O)[C@@H](CC(NC)=O)CO2)C=C1,Balcinrenone,Data.sdf,5173,HY-120274,AZD9977,1850385-64-6,Mineralocorticoid Receptor,Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor,C20H18FN3O5,10mM,Metabolic Disease; Cardiovascular Disease,Phase 2,CNC(=O)C[C@H]1COc2cc(F)ccc2N1C(=O)c1ccc2c(c1)NC(=O)CO2,清洗成功,0.2333333333333333
5040,Cc1ccc(Oc2ccnc(Nc3ccc(S(N)(=O)=O)cc3)c2)c(C)n1,1,0.9811782240867615,0.9811782240867615,O=S(C1=CC=C(NC2=NC=CC(OC3=CC=C(C)N=C3C)=C2)C=C1)(N)=O,AZ12799734,Data.sdf,5936,HY-123900,,1117684-36-2,TGF-?2 Receptor,TGF-beta/Smad,C18H18N4O3S,10mM,Cardiovascular Disease,No Development Reported,Cc1ccc(Oc2ccnc(Nc3ccc(S(N)(=O)=O)cc3)c2)c(C)n1,清洗成功,0.3157894736842105
9321,Cc1ccc(C(C)C)cc1Oc1nccc(-c2c(-c3ccc(C(F)(F)F)cc3)ncn2C2CCN(CCOCCOCCNC(=O)COc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)n1,1,0.9811632037162781,0.9811632037162781,O=C1NC(C(CC1)N2C(C3=C(C2=O)C(OCC(NCCOCCOCCN4CCC(CC4)N5C=NC(C6=CC=C(C(F)(F)F)C=C6)=C5C7=CC=NC(OC8=CC(C(C)C)=CC=C8C)=N7)=O)=CC=C3)=O)=O,dBRD4-BD1,Data.sdf,10994,HY-151593,,2839318-19-1,Epigenetic Reader Domain; PROTACs,Epigenetics; PROTAC,C50H53F3N8O9,10mM,Cancer,No Development Reported,Cc1ccc(C(C)C)cc1Oc1nccc(-c2c(-c3ccc(C(F)(F)F)cc3)ncn2C2CCN(CCOCCOCCNC(=O)COc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)n1,清洗成功,0.2323943661971831
3829,COc1ccc(/C=C/C(=O)c2c(-c3ccccc3)c3ccccc3[nH]c2=O)cc1,1,0.9811493158340454,0.9811493158340454,O=C1NC(C=CC=C2)=C2C(C3=CC=CC=C3)=C1C(/C=C/C4=CC=C(C=C4)OC)=O,Ceranib-2,Data.sdf,4506,HY-116147,,1402830-75-4,Apoptosis; LPL Receptor,Apoptosis; GPCR/G Protein,C25H19NO3,10mM,Cancer,No Development Reported,COc1ccc(/C=C/C(=O)c2c(-c3ccccc3)c3ccccc3[nH]c2=O)cc1,清洗成功,0.3114754098360656
7417,CC(C)(C)Oc1ccc(C[C@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)OCc2ccccc2)C(=O)C=[N+]=[N-])cc1,1,0.9811402559280396,0.9811402559280396,O=C(N[C@H](C(C=[N+]=[N-])=O)CC(C=C1)=CC=C1OC(C)(C)C)[C@@H](NC(OCC2=CC=CC=C2)=O)CC3=CC=CC=C3,Z-Phe-Tyr(tBu)-diazomethylketone,Data.sdf,8778,HY-138208,,114014-15-2,Cathepsin; SARS-CoV,Anti-infection; Metabolic Enzyme/Protease,C31H34N4O5,10mM,Infection,No Development Reported,CC(C)(C)Oc1ccc(C[C@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)OCc2ccccc2)C(=O)C=[N+]=[N-])cc1,清洗成功,0.240506329113924
8175,O=C(CSc1nc2ccccc2[nH]1)Nc1ccc(Cl)cn1,1,0.9811384081840515,0.9811384081840515,O=C(NC1=NC=C(Cl)C=C1)CSC2=NC3=CC=CC=C3N2,dCeMM3,Data.sdf,9653,HY-144976,,311787-85-6,CDK; Molecular Glues,Cell Cycle/DNA Damage; PROTAC,C14H11ClN4OS,10mM,Cancer,No Development Reported,O=C(CSc1nc2ccccc2[nH]1)Nc1ccc(Cl)cn1,清洗成功,0.28125
17147,CN(C)CCCc1cc(C(=O)Nc2ccc(-c3ccncc3)cc2)ccc1O,1,0.9810742735862732,0.9810742735862732,O=C(NC1=CC=C(C2=CC=NC=C2)C=C1)C3=CC=C(O)C(CCCN(C)C)=C3.Cl,GR 55562 (hydrochloride),Data.sdf,20417,HY-W010869,,172854-55-6,5-HT Receptor,GPCR/G Protein; Neuronal Signaling,C23H26ClN3O2,10mM,Neurological Disease,No Development Reported,CN(C)CCCc1cc(C(=O)Nc2ccc(-c3ccncc3)cc2)ccc1O,清洗成功,0.3461538461538461
492,COc1ccc(OC)c(-c2cc(=O)[nH]c(=S)n2CC(N)=O)c1,1,0.9810413718223572,0.9810413718223572,O=C(N)CN(C(N1)=S)C(C2=CC(OC)=CC=C2OC)=CC1=O,PF-1355,Data.sdf,557,HY-100873,PF-06281355,1435467-38-1,Glutathione Peroxidase,Apoptosis; Metabolic Enzyme/Protease,C14H15N3O4S,10mM,Cardiovascular Disease,No Development Reported,COc1ccc(OC)c(-c2cc(=O)[nH]c(=S)n2CC(N)=O)c1,清洗成功,0.3235294117647059
7295,CN(C)c1ccc(Nc2nc(-c3ccncc3)nc3c2CC(N)CC3)cc1,1,0.9810371398925781,0.9810371398925781,NC1CC2=C(NC3=CC=C(N(C)C)C=C3)N=C(C4=CC=NC=C4)N=C2CC1,ARN-21934,Data.sdf,8632,HY-137466,,2230854-93-8,Topoisomerase,Cell Cycle/DNA Damage,C21H24N6,10mM,Cancer,No Development Reported,CN(C)c1ccc(Nc2nc(-c3ccncc3)nc3c2CC(N)CC3)cc1,清洗成功,0.2666666666666666
3320,COc1cc2nccc(Nc3n[nH]c(C)c3C)c2cc1S(=O)(=O)C(C)(C)C,1,0.980977475643158,0.980977475643158,O=S(C1=C(OC)C=C(N=CC=C2NC3=NNC(C)=C3C)C2=C1)(C(C)(C)C)=O,RIP2 Kinase Inhibitor 3,Data.sdf,3905,HY-112907,,1398053-50-3,RIP kinase,Apoptosis,C19H24N4O3S,10mM,Inflammation/Immunology,No Development Reported,COc1cc2nccc(Nc3n[nH]c(C)c3C)c2cc1S(=O)(=O)C(C)(C)C,清洗成功,0.2769230769230769
8358,CCCn1c(=O)c2sccc2n(Cc2cccc(NC(=O)Cc3ccccc3)c2)c1=O,1,0.9809476137161255,0.9809476137161255,O=C(NC1=CC=CC(CN(C(C=CS2)=C2C(N3CCC)=O)C3=O)=C1)CC4=CC=CC=C4,FEN1-IN-SC13,Data.sdf,9859,HY-145758,,2098776-03-3,Endonuclease,Cell Cycle/DNA Damage,C24H23N3O3S,10mM,Cancer,No Development Reported,CCCn1c(=O)c2sccc2n(Cc2cccc(NC(=O)Cc3ccccc3)c2)c1=O,清洗成功,0.3116883116883117
11393,CC[C@H]1OC(=O)[C@@](C)(F)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cc(-c4cccc(N)c4)nn3)C(=O)O[C@]12C,1,0.980903685092926,0.980903685092926,C[C@]([C@H](OC([C@@](F)(C([C@H](C)[C@H]1O[C@@](O[C@H](C)C[C@@H]2N(C)C)([H])[C@@H]2O)=O)C)=O)CC)(O3)[C@]([C@H](C([C@@H](C[C@@]1(C)OC)C)=O)C)([H])N(CCCCN4C=C(C5=CC(N)=CC=C5)N=N4)C3=O,Solithromycin,Data.sdf,13476,HY-17593,CEM-101; OP-1068,760981-83-7,Antibiotic; Bacterial,Anti-infection,C43H65FN6O10,10mM,Infection,Phase 3,CC[C@H]1OC(=O)[C@@](C)(F)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cc(-c4cccc(N)c4)nn3)C(=O)O[C@]12C,清洗成功,0.2
7704,C=CC(=O)N1CC2(CC(n3nc(-c4ccc5c(cnn5C)c4)c(-c4c(Cl)c(C)cc5[nH]ncc45)c3C)C2)C1,1,0.9808713793754578,0.9808713793754578,O=C(C=C)N1CC2(C1)CC(N3N=C(C4=CC=C5C(C=NN5C)=C4)[C@@]([C@@]6=C(Cl)C(C)=CC7=C6C=NN7)=C3C)C2,(S)-JDQ-443,Data.sdf,9113,HY-139612A,(S)-NVP-JDQ443,2653994-10-4,PERK; Ras,Cell Cycle/DNA Damage; GPCR/G Protein; MAPK/ERK Pathway,C29H28ClN7OS,10mM,Cancer,No Development Reported,C=CC(=O)N1CC2(CC(n3nc(-c4ccc5c(cnn5C)c4)c(-c4c(Cl)c(C)cc5[nH]ncc45)c3C)C2)C1,清洗成功,0.2755102040816326
7703,C=CC(=O)N1CC2(CC(n3nc(-c4ccc5c(cnn5C)c4)c(-c4c(Cl)c(C)cc5[nH]ncc45)c3C)C2)C1,1,0.9808712601661682,0.9808712601661682,O=C(C=C)N1CC2(C1)CC(N3N=C(C4=CC=C5C(C=NN5C)=C4)[C@]([C@]6=C(Cl)C(C)=CC7=C6C=NN7)=C3C)C2,Opnurasib,Data.sdf,9112,HY-139612,JDQ-443; NVP-JDQ443,2653994-08-0,PERK; Ras,Cell Cycle/DNA Damage; GPCR/G Protein; MAPK/ERK Pathway,C29H28ClN7O,10mM,Cancer,Phase 3,C=CC(=O)N1CC2(CC(n3nc(-c4ccc5c(cnn5C)c4)c(-c4c(Cl)c(C)cc5[nH]ncc45)c3C)C2)C1,清洗成功,0.2755102040816326
15693,C/C=C(/C)C(=O)O[C@H]1[C@@H](OC(=O)CC(C)C)c2c(ccc3ccc(=O)oc23)OC1(C)C,1,0.9808581471443176,0.9808581471443176,CC(C)CC(O[C@H]1C2=C(OC(C)(C)[C@H]1OC(/C(C)=C\C)=O)C=CC(C=C3)=C2OC3=O)=O,Praeruptorin E,Data.sdf,18742,HY-N6066,,78478-28-1,Calcium Channel,Membrane Transporter/Ion Channel; Neuronal Signaling,C24H28O7,10mM,Cardiovascular Disease,No Development Reported,C/C=C(/C)C(=O)O[C@H]1[C@@H](OC(=O)CC(C)C)c2c(ccc3ccc(=O)oc23)OC1(C)C,清洗成功,0.1789473684210526
6917,C=C[C@@H](c1cc(OCc2ccccc2)no1)N(C)C,1,0.9808540344238281,0.9808540344238281,CN(C)[C@H](C1=CC(OCC2=CC=CC=C2)=NO1)C=C,TP748,Data.sdf,8206,HY-135888,,951698-15-0,Drug Intermediate,Others,C15H18N2O2,10mM,Others,No Development Reported,C=C[C@@H](c1cc(OCc2ccccc2)no1)N(C)C,清洗成功,0.2615384615384615
7460,COc1ccc(C(OC[C@H]2O[C@@H](n3cnc4c(=O)nc(/N=C\N(C)C)[nH]c43)C[C@@H]2OP(OCCC#N)N(C(C)C)C(C)C)(c2ccccc2)c2ccc(OC)cc2)cc1,1,0.9808438420295715,0.9808438420295715,COC1=CC=C(C(C2=CC=CC=C2)(OC[C@@H]3[C@@H](OP(N(C(C)C)C(C)C)OCCC#N)C[C@H](N4C(NC(/N=C\N(C)C)=NC5=O)=C5N=C4)O3)C6=CC=C(OC)C=C6)C=C1,DMT-dG(dmf) Phosphoramidite,Data.sdf,8828,HY-138585,,330628-04-1,DNA/RNA Synthesis; Nucleoside Antimetabolite/Analog,Cell Cycle/DNA Damage,C43H53N8O7P,10mM,Cancer; Infection,No Development Reported,COc1ccc(C(OC[C@H]2O[C@@H](n3cnc4c(=O)nc(/N=C\N(C)C)[nH]c43)C[C@@H]2OP(OCCC#N)N(C(C)C)C(C)C)(c2ccccc2)c2ccc(OC)cc2)cc1,清洗成功,0.175
12743,CCC(=O)O[C@]1(C(=O)SCF)[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,1,0.980799674987793,0.980799674987793,O=C(CC)O[C@@]([C@]([C@@]1([H])C2)(C[C@H](O)[C@](F)([C@]3(C=C4)C)[C@@]1([H])C[C@H](F)C3=CC4=O)C)([C@@H]2C)C(SCF)=O,Fluticasone (propionate),Data.sdf,15074,HY-B0154,,80474-14-2,ADC Cytotoxin; Endogenous Metabolite; Enterovirus; Glucocorticoid Receptor,Antibody-drug Conjugate/ADC Related; Anti-infection; Immunology/Inflammation; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor,C25H31F3O5S,10mM,Infection; Endocrinology; Inflammation/Immunology,Launched,CCC(=O)O[C@]1(C(=O)SCF)[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,清洗成功,0.1538461538461538
4349,Cc1nc(C)c(C(=O)Nc2ccc(F)c(-c3nc4ncc(-c5ccccn5)cn4n3)c2)o1,1,0.98078453540802,0.98078453540802,O=C(C1=C(C)N=C(C)O1)NC2=CC=C(F)C(C3=NN4C=C(C5=NC=CC=C5)C=NC4=N3)=C2,GNF6702,Data.sdf,5116,HY-120060,,1799329-72-8,Parasite,Anti-infection,C22H16FN7O2,10mM,Infection,No Development Reported,Cc1nc(C)c(C(=O)Nc2ccc(F)c(-c3nc4ncc(-c5ccccn5)cn4n3)c2)o1,清洗成功,0.3037974683544304
5009,COC(=O)c1sccc1S(=O)(=O)Nc1ccc(Nc2ccccc2)cc1OC,1,0.9807440638542175,0.9807440638542175,O=C(C1=C(S(=O)(NC2=CC=C(NC3=CC=CC=C3)C=C2OC)=O)C=CS1)OC,GSK0660,Data.sdf,5902,HY-12377,,1014691-61-2,PPAR,Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor,C19H18N2O5S2,10mM,Metabolic Disease,No Development Reported,COC(=O)c1sccc1S(=O)(=O)Nc1ccc(Nc2ccccc2)cc1OC,清洗成功,0.3
2186,N#CC(C#N)=Cc1ccc([N+](=O)[O-])c(O)c1,1,0.9807384610176086,0.9807384610176086,N#C/C(C#N)=C/C1=CC=C([N+]([O-])=O)C(O)=C1,AG126,Data.sdf,2563,HY-108330,Tyrphostin AG126,118409-62-4,ERK,MAPK/ERK Pathway; Stem Cell/Wnt,C10H5N3O3,10mM,Inflammation/Immunology,No Development Reported,N#CC(C#N)=Cc1ccc([N+](=O)[O-])c(O)c1,清洗成功,0.2903225806451613
5214,COc1cc(/C=C(\C#N)C(=O)Nc2ccc(Cl)cc2Cl)cc(Br)c1O,1,0.980720579624176,0.980720579624176,O=C(NC1=CC=C(Cl)C=C1Cl)/C(C#N)=C/C2=CC(OC)=C(O)C(Br)=C2,Chst15-IN-1,Data.sdf,6140,HY-124704,,2158198-77-5,SULT,Metabolic Enzyme/Protease,C17H11BrCl2N2O3,10mM,Neurological Disease,No Development Reported,COc1cc(/C=C(\C#N)C(=O)Nc2ccc(Cl)cc2Cl)cc(Br)c1O,清洗成功,0.28125
15154,O=c1c(-c2ccc(O)cc2)coc2c([C@@H]3O[C@H](CO[C@@H]4OC[C@@H](O)[C@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)c(O)ccc12,1,0.9807047247886658,0.9807047247886658,OC1=CC=C2C(OC=C(C3=CC=C(O)C=C3)C2=O)=C1[C@@H]([C@@H]([C@@H](O)[C@@H]4O)O)O[C@@H]4CO[C@H](OC[C@@H](O)[C@@H]5O)[C@@H]5O,Puerarin 6''-O-Xyloside,Data.sdf,18021,HY-N2135,,114240-18-5,Apoptosis,Apoptosis,C26H28O13,10mM,Cancer; Inflammation/Immunology,No Development Reported,O=c1c(-c2ccc(O)cc2)coc2c([C@@H]3O[C@H](CO[C@@H]4OC[C@@H](O)[C@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)c(O)ccc12,清洗成功,0.2307692307692307
7176,Cc1sc2c(c1C)C(c1ccc(C#CCN)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2,1,0.9806973934173584,0.9806973934173584,O=C(OC(C)(C)C)C[C@H]1C2=NN=C(C)N2C3=C(C(C)=C(C)S3)C(C4=CC=C(C#CCN)C=C4)=N1,BRD4 degrader-3,Data.sdf,8495,HY-136857,,2413382-30-4,Epigenetic Reader Domain,Epigenetics,C26H29N5O2S,10mM,Cancer,No Development Reported,Cc1sc2c(c1C)C(c1ccc(C#CCN)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2,清洗成功,0.1834862385321101
14220,C/C=C(/C)C(=O)O[C@@H]1[C@H](OC(=O)CC(C)C)c2c(ccc3ccc(=O)oc23)OC1(C)C,1,0.9806953072547913,0.9806953072547913,C/C=C(C)\C(O[C@@H]1[C@H](OC(CC(C)C)=O)C2=C3C(C=CC(O3)=O)=CC=C2OC1(C)C)=O,Praeruptorin C,Data.sdf,16773,HY-N0079,,72463-77-5,Calcium Channel,Membrane Transporter/Ion Channel; Neuronal Signaling,C24H28O7,10mM,Cardiovascular Disease,No Development Reported,C/C=C(/C)C(=O)O[C@@H]1[C@H](OC(=O)CC(C)C)c2c(ccc3ccc(=O)oc23)OC1(C)C,清洗成功,0.1789473684210526
12597,CC[C@H]1NC(=O)[C@@H](NC(=O)c2ncccc2O)[C@@H](C)OC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2CC(=O)[C@H](CS[C@@H]3CN4CCC3CC4)CN2C(=O)[C@H](Cc2ccc(N(C)C)cc2)N(C)C(=O)[C@@H]2CCCN2C1=O,1,0.9806138277053833,0.9806138277053833,O=C([C@](N(C([C@@](CCC1)([H])N1C([C@H](NC2=O)CC)=O)=O)C)([H])CC3=CC=C(N(C)C)C=C3)N(C[C@@H](CS[C@H]4C(CC5)CCN5C4)C6=O)[C@](C6)([H])C(N[C@@H](C7=CC=CC=C7)C(O[C@@H]([C@@H]2NC(C(N=CC=C8)=C8O)=O)C)=O)=O,Quinupristin,Data.sdf,14907,HY-A0162,,120138-50-3,Antibiotic; Bacterial,Anti-infection,C53H67N9O10S,10mM,Infection,Launched,CC[C@H]1NC(=O)[C@@H](NC(=O)c2ncccc2O)[C@@H](C)OC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2CC(=O)[C@H](CS[C@@H]3CN4CCC3CC4)CN2C(=O)[C@H](Cc2ccc(N(C)C)cc2)N(C)C(=O)[C@@H]2CCCN2C1=O,清洗成功,0.1985294117647058
2498,CCCOC(=O)c1cccc(-c2cc(C(=O)Nc3ccncc3F)ccc2CN)c1,1,0.9805731177330017,0.9805731177330017,O=C(C1=CC(C2=CC(C(NC3=C(F)C=NC=C3)=O)=CC=C2CN)=CC=C1)OCCC,Sovesudil,Data.sdf,2931,HY-109191,PHP-201; AMA0076,1333400-14-8,ROCK,Cell Cycle/DNA Damage; Cytoskeleton; Stem Cell/Wnt; TGF-beta/Smad,C23H22FN3O3,10mM,Others,Phase 3,CCCOC(=O)c1cccc(-c2cc(C(=O)Nc3ccncc3F)ccc2CN)c1,清洗成功,0.3294117647058823
2499,CCCOC(=O)c1cccc(-c2cc(C(=O)Nc3ccncc3F)ccc2CN)c1,1,0.9805731177330017,0.9805731177330017,O=C(C1=CC(C2=CC(C(NC3=C(F)C=NC=C3)=O)=CC=C2CN)=CC=C1)OCCC.[H]Cl,Sovesudil (hydrochloride),Data.sdf,2932,HY-109191A,PHP-201 (hydrochloride); AMA0076 (hydrochloride),2984963-50-8,ROCK,Cell Cycle/DNA Damage; Cytoskeleton; Stem Cell/Wnt; TGF-beta/Smad,C23H23ClFN3O3,10mM,Neurological Disease,Phase 3,CCCOC(=O)c1cccc(-c2cc(C(=O)Nc3ccncc3F)ccc2CN)c1,清洗成功,0.3255813953488372
8361,CCc1c2c(nc3ccc(OC(=O)N(C)CCNC)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC,1,0.9805307388305664,0.9805307388305664,CCC1=C2C(C(N3C2)=CC([C@](O)(C(OC4)=O)CC)=C4C3=O)=NC5=CC=C(OC(N(C)CCNC)=O)C=C51.O=C(O)C(F)(F)F,SN-38-CO-DMEDA (TFA),Data.sdf,9863,HY-145767A,,1224601-17-5,Drug Intermediate,Others,C29H31F3N4O8,10mM,Others,No Development Reported,CCc1c2c(nc3ccc(OC(=O)N(C)CCNC)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC,清洗成功,0.1926605504587156
6747,CN1CCN(C(=O)c2cc3cc(Cl)ccc3[nH]2)CC1,1,0.980506420135498,0.980506420135498,O=C(C(N1)=CC2=C1C=CC(Cl)=C2)N3CCN(C)CC3,JNJ-7777120,Data.sdf,8007,HY-13508,,459168-41-3,Histamine Receptor,GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling,C14H16ClN3O,10mM,Inflammation/Immunology,No Development Reported,CN1CCN(C(=O)c2cc3cc(Cl)ccc3[nH]2)CC1,清洗成功,0.3269230769230769
7316,COC(=O)CCNC(=O)C(C)Sc1cc(-n2c(=O)cc(C(F)(F)F)n(C)c2=O)c(F)cc1Cl,1,0.9804995656013489,0.9804995656013489,FC(C(N(C(C=C1C(F)(F)F)=O)C(N1C)=O)=C2)=CC(Cl)=C2SC(C)C(NCCC(OC)=O)=O,Tiafenacil,Data.sdf,8656,HY-137551,,1220411-29-9,Protoporphyrinogen IX oxidase,Metabolic Enzyme/Protease,C19H18ClF4N3O5S,10mM,Others,No Development Reported,COC(=O)CCNC(=O)C(C)Sc1cc(-n2c(=O)cc(C(F)(F)F)n(C)c2=O)c(F)cc1Cl,清洗成功,0.1919191919191919
7285,CCS(=O)(=O)N[C@H]1CCN(C(=O)C(C)(C)O)[C@H]1Cc1cccc(-c2cccc(F)c2)c1F,1,0.9804835915565491,0.9804835915565491,CCS(=O)(N[C@@H]1[C@H](CC2=C(F)C(C3=CC=CC(F)=C3)=CC=C2)N(C(C(C)(O)C)=O)CC1)=O,Suntinorexton,Data.sdf,8621,HY-137452,,2274802-89-8,Orexin Receptor (OX Receptor),GPCR/G Protein; Neuronal Signaling,C23H28F2N2O4S,10mM,Neurological Disease,No Development Reported,CCS(=O)(=O)N[C@H]1CCN(C(=O)C(C)(C)O)[C@H]1Cc1cccc(-c2cccc(F)c2)c1F,清洗成功,0.2911392405063291
7286,CCS(=O)(=O)N[C@@H]1CCN(C(=O)C(C)(C)O)[C@@H]1Cc1cccc(-c2cccc(F)c2)c1F,1,0.9804835915565491,0.9804835915565491,CCS(=O)(N[C@H]1[C@@H](CC2=C(F)C(C3=CC=CC(F)=C3)=CC=C2)N(C(C(C)(O)C)=O)CC1)=O,"(R,R)-Suntinorexton",Data.sdf,8622,HY-137452A,,,Orexin Receptor (OX Receptor),GPCR/G Protein; Neuronal Signaling,C23H28F2N2O4S,10mM,Neurological Disease,No Development Reported,CCS(=O)(=O)N[C@@H]1CCN(C(=O)C(C)(C)O)[C@@H]1Cc1cccc(-c2cccc(F)c2)c1F,清洗成功,0.2911392405063291
6346,CCC[C@H](C)Nc1ncc2c(C3CCN(C(=O)c4cc(C)nc(C)c4)CC3)cn([C@H]3CC[C@H](O)CC3)c2n1,1,0.9803842902183533,0.9803842902183533,O=C(C1=CC(C)=NC(C)=C1)N2CCC(C3=CN([C@H]4CC[C@H](O)CC4)C5=NC(N[C@@H](C)CCC)=NC=C53)CC2,UNC5293,Data.sdf,7510,HY-132200,,2226789-82-6,Anaplastic lymphoma kinase (ALK); FLT3; TAM Receptor,Protein Tyrosine Kinase/RTK,C30H42N6O2,10mM,Cancer,No Development Reported,CCC[C@H](C)Nc1ncc2c(C3CCN(C(=O)c4cc(C)nc(C)c4)CC3)cn([C@H]3CC[C@H](O)CC3)c2n1,清洗成功,0.2574257425742574
14184,CC(=O)O[C@H]1[C@H](OCCc2ccc(O)c(O)c2)O[C@H](CO)[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@@H]1O[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O,1,0.9803726673126221,0.9803726673126221,OC1=CC=C(/C=C/C(O[C@H]2[C@H](O[C@]3([H])O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)[C@@H](OC(C)=O)[C@H](OCCC4=CC=C(O)C(O)=C4)O[C@@H]2CO)=O)C=C1O,2'-Acetylacteoside,Data.sdf,16725,HY-N0026,2'-AA,94492-24-7,Others,Others,C31H38O16,10mM,Others,No Development Reported,CC(=O)O[C@H]1[C@H](OCCc2ccc(O)c(O)c2)O[C@H](CO)[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@@H]1O[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O,清洗成功,0.3444444444444444
6587,O=C(Cn1c(=O)sc2ccc(Cl)cc21)N1CCN(CCO)CC1,1,0.9802953600883484,0.9802953600883484,O=C1SC2=CC=C(Cl)C=C2N1CC(N3CCN(CCO)CC3)=O.Cl,Tiaramide (hydrochloride),Data.sdf,7815,HY-13405,RHC 2592-A,35941-71-0,Histamine Receptor,GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling,C15H19Cl2N3O3S,10mM,Inflammation/Immunology,No Development Reported,O=C(Cn1c(=O)sc2ccc(Cl)cc21)N1CCN(CCO)CC1,清洗成功,0.3098591549295774
5395,CC(C)(C)C(=O)/C(=C/c1cccc([N+](=O)[O-])c1)n1cncn1,1,0.980280339717865,0.980280339717865,O=C(/C(N1N=CN=C1)=C/C2=CC=CC([N+]([O-])=O)=C2)C(C)(C)C,Nexinhib20,Data.sdf,6359,HY-125792,,331949-35-0,Integrin; Ras; Reactive Oxygen Species,Cytoskeleton; GPCR/G Protein; Immunology/Inflammation; MAPK/ERK Pathway; Metabolic Enzyme/Protease; NF-?oB,C15H16N4O3,10mM,Inflammation/Immunology; Cardiovascular Disease,No Development Reported,CC(C)(C)C(=O)/C(=C/c1cccc([N+](=O)[O-])c1)n1cncn1,清洗成功,0.2631578947368421
8919,C=CC(=O)NC1CCN(c2ncc3ncnc(Nc4ccc(Oc5ccc6c(c5)ncn6C)c(C)c4)c3n2)CC1,1,0.9802623987197876,0.9802623987197876,O=C(NC1CCN(CC1)C2=NC=C3N=CN=C(C3=N2)NC4=CC=C(C(C)=C4)OC5=CC(N=CN6C)=C6C=C5)C=C,Zongertinib,Data.sdf,10522,HY-148810,BI 1810631,2728667-27-2,c-Met/HGFR,Protein Tyrosine Kinase/RTK,C29H29N9O2,10mM,Cancer,Phase 3,C=CC(=O)NC1CCN(c2ncc3ncnc(Nc4ccc(Oc5ccc6c(c5)ncn6C)c(C)c4)c3n2)CC1,清洗成功,0.3063063063063063
1041,CCCOc1cc(OCCCCN(C)C)cc(Oc2cc3c(cc2NS(=O)(=O)c2ccc(OC)c(OC)c2)n(C)c(=O)n3C)c1,1,0.9802294969558716,0.9802294969558716,[H]Cl.O=S(C1=CC=C(OC)C(OC)=C1)(NC2=C(OC3=CC(OCCC)=CC(OCCCCN(C)C)=C3)C=C(N4C)C(N(C)C4=O)=C2)=O,IACS-9571 (hydrochloride),Data.sdf,1196,HY-102000B,ASIS-P040 (hydrochloride),2319611-93-1,Epigenetic Reader Domain,Epigenetics,C32H43ClN4O8S,10mM,Cancer,No Development Reported,CCCOc1cc(OCCCCN(C)C)cc(Oc2cc3c(cc2NS(=O)(=O)c2ccc(OC)c(OC)c2)n(C)c(=O)n3C)c1,清洗成功,0.2391304347826087
2056,CN(C)CCc1nnc2cc(-c3ccccc3)c3cc(Cl)ccc3n12,1,0.9802206754684448,0.9802206754684448,CN(C)CCC1=NN=C2N1C3=CC=C(Cl)C=C3C(C4=CC=CC=C4)=C2,PF-9366,Data.sdf,2414,HY-107778,,72882-78-1,Methionine Adenosyltransferase (MAT),Epigenetics; Metabolic Enzyme/Protease,C20H19ClN4,10mM,Cancer,No Development Reported,CN(C)CCc1nnc2cc(-c3ccccc3)c3cc(Cl)ccc3n12,清洗成功,0.2539682539682539
14436,Cc1cc(=O)c2c(O)c3c(cc2o1)OC(C)(C)[C@@H](O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C3,1,0.9801906943321228,0.9801906943321228,CC([C@@H](O[C@]1([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C2)(C)OC3=C2C(O)=C4C(OC(C)=CC4=O)=C3,Sec-O-Glucosylhamaudol,Data.sdf,17074,HY-N0398,,80681-44-3,Opioid Receptor,GPCR/G Protein; Neuronal Signaling,C21H26O10,10mM,Neurological Disease,No Development Reported,Cc1cc(=O)c2c(O)c3c(cc2o1)OC(C)(C)[C@@H](O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C3,清洗成功,0.2941176470588235
12203,COc1ccc(C(OC[C@H]2O[C@@H](n3cnc4c(=O)nc(NC(=O)C(C)C)[nH]c43)[C@H](F)[C@@H]2OP(OCCC#N)N(C(C)C)C(C)C)(c2ccccc2)c2ccc(OC)cc2)cc1,1,0.9801856279373169,0.9801856279373169,COC(C=C1)=CC=C1C(C2=CC=C(C=C2)OC)(C3=CC=CC=C3)OC[C@@H]4[C@@H](OP(N(C(C)C)C(C)C)OCCC#N)[C@@H](F)[C@H](N5C=NC6=C5NC(NC(C(C)C)=O)=NC6=O)O4,DMT-2'Fluoro-DG(IB) Amidite,Data.sdf,14433,HY-45492,2'-F-ibu-dG Phosphoramidite,144089-97-4,Nucleoside Antimetabolite/Analog,Cell Cycle/DNA Damage,C44H53FN7O8P,10mM,Others,No Development Reported,COc1ccc(C(OC[C@H]2O[C@@H](n3cnc4c(=O)nc(NC(=O)C(C)C)[nH]c43)[C@H](F)[C@@H]2OP(OCCC#N)N(C(C)C)C(C)C)(c2ccccc2)c2ccc(OC)cc2)cc1,清洗成功,0.1984126984126984
3944,CC1(C)Oc2cc3oc(=O)ccc3cc2C[C@@H]1OC(=O)/C=C/c1ccc([N+](=O)[O-])cc1,1,0.9801490902900696,0.9801490902900696,O=C(O[C@H]1CC(C=C(C=CC(O2)=O)C2=C3)=C3OC1(C)C)/C=C/C4=CC=C([N+]([O-])=O)C=C4,LKY-047,Data.sdf,4635,HY-117026,,1954681-29-8,Cytochrome P450,Metabolic Enzyme/Protease,C23H19NO7,10mM,Metabolic Disease; Inflammation/Immunology,No Development Reported,CC1(C)Oc2cc3oc(=O)ccc3cc2C[C@@H]1OC(=O)/C=C/c1ccc([N+](=O)[O-])cc1,清洗成功,0.2564102564102564
15028,CC(=O)O[C@H]1C(=O)c2c(O)cc(O)cc2O[C@@H]1c1ccccc1,1,0.9801200032234192,0.9801200032234192,O=C1[C@H](OC(C)=O)[C@@H](C2=CC=CC=C2)OC3=CC(O)=CC(O)=C13,Pinobanksin 3-acetate,Data.sdf,17850,HY-N1854,,52117-69-8,Others,Others,C17H14O6,10mM,Others,No Development Reported,CC(=O)O[C@H]1C(=O)c2c(O)cc(O)cc2O[C@@H]1c1ccccc1,清洗成功,0.3387096774193548
13398,CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn4c3c2SCC4)CC1,1,0.9800864458084106,0.9800864458084106,O=C(C(C1=O)=CN2CCSC3=C(N4CCN(C)CC4)C(F)=CC1=C23)O.[H]Cl,Rufloxacin hydrochloride,Data.sdf,15811,HY-B0902A,MF-934 hydrochloride,106017-08-7,Antibiotic; Bacterial,Anti-infection,C17H19ClFN3O3S,2mM,Infection,Launched,CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn4c3c2SCC4)CC1,清洗成功,0.2716049382716049
3581,C[C@@H](C(N)=O)[C@H](N)c1nc2cc(C(C)(C)C)ccc2[nH]1,1,0.9800047278404236,0.9800047278404236,CC(C)(C)C1=CC=C(NC([C@H]([C@@H](C)C(N)=O)N)=N2)C2=C1,PF-06305591,Data.sdf,4215,HY-114301,,1449473-97-5,Sodium Channel,Membrane Transporter/Ion Channel,C15H22N4O,10mM,Neurological Disease,Phase 1,C[C@@H](C(N)=O)[C@H](N)c1nc2cc(C(C)(C)C)ccc2[nH]1,清洗成功,0.2950819672131147
9230,COC(=O)[C@H](Cc1ccc(O)cc1)NCc1cc2ccccc2nc1SC,1,0.980002760887146,0.980002760887146,OC1=CC=C(C=C1)C[C@@H](C(OC)=O)NCC2=CC3=CC=CC=C3N=C2SC,ATP synthase inhibitor 2,Data.sdf,10885,HY-150983,,2814540-76-4,ATP Synthase; Bacterial,Anti-infection; Membrane Transporter/Ion Channel,C21H22N2O3S,10mM,Infection,No Development Reported,COC(=O)[C@H](Cc1ccc(O)cc1)NCc1cc2ccccc2nc1SC,清洗成功,0.2976190476190476
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,
